From 775a986e089c92ffd8df607da6db04d7bf1d8e98 Mon Sep 17 00:00:00 2001
From: Ambriel Skoeld <ambriel.archangel@icloud.com>
Date: Mon, 15 Jun 2020 11:25:22 +0200
Subject: [PATCH] BuildVersionHistory.plist Index.zip Properties.plist

---
 CSR.txt                                                                   |  119 +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
 License©️And informations.pdf.pages/Data/453481059-small-18.jpeg       | Bin 0 -> 9537 bytes
 License©️And informations.pdf.pages/Index.zip                          | Bin 0 -> 94618 bytes
 License©️And informations.pdf.pages/Metadata/BuildVersionHistory.plist |   10 ++++++++++
 License©️And informations.pdf.pages/Metadata/DocumentIdentifier        |    1 +
 License©️And informations.pdf.pages/Metadata/Properties.plist          | Bin 0 -> 324 bytes
 License©️And informations.pdf.pages/preview-micro.jpg                  | Bin 0 -> 1867 bytes
 License©️And informations.pdf.pages/preview-web.jpg                    | Bin 0 -> 10596 bytes
 License©️And informations.pdf.pages/preview.jpg                        | Bin 0 -> 99349 bytes
 airlink-forte-55610.html                                                  | 2999 +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
 atlassian-developer-terms.html                                            |  227 +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
 dview.dlink.com.html                                                      |  174 ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
 package-summary.html                                                      |  182 ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
 playgrounds.html                                                          |  916 ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
 14 files changed, 4628 insertions(+)
 create mode 100644 CSR.txt
 create mode 100644 License©️And informations.pdf.pages/Data/453481059-small-18.jpeg
 create mode 100644 License©️And informations.pdf.pages/Index.zip
 create mode 100644 License©️And informations.pdf.pages/Metadata/BuildVersionHistory.plist
 create mode 100644 License©️And informations.pdf.pages/Metadata/DocumentIdentifier
 create mode 100644 License©️And informations.pdf.pages/Metadata/Properties.plist
 create mode 100644 License©️And informations.pdf.pages/preview-micro.jpg
 create mode 100644 License©️And informations.pdf.pages/preview-web.jpg
 create mode 100644 License©️And informations.pdf.pages/preview.jpg
 create mode 100644 airlink-forte-55610.html
 create mode 100644 atlassian-developer-terms.html
 create mode 100644 dview.dlink.com.html
 create mode 100644 package-summary.html
 create mode 100644 playgrounds.html

diff --git a/CSR.txt b/CSR.txt
new file mode 100644
index 0000000..43398cc
--- /dev/null
+++ b/CSR.txt
@@ -0,0 +1,119 @@
+PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPCFET0NUWVBFIHBsaXN0IFBV
+QkxJQyAiLS8vQXBwbGUvL0RURCBQTElTVCAxLjAvL0VOIiAiaHR0cDovL3d3dy5hcHBsZS5jb20v
+RFREcy9Qcm9wZXJ0eUxpc3QtMS4wLmR0ZCI+CjxwbGlzdCB2ZXJzaW9uPSIxLjAiPjxkaWN0Pjxr
+ZXk+UHVzaENlcnRTaWduYXR1cmU8L2tleT48c3RyaW5nPgpyeW1yYkErRFh4ODQva284TTBrc2ht
+bUlHUmxyMGxjcTVudytObmZLTUppOWpDNWIzMGNmZ1RMN0NVaDI4RmdkQjY3TVF4RVdjbFdUDQov
+VkU2YXF2UFBQTXZXbWRYdVkrRTUrQ3BoZHY4OTVocm1reGhEM1k4OFNNdUxBenlkSnVsMkNjQ1or
+MkxCSm1ubW1oNytkY0ZJN0FHDQoyWVlNbGhiTGxXM0pYbTFyUmZmYlN1RG9MczA3SVUwM01ZMlNr
+cVBudkt5dnIwV2dERFZ1bE1MNEhHU3pTTlR0N1h2M20rRmdnOSthDQppVXJZejJMZXE4ZUxnYmdT
+VHJxOXNSN2hlb3k2YjIxQ05veW1oc2x0SUpkbHF4OXI1a3A0NUhDTGw0cHcrVE5UaEpQT01QZXhn
+MUVTDQpKd1NPK1ZxM3MycDYvMUZlaHUwalJYOTc1clh2MTJaV3Q1aWlCZz09DQo8L3N0cmluZz48
+a2V5PlB1c2hDZXJ0UmVxdWVzdENTUjwva2V5PjxzdHJpbmc+Ck1JSUNuRENDQVlRQ0FRQXdXVEVl
+TUJ3R0NnbVNKb21UOGl4a0FRRU1Ea05PUFVwaGRHbHVJRTFoYkdsck1Rc3dDUVlEVlFRR0V3SkoN
+ClRqRXFNQ2dHQ1NxR1NJYjNEUUVKQVJZYmFtRjBhVzR1YldGc2FXc2dLR0YwS1NCcGJpNXBZbTB1
+WTI5dE1JSUJJakFOQmdrcWhraUcNCjl3MEJBUUVGQUFPQ0FROEFNSUlCQ2dLQ0FRRUFnS1ArNnI2
+ZlR1OWxGN1BHQVdYMDFzalFCNTB1NGprNjlhc1E4RDEwUWZtS21vL0YNCm5Hb0NTYnltYkZra0dO
+U003bXZXOG5hcFQzY2xDZzFtMjUrNDVtN1lnaGtucHdXemR3dlpNM2lraGh0U0tkNVR2a25wWVpr
+QWdIaFoNClBoeWwvOS80aUcxaTVFL0w1YzQ0ZTZXM2dycUx0eDl6MWk0bm9CV3ptMXNCbXU2SzJR
+bUNBYjdqbFVSVXYxdTgyZ3h3clNXeVlWQlANCjdVQzZtWmtNbVFQMHdBa0I3YzhMSllBVDFmV3NF
+MVdDYWdVbDF6VXNVVUVVZ3NQc2FCZDUxSkVCazJOT2FRREdFTytGMXdUQXRmWkENCnp5TjZmUUVa
+ODZpZXhrT2NaNWppc1QzYTcya0VBQlJXczNVVFJxRldYME1RUHhtZmZrbmRJTW5FU2V0RG1NYUpP
+UUlEQVFBQk1BMEcNCkNTcUdTSWIzRFFFQkJRVUFBNElCQVFCQnlPUE1OVFlxNnVMK0ZGbTJld1BI
+RWZ1M1ZWdFo5S005ZFhwOVQ2cmdHdEEvdFViMXpJZWQNCmFTZGdJeEppSGNuUXpzT1FyeHNxa1l3
+ZVZ5RzE2U3FUM1VydXhOUXVIazRRUWZmYVVSaW1QVnMzMy9QckU2YnpiVFJLWituU2NtZzQNClJ1
+WDNNdzh2UG8zTlhKSU9JVGkrcFhMTFd4b1hKb1hWTWJyd0JDTkNlQTQ3K2RpQ0M2bko1QkY1bFVI
+YTlSdmtOOThZYkg3aThEbTINCmpSNnpVYURMam80bjhXNjdtWXg1RS9adXlRczNWT1gxLzF3ckls
+bXZJL2FyMnFma2xLa1NMNmNBRy9CblpBbzVQR04zMVRUQ2FxbEoNCjRnWUZnOGhaRnNrZ3BQc29l
+UldGbThYcUtDWUhVK0VhWlU0VmtUY05ZeFVzODdnSXBYMFhySzhwY00yZQ0KPC9zdHJpbmc+PGtl
+eT5QdXNoQ2VydENlcnRpZmljYXRlQ2hhaW48L2tleT48c3RyaW5nPgotLS0tLUJFR0lOIENFUlRJ
+RklDQVRFLS0tLS0KTUlJRmdUQ0NCR21nQXdJQkFnSUlYbTlDNE92T2VZb3dEUVlKS29aSWh2Y05B
+UUVGQlFBd2daWXhDekFKQmdOVgpCQVlUQWxWVE1STXdFUVlEVlFRS0RBcEJjSEJzWlNCSmJtTXVN
+U3d3S2dZRFZRUUxEQ05CY0hCc1pTQlhiM0pzClpIZHBaR1VnUkdWMlpXeHZjR1Z5SUZKbGJHRjBh
+Vzl1Y3pGRU1FSUdBMVVFQXd3N1FYQndiR1VnVjI5eWJHUjMKYVdSbElFUmxkbVZzYjNCbGNpQlNa
+V3hoZEdsdmJuTWdRMlZ5ZEdsbWFXTmhkR2x2YmlCQmRYUm9iM0pwZEhrdwpIaGNOTVRreE1USTVN
+RFl5TlRVeFdoY05NakF4TVRJNE1EWXlOVFV4V2pDQmtERWFNQmdHQ2dtU0pvbVQ4aXhrCkFRRU1D
+a3RPVkRRNE9VZFJVRFl4TFRBckJnTlZCQU1NSkUxRVRTQldaVzVrYjNJNklFWnBZbVZ5YkdsdWF5
+QkQKYjIxdGRXNXBZMkYwYVc5dWN6RVRNQkVHQTFVRUN3d0tTMDVVTkRnNVIxRlFOakVoTUI4R0Ex
+VUVDZ3dZUm1saQpaWEpzYVc1cklFTnZiVzExYm1sallYUnBiMjV6TVFzd0NRWURWUVFHRXdKVlV6
+Q0NBU0l3RFFZSktvWklodmNOCkFRRUJCUUFEZ2dFUEFEQ0NBUW9DZ2dFQkFNZWJuZWZZeGpLMSti
+K051WTRBRkVJUW1IYUd6NExyUzgzUEVublYKc2ZmeE9zdHFGRHg4SmZvbmxWOGpiLy9ObW1kWHA1
+QUtGVGFyMzlaaWVMc2RjQmZBdWQvZUgzUG9wS0NtSE5mVQpRL0VwQXdwWWtqc05ZSERoT09XMm9z
+U0VaSkNTclIzVWhPdEY3QUMxYU9NY2VJUGJwaGRCeDFkQlpzQUx2SGFQCkNXY2tGR2twSzF2VzdS
+dUNUS0dPUnpjRVpUaG4weUt1STRQNmd3NHZKTUJweG1yVmJQdnF6bkk0aENHejRUSjQKb3JObzVG
+M2F1Zk43Qis4Rkw3SUFDYVljVWtRQXZ2cngwZWhsd1ZobTZuNkdMMkxpYis2SS9qa0ZaWjdHaHkv
+TwpuZUphVW5yVmxwYStzT2NXZlBkR0pOcmRKUHRPRTlXdUNQOTJIRC8zSExvMk5ja0NBd0VBQWFP
+Q0FkVXdnZ0hSCk1Bd0dBMVVkRXdFQi93UUNNQUF3SHdZRFZSMGpCQmd3Rm9BVWlDY1hDYW0yR0dD
+TDdPdTY5a2RaeFZKVW83Y3cKZ2dFUEJnTlZIU0FFZ2dFR01JSUJBakNCL3dZSktvWklodmRqWkFV
+Qk1JSHhNSUhEQmdnckJnRUZCUWNDQWpDQgp0Z3lCczFKbGJHbGhibU5sSUc5dUlIUm9hWE1nWTJW
+eWRHbG1hV05oZEdVZ1lua2dZVzU1SUhCaGNuUjVJR0Z6CmMzVnRaWE1nWVdOalpYQjBZVzVqWlNC
+dlppQjBhR1VnZEdobGJpQmhjSEJzYVdOaFlteGxJSE4wWVc1a1lYSmsKSUhSbGNtMXpJR0Z1WkNC
+amIyNWthWFJwYjI1eklHOW1JSFZ6WlN3Z1kyVnlkR2xtYVdOaGRHVWdjRzlzYVdONQpJR0Z1WkNC
+alpYSjBhV1pwWTJGMGFXOXVJSEJ5WVdOMGFXTmxJSE4wWVhSbGJXVnVkSE11TUNrR0NDc0dBUVVG
+CkJ3SUJGaDFvZEhSd09pOHZkM2QzTG1Gd2NHeGxMbU52YlM5aGNIQnNaV05oTHpCTkJnTlZIUjhF
+UmpCRU1FS2cKUUtBK2hqeG9kSFJ3T2k4dlpHVjJaV3h2Y0dWeUxtRndjR3hsTG1OdmJTOWpaWEow
+YVdacFkyRjBhVzl1WVhWMAphRzl5YVhSNUwzZDNaSEpqWVM1amNtd3dIUVlEVlIwT0JCWUVGUGJG
+ZjdFNWp0VjFFWloxczQwT1hPaHlxUmZTCk1BNEdBMVVkRHdFQi93UUVBd0lIZ0RBUEJna3Foa2lH
+OTJOa0JBd0VBZ1VBTUEwR0NTcUdTSWIzRFFFQkJRVUEKQTRJQkFRQXpkVzZYM25aTWZzRW9sWk41
+ckN2S0FSbm1uZHIwYWpQbjZkQzIwdGxMQ1o3OGVuUzFFbFluZ1JLWAoxSGgvTEJsTUdGYitCSmdL
+QkJ5aXVQS3dIN3l4WVRrcEdjVTVVQzVXSWN6dFZQVG1FeHpoSzAvM1IvMTVZWTUyCi80K1FERlFM
+RmVaMW5Jcmw3NlFzelpodmxKR0M0V2NnMDlQUWo1WmNkeWsyYWVVK0RrUjREUW81M0IwOSswaXIK
+N3RkbmpuM1hFaGVPS2Zoemx1R3RMUllydlRlalh0T1dQN0VHTFlEcDBtSE8xVGRjemsxU2lyekVI
+YmlmV1RaLwo3dFJLMnB5ZzVsWHpRNWFvejNVTFpLNW1VZ1JQTGlJUmFlRTNFYndtcXJkNzlacmp3
+UjJWdC90d0ltZHRMckVqCnkxMFc4V2FrZ2JOYUJRRmhqQTIxa3VWZ00zd3AKLS0tLS1FTkQgQ0VS
+VElGSUNBVEUtLS0tLQotLS0tLUJFR0lOIENFUlRJRklDQVRFLS0tLS0KTUlJRUlqQ0NBd3FnQXdJ
+QkFnSUlBZDY4eERsdG9CQXdEUVlKS29aSWh2Y05BUUVGQlFBd1lqRUxNQWtHQTFVRQpCaE1DVlZN
+eEV6QVJCZ05WQkFvVENrRndjR3hsSUVsdVl5NHhKakFrQmdOVkJBc1RIVUZ3Y0d4bElFTmxjblJw
+ClptbGpZWFJwYjI0Z1FYVjBhRzl5YVhSNU1SWXdGQVlEVlFRREV3MUJjSEJzWlNCU2IyOTBJRU5C
+TUI0WERURXoKTURJd056SXhORGcwTjFvWERUSXpNREl3TnpJeE5EZzBOMW93Z1pZeEN6QUpCZ05W
+QkFZVEFsVlRNUk13RVFZRApWUVFLREFwQmNIQnNaU0JKYm1NdU1Td3dLZ1lEVlFRTERDTkJjSEJz
+WlNCWGIzSnNaSGRwWkdVZ1JHVjJaV3h2CmNHVnlJRkpsYkdGMGFXOXVjekZFTUVJR0ExVUVBd3c3
+UVhCd2JHVWdWMjl5YkdSM2FXUmxJRVJsZG1Wc2IzQmwKY2lCU1pXeGhkR2x2Ym5NZ1EyVnlkR2xt
+YVdOaGRHbHZiaUJCZFhSb2IzSnBkSGt3Z2dFaU1BMEdDU3FHU0liMwpEUUVCQVFVQUE0SUJEd0F3
+Z2dFS0FvSUJBUURLT0ZTbXkxYXF5Q1E1U09tTTd1eGZ1SDhta2J3MFUzck9mR09BCllYZGtYcVVI
+STdZNS9sQXRGVlpZY0MxK3hHN0JTb1UrTC9EZWhCcWhWOG12ZXhqL2F2b1ZFa2tWQ0Jtc3F0c3EK
+TXUyV1kyaFNGVDJNaXV5L2F4aVY0QU9zQVgyWEJXZk9Eb1dWTjJydENiYXVaODFSWkovR1hORzhW
+MjVuTllCMgpOcVNIZ1c0NGo5Z3JGVTU3SmRoYXYwNkR3WTNTazlVYWNiVmduSjB6VGxYNUVsZ01o
+cmdXRGNIbGQwV05VRWk2Ckt5M2tsSVhoNk1TZHhtaWxzS1A4WjM1d3VnSlpTM2RDa1RtNTljM2hU
+Ty9BTzBpTXB1VWhYZjFxYXJ1bkZqVmcKMHVhdDgwWXB5ZWpEaStsNXdHcGhaeFd5OFAzbGFMeGlY
+MjdQbWQzdkcyUCtrbVdyQWdNQkFBR2pnYVl3Z2FNdwpIUVlEVlIwT0JCWUVGSWduRndtcHRoaGdp
+K3pydXZaSFdjVlNWS08zTUE4R0ExVWRFd0VCL3dRRk1BTUJBZjh3Ckh3WURWUjBqQkJnd0ZvQVVL
+OUJwUjVSMkNmNzBhNDB1UUtiM1IwMS9DRjR3TGdZRFZSMGZCQ2N3SlRBam9DR2cKSDRZZGFIUjBj
+RG92TDJOeWJDNWhjSEJzWlM1amIyMHZjbTl2ZEM1amNtd3dEZ1lEVlIwUEFRSC9CQVFEQWdHRwpN
+QkFHQ2lxR1NJYjNZMlFHQWdFRUFnVUFNQTBHQ1NxR1NJYjNEUUVCQlFVQUE0SUJBUUJQeis5WnZp
+ejFzbXd2CmorNFRoekxvQlRXb2JvdDl5V2tNdWRrWHZIY3MxR2ZpL1pwdE9sbGMzNE1CdmJLdUtt
+RnlzYS9OdzBVd2o2T0QKRGM0ZFI3VHhrNHFqZEp1a3c1aHloenMrcjBVTGtsUzVNcnVRR0ZOckNr
+NFF0dGtkVUd3aGdBcUpUbGVNYTFzOApQYWI5M3ZjTkl4MExTaWFIUDdxUmtreWtHUklaYlZmMWVs
+aUhlMmlLNUlhTVN1dmlTUlNxcGQxVkFLbXV1MHN3CnJ1R2dzYndwZ09ZSmQrVytOS0lCeW4vYzRn
+cm1PN2k3N0xwaWxmTUZZMEdDelE4N0hVeVZwTnVyK2NtVjZVL2sKVGVjbW1ZSHB2UG0wS2RJQmVt
+YmhMb3oySVlyRitIamhnYTYvMDVDZHFhM3pyLzA0R3Babk1CeFJwVnpzY1lxQwp0R3dQREJVZgot
+LS0tLUVORCBDRVJUSUZJQ0FURS0tLS0tCi0tLS0tQkVHSU4gQ0VSVElGSUNBVEUtLS0tLQpNSUlF
+dXpDQ0E2T2dBd0lCQWdJQkFqQU5CZ2txaGtpRzl3MEJBUVVGQURCaU1Rc3dDUVlEVlFRR0V3SlZV
+ekVUCk1CRUdBMVVFQ2hNS1FYQndiR1VnU1c1akxqRW1NQ1FHQTFVRUN4TWRRWEJ3YkdVZ1EyVnlk
+R2xtYVdOaGRHbHYKYmlCQmRYUm9iM0pwZEhreEZqQVVCZ05WQkFNVERVRndjR3hsSUZKdmIzUWdR
+MEV3SGhjTk1EWXdOREkxTWpFMApNRE0yV2hjTk16VXdNakE1TWpFME1ETTJXakJpTVFzd0NRWURW
+UVFHRXdKVlV6RVRNQkVHQTFVRUNoTUtRWEJ3CmJHVWdTVzVqTGpFbU1DUUdBMVVFQ3hNZFFYQndi
+R1VnUTJWeWRHbG1hV05oZEdsdmJpQkJkWFJvYjNKcGRIa3gKRmpBVUJnTlZCQU1URFVGd2NHeGxJ
+Rkp2YjNRZ1EwRXdnZ0VpTUEwR0NTcUdTSWIzRFFFQkFRVUFBNElCRHdBdwpnZ0VLQW9JQkFRRGtr
+YWtKSDVIYkhrZFE2d1h0WG5tRUxlczJvbGRNVmV5TEdZbmUrVXRzOVFlcklqQUM2QmcrCitGQUow
+MzlCcUpqNTBjcG1uQ1JyRWRDanUrUWJLc01mbFo1NkRLUkhpMXZVRmpjenk4UVBUYzRVYWRISkdY
+TDEKWFE3VmYxK2I4aVVEdWxXUFRWME44V1ExSXhWTEZWa2RzNVQzOXB5ZXoxQzZ3VmhRWjQ4SXRD
+RDN5NndzSUc5dwp0ajhCTUl5M1E4OFBuVDN6SzBrb0dzait6clc1RHRsZUhOYkxQYlU2cmZRUERn
+Q1NDN0VoRmk1MDFUd04yMklXCnE2Tnhra2RUVmNHdkwwR3orUHZqY00zbW8weEZmaDlNYTFDV1FZ
+bkVkR0lMRUlOQmh6T0tnYkV3V094YUJES00KYUxPUEhkNWxjLzluWG1XOFNkaDJuek1VWmFGM2xN
+a3RBZ01CQUFHamdnRjZNSUlCZGpBT0JnTlZIUThCQWY4RQpCQU1DQVFZd0R3WURWUjBUQVFIL0JB
+VXdBd0VCL3pBZEJnTlZIUTRFRmdRVUs5QnBSNVIyQ2Y3MGE0MHVRS2IzClIwMS9DRjR3SHdZRFZS
+MGpCQmd3Rm9BVUs5QnBSNVIyQ2Y3MGE0MHVRS2IzUjAxL0NGNHdnZ0VSQmdOVkhTQUUKZ2dFSU1J
+SUJCRENDQVFBR0NTcUdTSWIzWTJRRkFUQ0I4akFxQmdnckJnRUZCUWNDQVJZZWFIUjBjSE02THk5
+MwpkM2N1WVhCd2JHVXVZMjl0TDJGd2NHeGxZMkV2TUlIREJnZ3JCZ0VGQlFjQ0FqQ0J0aHFCczFK
+bGJHbGhibU5sCklHOXVJSFJvYVhNZ1kyVnlkR2xtYVdOaGRHVWdZbmtnWVc1NUlIQmhjblI1SUdG
+emMzVnRaWE1nWVdOalpYQjAKWVc1alpTQnZaaUIwYUdVZ2RHaGxiaUJoY0hCc2FXTmhZbXhsSUhO
+MFlXNWtZWEprSUhSbGNtMXpJR0Z1WkNCagpiMjVrYVhScGIyNXpJRzltSUhWelpTd2dZMlZ5ZEds
+bWFXTmhkR1VnY0c5c2FXTjVJR0Z1WkNCalpYSjBhV1pwClkyRjBhVzl1SUhCeVlXTjBhV05sSUhO
+MFlYUmxiV1Z1ZEhNdU1BMEdDU3FHU0liM0RRRUJCUVVBQTRJQkFRQmMKTnBsTUxYaTM3WXliM1BO
+M20vSjIwbmN3VDhFZmhZT0ZHNWs5UnpmeXFadEFqaXpVc1pBUzJMNzBjNXZ1MG1RUAp5M2xQTk5p
+aVB2bDQvMnZJQit4OU9ZT0xVeURUT01TeHY1cFBDbXYvSy94WnB3VUpmQmRBVmhFZWROTzNpeU03
+ClI2UFZieVRpNjlHM2NOOFBSZUVueXZGdGVPM250UmNYcU54K0lqWEtKZFhaRDlacjFLSWtJeEgz
+b2F5UGM0RmcKeGh0YkNTK1NzdmhFU1BCZ09KNFY5VDBtWnlDS00ycjNEWUxQM3V1akwvbFRhbHRr
+d0dNemQvYzZCeXhXNjlvUApJUTdhdW5NWlQ3WFpObi9CaDFYWnA1bTVNa0w3Mk5WeG5uNmhVcmNi
+dlpOQ0pCSXF4dzhkdGsyY1htUElTNEFYClVLcUsxZHJrL05BSkJ6ZXdkWFVoCi0tLS0tRU5EIENF
+UlRJRklDQVRFLS0tLS0KPC9zdHJpbmc+PC9kaWN0PjwvcGxpc3Q+Cg==
diff --git "a/License\302\251\357\270\217And informations.pdf.pages/Data/453481059-small-18.jpeg" "b/License\302\251\357\270\217And informations.pdf.pages/Data/453481059-small-18.jpeg"
new file mode 100644
index 0000000000000000000000000000000000000000..6b705443d304a125dd2fddf143ede97c41f4fd44
GIT binary patch
literal 9537
zc$}Sg2UJtfx9$l6LNinaBorkGQj|_WN{}C2q=OWdCRKU|>4Jht300&70YRin=%647
z0Tqzm1SIrM=ru3;yZ^TCUF*I3zLUMqw`S%{_IGBVJ$neFgc*QNLq%N$0D%BNjd%fs
zUjS0s&%qV|w6p+z001Ze&@%^sl*ouffXl#dkf2Ha*;0%K|AT}6bQ0D9gpR$dm#e3}
zs~eZt4PgLrTV0Ek^iSvCoaYav8)T0iiw8cCE{9U4uN~eFCd`tEt1Brz)X~#cQNN@7
z$0-uHrJLL1-w!*xczNil-sZYzV#)=X2B-iiaDnI@!qVE)O;JbZ&hIJzasN;35C84j
zfY9%`^cA7+j=ztc7=QDMdb!!A@ZZP(2dHcwd0G?ir$qC$cJuHe>LeP#?d#?Co2L^w
zlLyf$A}{&P?f&L1zq!@leDKd013e`oU;3@w+TPNJ$PbBJ(CXjX?f#Ab*Z=+oyS|o=
zfijn#4wtx?h>)m|sIagU*I!ENTzooW*Z(j6|F7Zo$nUp4K*`n3-^0Pq-iu3-_|_hA
zsk>O;5abdS7Lfpe-)r#q=y}q=-|ep9zuKO71Aq(#fk62BuQolRrs`1upr-#<8?Qf6
zCXr)x+$=pT|LFk9s|-(DG0{I9#IOJWl$!*?ejETmWr%BuB@j*x2!wOud>}Ibn4BiG
z0Q3|@ABw@Cs{jc-2uu$mv;&;PZZgmx{9|4a37C|O96~`!MNJ$~O$U&Gz+e(mFd5nJ
z-~<H``vFpVGKMQ6isX#CmXNFNOrl|lxfI;DD_bw>{n&zwS$Tw0Qe9$ZVZF?AjhF8_
zzqo{?6hc}?=`Up!RW)@DeFH-yW1>83n@6^G_70AoUfw>we*OUwPa~tAJ&%q-B_*e%
zrlr5ic$1f3@V2n%UGax1Om$6dU46snw)QU_o!GAK{(-@v;gQj?@n5sJx%q{~rR9}v
z{Lb#){=wnV@o!xq01WyE{zqN(L|r7Lq+n9WZ(Se~-`@l1Ny)B=kTWRiLM+`GuZo6I
zFx^hft!$;_7Sr3hXyx&P>JnW17ti)@X@8XczX=Qf|5El(VgJ%K0Vo0Fe?Ue2L8+*y
zpbStV7?>G;gBiyB2eALb)j#0<4Z(ln_aq<)1VT+k%}7PXc!TpY=Z*h02tSF*jG8bG
z(11b2U;@(v3IN`|H4(vbwR+7U#S(!-?;jNRwNva|o$=+!IdfdH4CkqmVpgK)BqabJ
z>aZM(;vksO7ERCGSthhFoB*uFdlG<=k~7<mO#}Smi^r0E;f-dIkdrZX&jh*m@&v#%
z$ta{sB^&|jV0tpjai0D2WW?Rt&fS@Wb)z<wiw~F)xGuYxE1wMNvG>6y$-j7iGdYdL
zyzUq0;lsZ8WmBB$hppyuxpwmHIiqpaV+^+}ug_x-v4P3qja+|c8$J6O#_w039@VRD
z0q}z^b_mYo^5b&eSJr+Xy|iN)57Ib)%EcGv?xQaRva311CtsEZ$~sy|bGF%!?N$w{
z&k*U9wYS|FDVZBpnmwnz>~_D~@x&iHP54LRpR{`)`IaLd`?%C|)Rz^=_gg&^rNt<t
z*cxvlr*MaA>jSxHT8aiyvu>SCTtblIvW@_r)>UKUiBdkxf@b;~5@u2^_UH3yTRo~Z
z0!bFYcr)$YL6Gjn_;0EjnBv$xF7Vx`zgB*#T5D|N;uWqSN!nPssWstj{<>irANZud
zXu(&jTup(m)+oruT+5(qIo|ApFqU4f1NPSAVNY!RjKQNZbxR~$_LYoroT1n_&ZaVN
zOJqlQQT}MvgeOX5SywDp#eIjqcfnmlN~Bj2$w0&5ZUnG-#+0x@U_%v=Be8vCwmO0O
zPZ|PSulbP|p7*|P1cIO*3K{^RZ)aUNEOgRYK`P{Nu*A~w+pNOL(J$bcTdF7)7fM!H
zNjY`S^2HWEA24^c?L7Qz?FX(dS)*CUgUenIof?y#q;d0Q+Bv{o6*l4`MwXFGm>k*(
z><GjCD{;<k-M~!blKLHwpj#)#=w8Vr^q9(hZmD3C&-2lf{$$VILPM}cUO%<9<zfD7
z1H9ir(Xen~byB=`NPqo(4f~B7Y`%i|p?CdBPxg0@`+)r!PK9q@zfD;OCQX%0+?E|m
zQIo|(Ogm5Xj;t6@c_YsFH_~pYx;OnwiN6{uq-6~^{nGsN)1+_PyEXML#IEb2scCqZ
za5VY|ZUT!~9#F`#b2Mg9tj=?J7ErNKcses&5c|&maa!1uj-{~`+D}Idq1UC7f*2hd
z;x}sXAD{+m@~iX{eJ7W9URo>HVLZ7z3|#m}msmoS9;6g0dX?7Qgj5?-9I(A<(DS{9
zIOmd~^?+yqcz9&=q<mCq5K6TyYEiQ~#*@ycWl60QQaG<WF(J%z&!fpURQOTNsIa!g
z{Wn(vGuFBLvpoVqtJ<$s|GNLpa~BOI6M6yje)q8>-@{37R{Ty!^I;bOST&@*X5l8y
zkqo+0Q*FY=eG3483_4E%wcgU@AB?_|9NG*(R#iHHIjhj?&h9^u?=|pbGyRg&*kG?c
zh>J3yxOk_u?va~^cK;i(JDr|l4F0l1?{sEV&o+oH__HD~;YU~0_yvWwG%32+uYC8S
z7Y`ioE^>s@L8TWZ+Vi6WZ@zZZ=uB(`Cp3q0PIVq;EHSp%9$bD6*L#jZAL4&99VJHe
zY>4{OKJi*3^I#s?$N!YA;peW^$6wvmUCo|5P#9nW)k~Z<@zhOFoxZ1(1_hm|Z#Y%=
zuRHIZkk?J0Y>C9Jr~nuC*eP%$&HjRE{;li*BdTv4lgvKuCA{mPt&=MPqn*4|><jeR
z@6rzHV-7zB>$p)Ct}y?FtrcuJ%G{FKHlcT<y@>T@S(HX!aMm*X^dsq3lm-FNJtP1M
zrOt;z=U-SE>2#k7tP&GjnbiuC>b{3zoD}D#_f^cLT^3&zX>Lf|E@*Iax)mO*&zRtc
zL-E&TFh7-)-z<lXu)2Hg7ma)wB*i8uAkH`YII@Q#c;mQOt+v-)o`V_kIUnqTmebrF
z4&Hq<poaVL)~HsN$sd+Bm3lH%JiEeVo#_J~;W(GneBWF~p{mQ$0)VqAd$e4YioOeK
zJKy{UvmgK(KrKg^VvCDN?Bz=L5O}5YUC)7w-z8FY>P}{khxcAq#7t_mpl<1q3$;Td
zo<t-mH+1;9P^>seNY7`k>mbRiEb36)5!eGJP+9Q{Phro4iTU2zfX7>aXx%#{%H(bX
zyeO@X$cQ}V1IC&8YfifkIcsb^;48;})?}-IQpOhl5H{)9G+l9L3A-Wh+_H@cE|f#=
zZX#j3OUBSPwnleDr>Y>)o)tvKkh&<jEzbw0Ey>+A|6^n51kRf69Zeyrbsd_P(2ozg
ztK#L&@)dv2tMkn<)t8zUHWs7xNoBut#(RMjX-<3WB2%H)Qkh=*mX~w)7t}H^;<tD6
zcbLDy&b@0%De}HQh$t^70L7s<mk;{X8BHHDCWyXV4m&N*AE9@lkGg*rCYw{BwnaJN
z2HP#k($>mY`M!>OEOYubelDm8tmo|0(KDqPIA**6rhv|}jerr{Q}yr5FCSU7Szelv
zxrI`I(HN61EzQG8g%MoG1NLBzRpY^%O!@s;FNaitGxw40k`)b8K%oCr+Apo5qdaRF
zukcZZ{?ItX=;I5&{aUk&6+B1UBh^5l+{g5hw5N($O}1|vs_RrPRiKc#c+-ylJ?0NQ
z?Rg8I_ed9a%DUUtg~c)%Bc=-pz=Kc(`|a+9u}~}jgOcfMGbsR0ey_Pq%M+fT>;c+U
z=&vx<Qy~K!T4;}(r$V=<n_bMtI#!rjzk8-4)2ug~-d881AJ~(yVrVK7XlRBuuNYl@
z_9l~RT5qTAxlR?#0;=VCz`vC5CEZF)6=W$bm^x|F_Tb}pt=ze-d!4^b7u(dOcT$hr
zpB;rcFp2caMquTuzlkMKl$^Dl#sGwYSy%2jGhIOw?<K!Esa$a3-n#kI#F;q{IWiv|
z4XWroS#N;>@rm#90_h*e9DO-_V?AWNJ4aYIr$P}X=US*R{PFRblU4tw4}yaj&u?ZR
z_OF6(`!kK)bmroE(ge68+3z=DIZ53$y-M=yU`CHh$LvUPVWz%mjm|O3-=4ZXD+_84
z&awwbjbI2s^<T$NEe-P!h;ttBQOvAU?yzfmmC1Vs&y!xHs^wYGYBriAh7V1Wq7J!=
ziUF3H4W4xyj<@0|msA30F+!)BLQ%op6qA698||R+Wif4OG_=N*&Rk0>hlO%E6Q#f*
zAh%~WjZiC-x&+xM6U(_{besHYX)C3}EJuk#7T~-8!SV&;;6ekNgMMtr;@a)!wJ<vg
z_c#+(PGaZwePx)&(x_#R;ul-T%c#jD*+QO%?53FcFUt?6?-s@+_mpyS(e#mOdBiSe
zlzz-&5@xMcBkGe@h;-Tb(MdHtx?caNNACOq21FRdBV4k7K8MVgV!frE@0lZmUIm29
zUGNA^JK`wgPKjq-MqUnxeDg3O<ZU>u@rwrBJC30g*z17>Q1bqo<9u~jlyZj104v8(
z@GQbrB#5Ns?)nb8<+e8R;~|>Hi`IT3S6ZE%90|7zr`?r^E?b%BTub1b;-#6{l|vlt
zi92Pq#OT{uso5YLq*>%XZ_y5(8+J0Ncg<x0d~ag@X*v!^MayGoYF&<$Qj3>DgZ53C
zbHOB)c@m8Ul_pJdD-rQlT7WP8m?o8rdo4J}vEqeGcW<T-tL(7Ir@EwoD#mPnh%K41
zEbW3l*vEc-1h|ZO!N{e1Xe_s2L$xW(>twUevypc-U+22(Yj}<xu!3Ahk-H;dC(pNT
z`;>(HOXMZrN|lXV1U2Alg3g>29FK_+JG7&~Fj`%@mL{@}&y24h@R7!W%MoP`941Qs
zPu5u_1`eZ6Wo-w2C$dlDv~d}@*#vI>s~dv;EnTg+7+_OY`q#1q^{rC91?8IBP!5}w
z(fJy1Y~u3tPPx>l;YG6u_7}5EaGFq$kmfT;wbvBSknO-O7V|VK!x-|N^%r^Y(!rW`
za75fkrwjn)P>`)8_|0VEo!p8H-`}D6Zw8?m(R|Y(`^xUgmfvw$=ZdmtjI!%^ZQA4X
z-f!v((Jki&pi;I9>EOV@m)zEg8;&LV(Dc<~(7A+N4|frol1^>Tdf-}Zwpn}SiMT)2
z+^rPEyc@t>$KF{k5l_|<{a3qZPD0>bZ=d1eBm1o-=nl45DSH=0CyKw9wJ6Q9tn2KF
z{qEA`{5bK8faG$zi+u-D|9tuo+I%*)znnC;1INXu-hs*iOMGC$F#fyam?^D1$z}LN
zrnd@r!p{@$W%JCD3x#j6Yz#P$_>G9ZGi}|Y5vTk~Ww5r~fE6NYK`9Q2gB>qk#5%g0
zI*EPtc6{@*OK3g<Z(YIhZ1-3P!VQlXcm;=7u4swoz+D;B=g97PlfOceG3ov{qq^XG
z*~Vx*MwRL2{0DT8ANcE?oc0}a;n@;JPoc)m$QYEcTR^<hI+A@<{z<s9wqPa=lz5;-
zoN1TZo0_;7)z^0`a!$EEEPTgXVBv7Q%do*r0Ju3cp--VLKD_v{59eEVqlH>Eopg#@
zDSP~IXA7M(d?aS~udW=0V5}nZAFoFvK^IlGIXX|1HeCW0)`}RE*kt<|p0u5pgfwVR
z$)Cwrj~s>=RcAAu=v;7i5l+SBh16bQ4@xU6<&E*ql3y6Qk{}-WoQn&*RD2gnOc!pt
zf>o*XH{3+mv=vv>iyKRBO~#(Fo${fMG}K+ivkee57B8~eIY4{d#BcB3HMELe$L+$x
z?#1}ep$deNE!P`f0}Gk;Nj>9Gs5@qE@uQ59X;r(gO2A&J%_qsvh*S~5hhoX@@y(qq
z$A(D-ogtKUl_&`h|61Flj*!N)Uu(ZB$CqA(y0s2AEg5vVZop)-bmvFuJ&7J;e}`XR
zC!(1q%uUnISMM-o?(>f-JP?p-&t^|kZA`qRHa`}AZqjwXO*WzzhlG{>56ku2$lZ<g
zOn7ZfSZXHux_Th!VuQmj{X`_ElClLSvbMPbTmSS5iq7rYUn_;|+sh*bo*%C^#LV_{
z+pEoGmb3O&E)*Z?w@2O-TrY!DLpReGYM;2f+BpYLTevxI^i7gI@WJMjgW17uLDAx%
zMQp$7rBN%Y`7|e#Sc~+rXIu)U*)Y!w#_Zs|2jRo}Mkc{Mc>bN2r4dIVFSX8Il+}K-
z4EA3p0K>%Uq;Ko`?Aa3FR+RVlR!Fv^PywZEZ1BTUuYeZ&GH%sdpMJb)*#KCH756Yb
ze^)ALT;RbTn#2L0JL)Pox}`lbT-?bmaFkoo_NiLCwPoTUN;D|w-Df7;VHJ`UKdR)N
zR(*wMMgP$3Y+Ac;{$4y=#}_!6+L}`(J^I(6#rE=F&u<7Psa(@tZ3CSj6b^?Xx&`vj
zTg^}%pDpowCczI+15-}1B~GuY-zytu377WmvF_qNRRacZV)%f6nFx}M50PImfxLXI
z_+tI}z>Vz$l0CNg+p2E2Msy{MJHJO3iV7qclw$!%Y!OSxEvf~KwNKS+KW?G@6p@_{
za$m;m(N6iH{t)ZQD<;2^Macvw)I2e6YOqTk{w=ei<U@ARzqF+*Sy;yBu0V2r$sTiV
zUmU!aGfS@gXz(5h2taVrS|Q48r7GjTqlb6|_;j3~o3DK(@dXcQ%aTyYkCiC-)4?C>
zZ&ne2awI3=2j2OP%5m~dQPf+~Bgzf{%Q-6`fIZqTp5q8wHP$gi&9bt;AP=MEeM?Tk
zzADEdoZbc7{=Hh%bQ65zSm;I*hn&iFlyIz|Fq%3pNPRWO(L-1dE6wH2G5AKxn>6<3
zrze4XXev>(Zf0!Kz<3tj<Xx!e;LwW~!PJrll}A;>1yzwq=b54w*4Ek3EBG1ju~2_V
z;m+F!=J%&2x|}?yL#aF756UAtM`Us3+8X24RpS#EO?{++*jT&a=exd|>ea6oCHE^*
z=<CR`#^R95GcfCV@KmU5N=jl(MJt4q(^O-rN!8kpY_z`r)f^`II&_6@v-2BOxDTEZ
zEGLllX9FM;kBU$RE($;3zw8%02!M7BT9FHANao<g7r^HjUK8&e==Y_H<`z<Sz`sL%
z7e^YvXcDP;@s)bw;o~w<{+=B6_1b51DYDp^#w^1L`|-c5=f8Tl3I^4c<!SYm@(g^R
z`=)ot)r4+4aTQ6|Mhr_+7MC*FFXwBy_u>ycL}iGF=i#XF)>)OH%j8yQ6g+{%eT2i6
zQ{!9RAiQr)zSq~8r6~(!yn5}kM@iR#3UX%e>eIul+4LXQngi8H@PWG*=N1(}Ebs5D
zkY0E7VtsYzkqj<HBI8E~n!T`G{^N8`fw!>Ie(7cVj$zbjT2F|u*m_P!{VUy=b#q)2
zaWAr!&ZR<c-Nvo%y%+fz3dN7Mw!-jEk_Zt7)F&}Jl!qU#+R?;RnSY&_wIs{ArB}ZL
z(mwYERPrn3fG!DFEljw{^tu?_t$f<27kmWGd3a~{y@zt)a&gjRhfO-ZxFF0rTVy?(
z0HivlW!W{<3CS?U`_jjT7F5M|#+~*-9tM^<jNZScJnyE|%LUM{6bGK<bk{rB*_)fY
zn5Cskz8t=7Ce7Xx=*=SMV01C8sV0^KG6jj4#=kFjn4i!r>i&2ib4N@7C1pbZpuzjZ
zvqs{`rq`aLb>Ww*8-Ix&)pgf(eNG(o9NZbN*XSE^wf@u`m_G3JLRh>xjm=3$?|+sA
zwM{Zlr!W&2hxx{ydq(aqu4YoTmSzcb<I4cDxBQaO3C|svFPGP;7T|)Z_1%%{4_?0l
zTzv3cn8__54p=PLSQ7tku5I&J&>6?9<Vk@QtfE7VLe=EoCD6KRwDey|T2IJ#De9N$
zjFw-8$gvFu5P&#=(x&=;@e3-~oiSOJFQ=OvGO@6mh8-j`r!91T#DgBRz}GXxpXcX~
zvmKm|%!ND_a0TGCZt_Xt&2Yh7<-<wL8tL7$)>|wDpe34nbzoWV0>gIbBNZ+@g`Pc_
zFt8I3Wt1CC{qV92{@8s5kmfw-ak^<`cAqqpnZAaiM~a4c7&n;B4x}EeTb-Aj0nNmp
z*Ole8Cw`V-l61#b^pd)=da&`0Ex94kG}3o0NGe@yZ$(kgaQqC(k$49imT}lA12R<N
z1vr8Y1^s%Uew<l0*zjJbt^4P*9Eu$I0q&jU{l##`pV$YtOVqk7k!-0W%#0d%O|F|a
z#83d6Hq49Vj9(zi-xZ~&L;{eyCm@y&gB-t<<uJZsZ?W)UZ|$Kyl5n{RoqnKJIgyBA
zxSwuG9}*oG09r*d=M6*-+Sya%QTJv5i09g^jIQk)?+E~<r5QN`wI<&_az*$(#$#Ss
znB`=SO5#P)g7#W7JQ<^tJI8y?i2cMeF!FTun!t4&13CfYBAM77(YHIZ$Ib`t*;wcO
zklyB2hrr6c(!NdW7UWnRaHU^g=i29eo5<%vuri<Lqq|dq0={w$$0LkEZ>N?&q`O*+
zRGg~H39CZnR7(NfH#NJQw2mCy4X6=q>hwH^`&l)`#e47}wlkSkt=C-*I+Q)EYL6@s
zSPM0AkVcHmZlR#dT=8`{i5eIIE(IiGhLe<rtR@=Bk6O4n&cyDdsSM6=Hisq8UC4hq
ziQ~NCIo%&BmKUdPuF8;VivX#p%eNT27N|O)WsQyL*cxk%jyU-f?f6w$CkX)hKu*Bn
zBPVM3QNs}Lr5Bvvx;^0BZ-0y?EoUdsQ9ts98$Y*wo@qg!Al63v#0!0aI!I=(Fnq*^
zrr=SH)$MSzjnhd`_Orfo3D+;i(Vntu2eu3LR%(l_)+`A$j{+7sedRyCY2<{yeQjCr
zz-fYX-z|89H>KUBs*X=MGm~!2LhL1am!+JizBYAgK{<`X7FP#-CU^eS6G?9&NxPLD
zl|1@QrelTxG&o_l4xa5cuI4v7oW7^f`RXn^dQ~_gWvuU`8xt%FyNWGKISu-S@lnID
zU8h&4!e779;w9)I+W8Iv>w^#mw|%JaPnz5ZU^KpEUl>pH+l0Tj-FJxQ5}8}j)cF<G
z37NCyp5%0FsjkHfavHpn{ht1rPIaoMe|jy`E_QLeQn1>rQO;08SV=}oAU+{?Cime+
zg4)$ko@=uUM#=G0(%@0+zCgo4kC+0#<@mzV$BqqmbeWn5TAdt1A1w;LVjb-qgl6aE
zm|rsD2%y>C0o8?=0zdoKCJaUL04WYhi|nRgiJLJJ*R870TPnPP%=<DG+!2W^F8ScW
z133g!T3Vh`+KJ@%u%-mdQ94rokf)rR*^3pp^1HVF*7OkjF?XyiC*GdKS#s#|H3vvH
zNOn77r1`F=1Dm<|%;LsP2>U0Qa_c~v{G%Q{I4jniagWR9I3rhl)+zMllP~Mpl;YxK
zoIS~pij1`*RM0X6DHb+r=)aDcD3zS;I5K~s^=8VjV<F`=x$xa!9ZIf%2<-O<L8{%=
zLNv|`A9Z|Si;26CovVdg!>Hq)JSIIF6H}4I)+H!NTGpG3Zy{8AX${>c^rS#QtlLP1
zCSUYe0MG~rE%%ycoG4=kuT{L(&B6uN@uY7R)28;^19b}3f(K6q_HK%5zJ7)u^+z$Y
zJ{UXg(AMbQCau|7K~d|Uys(KQZS8R*-`NwY>m%K-Qc2TYPTk*DW=hIUQH4Jx0B=J#
zHUeM<362e3R({T2*w~#rB}r+I`6E!0+4b^;oWtKFw@t>ie4!)Gjrwx2IX7LNL53^2
zYmz1RwI<Yf<7mY}@}(tgU;Q4>KJEM<T-Lq_7vTwod3LCG;n)S_ryO)A+d;NJ!~MB3
zVFz8axfU8nXbWpuFV^=uGH37DJpjw~a6dHFhojmL676`|vNlgKl=@zmc-8x_q@LwE
zl9B=Q0U@}$(_(v5!_ZK2-^W6+$8qwQrK;+gU_V}t)$9<#*-(bo1sl|4`9@9F>5N_F
z9FDgTHdK^{TIysB#jB*NSOI>WTp|dt{pqv*stl=@HOwq676x-9sx|)S28XxJHH6+e
z*MGetCpH-@*Sth>>vgZN#LG%~ebKau&y{!9xdLr)5=vbUb&rP9;&_}Z80V8x1cj$x
zs#XUQKbfJ~^)k#!Jf*pkXMA-FHqknYZ;h?ctx>zbPMe2ZvIx=3JzS>5=sYF%i5>W&
zDn38TU&IQZfj)an26&&thMuN=Sdv0Fe1jxUw-+dKfsb$lOIkk6mCNU}{g&Co$_<0%
z%wDPv)Fi%1Ik?^3^CuU+RQUxDkDvcaDZA&N$Y0@74@*H1lP&>}S;E9$`cmRBJvt?%
zE9w=q1i+&kU6v^1#Ey<bp(c-q4b^RYOw2a~we|eF2*BmhOCk>@1T{N;><IThm_7?g
zGWuaRkRNwpy73ihrJDTeH9uKH&BmOy*UC|%G&?reSz9<hnF8q4gpwRf6Dac5=oYYx
zICI>qNppgKyNFPpTt@*cy$?;_751{f-4p>=y5uQ{C_K~{`IN}@!Hg7<J-3kryQny@
zg{EorjhkJ5#YE9bAOCLEbZ6Cgiq#L-4;Sf?56lES*b>=n*he4S4a{*Ycze5|#~YHO
zH`S_?!YywN4$avT3p31u*CkIqNK6xgznq*)$_a6G1UBrp$s;`T*?r)b($pC>tm5Rh
z)vvh~OS!$Qn-3+W?<H@#W7?FuED-+D3B|H|#jj;EGs!d{`PyfeIQRWUhIN=FH~c2Y
zqC$#8*PLV?d-a$_0uc8#Tu~YxpDPZGnSJd?M~1%_4+~}gyjb2}m5N&&g>)P2&OlF(
zha=Z2x}Q{AKewhr5CdPK&j`sDy;cB=SSu!GXfxC3(k<z0jPWi6V9qeCu*A|N4nn#p
zd*Z&T-_9Tq@|x-|RcYMmLSa^$S!{p}G^+><Rk@d+$|S9|f$aULD*i=(VFO5NgHpaX
zc3^v`Ss6x_eA+D9O}V>ifUi@kyWXX;$GMmRpzbBBY23J2&(Si(_OzS*S&Fp&hJdzT
z23MA;yx0I20SG(yzO9xHPHj1@Lee$L5`bnn9Zm@2mLHNcT<q%JLCds_SF?i5C*gY?
zlQp?mfZ${hVHoe}_Wl+C2nJZoIXY<u+7sXVSsUuPHdL{t*G*3QmywWVY{#Pp@B3}k
zbsj&r@;&6lc6$Tb1~<tDP6+^aN26aamsblIyp1ORIn@>9-{8Sw4G=Fx3(Tq@g3VNd
zcf8V4uynz?Q1Q&&)aP|m%cI96Vi9qZ@janZn0PwPLIRNcFskl@Ycu6qNYk@J?Va~k
zV?2|a@9y0k7n<{|c-IvjC=geS+`|n>MDUm7lj#8L0d{f<{Cz*lT*Xh`X8hc)zdP64
zjr-97Rb5?D2JY;;3ErNa5xrV=4;+?*3_1>Sk{rH%!-eL<TvaSUd8DeiH``3BSBu%c
z5Sb~XUp{{ERheKiURan_%0m_1B|GesRM<wECgm&ee2ob^6S2ej>p@m8qyVs9rM^(~
zOr=^DZBj<7XTx=oowxygJJH`TzVySaUHAZIeU<{-3c9Oc`W+K9dw%kb_aKeNJZZzT
zv(Knte!Yp|=k%BG8j;AS*&AxQ1Rx%E&II~4&DAt)Dk$DJcD1!$VUz_PWafTQRFXJu
z@d*2s8L?O>p*PTlsY0nIH%gCTGD!kZql;lns=TEp&MG{Zl$mIq1a9o4w2K@02Jx^W
zx`}llXP>OUFbGA{pIxuL@lhYaCi!`Be$PcFFzLIU*<GPNlp6`1a6r;-L5|K#3wsih
zeif$5bNa*qJeu0<0dl(n(j9qM?wPyVCilx3n;Qz;2JPKx4B{`dmY6v2giTZn#y44b
z0gQ(_;KBrde2uhK>27yiN|p%EBxq#eyjnb8ycDxjN!eR8`?~P}ogl4?q{!h8%ZAaZ
zAy&^J<hfq2qV91Z7BWksIR=J2Xz}koU~lgQ{c7BnBh~_4ehAsQxY+_`BygFDx1Jm2
P&|h)U{F5B9P9OU}1y4-a

literal 0
Hc$@<O00001

diff --git "a/License\302\251\357\270\217And informations.pdf.pages/Index.zip" "b/License\302\251\357\270\217And informations.pdf.pages/Index.zip"
new file mode 100644
index 0000000000000000000000000000000000000000..8831a8a554f1b1d2f7b430ef06c1f7cb692297bc
GIT binary patch
literal 94618
zc$~Dn349aP{`Y@QIzuOEGEIgggwU2rCD_I$w1t+oLQA?qD=lSH!HsD<Z3Agil9W=e
z3q`7+pn!^qfD}X)6<I_P*~+4TqOyY`n;?R+h@uDx&u4<%d)0gYzvp>g&%ZC;-}#<p
z&VIh<d(x7!dm<PkQGQ~c+gavpd*S)&!GtIXh%53{%A>pF`zz{eWnakUX^=?8U^3+c
zRZSH~g>r66sSrU4Ygwj?kJLnHsLMj*)l~iSi&0(l6nd0~)kH*7gFeDS9NkVHno8F^
z{Q^CO=eOVh^wW4g`}tJ*9iGn|m`X2$EBmL?>EI0F1eQ~htSqOb#Iu}|kjiq(J6SBJ
zWEt~}R<k)Oo(+zAWN-=Mlxm7^h05qK5@0!{($RD*rO(irQ5r5Ky?dG~rK>|wR|n*3
zf50R8tc+I*`QjsoOTKz3;ECs|<nlmRV``;9FrJm_0v>OCM6EPDo*7>6^C;5miI0@(
ztLuXyPrN!P*M;QTaybwm=^qjDD+=fHkGd7bRmv4%&2hU1$3JUuglllzs==Yu;0V{?
z2-o1aU4!FaH8^h9;P__^j(^sW%Af{UDud!7m7-G_6zxh?N=^-zoEk0}(e>5Hf?^?2
zA|#4~L{YA+a4}ioVzR=;WQB{#Qi{n67n2n(CM#S_R=Aj~a4}ioVzR=;<VFTJzvruz
zs&gZ2H!lb)Z9<-4`04kBpOGPd;8sLcKn_QEH@_EvQhfW};@j^Q|M70|AMY05ez*9K
zcZ+YoJAhH%9l$6r4v4^810wLs07l6_AOe{OFiOs$;cP?0*@i0FhAP>HhO-S-vJDMq
zD_2$34p+&w0a_fOg#lU;pzg3N4*!EbFhKhSXla1vkD<k5XyF)IGKRXtvN-$?`oJ-?
z-xyjthUSl>bRZ}JgFwGOo`s<AGe`p^U=Zl{$FmUhokn#jS&}$nloSX_UO9wt>R-ZL
zv*bU8yZw83=3m~Q`Iq-+{^k9de|di%Ro#=Kh*U*%RYbQXN}M867131@-BwVx%5_h`
zg{Q1M*HB#*hEW#p33!5``XIt`RY(rp4sW87jn0x1XJzFM8d)ipl$3~#yD1mepngep
z1^5wfhfh$pPoJ#X+Ow1kKeK|tOH^}P6~|nqx_<@mGfqX5o>8eb&7B5irlQPK(YuzY
zB2G-0wnD{jemN!i;Wa91--MX4%XX-kyG~4)vs)EWDwTezQs0qu#~sP8JMOsSgeu~W
zg5<L*E*!IIuKkiqdn+*+p-rz}RYeRQm_IHeN)wTrn=dfAmBCKqA~Xn<<O>jg1P1g)
zV89=NflA82KLSIQz|dQPJU0S)?puNUd+re;@<#-21^Sf<5d-pXr4$q(r9eqRtp&Zy
z1g4<(runy$1`iM-PK<jioK#eRq@sd9l8X8cRFan53JgRMMSm1ttTeUwkEWK~5A$Af
z|E)l2KV&OavZ*x@15vH&k5>jOeHg6t0rlMPE)<x;yh3+4>Ha(<73AG2;QoGv=#i45
z<SRqIyuz}=aB=tFf4`vG^tx3Q90d!n91jkbQ%(mMdgXxVMT%qGb#-1(g%tAmeO*%1
z9x14-ZY+iI^L8m3*sq-Bl=GyHj3)Ca%Z1MoO2|ifzeBdqZ&nea&z&5WFNNjouv`$9
zZ>x5Gnv}Z=`q-S+DzZ^Uzfh4cRa88o>eStxmS5O4qtIDc;4XA_%g@YkW@Na#I=dER
zc5`Q@6{P2NExf3rS5+*h99k11h#}k(LBk!Pw~j`{oW2!vh`AMG;G(%jl)IlB#KmzP
zxonYqqza#B!g>`q^^X(vvdQt5>N7;H0`GzM!D{dUSOY!;Yr#6O9&7*`K`Yn<HiIo-
zEBFX}47P#oU<ddFd<u4gNnkQ~4m=O0fTq1u={WEt7!R7kS#;!Wq%8&SfMsAgSOHdo
zcfl+$8_WT(fw`as%meemE8unTCU^^6+cTA32fu?G;3gQ0x=wyEm0kr?c1@*kfVE&Z
z7`Gea0lo#(k@q8T6{M;-wdRt^s{QxH5r4~j7+~RO?8i5s$g$sqa4I5AneJh?QXZ(d
zH^+W7^4=WhkL<mFN?9>Z$gwYja4O>8Q~J(bmu)YGa4OorrzpOZT@g-2{C}np@<&RS
z6>GBX_dWASj#J70@9*qBI{0pTCD$v*>Ha>H^S9DwHg?K!?)d%Qzo-0sM^uh8C-v?>
zrMy1Go?{<BvL?s*beo}nN(oq=&bC+Y^W-?c8+gy(OLI@p&vA~LmG<|Pl26Pz&Q~(I
zKc%Gp+Aqic@ja=3?+<r>j~sjFBjoQXiJyo$_KRuHW&bT@#V4v9`&wyuw)5kkhy0}l
zV{`0_(?dDVHR^rYe@l6}yfDYP=j(Mn|CaK^5?9WDm>;AR28I8U64$MLIOXpxxL4bh
z{kM0%KVO++pOapb?OZ4Ay!+o%K3Lrc>&>^W=YOu}(S2n(&ijVd{Jow_uSVuLyI=V8
zoX)7ZFUQ`{XGym6u1`#VO4(lDJ;yHGIW^mvZoa9Ej{BLKd2N2sY91CI<cQEoqh#7o
z)@Iu`RAK4$9No#JG)S4(99?Is?_`f$gyrRa?7kdl88OjR+JUkOV{=5}U`;1KncgdP
z7)ef@i6ynfiY4{XV?$%J(h)W1=Bys}*<G<>o;Z*e+nJ1|4+Mshm}d`RQB3|NWz<F@
zzIvxE$3C>{^VwP7lBb3dda{#!-#ScV`g?n`+h0xJNZ8KYoKzQmih%*|j2y`?&%*Zg
z9Zt`2{`4{*dlmI`8|cLdKX?cu{IGS_-AjiNc4o|XG5vF#O-HKB@k)XYBcnOLINO=L
z!4%thz(!&bimiS0DyuuY!1CbHX6&j0Eq2w;PjfJ4@fsZ=)ALM}wJ64<7cHhq$*mhV
z_Ovfvl#t{6{IgO+Wo+O4+~vP#*}rMZ%5jeS@~)h;A*Zv)^d&K`&%XoPV1}g_dj30D
z<IgW8wkbv|<kA#(VP8Tx-HhaA?{vwrKRHg7<2-R(LQZ>b(vRcs&vAZmc1CvEwEE#E
zN%Fx1X!Dv6GIN~s=gsTyianYC>YM2J_&3L9J7<Qr-<>vbLa)LZBqf>ctAGAEY!+LV
z^XJ&U?2M#;Ee_oikE0dWu3pV{E_l6@;Ur`2(yX#?p)7GyR#&6PEWeveJ8->3mRj^V
z$uxtENg<>gP0`NnB{FkTh`O9}iyA0wIVONjA-&Wuko3p55aUC2jvO&szLJ2qR0CLD
zWBcptp2{G$N7xM3Lo<w5_9bLn?+(-v&wF|z#yE*OBZd}hOnbjb$+k;R^(4lwE6r{(
z&efCXu~f6|v|R$Mv~tSf@t!)8ybo4`57dz{%0UNL;6nu0f^}d$*r1N&aMtm~2B!6M
zq1Zq+A#yX=0=9yW@UC*;<+9v11h<17;1lqvI<itZ^NLwcIbJWdc~YfeIpqYzV=^*4
z2c8F0)N7cgz3kUy90E^*@#;vXc`v)4IeUm*N#0hkAxjba4p;`3gB4&Ucvsy@X5l#-
z%mJ@~xu6Bi1M|Tv;C1jOcuV~~b8U~^M6M(7JGcREsw0z>gK$%%11%f3+unvK!}Bd#
zF?|nfQu=6A4!%uV>SRuS0Z-#9lBVopdGf}s@zN{jWe2-iFBrKe_2x-!nRo}g)7Gc2
zMmsPh;X)Ot6bJRo(-W&+!?LlAz}jm#3vI_%>jgb`#ih>HM>?4A4+$gN(n#jn2sScV
z*s0=9CkqiOhFE^Eo@lG@fO|eMpKD93?W0J0U;*ub2s(l|5DQ{}0q8+A;DHX9fe9Ev
zTOiP=iylYi=Q#Rzf!$ya_yR1%BrOJuz#HHj#O($9z<zK590Z5Jm*6XK7<>(mfTQ3T
zI1Ww#p&NJF*3U?YrJo~VPJnP2XWGOGkW)A-<O?JoD-8>fF6Q8h(zRR`<OUAQif-bt
zf@npr0W7DqWhl!j%^609tFuS|<39$IF^;M^@{EqV*kc;pQl+Ug@l=|txT#8$m*A;1
z8#g6RY5E#Gm8NdOQ)%uFJdfE5wRjx2nK?Y@RWI&8oYKd$cq;w8gs0Nit9aT{_2b};
zeqD6w#t+2x10n6?-sz`R<cFfuf6U>H)2dtlmY!DiI)&FxgYUo@@NF^j{$^Y3h5kMG
z0h|Np!3A&;{Ag>f!Q&_JGq?<X0l$JP0JUK($DCIE_dy$Snr>i*(Rs*o)_t0u2baJv
z;Hp*`0(w@fi~v2aRR-W+iSE<3&cFd&AQhyepIJ&jx8AAr^W1;#=QT9!cW?vT1lQ5e
zi`ma(e~bl9ieCwy1mi(7cnUlXCV+|H8SpHa1SW&$c1_K?)zfSAf9k2~KlappnnR%l
zr@3dta#C1M4$J2h`R`pN6Kthg%<Dw+o1E`6cD>SJAyTdM`22tDasE`a@dfZAcnM6~
zRk#WZaRJon;AJoayaHx|SHUbW8_WT(fw`as%meem>$(5CQycMLI!xx4oF*+`9+(ea
zFZpvf=OFI2r%tPGb?|hQ(!mS=c}f?eMT@}_@FrNKOlgk~p}hs(21~&^U>R5rR)Ce@
zU9bwg2i^y(!3SW?|91bF|JJ|v(Ej(qYVZMA^Oyd;i?~()?BB<{(!Y!Uxqs`>q77gp
zXa(z)t+~s#%L{!o*aEhKkHE)Z8`y3;^B^9dfKS0r@EQ0VeDS~CIrhJFj-KUbMbYz$
zxTJ_*6mb>e&wG+z#ogYN%x6@%X)p>OQEt|qX0IW1P~})n_n<X<!9K7b8~_KwA!(-4
z_^-fW@HIFJj)CLS(u<Gb`3*P;PJwU1Y49C51I~i)!4KdZI1es>i{M9a3H$_p2A9Dv
z;8$=3{06RqYv4Ng9ozsn6$62bX4CGewvP0}@X@e7d^EI%<rWT33;j5JMC=I5oniS!
zSndhS{b6}1Jm!bP@@QC|2+LDp`CV9kAC~9C@<(3HlU;(*NPi87uZHFCinNiijL<@!
zQ#)+xa8MhT(P1fsrAf)~6EbvAl*=gZ7j>kqlM=Xsz;6gRmB2Lw{^EE{P&%EZe>?fp
z8HYc;hk1I)!=VMe$3>0%k%`0^iP4}(s2~~{VgHbXi`#!zIkwR!5jh?-gQvjLU;>y3
zo&nE-NnkQ~9!vpK!8Gs!coDp$-08u~U<P;v%mlB3SztDp16~7jK?|4%=7ZP40`LY{
z2o{0GU<r5=yanC{OTjx}8CVWhfR*4~u*!VNNIwbB@@L`s-4&L5!?S!KJda<7<=0_(
zEG)kX%WuQ-On8=l2+Ip$c_}O}^Y>}U?t&QdBF6V63_Mi^{$&jO3<NYvU?u{uBK3dr
z8x@~%0f3KZ>!!T82rn*1#FAUiq%BX0d>fJQPHlaaz%m5jp4tX0ft3inTQI1{*F{{X
zId|tSS^NBFDW4@qvn7L!t1txEv9;#hN12Q7y^qjp@Bvr@J_KvQI<OvW02@Io*bKIS
zt>7c@G1vySgB{=#@G01-)BrvQUw~a;H`oLAf_-2=H~<cUL*PsB6*vsOR#qN33XXx}
z-~{*voCK$KPi=bi|9qe7Avf+8`ddhAqWiBG3Gy+(EdtI6hHnRk57!9#s}k6Wz-Jg(
zq6EHBHY~F427AC>un+792f#sa2z+^a6CTD3UnAlOIEu)wExizP0-<lf$%2F)j|q{Z
zW@$?TZ&_=PooG7yRY?LlRg}O#XUR=aU3~8}I{Y0t1I~i)!4KdZI1es>i{MA_6Zjci
z2ETw`!4>cuxC*X;>)>~A1Kb2-ak*#$<G_<(JZJ__fv3R)FcCZho&}S@Wbhn#9!vpK
z!8Gs!coDp`XR15l|9pb9kQa**$d8zwpD;K-gUbL0jr<C(+@7AR7{P1G^zeHPP;V%c
zqeuMMJ<V^DCgl9L%N%J2Pl2bw1TYaib9;6s;q`yJ4q|qa5i<>;7vR~yxTp2?9&7L3
z+=XX))lWUitoU{3$8$>(n3wi6m+|jdmHB!7W%PFjcm>P^uYy@%Hkbom19L$Om=9hD
z3&0y-Ay@<!gC*ci@D_L*ECug?Wnej20ak){!7A_`cpt0=AAmLBL$DUC1M9&Cuo1NK
zQimiwH-jx;t9f*X|GWJ&7d<B}n4iBGDY6hOx;;NjFotg`^V7=xVWCJ^`}6HNlB@!M
z`7nU2xji*&@xs4-6kzMBM7FAVTW0v&>k*bY`C0lG(kCr@Bh5W=vHGiF!V6#RDM_&1
z&*0?xA}04!ZrI1@?>4X<>;RvDPr*+2gBO*t{TzG&c7Z)$FW3k6g9G3oI0U`~UxCBm
zYj6Y{1;@Z~Z~}Y-PJ&b5TW}hD2hM=A;Ct``I0w#y3*aL75nKX4fuF%;@C*1ATmirB
z34d;ZuDCP)PtGiURfnRC|9)JB<(06!7M3@{V@ku4X|*ISuxY}&j=w)jZ6e1o3uZ;-
z729R&cuV~jYJxI1-yv`YlXVt+4}JjWz<F>1TtvpgTkrha?!I+i{ffvd&5!ob{UQzL
zl6o(F@3qaJ^`5sxS2C!Z()o_z-}VR=?ltS9shr87<xQ!^xqGoY_6zooG@3sXNA|Kj
zH8IVUHR*-Nxn0rbM|JuMlc=MPzuuAOMgDk4?Mz(Zc~*Sz=Z~k+Yv9Rk)986TFM}I^
z*NS{Qk>4SfT}S9yr2c|uGoHWWd662GPij^k#9{%h;4s23qh(w6-TKuAM_Qld59=o!
z9iu7mX@YfLPbd`d_^LG?P3`9Q0wV%)=)|057hijE!9^X@SED($ZtaO#i;k^bb8N%Y
z(2uSCP%R{Bm`#gCL?hc81JeT<-Z?S*^$V+?*Jw22<CJuB*GUyMve?&CA^U=|FPRLx
zR}KU{exI1?N=_1s!+(9yD5fSScPmdLNj0HRT~?Pa4Gj%0iLExe{DJB&UiAnj*oB?5
zXi&j`l7XVTG+)f?SDIfmsHk7*K(Vmj0CDiZf+TT3LD_(Q`GfP6=p?ptOn%Y8K?90%
z2h&8>osr@a^W`d!&!halF6d&7T2U0^b-PE$i@_Sn>lJHd$tQ-;(vTde4T_SlQmpX%
zD%I)vVwFE2)(7PzF(B6k{FU_;w1gz-4$-8TN>31jR$fmndQl3Bl{6S5SBmA0;y{^o
zg@R%VN(}hxt82te(O-pt2buo(<CW|ggz*P*Um+7J{B?~1PjyX5^f&nAfQagl?g=%D
zQhlh#AMlKkX`SvR`bl;w=@F`tLL!Q(4oJx3t7h#^F1E=iS4&>8fPEmhnK1P}+c)fb
ztt?6vY@y*PBf5ef>c(pQ=%22I^T<K<Ka$Y9P{8j^5~YA_&=IfQPLkklnUm^$m1snT
zzqZ!z(-rH|^<sl3RHN>r9;tVUh5i7$Ii{{YQ0EV#m>ITvZI9bOOnIHe>k3J{{fs^+
zCU_FncPIH9<Uo>G=?TacA==D%d}?i{Br)U{D<q61P0&57?qFBN1jJg&CsoU~b#$~g
zSYJ`2dqtllHq^-MO{Tn2y`D(ygSrB{m1*#}OD!0g1dk^%ahEn&<Ef*?eX2ZF7^XTo
zfYlWe6Vj6Hi8N7L>kr7ZBNM7IJg4>7hl2e2J8V0QnCE~TwD)EbJak~Ea@mLVP~nlh
z=?|0GMVUW|L;UseVgjn58ZHo@Nc)X6GLp}3)Q<90*3-UBKy-;J-5!fP8r6A%bfOXU
z)_Q_X>XI7!v7&RiBUF}w{(3YeUV4Pox<bUgPOJ;aRdOI8SE}Qraa^r5f>y-T`YS!C
zTCz<f!Ia~AkFUa8Z;whUuMdene@OItYCZJv7z|a=UlnR_KSF}+NFyesQckLWlr7Tj
zP}@k7yf+3jSmmj%53r(9tnzr}U}jfizw+T2@WKxXC;1xbTb5cZ+F-p`7Q0mi{Iyu+
z6*ZC%b&s@(A*`Sv)^@G>5%(ulAYNUxwn~)5#Ext~l9Ya&=$2-kCVDJ{I*-(!_}SUI
z)5dBHTR^gDrq;3*DVfsyS~OzR;`JnG>rybU6UwjjNMfk5&h;zN-scaD$TczA20Y!b
zPMqN0));|>VECB$N7BT*bqBiDN|jipqa=@4D)-8hiJO!-Nm5Ix^b)CHH*2wxB;D_?
z9MNM~(B?%%YCc*N#mJTPQ6uI_3WZuXlS=v}9YUAt@)8oTgXPguZJk$cvFNc?M|pIa
z)REz?tCM||p3!2t?DaP!X8xX#F9$rMq>yKnEZPhtm?}`WidNpsP~8n(lbevFiTe_;
z$I7K3wzJ<SKZ{x_-8VQ4;l#J-2>UydR@+eHsc4CwsxzX?A%8%+pbf~QJn~rgM~u&(
zcs?eWB+BTPzi8*gMCWN&X@u_O)^GJPY+%U#xKY9y_j_&6bn;=ld#XJ?$;+Nd|Cts}
zVRfZjU5qD~xjQ?D)?Rae=3L7@vNK&DkZUDR{ameFCj|-|HcRuxgjzWudmFJ}d?W0c
zT)D@0oHL3(sa8%*xg6v1!ID);6<h87uh~wf4bFXuv~1#Je^ur$B(HVDxswAfQF_+J
zM5uT2>(qRJBO)D;>8>3~yQNMb?wr&YX~7m!X?=z>6cc|@8oM6ms(c+8@}P|pUrQ<n
zo3i|UW3axw))Q*7G9kZn4ssMc%&u`4NcpDMNO{Y)mh9AtobCn0Q!(Ib<BSy+b1l=^
zC)^h?8L+!mFpIjrG|+fdxWE-YtV+yEKOf16@#?|akX#wB>&qWf^Ixdnez_aWr|iYj
z4*0QrlWb3M<&w9c57Q8^Y0;WOrnbIiiOoessg17KULO|~Mf^gOn)8H$jm~Dwan=&H
zVE>_Kb@%Ycx%QQe-xvF$9=6BhZ9Q%A!i;0OwohB|Y0Dzst+t54#$ZUU-FLlZv)&U7
z*2}GfNyVv7y7;2btyj%UIjKE+4n<_vyX{kZFCJCW#`d)JLA5Qzhy$UbK6vU|Hb80@
zBwKrH+|Q7t<B#f2F!Jahr=<Tt;>K(8v1NjFo{D;ZeGs!(D+NY0T_b^sFY$3|T_0nm
z9Q0KC7F@?pvA<3O_dcU)y~`3`3d10YuD2o>SA6{CC{w$vVNs@E=^<%cYas9w=W^2)
zk<@0@lMJy2CsDa9`>^vXWKYWu*wNG)qC1|1sS3&?>#+d6jnZh&AE;}21Di?sQA0fD
zm$bHrCr;F+y2Rf6hA7)ql2<=by-_c_#DVo^u9dtsV5j!6YS(mDE8{%R%uo)g8Z5u^
zMzc!`Z$}U7DN6haHH>1YUh*#QZNawpRyKI}foiSK?{nI(b_-&|CBeoyVT1zJe5S6i
zzftmr8l6=E83`WP$x;4_mhH~S#tX!2COqBTI)V4;7&(cL){r{)w%mm*@vr(E2T-}!
zQ{ioNFV@$2rN*T80taJ!W&})SC;k)ucpNtDUFOv~K8G_*viS-$B*^cJ$_)_L9`4-d
zEor1Sv4wQ)*}|1cA%08LjX4zm&d;HVb1Vt+=nA<mBuPv#G;*@g%9Eh^2+t*ob?P5_
zuI~gBj;7W~qh#S*b^k6xpJ=_m3MSt6jXo%Qy-B(@dQWYgKfs4L##i|Y*R+@M1z8uV
zG5ghqBGTY)NqpTfN-NdXd3ist_4~Yy^kF@Y`Jilg)mY(`Jheex(nJ4HPQQZLu@e`%
z>qH+WG8mKs9(j(wN^#N_6t=_?&#vpHtOU3-3Bg1h@P6O%@96_Zm}?k<?InUn&B>lX
zb_%IwtS5N&w{(N~l)B)l><Yp)NJ00`GaI!ov8YO#qw51(5rn@{A2MCl!w>XStDoeg
zYKeAiKE)e2El${kQ|I|bT;~U)^Z|b`=(MLCKV+%!*DEGQtxxj!ur|F?L$KZxqTh2~
zxw_?r1&31R>n8G#N2RVIf#b|pqxu6TD4It^x9=ltjOHIxWBoOz>>?iL6n=d4)~&?H
z9!P&i71vcQT-KZ0Xq&c?dcmVF*j)RXv_<_<GcmUlTHLnvQ#%mJ+Q8{$u~G^Rek|=_
zm`WjmCzTVU^xa(I0NG^~h>QIP&f3OTzHF{BbvphHsVivZMZr+dP8t5K+WrFLYZO-K
zxcb_pqCPN9EXVlkQwmZCYbM@!cn8zsw?^sg2bdxL{tswtWjSR3)>!5D;^?sb*7?r1
zB<sf-E<sA9-7I2leJ~_e^LOg#Yvwwwvf(^+9_+8QV%<^a50vHxSt4x}J-rUSOYXMy
zG=)fcY{>k9f!3>k;rr+qkC&ey@cRrT;LgLy)_Qy`bIjR%|2rvd`i6dKxK2d=!)WPO
z_ffV_`WQkgV#gTam`ffX&uUngV{<fJPp4&nO=7Q@Mh-EMBz{m^_J(l1ElDalf`haj
ztchY@?4QII5Q$GQlXCMjM%`h-sVkjA=q}q6%Lh_=YGX6MINOlV&Son8RDZmTo^E=b
z?%{CI@Kd?iW;!JM3`tL;Ol4xzDw;r>n%b9n>tUxb>+z-i1{LKM#KUbK9kSO+4Z2D`
z7!_NSmdIgc&W_0b2T`w+u9#AYTrem0p2clqaNuL0q{>#&-e7y5zEOG~ZF)(IF3GMZ
zXv<cZy~V54+u6+|>ACx9>~l<=Tv|@qXVA%lS_^z%uPg=me!8jMDV^Bov84?55gSdi
z3=4^5cs<jb8Sgqk7%7-G&c<htC**EJe;S*5S>-wyk=`V5qNl2J&~Usfsb&k<yux9M
z5AIr^a#j(EF4Zcw#PO|QjnQW364np*&$X8bZjKuz2NK^l!ha7`I^ESwquBpv;^XJG
z<-FcTeh6ojrGQHuB#>yt9#FfURynJCUKDzA{9*$-#E;ROdW@00as6~KCiA%T=Sl5@
z%`1dq+^(62x^q%xrTZfi;EmC)X{v`Z4Iet=vm<G#CZeg*==W6zJ(a0<tAsKgnnUaL
zaAoRirSrC<x^Ih8`NKwPlC~b|9y_JEJ8WE0RNPiQYI1!@Ov{-HiC-!(aAO+u*x-Ts
z?6IoE_KRQ1jM+t`ua6H+y@PhXSKG2zNaW~8S{U$vx*va^k+)cTK1&OPFZm{|b+o~J
z)y!0S`1dre-Qwyrd`FJ$(G-<F-(b5ge6NYys--o;qtW$}P-GE4P-i_y=$+0y+PkH~
zo}0Uq5~(HGI;XAf-4Yx9hb}L@iSQ3aWsf5%t!L)*k4N+GYs~jVx%=pf=$*fvPaG&z
znOwcqiBp+07ym48)mWsCu8kTo=n@C};NJ#q6Jy}vDSvnA;cxQx1?`&+tv2H7MbdW)
zog<^{&IKQ5e<<i$VLaJ@H8$FOMUDBjey=9wuE))#hv>tZ(YAQ(cJsifhf>se#Ls_b
z?cag8bQ3t7urw`xeS6yw4qltNYc%c;?r-?R+ScB}?3kEfJq{SSgTf%KCsJ2TvveL(
zWlu2MOiV}~JYOqS2jrsPxJG|{!Pmkxc!i_oiuw@liqB^n;JZ~z0U?4bXmCABtr6|@
z=~yiRYZFI;E$uo_SL<;rl!MZKb1<rPM}H2!lzWDH70uRd<(HU9(6O82e-Su2FpA&X
z4*rWA?LNwnj#WF|1L(Ds&HWujj$g>5mXY-yYqs_HE-vWzo!aBRDZ&{E`C$PX+2@pX
zC=1#O+*fU*9glPnzBe0&HyvYpjx5zVB||H3NO(Jz?~MDuu{$oyu&Q_K_*Jp`D)Bzp
zfmQ=)tY=Mc@?Tr{R$j0e_zGR;Ztd+K37ajQ+rZwKZrWn`HI|km)@+_6&@=oVgR?Si
z3-QOg_zgx=`<6(O$R8AXz(<dF4-|_A#*4Y`fkgvT9xA)9Xi%Sig9nNCxd#kzmkuf_
z7%27|;Ci`ZM!!N__J@e~6qV+~nfCDRcG3|Nkj}<)9Pu>YPb&FU9DfN;p0C=xTr1@g
zFTb+Gsk``n8m>`nNW4oh=v;jwbbA-Uc^p(UsBb}%SlX}DSyWm$ps2KWK}kXBpd_)R
zU_f3URO`+y>RU8uNXr0=SXeZuv|yk)M<i}tetwyI08HHAzU~2H+28?X{RS4C@$uKA
zF~(kgsHGF`S9NgcJmp@#NUaTsm9PaE>k^f&C<do|z+V^e@R0`gN3Ke&7m`fG?;iU>
zz>#b!DAP;uEo=Eme&il~z!Mx1r0p1g1uZdi#-`P_5}_tmc+TYV#1`)4iyqZxxWv9`
z18rR_eLYgS$Ln!FMv9J);Y4{<>*wwybw0c-(JK%UW=dAh)@yOQ;`rx{IA=qyuKFaO
zT<!JX`c@$)CdoQ&K&lAY{lZ0EYl)$d)Gxj~{Gy5^G}j5eY+A3UT;|`8!G&NpsphBX
zi8m$Q5F{afoala+1cr(ci?dU6+VBf4DJvPTr@1W_tnFbU9v`l+lxn5wrb$~1-Lu(j
z^JKkyr9s05>tz1Hj)pJcXH<A9aXwn_vG8A;&3jG!)DF7Awz2eCUNDJhk&Ihiz*7)^
z{G*aWb9x-T%QYy{oiB;jY7PIAsE5<(@i}+WP1N|x+UBK>gN9;bN5gdbE9dnG+1D)9
zem^`;ujxR7a_1DW_Uq~-ev2u5iLIv}=&RuH*YnSd;m;ksRrS8kUvu<?ZAG>wo^NAu
zuY>6{jZs{JMy(u7Oe&bb>$L@h<i&Y9yp$GS(oQQ?j`9fhSaXz4Uk6XfQ?%O_%Vz5i
zc~tsLm*}qGKQv0Cmye-ih`aNb>c>o$`)Y7A7Xzv9L^x-*`tA1-zt7(x?kNpdQRC;w
z7%_6@v&Q}jHY={3)qFM2RLRX{T#_iU^KgZ)kPmUNJmyH#<Qt^1V6<MY^}$h_5|`M%
zV6(hSEBed5){||8sT$IyseyNOBEbUe^x)P7r%t<v>h_)KWrPRc$KSwfbaaI7d0UFT
zEOrQX>oG>E;D__|({PQUR`bhR>&_1JdqcaHBKKE|d$Y^<SPRY5b<s_+ZsnS@T#>5Q
zXi{nJrXwC9CCc-oZJ2UBi6K>KF>o=ea3-l!wYbn$o@(PNA$s`7fm-1Sjr+QLd6Sx*
zu6tUGsjnCQ5f2B%)#23o1urskfX_Et3rr*_(e}_g$2T(pnXlz^#f-m-Z%~s!&q1`#
zet*hQ+fGM!jcHO*D_2mOfBgQ^$UB9rTG3rrhG5bCS+>nKJ)g_LYa(u8(48qKX$)!P
zuV|%x>Ie0rC=T*ZPr-$rU#a75Rw*+6dRyJ8m~uZRB>>N%L1TV`KeI>eOz_Cw%Aknt
z;q^;vGRhmpa_o>1awsUqKk!i8!dNs<n5o}+o?Wc<H~7Q__cER;;TN5wI6B59Cgl5l
zcZO_B`0j#kBAsn`h_fY%!qRAAA#V)U`0Kru{5Mgi39X;-TRQ*tzOJBoiRcUAlIaUc
zqYFCGM1HrL>XK@ukW0J|{*gE6=XV;7{@Pj$toby*{3AArU%_d;uouD#jU3HX%6v60
zMEr2IyM5dPu}rya_}Kjot<^mf6U6;rjIRsuYdbQPV#|0E-<m|9>wJh$97$&yMR-ph
zIWCiTW?7H(xGrC1f9iZnZ<GQRHJ(v%NABoc5;Nn0)a2CUhr|cmwdKP%zZdX{14nFr
z&s+I8!nlKY5%goU9x8ZZvYS*|b2$2HdV`82xhxJwOrSOruS?_N6Yr*HNTc;-Eq~Lt
z{Ud8(ySUGyuzFtX$l?565Kp(WHM&A!kZySc<1go@v`y_|ZlsJ9Vpmc+W{e}DFWkz~
zfd$S~S2Ekxx|ARO0ax`TXZ=TKdN!Wbq$X3{Hok|&Wg|GmcUp=kMqPa>DsF6)y*o2d
zHc!?Wo@~+E<_Sl*{3=fcE+@X~dZ}6#tNn20gi9LNXpMEF(E0r+5`2i$4Q5;#O4EC&
z25H>2o`8f)5N5tw3gNU$>6WMAxugu)8FWgnV4YMUYsvzC{$+ty@%=b>=#5bv%!;st
zBbvCMwES3oywsM_Xy6{sPH5kmFN+p>a~7Y!0k`rB{zf}vwHWl*%I3Og-Uwf9gn6$6
zn^3rPmo`h|_Nm9%j5yd1wNpPv8hB4<;h?~G*0!F(re^0Qz%!{2<%suryk1=mzdDZ3
zi#M;;8R2#0i2Z~sG0LZYLZ_ImBFR~>j+Q8A{$5V_&|!LkJ27^au+Y)e%>pwUJTZ1Q
zThA|16ES-gVJ8T2YLrh)wQ?=C<(w$eXxrB$kt*|D@y1}5sL>SS?m#zMQ|?NTy^UEK
z4GPPb`Ogz=-0^9`5w*R6gv{d-Nd<kAl_xgx128OtkJF1%gVab{dZ2_{teh$lOS2r?
zs_6q##rjE*o)AiPoXh3n8A}s|6XZKF_LY!W%dfN3Y5MR7(SpqoBi1&Gb$*XeFh^-e
zdE^Fqz&1^fCirCjS4T`ptb(Hzkm+dJ16xAVj>zUlD^n}e-$;e~Gj<by(4qCpqvXUL
zq|)>q&2XI|OpV7@qqk`^UAi<q%mhTfnB#D>ZutQtW}U||4U*8HS$9wy6rEzp4=u^Y
z;eHwW!2L1?cm#Wf&yHm(M>Xxx+t9Q8A%o*Lv~_Jz(diZ(_g+txY+iF`3`VIagzoTH
z+7g+cV}{qsb8*5$RwK@)P>o2tYHK{zHR^9|Z!l6VzabWTNBAff*9Qyk)3ttdt~00g
z1jU9QJ7}?J8~GTuP_4%`Zh@XuCmywRvl)zHwbx%R@y}VcxQhq)1}#%93#X!$&)I7v
zU!_+TJX#`|-%5I^z%;rbRVnWA_8|^NKzPM&-?co+D3&#bYWy<gsyw6F-P%go>*1HQ
z!!=3t$#SJ!$qp}RW0IKqI(J0VM|34-P3AXhamV-B;>d`Wg`}46<2210xt}R%boYaM
zDND!a*ssB|+%SL7u^zF~Q|$>!Ua^Xg5J}+FbXrD&!fPo759XJ9{S_l%b3+v_u~C+4
zL{H+I@%DB}Rh|H@)s+%_IJxB<-_K55QXAVUgA+UbyJ+)^4&5=MR1d$_FZdk^u+zSZ
z8W~G^7GHX&79E%Qe(feN(p|D3Dkyua_(5uH&_JBFv#mqZqfCuVZF;G`(&N{4(28aL
zN`4rR+gGw6=rwWa+`g&&n`ZW)&Ez^vgyA+$63cm3Y!%thncRA_J<d|@sjilTp^1SO
zJAF*?r)z~XT0Xmj7IW`)ztA!f^AljB7Qfi~J&Z#@=;a;=54N{Bs82x&T+0Ci2ia4&
z22V&x7x)2D#A{CLl*+fU&7m=={Ub=IphL@fQllJ!mDX?V<b*VktMNB1Xr>+L<gAwn
z&aTQvQT7H~`!J(q^Vjyb4aeiy?#&xrhluS}^XFRgk$7Abo0ghWqAfvNj+i74lG+lF
z`NOuhnbJC2TJsyWJ+>6$;h(fL%_XDw6*lWwElzA)D*1LiTeWpMoFKNVywr0jrotbD
zwJ8eLf9bwX>iKFH<E!4a+_ns7pZg{I=hicKvb%VF2im;#f)RsVBueJuIM!k7OcK~e
zOOZGNRxi<>FGyzLdS~YhI)Z%xYv$<AfpmwxL9s~IBv^`(&)d@VSmB;3eoaRUj^4aH
zF;AX_MK9(Fv8g1edq69T3AOx(I{q`0O~f*Yvv6XCWVW}3snjZ;&^;a{a4vpmTdV4h
zl%6EfUBpz>q&%rq!GEWZ@ya1tJTYh4f|EGt{IDyMn{$`u)5PY2Q|I0HXt8ZWe5Bp_
zRa<rlyV;&rP^!gkPvRdH1i_|!C~}vj;NF4(Lk9J6A3Ae)$xB?h9O5etwus4X&6^!c
zEon#GkGKA+e9rw6Ew?Y~k1ME5C2c^i^&j7pIz`nyNjlK_q*^9E`T!0n{>%1kZ#q!P
zZz6+umsV#avziuhil_FbfeGZ$xWQ4ij|skL7&CWL)p<$}nzq44Ckh-cll(koiN*2N
zQMx0B2Y8FvbW%9ejgc$ki{jp{{jsec9)viO_HakSo7(wp%Yf7X;c#Ze9p;qACceYL
z`(1pmHlfxZ<R@8aovo3*x!@>oGYG5H_Iz7Cdp8pl`OH{tl34DicUm_&IMH1sykTX$
zUUQ7e)_-Co|BHhsaj>2Hd@<tS(tAq#-B-#kA+=2}C-&l}CE2#~>)Vz@vEQ6ZgO9s&
zHjUTU*SQi!z9tH1W6Jym6B&(rqMoU3G(XsZci7oa?Q@m3ZJ);Zab0*jop=kz*lu#L
zqS8&R6cUTf)f#;etHdw7c~_@Oxxy<2WSclh-4W(fSfdjP+r#?LOC$aT^-b2}n{D4D
z)Zy5dLoSzC>NjlbJW^vXO6<V*Q+q}jZQ{k(COx;cmQPXBt%8S3`C2e_asR~boV?7o
zm&1~u_=J3wPvF>b!hDB%5RqF5e3yM4dv4~uo>8_w*((U&qTyeO<HVpO*f{I_j`~V}
zeR*gyA+>CK25ZNu=64(U2Q{`ltd<HPJ6+i!eLU5?uDd=DuARgm&>Ua)_Kyn+wURH`
zV2-iI$UfzF#Wpd{qM2AB9bn($JUEV5MUzIFt*;J9mG%6yiTWJT9gywg`JL?+JnfDx
zm=)s*HRgx~qh$Vvb|mDE5H<*y^@r}}5(fMDp=u^5yB?yJDlrtO57p3JEeCKIR#x*%
zqZpScwAGOje3XNq9&O%j&{q2W0U>0xh&7%{+|yc?3r{6VjimPYIF{AIL<fZ4N%qgp
z8%<b0zSg!|BeNc*oH)?m|1sXG*M|IF*&1yjjf<b?`3qfSltLl7wr;@`VV1_cM2iDi
zaC7`?(e8)&0kIrBpnVgJa1SupaTBdH)7{1r^83ZQ`Vj4D9o5d<C5jd@zQ&Tb<DxZM
z<O`;qt99A;V_&syK0b?7vu#La;#{u8oj=jdPvrG}pH0lSUem&C?oHA9N63w->mmv^
zwH`j6YP-fh;x;g~Qme!EId9?JBa(Z&OA5q(*wdI47ypSaW_Ah|XCa*YfZA!YZqSh&
z<yQ_h!s;kg^A?Ad)|7JjDV!6h1za{8%<Fk3SjV@w6S1Ye;LmVZ$uE;&^E}%D^_%MM
zoG6CkL@g`mMI3!2N_Ka{p&|O}mG46c!uyL`t}~91<vP(Ln9Xu;T-vT$D&T9LnANOX
z0@taBNf0%Y=h27cy*QUEOdsO<B$mH@nn`pmwsIFXtX&+>QX}K|Axfhb>U#30dU6^y
z$G?%o|Il-gM#V888W@0x6q~@RJBupL0sSt46@Gds11Xsx3o&;KEXUijwNOVG;$kAW
zxl|Lu9i%KdL|Nl2Dg<UC@HSWqenaHe2t<BFS>`#0Y7qCaqO#PDq}gqd^bM3nkx+hw
z@&N~B4RT#WV7VHB6$so=iqRnO0|Ms|cqa;hpHR^IT6z!SP9kox4sjQutmL7bLF`!s
z-i<~8?<ahshw_R6;uNA+2vCk9&oLA-uPyZ`aYn@5RI-|&yljRzj_9}ALAi?PtrjTH
zwTIY`=y_Hs^HIWi1m5p}z;_6oQOb!y06kAw9}A@^4q^wQCw7GL4Dx(|z{?^6hf((;
zn=Mx9cRa%AGqdRq>eP2a;8VoDV2AP*Vqfb_cO(4bod~~#BECf2+yvSlanB?o?%7-8
zstgoC4~!o<5P9X+1SD*@3xV-T5L=XHIHBC09}Kx=tqT!PcA=Y*I5io%Quu2rwgx<w
zrqaQ9tm{ghq#Jz~>I-Sq`LBvB+tTsE^WAO5%Is%AKLO?WOej-sHPbjh3xV&Uym>d2
z%TU(!fN}xJm@H;ZPr6>8jR=ei^Gc3;5#qmwI;WQn9WpL-Bk2;t@8#Msoy@j8+uizn
z#7#%X4lByM0tjWMR}@0IuFO+!D3kg??7<r|ifk*D0WU^)1`5ZdGq2y{F2&>BzO)DO
zZz)02gi?r45cyI+$$V=$lRpN~_-+}}Rv~~@z^w0YE6@)>#5SZnI}nO8GtUo#(uypb
z06Iy2Q6_aTB7aww_q|XSBNlT>lv$sDpL>qdfcxDKVGw5z(P+3iLq^`zMsTkUk$$6Q
z(n8IAR<0JWEkkH4*oT-txwd<#K|f)rvI__2Dr;!sP>2JR&0p~#3R(FeQk1^|gT9Sw
znJ2fgTC$yL`A2gth??|}z#1%MG9sqr>JhQyVS@#ge)6#UF7k-G9a^^#Ec#bVjVt^p
z9|K4*`9v9m_rUvLD`h+V=0_P<{Yq;t<SP4XT*!9XI0}&q8`{?<Eowm2Ta5_5-I&sj
z({M|vmi-machG<?dA9a6k*uHwr^C3i5jo#QFIQ1Bdna<dN3~=gA6>~saPQN2vKo9q
z&AP#44b|%6$%hE91?#Ap#wVn5nl>EK6AQ^&euZD0$K?Lj@{yjP-b=O_{OUYhytvi}
z(8^~My=0uttFvIUX!*T)DN~?6Ya7jf7gp_4`0IIEWIjtfAz{017UCA^Ec##TlrARZ
zD`{8I01ML;YHuOq!s?k(P|qqVdBgU+u8;jyXm8ngc4H@Ow8moPrDe1&|3rRF866rA
zLrTtR$YDOFK&#>`n(Y_(1^If!CY7i3<agwgK-wUfiTHCR{E>WJH~v&Ue4xZ9`E&W&
znRKGc)|@1$WFPWVbUH$()iZeVct+!?*J+atcv=KixgXDttdVQO*>rl6$m)+z%V@(n
z1yyhq-p)X3rp{u_(nNA!3}V~El<yq`{eXcdKT)2UHH3}PMsn{AVN<zCZka(KTfkPZ
zS1pLxlS7bsxt~oX5mGFPbf2cXv5=NEDj%uoc+4YD-a}EV@%+HRYu7ezqG>&09rX4_
zqA9w>bA`lZ@1qs&<X*LIDdc*_tNHXs{(9vU>d;T$H<iA!e=7ap;8Z#mOrUfMB{L|Q
zOR+Y|GD`U$2GP!na45o+fi0K|2X4eMsu+Ea_9S<)iF%<E_gX*m)k3YqVfmdeZ|s4x
zno#yOl)VpJGxz9CJB0t|WE?+r0E6pXhMIN?{{``#Vd)?p*hEG!#+UVG@*RRuE!7Jn
z)cm)F#L>T$PpTd|FM^akRNXTT`NrKCMts8v`_+w&WcWs6?}qU3VZ=W9*3<Sao>jvL
zxvSv)^y#WWlhBy!XvB6rmmHW%zX5X(3R{Y9w<s)a;b#1;NjKgjRqv5MRl1)J-%tO0
zr3(s_N^kC+O1}n8sPr>%6qQamP%!;=oh?b^;DV(82leHg+NKpUxVgNGOQ6Kk=tz18
zeVxtUTbhLGPeI>|s(0|cntEVD&Om<?@oS+UJ-*+}8E9AQ4K>ZOz|T-At#B(^grfCP
zG)B?-DH^M2_bOT&MSDomA{DJt(ZW3#p=fGF3n+ezMj~3&Z(u`uLBpMHXZ{Dr5Ci*<
zbb-)uikPT~DT;VGR_N3L>ztTY>(At}YVFU*#5`85e|L1BJOledtdpqO4*HxgCn2;w
zwu4g47s`7F6mi5Q5aJT}sPbLvZqK4;ucMdmqL)wYe|VP~%NN3-2v-(Fc*UkKV9Gv4
zj%}ElOUV5*cm*8czlmbd{y(h@ehSa$^=JMvQCn42TUCFWs8bQcPeuF>tFi15YJ3yy
zLv0^pbQVJ2&@}aLmHt0nj%A;rwvW)?FEKj5K_8D=e=M5*pQ_}S4l^HB|6f#x^yAx<
zExbz|V|H*WQPn#4Q|7nTG};Pb#+(^k0S*t#tqFUoZTWaE`6CR%JT$FE`3f0+i*~?Z
z0aG>}9ae-ZYy2NZCjI`1<RfVM=O}kA-g$$cz$we?C3B+gKlbBUj_en@>;CA;XzCkH
z>A(6hLp6Mc>VKN7S1?S=(5{)N^Azen0G|8nu<@+UY>oPVF-telosFn!3#y$D{dF+Q
z{Jru2mz8nHDNI&O{CF-Y$)SH9HSR!1ck^*kEuGAhINHt%5ogU5s9h0Bn6^7zQ<T|r
zDSIwW5j`OIS7VgjeIeT1O<3m8bk=mrO-V`1Pf5vi7N)y1oZZ~r^PHI($py}g?wKjM
z?)3b^w7gtBHE{g4nCu>8MrLwhdP-_Ws<T^0W{R_0O80I~cLqdiZhm36?#Y?myA`<g
zw4Km7Rx9YaJ-X4H$-(eh<*l}S43D0~?(5M$PbAK}-+j?-7Y3JWg*fgjof9`7GkK{~
z8w+)CTMtd8>uouYUSl-9G#xb>-M$_@^GrKG74rm*?%mW$Zc|m&w{A;>U>py7C%jr7
zV-+|?ud=``>lFSnmt>MaGNcQ%jI%Cb_@i;0;|0c*N4i<ZGa8<wDCUCvQ?9UTBB$xh
z(L4Gs9P(qXY3_VWFQjzYe<9bj@p2Q@au@2)(*)*&Ub=+7UG{&GYkKgIBNsWo>itfx
z$u({^)ruGDpUE{5{mEQiLQI=W_vD(cT{qHAG3$3l<eGX!W+2Cyck0|GlJGzta#TMa
z+spLn-XM*Md1YtjM$-({(^MPt`9HSin8=nF4GA$nFI(5k<QY5<876-=#ci6Uhi4db
z<jwY|#QQ!nT-Y=**R(9S6&YTBYgex6$tgRK;Yz@eXChyGgba_qkd$YtFWrI+Oi5mz
zY1qVdN`~Qsk)hK{WcYSPRi3FSb1^dL_ts%p=gw9#Tn!+@_$kOR<>yeIY4ShDBg2Ht
z{yfvYH%2NM1Q{9X9z=%GD~IHn9zI)u42uSr=9xx&x+odO<syUF9vQCZI`d3><4@Qg
zjM*`^U7o4O6VosdR|d2}hOxi7oxS?TxKw$jD}xrfF`C^|ujiUZ8(mbJc?^yptI7JA
za>e|8f+Io95BTdI>DnzVjo<dPvUl9g;V*AU#=eQ3-QQT`;1+y7Rag;gon9HgES6f{
zTNcZlp#0!Fjidvo{D%>lY_wi7B_rb;gr;J%YBFVQSwCM@u4&6=b_?py>3$&3G_$00
zey#Q~mg(hAXCr7~c%v2(QLW?JbL(_6Zk-Nc<5Mv=l`pDP35MEH+WztHY?O=^2a4#w
z>~QLEg0;vld3YpYtSsA~#K&fa|5wg1e%I3v>d4s3=sd~HAFARE<tk2q-!_vDa?Y?l
zPDdLF7Ntrsxw7?y$;>y13?VcbTF=8eBS(n9j?xNI+<M(P<}KR(DCtG3$&%tCs(iOc
zr=dp)M}(T@5>oEUBE(w0fiUD#danHjs^{X@v`^hYSpAS!O&f^azG9t&`Gl@>=#OBB
zEpBm;)rNgB1<kW^O}m#o=KfjSt(l)^D(rYEuOx2NyOegMWyIS4u*vN@OvqSUH!?Qu
zA7navI8{%yk*!DaOlas>wLbMQQRk1WrknVun~kuz$ux$IW&~4wdz&6!D>o~>CW5hc
zjx%)S*}KUo;l*JVO>U#8aR<!L4iLR!UyrYTw4>d*akN*GM)|@o71tKDduEpMnTg&!
z`3@sI^ERBCUls3o#8&%`zMb;Dp{<w6On#`<LRgE=!OZ2mTeMLeiRY(=sE#vmSNQqS
zS`GKTaAulTr6*Ql%&S_VEjLS-Ng5LO>*Fnyqx@5Ltw<9npE{{qFWQHc(fi3TT0`rI
z(EO^oQC~NY(xfF67lRcP7pz-fKZ*@^>)Xi8>tDbX*TTP<{h~8D&6%7&D5Yywx3sL3
z^t+N%lant}+>^;z6`7#YOi|H|DpK~(uVwu@X<?aZ{L0;%C?N{ge|{}%KjkxX<^R_V
zRQ?{mT2{WEwS3fQ--{}OD<L7r*mmJ>K80<)Ooa#y(O60y%!fqSru--FW3jmGMaApW
z7M>iu^K!|l#hrVk-Sx%vrxQr3e(vYJ*ESC7<D8Rz{la~B$1lo=%FRglb!_kA$Wt@B
z!(!`8NLAG@Ct<C({d~5qhQY-#3cG-dK5g03w%0~R&}&a(75*wZd$l=#EK=yI(cgD(
z{~mW9?p60;=Gup1FZDWN6@(1qm1BBULWFI=s~ZzyQa8B;hem(y9PRF%?=G0!JnM?u
zJa-b8mSOyrq;W~d$YY0Me{0#`{`|?6^RDk{Z886h6cO>`8*LZQyjnc{#gk)&t9O2|
zOo=}hNfJ~-f=0hS`s2#&{rW!l){%-%$JbxU;gXQr$3cz}ThZ%F#+Md8KKH@To@RG$
zzp1=taa_=U((B;h-h)?9jqH5i*;zd<XBdCcJC2cV_Z4PD_9=O^X+V$V%ZJ5vRdOrw
z`Kz0z{#4k@^-fyquh&<X?7bcTX-1C+k1pwDeY#iZ^BKv9?6=~xjK6RWXy<Xy7NZhx
zcf1X`^@G{#RQ9JY<bAp0Cy&33J+9F9pEG~2M{XDxl0xArCoeGMeA}9K;V(?YT<`wl
ziwC<nn1hH>9E-@g`Y3Csu4(S>1u&4#JRH={ZutdiPIqQ%y0dFu*EAf-$(iXH-8--@
z<=cYh_fz+d;T_x|6!4|`9vT%kay$`W<f6D2bPjJzG#7ydWDpIG-BhD|8*r{wSqGvh
z!j#1%(~LH`f|}?kG3anND28?F73!rnCL9~vtBhdpkQ&0~G9;cNSj=%Z@e^$!WnJ#a
zJ(c2~YO1k_`Y7=(2SYh6ii=oN15-BuLR8mO;wB3R!LePd@u2DgE6d%be_AcBP&?Eb
zC3ojFb>!ZIaKF@bgHRgPc#*BQwGFpIt-q)i=e2dPQO0E&<g{O^B}DBkU{<KrJ}t^s
znS2@Z+UjR%#PzX`Hr$D}`d4rGNP8bMudUigsLMw(*2n5kXvDb*Nd7%mKcD)3DWZnM
z%=*|{B}AAGcbc1^Kd2F}q&nKDqt3ri?e80W%-n=O3g~ntRewb-UhLs$L!-#M)OTYw
zO<c`fNxk(xV>+C1v4?(=M!a5#D&Fd;|Kj`$s-hQA#l;@Ci@08>zo8bdmMIn7D5hz}
z%=N-sud}HBYMK5kPTV&noa!ScA9J<r_M7{L=y$W?!bg-eWvr|>>LTPiX5WxoueZVL
z3m?&c&WYQrZ)b@?8LW?4_{i-teyP^CMvCwI|5g4k)wf=c#Ov?-^(!OAv!iam-r>e!
z!X9Sc_babcAG4gko!IH@DE%IlxUTVbruJ+6B(+VOZMk_?r^d*A`oql=m%lmQ;?=KQ
zu(f5^^(PnRX-wSy!_T&UdhW*SIr?#DR&PFdZSgk;XuQz+Rkyh_7gqN&jO@AO^G}mP
zz3TfgXGf{u?S%GldX>Yc8NTx#?Yc%iq3;ov4X+S7Zxz;4@g0#PS2ODx)pclCT_=6=
zy2f7HkH6BU=b1HJI``7Kcax{nTVHMczo>f?uqKZ8aeO8uWD}BMS(6wdi2)5_G!(+2
zq9%Yxl`2}K*3zoQiU;*7MQgRKfP#v*R#a5#eYKvg_XXCIdS6wn^=P#o)p}HGt;XLw
zyGuk4tNpa!=l_46nR$2T+SzwzXXicUojQVPYn7SBdbK9JI;=ibXW;Yr0sL9gnbA}0
zaT&w3SO#m3C`{mIti7;X+6rA-rQ!b*pJJcGld&bSecR;sTKD^KK+1bCZFflNNjE39
zrdoQvd-P68YuP`oZ*n@%r@_lHU7)VTo*`%h#)TLaV?saYPkCw~qse*xw=qhBCrVJh
z1fnMDS4q$Y3DD(rRIqYCWB8LN%kA{$bM<8v3%`Fu6Gl(jd}dfHL~CG{o}%YCn?k<=
z^X35YW@Hfz#nl!~3Bo!YD@r3}dejsvH7yW|j&6&Ues4evV>+R3-C81)+713qX*3uD
z!L##N`$c=Dt$YxozLt9)YnI&Sy@7rBe^`rtJ$v^{vDw2KHVADH#?NcbebDlm`1js;
zo`kmv%jHX$IW>jJZD-Q}rBbStNIa?iF>8jz1sNWL|8>t~d>#BX@K?cK0sjm5%iu48
z{~7#G;4gx|0RBAqbKrjje-``?;Lm_B0e>3&De&KeKMDQ>_~YP@fj<iV2>8R`4}m`j
z{s8#>;J*W341OQ@z2NtN-wl2j_?_Ut1-}D)5%@yz+re)GzZLuz@SDMJ0>2Ub2Jq{_
zuLHjp{5Rmg2EPXUYVc3soij=RIS-mBGoTCEak-h95`E5ztcNo5sF{C`k_R2TmH)Mb
zgM~u?vepmKz*LJ_I^D|kaAoGNtYU1W4%N21^F-<qvL@)zoLCfxXzdC%Uq(kx5aPU*
zYMAX|0T(B0m64Ib2(_<x0~HTPY_yVLkvbD0SsJUM+QSMBvTBvc4wcDvp#ib6XpI6F
ze}i0UFX|j=s7G@tgUzyW&1pEbxm|}`&808pvYJb!$m|-$yp+2+iqVaNmoQ5W0tgtz
z(1*WdHCa&D!z_X3L-<ddk0b%C50Y3}pMOw(bn{zH4D+Q*KgPl7+0PICaz&xv^Jvo!
z#{Biyhxbc@cJFy~NTIC3IJxSqD}TeUUivAkhsT+7_Ki3r3EFq#hlAL7>x*beJe_$Y
zM!);=_I#;%&9u3byo0uE`g5!r>WzVVFO;0U?yVnxG5ev!y!q;q^^%~BUze;QklGwl
zZ!gU*km=`c*;<UvtM3;7<Pr44#BDR>%1D@+svNuqJ^T=8+Qq}m=5%Fg%KF?DUk9>s
zXl)B<(A=5s)&{RYett|WRCaJ_#}AQ84L|<Cz#4w={FV^8K1qis`Z3Mmvfz(`^<Mhr
ze@@-xZJu%L?9U!S_ZA<#<^>sFh18-X6VlgUT0!lPx<p`2Yls_hCLsdfTE$w~S6DM!
zkFC$z*kCq<4P_;)o%LYDSSjnz2C%hQ3)_TMv$fgAtcnd}>##v=UA8GpSRGrP)w8~=
zH|xW)EXP)3HLQWH!TPb`tc;bjk!(%20n4zBSS71q8?sTX7pr9>SWni-nu4f3Y&y{a
zcq{-q-2u2RfNKJ{Du62jptGNq{A{Gg6fP-3(a#DwxxwFER1kCl?(Xw<=irW-qM;^f
zegJ<)uvNp`tT`pxusJE%v>^r)EpZG=P-{2T>dj$@t;@$AgxCXup-tZ4X0d31bFXMh
zXSZlthnm=-rgnBf$qszULMXXiwCk}|Fky){3x+><10WkjgCOff10mmt21C|B4Z}^h
zn!zfNPKRa>t3ZB*OgVh!ui1ZI8TklDq1M0TMt9f4VmpCtF)*$FfRtB&Y<lngUj6&@
zO{Hf<&`C54esGN#j&YG+YBup=mcY-(L!#6#!*uw?4f6;>dO1vU$gWZ%!_P(yib7HK
zxr7-eWPq6s#jXiP`Z$RaC7^Bz<B=KaMMIFDd5pIrAMMt6zQ9&#W(jYwBVWeC?5W?2
z15`>S;c80lQZmWpDni9YNH&;Fr4$;Ti8sLCTS@=kOAT-PL&GqsUlRowm$E*5&({u}
zG2k<$j`{xHhKxNU4lN#u*_^riri}gV+R}rVGP&aNu~fqa46ca`F#X0tBW<Zk@1nYW
zfNCY3>!Pn>>ULVaX5IC?tow88vg@}0wQb_%lFb3Ehh7>t0j>E9AFV4HvK^so{_Wnn
zGGIA|71;JuW2VoTadUANW;6d->e`sKa*sDF)qA-L5xDq5G<TSz5WO?@rz3xCS^MMS
zkJycy*Zz3>+Sq&0BAMR9oef=y%fRmxF1z#~<I>`Jk?i_und^>@KX#-9vz~h8(`>&)
z7NQnUIxQRV)w1(b)+|h73zlx$^L6I-Z-Q94Ugp}4z{PJz7nXK*4uCa`jv4XY!I57d
zy0!2uW;Yx=zh%aX8$TbzETeZ_m7TmQOPYu#4I}R{#-fzMca9%>IAO$;*>iR5nm-D5
z@BZ%Wm5Z2F=owcg1{a@+iJt-<&*+$k35R8jQeO*t=x7nDuVv``xOwurISQ5}d9jmE
zAGkgvB7>Zu*}H3*?~d%fJA2mSIeRcW=ggW1%ctJYN@2b93TW%m?Jz1lkq<XsDdm*+
z+I9Z~koxPsdka?HnYMTnW;3ST%R6=B_<Ao^l@>3jzq%XoG`trNGyaYEj$P5~2Z`3J
zX*~M!LfiHSZhXFBOv&N}_1V$;R%Ttkzv;(FR_$slFKH_uv<;E{UdC-`d1l*Au07vu
z-!X0UqKBAW@c6F<Ifa=Ae#9&ha~2|!t%6?bwB}^-y(5dJEpTCW%kVq<PtD2Mu^Y4A
zPqR7H#zOQJ+0P_?{lxWnQvTAp(=eNL_wn+z_rBWsA<Mej$V=MD2W>~>zS^-JC7#>9
z<;1Zq;}&;db7uZ^^W3c`E01E<=V`7Lgy!0lxA})<$7e5sA+q4!qxlQ7ua8J%Iai##
zBu<XB2@}wyp`?d5&H2}jn_pZ%c4_ee%#J)T^VZ&-zhv9lYOdDulGgG;pJ8HRjoUef
zkxnR%+b2UB*Q@f9SLIS2L!vnSnW^XI{Q)oCh+~hreqOruUMuoFYb;FJk~sd>hEto@
zjhs7xot=5(`>jt7of(B$t*e#1q?NqiFd$*M2|kZseRl{<0~eNDIXC%_+=XfE?6rsf
zx}LNCR5MnW)>01Zih|EcLKpOUG0|{{3p}RgHnZ(#UEaEM-RZe=8nWx2Ot?JZ%bW`>
z*y^qp@{$(vw5^B~bB?X3{kR9NyPLoMW??8h_t5uyA6<E}JcZS}V&x^Ve5Q<QG}HLm
zBW~TkvT#8RyXf@F6BEBIE_{vkbvflFPCiql#<&$mgd_3J+3}xe?p?C@XUrB1&senW
z(U?&x*5Go;OC0hv7!o%$#%(R`wcmGa+^sbSW-r#U>wcL(apmpXH)^ppTutO9P5A2O
zYw0tW&YF@rviRUae|AFloqKyOj=mDc`njUyB~fyui64(9^(SxX_%}Fy{ldd-D;9;Y
zv-f;)a_`SiR;gK|tD(H4p*(E}Cf?PJTe<D5bi~q@8)eAkij-fBl#>Mp{hxbRE(TPS
z`3BX+2Ya6cen!Zi>c;IY?zg{t@apF4Q*O-Zz^=P=^Ye}SzStSf)^tV4OCsc{pU@up
zRR1`f3?+%<N6!3dasJM^o!JqyGe5t-|KXE6m^BZHkRz#KDB+iDLkU8`Is`BtzMefq
z>f7`+E|W<dQM5Aa#){&Ft=TQB*PXj|ZuhqrFzfGXATMbE!!8Ym=N4Z&=r-s6c<aIT
zY4h)5cGQVQH&1?XepN#@z|}}z(ug0#=>`~djlDZ%p4?V=VAIGse`0px=37rj<{tWH
zG-hiFSfyW&tp@$bj^zJ1^X{=53x;EM@xIlc|Cayb7e8ROw$Md1+hso6Pk;UK>xr|+
z<`iId(|4QC<*vLv8opkOD@I-tL$jg1u_JZwXqgeW4zE8su5e*LHhbUx+_h()teKA4
zKvy$)Ni%sz_;fxcZyFuLaHqMK=H8z^<HEc(m|Zw#_xU5=?>zklX6v|G%1c_x2Mxo7
zH5m&RHbtxB_sdX_F!*7jgSB4K`74hWH)F{vfA-MgX@`zP3?q9@6fs{sx;A>t%Kh`-
zV!wEN;m_Qk*MBn$vvtMq<}=z$88sibCe@6cuKiFlcFnXe=AFUp<g-7ldvqZ0^NE<X
zrp3wWYWPMR4e!O#87>a#I=)NiIEA@sJMInNPM1e*yM1MA_Pk}7opO4`)GzLCbbXH5
zdcqtsqzI93&Bh|Gtxw|J{4+<s|84xd@tB=?;m6ynzMi^Q%GMX=t|5TdPy7L`iC0e#
z&po<f$>KWf%;6I!uAWh}>LzAwPjf{C&|H`HeDz@X_=0)CY{8^CH-6YP@zO@j20zVp
zlh3t!!RUFvFI~3iBX<2yi~h(xnYsBIW?y-lYjG{W=%K`mxyM#+8&j~b8av~N>+$~S
z_qM{^8{&$WUyPT>Ll0$;uC<NZQ?@6b-@AX?h<U%y>B-J{vg!2dnG0`S$84xrAM}vk
z!q2{~4AOCD<B!OY-PKNB(oQbbFeD+U;nbbqFZN~WqWar07uSCnI*c5)7`HEc(rL@~
z1Jf67zcGI=X1D)xXu+<7*SEuuDNHDwmO=X|H!!Nbywi@2hp+r~ar@#+m|cE#`F9zY
zrry7g+3>XXa-ci3MxZ;iM(Cq^?GxTbp|6u_b(+4;Eo9p-KKt<NJ2~eU2eK>nWS<>Z
zbneiHY=rQ7^dtJN4vdxdv(Ha2{^{`-^K|U0$5S(Qe|}|g8XF0(cCjs=X?T!vdv?73
z^ONh>?wqun)KCY_xO8y#tw*OH%Gd^CHo$0;x-el+=yc*#<~K(QN6vvC`{Ko`4&{z2
zJO(4Hq4-P~6Zh*nicqKJQ&!EMwf*S)`S7<WTJ+VjJ)4)p*VG7J{9-#k+bU~p5lZ~!
z-qx#QpDY{;f1iavKU`6G=c~n-jdHb@m$aw<js#dTWRlc+#-i-Z_W3)n|CRrE_53&3
zS({5%FWI_qYB1XvvR-UYF-ZdI!&K0jLzfbudzy$<Xc-a~qWNv^4|85&NoWY0RXA?p
zW%!8B)HfDdhP5Ak@Img@1>Y@BWGBr1>(Hc&+eRg^O@%h5!q2BVH^oNfqw@_X>#5{c
zX_jtWeJqECp(kA!E>PE$8kF6l+DLsEvcN_Kwm*jIK52`LhNJZnmq2V!88Mk}zumre
zhclOetVh(>bu(gO`t|Fd&huencoSHnL_uW7*m-sg)WJ3P;ZIkChny%q-sWlbpAJ~u
zeq{IGBV8*IqTa8<0dgJEKkk$AVXu@F;V8M)4N*ph^j4GKz4=pGxL>`QNghJAs~6ya
zW|ZwFhqWjUXjs)LF~6TyNV}NP?^$x|bZ>er4LzQQ8Wb)yGF)mw_(d%QUw8>C!51sB
z6kL^sVrny&H*yTVq@0!GQbWkpWNxV$-BJ^|FKPmJ(o2}Zo%{l(aH}%OOKrqfW!AUU
z^e?p(TWUSF)H3XgT7KR264qaLS7HISD$BE%j#h2Gw$#EcHK1B*RJGJ#>WdmgrG`~s
z)F>)7z*^ogYE=eVryi@?sB5X=S87<a)YxdLA<-8#6uR&wjD=Feq($I&lrb1um7&sI
z$Er4VT51rL8r&>3!dYry^F<A4o_Gl(nkQetkY-f|J*kaJ-Y6*egU6mV3R-G7bPP;H
z^emCPr>j1CtEywXsydQu(sPdZIt2b6JnKIAKfvDs{{Z}-;2(nj3;bc4?=avCJU#q?
z9tS`z=2NTkhpRX@<Cu8f#*r${(6~&`oT%hrh^yiO62Fu^B!ZqxA)XTP=y2u7EIbhp
zWS|E#RCeUT<Rg`zRX~q3pvM}};|(f1w_wSU%Fh6xrv%W`0_dp$m7NE$4g8KH6|L)2
z>-*FSKefj1wzLnv_=sR?zp}GMDmxjYk|QK4p0RMGl5+`;RASEmh;aVNpWx{+7W7;P
zdiKGQBTtWWqsO=X-EnO6D7J;-(QovqH+q)IV)2ZXrDcw3qsPM0W8mn~aP%lRdW>7X
zc-&kj|0AA+yUdhp#ItndI8Oza;}t|aOGl0-iHF|gznqctQv1QYjdS6!9650^R0Kxi
z82XTv3T-7P@Kk9-7*%qb5Gn*;BrqeZvj1KF6d|6;c@X>|f&D2xbl9?hUc9IkaGt~Z
zgUE3ejet{2x|ApDHUoZ1!5{g9egS_4{NI?-MYqA<0bhlcY-;tN8ptkh@L!s7#M1gj
z4P>J+;Kzb5dt4IjUeP*ssg-+_2Ywp(>1De9Wo+C-*U!zRUAz>=(XyxgkCub4`tYUa
zcm2QI?X<VaLKQzAm#AoCPr!JD?k2nVyHn6~=x`Fn-<^Rw=yK9bC~!>xHw3Vk&vH>w
zi{$ZFKSSm+{a^Z&AT<x_2_RSip=w&<hQdl32oX^NXexkcKKYKKR_VYXt@xPx@CX<h
z<aPe;Pq=$n)c`r#yK}{%LE7;JM?t~L21l81pV;`EQy^!V;X(ZP*y#`}4iK_|kC_EA
zFEB*N2|o8?$Xz-|JZGGcJACdnkh{!CA-nk44G{Y`Qv`XB&-pFn6h{jAmXFy3F)uh)
z=*&QpNOET=@;4I$Nhh@OA0cNYQv=E7Q!hd4%S;ZHObnzMN$&W(u0Phhqk^9q$j|&U
zM?mJ%0r0EvD$ko5N@xG_)5FV54bS^4{97}_i~bZ|VrKYP{sB~C=klhAzg&4|6K}R?
z6C}OlkAU10CX}x=JXj}yjRM#rfbANVp7?S+rF(@x19Y`?*J+uRZ@2g;!f0tb#lvPw
zA4V9K#)^kCFx0TR_ND$<RgTQPvd>=huQiHVZRY}%zSJ5jZ~MyjA>~KddVM?~C5;;O
z<z(CrwTd$;HICXy({Es(J`i&SVrnXNxMrJlTZrww<aBys{Kv_Idw<w91d@j-RGdz!
z*7|Fp)^v#Y8X~GIiHxlc+54pQOzGF1)9r#tf2H2XxAp*dcF(lr0lhllS+YbjPmx*+
zNkci^Higd_+%>8tLZNsjnXl+q8{t-@kV2`Q)1Bon!Z_VS{vw>yRae3V69G>Qr&rQQ
zPWL*0(SXzS<1ZR=x-tAkBTlzOnK}mh*CerCsjnhr_a8&9&?JB|FZ!rHB*06!cZ%>G
z0WuGcOiJS;^1S-B0*D?Cp@19~ZpjTVs2Tr7cB^R3VGv_e2{putuqTChA{n7d{Tlh_
zk~B5Ev;Sx^o`<8zG9Hd3yLp&HF7hy&xB&BJW%Wth>hngusVTKKz59*cN<M%DUnT1k
zz}qKCSz4bgAaOO2e;V1q!`@^+58ox{dDw~k&cpVE@m6tu%4$CI*g?sC2Bxe%Lb`Z&
zG$Fi%4D>$DqR^JCCuvJgv(iwTEQM|u$RsrSG|P-QI;rVE6zV9J#e7W$kVeyEYau+H
zj3sZ4ZwXhgk`IW`W#cLIpG3aoVLsW*!};VA55FQ3Z-6n6NlhNQNE04DA#YKbjL0Bw
zp{H0D@VSd6>%0Xl9`hFZ>6Un}W(8;!;j1F-F2YO^7Km^&EA-RnK0>{JiSc?L0Y>-;
zy_6u{_ZQ(<5iS+sZlBa<7*8OFIp`%kp8U$gafGQx;aF0e!WbQi=Ao9nQ|<H|6dE_j
zlYGsc_C=w=a3#?|cf?4Djza%GiIs=9h(jZESAs_9t{$4xStv9LN^H>x-E>R?wb@%j
z%miAm{lpydEq`%(4mnY+(LiL6hqN_(Tc(qP)!rH(+Y;@XL%yyi^v>aGLhszDCiIR{
zBlJ!kjnF&IHA3$sYlPnUOe6HpOpVYx8#F@iBxorX=a2^)0V`Uq&^vamaNkaZeMC4~
zgo{M@tq9MH@Ud3tos&AD-ljSsK1qZh>4e_-Tqk@(S=EJasGz#=4Q=A#NK|asd&SzN
z@D<&up4yUrMMMuH*d7N1JG1)6(a0VQSKsJ`&t<P(_*{O_3!lp^y?}qIuYiBO@5VdG
z9t9=(`3m^Y_J!KQ=x5TI)*E($C6oAz(=3^<2mFV{Lt2Jj!2c}0fPa=`>IM84=mq?5
z)(iMQr5EsjPcPt~^A+&_im!nGHogM>d;1Fb&+!%TZ#D>{c(<>BpPzgM{3C;KZxmsa
z2;UT8x(FwUaD@oJGYI%!P(!HKtA-FCB*GRo1pIfaA>hBgpMd{9egghS`3ZB_0zY96
zEA$iQupj&=awzuO`2qIBDE70A0`~Ka0``{~1?+D#3fMnt6tI8U2-pv!*l%JIu;0N1
zwS`mc*E7;9z<yW$0<iyq5wIUlu^(>~u%Buy#eO@Zfc-v30sEtk0`?af1?+!o6tI8Z
zC}97wQNX^zBw)XRNx*)hNx=S1lYphqO#*gSn*{716z{K#kf|v^iwI*y*j0p|h;T+t
z0sCoYq2AL%ymZI0;O~56yLdoUH8cEfpaVk8LI;@qg${`F7doJ$zt90`{z3<g_ZK=~
znLou3?Es@cbU--mfc61G2Xv<}=65nUK<I$60YV4N2@pEqn*iv5aM}UNT0#f-*Miz2
zXb1dB>y3a8um#Wy=m2K`bU*~{0KWjC0~!XDc7QQJ=zypIp#$Cw5IP_|K<I!;0YV3?
z2oO5py8xjBt^^1jAgd*GKtL^_1Gdx>5Y?@gfWTq3gbtV`-ftA)NfF)^AzNF3HUXmF
z?3uFILlUT|XKkSiqAjWK)0!8HId_WiLT%v#aEbRdECOsO!Z$>iW)Xf5p9BiOhv|XB
z@8O$3;rDPjQ20IkN@4OG!qkD;JA(cmx(34UA%gxMR@4!G4?F4zzlW1`gx|xpIzs=r
z>InVA1;Otjg8m+Q1quB#EQtHU!uIboux~#@p@o{tOdi;WbgT)FY0lMAn!2YYf7H8Q
z&puSuIK*Zo+#449m)~b^#hH}aln(~-GB8N$-8Z?X)=VPmsJI$RPNsDj5lIU3HKNeS
zC`1O(D|;lw<<P4zdNqq)h107w^eTd0?G00L2BnYs7W-kZ<N+z%nLzrqZsA%#sK*bH
zkLZ=1UX7(!Vf1P)y$YvS>*!Skz4|U3?^5;cKd85VM;Q}3h2(_uEul{h7hA#<ADUzo
zo3c0DH%e&AkKv_F`8_<jPe7YGvHc}vXe4%8K9Jf%B5xqFI>Of&H3XAA6b{AYEQOz7
za+ktSF;PSU{0x(tkxe+O(*MKs-tWEtaWmdjroDbpi!fy4qzZB|Vtjp+=}9_RDXfm}
zlikkT5hyc=%%(AOGs&+!?1>)ajX+!`L#oxw?S!}#20hI0gzyN`xt@xvr8GFk;udiq
zaOB+v{s&d*$=&+Ibd@naMlz^D=^LX4rMS<HEXBPhvK03P5v4C26fw7hY*A3Nls<i+
zKdBWrpVh?NP{jo*jlpJw-ZMDsncJicO6e1t(ElUiQ%`z$(x4z%8!LiH+lFcFVJ!<+
z{Til0T(}|#egD~Dgd!knRYU*H!F!RpNB{mnLqJ)d8{|Pl$3Ud-m6F^&C9T=6O+G=S
zP9sNKqzE#$B^??$EQsxs+%2U~a05)D8}+atTR7>$!%*@G4}(cQ59^T)jUuZ_P^i6{
zgv@Ca8HfX8>jeLR$XAV^A?kDF01q#cn>@UPZp2oTM9o3!D<mW;QjK8=3#G5dwMBKW
zLp@}16yJ=_)yT0ZXa-~^g;7ESevA?t@F+@XfT6L_fQF4}1MIW`=EjjTap2m3V7RW|
zSZF}o#zF)7@$eFvz{4wKRb%>iJ3O8|XzVC`ew`+z&+pJge13Ej5dlp^1T+y5&_qN)
z6Z-rx9sx}#0ydcF^S^2$BA|(gfF{E8y_@pSNBQK>U}-Jo*+#HDf$W2uy4$e0sT&7P
zOL5Rt#6eRL2RsZ$1#zC(_j8H_2W><+j|2y8#AXAJ1c!(Ohlm7+hy;g-1V^MD!ylR=
z!SNIcPB#*q(11q648s*9+9{&JDWbtCqQNPm!AV;X!K1-RTd+;XqroYn!6~A_DWV}-
zXhBFc?S=>*1<_AY5bZ`mbSVm=MHEDfD2NtNP#ha5MG;0G2{GiRPe860lbAA?93in=
z5oy$XP+g=hB5(6>7x|Qj`^XnOJV1(?x2y{!Y|8_Pd?-du72$djo)#c_Kz>z9>nNl0
z>8OGH%f<9VBD^iaYApm9(SlYTMzj7RCMm?EdLnEq!v1{LaGKR$jA|yr6cLUT;ZmA4
z*eX46guE?AeJa8)L|7!kpIVTi#_WSkd~#oM$H(r?ksn$``Xj>|8dF=Ar1IBqX?*<2
zgIDQgXL^~#UnbK_4S$(JFXy$qw0QX#6+H%r>}#U3#rN+=Cg{kK*T@@MnHh*rUo#s!
zuuq>9va>q*^)>QSb#;JWdVhN8R@%ohe#bG9J1y;TvNSX#u)Rs<ueT-kPVbXqCL8p`
zqm6G}t4D+2x`-5Nh^38+3sTlpBv_N`E9&Y6{SGtvOix<1@wHkPS?yMYKPB%&wz^8Q
zBGKB-Ut!fWga1`}isB72p^a}ntI9939>N{T*KIESA$x=(9gmPI7G_jg5INq)HwZOI
z2txQFxz~pLs8O^>4IM#<ZJyG-_j_DTU;4*0v{i8yrJtfcYUHSoP#ZFlqtQ`qTlnMo
z$lmlkYE8QOB2KrnZNxcbk3EOUxo8z<Q`S~Qw}cxnEi%`=<Ug6rYwP<;%S%}HN{d;t
zS4c73#a_q3uOR;c<PN>L#ox3ehIkcMUs+4BrDZXeCJ!L*8<3eSq9#wc7)W|W8K?-R
z$0fAlf;B30pt&XYjz$Go{fhjeX9ASIvQQM(^lg2clysQlQ%HO?snIT?3kr+vf=Oho
zwiyaHHdDn9?AuM<jJ(;7-p4jWBrTTPuJFH*@V10LXk5EDY_XjrEtdFiBg@<Qyw7y&
zKiCoLOZLTQ*Jt{_XUmqxX8P8qvNJQXHdM-VV||f~%Z{aG-;O0c8k0LQ5V4bw$dBba
zy&HcM8mqDrrA(0n$riY7tCZEf57+5@Y7ahqoe$;BXn2ReKFf!Pgo?h7&77-9C!?Ws
zOL%lxtP~<I(;T`Hu~3zXFStd>{8ubl7%km18Oup$K0b^OCCyY;Efj8VfC4}BQ9nbJ
zA4I)b9iqnYQOSJxAXXKEqi&K-%@*};j(#Ua`k<OhUH7#918nal4~XrLW&Vs_>5ct;
z&7@5eoYK;O{C_4Fngc|3e4ohtW8+bBYa(v}F(leR4E#l~f!JCgAKmt5DkXEtTW3iM
z3RTus%G!Lppx^skkNeG}RvFhhN#7nPNjhPlx~qJf1qCW=D`l<w^-Sr<C1{(g9Wd-3
zHdA>q^Xe#uvgahqnp{#)b9H!P)@|uV3Ek7@G`!AljiWkF;x;%Gfep;NSc~P19+|P0
z&4{+wVKB!aq*qvFuf)rcJ_v>2hFn|R8l~V^RT|2|iXQCf;6_fdj{7~3bSlR0sODj`
zW=LnKy!cx*xDeyR7@flC3cn$Iq6E#6NLESk1_`%U0!>Y9!FVwRwlsE{pHjy~e%zu_
zZ|TDtmfjj}g;XhTZU`|q&%sKsmc9G*F*i%02L^E(wSO?uVp-@I2Hpkhq!~_24l?2!
z{M!U1=#a*CVE=xH9oIle`zp%7p|Cz`h@)|wPKo{Mn`5*H4TypFzZGNIRGZ7iO7G_M
zpur-uCb^IKwUm!<jzj8kDum#lHV&Z#JT6?aJ!6|TXrs?|<E!0UZC8v_Wn-n%qGJ>2
zxr;YPA@wNc!2UKlS}ffgYafjD2yr8@QXw0~v`OjV8i^DmrTd%q@W!@T(!D#PMxr3Y
zda2T@EzBtc`zl7`X>4Nu0p>PoCd?i?lHi1wvxiBrPm~VDgyl?whQx$H#joelddFZT
zYcaLn!kSyb!@GTj{d(<6cWS?BGB|QPiqj#Ltw)a@so@fv1-0_Gpl|SaDC!EAfNLF&
z%<56et%G%#Y199sZd#nYC-0;O^fD^YVrB;{NwwyH)l#LhL;oJ>ZR@%ENlW@kQAkW<
z)GBy6_P0PpJVay^Sa9$-1b1=$q`AXoZ~?9hq*#RqRdmJSum*D-V=8sqjxlW1aj8;m
zIL7E4jBA!>+$>Kff5wcQdkRf-5p-8{u+j@Hb1A(NlwN~QGEI^ql^Qk1w_>!DkU7@)
zd%!fWh8lI~JG&j)z#z?b<NIqH=*(WM5jrJ0@IIqz(Y<HN5UUq+ne;IAW~2{>5u!pF
z#Hj*=<ypN@D+0kB{|JMPa8s1BQE67MxDSvtKohS+`6CgLDT7BMX{@2+PQoJeE`Edb
zRWM1Yn=X@(WVI!hBq<*LLfBp?4SkBc=(90G=9qEVvwrMEy7iS=f+Z*9xDWE-tevTv
z;~ayPupcX{bA-!n8<5)}&`MPAC=pA>c*CH!u2_kXglnYwEYBO+bq6{y^_a_sd2Ib6
zNdQB)iF(!3W3`ffMUMlNG7SnQXHprZKiAEes9xvSzG2d8%s^f1$ve?8)@tq3`VR*B
zFTVevWLrW?&w+iC)1tb)%LYZ`(v9l_{cX@}S?vsr=U}`F<6Yc&Z+0)nXED~R&SQK}
z#-Rt?WN*zV37#%_;)9#xITE~zH|+qQ@hJ(uBT3>UiFAMM0}1NZgOM0;umvGDHV8Mx
z@9KFI6R0!xGN+;eXfT3rE^w;1t}lyb%W}~|nI~E<^Ykmm=rG2oFdp5;o8Jr!(*)it
z!KWnXJPaT1hc2#k9GZ?o<I*uQ!?oK%1lO<QTUXGIoGTI(pj%Ka`ExWNQuZbabzPOX
zUBOiex<(rKy9VOWf$`TQQWWdzB6Yi#U8Lwbqy-OzHC$X*DPrKp?cxSv@^*LEHOU*-
zP#D~}j?3IG{<sX?fTZASu*xo5C?5(n=qVJ6poQ#8w~Mzc$--WcDPkasEMKTvs*up2
zd_v~?LPA4YTbR=A;=`2Ww?0Bzql(SrX1o_@RNoom6TjFC-Ew)dZWrgta#y=IO26aD
z!Y5iLp#T!1dI-3J2tT#k#rvtbF+GKpu2R=AncKx5lW{-va+fL7_V|IAv!zy%f*!br
z`dEkhRA>PDQ|OQK(GM$)=04~TZ@c<9eL%U_-!XuHbom0Bv_=Er#mja}fnCXU|4_h3
zSo!>G)7@`S?yWrsRr-K8KN1Q+LvC?y7k`W6mJWtTx01VLtlJgHSnlD+FrIDcE-CAF
z1yYuKZKx3K!Ma_62g}X+M2MEKZdV{-xf`Df(U^6+0?cxbVL~)w-7XKYu;7@O!6=zU
z1~0p6n9|I3*_L7G<j=y2;VtDLFT3=-bNAdBJ%{xEW`9oSnF+t_1?oxcEUnU)iw(~7
z9aH~-Mj5Fz3kIeFYlNz(RUa8EEsW+y*%=lYu*n=9t%ccmyH!dI?;@_GA)<S%2f1KD
zQtU!&-U-XQ6N~KD{&v5G3u-%U-=FMgIv0zgQvFcy#&AbNgyK>mNPv5kWc1VLe+-$5
zA8W^=ZZs;D25B@H0)aFOr^4?&x1SL;=dDC~%)y>ZuyhqxY`{tr8{ULHjD1dF*?H`J
z1#9l$S33R`L9T|e@TZY9<2+-e@G7?=G)`FYpoin_NQ#irF3pnUc1LzQR18t7=xDP{
zn};S3fr#J9Mu)6BECE!qy#w+kXr2Tulb}r!v_pc5CFrOGl}OM<n0q9>BiJdEIj4Kw
zMZS#Wj<=9TM+b*V^Bj@rjyf^q)2upCmcwBIPTP|w!;FcMqdoEx5qhXjB<T^cUrIQ0
zOz;wfxtvd0O0zr^kGdry`y)iN<f;>EugQYiS3y9RWbHAUtWNB<1QkC*DF3rW9?sJy
za`7$UH)D%=)%Q{45|sA<qh(qspYQ-j&XMFTz|u7ylTzcBAhbzqg#RGg0U!z%bbwHF
z6oQE*9_YLWzT$yydEg8w8YM*&rD(bo&5@!dQoL3Q4Ij1@X7yd*4}d=*^OTlITkp#I
zK$7Q=(M5Hl>jO#f2Y?aUD1h+Zu16^N5&xdu9--nT(2KIV3%VqtgS#ZsakAvjs);f@
zTc%*=$h6C3gFf-xr)Q$gIC&a!6rD$Ff~O;foNne=?E&rl70uZoV+v)`!!p?^8FOC7
zT#-p{$(RQ+Cc~2%<td%$iKcs^Ii4tsX<E%+Uv$oz()8%)*Mb!Cy^3n1ZcAb5%jJ(5
zvQlXZ)=RT)yH+aQE@!1OWMoc`!*cCvZ>MelcdxBJZdj>I@Iz%ol(2M`a8o}`Khk08
zc>?lY>7X53F{==oAT)|$*{2Dv%SvVVci$E{EU(vj%V~?N^OocOdWL4kl7}mmFaU~I
z$RJxkxL$&;2{Dh55YuG|I(SV!88UzHwB}84E5#*!JxoI84<tfn*AfI{3nB%)LuBwu
zrRwtKDGu&jqRJMQ-^DbRA?-EApJSmSXgwF4M-kP_zif-guT&C0wb}Cf-4C6%6UUF=
z-e1+5Ln!m}TN;_}v~5zH@OdE&L5Os&F4}S~s*Bcd-@6|>Ez_9BWUY5_ly_uTMP83;
z=wUz?EszQD@sz~M1G{LG%3v(vv83b?f=C#DzK=wlJ*paKA4o);_4RlT&Sca5f}#gI
zZR`f4y8<2HYR4Rkt9jP4xS9tj&dkVg1bbG8k|;9@=Dd|kM}?5-sLHgDtvn4vJA_6t
z%!7KWyVT~gZim|JxBAvFr{&i|o&8No>`l*N$crVhi7=V0P@4fk3GiC6a%fT(H0%*l
zKZ4rgOUDw##qncl5fm$fmxFN2k0miPKbEq1yr`EzTwEzyV&Odp&p+Vck~;^=YY1I-
zt&5iH_$9^3*|2gr@f$T#?zC;$+}LzfRn<E~sJ}B4vNiZkJN5+;<Jw{^>vnIkh8S+e
zIxStUOmNsvOFduz=~>il5?-qmFY)k&sm<J5KL09W{49r}oVLXmI&EDl6o#*uySA1h
zM&Gpjhm{<mv79{d2A$#!M^(@HutHWV-*j499E7Zmir;v#Z;N8++0SZs7cJW+Z@UA2
zS}I#y-gfI+`dzK#ryuy9OlottQvCcEGZ4j2yOEzcZJ%X*W`ZR--)r}`Sh=Bv$SWWr
zi~U}r^yA_e6$Tok(Kkh-;m;PJ^N1wpGF?|QO;<Bj4ZWiMx#=IEzQo8fLr|{kR%YC-
zOj7cJCd0W5qfM^PD6TV-?!{zV8oI@q(wdBtpy?8{MB=eQqAHYNPPeBhCly;yMY>XP
zYAR+V(drec_+XSA&E|G}2$9`Vu?hpp5}AtqfM}5vN(iT8zipHn9GD&W&P?5>-@f&I
zWMFp4m|UgPGG>gI)0Ug748G>UIQ2L%Fk6>7T(6f{`g6mhh@z2h?MGN?lyQOC$Pyoz
zUH`RrpwOsjC^Xt9ss|A3aXsjYM3J1(1L-!VTLZJ<4T3u($csGqQZyJ&8f}ECr4MUB
zXqd3GQEznC1zG<+mj~gUtV-QB2y12k0~b&$8zGk>`=BCQRdWe8nH1Svm!k=aY}4?g
zfocLNLm+1N(UXr8tygAnKg>W~P4!ubcDv6M*=QnBvHVKcq^=eW1Y+H;ZWmv-E7$Wx
zqx2PzyT@LUlr1<93g$;%mD~r4<eH@4<L*+$L&Gm)7@Nm~fG;|@dXCQOIXYnwf{Qgh
zM{|l(K-9f{%`~-HFi=3{=$xd}{G#9Vc2wDv&miT?5+TJuw0z2=GeXKQbqavWi|arx
z`P$oc0O}>{xQssbxNHrOF>TKZR0c|My8@KL75pef;}o|mz$x5s=lJMtl9Yt43RhQY
zR#z#ls;hKOS1A{LAqNOA`1<Ll#eqCqA(-w?R0eRoPGPz&)b>=pkE#}S4Q*tV@p~If
zc?`%%nNyYX7~DKY8c^G`NVLFJhVg*Sl=0B!DdPdtEYETt>X+J*6j%@KE3zI8N`03>
zsQL3b54GK#2Q?;?e~6~ahE~CTm{S@1fuVa6xq8fHZ(&a-&y4X;R@I}H)I?@X(}9dX
zr%$5%gH7p}RXl{>t$zy*454Ap2&_c!!l=wi$FvjD@tSmu=0`%X1EP9dl}PO&n+D>T
zV9LjIvn)1Um7oP8Pa+h^dSoukv54y;MGJ-0ZC#}?mtaf^?%*{ES|k<=i-VhJcM>=n
zu~<wEhi4`n^JJh`Tw9qzTN&E8*77y2<!FhRB?7X9XI*dVu-vpZbl6;>Ar99zreGVN
zbs$~?S(b`f%kweNGBKe6w7nmcNS8bvhu0))pdnw1IVeM;Uu$_n7a2rk4a83?|4Pi!
zh&B}}D3?4r5`v<f$)raGLLMy#{PKi+MT#A*5UPcge#c~YCJ`0+zE)FLcMZ6b?i#f6
zY4SD6oq-rP72c`@p0-L%J1#5F$XM+zRX$}+l__6Wnet8L+>a^n#&`VG@DlKv-QZ=n
zGT^RlWzgp^u9~LDAC;Bmj>W?mn<^w6sgRH-Bpj}gFpW=eozS{n!3iyz&c|*$uDu|4
z$<2b>EjKeh%v%3+m6BOhM^|EDDHox-X`>~)tg35DS5s4shUY50-eX3fA5h!poqA*@
zjcb<`IMnTG=^igbW|7~(jKY%yhJ$7uWjL@tlQq1a?1#Z)Q2oi;GK`0-fn^vEe+CMS
zhj2IJfvU-rXFMRQs{?A;0U^7tX;AIWn>INt=g)O@+DKF#L#B!6KcH9|#L+-tKhWTB
zxek))n3;pUc&>wb116>)>o(yIV|^*t!Egt^l4kN?B+ZQeV<^AjojNbfZ;<{TyD(B?
zR@z>G;n4bGS%yQ~36#gda~qH(W!+~0fby<img5i*U`1O0?z;t+LqY=&ei58=M*70c
z277y)x1<ceL7nJ-QD>-+l>)b+4YXCA2qYHeH9SJnH6Ei=aX~EQHmHpWl-mHHEVlub
zKrrg>`3+J`84jwl42N@hV<dTvd4@xR373rY5Eu?)p3iVNM;Q(=Up!?v)L14Pl;^q6
z&NCcVBS+Cgv_?JMZ_-58Y5Dz8Z~G#qNLCfoL0TEpp>DN=hhBJS@l9z+p+dD+;VbYQ
zM(6HRn*2<Z<FHTZb~*c$AwVBCwiIr6I&JrUPhWl0u#aE7mkCkA(skvcDu$+g{5qcx
z%RWJHUEn#-a2ZUt`bays$K`!=rOyw8Mf*y*4f~Y+_9?~AenhJjSNwduxZ>Z(ulUP6
zApm0dZV>a2kqG(4MgKmffPIJz-ly~%^IA@0%f{}l+{LZ?lqi>?Xh5B^wT|DX<UUZj
z`G!%?MZt@p214ZLnyfA7q9#9OFU<7}2#NtZF)zQGX|lE)dVmxvMbEYW05P)ZOvx+F
z=YESaOp6#&T}zoUd;<-WwP*~*&(4stmCplQj-@om=1ozr*MdwfoRl`+r+lf<zK^G(
z`7jR<WOTi4F6(x@Z8n#(7aT<AkI?=1Of<VdB))A<=<k6Og`tzRPhc+q>V%I_h>PRd
zE`UVGv)GA*7!ytoD^65Hg_M*Y=^@s_lhXTmQkq9kEWGQwgP~5_%^Q6IJ3{&U(A=>U
zFD=5$<K?G|7ag`)Gi$tF>t*p#DOOyy>y>r8YuBrcw=h}j<}FOt#+MElc%AqqsMx`X
z@94(LlILLs#*CPsA2U_qM7m4ov>iGazx7*Ts9b}gGLE7oziD}t%$_yN0a*{4VuJo1
zoILv#?VkKBH$gzjzNhS#eadnuas3DQXcKhJVVjw6aF^D>7|Eu=Jj1$Z4bM`jW?C2R
z$8W4j9^Bi$kun$NOEa8?HqmAE9=i1MOIGJ(d8!(kqy0HaFVvSr*;PY;(9m6t#7Xhp
z(ZQ>cq<Jrq*`V&sW!J#6w7SN;BA(~at^>Nojq26Bl;<GXAPJy62PP*k6<d=UM5bbm
zz&0Rj%}j2tvT3RcQMSQ1vAU4nrECLy3Pod?V`HqUp((mnd@6pHYtS88_06>1Dc7KD
zLU&lvV1Z?z0a6P{9k|z<3MI8UW;1;puQj4;eZ02ay+O?Jy@c5)QO68IhSnd(_~3Ic
zog_x*Rto8WQt*3B8p>+>Nte@-gWoc`TJM)Cf*g$WsQpw8gmb;$yu20&v%YQ`Dj3&N
z!z+QPBhtvuK89uQPyrOx1xXilL3riobgqIrNFdjuj4H^bPJzje@>(FRSNJ?f2jpg(
zr#c{1U;5ur0wLY~{6ohzVE;!okk=(BBPQ%wO%SwK7t_4%BGo@q1W}9^^fAgSg3Q(a
zFNz>hlDH_zf2;^1jV>bJwfRSSAS$W{q8mbXZ7HV+f*u%VeI#gkl+^+WwtDd@Akbru
zQss|ezZzr^Aq^D7BlsB=5Z5oH<u8Qkh0;i~A?6Hc6}lg}Kp|})R>C}^{NYc`HoLg3
zG7w^^4hZJfd#&k_K<02ceL2R?e2d4N^c#Zgj!8pNh<Y7r@0vK&?S@PoigxlOnaRqt
zy53B7yZASg(E*@;SLD7Qdqq-F6XKvqc3zV(DAww_In3>1Zw^C;gjAEEd2l6~5a_U&
zygMqmqAJ7@F)^(?mkS*gQ%pg$*x_z&7k{`LIwn%P8&lk_U}Fk8E=F%kal3*|Dd>dQ
z{LLxl)F9AFvA~uTx69j-0;t>tbn}YzezB8@parob+wJ0ZWTWo|W`QejjN8r28-q?g
zCC{JLfk3Cll&(_OVlTI&b(d60(x0g^<%i0N{j-%v|5$nSxu?~a>y-1A7uZdC2^AS9
z7X(}+02a#do8r4j(ZwoX;HS!;@bgn<$+IdDXb*jM1r-RiSKvH6s{w)b39-*AK%inF
z_F4T0^qmm<toj4mFT_5p{Q%$PCI9pU=zcp4gOdQa;7Nf1W?5+*j0@(0Mp=^kbg1O-
z$R>Bf%$8j{n>%gm)<&4tG!H(}&LL<jKqy?lKxl{1D28UYq5>B(K*j4R?8sJ8Jq3VB
z<La4G*6o0BM|S*<Y@pAnK0x-XK%!rcL|F#Y2%sNOG?4GE6Ya8~YF@l)FGv!XP<$j^
zLfvn(2vR?wG2KqIL&&ux8(hMY>~6ju#eF^Oo7*`$;h0@iFtfQ`*5-D?GHP=>L24Dd
zxgFA8UXpFO;`iW>k6>x}xI2{$cWVX2NW5+U%oj_t3zlT7s61V_BpYqbtxT4lzf$R7
zdOb(D_nfe-RIgHrIkX^tN%q1dSXdU_g!QB-h2!PEf*cR<@ox(_U61;wKI#wG#VeI)
zTW)1?@n^LMOwSeIJturIdAMtQcKrBkQBb#1`JW2vsH#Ads3{Iz-2&!kMOPRPLNo4n
z(W33S6~x|v3a$?4YC5s3Gc}#4Q=11>F1~i9XLn1_b~Nx1UM67-B`E*V>m>UYyXE-L
zeIeO&SFMSuwI;%A6vJy2=2j}Ho|XsH)#y<S?aVF$c?~e(WkM5#Mlr0|lU*Q8%I=nw
z?WjRt-d;f@P02>J`QH^u7w>EBwDtHs@|lh-%B@T!olx`Z|9uo!DtRW2vw3+)bhb76
z|85++s%`$P+GerSH|hXcf%N|nn7sp_7r^4c>@Lf)4z|sL1Qit%Q<3YYJYGl~3295w
z!IMA|N}|<}!POlF1JMQ1ozclu+%hn`cBzn<xef$ZFq91|CtU3aalh0}gVNG48z=k7
z&~gyU`gi5G|B<@}EpIPK6}tdI;loh-lT_!qjvzPVSH6OPF-%<gic&?O_xJ^{kqQB=
zWp*i)mmq2>;CCwMdBK51i)%4@7$@>>G6d_qyLgO>3hESNs!*9W3zANMPVe(olX5~%
zSYuCoA^B#PVpLX%8gHhu%%C!|On(LYTv2ALN<^7GqVdZJGA*5-BgRauRE+sMzY3~c
zi5fi?<dIh-OaSMbR2kLaa#IbJXiq<JJx6<5MGcNVe)T>iRi;0kSt^h$FG9>J6+>3k
zpGL#0k~@wll{=PC$SxypEKfM(lnNRvY2LlaC0<piPot55o6c7&Dld<!l5!aRlyWF1
zmCUVjc|E4el(CgByvJ1@J-+hj2~|=K6Du!pAE31&<uFM=MtRj~H2G=$<z9J8<@JAF
zCEf6ctCjq5tMX*SgG$MUKPx309#%>={8cI0@Tdy1VJfjHMYU;B;Q3MTGq!yKyM&gC
zJHHEId2wg3mmPBmWqH}%^37jkWTJd?*0b`>fUBVmp?KB0)%8MOM8rvTt6zst($wEx
zKf`Ic_j|h2cI@a;hhb&d{~+Id5v^)bzDZh!*EcJL(}`b9z{&g`Yb0aCUr@yPtWI?q
z5$E43RQu11ZQy~lSSKh{i!x5^NO)P5>fl6#m(!;|Rj7t2$1Ac}nBlpc2UMeab}F79
zOr@N`M&zJkP742Jt!jKRmS5w%h+cJMip;-T4zFB|<11ILj`_{4T<uq9-C(C}_AI|o
zSHGl!b!fGY>zY8B<5br9RKNO$KoOQ(N}G4@YT>l4UbU*}^5Ye0K9sO^*8ffzmJ@PL
zR#Q3NddB`#<um7wtP*PRjO^d07MZLO3FIr78p~*XqMH?|MnDXcKf{-t@rDm4?tdni
zt0ouS@=g0slE2e}b^Xi8@EfWLcEb1G#$6iL-RQT9gd-g$RA1VbnSq-8@7Sn9SGtTa
zbFWz#B>%VQIC}7a!*=3$;xp*DRgnM%^2>brQi{`3R2bbPc)#4BHvbER*xx8gTdP_A
zk9B~V2J<`G$1<dIIF)zvtukz}qT7|yqvo~WggY%TKAOh;H)QE^6{7$9Eg61Se(CA7
z1YfNU7!iu!hrw}`j*xi<gIj)SC?mfVl%uKqa+R~J{L=8)RPvXkjFPmefgru?DM~MU
zMm|SXx_Nn3Y35p9RhrUq<us+A62UXcux7~XjpI)xkKvU|9?1wNmpm|dkgDW+Nk!q~
zkWVBB`(xe4^eRM;pAXcFqDTKUy&!p<R$lT5ly-EF7nM8?YW~b7blv#I{_*8ykGfL>
z|F4CQMMwQZ4QCtwN5aR2&HioSBfkrs{LmsRN>W$*|6S?hgx3G+E_CL>FsG@)4)jvl
zW5w;~21yO_0kPDiGRU>IN@S3KxBYwq&@9u5l_Uga1Cbq=y$#@eJm#c$>vlgv!~(ZW
zF+a!Eva8$0x9rO6)UMc*LDlEWl$r;nN;PV)Nf2_a9`1H=tB04W)0)=s3iD+OQr4QN
zPiq=nnKV&UsWmw&NE1bsT9cHQCf-bSyZD=_rCPNvV~X1q7*pITwWbueD=?*?wPMq2
zR*)vH6APGA+%C^drHKovG%+w+kS3OYqxGUJu^fgrRLK$8Sfwm+Q<Zf8<|<RRR8CTF
ztvq^L<<Z-#<Omd2USLt>vc#gwaj~OHhQPO#SHH7LhQQ*=1&K>4<p?aTlq0aLQjWlv
zm2w2Ws)8f1%RjyJ<Dy^HEIcU?z&b09iwn$VCTo=?H%GXUkRO=sH+PQNX_+v7Jc;av
zGE9Cg4XH_V6|ym$hMU{HU}%ES_%y7PFFQVv^3OSQ%;msrw~TOeyMCM73Dm6VqaorV
zg^%pQ%Lpe!l^@WUZkyZbYGnBBc>;@KphN9%j&en3gG&G>XfB>;Cu%O9XxHyVJ8{`^
zqMfL@c%ohKiFV9y-i=AnNc6jX5ko$qvO?F0ByffiNoY3JMr)<7MECXklO3IwFPANI
z*z%@o|99=qN)=z>P2x-C3n<I*+W2y6uK$G|C;8-6v!z|<?;N%Why594#R7_pS^nje
zT$!y~ns9AX$VXX@$=d&2#nqLRUD1tCDiyN)pQy6>P1ydX)AG&NVfM1G|3xGuW-bhP
z+ibdJb?FAU-FV%AkPYh_I4zSVPITCwxLl^NzJ|BW|06D_j$)aIfZGjWdUkyJKg2~h
zs4#OOxQ>|%Uwlm;a{XGW)6%bGgTq!RujLx76`XFc7R{kVPQCDQL{7-?EQ!-{^-3>?
zt>pAuuh;r_Byj236`hX91k#c#hTZF|@O{LTC-><5p{(~W6FFg>eVrEW^e7jM0^V6~
zS<zgIiyq|(z6;$n7Jk1lsiilZ82VocBl`=&$n<P$`u~M65{=_dZgQR5WIeY@zj;%X
z({>{vpm8;UMR8wkMl+~nGM)Z#p6#zlh|8yRn5se9=pP~aJ1TDk7?Gb|Zab=JkSh6_
z%Bja@vTG10{Y!V~>88|kgLEE)`Aw<mbW>{j^Eai&rkCzWO{Y6jX%QOisheg>=QpH6
z7-5TosI!$0w~B5M<h@dp$`soJ*~1fIJmJG>)Kn};ck>ysOk?5An_(T$WLm7EQ8JyI
z9&1DCG2aUIz<@6Cd5<y2T5vCxC&gr=Y6}FO8K{#|LJT>x#-X5AJAiWg1_%_iS1~Tg
zO`@3FShOli9U5odoQ~AfffC!FW5N0mO6awU^__09G^~uk^FNx;Q!pqSXqc8j!)Wna
zQ3%D%F0~(KDd1_hB1!8apxv^(G1?mwj?lo`5LnBQrmj%QkD)+T#f0iby7J?W5El<|
z(Www5B>z-_fQ0n8P|2G2rEmc*GL%wA{AESAEmRW3Q$_-{c*ElAC5`JP<!PfCo~0(b
zAYvI-ib<6G>m{u~B2B$lo<bV^nLr@T7$wk0cNv~Oy31SX+QFa<a+jer(p?5<BnT*t
zG)f9I(nim+G*Zz<Ad#3@^ajC<ACN@6^w@M?0b`Ohg)jno`d!TZrKo7(?&@&MoAELv
zl25S}$S1lF`GlN2RP6O(=-Gai%d#UXmt}J!lt{Ga)nED9N-CW`_A=7x=<?EOtD=mF
zFB?;}iLZ}wMH64oNT=WV2h!=^{!Thw#=zGrs+X2cAAg=~`t0AzrhjzPpZ&T>rHY3K
zcC!4|+vVT8x=6FS@S9G%NY`|cma0keg6i_Llc*?(!pe(|FH|L=zE~=u-ZT)CTm|=$
zSMZl!<+g5@YDZQSRsUR-sQOZ=sG9D3t+0U`T`rYY)8vY~W=~L>Xoyc)YO(;R$zQ}B
zu@!{XSDun%<*2KxuF@UG37wx3YPmqDT@zEv5THN8qpw#^zy0dYU4A!liMF6bOPg+2
zt^tDahC5@z6Z901!h79xx0CKCeuCUj&V|I^Du42=r|m4=1O4MQ2|8Ihy?XmOn}+W^
zefl)h9Y3|OX*jhuxRTV`=<d_x3Y&(1e@ecV8*%rlq~q^bnes=KDGw^g!S_{e8a`Fk
zrs307Z5l4AYSZwUN;eJvP-fHcih6?Ey`mma%zyf)^CI+f4MY+8YvIp|(CrOGJ7nh?
zp!3D!8@k2j`>Wa(9I&+k6`Mb^Gx)d2GGg<08orR&JfsoAvg27HjdaZ#)-Eb6bXc};
z+vcDg^QtxmEByQxFIwcVtX{RsKK7sN5&pSRg+0POwl)&YlGSQVw+Z`(yo_100nPu3
zS+ceh$Z7}t(2JVnaZM_25Oy?()ixC+=m}qn64TyIU)&hkX=&Nb!Q|bh+>KV8rHnB$
z_x51k6xrz1g#RCI4!%H;(^9lc?x^lrwZOdU&B3Ib0y%>xd&;=1bj359gbxUtgv&7p
zYTv$f%VD{D=MIce<#M_~7;~{zZ4oA0nAqLSzqCu3-@uo5gfTtcCY*ClYO1hPxcH3B
z^dGPgSgJ8lD$82Lka#6!EAjQf>!5>`?ia58)tB|0mgQg7rz5j%t>^FxSZZiVtX@5~
zGPM4q{lg@`T93sE>-H(1;V}Hy45uHo@tu8zf>1v?RB^8`;3gre`t$H{^~#l|fDdBQ
zp{9|5j_QAlju+W2+-*ST^2qp)Sx@ZY$k~DfcmBM2);DTAMa$ueTZI8Ffo=87<Vijz
zPwjKC6Ea~uaaul~Qq5_b^F>Xcv4$!bb>-Plf46P;P58vtmDz^>w)y`6Lm}_9YT~qv
zzZy&R#S*rD`xHY*D()Nx46*z6wh}N}R2XggRb{AhbU^6qM+Odwd_na5%?{%7*!e#h
zKg_<pdr2<C>~+{kYNo-!2z__Ic0IK3pX?)URPA7nOxQ%s3`Tv)PX7v<h~oykHxVby
zs#&td!@Yla{NRfFhl}0&ho9y1l<psn9jZ&oc5`_2&2<HzP!3O(8;BPTeeMQgKe~a~
zhZ%F6dpHzbG4vnW>NRC8r8K@jEUh%}@n;y>J|uBNrMB+6H;0?z-q$FS0vODitc^l~
zP!tfs430xd=v|UBM23Ul1?U;{oELLd-ML8~R!+dmI$Y_AM`Ug@MmX_k{ZOA2jXbHF
z5^=4+?=nOpMKQsBam?79tqSgb?Ir=pitH!~wU;L$j=6hUwp6;ex^CbnwKK5N#PLTY
zk;~b7@rb0z*@%%Qy)(qzBJ!k1rXpu1N@=5qH6aw;QMZZD6wPw1tif@zQArb#bPRS)
zLfs~zwA+oP8MDdtSTx6QyRpg{f*Q&S(YKL>2yHhOqR@o)ST!3f-%IPz?4XB_Uo6Wh
zTBRg+k9i+`X!*15dk2pqv@`N33Z4wqXu?sHH5tR*idvGiLRjF1leNw0n$9C&c+;2!
zw5tcy8aAj9g*?<h0s?B=Er;#wgHw<9qv&F%DmMee@&^~HGMr`!nN*7#*c=z4-LxfZ
zIwzp;1h|;^8Ry~3z)2Z6p7TI5vZ0mA$uWB(cOmqxaTkh6*o9Pcv9hPDx<||E9?=?3
z-LijL-{d~#4!x4Q_y5R97AkUQ;`lR2h4jo?d=mMrz1r{;wo2&<>dG}(Y2bX4KlKBI
z@@GWtYPb5LN|`hXyMB_T{v=DYc*GT>101VNs>vd5ST4#SZ^cP7qB9#_SkGoeC&(Cl
z3N?ZC85a?-C<~QjZ5yVyGW2BjvHse`5T#e^e*IE<eY>zvA9EOINKYA@Zfg*@CCgHa
zwb2tiLW5k}v%sC)o~0SUNDa6?+{A9r^1}}>-XW1O{%x3}5}Bow{*(ltmq1Ucq+Dpk
zH1vJWG>oM9RjJY*JOwkMoS$V1Y8XESBeN-8>6(hcl}yFx{ivx}ni1nl9Kj`y2%d_$
zw?_C+M4V-T3P$QL2CNL3B2ijO4`k3<x@$sgeR_YG-ue#tNcs95M%oEEBnYJtsj@(Z
zP+x4L_5!k1eW7Py9)Oj<hHVBn;c(Ll{3lq(PHdK@Qj->HGMg|+k6i?9BZ$#6>v9}2
z6#AJ%_N;Z7;5({f51-6i$mw#(dN^c|bA8TjgzTT)M(oxtTO8tq6WG@KGN*FA;@RyL
zPsp=@<_Uv5G4oZHj;c(@qWZ4e2wVchZ={Lg5Ew>!6Hlden$2}g0xsbg&=WK*;@WMr
zV;$S#6^QI{OaheMUVIxV1LhEvPQD=gX<y`;LdMwldowtxgR6kV6%fd_uUig6p*M4o
zIw!9^%fPgSbC6er3N7MJcv)mpn>}tMVkAi;KFe1fY|0MN5|qfjp@zk_XL37w;lq4~
zH#XXZhJp`E*Z^dhYZs2&g_!`EntZBaD5W^AQA?E5v?U6U8;{`WDXvg<awvV+fyfy^
zsTgO#xQC10uCLXTzgFw-2l+XhFq81?z+4qNmUCCh1$uFRDC^f%%3FTBE)Aw~u6jV@
z2_5fLa}8IyUH)(tpmDSR#6T}^_6d9u3(0*oI?y7LlX@qpyjha;C06RDwjo=TBt&Qb
z(-U!n6xxHK(mS<1{YX+h2C+DRd#LRg?9Dbr^h<cmbb=AeSZAuy>6|4J-Ar}uV5Pi8
zdhhpB($fvo)Y8yKj_GQ)4Lys?6s1x%Oj?7<ES(;xqE#_gP4M+eek}&4rzLmm)1CWu
z5|RasABS)p4P3uYO8RwD!XQMPgU|r->m*|HMp;(KgiXIr(#W*=GiEq%-kxN#dvmkZ
z<o+ahvn{#HB=Lh)j%5=4_ljtzZGG>6K`PfW3Ap>qB#>cit{%sKp>pW4pL=WUc(n^g
zEbq`Zn!a0Qhs%tXJ5^5;w$p?ge8KNuY3a1}9K7Fjy2;b@LYl5oH`RxHI0Kf9+giz;
zwuq0KxLSFDThz(}A>ug)A+C2m2QbF2l%qrb`oM)6w68!ZZ*JwDIp;0i7UEFIgH2P=
zm)6_U!_}=)`V2~e^yK)IfhoJ5By?w7`-W!i8w%JddcsZ9xUNs{czt^8Lr<n5bC3LH
zbY<a=S=jV;th9Z@Mp@GKF%SW+APbXB=tFBJ<LaBQ>zf~!McFr5xCdm`Gzx~hcZHmS
zYnerPI70G)S7`Ep^2v9EWb44bCm57bKJ|f^>fI+I3r#Ga`X|6{Syb(RMPhJ{6s;<s
z;h|7GK39$k%cuP%ra`&$Wz!s482b4znXC@{Myt9DW1K8h>y;<4vKD7>3{-PFwe}wk
z)-{A%WCRjnXq`c8h$?@EujAsW#j@Um&ewoWs=o>$-OcxPxhaN=wHcCBosh+bEm}w^
zAo#YX6Z~rr9p=31N$&>hAY2nkGzR|YJhEN~)5l*(AD%QZlEIvAqmI3MC(UUg8D^F3
z!5<&_JVr~nx{Lj?BtIMfA9wEo9o3Po3s)&Xw~(5nHbGzz5=Iy>Vu&(MBnw;EU}KCu
zSi>*~12(q727?1LV=Lz@b*mLx>fFjwE9ab3E9abZPOZ>-`!up_&mG@)?_2-+?|N^o
z(<kjyRbTDewL?{%)0B<d7k`p%r|o%(&eK;1<@ciYDg7<9t@P)%zNd<w?$<2)5TWhg
zJ=h9I6`j*^IeNBD$`RW2yQ@F__DVjl{A`<@SB74+w7N|$VMP2cmD2C7RDO4*^Sdj`
z@2;Nv-POV0T`B+WO8vK2#9><{>`I%BrH#Y_6UJjzij>~_CJvR;eu~`$h7R{D?e2Pd
zMSCZWdAR7am$kQlBfp9cT}9fq#;Yf@hN~xCPghU2e?z_`VEUq7oc69a-iszwH|?D@
zG#)rqG>_pS(uckZe#Q2e|4w?vO9&-Bg<~K>S&;r6AQi11D_4(=tH;jO<KXIXk{onV
zIROIs?Am<$^xtn7DU(^*uikQBJ^DN)*R2!{t03O$o#54D)ao&5^_WG1@l^d+5Zdjg
zxBQfgI7)D`TFt3<$i*<|kmh;jhv(pG_4aS*&rXp2cE8noU^sg2o_`)4k)MD5|Hkd<
z`R5O(^&C5;S8xwB>1zoF+bs{!)@zmtwY1MaPc$_){^BAW`0Aaa&2+eVux;_#x}Vef
z!ns4`OlW$zyUL;S&*Mq?64G2c3OsS71$;tDNq$XVKs)w)nE;cIJqw?Hc^;lpx3{C7
z9#wn+>_3qITPKj$I~=7l_V%NSI~rI2lOr_$==taA|C<NNto@V^`6>TbivN$SWdaKp
zN!d91Ki<m!A8t_L9Zbe%#XIh6H_Kp8HsODg?v|o?{tI0HZS!P7UyIO2<_*e(;?>`C
zs%S^B%ConDRi8Kg1;^=M-vvHHz6(sgApDz2-7D{)Z8!d-TF|)qTlwAwYKt6&{@<!9
zjjQK5&yu_$0A0aRQc>EBwSVF$f%1L!$g1{IF<1SkA8t^{_Alz|2Rg;ALJ`VN9eOrx
z9A!X;k)%<(qkl|am2z1zxBJVtl~?WCcB`j{74}W>#va%=x2LZMD&}r~F>qMThl)3m
z#*Kp9Rh1BZ^;@RfpB?`nuxs@SyGBk(latYbiuvdwrGGcyT~1CSKeKdbQfbQr+P`SH
z(;Gp<A=9E%y2^qQ^(t-sb8^k+v^Ae2XDzNC{;hiZStF4C{-&benxD1l03VI3v=q(v
zGBrW7k#iT%bl0y|XzjtIwX^@WIn=m%1LO;xIrPaEt6=j_w)|=sfBIxg(H~evP=UYL
zMCeOrKX^50D;Us!?PmYQ?!FiFmzY#y$N$GQ&;Qv525!$qPU<PWcVMTF)ehV^Sj65A
zga_xJSIJ)ibw+#V`PsnVDRLm~`E{i!O?-IUubR#I{PUFBnvXP=C=Aa{3rqh-@2_p|
zoqzs@!XmBZ{hy!QP_*5D<>CKE<E4^~cjAA%8UBwOkM_Z#_dY&U#@+TWq#Ljo;6nl|
zw>S9zf4gCCut$?pUanXHG`(H=0da;LL!{?@@Y}!TK3eg?K^5a2YDf#8LGNtRpuP0*
zFYD9DwSyE*O0~fiMBGx_OW%3u3Oe)4droWr-L3u76?GM31GO#tt`II+PuAwP&|VcS
zboVhrHQ}&3dgU=9c3FM-3)vp-)slo`Bq985liw2RNWyWF@CNyZAiomoNx}(|P+D^F
zw}dJKxObim>kb(z{rcbFalT5Z(%{bs8J+S~I=K1=;fk@{IAeq=42;n^38ETjNf2rv
zAN$)W3V!xq;qnX0hb}0iM&3gte@prPTd0XVdsF%To2Z#QJEMI63~C|I-cY{(2I@6<
zh+eHyMMsLrRVKhN#f7{|^$Hw^0JYpn>5>x~CeK`zF1ex+^2|f&k_Q?k&zMS=m}meh
z@#=0!*9wXH0gob+upi6d&<9vw{fDZi@mp1@+PM^+T;14Hdc_<6cA9qOZ#6Styh24|
zPXWw`>bVhBG*05WseJz?njp{qs(k;iXp%fLR=#hHrpU8DE8qV!S|U-y^GAzdXG;6?
zi+kznifhQ{3LMSWfSa!Yw^##ixdwd2fT^TN*9tp137otbgxxX;djw$L9Z@~(zvB10
z9{ZT#Y5kw;PB;VA%7BT_t)aGFLv6E$+I9`K-5P55Rn*5w)J&4s<i#pvuQkZ5HOSs;
zkbTx5Ge};O=}5?)tB{Y8kUf6kGzr;k3=FOC-49RevkY%)zxn!u#tq2#S4R7-L1wQ(
z_Fsb>um(AB74mTsa_B1L<ExOv)*y$kL5^619JvNLWEJvp5_0e=<l`jdpx<)&;5O(o
z&T~Ph^edQ~odK`pSG-Ycc%#?w#;oCuUBjEUiuVMGH)|E|iB-JWYj|_k@aC@J&0E8p
zxr+A$i8o^v?+Frb`fu^(e?&j6_ZQA{z+#W*NU6yG6>q^B-oiD!MQeDApW(gpXUa)R
zEA9R!^&^ztja%M)a&Y0_E>k?ISf+SD#gQEOf03@eTUB?{RdPiBu<=c$lP8Vae))oq
z&e;R>Lw~!g^=$R%tGg*rX?qVH%D(Ztujf2Zu20-#ig7Uh6Fut*-gxdfI=C5`vfqRp
zIA?S)ePp}NVRRBH7BAASKV4nDcye|1qSor_McVq$(26Fe5uY9Z{o=(f8}{H=pm*#c
z7chQFP7WMWeV#%tUwn~VzKH+h$93p>-~A^m827ENU{p*iJUqCzit!|+O&*Qki^hj|
z%5d`A?X75Xb>TB&x5~dEcB~TjuKPE{&Q;>)>;DaL8jeSzK}G&d`R&I0nSy4XrTZ7k
zcR-o_L(1GAQs)1VVo&>8Q!XcHa&mFue}v)ihY213kmB@*6z4yraGr7E*uR0m{li4O
zKcw*gkRtd)O58ID$Nvq4_&-dP@Q0MdKcpo6A*JLQgcJV;Lg^nSD*Ho<^baZJ|CaLL
zX9|T*>7qrvK-oYU*uHR7CjzUvVzrmmw$SU2?t9PV{+-n+!Yzh@h;FQfw2ypDQ8xbY
zX_MH%^%m`*w{@e3)@5a5Edn3C()uxECNs}M=!kI^I;4f<S!filTufemWQozy-`y0F
z&mH^Stz`1n@!#F5Aa9-c?JX52DZMZh^*K2nuTxTcQBC#olLucurf+>ryYaHt5ydRt
zx3scQE&X#(zWVCUW6cQ4`fEz3ln`+T^wVj@Y#xnipmU#mw;OijSXJftIlK{kDkl75
z;8%%NcZ{EVq^<!fam(j_QTb&qPu(12{hw5jN-(CqfAVldcsRM%@YHGjiSci=Uw`c|
zXuQ`b=GEYL9;XcIf1%T(w417?s-}$T6DKt`&?Zl!4b&}%rcT~&R#H2nMqisE{r1t5
zTaWI2sdI$BNuR&t@z<Z;dGPqrk9y)G9Lg)k5^eMf<>uJ~@BJ-+j$a`Z3mjKHO)q0(
z{0idGMd9+wleEf{_^Wf@AvmIk+Lb3&h;w`46lGPOJbbnYQ`Oc(b$D+QN;jHLqI%kO
z&K^Wpp<pe1lHzBwVXw!2RPOKg>YhVts#otlzVj7bd%yF(!@vHql%DGjeIR^wN9X7f
z7UiUI&=J;-vU3ME7(ROP<sr9MkLL$GIIWjPsGZWcjy(0oDOZf}QMXsmxngzox))L^
zZ@qfuJEZH1zR`6h4(cIv@(tJBw_e?(y7}0#W2g6i_No>^zJo!WJ@?tG$dm~?OotuY
zzz(BIe>+S$thQdyP6f(#Ku11yApa`~b}ZPLap~7z18%6v9k9OxR<Hn0Uvco6d~Lr2
z@;89zDu8hCh}!xOzchjR+@bHfw*?(N<$!mbee(G8uOI0gdBss(j47BN@rL^Ga|ft*
zwyK}|`m5Vk!Yctv4B^ww%Ia!${MY51mE$%mlizpw=Vo*!GhXG)nRA<!qwFyXFo0c^
zzde5aWi<_Q=JBq{<Ht}Cz;y))cg1Y+30Fh`W?T^{`2$N_vSwbdbS2k-n`}p4MF~}W
zfM4hx%4q<`F>u7F(BBbnI;yt*U6XHe4<a47ef*R)-t;E)!^d|%-m3hT4c;*}3LLky
zrF5jAGie9c>AqKKL*}S!qy8C1Y5U!S>kc@dnKj4i(7;>+bBqf7%`tIAZQYe8v^S_n
z%+QG&W|&D)KFs6lp4JNr+;>_(G~^}iG3pbF!KriS!q#`P6l>Vcu$~z@YY@2puCg-X
z8JJ<zATq<7sOKJK$K5`=qC($^*HQG37@V@i>g3e^A$TG}`!IFinX?BpFF(2U)xA%@
zrZ2upT>1LG$%9<ov!&-wtcMoGZ&X6Zcm-NZ*KW4~b$gzgy6M?7cyFE>p}P6*-McO1
zA5*a3G-FU+r|@;%(TUxc&!cv0cdVC7>v~gN?U>qz-8a-piD03ZudwieH>h$JhAoeU
z(UXe(`YeQKhtI<^aPJkCVl}~yEw|JmJAnZkqi%aPrg%%;_OnkKsHqu($MdBL`PvU%
z_ug@I@{}LOFQ89VU)cKr6-Anyqzz@DGc@$}KTmGD@Yn>ZB!5L2w)bGq#o=76duu<J
zvYFzn%SE)^6wQ-0N=Lx~(^FG9ckip)^euXi(a{5Hn(7zsn|!wW-bTv0YZw%gzlx^n
zzBH;P?OP3c+1qrgCTN)`8q%`ID%+JP8m;R=U(u+VDi+mps^%%GCOW#E+`+}O?Eze!
zX?RoR%-KVisNbDhR|MB06ZO4t=&%k`+2ZrA`s->MS7{Dks(kgB)}^Kn3TDr}lW%Ei
z()MS9X4|TH0MJIz(U~tI=vTg7FCSRnJFp&o=|83Roe2Awy^F*KK3K&?dHaD&KOMhB
zc}-1yzYpcx$M@dweruPeo;Q8w{vmI0l(fA!A|1Im*7ufQxCEQ=g-f(PIzn*jeBlxb
zlow#V0(A7D$+_#AhYIk4LUq(mBPiR6_iqtf!cCNczP5o&4?E{tS7mhUNWnQzMS>qT
z$m=gZ+k9Z}qRewqhNvJP+rOq!I6*N`qtJBJGJ93%FW_}5`bXcoOsJTALrd6zbZC*Z
zy*?Y{L+fBG8(Md&nkIi;<Iw9G2%ma*g;q@i2RhUM>M-hWPq}WW_S}c}Zh!vdyC=7G
zzW(%cop0~mzWeoK`riG5bKelih(7sPU1zV(Tl6bW<YK(GC4uIkQ(Sb#Xv6L|Gz_Im
zYKPR+&VF?lg6YTizWtKEP45SE?7$g~9T)FBhT#0p?IT}ODA$w~2I-@Z7^Fecep3V8
zq`j?;+Cj1Jqn*@7H{rw)eu41IfnWQUi`vNaz?&L0?niq+&;UVsN<%6?P$8Es+cr^v
zWjB-&<u!_>{J6%s;~MDLc5(+7&$b6}m9dxHJ-YzFt_I4=$4iye4ysY!dvgELoku3O
z?_+fQpI99(Z^^Opv#k{?BXT8-Jshpz`WzgOlMk*v@c=7>soDL*7TC*A5MP`iC|Z<E
z6O1%>*X&d8Bj=uPK1Zm<Vzr(7zo6Xu`UmZXeRM5d$r3>`hIr(sfO2Gd)LX>N*++Bz
zS>^QZwCKNFTwM$HY_SE}typvRF=f9xx!i(&eiLyGy+$!J;3}yMD`{81K=a%9UE2$r
zx|GyTs%_bAw$<p{yP$&~-}&^*2lpO)29CkkpX$?FUO@VK23q>J6>sA0zNjYeePL~j
z>wQ68lQP{vA2L%3d~eJ5HxBEP-?zE_=<9FvKQ;O0$}PO(C}oj+rR=56$5dkQPv2>(
zt7*|U;;Y*}M29~Zp=>a|b@tCmKX26HU<~1oE&Xt=^VS<WN7W8P1(dZA&GH82GX8{C
zy%A$%f>klza}PoH_VzA3{g6r}22LNPEE)766kgPac9%W}8D6KA=&Bshpylh*7S;C_
z>*Al!9e=*I15uQ;aCiqo%LcFuE$TqKFKNQ##(D+k()HwRXlL6d6)p0MJG=~x<OXdB
z1sAoU-M0yN=$c-}t2QqjZb<s_wBGbK{waOWf9PyKxDP2Ar{F6G5pBoL57<#D7_E%9
zAZiOb{-foU7Ig5fOOjK1J;`TJ>pzUuPW$dg3xa3wwjh=E(~q7iBh$>+y-kq6c^~a9
z6BTqqvju6~eX6Xky72R9T7b3sX?;Au+r7XzjVu9osBkg+I>P4HRfvp?r@g12?yE0r
zUXKoJ+4kw-*Oo#~>8bm_aa!Mf{K0lpU3Dc*N(9Y`LQ$jiZ2#&doo#BGYLs(#9)I0&
z<;eaW*chZjlM-q05<0$1ZL1pX?K=;?zW*(FPCXVoj}SM3CNVgIUf-#<Sxx<;2e<D$
z0@{-=@9h40Cz<vd(4!3gg!XM!+o-ng-6xN}z4zVDYXpIJQljyGv}JP)x^QUm_9iuT
zHRX@*%}i6U@yqm-omYy&wU6JvvJ+8uQeq4~L+Iks&yW`6@ctu{2YZ`#XnsN4v{7Bp
z!<|mc{}~}|wf&l3z|%XnQl|6WF`d}$rlYQZK*f!gaYvolu1djF6&-v8Q&fzf!-m(+
z9-yu*b74XFt3*LtDfR_N&m;At2UL7C&tvMg^GNk$xL!{|Z*V;*TPceMF5o-dazT`J
z#)nVA;Tj&Kx9a0}&ZVr|9EvOqLJ=~$bqi5cjSro=g`969G-?1&^~GB^5wYI*DEK|H
zT}MB{&bJYoiMowW<ss%iQgm*kNA{Q=+>w=skTvPzym{*Y-luB3|G@f>?>xF~^1vq*
zp(Sdn+h5d=98d}SzztJBaZ|^}&sUy5q2eZ!e2;V!zXyO0RDtFNbnMmzL?{{WyoMjW
z3#Q$`6MY9qL|#}KFu}*a#Y7NT?4n`nqf4ZCv(VE^=&28Q=mwY2qaK7P-+@ifrKzYR
zVs|J_{p10aWZfKe)XEQUIFyIcj_oc^S1b-{UB<@1v{r-5;Js^HMq2M&Cd*Y)LwFrQ
z0L5<qeeLg^Der({vU6570FGKixyLoE(a$qE=*cISRL&^TZJZHj%jXB_mS619BfnC)
zl_J}JLh}|nL^4vzSnKXv2#rzS(hm8O@-AeQxkEJ&G72Qt86Vt<Xz9BiUVZwlipqKl
z_kDsmx0PbKe}m?y=+doE5n3;N9W3_dPt6~zY`cSO4ep?y3J`MLc83RtDT9|V`utV_
zqEL)4ST&=|+wR=EczBxpYTOL$^k;kSY_FpH^z*uHU1*YOdSn8<^2G#3FFg2AiSmxB
z9?j<jWe>$n_c+>l!W&t>>T&-pdWWh+P>k>FM2F5|dL-pA-O}=u9@|Rww0`0AW6h=`
z86cgAMVqhMGDN+igLW>UIqHJ@IVHWPe>L=J!;s$szSBs<JHL_B@J}@I#ymBs;s&yM
zH6CY%=*45|j~O7oU#t3F>8Cv6sD5z{?|o5iyVJm-_m1t@LoqD?vESJmjIL}^di1CD
z)Zi;8k!CR2f%Z^V_Fw(r7BYYJDmLDrOj&RI={p;gb;#*ry$=(tj~~*&RNpKA#Q&sT
zc@6!Oip+IC*!#l<YYUaXddn?T%q)<Nfhj_FZz-!n(zgu`tsDIbQGcSmK$*}Lq8%T-
zkG?q6uKq<S1zmkGuk-~Ae{k$dEWZ4%vdSj%U39d=x%9GTxa&t-;hg+!hu;NI6F>aP
z@as>XkPFZ*-Fa+s+vKsyp?lw(pyv?MJVT?rO;@8>eEe*B81&EYvorXjk9`5;j{MQr
zvin^&=P#q#B5bQmQKIjp$Ul0PQA+{&*R;xNSdGBsNL{Oq2ZST4<0kZd^gYK;oPGKH
z@e?QX-!y#dg#K~E^C$GrzH-z+|Ja+yP8>aFc=#2AlP_y+*!}`QBmNcnZe=Be4v@Rc
z=q7*N_5+kU$eK?5_}-oGKYVQR_|ERly8Dh&DVT_?b%Ua*2R}bY>1hB%r}?JISD!xl
zO5qcqfAHD82Y0q_JNF#Y(LZ|Z<jY51KDK-F`&2{9dz5Z$xM}Oz2M@k}tor83XYtgB
zkH3bX@y_;L#@i5dz@tZ@6ZWcZpM6T{#~-NB4K)V#DCW_>{rt|I$J<^Szw;`1yO)vi
zPD(yG{l0}VlfCHO(H1Orz=W%>y@zj<G_)Ah3dNKBK=~#Lv)#)pM!F!{NjQpU<|lJ{
ziZ>bWpmdPL&6FwsC_&T8Jl_cug4C?x(1wMPKS9!PFy60S=f=xwd%Y3`hlzN*<(&NJ
z;r`Dd<zkiUYc~_byvaUxu1J$G_vJK?^>ui4VL&uduFANX+gZ8bDwz?*VL~zx=~v?`
z>yVIm(s0bpO%$JWx4N`+ckU&^Z_X)&Ra4`B7BY3fQMWf!Vi!D?7X$41hD1!=*i@$z
z)29#vv7V}Zy~Cz^XfC0R-;Ifc`0APQ9FMTQKoU}!*GobtXI%Rn__>(y&aSDNUCwKI
z3dK!g?c19uO`I7<$7C$`BZ3oe$_x<a^*#qU%cQE&7lR~@l?%4Z;$+~P(4%^ItSzh+
z|A6{&<>k$kIlFo0Fe6-al!!<+8?3MlC=ufd6icnRmb0|rRyHsy`j$xK=le2>{W`A$
zkZIjgsDN2SxviJnDiqi$N?#0L3SuNY1SnEm0X3fpl6ubcn+c7H)Rnp6M4nsr^N`R_
zQFCdC+hAH@zfgb)i>Aqj^tt@D9|7k8*1o!h65AEiUfR;m9mfPab0NAkM(*#9qfxE`
zXlmj}MPHUge2)n8^$9FXV6O17Hfp0*Tz51N>qx3A5@%r|u5EfoRv~jUh5|!z1thCT
zXv?wgY!E*pY;7zuVp<1s({<aBOi^AAJE+%ZrJf752u+oQ^9#x%Z166WhpT`n3SOv+
zvuY3sF%b|i_nfGWEi=bYkq3^4Tx;u^%47Um1s@Zp0iG7=t&0Ob_zm#W$y_I!T0P1Z
z>jZh22+!@x6W6z-_Ue9tQg99MX38lxE-rL}^H0KJpsTJwVK(O#<L#7MTz&mHN?a3z
zA7>lI`;Lg0W!IVYv!6gM_&5g2^IUeVu4W8!jEJNjZeCi1sgF1QGaAR*kYx&2R-3?2
z5<MjRymMQYaz?|yf~H8t<v<e-2nLrb>i91aA<3q;$;GvyCxF}b)X0m=o!rHSzF=V(
zFfAy>Q6|W<>c*d-I=l;#EefK?`>Mnub;7Q2qT0(_X1)=iL}Rk)M;g2(9o?pa3{2QX
zEDp%4=OVs?@_eYC*P^3_lWJ4_`R9qmriPBXp~94%P+A|}NwRa&b~?Z;my>`AR*OX~
zQ(__X$KRtEYV@_n;-Mzb<qV-N;WE@6@7NaC`xazq1{rotX3Ll6J-DibNSG#O4UhC`
z1Eq|*^IGq8h%DZ`P<)$kTy~tEYN(#M1PI;mcVBI$R7K}Eg=X~dGNE5CCuW4l%!=;;
z4vPYJGlz@5!=-t70wITqiC`;kRp&}pX|!%53c;QLGGfJjEM%gFQ-ld&541pRXi5wS
z#5{GEQDH)BYQ}PvcnlN1v5m4|^YA*o3n-V$y2fTm1s>xby!Q!7YSeI8ex=}bfWqB>
zL2JmzqCY9R>ul-a;I^qAui4_<JwUOg#$9hLt6^3Iw(`m`;V~d~_pz5P--4ReVC{>W
zC;>ffX~EG}+;<3JP-jNn*h)Bl4e>Ao<iMWMV6#%3CeR}UU6Eztf<?Ewvqj)>Xd8NU
z=2=elFgSY&Uq*H3Y;e1;Y6Zw#6xpqcWDR3AwmdGdUgl{x+?v_rkH=LO^7Rf~Wcww`
z`0OfvD<)jhgXCk(qJ?aH9j%-#fu{Bu@fOb3ip4&dux3Y8mn69~Z-WYy;8-A*3Wp@a
zscs@0Oo$~@9(~i@!hZnKo65RgUFp>~SQ9G}VIoRc-D@tIs<{iK3H&2efgRE7EL(09
z{heTSFlEV$arqsfjG}QIv|MwwCA%-eg|mzan-D*4eb;ouHDHTrwOi(<Yx#mvkEskR
z-rtCThOU?ZzpOw4TGd6@8md?n7B4E16$mDw;p!q|2l59j{jjmhY<cc6BM(!L#s%jk
zffgYVrw8VAkIvYE;>e~}UY8cQxaB$43vDqGot)P&=QSW%2U)t}O32bJb1p8r%26o6
zgik<Od`xYhZ#new7Q728(Vt~GXXU=aJ4vv|yb@b#^PTfeG*B?Eg3c3MQW4<c+{XWk
z2<660^TYW~kD(58AhdR#9#OfYb%Ol_C)T2>%T<!_1+Zm=8f|3X+Y&Xik}H0LNSUfx
zZpiCdh{o5DjN1VD6{fNSIrH@q`-pT|xp$dMvH5e5pAGf^n!9_0O>cm==tCmTCL_f@
zx30+ua;%0Px0zxQZBcJGGR+GHE56bZ*uqW<BhHp#4}c%oRaxEURWDW{LKY)Bhumak
zE_fJ?g83N<;B<$iMv7W6VV_y;Fx}{Adk1n%+W+?TY+qKtbH5q4789JHav@tj%=r;W
zMY=r5(JEZn*_hzWH6q-q1WW9I!ay<j+Y;*Q*F{dX@}%%l4k#KIzQ1oQZ>sYXNG6BE
z3Yuh7!sI$(1tuIBiJf7kcEvvf|BDs;=Z`xz<b?R}W1$yYaC2DU{Xs$aFNj5ry>2;g
zlV%al5XhkqFXz;GcSqG9gmgU$_1hC?Ww+wvDe}OCQ??VoN?1JAqx(6^#Bso{zQ!^4
z)<iq*s|3favbcS*ulYVCY|`aJLXNkKb@h^fQ;iAJrZhWte7M~pejNoW5+;@g#=F`{
z_@yAyT|JE6yw(#?i5a{TdIGc6b7DGbisuKGBDL0UEUGa@4Tvt735*e!#9P}HrwKnI
z(rWC2qQ$a+5L}6xq4wzs1wGl0)gln~$ev(H4I{SWCrFlnqam5^e34~yMWFC9A*q|?
zq)$q{Z2?QA!WeXBB{Lmz=lCZHzrrT3)QZWb2oUH1@DRL2LDe~Y315ndwDhsKy5(}O
z7odK_3dVTE$EFNOy*SO7;EmLJ6|ooMNu!mhYYTO#8W|a0sLT`qw{0V8S7fFges2L7
zYig`ffM2tDN45>v!H9qXaif1|o&=y&QMHZaUBa3ur!fFx!L_%Gv&{4l(R~NCUKqWe
znmgbfT@@+5OfW~frHf&c{BI$*2<e?>qbf;SNw27s`;@S-@$#-O^ATE^4Iw5qM$6Np
zsbQ!fkG4@whqLHC#!X%fu>{r7g?C-t4CdHp);*?3WI*^d40qSpITh2dQ&A+YgvKed
z^B=QosN}vy1Xr||Pf7!1C!w@uMdSE7+KpASO87w-x>lT*Uqxuqdgwky3QuKvqM*wo
z*+qPcu%655S`^sSKLK{x7KUH6b&i}DMNNr7*yAQjBNr>9!WlRQiNF=vLK#brjT*J;
z=FWom!<W^Yvs#7pTncic#u&{Ao!dnTJ))P0Xojt+MQOrH1@O30(Ex*q1Jm`D3;ab$
z)*-d+&hMMHz!OMJjWbHD9k$K1?dKdJII=GH9G)y@LiZk;R@irOuf>d)dywcD;m}pw
zTsl(8yZ|6G6;4V+LjPi&d56FrYL{<OE$QtD^nu1%;WmREv6TnOx*6k~9|)&HU+?Hr
zzeKJKv2hiM(6T2xvRM+(`v(yq&5w7gO~~>E8)K<(Tx%JXT`8<Wkv<U{ZzYdvsOZrH
zZdNF`=_Gb3HJf%5d1CNtv&>rto6}zeF#ZZVBZ~A-N?D2KaX<-|%9cHYP0NIM3=QF3
zkTNKxD4<_16(1uaEtqkp3I4gBq_3QyXuy$bKTdo@m*^uR)hlJVhhNU1LatVs-$1UT
zrM<EKvz3Bq@ECK$^DSd+{WCzd%;GW7af3c713}UpP6=pmN&85pV^YCUnm`?upJ!ZO
z&S<ilE9CIQF%jeBT~jy5v8F*q3aC}r8v|F;SqpwVF(!iSJe(G-h8T~5#DE4I@m=nz
zwqS`*5>_7Z`OR`(W|?j~>QpqKw9wT)q-BQV45}=)CO@m&qNN&pp$J?B6>JryGjrPo
zoIq#_nW;@sk@L!*AkQVL_Qm!hUyH7ZcrgSDQEXdjjFW%odo-asj)kgMrMOP;W|M^f
zAl$f}L(_eQg1<njbZX3XtGLBvUIBvxZf#P&#L6mMCer|}I8vE9Wee`bQ7)Cdcv{s4
zt>tBAYyCh5jztaNr_^w`m6QHU!Zu8V*ri1#I0R=3<w!*JGVITuv@IBF=U*kP10tAZ
z>1G1@2Wn_a;c^IsERjcKurA>?H!F^D%ypT=<4Ahp6Qk5ZM^lD<Cf6Gi@e$6;3qn>F
zjiG@CKt*q+n6F4|Bd2q@E|~E0o}8H(wd;SIYiagp5HLG;#soh)AlQ)bog1AVO-#4&
zg+{Z$F(jvaQsYV^@_1xC!f<H|%arA7L7mG%qm=T3;%cHs1xe7J;xZ{au6&TTjtW9c
z>crTNl%<M+2F@lTR@RkLXFW3QdiHxXsOTii{%P?ddt2Vygot6A5<Kr+e;%@o+yA*y
zjaNZJg?EeKCSewB<-g#R>oJZQD33a36v^~0tca}#3e%~x(2|`x5vuzcIPqh9wopQH
zMkDg=3q@S+j#$n>TX?Zm38<nl{1+(8cE&N(!*rf+LI~$7?fSi);=hBk78FLeY=vLa
z*WfJhg7A%<Z#UW1T(f~Tv=M}L3#B7qprfRzj02J^aN@L$E#~xzL3}(F;f<$DZE-5U
zheIWj+Pqp=J^fA4`%wqj39GWjsiIyc7wklAs$*rYe93t?l$T1aGMe}8cPOw=5q?H6
zSDdCQlicD(xC+%#t1e1?f;>`Nrp4fH+ZB!^H8!!EL1Q2Rj=Q{x!VO=V84XK<-tQ97
z<jrlX>H3KFKn?E%HM?vcpW87i;aw*py~g@|&6lm{57bbaLc(JcY8pHnnmI9GAWPd*
z5(`Q#4}(BD;251Plo;=-`rsVC*@%uy=5Sv?U_nF+lvl6N-MJ2dPE`rX0yV;7DlE$*
zDP>IfHj2SjAb1@k7KO~_G_DR|)nHfZCGv3r>*x!Xa|@+JTFb90cN2GlIuVaImN+gJ
z2)PiolK$7AjcKHfcwGEv!krP3*j_OnlLKlt7RLgT>bRK|w~S0$yoL^|ZMdhg$<HEI
zcOx>#UQqSM)c(}cb{_v4;al40HYoMA(V&fOr0z6qZBNZ>b*SgvCem$My(1ajWpE$D
zf@r9CVSa+AO`;h$8xx*A1$oicC25;Lce!H*NJEk@k5$6%1$)LRb(stbnlCsH5nUVJ
z2@zdlTunwpsZfuwpYsSEs1#Ui1%8D>^i@1s?j(tl2^uhAX){+p8RKWl#!@7s?z-48
z6IwavIK~B6Hejx1G*b{ClBjzZS$6D$dh;C?#1qryqV<GCV$SNBGb@Y(DdAD0uV?x$
z$t=t~xfbBK1@uLxJJqKg1Szq@OsK$|ZD?8dKrhD*h^3*4B{9(>X8}nq)&@RDrp(Vb
zb=!0LFyUPn-Q-uu7!|&S_?QI=9isb^yv%9^V6xn63Ot7!x{^MHT*slS=FErq2y42z
zX9(w5uQBd)isOu~B}(1@nIR*K72=m=DfpZS8c6XDbZRHN)ncK6QQZ8PUrWsZUyn$2
znHwLR%8@riYkN~GjruEE15(T!M8^r!+)VobhTJP0f>Be2J<9c$EXy;b!gmN4FRRJ)
z-d1l4Kq$pKfgcubv8)xr5)UGc#Khc?w*Hi8T8swrp+*^rD`jOFnNwuI>C@&>IawQ6
zl=%?#L5JdmFw+Vm0)-%0p~6IQMb}K_KY$xCxEwlZ`0~7Mldrd+9a<(NF)g?tDIg6q
zky*!!0L5d}C2Jt0i+_-?V)##`*8Ata3kfF`y}R5dZrUxyj05pd#DF|9GeA0%07}%A
zI)1%++^ap*FI5Dl!OUZr(_-2h`ZuV;oXH}vc&fD2r82>X2W{gnD=27<NN_j~#2o6x
zj#8%7KGUw5PkW$#urQieJnm(&4a##<n10ScnpNCLgaFEmuPd0$&l<6o;vZ3~!rCS_
z6_v$IP6*f#xtRr27gx82eFG93f+wNR)tIiNdo|YZG2zg&V(FY7+D-df4b3YIe8?m_
zB&@QFmjWJSK)qvBV0!UOfM%2$b5WcY;nkfPDg;l;+bylAY2Ll|@7&vk4~?uu$xXZj
zhp@jB)-x;CjTL1{Owh2lRK`X3vItIaL9nn26YRpJRDajvfq&8t5(<sIGU{*dH@d{z
zM@XU_3+CDi8!tjZ$@?{QmOFbQSN!a`=CnQ3eIpHvg#}B02k>J!8j`g#WtDYH4BqR6
zsaJY1!^gSzA3!VCwFH`U(#>f(){plkkzCg+wyjC1eG#(kp-QjMw#}NiBn^tdu1I=D
zb7E^Iqke#7QTRJ@yvjSqHc5~rxI=`LW(!8=n`UoAvK0kC2HfVxO2<37U``V)GCP*y
zmY9Z+u!LH6ttQ#FkkygQF(h~{-pLEXrR=jn@uo&zlQ}Yj3w!zn>j*mr+srwku;eFb
zwqC_Ji0eqh&`eCfC<KI$(Nz#4uS%ZKJ&&@mR0rHEYnuueUf0>d9juzdCcd@L#93F=
zjLSdYLXr2)TMtDib1g9uXjc~M*;o`lLOM`EI0l;3J;YR&kjUcRAbi<j99u?gJFSZX
zJ`!2taEde{GS`$hjtQ=~V$sd5rDXwpL<oSdnHBRpVg#OouL(bHvL(Yh*IgO1bX7Pe
zMKb%eMbPNFM9@&$sEfC=^aY@`Ko~n!Qrwo}F)!Lh#8=n{_Ao8`bbykm7;p-(a^r+&
zSc5k7oXF0%o@J(;f~r?hr56kMtznU@K)xHej$YFXUR^Fh^SbJYqZk$(9SUFs`FZld
zL-GsAX<4c4?ofq1M--A0-|JE9VO}P_MnsMk_ZBw9)O-T8Bx;$Fg=fo{DB71}M3^Oq
z3PXKlv6pE#397_UP#2zGRW1-46Sh_Uslf{!J+zlMplSs_njNz;a?KpX!_WfJvKFB?
z)1jI>386&!zAcn^r_ja7%yeOj$zQc9Yh|n~d7kcD$cxI*iq2|T3AIS2$+jL0k(IX>
zn<cA4&ARbUFgXH`ute|K7;dai)KqX`adnsZ7&yKXMYL8h(kgMUp5&_%4&2DD-cEOE
zGk8LBMa`o8Tso>VM@2h{c#nxRc7BCi18hezj=lICrLVuoqG@<sU`RMvdFT7CR8TW7
z6j~X1$l9HImU#jO1STyZ@i{p*12n^}NUY#~SRlAs!eMZ-L#5?HQF}tzQ;=k5ECJby
z3kWYN8%w8srMW}cv7Fy-n$boJ+K8G!mA6fbWK}Lwo)W>IvCE5@%};H`kth%(d1W-H
zMjl!sc#m*O%quCh2(mMQN<-KSc0=M<V;1QV!A}FnJldgssjf^!KdMDaGMId;rQm26
zt90>CL`Za4pZ`p18NEOYnNll^{1+nfGgmBmPl$l9h2iw5;mJwhus^N<F<8pVX{icw
z7lQIla>-s{j0D$RBm)5)1MTKyljWb(VJ2|Ggnz|Qt9L`G>ws=6nhP4&3ik<*YUQWV
zUsT)SGVCRlJ9xA3E{KTZFD|8w$BizvigQ3|c~!Rz7KIh%<G-U}g%>g8EVC?28WK%F
zp9+h%h%3omJR6A;aSb>M9?7B8#r!4S9U{E1u*P95VetU1LES_Rl1T^Io|73?g6|2>
zWY@x)`Wj0+@C^&8aTgs5Z6q_ZgM2G+^z-MX&Z2H_M<6k&KN#7R6yz2*_Vf1;adl}~
zqFML$YF#^sZAtGtve4bPZE{3(hG5vZ<izDm7@5`}kK}+~T4iE!Nk+Kn0g;wn8)`OK
z6A=l9aTywo$Bpo>aw-u#A<V~^PN@qCPEFtnjOyw`s#(jtQcGT;csr38Qd5)PH$GSg
zG{^n6I%x?h1>r4T!VH>|*1j@J(Sk+wr@-MUJPsV5t#qz(s~qLZ!Gw+FPj`sj{No_#
z&A<~NTdqP;k7;QWs5^;wp(rkByzga5=!7fCgi~Xtc{5eQC<p`s+NV9MYW-)y7Bwnt
z(Rg5Em4Fq>2XmV|*6Un3H<<bX^k1=Juq?31v^|Ga%GpSSIk9UN#$$%g0BxEaEMwVQ
zGnqXcWx~C5v2Df6xBFWtuN+rEe_PJ#YEI(E)4q64$2*sm-D?`V1l9pU0Wz56`8CMv
z7dk}G6HYyz>AvZ1t(wpYW(Qs|iWy#*wlf_G-cOi12^$k^tzye?6tbj7T^#YTZ4Ov&
z<h6i>cJmu<8EZ&Vp`9VXSr9k-3;C=*4#fKI>?E6tkvY#dAv=GCW7tt%9k9X;6M<@t
z8S=A;bn=PW4e*B)ojW_cxG$qSk^3285yJPikyT`GfrRn8cgO*_P=0vf9D~1`h_stY
zPqfKSh&uZi<x|Hl1~?2d7K)`ja9cczOL$H(iBYzoOFF1y*Crz-+S;Oe`CkyG%f<4V
zdKq&UIfaFd$w2~F7xSP%AO2>-X_;>(mbseW0oo#U=glC?gvP##G{Gan-e%O&nH61e
z1SkcSZZy5EhKs^N7n^x2@lC?tqP{0JE8dEhw*fK0y7fBs`#D5QAubIRIxa-?)r`Ij
z$vUB7%FPPA%7kpue!_7itjK1#e~=t{Ps634Wa^oV4)VBm`Us(A<}hd%P&z>)HmKB>
z!wn<3ooC=oW;54-;0?@XGJ|@&WxD=Ih$DfKd^>6KQX7-Q0e^)r<<Iy_E8l}mC#l+o
z?3m2P%F0;ih>`5BK(k?wR{Fy&C>=|IjhU_%jlASI(LKU_rAywO9vNk&Yls{*qOW!a
z^eu!l`Im{{d`C+w?#iMHpl<*_-%B8iX)N`H0EgEW%*Yncg=0??OD#9@3<>Now=#pM
zP7p9N+O@)sU_zgfQp>LwhUU0f^i+za;7M}F>f@yOox4F4{csd$L9^n}LXUtFt|@p^
z;tcDCWj|j!4+3QH<i*(*OQQ)@V({!dgznW#qN#yKd>w*dFMwWJDRAI7%DDPOTy|$u
zgR3}>4aGqWY?vTxb>cfza5V_`CRdNaj(|Y=6B-Jo#%YC*266KGy=n8C4_k*x`_se&
zQLjO@Jn)Yo0X5Ev;}R>L@CK1;lNUVT8#;CYIM}XmlOa~B6}V*aj}Q?RUDD>3xk9tE
zp(srEGpImOd`S3|KUZu9qTdoTJL6THs2YP7@GgjEBi&P$rMV^CMld$1vyIEebAo-e
z=Lv;6mUMFbTq>Cy@Qf@A%O)z^`ZKy9;<GAzVB|DCI3~(#;J*k;tCW=)$eQuNPa&cp
z-Bx>^g_FZ%g^&xywV7E~2Q*aGLFi^rjW=>#Y-SY?wh9agZ>QA!Y))tf|13gvip~@?
zR$ZTCTF(Cy5mU%(khN5feGW|^z_H}Glea%7ez1x|YTbsABsb>xiUdsTgd+AV@E6xv
zdMxliC4wEI-P>GdYgJ<*o~<T5Z;QpA`5}SW8WT1VEOXzC?tBAsik3E|PL5J^rCBh;
z6Ge4kZd!u9WW^SIBPeo-TSrb5CHY$W7Wi>jFcD@aShSYcjrrqAh&v{Y8kU2@o87uO
z5QwE^$4YA3`*`%`t;h^lLqnKmy3DmiRC7KdVv7d?L@~vEOOUKgQAHPaVQ+p^hiE$?
z$W0RrMG7rn05rbTDnlP>bE2%SoufoV2%Vb?M@DmVdr&_pr@ES<>W&<th=mE)frMrE
zm<;A45QtcX!k!!BR+!rG1TPZ|yXmlU4|(W8pqb-wa*QuFx}=>s%-u(Lj4clhnZ^gb
z3uR5=G2mEid0e`AsXL^T6pk&H#pDmrL$@F|JPJ$^_7C`UcQ|oCPYME>{QM=uaeoD-
z%$wW;N%9Vf%nj&e@lrA2(hwX_>F*#^9Ywj+(QDl;$wKFW5zYq$SLPb!<r5lX0>!yQ
zuS?Ewn3Sdrh}RQdT>?gMyK`{6ZX0R?`!-+Pvdm>O!T(9ftZy}I<wk`;d>M*If&GG{
zeotY6l%I(SJMP><QBkeK3>bU}pS9BCIul|oLTI0=>jXGV7EaGPE}2268^dwrut9hE
z=oC-LsR!X>&krPw+EvjEcSCF%Vk8%uwv^ixhhHE9miejK@|=tjaFXq)ETc)ggo^qy
zGagvQNEZofvdB$B`#=Mc!Sg0cV(eV6hh+qB2O$m{sOS1cls=@rrK1@6=Zu!y&cw0B
zT7;)lV2XRT*>n+@ZZdSPV#c$~T3omp5RL~WMh(ZhRMCE<p_2VJhI!IF`-zrGjvB%5
znin_@%uDXvMZMrQC9z{BdfLOd?-CCAHCD5E)iHS><C8!U*0AOLCg;#6gu7cPe`>-}
zWDA<a6i0(TPL;L{jx_nvdbS_-^r#l4Ek=yK4MI?=5V(9^hHzo7k9(JJ4HK8n6ggHt
zfVT9((PZzo9hCPZmhe0<5uI<_nLS+VB!cq#6n@hRx5CFGFNptyh_`B;i%pJA4mVLl
z(HC}HlO=R!FQtWv=tSC3k8N<Wg!?KqbhgIWwc(~fKT{Vz$cC59e#u@6PA?fw;4uI)
z=<ZYOK0YOWiLjdJcFK$^jd=r71><W_R@}79{QTSq|2)Boh{$Bg1buQ)*mEHK<($em
znTI{c789}Q!Pc#HEA{Ij%N&rmfqZ7a<?Mjikg(tu*BA1$eclC%8<s+0$;s`GIe~%V
z%|!If<nT~Pcc>~9)~e8xGkyK-)`gbb`-E5BNRx~|>tBMuLrGMrp;Rc#DUM1P?ImpT
zqXfKwKqj5P165O{*M>d9Qj_Y<#h(xYht#6*`Ie5q0~fhi0$h|YEjCwW2!(T)2=}$I
zUFHl{cmfwk6`E--u{1KHg(rSUxGe_cii$*5^uQNTGA;+j8}C0nHW=R~U;_KIeeCNJ
zWi9t;O*+(=>zVd!iM44DcLWo*%L&D^oUqid0e=k`j-e4>M(#u>*Mx|&St^ar^0cMT
zKL=3=Ih$4==_gI9knoqmvkn1o+%&glMYjd9uot;Xz%i~hDYcgShzR2PG`0H(9WMgA
zdcf9~#rIWo+4Fc0iP%C`kF!q$`va(4ltM&m79wn-OuGf4m<Y<31o#g*B+r^Oq7|@w
zmOcx$4h61)YH*q&5-c+EI>SA5H=+`1tWkA($aLqN755$yKE|4G^QfNB#Y|+MSp<G?
zc48B^T{H+z0As4xwXwlAkXEXJ0u^J;h1Nl>-i=9I5hmPZqNN7wJloB*@|}tS<-op5
z>*_!O7uYOXobhcJr8ntA1)3E-w9UUT(^*!`eV(wID`I*u!fc<Xc@m1Tgi;B+dSbL$
zc#UwWu??CX84UXyB%6hLJC+VicC`(FtL0-;6z1EIW2a2YF@&6Mqa$ujWnF?GOoTXf
z1T~~aMAHU$fqE~4CY5>xHj6#GAf7h!W|{VLg<bRjH58zbyQQeX@buDY!G6MbC9zgg
zn%RFI3bTeFD{Dg5vSQ8Q9wo%={>d1>a49)`Sfv<$5HIBoH%q643z(2NSkAeyqiy~I
z$v9NWH6brp#EuH#e@CPa1Y0hfw@5!DXOk6zEFN_C9<A^NQ)*Y07BDb3)=;baGfGkb
z@f-2TX?2_vA0=Ya!^Mr>QcEpp(_AwlsBq`p%<-v4As;xIG*(a=7txc{^D&w)6oUR)
zY#a^q7d|9J(R1GRnFR@4-8r;uat=xh?sFFv@RNAi5Jz?R4vLsrZFm$tn_`=os1&Al
z2*u|J>&({p<;leuaygS1HTt5^H-c+lpUUM!{FrGrwpf?E{2on0C}vs`R$8(W!UnnE
z1>5@8w7Rqu@fyxLugY?FS7&2ca<34iD>}k{cEoMWJQ`0xNWBYWsHv{Kv4q{iGay`7
z+B-+W7E);u8$kV60?lF~)wg=sn}3N29B5!=X4+?gMRC$i1My-Fr8_ToN_fye0%FDS
zX;Bu5|D<i+M;*H!ALbQZ@5m5C*y)&E;3VrR6ub;I$i!n%^PK!i`<bP7@d+Yn&NOR!
zlo5~!aYz%j^5Sr+i=Z&rf;$G<$*XBF%bgvtsQV5GGZ{D3=JrmRXQhe7V86^99N3bg
zP<3)TnX0`bWU+YGvZYx_yRCIFdm?3IG+OeNBBUTYYLjz&uyYfKbDywuVT4Q4TWs}=
zw^QbH+b=#x=~%1^uy=6?R3of~!pd?%)DIx$RL_eO<}tzLosGOma8TJ94O2-)8RMWq
zD;1htlwj#@mQ^O+LU63Ym~wWbDMR-T2&^X*W}28(YMxjke3J;QGWE&|ot*kmF_%mZ
zcnsEf%`SM=&>n8skscNk*OwmKOfROQ1l^Z_I9Z-OVaa1=X6gireWRJnBQ}{33>NIS
zHZ1S9W7{&kg(gH|OORc%+gzZk7wW`gV5!oa+=t?AWV8jf9o8LjBA1zY7h3gh6hZyV
z#c)w}V2WKj#~l-?(gK!;%zLg!*9I+7cNtBGhGw-}1&Ae}U>Dm`O_M9;=&w*wA)bN?
zWK5@rG0ZJRe<Px#oq=Ft!hZrzb}80j#n0FEW}B^u-XT)05-jDu=H?HdO}iN-4zc4p
zX5Bf^J=necMsZz8kgh&zPz*&2DwERuty}r86Al9db$Lq*nR<}pl!9F))@-km(0Yy$
z;gD)E-|c3~AQw(#V0U11LruJ8dc`CMeC&j&W&3JLFY|0Ea-w=%i(AR=c32UMe<FgW
zxFN2K*2`xgRimO4+wiNTBP}w)D}-%vctp5mG`A9apg1gn(gt#S6Kj`*VpT$zoM-OO
zwW~J)B<0jd!{YJu3M(@S*AWCy%wjPL#N1tot%$OkOcN}ZqB;fOn%V>nRVQ*A7C(km
z&t}l#YX+PeIn|;Mh=>*!%go@!-YwAF@wg0HG`h&kZ86tN_1X^Ma+);0w>t|WH%rB&
zuX90yFhSxaf?mvCsn7RZo=Gi)E>NN9j7g)hrXBG@p*msJQB<5CC>PU)_Mk9aPGhNG
zEf6&N2J*mz_GHAk+b%a{9D<sADqJUTdoO0nT$Erp;Z!Va7?aLtbHR1$z}mEjd(N;@
z@=PlQm<YA$WzV#XR34&TB@~08RTfVCKnK3?OCl)UGGab5u95bm8iE-3S|>MaN>n7^
zo*~@l7**YtA@aLWw*njqb(@u@S|_HYcZBKixdZO?@$5=-P+r!V7l0O4-OmfPtDwD4
z*9i`qiM9ptE5HmSz!gv&D{C=>IT|e3La=5gV)Jq)r)ckQLJl|z5@trU#?LI6o2crT
zi9<$W+ZKj9@n29qn8wkfbk_7}J_jT=Iv~P5u+e!w6<k*#_@}_k`QipidX8ua6De)h
z71hGgHq~8dnfn4{Ip@VSXGl_M>J%N{sbQ9<*rU?IBme^8I$&6{g>ZtC(I7rVB#W0_
zS9<cQt-%L0$A5=bFUf0*PY7P(gLY1mGMX)2QYXF#PD{aKXbtkK?d*=`y-&nMq<E#V
zB@)%wksoG(DI3g+m`hm{aXuyd0_Lo9dxyN}+vw=oI?e0`Gds?ph0q1U4tD$GbVnhh
z40?DR)yv2`UFsI^#1ZFX!mo?rUQyoANV~ZmS<oCbNSH0%0lrx>&i91Riv4&lKT=w!
z`xTnTlOTUt=>ho-yiTDO;bM~^^|a^p?*Q49-P5?1WZumVv!CZ}BK)dc_%%(=v$}vk
z4_x1x@|nP?`~rb7Ve4gT?mb-Vx~zK-d4O>Vtu0&}v2o!6oBh1`1u_0{Y$>q09a^A|
z85tp|Yvm1Kf*%%B+hxNXF~yZAj9O_FIa}Hya%dABC48sy7ec(o{ab;J<Jb!<geb6L
zs-RQC>47kyW3D{6b2#7t4e4VR_!z^i5XS{+4Y&)@Hc2ss5%I#CK%)MjRn%NmS(xF#
zmF);@TF&+;ab(kHUP5)Cxhw`I#Y;Zr0#Is+jFKK_%kWyzg#xOVVeM!bm$gvF-${fA
zELy}dD*EU@=s+|}a=xg{b~rdZOvnTApJUo)M%4{D;5bxzwszlUiruuCsjtPNV3OAU
z!oDE^r=_QJADD+eTn*;Iw%4?$Tr|9w5Sm$(1-V&R-sHZhaJty}Gg00yHoPB+h+I#0
zQHuE(Eq@F6GvthWW@>PstAj+`3${<j@L_u}hIECf3__TOl;w;(GnP=92<oVJn;Wc|
z$^zZwi=!Zwi~aHfv#OCF4A!k;C@7)3yoKhrhYVN^JBpfT-Q%;xbRuqmlU*udq|wK<
zQH<_qq;Rm4ZH65^1WyV7k&x_|l!*)%-FB3NN1$U^R)>w&4BK=2!Nbc8H!~YB6VfC0
zqE<yTXye@H$?&h>G(vgF{p_^ik;S633>1Q|L-i^u8tsbeN_iK+xf<(P9>^=E)oexc
z)SZT7)AEspj26LNg6~v4T3s|<Lu*w-xp>@Y6D7rZbbPr*CWIiN!D69hyq11_8*(Q{
zudA(v;W_cV<3wVg&%ngwM8FV!g4z@sv?jEy&ugHW_by?-QpPMP3vgBgEt5<wzvw?I
z=T(i0g_RH)7f(*PEIE}W>Rv!KxEy*~H?N>3+df$EA(0?W37O1l>7w(WLp%j5XFcVP
z;@E2LmxLssPgYlwoG!pWfHy-H=iNNjkrU&~eMm%3M31@$yOjJ5ic3+<Vh)${799M=
zLK&FM<s{#<h<0~d-OrGnV&rB%r=l~%%%0ze2_ODku-!1DAsVz(tzzk~FsZzCW!98W
zBP^T*yke%G&vxi+QHoVVyw0qg;R&(uCBi+EJDk`N+g}XPj5lUNrcD#(j>(I5+%RzY
z^F6YA%=&D+!71xixET$L?3SgHC};#%n`wD;q*whQegj2Q<BT$bmdAQZI(T3iJ-iAN
z#tIT<=|2(>y^>>O7OjOPNlh&rUrY#kD(c-ErXy&d9Y&=ff60zgp69f=@FWqCUa{<)
zF`pI&8pt8@HAv=a%?S6a9OND%L{rOS))9R+<odWEYPC_GdCNkLh`~QixJ)>T8C^N)
zeu|X=uY;htCeP0b{G7#?2s>_u*)+S9ON*kT7R8Wq0kfgbVXT>Vk`VR<^#`VhCg>;v
zRC0lN+d@ubyo+1}u4<%BQ(2$)P(N)<2hAz^tFNGNswvD|7=Q_<iRNmrfW*OAFd#Y9
z3at)dd{RS7p4mr-JzH|eT!%(DdeD3v=yzKv_J!`AtwT-x7~l${F|#hjIgqZeiEOYJ
z$jhRrE6qNtlJ^M_Y*!T#DQb_TUnl3b$hrLSoK9OmuRe|s_{|+%)@{y{1N46oh>N|+
z!GNeD)9h-0n*Y(mX2}lY;`;K)PeH|wD&`>Sy4stB!3n~5h^Pts#<_7<N80^^D480o
z)e;n2n&~!9tJ=0BB)!QhXwnmO5t3yZ0G8@OJJ-pP65$Vo2S2RTEMC%2Ke-9X@6n8k
zYNw(*+nfYH63!J>q0$obrr@(XQ86{<Vq|!r2fI=zhR$GPSL8BOp4@H?s+onEVCA~X
z=X1nub2N>uIxey4WeL_{Q=__<P>({48Y{Bu`KbjW=;$tt?3LDx$R66KFQO=FoZ+%<
z6|bsL$TK0*=cWT%S{#I6$yTV^S{B(Isfi;^G+SLA|GCkMnMj7&ej5J;YW2ms%E>W5
zYaj76gjO{ZJ&FCxj*n=pow{PMnO)ua^-aY?oI-He5(8tIX}#0NiixjDXw-?h>0Y^K
z8pi`*SV`N;U4v8Fa4gEgQ(z`$Cz(xk-jf_?aj{GFvLL&9<~D6`Bem-K!f?!Vf_sF(
z3hJF{7sXpj6_D#^$)%v&2u4TUV4!du67>jpi7j<KC!x3?#fYgaDViDNCgDRb@RzW{
z1`=7-EMUnjm@@0R>fFhQ1tIjFupT>COO|zYCuX5x98a#*n-thC1<mtvFkzoP!|U^K
z?I8oi`ONQul}QDx;8}4>$ZaBJt~KR<^>rm+Q5@U4+JJ9Hp>0M`L{SEp2yST97{x>l
zNyfyRn5YRFlV~C_$uo&hlU#EX6J}sw*ctX6W@l4m--TflhJ6zl7<Q0d7TIBVr{?O-
z)px%KU)R@t>eOFVr~Xq5U0q~9lI7rc!VdHRs}TOZJBu+95ua0Wj!v=l1!W<OW%`=!
zp4^OP`v-&V;@i~y+5qpw96`@C;g2Hd{-^Gas*{)8+$50%l~T{kkhca`v_p?FtZ6mh
zw%MU#cNg(iDl~aW*-~2Y@S$eg>EEDkp&gOM3tkFYE_6k9VRK34Q`~yus8&fO<AM=O
zA)R-%Q^W}=>dtTkuWdpWS`NhPqK{u36-SASdxj!xA-~eWq@MiQS}Um9J>pZ~q;e`>
zo!ZwVI!z_JaI^cAfda;iE?U&Eym>|>s8Uu+EU3&v_Z~s#cq#e8W~88xv7$3mGfVhY
z(w$U>T}MdkoTOGjBq4vzf-^Clqn744%L>88o08nqc#$n7gdghGyx!_@9qi0sY!bD@
z%F*93lD#-nO@UYC5;ZU}Smc%$s;4-D4U|*<prdc^P}z6npbm^9owExw!QD=xCW5*z
zm&{ZPm!`;duOgXd*mdSRC$y?2Wm&)!NxMQ)5!_AEcj4`z_z&n^MP7Cplfpz;Y)^M^
zQ>Tl#_%A4OdM!)-kUPoY@ufusmE=F$oWD@(-@!ocnoge^-?8wZyHu0|8TJeO`eF;(
z*w75knmTl;qDF-I?IM`a1;r?H78dN<cS9Xg>9y7~*^ibIlR9NDQTD!W?tu>JAq>15
z6mlyN*{h$#W{A_lDh;mTUMin)ve*QL(UVzI8KDvF{eH4Bg5u2cgBAYn6^vRM-U*6d
zMmQx6&EH9qQdEkag6*49Yp0SgLus1rVE#dO8v65NV0Ir}UGFla>PROy86qxB=ms5X
zoTk(6O8ub8m(&5uxxu7Uq^>SK(Ym*jzYv;VB0NF)s%G1}NBNyQpzOZHFZeBPLt&kB
zLYMRk<&l~u9jG5<FC$+zh801ke7akv$QRtCT;#S1>FG`OmXIip?q%&PiyIaO^$8AA
zcN&x<g>8?W@D7Fr&9XOkM3mmti8r~~vRk^wg6$r69RC<roAJ=~7OIx`5h07>E|^vZ
z1~``1)ORq7_8~_(-ly6sPf~@?7D_S*irbUwtMKi%|B}3Yn5Y8d&lTq6$@_vNa)OEw
zvGX#L_(6D&m8)j=0C%9pC&#fv0JBbSw|seCGOwC#gqonwaO@xGk4+90G{O)cCG;yF
ziJU$Q1(niM3<XO;9&U5}q^re-;AZcU;D|;M<HxONLSz1Z_qy<q_EPCrRBV)YS??Vw
z+wJ%vl&g6ol2TulQLzvr0&XP_56-BAO75-#v#14PvYKhB_Q(-BOW&Y^MFH_%73wtd
z#zquEud%8Ls`X8g=75p?L#sQo7pwdjCwAezp3tDqp7ky{+2gVURHo>OfD=*IeEB}A
z(kyRN(|M82p-Ix)ls`WqCpB0cS3vlnP<nz%f=iy76B#64B+FN9FCWM(Z^*;j00uNe
zTx?+xKcS#j8V22A*UY4cWT~0)))thiS(EYDCB;RRTp^PRt4*IT%E}5LV|9={8KR4a
zxN+~?sPP!d6)OC(=*djHGKKuc1Wgjdwg$9Zxw2&PNuTsI71qEFt!)w|Du_#-%Z<w3
z!3Pps8U1op-}I#w2$>Vww0$dRB>yO)$eSCq_GxSD=&h#B*76N>(2TJT`SC%$EojQv
z5KY2E6cZjMj15VdrJf<VOjl2b{M<-S2R$~nAoULF84CL0VaRw38U*FJ-JskL%3(U7
zJhKjzhhK&u`hcE};0h>q8MDYj6Fo!J0r2gRV!aNeXoUxru?}i6)?qK|S&*&_P;D~a
zLay2ksttgbv=Z<bfQRZpJii~F)`JqMV*)|uE|6CkTcUCR%r*qTQUFu{m<`+)!~FvQ
zFNCWAu6$6syiJcq4q52wuz8R)z}P~5NzYI#sPcRoIlCIL%`ogAdmzr)n1#Q(GB70f
z=mHoID(VOz4#qlihMoocH_*Gg8iK9cA!vtcYE3;@cS}&LXL$J`NUU(2lOBlYYSxXC
zqfj66XG@U%tb+@_0w=;&dV;NVWE*7o#Q2iH1GGAE5fXMoa2V?!#QJ}%)7bhf`Q`yI
z{3ehTV<UV9s_2oiCE0<kq>J&+V!Z18AnyRXU_)1Kdfw2a%uvq)DZ#cpuqJARn;i_e
zc?dT@?*g3HjsOH>B|y{|TcB!4VY**$3;Eq~5Ens>NE2Lu)!6o>(5h}LAWhR+5DjjH
zAp8{wUc$O3ux{8!J#6_)q!Ct=VYS~u4c!M8c^?B&4F#gzSStfWYY&4ckq)A_uxi6T
zkS9R}f2Tm+Yz$BFKm*BZ@WjSiV{0Jj*aGrc&@#k;YXJ~NftJ$_sFe(AWkd(DGuHeS
zYl<MBsy9GXwhEpiK$D3z!$32c2I9}L=EP<Qy7z)YAOPF10tJ6im@)^2n}<N`1L<ZB
z;OT!r6Y+r_o?t083C4B<#Z8AG%H}Nq$uodpJ%(EeaAd{n5JZv?Os|JvnK`7kGrmQh
z##qs&AX0;?X)RQzN01lIAlo@;x><mBvjpfFfZkvV(q~>O0dkTSfP}`OKq=st<OVAM
z`BWc7BhY@s#+W%e<WXJluL^KrQh*uz{lR}y2lYbSb#Qf(vj;QrC<JS;uRCC0Z-@33
zZ34_!K%I=moL<2Mc{A9g9(N1(FguwTl>}7akR@sJCdj|Ss!^DpRbcIwbs)NqnfWC+
z3aRxbrU=&9iMjqWa2=fW5_#|>sQn$Ycmy1RRPEPL2O1yKvl?ptkOc~IU?0kb%F2(x
z(<fLx71PZF)2($Q=HX6U%fk@dW?@$}#5}~@+_qmsAWt$v50XB{q`M1137B+-SalRD
zL_&$L8G=Z$^(m9y0d*t>i;KXRLbwEAw2xlVvqa%gs$$GdYn<^;obk+SkSYj@9l91$
z1%SfJS3sfY7{r|hry&Dg!$qbv9Ac4%J0bF|cR&=1$?gW3?*>5R0@*o3R!(s7AiIt=
zdY0ri%wH~W%^oDhtAG$3z+aB(YYX}wAf4C?ZJF>k;KgGeD}i`g^Hu46nhyTzA&A@#
zk-(iT<SUyY>)$Xb_q~Cg;}it-8z9&Nq{Ix?0rp(du!pu8@)~%`!~`=y=>{I7K0x7a
z0F>faF#u+-19YzBQA~2-d!W$@oz@Xd;}%HV42cW%0jUW}z0Klj7k~IYxT%Mm#_fPK
zV1RwjyiS)i$3#Nl^Q1da2ZexT&KQB{PwX->a~~48Wlvsy74T{>IrIUh5^ltpB?8>&
zrMLkXp}jqigQ($s5cz=x$tg_ryV%?@#!0028tlcG)~?3a$j^Y*(9V{~7wUHADAcqL
zi~}uhLH=qCiZ5fHyO@WpB8PEb@FDgiPvdJS6e>FUHmJ{GV*da{BG2K3QfOnvDZrFK
z(N<%GA>4ibj!k?P_o4Tod}rSV`RbET`8b2gmx8+$Z>S)J?Ry&g^bYW8vK9(Teg_rM
zV%G)UBTI2-U<a+_Y3zv>%*7NiVhg$cJ>cd%@PrKydh5YLKo9aHwy)(5O+{~!J-EYJ
zi_tFO&dC;!I2SP)Zo{yHvO#0lySS6Yte}jZQRBa{7jMUf=YlJvba2~upq)?}G;g7C
zBROOMCRm111sL^PjQS?-M)SZ9$Dr3mawy3N7=&DdL8mdO2L|1ZK|K#>ERsu}!k}>g
znq_<ojADrU9Sc&1F>heZUAUy~c!1o7x%<<*kS-buvmP^~6@#W=(ES)R0E5bnS*U`@
zrL^&J5eA#cORvNHhhcS2Zy!>V8)+A{Y28hH;_xz>9$a*|7;w=}Ba*QJJ!HJUf%UM(
zMP4?n7QaDp`qT0o=cBqB$PbLr(wdyL7h_!%s_dCwsTSoEnBO+HkkWk?X2JH2+DBOa
zs(NYpkV3SF3QTTI53b7{%_WYYK+TG7+^+h5XK;}480AvvJ~EhFHb~ZOMiH7B=7cgX
zygNBprb9(~$0_<$zEWS(1I9C$Jx4Fr+B+6{NlmCgwntw~XiuRhalwc-N4~zEwVLLT
zDe=0Ssg77r1*Xemn~P@2pmnf<#IHh%Q|E#m>&D5QTTEmf!_EFp;etWpJgTOjHx#-}
zD^==7^3{|3?H|}baCuPMe;%f-fennCXIbSzl_NpPL84-q<tL_Q+j`l%Fy1<cgiIa$
zVOjNfRa;HJY@VP3%T<rNB2^7F#3)T!&nLe=WE~Nba;JD$CDW&(hLgspgF_+>U{Zch
z^H-}U70Nc@%wyR{REWGY$iLLKh}^v&<rBB?(FaonJi((h*>%cARna%-mCKuiC9MKh
z@;%~_uz|KIktLNF9H$76t>(-Uzo0Vud8@SH@UF?}0)YX=@s6%aE{b#_qmQ9LCXB5#
zHM{PigE(5Sf@1T1bDN||1<p|OHu`y1;;@}~u_;NgkxE>O^Y<PTtGmhH)<0dahAafC
zc#lTK)%fF+f*_%=vq;J0f;n$pTuqzoPH$60Hor{yrk4iU=L9rghepq$|NUZYVqaQ+
z@Vrz2%bPnw5kDx3cL8ecVz%ANBi?bbi=QC6N_l!$PnO4w-z9IYhjJV_mG71Hq<p$a
zI6_d;32)a}|M|)zWW*V>99G;+oT}2HPo#teSb9}PIcIU4*ofxomaHI7cXz_nywI9*
zomH!s#?@o@h!I#$Te3KF+)?k)LK%y?)Ad+YrgSXNg*3(VjaG3^QOe{5o<xfh)JLW-
zP85$bI*m{kJ&`4I^>wdP*GJr@0{9X39oZA&i{#<m^uMz>A#RTKvFU;hRKR?7LSJHT
z`#duOMKHHRBXUbaqS{kpg{vv&+Wxu9<n$V{(Hto>AC#3UI(rklW~KH76<^*N+LMsk
zc#Yg{WyU$B97vs*S!xuvz|zpMKVhuD7RZ%|W;L5jd_or`g1}(WVJb=<?bDglSix}I
zg^D#FR)tju3I=-vW%c+&4)H>TI$FuF*#b+sQC4|HpR6<8R>Ft2D(SKFaF7&T4nv8=
zsEGlsT+N+pzRMx!%nfVr^Jk<X?u<hgs1oSZn-vk*kv1l~M)4AxokvuzL4Cv+@+JJq
zAI*+A+D1!9B<rZGO7HGcd49k$@`@=erVVI4!i?@f7b$78&4gRu?lT#{0h$$^So6&W
zmQQPTJ0~(j>OoMhcItp;9{)af4T`28W$}YU6UxW?A`&2`i{BI&KJH9@Vu8Y#r@%M!
zTAiliW`arfK@;9$?cL0zJl~n)l_(2FK&bYlY_WCzk&Aeepn@u^dn@FRV;QWyNJYGk
zzlq_O25=-bLXzUd<TbP<mZXycQzT-Z0^Zli#&aKrMTsmZUh{%d)e`CGz~rHRy1#X}
z+-IDZ*DL*r;@c%8a_)w9XA&0-Y3$Y3k7iVYVp)TPqN0KywkA#0bG`=l<`5rW(x=5W
zEzJZ67eo+LQfi!StAEQAyj!J+Zp^BlR=SD>t&;VWUkQIf8PqfT32A+bnGIg#pI$T*
zG212dg4V87i!zGKd;*C<<U(%4i{e4AIX~a9C(>4e%6c^aAh|^1$S5>J9J8-ajoErm
zmUoW}n+PhSJm0BKl3p!l<{~xyA69ODY56sAOM*`+PO0GW%tCe#`SwOsK>TBi0gYYm
zK2#f@DP#(FmJ7JEK@F*RyNW0C3g&C9AY{TPLGlgd^~fV9C8<yi-EkBBh)Kejq{9|^
zoO@)wsiDh&uZtJ=HZf{u%Mvz>#oG4_O0Q9p$HARrvoQ|)$@0^LH!!uawxx+JT!P*$
z#y2zLe!agZgJX@dHLo~YhPa|THKigO$}gVFEq@pyGJ+1Zhz!B~${eRpRW?u|6M?gP
z4B7YFhSd%;cc7r-r4SjAEDz2Io{$U^l;lx+yn-JRoyKg|>aHs6V2!)FE<Kzc5|~nP
z>5F6CbsbO2h@)tM_!ZLC1!cJ|s=S4E1Qi??GbeR+EG!~6p%P*Y_~qGE+*}bhN0K{C
z;$@FZ{d_vcQizL4K#X58pykxG&V_Wk3knFzBizxYq<kU)f8-@Sd5+aq*BVzl>>|5C
zd2s`iOVW8oGlV6Y)SM&}>Zwfea2*pKru;;+Gv4=leUpe^Q4Mhc3X|j6S5w0q5mXQq
zuQKWG2tTGw1to2uf69`?y45OrN@ed;cYE$MD%i~ncF;Gqf-?ri*xd`4B+AUG@GghI
zUS)KA0>tz{Oo}{!-Q+PYd4qEI<who!tK)qjhOH^R`(VtyJFV=9tyIQ?g2@=q{_;-z
zb&-c=jFmiUsrBw1mTaZsk`=*qZV%+-S0>0$^EJ(UuiY@Glp_iuC~;;`!GzQJod-lM
z;uB*KSsv0Y@KcBcGtiyHjLlbwD@8o0T@TY48s0ub!tvoH3qGcj<&y&mDFKNLyEFK$
z9Uf|$@*843C1NcqrYFu#QJj=e0~SlUyb9vNY8=Mm9TO#2smM6qaFa__NefgXoo<Pi
z-aqkQG-Dc%xeD^miwz%qq?!^d@s@IFc7^v~mlqhXf_~IwaN2RaB_dkd%XHGun$COd
zmrbtv0EvmCcwhG9{WyW`ebHXZzbSu0DVBv*Gk2pTW+B+2uhp%;wl_qoOQqQjF7)>G
zdXnE?fEm#dyw&e+URO<xt1KDpAgYLuotak@6Sq*k=5KD?oLEJjpkMqhmDA-`<>B~9
z;6+?Oe#~6}S~j%QIoZ`AxJD&P3I){*b~4h7iE1wAgNb4W8=ak=bV7d+oL-dKvXnf|
z*hfQMFyi`-46q-&q{{xJf)bbHk0R5P17R#~r6*d?O;p7!%6Os=sjQOh7I|561wJ!J
zO#j8YJ2hh_b>X4p1eI;K)VA2ktFi`fVw<&{3gD?mDiiVry#&Q($F*c~QdIQ-_keC`
zC2n-`kj35;eg!e&s4TuXne3)PweZKn9^Eq?S&9<ryHw^QeuKQh-<9FA8F+DlW<Xnf
zKbN2x(L#xhFrP{t_UsGEb=yX{Cy)9MyDj;2G@voMwN+p5V$rlZLAI81ZFX=P7y{oX
z%+Va%8o(O{!h$@i6cN8u*-@n>tq$Q)jEy@{E@6$|z;NxNGww!<T?s0(VWjOrS$0_=
zjHXNUPYrn?T<^jRd-Bh78*IaQUOiR)nXr;TQZqYNW}<8<wxvmWk_t}@PY)PNsENG1
z0>v<Gz_kVTyq5l~VzT{jCUy;>*$+!92B7Is6jO-(zRn@7Bqo=%J!}%^TR2--*;mA7
zzKiZ__P9(3ck`w*vZXeZk5k1!&ro!QK#2V4bu9k?PrEk1d(vMiK6^~$&@6LSLZd5*
zBY@~zIIeaaQ;-){{uDp&@*rU>sh&?<5-tDEaD~p<GoPHcy7A-nH!okm$snUPBO^k4
z^rRP|P0MifCQLt|=`!^99UVw+y=THA_Ak9xn323~^Uj<8M*3fBPB#An|6iAD-~M28
zbNBTtUz=~b`t1)_ZEo!OXXMR2Umo6ys!T7^=nVbehDz5}TmP{%^itvJHpV$q#x2!x
zqcuN$d(GyH>zA+F-1y>qn=4muT>f?Uch|3)Z@x-Dv&F*V%P)TV#^!sQJ#U*K-bdQP
z<;x5S(+e~jLqERptz!pQMp`k<hVp(qb0*|=g;utaf$;&_wV$r)eWqo4^}EjyefzqL
zxq1x!^F<?%xm~ZsxoH)8erFeWW#h3;KO3#tf8dq<hxS?=c<qaWd-vUXZSNt-*XF7@
zQ};8ieFt>YPi#l@i`S9qJ2VDE|J#9+$IAlRIn`70kN*@B1E1giu*XQ>V87w6o8Mo)
zc5OFtLCbXQ;WbEW*IwP5%xtue&^~tfr4?w!G12mmv}yPxy$c7oR_QaS51^uqOJAWg
zYc70+Om{ndMH4Q+LA;9oL1-J=652e1FwuUUVyvS%e!PZr#oEkV*IvmdA~LL-N>?gN
zSFWJb^cdPSLjTqZ8nlcS4PxMq4tJmccQm*IJw5F$I*b)G2i<qK8)^O*-q`5%XD7CA
zc>2HaDB`UXI}lY<{o%9!<zuh|qhR5`9q?|j11aAHk)y+MthaL)zIh69`aNRV>*%ke
z2Y0Q0>~ZxRLil2!7k{2V*AO2>`0wdeJ7uR0>=SG92!!xu^jup1bI;Oa3u+Doe0sv)
zi#WI({+mkw@YjM=aIJn0hyTeloPV7@_@4kyON+HwdI;fb^K$^_FFphKKW7s@JC*Q7
zK=!Afp5Ah%xyKOh@n!ZLVCVPG05t~~YVe*r!tg2Vz87I{UzeSByz=CrIu0RxZFmm$
z_zy1{{IBB<|5J@$JcRPEpI<i;|Id+>FXFs-`s80f#s9*2KE3vG97}`WH<v-Ve}uM2
F{|mCgafSc@

literal 0
Hc$@<O00001

diff --git "a/License\302\251\357\270\217And informations.pdf.pages/Metadata/BuildVersionHistory.plist" "b/License\302\251\357\270\217And informations.pdf.pages/Metadata/BuildVersionHistory.plist"
new file mode 100644
index 0000000..51a87a8
--- /dev/null
+++ "b/License\302\251\357\270\217And informations.pdf.pages/Metadata/BuildVersionHistory.plist"
@@ -0,0 +1,10 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/PropertyList-1.0.dtd">
+<plist version="1.0">
+<array>
+	<string>Template: 25_EdgyNovel (10.0)</string>
+	<string>T10.0 (6952)</string>
+	<string>G-r1000-10A161</string>
+	<string>T10.0 (6952)</string>
+</array>
+</plist>
diff --git "a/License\302\251\357\270\217And informations.pdf.pages/Metadata/DocumentIdentifier" "b/License\302\251\357\270\217And informations.pdf.pages/Metadata/DocumentIdentifier"
new file mode 100644
index 0000000..fc78cc9
--- /dev/null
+++ "b/License\302\251\357\270\217And informations.pdf.pages/Metadata/DocumentIdentifier"
@@ -0,0 +1 @@
+A0FDFCF1-3896-4FC6-B1F8-3D0EE9773E94
\ No newline at end of file
diff --git "a/License\302\251\357\270\217And informations.pdf.pages/Metadata/Properties.plist" "b/License\302\251\357\270\217And informations.pdf.pages/Metadata/Properties.plist"
new file mode 100644
index 0000000000000000000000000000000000000000..d74fb419963600e00656da05332a22257b84330b
GIT binary patch
literal 324
zc$|%kOHRWu7=-_nS6e^|3vR#y7Ow305xWbdB(?<$BsSrpB1HiVSW25JNqZ8w4d>tj
zTm*%#*zs-V8)@coS^2iZ_$wG}ZSU;v4M*esgCab7@s+c6GcUUv*R;M~+%<0Pdztz6
zYE^aqx_ou_?OWNnJipWr&-K%4?iO8NX6wzT_gjJ|ctUUyo)R*hQl7+yagH)=Ibzyy
zl&DA`no%C58Y>~=Q4yXb*lL?uf~ZsiF`EgL5-Sna*ccVZ)F}4<8H<&bf--~&O%Rg_
tMTv<bWM#%A6Db#xzz~k%3?ev(3&^1a5AW~+pYRR841!I<A^ag2{{WsDOAP=3

literal 0
Hc$@<O00001

diff --git "a/License\302\251\357\270\217And informations.pdf.pages/preview-micro.jpg" "b/License\302\251\357\270\217And informations.pdf.pages/preview-micro.jpg"
new file mode 100644
index 0000000000000000000000000000000000000000..c2ae62edac32349b2d784893bf60c2b232cae093
GIT binary patch
literal 1867
zc$}S*X;@QN8pqGgO-KUrV1N{qIuVmlgoixr5{hLTgebHIECT9KKmv>)o0$N^QmG)a
z3<3sRMp?wND5N4TXardT4MGJ&sR7F(qC^-Z48*X6J2y<n`7$47=6BAA_c`zT{O|L-
z=O8bT39xnlKGr?}K>&E63m}ug+aoE81AvbYFarP(0CYAAV9^R40o#EZxB>$3<_UUM
zf%({_R=^)?d-WjlH{ftEGWJw#Vq|RGP8)_LaByS!V6mGi|E%eo<<_Ac`O-qrgq3|u
zyf~+HOGlmn5&;dN!q6^&Awe(+Lb?D2&Bj5SfZu>HFcznQClEEY(1E*K0S1C$3>L=W
z)SrRU&_2MDaJt4;t{Qsm5d5xqee2Ujl?1BW?RK*7-~!DiG$E6y`H6wyw(WG2&rEll
z+1lCfabP;S|K4Mtrx$C#-=VMl4+jJWg&hy)L_|jYG4T}lPrRh$l<&@DWuMJCms?zN
zfnQp7@zUk0>(w{Duc@u8Z@SZb_ul;nEe|_7yF}eRKZ<*wONM?P{^f;qWb)P2>*+Ud
zXJqf>i+^8QR(w#dtg5}x{|Wtz|L8?Ry)alTjK!<HAPi4EK*HjTtu%C9+4zuny<OI)
z3HokDmABi8R2$y~a%jS!<|j1UNxEFEwrTd?iDmv@W*^1=?KKMA0cH~z-B=h#jj$*<
zJWdUsfZv4h8=9MFsnPz3Is{TDz_13owTXD5_Wum>EBY*9WCU!1A@ni9B;X9z?rdnL
z&&IAXjs_E{tXs<}vsc&)dY?9Rzt0&33!TiLAb8t0L3@GGm$5oC1&uNTOd$8c8;_`f
zItjsLIy`zu$wbjMr{tsy+@l#^1~)%@(y&L7uZ$emwzG(7rWdb{sZRQmTRv~#g?M|*
zv;7{GUvB%twopksS$5;--p+OZp_9TD_-Kzwp+Q+(%NAb`gJ4TqT#8_!$c0iUpGi4c
zg}c}GIzYDAV^m6{cT{|nT0B@GR?Up{SwA(TyE;)!hAnhPYJ~T5Umgp78kahS`FwxA
z+a=z^QvZ@S9H+zqP1VX{1Z1+4{tz&4ENL|!5A1O$(^8e`U)k=D-?=i|VOC!|2km7w
zGQLt$yR)Z4Q~iVm4jql>3=CI){lJ`^b)jS~9;gp=mZnSMDWzak%hI(c<^iQ9C}MQ^
ztCe*$ymfs2#D^FJOcXd8S;Z=kIOaT4xrQL%b$#qQv)mm4Rd;LAZZTzJe}xV*u=-Y^
zY+jJd?|=7xd7K=ij1d2jTpShi{xiPru!30aJacak&C{%KHv-ahdi%W21A}*0{S=Rt
z<m;FE$8Od(+t0$Rc#XU|AB?JMcSL^j?NRIS>)C$!Z(o0tY<R0Jk3tk`$qT2>W;K@^
zd8EZ%Ga78PyZPr+*K9)Ky5E@!A6*IDS<(k4m0TR3g{>l2x7|M5NldkipDge@^oyM#
zW8)_Vz2)*~A3vs2c$%DfgqE}@IPP!69BJ9Gc(S9cvu)(j#2!(G?nsjRli$%dhJTKw
zUJjV}OYgj;E{+pM6>C-}e@%DiTZ}p#9<-B}cj&wbo)~X;-XUuvIZ?O`tqtFI+B(b1
zEDwCT5uG4<c<|ngh;I^(3v`8e8YAX&y}-087a)UcHHslsb*phIL4G*9xebb34ap!y
zNkoaSv>t`oj`-%~4A}F`3^zj8DAV+WIHsV4irzDSJ;U+X^w0)*K_wjKNEJ_`xNAQ)
zhVjDs-<d8tbA|I_Jrnj9Y2}UM`l+rBGpjL;S0`_}+SlE5I)B867U~sZRdZ4FA->l<
z2G86j96zS4d}UKJlagIBxpL@=xlfq?{bH$i@sWPxtck1xiN?(E_Gd(~cJ7L>C(rt&
zcF+YYz2=IlvGTsTwtj_=jjU-*uP3ZlBJk*z#F&dM1e`S!Np6~C)UEJLI%9p`<AtUZ
zj#<}=Zi(&h*2(1koI8PC1Jb_GoT}=wSz1&5yvv>F^Tp(E5B4u_(MZH{rr8`bCs9G(
z&gcaF^VRuFG@TnsxyrS!@`Wagr4z>(>`6I~QD_<9d6Ch@;XYWCZao7cDz*Q5N{}cx
zVA21>3j~~4jtZ8F+YxXsXjbm@@|mgNv?6_MZ2b`b>Jo2IkrJ)X_DJz8%|M>3R*!oc
za<@26<Uco@qUl!fXS`%fHG?eC-huh<ITuk!K~F1lT{gsaV?~>1>9f6c5a~Yv`#T;1

literal 0
Hc$@<O00001

diff --git "a/License\302\251\357\270\217And informations.pdf.pages/preview-web.jpg" "b/License\302\251\357\270\217And informations.pdf.pages/preview-web.jpg"
new file mode 100644
index 0000000000000000000000000000000000000000..4abb636b094ff367e662c923611a999e5332d99a
GIT binary patch
literal 10596
zc$}Si2RI!6xBloo2!bFIB}5I;f><J2M6~EZL|uaDi)DpG@1jKXo@h~433l}wMDMH~
zHM?3CYyIVWfA`-1eV+TT@6LIivomMU&O7s&ch5O{Iem!&=$@)-r~(880HA*L0xp+<
zXDSe|9RO%)0RjL3kOKr^V1W3_y9xnr0)Ii2LjVx{v*&7G4&i?sO~@ho4<Ge6@Ny53
z(Q$C~boFp>eS7<X$bCTOv4$2g@jqGq&FB5cr5opno{0mhiMN6%(sr?r120<vdh)9z
z2}A^303kgA5k0|WC%}1?n}pyW0RI93ArUbNDH%BhCDl~`oDLu)AR;0pCL$sE`!xgs
zSH}TjdXnpR#FR)Gbgjs^+!)2*CFGKGKdx$H(i=hZJb3LMOhI{rnT7Qx?_ECrdjb-Y
zQqnRHWtE?(sH&-JJk@_;U}$7)Vrp$;YiI8OcJ%P{^7euF`h~pz5E>R95t*3uF*zkQ
z?NfSQenDYTamkmj)it&7y84F3@9iC(UEMvsef^_j;}erp(=)TnE30ek8=JqjwlN2X
zN5?0Bu%~B#d0kykf`7+<%ZvVs7a=h*5i!|cUIc_be*@@=N$!Y|URTm3vvOnL5`Ra|
z_&6cAs*QsCfgYOawfhL=4IYVQUd&%=|1kT%BNqJs#q2+b{U@(EKp7zX2SisJF%i)f
zBjPKNkdgca89CWMApaLA{{hus(EJDfCL#EnfryCoYNMebqoDbJ#^u7*vZTD61*nM#
zt`-v!JpckOaCwpZM2FIN$}TpIb3xUwxp6q&o0i1yaLl*hSSz%>W=MA+Bc{HCIBaM_
zR9LuKDK|{@N2=e8p!vD(){IA8rRt2R;E@m8svrmq^(9>xk31JwD%$!c*;%;~BeeIt
z|BHggqo93lz-tAW5u@FujS8?3#VUywMd{U(*KAiUzmTwzPJVNrHZ_@G27zVi9@PZY
z%6760QgPgqBEJT^bG-LXb*sOL@+`CQ)&v{V?jLGvWbkOX2U@W%R`sfO&DF=tLVLyo
zy|xkZqj{Lg3<U|SH*u)2-AgCKw>dLbWqpUw8aTbFQht29HREvjv2R5p;2vD}E{Z9#
zG<5b08(jmX+3gQKEI7ZPWW`uvW;4|&4KQNbTtT_>>AEt%AveLhRSt?@?t;HSbdEP^
z+h8QfNXZxl8qLlrcMYd}vu9L~|G1T?euoUxGS#HComcW3uy)*BmZvS6#R-gBVd5fv
zx?Zyg8J6C)8yDqJGILNHd{-O#3G-h0VkNhEvj;DMz~E~<RsvvpoU`KbrPprCphEAw
z4<@#H|AGa$=9iR|5#(;FQdG4nciy6J_C0YQzqOWS_9f6hVdjt6!-wnBHSF$?UxN0}
ztH*vAxe8pQ3@ynO{IYEmczf-B3&q-DkXSk#wbNUidF0H<BQ5>~T>QXRD&FIp^HLKT
zu;0h`sQcmX>)U_QEApAc)UO+FCBEJq5IkHzFd!Eai*5Lwq{#TDve~F;CmWrJ70}ES
z_iC+4;UeO(dMY&^a?o409D3g%jXorDvpE2b;AC{5S+%6$0BIw}D#~jYT(u9c&n}3H
z<O#b7f0~ZVw2JSIHhBHkz&P5dRC6VOP37lMUX3#Em}=cg_*eEWX_?ou&N>f<&2xOd
zW>ew>7Nw?MkFC8kQbbR*?AMgOe8pMctjroO29($te`GlLZMWU2L(17v?qq}&Lk%El
z&6Q8gmgv6sl_(3xG&U_<ySd0OQgofgh+6)KS|}}-lu^j~t$Wx<6|i>QvUx|sVYSiP
z?s{gACye3pzg7>BZfy3@&P_)YL(4}JcAxaXENH;0Ij8n`C2_qeqM+^%vtE4~{oQ!3
zs+UAnN_IpbPXHkN231;x(P1mQ@mwvVUSy%e76`rY+}E)Vp3~`zKR*Io-&@~O1}Ry`
zHsnxKfe4{;6GAR|@RpY9RLxQ7dFen2ZY^tHqy0;)jF}i$_fDgkzpdH0^$1RInKKyA
zieV1TugAQQZEOmjHGhho9iTy^PvsgK7lIKcro6nWz3rtpgkD-XB}~+YL#3BRtJRa(
zS{yxvNGZvk$)2rAi?klyK3ntX?EK;i=6SP=uvYsf5L}_maL6!3xE4+55eZC<AMcTJ
zsBSfb3bwSV6TU17=cEoKq}@1(E{t;4ulJx9BdMc~Hi_z#RZX?_eB&8qHmI)?<KxKC
z{aVUS>g@ofstyB}^Ss9FgO~zTtT?&VbbpTvUG;gL8dE^0<*PbxMcAl~p;bnSt=?CE
zkJ{|^AZggL0;U*uTy+Vws>866p#S=|<D3JDJL|gypf?qITrUBIYS<EK5a{yfze&|9
za?a`L2>cTGkj@u&?3*<K7i9vcoJgy`VDrDIk*tZo1O#ct9w*D+e`9nofT2~cs=?GD
zNiq;#WwJ5zZcj_NujTpZ%&ES;FYDR!6dwyhedXH3vnG!0u0!m#Z-8mptE!CD3^GdZ
zS-4*l`)xTyvp(^aC(eW3zhM5B+Nn?29VH@m@#`L0W)Fu*06%1_B|Fx?{cJaj1ryB$
zquIHG%4n2{)X;zB%^~%h(j%tV;3azn?L;6YmI9m)MsQ)vS7Y=z<XUBU5{1T;xY*|E
zHf=L&sVSJBt5Vz+h|7F_U#;ub4QxOKB(6g?E=puCed=-b#ek#Um)Lpj+DwEs^^H4j
zweCIS_th(l6>bKOWYa<|i!GqM*p?gt?DMTve-6iCE`0wAf2Z5R^TyeoghU;}NbmTa
z3;>cEbG)FxlJ!O8d#JF$z_WYcf-S30dDU<W10S39dE5~8N315hTZ}gLNrj{{K{;>I
z&4Pnoo>SF{4(O1^Y%8>t(;c$5T7ubZ-?Lv{yI+_*J$~e@YQp?<e06@ZUVHrGYei~O
zak2SV$-tySHcT`K`beRroRBvyd~f-X@$}$6&$Wk?#jIqNmQR60GZ5J#xXjbm!Au7s
z$`YfByE}Hs9?y8@1w?Naz5&B%@|uuZk}hlUWp=93Pb&2Ir#v3EktmWi_Te1R-TAM)
zqFU^`^3<9?Q}?)6hc8@XqD&;+UFB?Vsfj!)ceg=b0wL)%3QE`DE51(vLaHt&77&b2
zfbHOnj-O~qNMeuEXrj0#$hBtd)9SnaU|zeSEppc0+5G4OfMaJ#{vJlN9agg)7Z%8i
zKDvoWUSYYReLXqLq4G_lmtCw3@3Rs&hSEOvD6Z@M1yJ}plBUdNR1z$2;Nj{d8U_`1
zKKZ<srJcULdht@H8!0H)ydl{Q(bHCX`8>Bst3unO3=+@893gqU+S_sc<x@?C9|zPi
ze~dD$W61!{XSla$=5|X$sKSK2>#~-z_C(?exv<2#Zx^D*zGNvcZB*02gN<A`MFaY4
z`pFCxoZT6e?Oi8sx&V%I*=^&}$WS$5y`?Jr&GX^Rw?vsu*2*X2IT%U{tZS>^oa97j
z1Hzbx^qCqYWVZ?x)8pvkMV6BqOXCclOxKQ(*Dl%C`eHVx;_$P_iKCsaMwy{ZPB(~>
z)taESRY+z}kqP(qBz}AHhFg9QO~q$A^53aODawMr@6ocWWI03%A;ZUPX<k%<#<@?_
z%mzO^CXwlkCU`{<*fLB+#Pk!J<>YL5vS}Ln;^4PPfu~B}tH`0MO784rqhj_r{g>;t
z!dx>o>)dAZ($)=pGD8o|=Y!Quft)jvuD%+FMg}#3q<Z%JRUob<IyL|^Ta>DvHT6`Q
zp^n%`N4BH!X?1+>kN#^ff?p7-lJjxU_}p+wskEZ1n$>d-%3h&vYUqL6Y@h7-fXjN-
zF9Ee+!H=&ySk1!od-xKS6W%GZ*Po1C0>g#%7iX5}{B!UnusJ%1zYxV5xbE&C_lvjG
zPP~@>=pW_KUXJ{$XtKvs77OX%f6&QK3tj>gs;Tik04|lo>2y9$%k{=~yf4jqW%75h
z`VY4!<?E+$4d{lp)oDPR>4M`DXw$0wB3U`pKc=nT8O0YV(Y_r2otWaS2Gmn`{)7p4
z1i4bU8lg?}UQDCE*+!^k-E4=vn{Px0HKXwQ9iBI{)3&D?-Rh*wF;HDst3q00tZmPU
zj8~$sbmpJLdvE02-v%8-y!+<G%9Ew09Xq@DXCR`EyOe~-_M0l1r3-vWqi}oJec4&W
z#=!MBn3dG;nt0CPoQwjz(cZdj(1Shubvg^KOFNwuu%}vLZC%@p-JA@1<l2g4IUXjv
zjZO`3o0Ml0?&woUb~_|D)lM$1u^wzjd3?MrrS5V~O>;GqK^?<%q`-x?`Qz8~p3C@7
zwY<dSlsoaE-Zt+*=lSqJgH@|}VbGwjGd@8cQ`l@8(1AGouFH_YV@=EuZIeO2_1j#!
zLvxr7%hv@ib<p&1F*jvPo8&UwrYT^tF<~s__UYvzRNn{^;-qd90((eyo&_|Utv8Su
z{4k>hJpjZRJvn56wJAw^g~}BzuVc2R&nec-GkelfHtGg-CDzgI6nyLqN$KZuU0H13
zu%+l8^>1i)C;LjxFAtn77@|Zyokys%yvh=teP1sevYZaQ8v{5WVZG1?j|2{1Vy@MI
zB@6?v!4vV@_pB3WI=aPNUDC{32ktT+&Gqdm-g3iSAD!!<D#A&O?o(H{zM7Eids!of
zNCC}1Rw5Flc5Y%{F5o$ksjqN2bc`v&YHRdn8z$J>C)cx})TmgkI{=PYW3&N5H;sn{
z<CTs@;7nGD{Qaqyz!P_!2EG(Vgfh+7B*edE^7FUxGyD_fMJTa!15)#}HbebDZTW(y
zOq@(?UNFatJ)`U%H>a9_$7qnetH~rU1{4ETS@rj6G_UTJ*s|v2OQoYzzV&;#Q%)@8
zU9=BrsYAkio0WTig<UKs7kPqo)9}MtMiC0(v$#U-;?D1)p}TvoZ@j2#ydG$txNUT}
zGCESaIEVN@(8x}uydRRJS?<UjmuI#$tMJL!rhfF(XHw@;9$$;+ic|?f?_YUsmILB~
zX2unU{VPmaGVgU7ma-Rbn0GSCqe7OLES$nLOTnm)u<ytQhiR)%gaTFat1j+@tA}6X
z`(Un4jKcOFjTM?757-C{6j^%Z-F6})H}?0B=1jL{ox8qNhaUM3GNgR$ch~4gS*iYn
znF931wXtJ54&nYyM*M3j#H6R;9As{hl@G10U?e}DfIcRbHgLy@OZ8v8$Zik6gE(h`
z=higPII~A8MGOz#nScBEXjh<g+ObG5wGrN=D_rowjVNRJxmYWnw=IY4^du|nFn_rA
z2$X3PkZpVkWXr{!qnDP|W{%@d4;wB4Bn_UC;BxdIp&+0vrM^$>chf$Z`495}6E7nH
z=RY2!uP)3Dc1KTFk^b}_Pwn3WfMEflHLf*(y^s1C?}jbzjq4D}UnOloCiDGY=lDMd
zT#jAfD&vr@mJzq4uxjV`Age319p$=5u5@6{Vm7(y)mX#uL6|eu@?ACM@6xvG+Los0
zqzJN0AUF%w7Z1G>Q4ftvU@Wr`2!!k?NL}s!fK#|gx+>WmEt#OU)#IMdP93u<8*%o|
zwyr1V8pmck9C5duAKmG1J;<lo7oWFhy;YC?ebS0;!jP?!?Iu})S4@~yup!G)br|z>
zCD-apKz}T7##ugkQ5VveHRnA&LsloaQAt0IADdi4KXbkQ5^6Ip@wt*fd-)O|$tF^I
z{Vl3QIB@BWo4a)cOMTLMT;}}Rt<y@ni^Nw`P`+~)C<9irEG1Et(tL3Nd{A##J#|z!
zp2u<t)O8`s9Ei>;uWlFczcHfA@vCbV14HE~5Mtswf6wssSdgPhliVttW)rvaM%%}U
zBoKzV&VqZ?il@4)agRs>k}V(MCoI_tFEa21*!oqP@?ghQKc;4oO>J^ym+;^`W=?s7
zsl(UtAoMLcuM!aKp~xAvc&GlN8F2^SXT({JK%xaUpO1Q4(r(@G3(O_A_V*G=^0lur
zmfw(XR^Oi{+RrdTs+|i$pO0Ju&YUv?t9LV(KX(+EU_~{mG3NbWoyXw9a+>Ks$}RyZ
zC4MWV=!2r>j*cbtRku0Z{zu#xYIY?tAAGRI%Uzd1ocuk>_u}uatAIVc99<aA6@IPV
z7^-9y<XYocP^v<Y;VE^`jf%q&EQ>f(bm|A#@>S<^(ok#GBK0u8@$Rg54fwvx#@zZ#
z=lR&6@0=f_g8`6#N#&sEjQ<G&n~O<35ygg_D`6|f)WSLuH*VdL(wQ+E;7Eemf-&aG
z8>)xBd!N|DI-`<NuMRC4cb3pPOLIj7CouHp9!D|6s4Wh)pgdTG9KS{3o}Rw6U{<E#
zdXd97x30pv01sX9-3357vV!QQ9wZ!zWBjvR*?tF8bH$1lM`OQiP!DfTJXTMO@;~_?
z{JAgg1=xL0JXk96K`)EsyA{j1v6C}&SP-5A`?=HNI@+LcxJ&CXd9!F*mU^YI$m@6c
z-V`NO?^7G%6u^1}TWvYCOO%4ASd1u+iRvUD4GO{E{$(MFuKeJ632<VmI={Olxvh7}
zPYToYHfyZfXx9CR;BB_$(eSRW>fa=7*;KlETtcDREtujxCRFCrfybK2&_Kp<obs}J
z%Asi1*(*yik#`LW4nIoXW|_3Q1OOoGlFBx!-`IQ1dnT(5P#V-y@FEL(VKb_-nFACB
zRhInmyzcy!w0N`kNT26Bdf{9{xy*%ylM1ont>3%4=TEj_aN6BVARnhcReK)rz&LT^
zxAyp}THzCGH-~f0PWBoB^$%uXI{^(=nLgmGKaxL(@P9Je%ZaOnPkm8{U~;fzLy$s{
z%l6@3<h7q&>5Nb5EuXhp*EPjVnwgmK*y?#cR#mc!mz`>yYKNiqU<8oL73p1{)i_$L
z=<{sD2`*W$vzgi46kn_AmQZkWt&YjeYeVOp>xweO7)8#QEW*j=M@3L6Z2dV1|8wzX
zUEEbo{~K_cg@r&B59H+2dAz5tow$iNM7~gWu}PoRD*jOykBW)PQbYNKD#+mcYc8^m
zS_GFDi;E%B%RGKvYY3rFy!atRed3ws>Du*X4LY&3=8sQ&S+gI>UbD8aWD6Wc+!@8`
zqbdn^{Is$=XoC+RJ{FA)b#Ju23b%~BKN+f=M*o&@>telF)^TspkDEtMYidqNEMfVE
zKX|r09a<SZdBkjKSeL~YYirknxXm(6N*qkS8n1fQtb(Q)@VZ`@)U8#}#RDZv*&W!y
zhb7ueV0x7gpD9wBeUSnJ(_Y63U8F(n&qW<URLxqxzN_T8CnGx)#8q>1Fo&%?5*h|Y
zle$_H8LJGGQO=IVb&MITjYEQ#wj!z|Qx|H^4Uez=IR73$`rWx(xT&>`Os1Qk=(p&c
zKVH}0;}Uqi6mkh16>C?1Ksuc-*lS&6Ag%V)I#QJNCd!>9wswWm_L!x0=fGOjJZrDi
zQ6lcL$CU`AvoNR8I1Ke^>ZWS8wU<{QRBoB^#<%tZ?M4yLi;e*uOTmx^>uC0=o~2r!
zP<c&Xw9g4+@R&L>-CXj>!!KdBf6(!UFrUI(sx(YU=Jc-s8X(XOYBuQ=$M6fpDX)d$
zd;VDw8v$FrxUOZSqTW7hqIwC;+PyFmm#Zn5Ga`#Y-nZ-P&h8r2HbWcrz+x=vgzBYI
zg=SMjj(HU|dLlear%`+t2|R3wuY$;nGAP5UW_F}yZFn6TUn)I^^C+4(P2071lNb2Y
z*=(y5s>9*S4(*t1*|-EymErh15ZKAY*wPaOv*7_2W;seV+fRM4CBC4=A0l|(?I7RT
zZiDNX43g(Qah;I&$irFu^a6#>@)k$PYml|=gxD4=QO_>AXxuPfzxC#!K83qlT4RsJ
z#NVEQxDy)!#t5D`!03#z`by|GV%R8MxcP&Qcr91!10HId8Hq7u+B)7ENk;U}G8#lF
zis!-)T>?x9Mx1I3HlPv`%*lXz`1$eJo89sPjiQ#ubA#;U!(2l3bxQMVEUIm2CDse*
zm3HVt<T~*L7oUzTDIh&s4Wn>p>F)Fi_#nKW(H3I3DAf(Ioi8AL`K5>WC)rjeqpl*!
z|74t(lUGl37Sb_0W-7ZTyETphYW;20dWsKyHk14<-NPj*;OjP<^(Q9wiV>0D-#w!J
zr+&iGAROZ%{#nS1+IhM*K4XucXxlZIlb#RTh=#RgGm5-P(n{?z<&CX4aqG1;^KOc;
z6$=w64BqcnXFaOatNettrahHFzUMr->wrAd<Oq21Ury=2GtSGYtJ8dkL=_j%PQzAI
zpDSqbT>{TjlK%|qjY}-Z8Pz0dPdHn(z*BG8Fw>V+DU6cO$5Lj{k@xN>az4a&a~^<U
z<e=SWBe0_s*)zM+SyR(#GZkBFYVQ;D?O6WTIth9Ftp)}FK&D74*aL-~t3v6pW)&|X
zPAkmOo_n+}YR8yO(kHjl)YJV3*M!ytvf~F1uAN>L_!BDjTe20|6<gkZiwUyk#@jbA
z=BC4(_k<YuAqxSY)VZf8KLCunD*sD^{T*jjCLmpgBX3D#CC`PhQ!8p6nTlYGJEP3n
zQa*Mp74k?0{30vJM_k@HZOy7b!=5|+Y~#N#zwEIccuLN5rJ2C?t0E(=0Q*%2aeI4F
zV!|^(Qy)KEV=bKdUQ25DPR{*%RBkTPLa#7WN!j<XjTp1l`aR)QOJ>JK_ONz0SbG)L
zvdA%zt7*d1U-0vw-Ke0M=D_q!5j^|O{)R92J7~!ZemwVZrv?AWu@j7JC!1=W_97K!
z%-J2kmf?b7_hYK2JzxJAXFhRK+zL7+$4_vcD97PHmz5Ard1lYio-|_zSCH>60qQ_v
z$Y*u5<Ww}2ZjZNgYqGqk93Q9fg*f)}UWHBQL#wf$JWd}UD+1K%`RFD*CHJ{Dc0doy
zS?Gl4u7%6?bjoGZKoTLf=PEZ-vJ$s=SRc^SRrAjGnsSN?1_xTDpHiWga3Y-8tIE8l
z1WR_piPfeJIY#cr?Qx3k&LL}|N}Dc+fzM8F*$vLSc0r2r-G|ZE%O5Rh;LRajhWPs!
zou;&>)skI@Dg_dvF1c!{b&pExH+b9L;93FN(cj^qdY?TbFLcz3bk8L~3TXu+Zh{zc
z(3S7Y|90&*#z)Jp0UjczX5L_mXj9w|<B%q@^r-Iay41Zkw6;FB5}mpt8hw;$*=fO!
zo=mO)e;*9ZbR?-+Sl9|9FPh{@uz|POc%^U|v<g7_4nPso7ED*=f3OPlfi}(EzCHY%
z;TshcB(eE5dUir;Wx^B|%TkdCmC;6=^s5+T&kk%>WRz8bR|}O*o8}_X`1+>j4RAmn
zqb|FnGBf<ZyAJgtY@Xsx3E4Jh`vo(evL3^?9Qz5wsfC3vGuC2MV{A*onr`+kNsm)4
zUak(k7&TG$<^34+l2rcIF*A;#bX9b(_*@Yixw>NCiR1(`Ujj5x>3|Zj?8N&?@4D2)
zmpyj8k?ONl5`;Xy)^>Momd$R*B95=Lam95u0zn7vSbYi>MCmS@GvMhwtky0HW=?71
zYENzIe)IL8<2D~1S}0!yJJr=UV@WVKhxR4YDR8d7>{Si(6>-)Mtj4#<Z=)iC^Sqs_
z<zzGZ11ekyDebD$5i=TZ2IZPtOxybHW;^l(`4uhy($c#GLT4|s*|bfTCq;|K7p>n&
z$Q%vSP2iR%Xo{1Y>9+$dW(J+`;|j8q2nO7(SWwssji~O#F$bu_&#OJJ?55A$(!gOb
zz(^j?5yC<f_sodT_nZkT8rND{=x|^@gB_X~$|Z||{=v`4)=38xY5Z}qu|FRPSZKMw
zBnfy<a>9E$NSo{7nCICmmSoD_JM7E|o)H(%b3Pv#9T#$kF}_^){6$2rp^;9%60r?^
z@9n7}&KjRs(LiY^`RFl>({yghLi?me^abtB7WmH0vy<N<?NZ69b}M4hNwI>z)}BP%
zkZCngWK#SEpeO;a|Dv8FR}vG2MCDpgVthKaXBc|2Xwf1GJ{3ED!CS$T?cLmxor@N^
z&fL2yYkMkoGP^VZ`B%y$hh)42Y(%3xu(T^F@H{M^QPTwccc>+m=bW6nu*qf$ex{6B
z|HBLFPr{)Y<>JRWs!oH=%4pY<imMNZvQ>sET;EX;9m9)5CB~pqE<)uS$+e9YN9Qv8
zhMpgI?mem<(O`|$3PR6S#lwoe55^gfu20zgT>Tyar-JCMXgYTc8r$$1^dHYYP00Gh
zQm~d>G4SDGpEQ%dBQDiDkQhI-RPECP`T(jO-ktJY;iTBMoLOW?yW~hNJmrTD2umI6
zCcSL9QS-bYCq>MQ@;-6QUXc0*!Ug-_Tp)17Pc1r-7Uqf*$FSe{F52Z3qi+B{Iwigj
zuI|gHRZ!)2{b)$xzHmPj`6c~cJWK?}fV5qj)o;H9t|9IP4rMW8Jyx`=JL)b024Sei
za#WKX>)raSzS~H6!bt1w{SSK{vD*QH6R<a~GsxA=D5QgERNx(SeURjZ*|RAqRSx*f
zYaugfkfv**YUEj!AV0TXK$dw&Wv|m2--MU5v~pFF{-nt3n%eN3MBg+Xa7(brhCE;r
z)VG?BD67c*8EVK%>`pGxn0)H`#U*2$NwwC`vT&jTVPxqC5(ZgmM=rssClTye28<C3
zk&8l7LyX$N)@0$X+>O!m+Qn+r^xQ(>bP@xN-)LD@BVoAfNz0a<aqpMNpw9WwXXwSk
z<<C36S>`R~%(mZ3HYd)(3%^n@nSD($WZjB)I=&le!_L=<3{zmmR-(!^TeCzy6pq1p
z2-5G)NQiTj#X4kXR;!}Kvvr45RiI0JZJe`)f7D$G94%S$U{uX8+r%?r4u;O_v)16~
z`O{EIcjUb^5&VVI&Sws5&G8CRVIh&ctN;aFl5vOD=Icz<OjBPI3+S`*3&DEPACp%G
zzC3>mtuYJ?^s8)LYo<WOU4u%aV^dKuin)L!jZxvr#YJ%+DN@Y`^%%J-p}~a+$;lBF
z@&DSx{M$T+=yOt6x{&GMN%-MwXYnpCswvR+-m?3gbp7i#)*$@$<|tAI>btsUv?3i1
zS_VTj_Y^n-M25&E`h31*sl*f{EGjm>l>QXLI!_rb%||qXxC{0A)|k3d87$<i-q@s@
zXRPUT(=~BJra3CCA?eOHX=jTZfmeXG`~vd5R(8lla~{X5+3-i+Q-_-oFCmG=A#E?T
z7k!-aqtl;W2s<qeN;=bS?Gr4Unh=9(Jtz&o7(5o!^LZ}*-d1<cu3&w@E;G@|$U7hg
zt+}EMeS!72UiqA6xQNw|%sc|)%goKh)b3?@D-iL^2TgA>EkWWsWnDkinq~SJx~H79
z+VIcs?>{bZkZWqB%x{!D9XOZ5S&!q`R**C}#+IsB!AC|q<LmzU*|HiU^c&&g^ap#M
zf(;A}^sPOhmw`WF^m~CESlE+fROH60?qoT4gq^|L2$#SS!4lV0i26w`$SY0S@j~wI
zN;=bl=pJRV!B*G3{#g(H(zER|7bqDs#LJSTTdcoi<YL12;b>&yWKu?XMct^Ve{H!}
zz%}KQBy1GewNMkC)jzloe-t?M&^F1h%-g&Bm9)%S%{R4apl2Xaac2Wr)6-e*+M)2U
z4ht%O`3Rr<MdiWP^<Is{Np-sZ*Tjcw&5m70Sk|`+`tSNBaUdoI0Z3eTI#j<X^R3Wc
zIZgYAcokR5QfSUM9h-T@VVK|H@9R$A!`hJ%eny>aG>=@9RD;*Z?Re=CBMe<l5Hcqb
zT<kSJ|F~YUz}rJm<FBe;U*w#c{X%6S>W!SxGn^GR8Eo%UlogmflPYDO7Zw~FM<~h6
z)bBSmDd)jY>+N?qd{5vQ!4AK>F)IPyKEBRSeo6~*g0Kequmf(Mpi$_rhONe+<1WsS
zKsi|WB|s(ra5XCDi$dY+N{@H&Cm06yX^yb8m^eo)tZV7!E`k@!tb-2xWH+K+1}S*i
zUWdt3^!&9?{3-bz^=Q-GjoydCZLO^rpTlKJX;M-7k((Mr;vX5#4P!=ey4WxZtbgQ>
z2eQ-bTGEb8+?3^@kR?agVfFqwpDp{r9Sd2^8-)iG3X+glbqW4n?iF<+cpH6_9(K1f
zAGSav+8W`w?>z$U;xG*y*~%Q~7UY2{Ci%TH<IS#*(oSsdBcB*=JoZn16aA+PO0X(Q
zso{#+>J+O=S63%ceJlGGl<b{dUEH0itUvWefnr-q*Q6sC;ubixl{hxwBv9H!Nbnfb
zTTr3i%O{TtG+Bn-)MSV)*JRdzTJ0iuKDe+odUp0JuyTcudUOclX6I|mJNW*OnYMwd
zSoQO>f#li2g~Gti#Uou6m}2(8I~7J9f`1v=-&yBB|Jh`(7<KG{+CaC~CWxd@ETe7C
zAttY#;~lBq-8bU4rtoM6=0aSE32L(|vfIzp(MvyG<n=VcTr!=;;Ex2KO_ty6FoK63
zEcD*J_fx%*;~KeqY){G8d&@BtLZP2ebS9%lne9A#idZt@th)l~GayO=r`-?k=b*Nx
zLTYV)Gzx%f%QD9ncE?6sJ&vGLaXWT0&o~73pL*&=ISzkPdvaz{Xghh*<fCv4tBH>6
z=t8osVe{-=cb6z@R9xxEoV(7u`x?y%pbfeaGJN9nKZ&wEFNy=%D?4dJN3|V?Z+%&w
z`!G?)!43A27f|l(f0tH}kVpZbmg9h_pLHiEC-H?XWngOEXdbr`1KqzBLptIxOoo{z
z<?Zhi5)=RD4)BMj^Mm_)K2BiUz);`R@R?Xa`3`$sXL;G^SC#&%k3^k)D+RYs%Bv2@
zb}xz?z7L14jNhJ?=3ihTc$zfzmZJ?d#c}=^B0lw!4kD-a>U$Pk-utAVK+b#``WtQ>
z{u4T+_)BI3F&x#N#Zf=bGvWM(tN#1vyC%0ux$ivEe1BU^p}?-v)M3`(LuaaYN|l<M
z=viNIh@d|+NbJ^3SD^lTw8;1Nk+!LFs`k>4UqxJe^-W7=W>i|Tn@68+?`<t<c7m-A
zXY4&0E1O@>j+%>{72uNm9o(0wn@Ngs574AhC}COEh7ff)oy5?6yMzc|8}7PO*3TR@
zkyud2)vtW*aF``497NO{cCKI+iWtp;d}0;eH%@u~0O0I@6V$IR82r|qY|GZh@r*R8
zvNL{1N@r2X`8!CGNL>1>w1EOD#Ig_)(W)8l4nf_od9kezZmZobFBYt;b5cX*ZlI?)
zUmxtMiWlA0OYh<vwyPZU9zU5VS}#i1*!H!Lf<DZj!@6i}@<&nI>|6IdKVG)1;cFK(
zmbb0IIi}m&AWUla1W5IotVGJ?dv4pvag{-adnx!fTF<X*)BH;6U}_o6d#Q3wisv+0
zRrc*#NSxn{!3&*m!mrVQ3~;Tz*@6vS_b?DzlO8J;{VM;aThq(QN#`a%Uf17`JWYPC
zW>_%uciKXHHUFGxG(nl0B2976r+iG!o!rKCRRY_gEV?R;z`u;(?<D;HFfISjsrk(R
E0Iz0ivj6}9

literal 0
Hc$@<O00001

diff --git "a/License\302\251\357\270\217And informations.pdf.pages/preview.jpg" "b/License\302\251\357\270\217And informations.pdf.pages/preview.jpg"
new file mode 100644
index 0000000000000000000000000000000000000000..28f5d3d737ae6609663281efc66ac8419dd720c1
GIT binary patch
literal 99349
zc$}QK1yo&4xFvYt0v9K^OOQZtcMlqZ2favecXtZ}*Wey31b27$Ai>?;<q~Z8|JScy
z_nMxbncnBrs=dDYs!r{aQ}w;fzpMjqK1#_-0WdHCAoKbFFB^cUq`QSF0LaS&^Z)=L
z0x;h!0JvB7>H-h}{{S`z_CGDKNjaeZ<Z%BMzMKHOO6GRXc24GY_7oh<tN^dLtUTO*
z6#fUN`Io+#A&p#!0jl8+{E<?Qq2j(To3Na+A3o?SsVGXxev<sRQ?S$q_V(8QRJO5o
zc2toTr_j{WrT}jM;MWHYzyl}@jGXMnl$1XG)8v2V|1)l9|Lr?4&Gb)O!$gUJG=6X7
zc~i0fOdjF}{@?xoCm<V}I2pa>kFUwZ$llTURjTnTr*d<)|A&XZavaCkPQCJsf4JFy
z@XCL<;eYVne|<iye0b&aubjfj+~Bnh80af!H2fdzX8!~KZ{Pg~C=wP<_SOa-6iOWb
zFTMRgfU}9a^FR3qJ9`gD3o~<P3bEHwGNF*QHDYF@U}t6H0f2wT{6D;}l>Z$|7`)N{
zvIVUHfKbQF%S+3D**<mvK-Fta<fi|!(eVNRCJF!yHrX3E8vJVly(U=G*VT4e1ORAS
z0D%4bwGPC|l!N`>au`%`0Dxb8dAWKA0N?}wc#3^_dHC`2@|5>lc^LpYZC^S8OhmZX
zg$RP71Yj{?K$tKuy#V=ZU3i#(@t;CrU_o&32w+4cWRzEjx;FqU3<v}Z2ZD$HXK}*#
zyp{uSnDAI{*~AdAl?}j@4mj)qak+?8;#FO^DwF5b9EOg8NXU5j1cXF1?`Y}X({plh
z^YHTVe~^%rl9rMEsQOt=UE@`*k+F%XnYo3fle3Gfo4bc+(AVIQZ=qq~@d@7(laf<X
z(|+XT7Zeu#EdEtpQ(ITx(Ad=6-P7CGKQK5nJT*P@XLfFWVR2(~YkOyRZ~x%%;_~YH
z=JpPH|MwqVFaQYVKk>iRh54!r77h*s2mVJF46NHf4w!K8Z`lyA#FW7X4%n3J0f;!_
zak*7pNK_mu=eUNBlgN0~oEtP3|492++5b0Tf&WL!{=2aM(zOJ90AT+G==FsIfnF8C
zy#gK#{|~^3;D3Sm-+=rtQ2qhhf5$(K!2Ht!2!!zZq9K8i(EfkpW##oRM*p%1pn_mt
z7ZV5*5CNVZe}vNk|BD2IdL#`lRgY2IRE0RqKg31Tr`gKN)<;&yet6GEP;%zAC%Th3
zk~Bz5qo%++@G;6ht~JS~>0{>l4dLTHh}|Z=fp+BS%s~Ik^FaH%>S<rvY|!D|r*^Un
z$=2J;2KshK+Kfn;L9jDDyY$C<KE~}hI5*@<I5Hz7gjtu{!Mz~JD$0dm7UqR(`X+<S
z=$2x-`_~LmD-H#j!`)BNwcTwQ6npasBV?7lC27caWCN1E&ulBE{xpqZ94;=l=OC`Y
zaHT$uSdb##E%bBjo3+6_54p1b?}ig_$zc}tQ(_(Yo1Q{JbziFA&ui2IpT;a{!i=S9
zk}14b+{u}(&S|?m<#Xo@d`#VwrpQ-uT|vHt?t}x>O7IqM8(X7xj6G1@;rvBAsr)^*
z(yqP2Y+dAGM^vVmjB4tpx+QtdbdS&K97`?}prG&_mle}fhWTToP)OGdqdB|S1Z{vu
zD_^c<JI!pFAWe}xm2B~+s{S4U*loM-0ojQfyR?-!F#F^vk31NmHv;|5Ee{9@MGU%@
zi=}yNUAE|Y)I+*cl|yQ9*|CpB4OAEUn=0Po9U%h>-yRrxJU@okmT}|Vi|H;T`oqXo
zx$z<M^4{^k0C<lYRyp$n=XRaFXbf_G&~)9tz`w!g<idM|hM_0){+f|wK{@w-bm7u>
znJyy%-hm@g#0II|je^WojZ@h@;f1^MtS-a4a8ig;m^NMZwx}3;y(7=fx)DkAO*|8a
zwe9-XdR9039sK#M)H0e-U32N7@0^EAtHQaTZ4VCal@JPIBA@%Ht07uFm?`T&$?0^^
z0kSO-?V_SF!3H@OAF6bx7R;vZMyd?6Li*sO6n%U&f*m(XHi~+5bRn-f1D5$ZAyIj1
z*i{sQEmcebQ0xFN*&{OGQ=VS5w7Mh--+pA3#PL&{WII+3V!l<*2iuZOxCoKPOD^m(
zZ`O%=Sa>I`CD=8g>+dx9SQ1y$+Bn12RB=6z*Z1X9@WW)ORR(rk<hrN&b0Sl8l>=iI
zWs6J5{F_vO)zK-tm6iW42bsS&EfRm*rxJk?-!cOhOx025a*KUGV&~!7x4K-6lDVX5
zgo=1aNLf|poWeCF^#d(e9SOH<L!*f4H_09$*NhHS*bj}snrvT3);0JfU+NvZJtExQ
z_{Nba)}iC-kv*;~^2gRlSRNkh?dv`l<-^-%lg{++JE?K62$R5*4^G6}r|UK}_R@8R
zQfZ~El17|}WsD`*qu@`0Qs}D)LPunK3NwOi9v%g&;@OrdvG1sxmX^ym#ytpgFhn7r
z<pfF^w_}u&kN4j-2JLoA@)_pTptWWsj5(PpHdj{4OWM(R*ivf*(p`#yL^$)!%t?HX
z?LBADg5SoY@e>PC;>XKXQ#OuEr<8Slh+HR$(_7f^5~Aw6bz4Q9x~{L8{Sw-bn=p#q
zv4TWQo=zRti38KuwNVm<r&ig5u>UE<kC``eP$y7WUHo$-dRE<`2;2)`c61iW?H1!<
zg;x4kcU$9q(Wo+Y8*xLaA<x@5*%(wrL2dz!A6@HyxLrT@+X<pK5&Pu`rr<r^rlY$G
z7I=@Pi}DH@U!UnqJxV|W*8LV5Hhe2eEMt4@Hkan#jh>If#eY0}Q%f8km*mv&h1d}>
z2ZP|^1?XeKztuV4E#}%<9NA*n?~COB*jzm?iDR?#%bFVX*FXy#;JH=c`-vq?12R_#
z{dV#3P*&geh?ut~JswdvBAdeyBPCu63C@LU)O~Fep>1moSI@nqSG8@l0h_Z*+J099
z6N?pvhbC2gj>p0G1z3z_`YO4|`JRLaG>VjwP|JPFM_T~c9eI|W#XPDCSJ+q}WFito
zFRr*kmc)|YitiCBDSmP$(U7&Wz)Q|+j}l~E9^tddP4@30+{?JQLVw>3r@a67bCtsW
z1P6%!tL|`yanKxKHqBXYq}bHl6vBRoxXx4?`7x1E;7f+Tm#IGo=S*yEet!am4vsfk
zYqXSKcAKI@{=zuk5&Mv}hvDb!9JELhml6zwES8Pm70i*Y)t9z!;B6i=*iaD(?yfhR
z-3hOS`1hnVqHToV(Hnmu9NG{Q7vtq6=uram6&)y+P&|-yuP{QMg(KiF-wIty$$<P3
z1vMbt*+s)crTcG7?eIjH-&XGKfp>jjvz4K09XJ-ZWN)Wx8AvJT4|pTrN56Ypz7hzI
z|H2)2<p>^S9UwT%sXipas?V_LZBYLu_+z9|3Iay%#d0LbFlqxFuMSHn0>QO%US<o#
z%iIJExf8>@{qE!+$NxAt%nFLKFhj;e=(<y3adqRaJNbsF8jp0rA<o2^3QNk<E{T%$
zSaz<a6nTM&?>i4gNu|jXtv;CEsrngzJh3ARA{td<l(qZaA}lSrM|+inZn~q|)9@P_
zoa2B(p%&1uexd>T){npz`NmTt`f%~cia&EU|L0ps!_&68@26<dzn~y}DQNd4pL2u_
zg93w_MM3sEBx5x)BVpYP)|FT!s^W_DlNrbeSM%bjnN4}RQ?1M379XiOXtH#!`<dZ<
ztUb9@Z=g_Tzl5X7c=-;qkyuTUWRoMh&FVztEBU$74Ag8xjwK|hyRtsZ$V)C$XXyF+
z{<sV;QcHlpP_VBbSAC{|Y2478<}{;51>#f6TZ6%MqCKf7q33*qPm)+0qnF-QIRmc!
zU~S;RYE$}nz^n|~b>sK7Im7c%bJuLfS0Z{nRt_>)5P)qXB<DydwWc5H?XnT2s&>KD
z*KliTPHt!xXwIC;)IA#c!Dw_LON#eEFZ0}Pt0?^Sbd1W)(qe8E@o*tt?bK&#`?#q_
zjfJk}6v&Q%fqR{Og1i0#AbV@ha@t|-&#|oyZBZoM@(@{IkS1P7msYJ(%U9`1XW~Yf
zgkZo$DuH+1LLb@6-Blhf7Eel(rmCr{lE@k32E+IFR|vH<--uBmR5Hx?GMK*rZ(7+l
zF`yFdluU!IlVY`Bm-7M*m2$aj{W;!sws^t!^Y(eT065B$fQv7}`N>*@pl&|YwV#7=
zu7NH9%%^<C?GqTNSm&qw0wDRB=zjytUC@SjtNq;PANb1EQN4)B#B5{ywJfMM4i1Gn
zJUa4FL5z0*wgbk`RF2mh*XEbE#h<d=Bq2`OA`5Y+TJBtW=988HbxN>Pv?8g%p9$ng
z(~Fp3+}z(TOY^o{O)Mnwx`Xu*oKUH!{w+*FbeRc7OW+CTDc@W7pI_Lm|Fj_C#u9|d
zOR}ROaO(7r_`UjUoV4}NQhdk3ejX}+elos3Z<~ud`KMT4%18Ohjtz|wpY<afBg4a~
zA?p(hBlZD`r<LlZ?s><!gb=|dzOw8fJ%TxxiO?+ii;3Q&pDw!M(=uLV>}RSre{KFe
z4TpVcxT1!~tPTLw3;|ve!&dUmfvy)I%nyzFTc0p>B_smn9?xWkQEjg_YJ?TDwvbcQ
z{#!V3sTlPFAUw*SvuwiO`L})=5m-u!pS@)C&`4S}>Q5M`%dm0$26Fg27pF1lS3A*<
z)Xw34xzvjqMWU|ltj@;Zk3PSX*w6Oc`w{tm${(5Thd(j{MB?|2BBrI11;0?s^743>
z8m1hX0=sLVy+DS>0a^M3xjTmZQ|hDih11D2G+BGno;j~7vaPM=%>eP%_dtAr&lp~x
zAsl$@FQOONGfe6n>Kupn5>B*Ow~Er2uAHNI;L2$7DrsDzitR!`p#vI$OICD`16_rR
zLJQBjqVUsNS<XzVkLOT1V+4u#O=v?}Rf-%PQ_INx`2g`ZZQ#B>JdN&MqfIQ8%=|cx
z@n)N%1XQj<LFKLw@h@2#U%XZ0BKN?T-0ncx&W9P8y=Jp-Hz$??VYN2gr+)=Fub9ae
z!KntHu$#rh#hGz3GEhMWDhK?yrv;_j7G#k8WR-j)diQ0~i6eb!ix+@sZKEOBTk(8)
zqt^BOAd6BmMyV|cF~2p5_b#fKieZR=Ugk?Y%#~Y(^toauqz+2!^dM%r_>@7xS2ta%
z7Nk>}-7b(1SFAqPG0Zo}2~*;5KB4!A%MJqy+rKG<EzvN%q`%gy(y!$@^40>S*5V4w
z2(EG)qrl^?Pah8IOCCDq{!te}NJL{AbG;?zqx)|CjIE)WD$~zkEeYF0hmZth=}~Fg
z89_py3$x9=o)$%vvTGhD^dGacD2#{&8MG;C1)rH&2~*HLeYp<wcpA^`jz^5h1Gg*5
z-a*5Er`ENZKC8R{292Tc@#CYiyGc)*!v$5?z_9Bc0C>ZAt@F-4%^lbLg8ejvc-20N
zAGG@&?mcN&7nrKf(>3OSR}-4_{&eGlJ2N+*^(k*;hWV|^BrHDt7~_}tJz~*!&Dltg
zqH|oN8oj=h)3q&LLP*wyO@9no^B;zK*g0d!2PdvFw#nKPuWZV5nv?QK`<9Q5WZejM
zQ|=9L8{jB1Y-sD*M9C$f47Ub0elqRx<}7<HnV-@m4nr8^LJi?}z6-pU>h)uVsks>}
z_U1c>Y#1xAya2XG7My?0QlE0o<NM!5O2`<dt~C1Rzk%WFGkX+!%J+Te-l9|2T-mA%
zmY*t%DhSCg3~p!$!Go89rHRt4HjrhA2gclAfROmr7oeBJlIYK9B~4e7RY**#nFk36
z%oVd6mirjssY)Jr=XORGys=ae{5dr3a+iB88p-gBf>VZ<##gzG^cAPxi2`#xcIn+^
z#Ju3>kNDPr0*=F4fUe!wfk$~QE?$~s#gyt6%6KEbdj<Cau`FrrYdTIvoS_S}M}}Ow
zbV!rYtyM4rr#;H1YLz1Sd%muNS${6$rwr>yuJx7|0LMyuR6DxDh^ba(zy2q|!0p$>
zJI=%LZ+1yAI<QDx{R{;cBrF>cBte!Ecd^<sJ44wb9qqy%5{29_S46k?QN%7CbcSPc
zSm+CI>-UuLNa$7sy*yp(TjkAK9{P3A(bN=hrpXzeWgVZaF5ZWT35!HUqS4)fEn=RH
z|0tVkD<A2qyeRUQbNJU3J;`J6W2Fvgn${o4LBHDY3n`f9l9$uI7z-ZjZNSV&j-jZJ
z(^A+}Oe<9oyT(0%w4%HKqH-~h1Rq|2{*tR{jf>=nx}$*^7aQ$Mt?ixqj~5j)^p(n5
z*-J!oPjD<9=ah=i^!_3*zyCKevRk}l{NX3q-!ihD>v2mrza*1L`0J4y6cs-n?^acZ
zBb74^J-nghEoTSuP>C?}I148xyA&>TS^JJS>>_;@R^%g<p^79g11#MGt`Ck+%1f!(
zn&gvFw|Bxo#G=$jF_zt0oK0OkpMH<FzK`@SkQTahN{g~){+L=exQK7B)Y&jH7rA%+
zOS!aWcU2AIGJfkyKyf{w7ve9Hvj(M2?v>Mz=>P=P&i(qmOcNyQpGP91qHa-2Oam!D
zW_?6VNr-&1x;Wd4>1sI(A;)=?UT4^G&RSB6tGz=f!mmxakIP*1dP^p_jqarT?O5#s
zzc(BCS!n<D{>DQ}lh11TFhbM3#LsERm_p%uK)P%;)gjhlogIQtPIxUqPT(yRBBZ|i
zpt5M2YrL>M8uLwx+CCjNOL0S#JWk#7^F*l!(Q)thP(~BB?mgkmYO6oYf==r!A<bM*
zMZsq#vyalh#AoGye(!bVE=A_2pnSW_FA(_2E}B(rw-F<>9j6WIv}GgLB}_A;2YGsH
z^xpBO+ovh|Dp4_e9IAwjxHzar;*qLFnX5@<;*M_WXevwN9v?5^-%WqUqvoj60~@>~
zLaL+pzPcG(j0%dX2|CxZ4)(^YjWOkZZ_|Qk)*L+@t$sY1^!@ox<jq#YNk#Dj)Fj+H
zn!{Qh<eF%5wuD%jzrnu(2!-bf_i(?bWht?IFPY(Bb{zI{>67LR$TeB2^1NhS$gd9;
z3)fN(<hgLQ{SLEoFt>_df8IBP&+j}(v|No*xmrR_zbedL+WuvT*Y;=6?$Lo7oYZHz
zBC}?+3}>-phZxVQ0<OX+0pYx`vc1T_s;hvwXsLB{X$R#4qTG17IDW(rti~+Ugo6Y*
z@Tq5*+g`5l#$U?Yc(4>f(Se0tyLE^lroI_e!XE~~2c6VLRiuYjB_kfE`bzCC;pWPs
z^7;4vKFe;P@V(>G_CKDJy>6ppyL60r6z$s=Sw510m*jR#9^~NfbBmSzfT~aRVttqG
zx|?_;3E-pYT%ma$6IPqv$ig{^6}m@blauVaA7~32`J(tKrhOpit|IYf;*Hgu_~Njx
z)ZyPD4QC~}x2#eK_LzzwIMbFGl)CM|p9*=?PA%}^*QMgkL7@0tH*V?56H&4-FXkq$
zBT9uR3)Gy{RC`h2u?S^p-t|aTuINzxj@(KmK~tyxBq!;u*BeMy`%UqBHr7~CinEWJ
zNNw(rlZ~JPjFJZ`F%>Oeh2>-`PZ2cy>Ote<w00M@&xHk@+WO^Od|#qCs#90jra#9c
z==?~zrK<VQ$}AeKS*j05J=~j0T0z)_r50kb1HFiK^(jI8P5pYP%A&kFp~hf+W5(84
zmXx|wB!X0TY|k#J0bFL`4S4_uwXziGTHN($KUfPJH=Cq!I&|-R&R2Olhf<eIff1Tt
zfQ6$Cva-!CaCF^gA1++)lRIMdHH9$!<ooa~7_o6t9GF!odC%X8p5(R*{m37eF0z=d
zJp!lEC?6V7T}kX1kt59lMKFf-7v;8A3oiWnoe<j<(GRLe$THDKWvLCt-KuD!wbVGS
zjG}>x{1?D_Z4rHXlabw<4eIAyV@_m!p(vbBZNy!`sv7?S*yHF9gNHp7>h8yW>XI*u
zp-aTRmvUSnpg_kc(%bc?nRH%aGSay$w<SYy6P5jh)!`N`c98Zvda8dxBK|D?bAm;j
zC+>jqbVr?t+_c$rK06+zS13U)h#G<3k-%+RJ?gvoc8?AI2p|w1a8+~F&mRC)LKuy)
zKH1@Pj|qwUo;eOVjaK0QYgFc05rW_2BuN(GVaAwzDdjsFYL6v7kaX;Zj!z}z8`4yQ
z#=bhZe5idA(c}Ef&zW`dC&h_(Fh#~KSWv@YLvyQbI-kfH;$pFemk<!Rz722WFD>91
zH|0-UGT`H}nUH^&bU~`HgGXQ@7A({KZB=wDs=xzo`}$1H+sO(eWT$%SdTq4_)zqt{
zaHl+MLl+F7jbzy97g=7HK$uJ?#G7W0vp9-ZeRrQPrO=HcF+=|Z!GZ_BB~ghK1zR;-
zE)MuvVAK3ro?>+j9R*Y{2E`~?^!CDm(T<rL8-4XEUH+{T>{i~lpIH*#AhJ3F<80GH
z^lL$-E;d%5pT}Dp?|G`Q+zj(huYc*`R?XbVeTVSEmq>7M2G4Lf@{?5PDSBR?A+2f8
z4>)0asGm+@Uv0Vbf~W)8(E!)Q_9FCb>%gwu=c%TKOH_1XOUghWJ|QVbtJsdYQtX~L
z?(Bc`1X@~Ue-6<{4YP9ROPB>EfvJS}O7QD%o3+06RsUM$l!#E8C$oy1DZa1&Y14T<
zc%-MiDT1%7`-x>Y;e=<pHvKmitSuG6xI^T{7+?&|*0XZ&kEFe#QXmKh3i)9=C&;zC
zr*{n7O~yY^#sNyghGN?f>oaLm-@M9~hi>EQ+1+FrUI2_7LMpD+j<02<Cz+8u5`Kr%
z6k*^G8O{S81%O9}9LH!<Wq<K*6;{n2ssjHOFR7>D&()>WJu8RzNRgy%yhlsCW1ctB
z5qQaYa=#=-XjT@uXRAnfhVQkALD|U+6R^3zTS=+8lkIg(1tMaad(mOG*Khew(twMH
zGLBF6b>@W@`l`~fbkk&Vv?THN3rBx77DPZd=`0In*CKfCc^{JwxB4y%`m=3i65mRw
zF|g{h+4qhj!o?*LlC|5shOQwF?h&8E7cW0g&(5S4%rKKuMiXqpUp0&8>=6JY@$MBo
z(6+7IO+~zz<MiFMHOWXVt(B5D)DHrzTB^LAf|xPm{=$Era-8)seW!0Ht)6kixbCfu
z?dl;Pv1Xs)<LuM9LpMy6Qg-H_R$J$G)*{;Rp#xn*G`nSmBk*Y--(G3O`Nu{rDNK0`
z)HB>do{<*vpjQ1#V?0siJ2R24m#t;*v4~x<W2x^GD_yUJ6E7S3{Gv2YHf^LgioV(5
ztDcufuqMgYQCt>mN9LR+q|B^0DzRmMe+{%<EX@C^?Kb_=-oHgA+Pzc@p-_Nv<0TZ)
zei(Yjd_;tn<qkOHxrZ!u`!dDTWM}~)-FCbPh&hY~q%sB}-?KEL`Ffx>=Yb+Y&y+K*
z1{Xx4jEu361ANS%@eCymloHOy>@c-bodM&D%2WPA*u7+LpRz<Y5Y8LA(+TS2Rusjo
z^?n#It?o+2MRwigWk^#f*z+E&R{K)8w`{D2UU@T~ONCZx_K$Abd~V0PkDhBZ3z70E
zsUrMrY~t|=3nRm#9Vu{ni!?dJ{w~RB&<tBDTYySxVz8?dZGf^#B&_}(8dGNRo44iL
z$<&6Tu%<M1KZZDP6io-3@wVEOx7s-CDFbh8^VHA%wyc)-`6*{hP<pBWb>;ZQAFQ=(
zk6%&wI<W>@<e}5<@gm=}g==uj<4UnusAiPp?1)f>wOX5Kl(cZrGPeI>>zG!Ru3DxA
zx97bZT<w*%f}{HSIh5WWX-fdXOXJTPs8%0rwU|$2edr?O*FP!LT7UaRg0nHlrdyWu
z&z}ZjlP$;W)ffd)VTGssYb`;6i-cZJY{dF`Jw-d>uI%?yd^!m7omd#w{#FB9zw0b=
z@Y$9)q~?2!-40ee#Qm%*(ByNWC7r@}7tVN5#U2hQB_$HDvW%Z{#ds|o9jo84dtTq{
zJTqFXq1Lt;^|+EF)I}-ksMpl;x7EJ@6g>_ktU<80!K`kn_`G&4_x|1q=T{r!HLn-G
zqYWQ^O~xI}+Uhaq(JHBk$arPlCTbXe&$$Ipjn1=gMEZd)qzWU$Gc24TUsqRj<=9)o
zsAU#xCb@F~ZeJI0MV*&)FL{U`iZA9PR{e!k8S2m$lkbN5Sh>MqJS>E*O0%YsAPiLp
z71b!WB8Y|gG%r%8;JCv=iiHx)m^U3aa3o50;dWv6>D(^t!~hD()oxW^v`e5_9zH%M
z1u}IwQwRpsbp8_6ZFVfq^||RGiJ-Q!;gFF`v3x+2BG&vG=1fw<Ynm~-#k_Fu`mCcd
zu7~$$^LZsgbCwGw0<m{p$K!2~EDFz=Xs2DPP|WXH+Hk34uT7MeHM9>*?dc349H&Y*
z0wuyQ<e=Rzkkd$0e<6l0^>(-mjEHL=k-kA?u9m?Q8ab>NphbF}b=BQwU|D0WgWQ+I
zcf=3X=6WLN8GnkI#kMs0WU;)+iL*C!2YHA%F;#=sDyUjm$Wvo?qU+Cx3q^6O0{R%o
z^D03&si+{i3Gr|_3<tfN3y-p6t|vE%DcjxI+Qy2)@HwRf>hVvJB~61%^F~G5K+^?i
zJ*4dX;|!Xr*5viWm^gLYG-r!z(#CF01`<xPyCx_^Cy0XUZ``@nE$y_%#`}wyKH?!4
z@;6p`I_JxagMtZ&bP@un4nOaMjE~2O&piD^h)VeNM&K`8;{Z4|Mpb`Ng!bk0vy<ct
zAz|DVi^YMMI%0V*QO&L2&O2U3^{v4Rn2+71YFe2221)wOyf?rD%5B=YbdNsRn}60t
zB&;2?3hLtIbnCPMvEnOg%2qKqK{#l)C{O&HCxLLQ*y=E$7{K)ckh+UNpf2EGZ(6k1
zOVab4ozQi4Fs6Upa3eV%AMrSATT?|=tNvC8iMM2HjQYiCn_q>ZZHRzdTk7uRo2xpW
zc<~41gGcgWxgsdGZoDsJej2p`I+1*Wkw_Wf8~)sbzle}vvH5;89Fp>-&Hb3_yK!yx
z2iqnA87ktGn-hI{_kkYIwwM!^5~$n2VtAjR9(9}Sj*<>IX(RSm<~I@cJA&P2#RZ<*
z>=z&yvs|ZOHQVl|)@s;%MBsw><WJqk7r+8+yW2|JuTSQ!yJ?4G<$1Pn^0ujcrn~}c
z&nk6`Lq_M#(j|A6bQ|EBjr-`9>ux7LBa8yYo9Q9emvbmRWJXGY4o>l-YySGhINB(o
z0E{bgUBNHMIELBn<XgaQAe%9b`&vI)O1Ct&Hm5xws&cLLhG>~MCAk^O@(Jz<-!Rfw
zj|%o7yWZSz!qoiIf=C+VTcVTn3GzB+Rl~z=kt-{lr&-*tzOQPZ8KKEnVJs5q#huxT
zv2<DfEuXL5gRph$xN+&epBK%5$Jbygth0rTasJoPUm!xRaN1j`p&mhC5Vauw-Qb7B
zevB1Cm!sLXlC9nLzw#krdHZviTqn0_4Q_W1u!L@Vcl0s@i)zgnn}=TBQ`C6RkS$;E
zG^u&xns0>bY43;2(=KZ4PVmw@e>NLqEvY-2jEp4fD!xNmu0pMXYR$Lby<-x{cn1Xc
z2%juxoW|&%LMW^9<(hSKb|#AX21uS=IF%r_#vVKj7_Cy~plt3t3Ev$zy7dPl#Txw=
zU_xX@eI-dNQ+Ay!FHT!n^X7>T^fLLsiQk=5PyeVaWF~PFKmJhoBchPmM&B|)d+JYx
znZZgvFjc;iYKxSK_yv7zHE24fOx^%Fy%873HmX`t$zGb|H(1ujggJ)t$j!2f<h`6l
zBUU*K?}W~}tB_UdtP948*KJcgb=~V>sZ6(M?=;Sq)t)$Ml`vEiN8GFRJ=i9HM~an|
zADw|K_i~o*t0l1j`-;aNxPlYr_%+m=Ek;}GePE(hQh)B9F=(!D)0_j4Hk{$B`Vrj6
zd@~MS0L<D7Jd0Vsn!UgZgv4@lVe2$+^(h;#8J4f8O2yQv38390{q(ekP)_ootT!Rk
za$lu4N!7<p94HV>m~%fk$|xaO8~vUeU!?8Dz;}1+bJfSZwz|jGuWE#Znt)>my8>gS
z5Qi(^F#7=CnCI0s_zF%hU4~6+d(Pz2IPF6X*7E(4(`5J*hZbT4*$FZIlv{0=zLgP*
zPUYvShj*UF4|CVxQs{ufQ(1@UNDQ_+^V)FWV_AEV6`lG6?pSU39(a$>7}4`}^ZQa9
z{$;8UztdK07EDR$K1CY7H!E?Z15Myz)GQ0HWk}3hqefy}loU$Kvb~8%@rV}Of!k{5
zaaeXPS`p>E&#$XV`B)9l=tUCk=nxmV6+TmYf!9#9@0La>C|6|p)nn;L)Dr#YsOVu`
z-}Q%lx7QsarxZB0X&SA_E@k)&7#L<-5<1e^e*sL+OFa{pw~XVzM$_!f5!b8<H5-;J
z9NgmD%QDW1BW;N7ggkQ*E=zBu9o$r4E$Qv2*#^<1^;ubh&+yMa_F|+wd5A;-4)&`;
zz2fjuM!{km?H7CHRz?al8plJfvy?8O_g<k-OU5uGU;L$<K22$(@hE*$X;Mqgp~(wW
zz<jW=c3R{54ZVWQwCa|0gtOo=a1?XM2_;rDs!w9M*+f#7i_#KOkidwNJZ%>A)NLxl
zbjQ_&#|q(B*d~6QT|KX=RD08sai+I^6?qY$U9VnxwIqgC_|Cq9Sho9wKnRBKQBuC-
zfG8=-je0JgC7C{u`vxwcb6pAEucqt@qJ@NoQ4<@L1T*gj$`$gQn_R_-kUNiby=`V3
zc~|C}zSjx=rLI#b=5N2c@K;QIVGNWbZuS8u54aGyM0nf~LZyT&2k2ZS)JP#xS8I_`
zrEH5}OWG(&pc2E8O_Xe>5RFz1Z)#P$;Oj3fw4VOAYgc4ip`^ZbC%(kz<7FF6mW!Bf
z?Va&8Rk}@5a6pm6sigO1Lt0{jWMOlCt{dD&{2yg|DWq|C+A<%l^X@fmXn`Mkx*G^0
zlwKm+5)d#x9eoXR^o$LC`vaP%>Eow^ufHHR$#^n@qxBAMi<Z}ToZZ2nVOYeXBZi1O
zp>Ww71#0jUjed8SN7wdr;XJ;Vs;dq?SX897$I;hV(5%SiLB`vo2I`Q@(>(#wD;1_}
zYG7T_^)BFq4xccLpRJN)WH!OObKN7+B$aFtM`>@^Ry}1*2%Su`tvI};uE7rU;NyKA
zStcWe=q*M5Z>P>9hC#<riV=Ic6S}+|+KdLm1FdOy^lNGOjM%R;x_D}VA8JF#(TykQ
z?J?k7%M#!xQw|-M`iJAfn2a-1D1Qq0ekRm8U0G~;QdRoHQaf>C)ntr*hd##bn#z;7
zFD=Ty{>4d@n7=TXJLPus^cj(+Ax!HnoXn`G%4hG+^{n}FH^t_rZ<<z_Jj0nqF(5kb
zpsb$QqVTEeX)b*%c`Kal{+}@DFMvnhx`_fGZ$Agb%Bk=Ge@pcIaKM4OhyF=Zn2%&H
z0~u&59QvsvM(vg`LLJK|U!Cyo(j8G&@anf`+AT4IR|OdAOB_<e;!}(n`A&F*aALfb
zG#?gSicQaLqs40lmX9m*lWh}rL!xOXUXo-#1RV1{*7LSP@|&s$qwn-)OQM`sZ~SoB
zbJd%SSa$*#MI%w-#ev`(MN}yAQa_JIx<N<s5FX?*0e0*vF2fk-T8Lr9b~AA5`BsPw
zkyt*SoN-y^*Lb^yu^~FIfXtqtTAQgNf%`azQNGNjyK4^`?llzRvof~>x5q54P`fvS
z_MKln+ru`Q()~MLMAWeqAmY}cUk12k;hmGkm~5Eao-%*X(KE3LjHNdJ9t+_canbRy
z3c29UL`Zd_DJb~KE~A#3{p4%}`ej7RdqYCB&xJ5U6F;F4ePz6pheYHL$I$tC-5#L8
zo{PR2_LjV0PPZyumY5UwC{t&<ZM>*=rAG(Wy>m|X`Luz}R;x{`woiR-L@0JOQcOvU
z*bj}}30Ggf*!Fz6_^pvhH9^OObsv3<zG*)olssEF%k}k-N!sDs6B#RPXtk{C1ns48
zTS@bIR+z!l_q5>0^vv_vTRKPu323R@9Mt~Xo4;eeged8Ivz^(8;d;+E{FB=eDZ~mL
zk)pR}?Q(4|09{N>0s%=p+gzJ&;Bl>0!Qw~C%uvM7PtW{DvoUWD)q~5NHQ%C8*x#`m
zZ<+}jRfze!_W>rF+N}*0PWWS}^3UOA-NCdKg)$(@`n~!;E+~KM!V*E{yNleF{RmS0
ze%k*WYu+?PnjZ{GmOsw9>FI2XB8-?XWnd@LRC<1iX2`9|?ja*fvr&$agU@VgX|{m&
zHRI}LkP(KdldbH7x}JFz{qh$q+OaE><UCl`v6m$X@^g8(L0jPXOf>HeyB`x?6b&I*
zg)~B7a=LNhRt>ER_jHwuv#>Kkxzgbmz_KMar60CbDcTiiBr7WNycP)-#z`0u!F&zP
z_9NbgJUfuYW8T3$oGJ>^UqO|?&AtO2Z|eLO#>p`s4KLuUn$Ig1UM2Kr3ybUP;aTAE
z-XVY}k#IxRyM!2a^uyX2>Y<5Sx~jcI%<1GI$1Vq0sz!DJB<SHKwKkgl(>oy#IksG9
z<aIHTrN=kv7(rwhqG{w`VZwd<4L5HlQLA}WWD*Mo1VO)@D-t=K+uLUhqUX@w$t+4M
z!O&h$Y>5&lzW^Agf_yH8i^Ow8Avu#z(R9^%vNZHn)^Drb*a#?m7_K`u8zS2=-0|1v
zf?H|JhRDjw&C_(`nd7MCs5=&u?U_2`wG?){Irw8$qo5Nc_Y>W199^nC7||i|%+44g
zN`BUQ1HNasHN}XdNt3zgoxRgbbTAp{9V~*6ZksXK0~b^S+H+wydE1Z`on`$}xkt>Q
zciR!qz&G=~I>4EX>f*W0EU(L}dU0C2&5wIcrACR+U`H@#A4c^uUevC;)pPUIDwTG|
zI7!ukfn>C|MwaSncUi&FY0TxWxp-z>eTH-LmPV=G^6Q4esm!)<c6vqGmm^sV>cZ9j
zl~T&;NXFP<S=WTvu_4<=(tXgoahIxxPxyG<e|I-oW806vGGmM)plg!2k<3kX)YwJm
zyZ~RX#D2S=k(^m<e_gTg+iw8VomCY?p_p~h=74ZF^w6tnTH<$i_ZS$(@CLKDGOy}<
zFh+sh_TNv*z7#s{A2u^%f?c9S6q6-d+gN-a3fNm;0JGuhk4iErYD(hO(HO;pa2@BW
zCkTEB-md4ZzX{>|&ZETRJbIHfw8}$Hy)OA~a4!bB30p-<yg!_mB^8ulU~n#GFcn+Q
zl~dOnP8Y5WpAh{DX4FjX2XkH1KH>yzhC&M-<d2wa?3o!KIb-rfhoZiAIoZ1p=#e;j
zRD{+>@!c>Sc?rXg9=5c=%8+XVPnIu0U|yf+8ooEzMhtq?qIznM_HsJJ;Gr-sO>B?a
z>N2WZA;;}#%$seKJm_kl458|xA-wKEA7i4dhFAz`xb7ktFp1Y3$@@`*p!~gGy|S(%
zDvR?%B($R9QUB+Vo5wBhv0-W)VH_n}qMj&VU=`AKL9=qRta0Zg^yl$Q09O|~eIVi@
zW_38L0zfJcsJ73P-M9rC)<ZPcgAEt`Z4<W$%y>b?glDtWpekg+adr(md!hT1Tbik7
zNWs!>^I$LQJ;aSEV32HuK4d{Low9JFh44;r(_iRpT_FN@t(RE;jlL+ebt&U1YIqS!
zyNrqCN*7E6`@{9G7XbfJAG~DK%CM1td6MVk<c{&TugMTeXNy+~4&y*~ugiwghqiNZ
zAi|b5n)*t@aq-i~swlyF^nCQ4N<NbC`>XzHZM~zKqh@b*X|%`a{c=YcqpT+3_F9<!
zWkOq9vRzwaM|MbY=Kx<}I^hmOog0q{N<96x1Ao6+h|q?x`q2JBmL-I?>B_Cd!x6sg
zoj+AW!=)jm5~7Mb71u#?Naj=W`7i^#d6wK!oO7H+*NQ*Z7KI~QEAqx$^V?u5MzQt3
zTV+-{M?BoK)|2H!TWt5zXGWG;;mb~42cje;VnWT*)ZwU+2&`V%kq>IRp8YmF>Rukn
z7Vfk9pT05ub$~ePt?I3iDt?YqH+%aLz?C881z@0RXb#)0&G_u-vWpoBU%^G|Xn@%-
zt<pEu_&lfzHzwVv<jLT6NiBEpvL8}}f_qbC3t}0=<LS!iD=UM?yhpOmD(+LC?>)M3
zfZ1rtIs;5N7N!_&h=t*0&j8W=SA&$Rd(_Vf{aE-(jDbE-zMs}gc<{|+D_5e}QojzW
z?rmiskBZLgx*=MY=Vd9a><|+%-6aA90spRTmq&(7C)njgrYhGR&AZ$3y^Z?J*N8uC
zeaf^MZ_-kZj-4zVk6S<yT%p+SFWB6_UmAr{KATd%CrH-ec2n|Orz!b8-XG<t#&IjF
zer--7>G0Fi+9CDRMWj(fiHBe78{cf5vWJVilO`2e8{-08h`9k@TVB2sQ9|Y`ZJ80|
z*orHsL-PlhxqIB&O2MA75RP}k>bC}qnYUII_jmuqic|laSkWtlH!q+|-Hvme=iHyw
zs$e>&2`_NGGelPNqw2G^p|DfSX~2YMNl{U<sdYJ(2BTOk8LH?TkL!aIy{+?>4Ta*(
zi1ae`E#K@P2GZGq?ZzP2^`f2i3VV5gqgxnxiYp?qvL^i0Vpr6-aj8x#40!huCfXq@
z!==1u)3jluA}~od_h8JZ^r#mhY;&Z~s)LW_doWWiW{=;S&0mj@r(EYUtUf`)^Xf4h
zn)(km%y|UJ4z-{f%b0XGfgm%gwV2QwWiK1Y5!YvjhtY?IQ`)Cr0A%FoN&VJGRV}sL
z)>b!5OJ^s7jXHZYL5A|)_u^zC=T}^gP2}-N<D~$MMxh-eE}?CJ%yl2&BmF@4=soj{
z{3ucVAW>+CdT4uLsm_!@TpJPW&BBLTe6O+8(XiI(gCR4=`2s||0LT|kxzNDnp`W3;
z)R@B%2Syy&md8%MgJ`RZ=anQr73D;RX#8@qBmMFhpqjR?gj9;5BQT3g&JW9CmAO7D
z-oiv(o_DaESRlw>1Gv%q4s)MpS1{lr(Bm00i_aVN-OS)*nh#v2+BQur6SDW|4^#FD
z$~SSu?x0BQxu4H2Hx(yn=c+1DmaTzF+a-R|r;)M3LoYdq2X)9ix+|X2Ix3HmKF^_L
zvY*vVdAUiW#9Jc|j$N5NJ0)4(iOU=ez9!jNNFIeL1-!Kp#r4@@vw(XYq3;Nh*lt<T
znXw~lE&|eo5ZGIF7B}mFg$n`kS3w?fqta(A9H&610O)K~{@*_{8r-*|lhRcgiH0~-
z#);kzgF+a&IWX4`71&2TO3iE^Q2pV;Is9Fj*<q-o#g251wNYyh0|jod#o&yF=A~wo
zTcVwGgbEfH$FLXc?{v<$;60y~Z_C$uj8x-^$EFx7IKYc#aRGxU&#?Xs(7-W08MNTB
z&d7$p1FH2rDy$`!(J(K-%`9m?e|qJI`cv8M`FNhY5TAhpFZ6VS3iqVx2liRsL~fC+
zXxLhJ6841O(N-B#f<iRWb<EiUzL%IOkM+aJTN%+DL87D~iFg&8ARF9;_)RM<#4Mda
z>5-*5Tc>_2H<cMX^gQx!$2dbajpEGTgFSR&^GUAvp5kWfokh?NXFZ)1E${I9JUnn%
zm0NZe$2v_#W@`o6){n-dHG?EW2-7wGm?4>lm-ZrjK^@OaL}}7&*h&NTpK%x5;~rHl
z3J+o@Jbop!bxWbT4l6jW@Sl6$Rg^z-c<WR>WedK40T401=?Osw_?NwI7z*x_2H6(p
zO%_{1#f7h2NYpjL1l2ak=N~p6?-FDYO17fpC6p7F+QIgk0x_BGN;!Z-tk{^Z`hhV0
zocD)K$cmYEyN|-2l6snjtqC8h(+D1;4B(c7o}kv++Bmx?v(Ep$xp32j+741Id^I#k
zfV!|RaHXC%?Yy7mhqemgZArvkJ*DKfqe?uB#5;7~thuI}J8{!cC(2+8oo3!t`kauF
zv5hWd<=g!Nd~D|!d&;w|UhH4B_L{rfYEo_4r6mnG5+!iESSrk_M?9fc-=ix~9QM4N
z2O_in^y*kNw7;ur`eR0kX*yZ5x1)2qWll?NcBEHayf$y8?WB1?ta7^o<35AIGQ2Ve
z3Usvm7Un!y%1KHr5sY_qqTcOM7#2XmUNk%pPV5rQx`yet(*Dz%RG-A7nr?9t&l=y)
zV+SKOp5DyNq1zC`6)GsbsabbMph+_umA8aTITPykxNOUwG_?Ha57XyR@9C3O;Mr`g
zTs?x0evhEen+&w<RSq6S)9XsBPr3BiZ7|^)*Gy5UObs`ox$sh-c^gr{;=^S(W7Gj&
z!5tCL=<eAn9dj%Ot<`@L>>Fxpo>rQ>+3iu|+GXHg0P+HdyLRr$3K#!&(3D}2a)85a
znQTz9p!57><Tk2n1wIYcOm3Bm;pc9I4_QcE%hF|@>ZuzL%^TkJ=F7+_`sO#C2xx&F
zJa?6nfEed0(}h%txy#5si^-6Mk+p|%;xe!Wb=_*(zBz%cvIZKJOEaYrFm5Wc@>2Yy
zs1ihX@MoBt?)fYIE&D{i&cMC3NepB^1g5y%XPDr!VRq)>zmh?S{@h~*R~93z8v6_B
zsJ0oq>qwL^t(Xk`yjtI<ROd+h3W=gxr?S4L2R}9Z90eTZzY-UZIH8#7av~*AyoFhe
z=Wk5g!6%YsWz@@`R0codaT#h`MQzM*Y7+Sc4(^LT0zej6$$2DlLY$K0PGnSjrp8OL
zopH^J1A`V-q9^F9^X03<)gCCOoZ%qC<B_2R3VZsXJ^L=G_wT35vdnm?XUVbZ)4_?P
zP8?(~J9?Xtptt~sksY;pmPz}%ci*ui?^)Wx2{Ti<4pIuEa*omfh&m=!aSjJ&za0-E
zbG+8;D8I9!!x}ig94O@we-8q|%WOy236&?4-)3mI5f_9jCc2#~uzRe#a6x(;BU+%|
z!m|R8wM=Hn4Wr`&d=E_`?ziQa@?f3jsRYI0vi0xaFCB;CvGWrf)6um+66LOsBgCcl
zK3DYi;*D#D+4i_YQYR>F+gH#s&9(UFytmMK%B7l$z=`MPhrx_@m>idZxzr#4dqDf-
zrh+&Iq~G=H(}iAPjG@9f{t5nQ&@ig6_18E)II^~qZ7LtH;<Xja=Ew(q)x@35k@by~
z*sKjH;1&l4@<8;AsLo*Cx=<8L$x5{gCK!0Vg$K1W9A?7`iu^jzBM({hG1I7fVCq}i
z$yQ{ilGqd~Z!&0WBK`*3Xu~aF`up_ex+xlo^Qme{N{5gz<tIyIAOi7poqK%+o7aLZ
zZHgjesd3!QHV2k0-&um_8%sAduM$NM&NIO|mDV||hSj)jfs`z;qeGwPME4p(rk|!<
zBpc?oQPns=o{oIQgsqUQJcHw5a%aSQoF8p<J$<VWeJ@<R$s{0AA6LXW#5H!DD+7zT
z$ymzAI~t%-p+D@;ufIsVF}enBhqn;MOjZi-dXyxX<H`?{8*1vsz(K@z#WmJYk@*7i
zI(_$9$w_ng_*hHSvR|rTShA4VZ2;phG3h}|9Uq?vo^n`PEiP#Li5fy5HHwA`&9ym%
z@-c^xwVb=CVz_$fw>kY>6jcxrI{50w?7E5kA~0?xTN@SyIWV~SI_zsG`o)b|b*=`-
z0JkhyVOV)>d82-%<*^?YN`y8{Or#Qp-u?yEF^MB2{xEkHj29YVdlz~oekF%^7ky4Y
zmxl!IKZ=U)z5R?e0Q}u;L+ME);o**_jh`i749E}Iv5D92ZyR}oQcNc$tbAqGAnbGt
z`entcbuhSQ9;cP@<>Vc!R;CYvNFrdPzjzS$0(1-H93-^*8ZoS5KVrNWFGc^&-jY7s
zA={4hNO@iqc;anQ0o`x)B|WcCVo|^JMk;L1JTX$fbCg<`kT{tu^Y!u;p1y8bBeqaq
z?2%@w)%a;QrNe+onfT#^_6)13d+xyO<Zi3?w=ayQyVTM#+X}S(bm3%m#ISbJ_&wb_
zDFscWlZ&8!(bub!FAe9FetOCM{gsJ@$5C>hox7Ir#4nl)M&AkIk2sDz#VSn$mLuW7
zd{_#7&~In1DRZZl{n^FBA~?(m)L3FEc9^g1K_NOpS7=2=oG{}HwaIr=W5RBued%@$
zu+2d>%<1-&GfWA&bon967$5;f%d!oWngYFu`Lg(f1jky(erjS!`xM59)iw;}^VZ4v
zMXSrf_=7Qj64|B&NHB%V!$1Mx<f&Ke_d|SlmSC*5ELB}p;aucfAn$hg0ZT1P@AQca
zZqSI2WJEsZdOr>p-*(2ukwVLq%@5~kL%Z5ON}3^4VpM~Wld_?0ug$gu`RS>{+X;!7
z(ZE?8xv!=)+lDx>Ki#RZde=Rbz_pKtP-Q=iphxVDC;C(P$@NL!B_9t52NbzIQ@@p8
zB@CFC?-07h_-Jv@z2`KDj#bSuWn#4sCMP&m_>jkq2nVRW*XWM<$}2Vz>dF@^S3muY
znmMrT?XwbSkqUJbR_cw>3v3PUK5W4HG^)bmcq)WKvR4OK%aYvMFTMcAI*gkq1jEIb
zu^Uz2#`!vbxvQe@32aaBK4Tv!PMw@=WM>Y0zSjfs7%JM*-{uzSS|l4z9lpg(-c<+h
zeDMleD*!ayH{yBKG|QH%mODDBwk*c^Z_W<-Jm<a%6F}T2U0iK6jxYAL8JkO|j4{$M
z$tVfIt{=z{6mfU81LbTl7RNDll|NgP{6)`n(k99(@XJ5wCgs|#k=<Butg6!IlX<9!
zG*QeQ104VA#C^nnkPU-Nrf?eooP{$FkpxqjP2BSg2whF0n&>ga;s$U{JD2i4IB-I8
z;m#s6*p3Dia}ShPW#U%HZ-*!Qs7t9LGpch1Q6E72bg*##rzR##jo2}kH4e8jUl~wX
zP4!ok4l*)~VhR-PC#A6{Gsp3nd!50n)#WrAQJ+#!GSFY=%gD}zLtEbY@C4Q2`TRZk
zd%mT=b6h4~@9s<;2m^W~`xV4QHgwywfB9s0yWLJ1m^GV3zXMZSQ)E;$3Tlv}^ccZK
zP`~G_Vdmi_At8xHxA(|Fc5{@cj-I%}r>H7l>b%7((yL2?rmTl=(pvBbwlwJgvV#PV
zRxyaS#^Az>NNj&L-Mepivn$3Sn}4a}v8vI<c03k4cyyxMuVDt<t2f6nh>lnn%#QV~
z<7HF{Kwe1)U8EMb1EayrwxN>ZN~{lKS)NXhB?5hu(%{hibPoq-xKTy@6ws3;tsVOx
z<48wd<qSiAeoezHNj%I-F@m)a-f{PFN0>)?yW^IQ`~B>@*L4$RdZ=%V)dR<4>K>1I
zwKZa5ol(5KN9uH@^<dMnSMma^N%@PsO#eSelK0BLeaXGw&d|mTq}@y--oU}GeF)c)
z6PkPY;8`h(DDqy!`Qm8I`^(&;e9?iQ;j}T4d{n6+-Sxh^vkEK0wk^Hrp}dFuZjvC)
zmVmCDR#=&J`2vfLp^Da5$#C>-pB<s2Q@@B+aCYA_*7-o6J{rNP_1Y&ZNGAbWx?v>q
zjo{vyBO2gqY&GQZOJ9^ri=x5Z2z^x(C00Dkog^+uCy(-npk<aR`e&DSbzJkb*~(4L
z&3-~Vae0fp^VmCpy#R*iNYZ;I(AT#R09P<;Ef_Ex-=zer24$dQ)XAeXd?zVHc>%np
zQv4Cd<zPj$y|dK15fh2WRfnjJ?C$#jek5Ff6&`p#KZgUort_m-yF&M3^)52_rl%S6
zNVPZx(ffdvejlr0a3X2@Jc-%ES26|9gzNI4o;f?C;t$2z8|BBl(VHv!r-X06Ky5Ry
zz~XeE+oO%>s*RXMmW}Tnh`#Ta#Yk^T25j<HJ`Kk&HDXDXkM&><XStbna6Z#`3uJF7
zhI6sN92LrCdaiUTMLbm5cCvm!RPpk|@Vp~c?I&Y{hOIZYN->={PhgtY7ylGlz?|hP
zJ4qlASm>g**_ZbGi!jmi=6P-n>39voU~@qwEB{w$Dw|GcQR27^b<Kw(mGm33eO^{C
z=(6AE-JfgqIGVVqYLn!L>Mve<Qzh>D!$~Ni%=w9L3UB9O*kzjLTeH4mr`<+mBkS$A
zQ_ExYY8x(Dj+eg+Si6&~?4d5nFbELx(m?xpFq>wxJR8@L%91sFLA$a{;GYxs+xZCk
z8{u8Dg@ucN#7Mj8xah{6s~YJ4;@d2^qF|Udytu%ElysM*bmvkcEt1mRxGdcr(hU;Q
z2uQQ^(w)*F-6_q|&G&qN;Qa}6&dl7`b<WIk^4+}K@5Q2$hUvM*)B`CVC{rZ&dIygf
zYj)VJPD4}J#An>X)Z!CdK@eaUO<2s|+$g+oRf;N~b&c>*_8c=ZDL*}Na9fg)qhX|y
zPQn^^f=u$;l?my=`f|*hGmL85_T*|zb}B>m`$|zy{Le2N;`VaX{H|p4VQf!g=G0LQ
zBt-hUv{dfcD(Q!q_5hmeVTnK0^^h?Kt+?eLaim7bnBL2V)koAh?O}{m76O2*OPrh@
z;HJ`Q8sUcKn$2x=y7dYev3Vcqg3ht*tav%VJ9z~waBJ7@S+BkAIRNW#&4*|pJ|`sN
z_g4>Nj_0;UO51IcY#?%k$Bb$X@o${&v<U+6rd3W_l|tAv8tK=0S?HP<;}aO2hVDcC
zRi3`xwZeQqBNpebwUnZf*w#(L?Pt|kak2x2hmlm6&hv1%?qatqtp_@oS`eHO4wg+K
z(OyBiwR8pmR3RY1tll*MJKKxzSx|-5+J$*!jJFmPvmX+J=sqzJ8zs8g+xv3^dYQ7q
zA`iwirLZ3at!R7vT3zcX`n~q=+^?a+e6(iVsqJYIh$3!4Z7xad)=vI;`fI%yxJ~e8
z2FxR{W!g-0LaQK5lQ;+zE-^hn8NHp<Q+czX{FZej)#<So>Fnv#JIMn>cs$3G={7sd
zd>=f+Rm3QEkDM7?%QGz%%3R>nC<kPU_lCy(#EE)eAMC`d^joUc!Y)eR9<ZVx>@<U{
z3IamQh6^B-9#D!JW_5sRa(xw7SCYu3>cY2-lMy8!`%2c2ebz~+ry(R=gooM>{JnQx
z1DTlbjlra62H86%zCkYWDjQFbp!uTNdK9=I@eqBha+hRtpB%|*ii99zAoqGd(Rsb&
z81%ggYwigMId%x=ZCf0d*TGQP11yqn^S6v?k$(D4l=85nr`dOkkYG6tgC9-nPV_%L
z65&jxOyG>dQU^9m<ABT@w1L&m2|lEGB}eOqhS~QyLJM!cTeBGh>4U|NmV8lstZgCa
ze{mNJ-E1tur;aK>rr#<6?XZ7y0xn;U_`b7weK_n3f!9!ETw!r)G*1#)hXFk?u`BW{
z3)aVF6?fw8CPA~Q8P}aL97U67`@!hbocsbO&$BF&3<ILc>tZrqusCtfJEOy;L51@l
zPRfuX`qYH_B88L{w58o@9h@{w?g6bfxdEzoZRerodMeJB5FD}<W3+TH)#V|7P5PiT
z;n)s!PYDA@GP8z}=LG!%JP%SN+63$`Jd)l20heBfcE-a_MXBqB!X7b*HrgV~yqbw{
z-u8>DkJq11r6hxyy!dU_)J$OP!MR$P_NNAT(l|e><6(uNv!-v`J`DEFWAXh(Y*E|R
z)}a=O|0gN#tgKLB<p00lsZ{D6E?!>hcKj__Q%b5Ho`A+AJVf!=&)twtx+9LHP?yeA
z-7;3*Y*g0gVIIlp*NEK(`?5n;c8SzRg0p_yAly4+ZEeG7nLS_E{@t6=`<~<&Z`VBR
z;1Ru!_EyMM`hpnjjK=rG%BjnE1ni?N4c*GcGccle*Ve#jz5kegj<&LZxjO#l6~OYR
zd8X}-Y~%g0Hnq(Us`$9x((Os@{D1Mb8!+U<906!8M5G*pk^_YKRqYQtBQXBn>J(My
zqFqc9T)bs5=2j)WnJu8fT#dp(?&QF8zM*vV1nJs_Ng3Ih<!Ia}!)^lI%PxbCasztc
zak1rk-x%fpj3bbo87L{9x4gP1s8UvzbiWxfHNi7=;p%W?mfELcZ{IQ@F)n6c`sGRe
zU@*j`^-tul=Fs$nQ>p#rt{rdJiV3v-JRE`pxHxl|EuT~X#^Jl}(O5Ie&%>l_ox<^s
z#y`CV=_+khpaJ>DqYnA<8N@XGH1zWF1E@HimCz?qWg-XsL6<EBtJ>+$FP4jNq@Q%c
zLV)t*gD%EEk%JRo2A}Q9FPEFy4ZHBrjwzf)c9`6QdOv)BP5O_QiTwQp32dn|D2Kf5
ze7%cOt{*Niu&#k%@6}yiF)8S`B#rvG8hF3yl$f=TJU^BTd?B&zU_uZ!#%_LkbgL@Z
zB_|)oUfilp3D24iCcvs10u5(jhi5!QZ{^1M$`$yk8DlNkI!ou<&V4{>%n5Sdu>aBI
z?$^vQSdI-+1U%K=Wp16|$j<soIY~q~_^KwgrILNN_?7SZbGE)m5GgoZR_*eQGuohW
z;#K*o)|qa^@?t;#=nTm@A~wXwI!~R83#9lMy=@e~c@~=kZkl)Xx#JVl>LP*hWh)As
zYjE7M{X-NCcnwLkzu?~8GZt+GQ26q3A5GdSa5cSI8oyYavq>KU)<M?{0K)^Cs-ST_
zSmd>?o9MlRHTEg8<X~t_=#pa~07O?!d3YVsT033UCd2kg#XCp2U@&*}w}e+~9;sZ{
z(VbSI5%tVdAADAAFXLiIj=#kMEYrM_Eqsub#HB)&O&#w~e%OJDkeXpPWU8ix_F5#7
z>Xf5yI3tmE{Wq6PUHVWAbwqn*PEFy;k)XClFSK~jZlayjDgiA!Smac7RcZw%AEx^X
z2#)b=6m!_V^2dkYvp+Ev>Mlm$BjM?)8e{=HUjargXBiv5#J}`B@%!hNQVYEJD_6f8
zFKr)h2>xj7r<bMArzn2|GS<5<=%b>YebR*)-(~9mJaur`TV*>2SfL@?c6B|LwU@m4
z&W*$Alk0SLV#vQ_sO#xZQix<StMAR}+nbo2__FFUh7T^syRe`IP@--JJ<MxtlV36n
zWEZfoV6lwT)B4oc4Co{$k81^T)!Wk7btvFT;hLyrZN#{BgW~?41}u^7$GK&*shD8r
zZr*LfFYJ<cE()w1$Lcx0>>sYBY_LcnlijGieUe0g-(~ZvwCEf2nJEwwyO?KDcEvdz
zNK(bo%(!*FI~3_C+gckC8|o(fn#8wSZDQ&YuVIvUzO?k$!q8~XRn2aU%_qW2-;Kc~
zY&!?1$Wys!XDYn4jTLJ!2Lq3{U10~2IOa#Wd7UPG{u>UHrQubv_;@;OSO_B-+S%qq
zx&Za9;|WIkex6tBr+|=L{91fcN)Gh97-;sG;yl@sX@Nu3IH>ngzKDd(<d4bOPmvPl
zF!Hc<XHGKHY{LxZO-qgZ8c&rDvRVk1%AA^2v5^KTu$h5j%?%mM(~{x_3B@%M245dZ
zP>%8ZexG;@fPT~oulS{v3LO~+|MRB&`&}dpzJ<bM-t~1f#%ovpV?nWtYzpDP&ks#A
zw1H!;FNVe0NmCTgy~x<Ia$~tg04H@_&Sb*wAN5@)+}zI_bQI<=(lU|jz9|`GdO@1g
z)%gRXzX;$aQ=dZ^EN|WObdHr9*4#96`aa{s_do)UQ95hZ-qLO$O!4v+5K%HWqqD5|
z?^s)O_MN_?M(Q}oze^QF-(k2~_PHr?103xC3fR1RNuhis{T=s@6?gh0>YKR1_<_PY
zCbOPH?i{qE47igu4@S7dYNq=e8S{B38XSKafVB!aSV|VnjH|aw?2vV!F||woz5mra
z40j>nt(Ni=T8s0CZ%gi4Ov~h6-|g3fu>mIuPA5^@*FqLyI=>`7EMbG}>yc_)e8&j5
zPmH-$?JfU_)y(j#bH2Aq^@;Q#ne=ix#}JT6l@VFvvq+Mm=99$F+4+mN?YSUs=5Kmz
z^Jck;1xa1tLe#3BZ#mya2Q5`D6S((+{|cBNqp5C*nr6*Rc_TbqFGrJ#6qN(|B6ak6
z+Mw5q@G8-3QcszpR_^&ZhJ;hq(J3TkrXAqgiFX3soAi}{{kW*&z|*(Il_ln~i~ZuA
zwVgGO@>U2f@M*BYTcTfu%E(tzpHg-Yja{8UN#94*%~D>SKxgu4w6Bik%{n*fLDUAD
z6GJBID?o3QN5w>p8E8K~sNDW}b$Dl}&22z#Upt`s%J}|~I=!6e0aIP4XlwL@wUuMF
zvYrMIlHD}!_X>Dxd@TEdcm;H*+^K?IXa9#3PTtj=zq{+*j9Tl#OzR-dePNhplWcfy
zC3s%6+Xu7?2tQ~?Jh3GYW}rrHVKI&s!)G`vi-I3jelEy4&}eJac(4QuQg5CZTf9tA
z<5sq*ott)U(p$B*Y#}Ek;Gq-H(x(jQly)I|YnS}%#Au^s&uh6@V%2ZTIXvC7WbFjH
zIJK1?Iy*B1&pD8lpzi<1J?eSohj_b9p1kKdz3Fp2n$jXEE=0&~si_Y1*j{+&PhA12
z8PLj=V89bNrZ8A?_}&A!P7!sXAFecV*090>ycmiiE~Y?=R|JfP{ZUX`Bw@*0@o;n&
z?%L7#J^fR2W$=A+J#X;G{g@4l3yAm966+M}vV~sv<1o;-Lc0`rPSqf53q7UR(RK<|
z0bp{2;FK!=`G{*Kv;C?2yVKFa_a*yuxzbCa3H_ezR&XR*msF!RcQ#Z}ZMDsN+Vkt3
z`HTvG3n*?xp*hbd71~ylD@t#&?J0(@JOxDReZecIbh8<NN8(N5K?S?h3RgqBkL-rq
zbzm;zI{XHB&7X6?xF@W+4P|5fPD=tWLj`GdxZ>Y!>fQx;gn<Hqv-n>dc%NeFM$RCp
z$X{6B&@PHO*Ivm1gXC@3eu8}WnX%u?@GF4inq1Te7Vc5WFrv(>f<d&l`SG`=yj(g+
zBhX2bTJdEn_id&B2gOcezTxeL+4=~|C#hdOLu1ZAIrkY!b%J$oeUlusGM@HkIqRSG
z4j~XM5iA~7$Gs2ln0w-Q<S{M<k+1goAHuhNvc;$6pWHS`^|eA&5>MQO-kY8OsSHg;
zmo=2<9+Dgy8kfcL<wTrqGVHEptrLio!csP$?X@9CXub9`_FSK9k_1gL?lZmALO10k
zkuGO5*w-_y8KNUGH`|7Oky-+(SB`P24?${1MVpn_81Ph49U^^Ei45g*cKSdHW`G;=
z8&7(xa!;WAUua@MhfM})9yhu`u&M)AcE3vw_gs7D=6qK`gam$@hQnq+m@|oM$+~|*
zSy?iH+D0;c1rWtrlLqs8kPk_FGrTuGBA2pFn>xJWG-u+|4A*>IVCUktd7r~$KNc;T
zqyg#>9cB3y=caY<3G2p_;2QtD>p~mTrXe%syf!<9c18sPaq(2sDP)E^C`5U*Do*SR
zo&sapfq8!&sM#9fPtp+UO+?bKQY;nCVx*-vuY9&B=XyS!r2fr%5r5PET-x9eBhJ}=
zeimkty4?Lj=|Z7ci$t&t(DG&O#oMh`!Vi(8;(nBWnQF-$bf7f+=1(KYb-)EA{NZnx
z)D-E#6V&W!IQBd#GXJMhO@Bq#xaBOzWMo%5H=T1VScram67z3)G;H0kjK?Atjfb^l
zB@huZ*G}9^g-LcYnwFS9^RABx{__Gnjbu-dfMYLAF$qdFG+LRkh^3ISHzzkTfG!o}
z*<I#j|F>C^mhKKlPz$IE5i2x{k4ayLP6gk5;rarZ<2OcE*<w8!0*l~k|Iwf~1@Q2F
zD;W#Q!dg5yGSc(qF8vWFeDXBR5qIPoVVMxuS`9MsvjJALAgEe>3c8`5)9t~cN)SkU
zTaiaMPZ>qvARsv=*(lsLe|_=JXjx0(l4k`+csKT@86ztOpa6bJ*`2gq+Ko}NEn8fX
zap>vi{jgNrY2Y-|?kBjh-_$u(S^t=#36J6upB&_Ve?=QaE@j^tl!pVZnW=J}7a7R6
z^&t$K;3oRyoFpvjzHcw~;G>-axt%ojD?6}zDo%{a(KYN)9X}~~8=qF)?-x*|<Ys9P
zJ?rWCS?~4D>(hQ6?(jII*G=a9ror<ajr;}8nkJnP6KPM*{l;D(7>U0=ZnZMME@GH=
z&kCvNOFK4?$bUAH)NSsS@%L>?+G#6p3fTG~?(h14AXqcQ@w*Xj`nX}luv@s{y0c>~
z-q5F<XMB((<-}eemAsn_cq+6o*+0kt9N4iRUscM=&aw|K{*tb)Mk8sWbC;*t4(8TR
z^c*<rg+F*iv8!_m^te6}w&rt>keG~4o5aNYdaxi{oUEr5)o5sJnLEu;a_yUGi*C@i
zC;7y+AR4j68`qGzMcyu`+Ce6sZHxbTr?Ngg2ooCE`r{2MPe(g5Fa?p*_E1&sQMRzs
zzS?jvo5Z-%n#EFTrL}XiT#qMWqJ>fwA7D4FznIqKwY9q2hrwG4icb@wOAaxtd<BFj
z%eO?0GW~p~JS{Ibx{-A*+y#om`F7=Fh^f0E5m_(fUQt=^+q!7(3(yv(0MTFN;p9TE
z#?<%LH0$8m)^$Tak)f?4`|dADT?5$Pic;F5PTo6YED1iJ5^Nw=T)ODBr>NOO3dvkc
z8FpU*r!a=M;--R9ak8?G-Y$A`9q2R1{PX9NO<{8w`Y!xq3$d0Fb(_ISPXX_aW(bfr
z=J4cPO2@?h4eVIKsV~OJK_rxbE5aFDcX#;vwKZ)<#D&$;_f)NcEs#chDNL=gVJfc%
z{xVh9NWv0@2$W_bvD<KiX`k<hJaHt6UFy?VYVh%5e|Ca#IA!6+I86tF$>w{AMFv`Y
zC4L*yMvvf?+jV~;mnJ3;6E}}@(#;V<yhAud^xaJLI~3SDMvDmu$r75WkL^LP8HVVQ
zx~kw?*v;mfI`-F;EGkTT^XtQ*+dW=HxUsN{_#Z?`{B}WERBe~r0Z@4A3DMMO4c9X5
zTimZ+Lgb#?Ri1fRLs!qAq$pQZ_!3T+#)cyk+$UrJZZPS;R|Au-nNa%=r>1SmwvCNV
zvayyMy9MlV-_7ax&d`_EDy!>bFtWw}p+v4qN|FbAzjI1V&Y0_H>kPhc@M#*TE4D4Y
zaU$#<T<h+W#w13@O$>RM1d)4q^WQ^HpOleicK}8Gb(AxGqiC3<A&J3KkL~4?V21M%
znGlV})Zwu{%-}=$-6dUuH)BcOfuN$Vh_&#7J6`Sj^Ow}5Di|Mzn~Uh1dmbVw63nsO
z*6yw&V;TSPHMI5|$U5#_7%>@D3UKWROMJrw9>$a~pz!!hvZ5d*59gOSp|AEi({V8a
zEb>Wtr@Qj*kPu#r^1U1avHxh<_f3&4WW<+S>iST8{yg`D=^SSpGPsFDx}sx~^FGr>
znzAplVG4BvVK5X)%9L1-=gI$c=xc$9_PpKVsNC`_@`2*5d4wo6rnC(ut*ztIM0)_e
z2S~Or#UNuF2<?cg?2oMZ9!`{9mKIj@!vtRY=F~r3CO*4~*CRc@eVOX4fj==l;7OTU
zQ|06B$+QOxE!l?fRO1X=8K==-(PTU=PquwP$ZgEW`buGl9qSQ?+QD^uEN$2slW~Wp
zj#q0UOuEW0ykJ#r#E-^z(VI9SeCzL&%GNx475|>p@732?Dv)7rj|CNpu6rrqYA5N2
z+c(^<CEK1$+$5iW_L#ewgSh!YDgU0No4^GwKZk!{DF7xYP`qd&-8G;8?(H@vd-}p3
zt07PJbyVCOE8ug4erU^ES$Zm6TkL^XKu!p}NMYj)+mm;IN&tZq1hy<eC8N0b36>&f
ziOd!}PJui04ozKMq6_!?Aw4QT;UI30H#Z^ru<seFnY~;iH_MOde`ki0J|bQaHwqWq
z4r_MKLa>Y%!Y7ft;zw;`-8+|F+oA(9dhK$T$|F6|Jy}&P>HRjYKCcD$a)n@pYd)lf
zm&HyTFzGpPgE8@!r}GxOOW!L1*E&wWUC}WY60Q_R{5GP1hXw4Rkfd+BP)wDZXvP?Y
z7fuQ$dz8ERi#YbDyZf_-H^WiIQQ?bg?y&i<C}o5#*4hE3q84QYpnG!R#gx;4h#txP
z;eOcXmWPpnlAo(z8_aK;{<+rfOXV)*4mOUd>XA!yrH5Kper(3pr-i{3w0_BdBCasY
zJFE?;L!VxJM4RESLg)UCXU5Z;&0X>&37(}5&aaj$Z=G`PVCbp4XI8nYnR`CXMjkXs
zmx}$7UE8H6lGxF|QM|RkKS@AczGZ~fo<J-NCo<61X)#jd2h}~yg~m}FiL~Nr)&}2t
zTeX9FYjqo*^o+{AZzj7aC#$hYl5M+?(vh-|a=ih!5QngvTW`avN;mh5Zf9ENk`5O+
z%s{*f&FqQ-zz((#cFMm_{K|St;!UzaYsa^%LU48N_H@uuoTI>2wK(~=#D8m)9gTAw
zE;qj>>^u{R-M4sjV)HCqtF*UfMWSsVv=U|tx*{$cvFUnwafc`!XOS*blj7aV`!S0Y
zTQ}icOP+@=gM@RC7Ctim9fbZDrm#)If@EuyaV47l8XBK@hT=iO#xj!>ot<-8e}lJ2
z*BI>r5G00~p$^FeNmcvje*-|@ULcM4Gc!=B_a^MGL*>q=?7ha7>d`zAacy#!$;2d~
z1B0jkxK?bN`Mq>2-cxC=3{$XNgA!*1KgJQg*4MZL?b}+GGH^s2$J;<zR1j54v^CeP
zJq^4)oxh36LJUplATij#9%<q5g&yG$XJ0?%!v-g6QKTp0W_Cfg4wRx#(V}5yirLU+
zKq%O!-i(XM^2b?xw_ts<^4{%exwygGPK!9T#fT3h;^gYFd<Ho+4rtg9w#$m`&NX2Z
zUf~Vt_ag4&^?0tQn~hdrV{KHRj{Wmy;{~9KDw|B_m!)vA$D5$ya&kXaUNkm3;1jsW
z<bs<dtD+t-P&92C{wSEx|ML~#?&B`rAT~R%n(vv;vw}|%^aDTfAi-(A0l?;g7fW{x
zp%oIAQ~|go`B>*P#BQ<j+IkT{965MN%-<(`ak+Iyhnbw`hVtphV;dckAtY>R{F3;X
zgve`0fgGrk$KLaaM*=XE#l}R%1ZN}?p*+-H-m(PV$1Xw48Kc>7*;^1@yD_|xlf+D1
zoqHz9$K|?`^jNu}P+ipWA#{*M>>rR6PjZae{i{?U@4|N8!`~2ESNY1tq)+r!<3;h5
zEwi=ZKhT0rTgs8*#8Xg8l9sku6P67rgsfC0SzIR1{lhB(db3MQ0a)cD#jE;;ass`4
zL8-!-dn=khfWnl5_+#e(6mFJFPU?0e$pNo`EbUowp=o|<B45gBw@2h!B@CtjE|v;y
zjW5z(Nd%uZ38y-vskt^>sab8OnY&_}rL%j3aW*BX^46FTUpo?7_=rFA9YNA;Ziv(^
zSn_r~oCZX-9G>Wn=w1Q2%>iePuK=<=4(ntmo!w+p(R+G}9Nw7gvNgNT%h?yJK#AAC
z|3jdIpJN*mZMXd(n>jEJnJ!*ES^v!p{*^(x+*V5ejJq?n@ZMJds3BW%CA3Ki<A*=*
zG~)_rx)T8A-imCa+ot5~Uvk|e<$DYTT#%1Aq}-E8xWy|z%RT4$i`tOEyL|MGv4`lP
zdP@R7Q_?LAWCeE!DFt0J08iCqqf5WmZB_7;_EzMNBxu8K%;WL`h>O4Np7QB0Lne-U
ziAIX=f8e2E+&_{n&sKE|Q>Y!JnnHh5G@tgC4s{(Wn|~wwo-_(`Ce@Q_R0tY&kSqo*
z&jm8fQlS&_wes2Yx0wCA^^yZoTn$w~Skvt+lial~f9<U{-BY;IQ*~AvC@oYvY{pHm
z#ssBsZ8KyFfdIgaXtk)rQ%Iye9kUso6Oe@7;tjUXTR;@#?^10aMqSpQu_x%+9ny5p
zv_h@Vkh$veC4E58_Z)#2@#|s-Q-+ynB`qobo)kbeM(BOhFu-qJZ{%G=g{Q}8{skf^
z;p0X~Vs{=|e#ZEo+oQZYNAVjlaL;L8tRrRK6VfNr8Gfn<<*{gJ^&O~^^{sYv7P*id
z^lu3DvE<K`@g$TsWco=G`y;kICO9vNH*ua&7TIgz-swlo^S-?%^>m<wia5rTmeLur
z@tw66Bi2V@JS6jPdC{xgnxn_}y#m;df5eS);9%M<sCkzJ!I@o~n@yc3YhQw#dC9@i
zrI)}3)R-@!JB01?{nB9abO-hw=eCkD@NW6btXpx~F`ketH}{&5NujB6;3zt|x3?R$
z<B`DhH$e}m<;~B{zu?w?_KYYrslq>ocZS=wgDJ3e9C4@uslRwaZrE#E5Gyl>EoHBO
z9w5EcF@1yi-WVN<xW4`8K=c5W*7^CXkuC}JD`O-Z(3crgLu%!>;!|%Z*Ua7rVsNi4
zlI){)3cms@IVtYqdpW?=l;z*_K6o)IS*=X#%S+P7P#}*7gp|8oUr{ez-ee>EI)l%y
zUI9o49s;<FVc}}6X=5>cp;G}Ki9{Q{bgWG-lGNZ=K(|z<EmT9JHf@u*7hQd%H?<6L
zD9C~a`AwpMm!tqN4chd+zIqC*t(^tSCWC7$1SUC4k(>fmNSSgg-ImTGuLE#By?x}v
z5cCs{F#62hv{BJ`NB=gD3Q8r}mMP@-*3u4QO_ml$f?4=fQZzZ8DF917nd0{4wH3wp
zIxb|`?qfNkzzH#g(NSUB{E}7TjnelR-88mAAsJB-#Dt1B;_;Cc>kG;Jr-no#v~8t`
zAZj||$Kz#5Krl!=<<xq!^0xP}ooe2ot?noIYeD4-4%RF_dwc7rnEdbR;tb2on~h0w
ztH*#3Qs649j!Ahu#%=oeE|y}f!F=(oIZcmqmE!i|a9rqiB7E4hD`~WeL6fr2n&h#d
zlA}hfq3`@(3u|Y#Md1&MiV)$E1i%Z&_gOOf9Qqmlqs(?5a@Mp)RNXu)4O9|B<}!Lx
z6JZi25QqTD?`&B=j9uUzO;aK$or1Enl~T?~UqbO1Oo}pgF<hV^qSp)H5#EU$g~njx
zfODmEI+zd@-p}8;bZxa#jXu56|J8IE`4t&EZ^r}?EJMZ=dCYz_%t3@4#vd41Ieh7Z
z8z?Nq7%1{=tkp2*Fo#~Wb$0tH;4L9?(9wdwTl{7`I!A2fD)l=WPU_R|evaYJb%+&g
zIWZZ_J0F>P1pjKxe?62jwqw3G0!NA3*-k;mM4D^Q)C;Y0`>!ZI{z7-BdrRU(8pAtb
z15~D^K%s1<-Z_uj_&Yha=zG!Zi}f}Z9OLwp0YBjbgV0w%Si`fRY!uY8a&BwOaZan3
z?ah^${Dcsu_xvvd<t?E$1lIRR{wFMC?6OaBF#vkbHHx6QrvK<PzNb+L!9P_u=di^w
z7XcoLX6_ck)Ns0Qe88qg&=B&klic~A%=bJHpi|{q#Zle&+NU0on4$Wg{VDV<sPwdh
z^DG>i!V<W2c^D{l@Dn_5ZYs{+d4}@4)<VGqo`LIl``=Kyhc<ln5A<3HkLlFoPH!aY
z>5y?{dufIT&^OL;sN?kjx7iq7-f_)f@3kV5*5DJg2v#U_^u^V7OHT8VZi{T9D~GXi
zOZx>BsxySZxwk4ElDf#+w-=q)z=?1G^B2o_feXep#q~Z2p`<_HFIBe*j8v}vyyi)5
zOgzijyZHD9bx9H1rw-6G44y>MuA4mOv~I~kHTSyIDZ@{YTT85Unhm+Ts$iGB*zUQI
z!7no)4;8mnS6QQvD|CNT*H9j-c&67fYvu~ki46C5L}@uMLK41DaT%}$({37S54_OF
z%hsDU7GeH3*P1ei&V87t+lV|I`8(61L+}66$~xWLlYAFXA@|4j@)K)$uKeFBU#m3=
zuek~7^BwhXWc}S>za-8aO$s8>DH0A;$YRITW_<Vy`6a)C)(2`kB1e`qUi^AleG_{n
z>TmZr+wl>w$_7zREYcs}h$G+`zp^&fKl2G3^WLfwtD}RxJpdQEghw~xLWsDcvY+Y$
z<JP!(HCREIEHx!Stk_KtDv>#&pQa^BrI|usbvJ2DvQRZvG;5?S`F}+7VSXLHpC=^|
zy2r+$&bGH{acejUADS8V+5-~jMVP}zhAD2T6#>@=Fn%mDatO^ZAFjUj&SQ;e$y#wf
zJ#HNDbfYg%qn=ix-&T3QoKlfMqBN~pG~K&3Q(zX>cek_YrgW>B3PLDnZ<%~vI5M{_
zXsrv7LX%TG*V;~cwW`<cD_kr)PwYIr&z(3h9YSZ1W}KP0ex8Sg6K+IWj{uhklq$}v
zi&n7GGL7<Bvw#55VM@QFgWM(20ob|6rZT*X8fzgEth8;&??!3w?C)9e>#L=t2g(Ra
z78Uw!C3VPyM<^I2?^`b3(^n{g02wn6+P+$&mn4-stI5WFMRER<Nc>oCG&R1j971U;
zb|Q{rai`;NRj=N%ex0a{{S5D*eF57bm8oh0%v6#>vt_)_C66(Mz!oJnl~D`%jglzQ
zPF9llqc*!~iGkQjn+N%4`6AsNkPSr^h09tyXMdr=Q4;%gMd}E9Jq!C!Oy@z7Pf^R;
zrp>yUOev&?yav#-o9fAlwASOIn|zv3>qAeb<hYkvq}4mlt$^q!y6sj&xn4mkTS0Cq
zYX_DBNi~CtZ{6Vl`=jn#*qln}3w4O}Up|~ABWk?f;>w*P?DB&CJzRlbNx%l;5z7VT
zw&wdmHts={o*}BO1>V9+s;_D8{wDH+BxlCHo}zto8T-9BZ#|V%8VyA?&QIbBoCpL0
z>mOqOj&-F9LJQ7(2eYi%XH`MRX}uH6O45k=zHIA_!D!cpc%lxs%F*F;dpc1bSU3~7
zk*gqY5B}r>>JC^WzX?F>_u+)QC)yV4!_!M53lsQPr|+Gh*nNR8n)jU;zMAWJ`YQEz
z*B+ZkBT}39#43OB_DE^qoiRz$<?_Tn!1o*k&G!leNQ3&1+MdOq5fVKTXm<_#Zjesg
z5+B1i9|SqlY&t$ik;;0}E_ySq97s}wjzroAn#<OX=BJ5UW~&%lf8-SHneAVH>m^xH
z^6jOrME$f}zmqsvTD~L`ZET1(yTzR}HgEF^xZVmBE9hQ-mv`rJE;wLBREvjYK6uNu
zTpxuxbX>9a!Ha%}80UQ!@J>6%W{Gue;6g4miePoz3**38`bq81gF2iK_U7O1G$TI-
zuMa&U6qzj|?*mOWh}jc-Io;;&1+BkIQ*8LbrYiptj!+mridQKD$k_gx@Cv{xWMSYa
z>H-06hR))yDI2n9FF|n0KZC+oYV(z%DybK?(QH+us-e&Y!{&qB&yVxQg)C`x4NHI0
zIFMth|DaJ^cav-dik<*JHaF|D-)lGn8dd__Pr2(Gg$LxTMsDIwf8Rw*pZ}y~hq^9Y
z$Vu~+CE@3`2kM5pd0XbBa75C{FEmbD@E$)FMtqS|d(!t~-HRvmtbGOachIyTWSg`$
z`aU`K^wp+ssgVVv(_@wKcv}SuJ^EA_jyTbdC|#ri;}PZXw8q56X!(M5x(^_CM{)|T
z?&}iQe;z>37|TZKKoV1hmoqVunW{6kx0$YW7dZ-FZp_fXPRMi-AXS!2gl|MKOl>EI
z=<VrRg6~(X?Qx_g)C^c!(ajSn=z?WeJO=e<Vm`J+MZgu_(Ub%fgH5b6V8W@l2JW~Y
zQe{Oo9os?%CAKBW$xsUzI_e;FirszRF)uI#sZ+ggOWM4gT%cRME{-MBzvLL#6mt{N
zp88dO>B>P%m7ry$bZucWQOtBGi@WqylbV9Q*dlWdeVW<6U-_I%Bd0MO)xxGbo8yCV
zyaBmVVZwGO&yQ#)jOl}+kKJA4az-qEvTN%Be~$k#e1P(t!-7$DD5%oKKzhmD-q6%i
zh|}-&RrX{89x2{!R2dfcoNP_1tBhV1U)oF?X%bED!AUM~@;vGFO&*rAIBVn<#4VZ4
zu}BU$Q>lSSY1`Vv7lEZ~a@#)-u-2awI33KNa1=ltO7#0lQX#gwx=cpo*6M=qoYp%D
zspDNYeLS$s`6SHXKkP!k{vDr6j*Y%#9`~Zb84nazVkHl#E#P@MXEse9kR1DVl;Qb^
zRe5w?Cl_yN0kB4trxH>5Wf^Ia^cB0f0nFfpbS={i)hYL%TQ(@1a(mkWPHGDl(jHWQ
z+1~PSxWxI}`=_klX>1CFZsDLnUPR`fG#m<g^H+KuP|De2`9~E06;)TaoEUCgYs}S}
zho}TIH((5;SSK?RYF1dv`lQfYT~{foDV2|0MNRDSj5TN`l<g$Kh3Psg0q)*>8K1e1
z9+cY`Q&%^1wi7+P?B6!oa!JzVcw@J-_L$Tti@)eA7zjmnt+k_>wm!_a-C3(upI_&+
z+m;>dZ5<t-HPMyg{t0T#A*^k?47rOsNB+@vX&~|EqEVg_RVWWTTsw%pO1X`5Zy?vL
z^%bBvJow01Wl(KOI*ukOwB20RdH$cs`l*6m=l;hdseP(w9~+#$oOTG*=vQ7>hoF3Z
z1%z|(kuR72q-EU+-YH`qmn7XVc{`L{S;e*;Y)kMtu*P&USNiO#?50Kqg56VyvBUBm
zGf8rr^m<j2vQMuuvB<Xi;P)cTaA=i|Vp~|~tMGu!G9_zH)AX6!(Xg@7_rc<2u3kb>
z^9^e@Q0X>PyT;7)jC}JeAhNDL-5`Cw<eyxz5X_%vIPXbf=JyoY8qS?OlM?~2#Sj7N
zaDq!vdK{OEP#(^^sY-SZPODBiTda)E)K`G#PgT5HK`=87)pm#$KdsAi&ZTq$HK!9e
z@<N$*7)fD>1UV?~uXuQow5^9v@lh?g&sX)C5z?LX-gnW7@maC$qO(i65h@XcSBpjZ
ze(!s@8Yh{NGHu?Xo1wGy(myQ>i`7U{RAoAVWm!Ah>)hYgtRNwq;0#ph=<Bh`-aMGm
zrD~9s7>?#`Cnt#oDE2jEC<&86P(_EjR)gQ<G~X6xY$zh=3wbz{pf7Zi<Z1^~tDeDP
z0;~mLOYajSm%|27c?XSxD<DoBX(cPRbL&mYA+8RWZ&oOtR?#b#MO#fv7QGgugea(a
z#8v2V=fzNbjKiNOi#%ugiMj7)zJ`CEIhh%KlxLt)C3N3r?kzXZJCLMe_`SUR>3pno
zjNboqB%9Os5uRZ5Zni>K*lhHes^{S5V36;Je8ELGrG=AT1N<5-nutWw#><|jahJ7D
zfnU=c{K^IkYjyJT9&adxXpnZ)7mzowg<;h%G*5~l8)t#8oEUdD(u{3$tSFD-27Q<c
ziNho`xnE|H9^f0f-^r?SH={9N;bbQv-x@2%%D(}EYva?sXks@U&BdB2S*82Q=#4nf
z7tZ%%`2Nn?yA8c1`6|$+#*EY46Zl1#Cd--i+-0NlL>K|wB#t#h_-B{$kJZ--x6Nb|
zPRm#<Pj1A0Rl#JvdE7`lq1$)`EJ>W?u%3UX`#iV#eomR^44t=BeL#Lzfq6-~`myV&
zI12ETe%JiSb638}SjTs>klCy8<pko5{9PK?;hIh7T}7GX_!GjI@2=KooyOL&IcaWM
zirx;L;S08cebWfl@6O*?(%o}ZtmkV*o1D0M_?F&O#M<}rNs^igQbRlQ+c^CWK}nu;
z12eV=9lx^arR@*6)}oVDn@Iv$06!bxb}sgzcj`~dzoR$tVpY|_=)Tn+_Q*UNLC?pI
zXk#AS{~juf`a^GEo_l*MayO!+KZ_C*opy^;_irJANC4dXudqh``e~(aL7XwWTVF||
zkOD~q!MQ)En)hn?@x3p{+^pzZ@r8WKr%|PA=&ONm%g~uZ|AX9vzw?^8s;v=HzYS_b
zlOchIfod07A1FnTbOZ$kKj}l3F=l!H+@<m-J7KK{h{<m!>Is&Z;jbUoGFwH`)yE2P
zxO0wrdsAKSTrQx>{uri75K2^{ZsXy707_C8Ew2pvU|o%-I)P8m=$J)^O}>(TK_yQd
zeqvEF)S7<O%;?#gwv33K@{&B}b*fL`5_qRDNVim1RiUjqV=`y){!l^Jv_4j0og&f1
zK2esKl#bG8zEIy-#x_r1f8BPBays_Jb48A0<tZ}kkT<?XL=~j}3PAsSQq+wS+)$W0
z_{R$ufX9pHj5cTmJcmh7g~6OWpoO-l$dzP!KFR4LLBm!iYd@<*CE+tCG_@`BQc)y-
zcWC@3_nk|`?uV*grVnQiK0n<4wBV#mvZ)LMMg*T?B`2r;6Ss4cB=sJQjthbK-@=XD
zYw$CbKB#r8@P%#B&IIQ<ifRwO@c!q%H{~uBhb<{%r*P-57QoZ*08CP##W{!^QhJxN
zbv1iEBHB|5To`)a*kEuXZ;s?U%%i~Z_%)v1GLE|oCeo?YbWQBlL(LcYUTsEbIoH6^
z1}G>QhR!(}7h7-n7IRl;$K=sE>Xx0UJB{f$Bj&t<8xPqANo<fQC@$w(rHcx!c}{nm
zm2AyG<QFUVTNMPA@Bo%K5ln0@ws^&+#pipI0!mx&nfVB2jJEKZBoV(Dqv2=i-%{wd
z(xLIla8V_f0dIUA?H0#|sI%_5%eHBK`7u}bms4HMn8e{frOLhWJ?-;fCiBjjzF)lp
z2*1UhduD2{G}egYBtn{J|NN5`B#H^T4I^>N$x$j%VT|WlqfD~)=4*FE8`z$yvH^z9
z)<+K!&8?~JRn+XJ;;E!Zf&Ku1AP|N2)H+tZk|-y3z^~q&Lt>5|9$89!a5+`ey^E3l
z#wyF1;hf3rUP42bb9DqG&-l2Ag*nKf(oeKlckKWXX=m57-poBnI*gN;#GO2j8t@i?
zIHS0m=v^{u%gD(qFVnkoafgP@D@AWM6L2Vyo0-*`gMuct2iD#rFxOcBUdQ9F2mGhB
znImp&u@~$u&DIwMKsxlMK!7TD7vaG=k*~gkPk>->#Wot>qR!|)o)b@WU19niQ@L*l
z)W%f(2+A-;!b?r3kah9>48Vaa7PT5gv$YwAp|<p53WLI82QecCY0#R{R%x5%TTZt2
zgVf7d1agZ;U=HqqkQ5|buPS}$7=DL5XG0r|%t%GIzBo#}hXf(U>nyR07&D8V=+!Em
zKWBw7o2eKrJ1qr@U@>lg{##*Brj(-8s<wAO!^OO_(~`#o$a05Obx_>#7&CpE<1-|6
zplxyBIF!`+^F8^o>!To$<WOXOzdsCa{d){~ZVEMhlY`Fp-a2nZcmllFsUKi&OgLQV
zD}b=>6H{Mhgimdl+w@WXf{ug^NYatFOoA95zagC;_2!V=;pQ7jmwwaxl`X9S{~l97
z+5O(m-mg0!`3*?TIHTHT2_E8xA%Xu5S<hJCfOlE{WEIT2oMK`T8#pjP7m~HH*MdWR
z7q5%Bjj7_Vl-h+HEn?R4<+92!)1Mj^p9X>`ZnxTjecX522IpVW*e*oxrh5e@7)n<i
z7~0IZ7=8#3C3brHe+7z_0LL4k&f9$%#ZL@my<QoOc|$N}Roq=wA^~Qu@=zm3mO9({
z)TMvt*DF1HbE8Qw+G9jF2Iqc`Jrzp_jWq`vhqpn$1WwHiau^d%X#;PTyv-{WHcEEt
zr(tfT`n>YKCFTKJ^u?n-R}=oTNc$R|X0~7jfouTd`dE^-9bQdOVXFB*fsp&Jnh1gB
z!fz)Y1>cB?pcZR}4Wm3fTslJ(Tw>^|PC0*1)3nmo@Xx=LR<1-WZGY{f&q^>o2;FeQ
zqsX}b?QDhZ%|y>>Igx)PNp0@Scn3q!ZRJF|oQw9igzlB+9lBs_oc+`r+gegWnuj2>
z#vbzAKim}$p1reO8tfy_WJg`mwOs;Bm^Q*czAcH&a-{$UBc1hogN`TMpqo(XK5_AO
zo<ZwE+xYOV1<S<k7*^|-7V8jWc4aq?d>8)bsa5usN?!O!-Fxv_qyul+w9QqOFEb&7
zwObmy6Fj*|Yzcyj&Tr!G#p;ZH7Tq~?Cr%KB`VX74jK3Ks$jsOwT))H``uMnWQE+}q
z`Bt8d&w@pOcL=$b>QhaPu-Ykz0_hr-_k!&yKG;W%|0E&MPMaz;2WgF{YxvHb^!^HX
zcXN9nNoq{_<WvmtXL{+btNqVcYbERIR~EkN>_7`hHeTE=zvNqcK|Pq36X@d~2dMI2
z?0G<{keL@&V`I;we(&7)cOPjwn!Gfn6KV>C-P9%81if=B9f_R$s%S2Oyy0(0a{mKC
z;e!DbfNS-NZ9lsUAP#Mtd0B3aA#xb(J)ifF%&pBk{NW=`jSPv~C((#xCS)ou-k3lq
z17}$~0fTP>_7O*oNbxJfcl++1VvpKto3x~#e2Q$zyt;Bt4~Rzsg%7c9fJ?BV8P`q#
zWa)Qd|0xGFN60LCXX!YG&LvoAc;X9WdrV|Nzuadzc+?0C#Kzv2?WXq^Ix*ILne3pQ
zf%<;P^Yl?Rt4RN8W+GUxw41Uf2UooRBXrG4crfD2KDS2ByDN{_vB*lyN?r<NJtVrh
z@n$u&sZFc(LgH@f%k2$`f%|$?eHLq&J>ump;8wjSrFh=Lh7?52foh?B_q$FMy7!vc
z3Sx+uIk7AjjAa<J!rF5nrIRGEEXf0w#@nQ0;gEnbxORJ>Drd{wn!wfxHg|FvP^r^Q
zQ?Tz)=d0{=7ibhR^4jqGKor0@cmHd*x(uWi+l$D<f?=;e7i&#hG@3paK)v?Z`<g6$
ze=J!r3A0EE3y(um5e;K|MO&+iM{4QH&eKm9oU06y08H~3Y}Tstr!<mih5AoiD_+X1
z@taPwcwV3b1L6oe{Qx|}emiM49#(7xlt9v9@%ucic0ADlp4BrC5;Ts(wgh3dI62{G
z)-RiM!Plt*5|*j%OI7^_1Nt%7gP<H`h^?N}{MMuLFQQI&al;>mhMJhwplZPFi9)5#
ze5&>wYuP8WM*}OJ;SHW@WZWpg%uEQ{`?{DS_)j{XPSPckR{(A|U7}q4HMdt;&&~cD
z5-mo+Q*n|r=*xAvcqCRzd(mlDk1cy}>z~3DEr)bq?&%fSy~?Nmn4kTt1Cd0X60NEk
z*s<Wu4NT!ZiP{*;|L0&$ChsCTMqo3km*ToAr)TRgyT6YxrXzyxoxjJ!gQI7~D?kJz
zwZ6Gg1OJC+GgHCIX<M$wfgaK2*v-%PA#8y=7MLzaXOa}F*X=u_H)A~DZ{7JZIfU~2
z)RFwde1c5A-H02j5uW56k#};w^IuD$894Q_Taqei_0&JTm>O9VnLoiOo4ERE?bveC
zpS%c=7N5kY<f7suPcS{wJk}S91&PK`Z&{|Q1my{v4XTHQ2{+t9qY35iY{lY(pleuJ
zfc1WYuXMu<v});({;{5l^P3bUU3!^>?Cvl?_xOylpz-qZ;$5;veN6z*5^3&8TGfk}
zM2?RtN^xTpM7}%QJX<Fi7WmdY7~9Wfsq7VCoqPWfeMyLH?hHy!oYc7K{}&(vc%A<r
zY8qEN)ptq2@|pQD-NOET%X0SCDGo2Lj9tlGnYdZ2Q$2-;5NSmx3q(t&lA@x{G;7EU
zh<MQYdmDCL$)O~gS*m4xLUOx|0v*i@RA9{txx^#`?DHQT>F<(#Z!C2Xf+iIP^!ae_
zT!ubF&>2$=CD)7+g=1p>c>Ou&9sC`jI3G8C*sGe#8vV8TGDxzP;>0{YI|xMb(h%+9
zKpC5)LO5zB>s*l^_7a{v{$EUsVp%JZos9im3t@w&raEGT+sBk%a<3<dA69v518v5f
zTpJ6&hiR+g9Aq5uRerowoOFAWYa4%3!^TjV{VR4hxKIHejw~p>u-)#YRW+%YgzXDQ
z{y-_5hb4*#PqWe4QwP%gBaZX0ub3O5P+ukjk%NElq#h&&3JE`d(EHGUUd5s2K{6|U
z5@TV(xj9UD(241fd$+s=kBH0Mc;-IaYiJa#yZ^QjMpLz!ULxu#JK&V1iqeT}qqe95
z^`UH8J4_l1BcZ^H=-a`M@$rD!=5}ivv0qkQ<0TzxMYqW&)_GNM<$F%Z*j=9(d;3Z}
z$GYKQ`BI1X8Id-;0=~x&lI@ft+pqK%?T?~l`Cl^VI~Zo;Y+ep@`faH!s(hZUuph{+
zxGPZ0`oN3aq%Xh1ibo1Raai4^pb*?cx-5zrJ2zKO)@haLM5MxO_w@5+-DXS^b<r6-
zaW3V>Z_nez{0$IP?E#g>6D5Z;;9D1A50{mkhV>_fyU;Bh{G(fO8jq-P{e{o!z2CZM
z4aZkbx+HvWV01ysy;vuy7~?(}fEt@P_dmq6E=^P^t9JpK2*I#xG%#f25kA9lbs#N6
zV?v2`5U&;zwYhC;=9hFTqmd9ElUw9Q#H;LFYRWlAbl%52VzMp#U=}E0>yPTc+}KH6
zA8}<I!IOzYZhNCZ*(5oP4clcD#9Qu4iHfUe=Ipw9aOq#t4)teRuyq%?dl^8W{B7kg
zXj*P2IH4Uzb{i0;(7v26J<vv|K)0~SPURVAj0E6GD?gIBzQ5c2u`A!je;d#%u@pA3
z1q(TOA$ijKD^YvBjQ<M2gAr6@GO9Me`C#zF3gqr=`GPx`hkDlE84B8L%>U3a6B9GM
z+jSn>D=aoov%l0~ImI_p;)W46@4ozR)W|1-?q1KV5dOm@M}>8!-9OpW=x9p-X4XO+
zTah<kucLYVclowf?~MFYj;Z$0IB4Cd9WvoB`Z6w(8{9^a!#idAvR0F#XIEi>&xOe#
zbcsZH`7jCE8z@_9Y%a@m4K-<WXC(uv)xL8?RTywY(ME`;JLpaJ6k`46OL)hl&9rw@
z+Mt~}y=mGBx45_%q4=W7OXVm}SvTD(M#vX^1VJh%3WKDHN=dZH0Kst}b4e<<JWn^i
zJA1}j(X)L9Ml(k`=^SFAot=lPN@bB5ZNbJCx9gde%8KRVEfaUy)8%$lFYu*NbFr>1
zaYokMgGkpFDJ4_NO~ef_i00T6IWB<gDy8K-M9Calv>@YDk|J=tsae)2d5QkkCnn@<
zF7U%Qk%SpnB}!JcYTIkuiFCC4U%0!~Z{l21CiKo7qQqGvIo`wdi*tPKo2@`xEeW3#
zxx~NP#XWhz)DiPh94}PMvG#|Wvkj#9e`bCmbI0l=Op81%bghAaSuVynhh+T&MQmvv
zczj7KqP%t4<EJZi6qn;RNHAYGS*D>8kcap`<-wn>lJcTF>0LQY5=;mE8JWb+=2CVw
zqMUUdVWwk}4_9rH{Q9(2#I-LPrWUq2GhgZLc5>G1a4gu2zzHd?pB?pVXsT~pv>R(J
zAE-t-NF2V(!-n)`Jm*9^a#UfA2}S1DW$*@9X_oEaW;fG`3Bf*{w*htkve~=&T!)Ph
zxOH?SKXy~_(oiJnSd)N?JilcA9x0LMV6&1*MZtPM916I+MUvp&Zt%vs$$!%gEnNJF
zDMeUiEp^#efn+Z^yrhI_6(|<1g*X|EXm}hMlS~cW`TS?~lLA>DaGAy_X0Mriac6e#
zqJDJ5)a}E&x~n8`NS34a?tYeb_Oih+!{Q8{F%M%*Zu*Yf#Mn}Ma@Uf<_LsQR2Z0L`
z2hHvU5)MhDE^A6rRZznnP)@%U;v)twYMP$XU5Q~$-M3dE-Iyzm_w`;!uZ)j!uXy;8
zc<-(@GLbN@_|rWYXBD&aoTYU0L{;GDb6RL^<cbRTyB%&{5nPl?T$LQ0z-=t<tAAH;
z{tDQV3v;6rYhQn&M;P`Krkq|tGp6|grOK_Er^BnQ_miL`j%G{SU%iZp-y|BcavRo$
zZ}+WL$tgv$GN#Ta!qr~^ip{Mpvb?7&MG=_P$>Tm&&3;64x(z=1x|-t&8^{Bz%Pzqp
z`?=%ojecL&J`~OD)!LkK5SW^ga}kTZ<J8De@doU;9+9_-Vq`}C)(j(BB`d|8;QRt$
zYJ?2I>Y?iFmL@-OvOU726BIBN5phr2K5j1j9mNzxJg5oHSVU(jF5^xM5A*q+`cm;)
zv&Zy*FR6x=DmU%Oq2&n+Lfc}fo5Oi;Uy$!;*7y(%aq+*qof}0yM(5%h^1S;)jcF>W
ziFb@AqY896GS+`mL%e(b`GU0a#B#oyxwz)}3*lg|E~}L^w{922MNDG*HR($@=?<{p
z5BSLM8BC3N*aDBBnj7Eme&AC#hAd?tNBFNhp?R?vqRa;NRaBHW$LRweUJReC|Ns5n
z=&lInnXH<@I{&El`2LTy%#BT893Pr9_B&3MFF%lWiAvmr2A3(PezVhNNGc)4fq=~<
zPmr3Kg0#o~!af?BYZD`9cQhgljM>O3j8{xko`$)O$*7-=Hm}-KZs)vtA5&vmZ%=RC
zbTH;E(-Azi@Cx`p!oDi14KC<5DPFA5LUAaB;_j|RN|EC3?oRLk1zKDRd{7#oSaEl^
z1c%}fJV<ee;J5!>_xZoCXPq^(X3orBd%v9R`tccH)zqLdw?EdZmli#8PF;xUdxt#D
zC4Bp{px(o3=eEKXn1TabDpvsS4UUV>SAx0Z6OE^BCMkv_Cp?6HNL(b<^_RYhOaxh|
zFjJN6`(GBda%PmQ#UiR}mYXrieiNMtFPqh+`1jmYW_&o)N%+n*Ew3VQALS;pph*4|
z;4w(&$rpE(OYnM=Z55Sc=7t9LeV^%l@29`%s|}E8u3<;$MaBht4EV1_g^;82VaX#_
zg)(j|)0zE$rxjo0@u1@$w~Z?RjI(Nr_A^B1za3lq7k;bC(vDFwhSMpo40#M03o+!8
zlU(f{7N7b~z-R>Kxdh6tOqluv@q<B0$T0^JB&Zq>$Kt|MO%)Jyb7uSb^km~Gv3Es~
z|6b=HcI@M}66m~JUP+i?Tj8(McFN+Xup3?;)0VToe!+l~c&^Rq*kI`7Ew@<CPlyQP
z{ceiLk*RolP{dU(p~fUX(~Qeu!4#89=AeV^mxm}q_BdiAU|nkO*8H?7wJ2uBhD#_6
z8i+9Nv1HfOk?Qczvj1T(EON^m;7xK7+AGF<<whivZ|j|YC*Slf7q6c`;SF_J_ySXr
zf0YetJ3q9yddhn(vWl*yRq^eO7I1qIrp{+?Jwg>}v%i7?04pT>6d17QxZcawmu>UG
zpDOgwU-dbNMXCRzc7G}!I38=<B#!!#AN6p3YdrY+n(fd_$ZfEi43RpO;?u<@u91GJ
ztb$(60TBtFY@zCPP4-Ow<Y}^v1j57C%uM31rD+R8xF*|$&Y0F&!Ri|cP=TSWJy-tU
z|9y3Jc}WaHSJ^(E827}KbiD2BH6@?E{4qjE@M-N#OgUq`ZhyEK(gr~!$uMQ@KD~J`
zI#cZJde!sW;Rc&AWmQS=BOha})L1L8ns&A?T9jl%<_0ar;1g&28QKfZ2o)xTE#(&N
zyY1|AoWCLm(&V(1Rpzq~!6kdGb&tuH0{7xLHzT~HCIyv>7=R-^dQ`~u6UMZ-?;Q+!
z+9r-uXw-D4`E%la2xtW#3?yu4>kX1CGj@8SpK17!Y3jgvypuYX9Lsm?DFZt9$~tm6
zx^z;d!7T%X*4u1^tzStf8oM*2$<pFEwkAgTNWI<rL?5A+aagBtSo+D%78?|I!Q^~d
zss5?9rFME+3!VPsM|g91)j_ui*<j@l?HT8z2dTh96Vp$zUs$ZrzkJ|;Z7)wmguj3&
zXrDLi{^iV@eql1iph!1ruYZ)7;G3|BEE3f~yCTdwR{>Mo5H`d@MY;#kk;NZft?nt+
zw<A~H&obmOkhmhGGxVmnI%<;MHp))CjH?59Bmu`mU-shB)yB&(rj2h&h!S{6Q=3H<
zI`|aSK!9(inUe_O_~uU!3{2loGK9aMd-q-PerPjOdi#aaa9aoOTY<k)FE5R#^*%ct
zEY6K7rB&?GktEnpR%`O+@3`c8vW+$1##SB0Yxep%u-kPdSDMJYkb5l}U!25?tATkE
zbtP88q|wk^W2gLrTbG)*Ck)=mW@V(zwHwVY#B3!-48TKed(BwWU^+HNm)T!a++>nu
zw$>8ydl<Fe{!qqh!OG6wrDk=J9nmmhbh}m*s26&f(v0TKIhva%zB}Cja77fJT(d2*
zf9<0cj=R|Q8oGh8WuAH1%~T*$G`8sD_l4n76+Tbo_5;i5f`8b%?1^B<ij+3w!t3W9
zY)NOAzP=QfS;6J8^av6(3v^E*pa1dtm_)S7GUx+gFD}+-8tTkXW7BUv$A>y4M?2ui
zt4c!I8P1a{^t$0qd9k|j7cabyOk`Dwabj8$lorAj&(H@4`GFrl7Y~FSvHq8F3@6l}
ztP;K+^U6rjWQ%HvkMJZ>z73-tcnW3<KDoU2SNL`MBa>dNy-2J-@g~GMq8n@SvfM>?
zE?7>qt;Md@FO>6L+lVpR1+x_Ec`()+;8GB9*850m(>9H>C~l6A7w$iZXW?MA79P4d
z;dtTpP4|gRop{-i20Ovt+hNB#{{41D=-UsbI9LsVw1@D(^)|w|R$}noD%;r0eee2~
zi=Udp{dN6#k^k{RN-3qr+ozE(6OrW)c7YpRz@{I0dv)niNZ%8I0?Ki0<V)i!t$#gt
z_dVtRN(|yi0Mj%`EfhZkpsLS+pse{noZ<-c$z&WD4k9~os_|hY@%EPX2L22%{r?!Y
z=IH0OD0DhSP?q3QB&cL35Cq3NI%Kffl_|{Yadvt>qztNHFM9*1AiVy_2AwI}w!WuB
z{{m<7r&j^c4*$xE%1dhEMd#zZ_glY{Oz4jL!~!S)(`Uv3_<c(z4w~P5u&vyh){`mi
z9AtUc>@P{SpWdY}ZF&^%={`B*`Bl+!yA${y#1R@^D>=V4h#xyuB0i^DdIo^M1Jweq
zm?X;J0{T82#OKs0nBPn2KRmrsCVK`*)&nO#h*d=NGupauv4hEg9=g_31sNYj%LYrT
zgN7!<CYpk5>#FjhIP#vJV<X%ZIF*$lBbeDaopG-oyeIM={=Q&SG9}a9v6VC~3vXfQ
z3i2JSvPZcfRn2<+lpWS3WcR0@0Xp=n$NIAAnb=D;L5qN(QQ@B3vb02*)|o$@gCy$!
z|M<ywgX`7_{xls<2NRJ`fYZcY4*U=naOa87I;P3{{z@xPZA(3%^58P|ZAS7GL_%eK
zEiQ!N0aQQJP(|r99~)eX^ZMgd=95J_(-<41J*atW*H7Rq1I|So>bmCQ&nUzzobEt%
zn|a@dUL!0as^_(t^VM)Z#?>vzph%S{*`O#x<Hx%cp44sm7IXln<lg<SPL-Lf$eF?{
zG9huk&K<k$rl)KTOw3;fKY@da+c*dHH$}tAr32R%QDn>Tt_>6PyARhTWk!2*jT=Tz
ztcT`8&gf8O_{TbrJmbB&UwiqhLkuNL!$J8(@0#$o&cy;WFsW`5eL|S%IM)HlX0nQA
zX8}sKL|#l_np|UG1T<Sm>0M2ts*9R3dWv|bUPeR`&(F0&M~>N<x@xTPa8e!3W#X2<
z|MOYO<bWSd7O2jua|6AW*z=7Qqr0crycC}2k3(?>ynXS(oFeS*Au@P?iP{EqRbR_J
zQN+wNkkCT=gwu}HBUeNNEoixk$|?qM=XV|Q_&dn#w93Ru!tQghUa#Kk;~8f=Z3mDh
z0E4XZ>ZNQp*5{rpk;nYgXqb9b4p|VB&o315=@7|PCT_kNgw{DZnKngEX+gt1#A2x{
z%jtHp()xoKu`?-Jp2#!cK+ho`wWf7i*wB9GTxYbO<sJL}N8oFVU*<AB2i>goz#H25
zP}?=Cssy(afge1UmHoY6azIR!?j9)~^9+?vy(cy;Q^&{k{~e|~<kJ|14OfaVDsOq1
zIfabpG(4URv;}fS(@20B&fa_$<g~-Hn9&v*j*}77X9K1TOKK@^(uUO>7^c_wth0p`
zIw^X4+TSeLZ()@w9MoXS(AiATLnIle8Z7ec=grLPh)vZHzTx^8*=VT<fj!e#bKcJY
zJp1{K)=h;BPiedCoDI43h0Zt`YM$u|Tf~F-O#8d?$JBmOH=968vYiNeX^|cuZ}tMe
zdssWx=5c#dRx8*}-RqiK(sEPx0F(eU4{$HnClJ-ZV%l6ImTW6k_ou3)uthJAmNW#$
z=Xzo>NX7f3>Mkn(aOiD8WlNyByIs|T75+zzBl*D8i?{pg&U#*U>(sK8xYUNb&Me-Q
zlj{i|f7MW{5sr#ZVg}D9E)Fyl=D)MWc`fLXZq6GJinCei7*MWNYkxktX7eo+tb}E;
z6^^rYuDENsq}gL<!!ce$Nup~F@?6BIN$7|!<Q?gui2fQh==}Ao98PoE7JL~$0aJzv
z^b%0_%Yig2B$_i{d^p1|Mi&uE%R*I+7Ll}U?OTo>zK>0_y3*GU8f0Wj_Z=}O_-{;m
zCaREKLtW_P!>_Ma@vSf{0CYL@<6v8aPU1%w%^>Crd4F_bIajz>_X~*V80*y1%4X-B
z4R^tp{M6o)tvI3y88c-tgF$uY)X{dr2ID<CjJ!u!`sHt3GOD=LTRqq*$7%^i{oBgk
zNuECIpsv6srjp8&zUyazg-~l7@pa?p!|#_E-vxV4(&;p?{;bioTjha6dnX;9DBIS`
zoN%^RUjcL=it%N8Nyut(Jy>1G_7+k5*JRv?1~ELs+$+oyr>PMSHpjY%*bGL7arfff
zhcdw#<K;#ZiVq)d-_YFd-A!V(gH46YH|nN`BT9^OR#e{g8*{3U@`3@-G}mW<UhT9G
z+mE^S*UJczufzVInL&~gvdORy{znrL4~luAHXUb+Zom7PzPupg+y<eAtAVdeZv+j~
zU<WE~-f?9@>Ds5O#U%#=0B^nzu9IEKp7@vj6D;m;ovp8o{X|Ii)^IKt9<0g@6<uwd
zoRpf(@_8s%nlNx9RvHs#cS9&oX^P8-wqbm<7~4U?e|oTzVNNG*i_d`W0QE2<&9kN$
z9nFzGcU2!BR`-;qbX^SiXy|-eE`ix~_L<tZ)3Obc#GVPl3C7C8O-2(lZE3i-hf*11
zJt&<i3=|WZSvBztc<Im@yWAs`df#GYxm(t5QLQx5DK>9(rl&La^nU*)l+@?odpg2+
zwlcCk^n8w4zD0*F#kaH>Eg@}WFTmz9wsGn*Ql5j{ECWq~7o1CIcsky~65}s`=yhRV
z8%aQn$g%G?)46uL;!La_8QxqhDf?g+7b|lj<~+}MmTMTyOV?9`@ZpmGktlvR1!WaO
zTqWO;j|PPN6j}so3Qh1VCiSIG$&3STDnjwZTaRk{1ezNtoQUeZUApmiQzu5o0HnW6
z)W$e$>I40C|8lgqY$}Xkz$NaGWaYGp8V*ZLUn}^H?6;ay5BEUpK@}HospW$41I!}5
zALX=WuDFO$QCD5H{1_Jx313SHeaJvHI)eu@XQsHwP|~F!nc1zDa|#jpyf5qL*ZV)D
zMRt83?#;b(@v89Pmh-;X*QH~`>O?8B?i(aw3{~WS%c`jf3{+#^`o!ThGV!fqF?PZH
zFF{|uLrI6N^JAq?#0tPq#F*f!QQ@PF`uWTIcNw*5ziiJ@{#L#)wLl~^V$aMrWD&|1
zHL>p3+Z7#PeQbVS&~C49p1Z`;2I2em8|^}K|9t2CIB=wh5HxP`V<z?U!@bP@;!aLA
zL4LNEuCsF`7n6R)WFzlkw>2}>#jOU`q*>k7Y+-a9J0o+I;APtAm){UY`ppjvDSaY<
z)4+MgGqZvDRRL6FiBnS@d4X?&fEPp%7L!l5?p<Dm%WI_SR|?01&b?~;NJU)iMi*xu
z=OWMt=Pz6-5Fb`M$rC~QmqO73I8&+I`~z=P*=nX{FR`SuXnVUhl3fM9P2JWT*XZ$J
z>@jmGFtWh^TjvMvwrjGQXtu{)%xuCY3x8Sco{{$yDY}rf+M(4dL^Kq4FC(jBYpKAQ
zF^X`-)wKgSaS-!YV1!z+uhr%{-|-K%=-<ce#7(=w36Qn<E3m*Y*mZM%{v+wNrs!=O
z)Y<z0eojK0P+6IwFokTD>T0uX@urTz&xM9A<`U2>QR;#F0LlHn&FJZ&MS(fJtq0l-
z@<w%hZr^IIJu!78f+y6+Yl2t`IV*x+wYW5v&}S;$4|t7BoE;gBQMbDUKV}=iHj~*x
zz1`JaJ(<yn&&Sk$Nlw!bG6JKfJX?f&_QpQXo3}Kz#*;OD2Y<Trm|m*)9*DZWMc?@1
z+%014v9AzZHhschh1sx#K$xlrBqM;|^zh$Af_oP7Bd+$OsqA`D1))SAl`Wj8*cr`v
zMc5YR-<1bv9N}X$u@MPhJvhyJ<9Ms%Iwbm0)i%sb|F?x?eRE8g&6P`iFj_e6dg7z(
za*28v%JGm^GU>*HDx*PgatW1AF)|SRElirKMbO$YkV+r9tTojYOxq*dW2!wuyQ#UU
zONiF_YsL0V<z(K_7q@?uC0u5LyviEoZ$o}6S>Z4KYk`PW%r1S{3a#qXQ^PthcKpMy
zW!KLP%n}G_5k#U)H<Vy)%*J6u#W&Jr{e=UsiZYKc<E<6sRT#YZ<8Hg0g;z1iiDZA-
zXhiH8P->|~SH+G^E*>$}=7u)mPa9R#`r~lS#*K{uR0{i))a4zHbrztPW~y$*S#s?n
z=7q>yu_T-at^3l<09$=p>W!3;_0Gnf1jhtxauf3c1Ewk-64OJT%4vg^>RMB6JEy%v
z#hrzIe5~@l+*r2G_cW4*$V%_s@I9jOZKiG4%v^$lUSHD0;$=t5EV02KmNoYf8iJ4(
ziPEuw(Q1sA|1jftq`QL(5(p#$G@3}4d}G-Gt|<<0-b(0r^4;lT=J`|9`$EXyk@2KX
zgYa_3A@no0M1!EnPZsm6gbX4_*>{>oj;~=hP@I^LvhhD;G&4o87{cPtMau8*zu9^7
za+|*ecGPJtEH9zAuooG;B#8^bV!FyDi0!-9>a3oxcv-9ThL-tfSr_^%un5`1!BAyV
zW6eKkgDLNJ1e2dm%^nG0pK#d4cYiZRBzdt6GKRDu&#G|FJRqo2<e+Yx7-4d26&gK+
zV~<{&x6gLfnr@3qca^JyaEnb$y(xAq8Pie&6R>-0+t4{i_;BSm@(ieuru|>NFiTZU
z@LNaeSNP+I)Z8gSp5U7bN^Bp>4(0l?C=HHhK*+$`v6om(krFk=*Z*k(3AP>|Tl$lS
zmaVEqw(O>g?mZXHOiU0a60O68qud6GBBttU?)GR3o5wc>GcM^160<iyw~UO6<RsMq
zxI<fE1A1pa8+NiMjm+dZT&<QUUZ1D5aHQWnrKu}q83kK%xEuQuf1p=>v*zW*DWWMn
zIAD18$tm>rr@OTNjJM3%^`rgY^w9DqobP;du?$CjR4zaV_&*D`obXcVw=Lz8)MU_v
zU7Z5vdp^#`V@7i!D%dl|vy_w!DEJ~^I0w-G1fq-gUM(9{EgY*LhA5>LYcAL@2Jt+V
zu)<J!Z9y!jv&B&rt`APg*X*9?Xo}UcBh>xF%4TBhkbXh)ZEITYTYI#YQ}ytIQ`<1f
z;xh*Ml;NpG6~uy?EdP&8*%3Nxu}(|rTbXq)Q=7Bb{TZDiQ!ZB}jpa%M^bHzHQMBJv
z!@=E>5rw|1lBl}MAnD0#$Ff>wYaD(=*i!6pY0+f!IHBY1{(;;X%{R2Q3HGC+$fVxG
zVyhHxnF(s1gE@%!KgHIbZnY&%o-3<M*8)iHK^_>-1Xh?dQK!(ro2Hr$855MZvkXXi
zg_K(E^RplMP`aSOped8~Ik*34*1dD_*9c7!DwRg?5|a@dtkG}c@~M<bvQV+tkN^+E
z*0IXMT*rA1^t><kyn{%-f(UoZ+!Viv)T^DA6^Y#NeU^gQvGbqSiwh91i6)w>X%#>G
z@e;|>xpU(-#dF0JO=9WAgaBqT7$6sKe%kOT-9>Uv9{+*q(Nxix3Yg_mt8`wVwAP;V
zFdX<O*&s1?b@`d2>c3TaJC^N-T%N6mKCG5v@gm#}#&*yVfKY?i|71o3%Lm=B8Zm(0
zOR9meBuCG4Ch)%t(3LDUcX{}m7d*y%J91iZ2mGgE3Z24-=l>jQ$8n9MgoK)Q);qmJ
zhX1j0S+mz-r~xI%#reTEq^TH7Yy1d!M+VWYJ=E@{{Z!XWGaf|5*R`8pnhj?-xyxRy
zKzVdNj!|Z~^NNOx(iQ?fUZ;HcUBEr8DczH<Bh0EaNOyf;R%Ql}<aRJ4Z5Qpr>tx%X
zy9@ose|cUmP*U{5>FXOz+)i1QPPug)zLbBkUTMH_Q$CH!6(^{`8)%jDv8!mmsnulE
zaIB3;Tr)JkTG%=$c;k>yns$;Vo+^|;oNn)oQla@QCwlFObXN<UwR5jh&EW7KB((*T
zuNhF*WG8ZjN<53|>#aIN({DrhgMIK{?A+-!T)egZov_F{=$l5D!maJSXS#CAa6Nbi
z?>jQMtfE?321h8&*szE$*Q(JG^AL<t<(9#t?&EwRJaH6P&j8A&2`CU%;vm(Z7-hIp
z(V18I@!~_V;qQBazM&Kie^+@;EV4x^@Q^E*9Ds_InZ8_+onu-3Og)OH{545CAyWcN
z&P4Cqs$d|S@CkZ4_J2BZ<3<1|4giAXn78RhumTp-FvD0g7_lj@1$^qsA5Jl262GKL
z8+PL9jPxf+Kd1biDe3Sk-MlXf=6`w2jMiCuh84}vA&{3T{-~@^`Pn-%-<y1J+Z~57
z@ELHGGSYuT0nKx4wYDb)$WJNwDJTyubemII(=<%%pTE!BFyc_#oD^EL7QA*WMW1SO
zz0Co*zqBgzA(;WcRi6?UD_q?}%-w4zOU{#xPv-EJXacv^X;%KeIQbTYTWPS=*f}Lf
zo$yO(c|ayZc;z7|jvJ;J&|iC+R-ho_$~k2s2-4hl-ynm0L^4$gBO4s{P3h0f;*p=d
z9Iw+!jjWm)M6e;*)*A|7xbbBLV?+4rlo+m$9WRSh5loM*8_tvq^3BB$B>;!^c$iUB
zY%U(hPqK*i=kTL%^pGhW0`Dj;y5dY3{?wyfLMTz1!g^}c1)&WqFlndE^HRAqz^hKf
z>hX}P0Nuh;rapCy5u|lGTfE9=w;G3JNcmQ3`hUk*?zoi23h)j1kdR=GO%_)J-`dAB
zavMF6(0}XU>Yy#6EWn^yJ%7}!e!CHB=oU*Nn5}lY{K$Dj``$@Wj0)0TGSMtt)`^oc
zN75nW>#;&7{Uk^DUsyK8BYAH?a$fF3d!+4qMIQ%KM)Gql5MK6frIaY(a=WW}>JZmN
z`7!TnI2sotZSinHYND)g`HGaX(Gj;<lt+*)UQ+XtiX8)9=ojcLO`hMIF@mus7G9?G
zKQu%#6Ljus5>8Y6s)EWVM|0a|76~l*T4bLv$f*fs4y0+0PM-lvfgHf1c@EOmS?zyN
z*mnEl5jn0X0WXxhw?NfB5rqQ(n&GvJzpr;AqIV34FV9O};y_7{d_l)*!b%DV5x8WE
zevsK1!|K(2dVhuyZeri+>EHT0<7MTmH0_mXkokJ@R2N@}aFE{26Z?boOeft6P~f*4
z>mNyt>b}%Qe(V>K7(?Ax{J;&^(qH~2^$~?%-21`2fCs0BSh>!oKcr3*yepg`4kX%1
z9!Xd<`B^qmksiMn9;=VSZ0TiHr~=mUte6BEiua3-#ww0RAxrVq{lhOC#j>HH4AM07
zr#D*agiFO?S7lz;s=CxEaE5Km@77T|Fd-YgtQMLa{|yseC9Wyu%Vz-36dGmFH2OLN
zu#K{rD&gwe#z6<ur;95NH4z`&p+6xLpy=%{yBJ~1{%GP>BrB-Uz6>baOnH?v7icC0
z=f=1+rH3yZM+ZdkC8rQz6J&5E08Kp|XA|bYXm#=f%F=+OOX#bmn3*s-FoH%qX=e;K
zrzo|POjKz$NtAGCj7|c)CqR1nLFO}SW@iH9|5@W$<?|WAgcoYLO%8cxqO`Ja1P1>G
zWPEk0zrDJD$2c<Z6is9GPeh=nU|YnOD+U1eCCO2o_hzW7Jd_Kku9nwt*`1rH^Yz9g
z@gE_sKY&lHUH8`DMnu09X~9(e%|*qf5?zhnP>+)l_?;ziuO%t#PVqYMv@)>>CDflo
zR8>(}Gt(|&!#~+DoW^;Ap2^ly{U+@ovA0V|T&qHLlkkn>-PLp^&E2^JkV$w1`t%(L
z8TSY?Jvi+%o2+<{@>y>~csT@DPEe_olx%BP1C?;QheSrgB239C-ln~}vWhwO{+iBV
zi0=F)GHoVdTg{VjV*n6f7R#?r^zd%_cuwQv0Xs+j4-5U`CSZiOC8fI!Q`Twzc2cTQ
z_OW=8<lat)3hW7V#ue9|F~gXC2kYZTNQZ8J18^##(e|viPr>GF{HgyyAU1!Zu!pF-
zC;-b*n@28`pID^={F<nm)Sdy6a(;Mmld`3Xr3s2|A6s14?CUK{$0Xg!6_=@et_6xW
z4pidh3>&`uEO}j(h42I9K_u+a7Wn_z1zcY*xnv;*SdYAg(MizL$KO^;u))Q(yzB(q
zd;)hek&V7hN@N%Hc;S2xBCdT@dQA>lM~&Yk=Hn_-IMS7Z+6=;vzEdgqM&T8wsH@GM
z&%%DWZDpNnpx3n|L(tF=O~r+P05=E)n*o<kD)Dlxkw4|IMWp7il86Y5XMix!341Ap
zld3KfW}uR?oTC=Z_G_wM!m786Ku^CbVa4jq>g$n(=Z6tFLcIM#$pajj;RgSw>hykr
zx$Jl<hsO5?lGhKuTU+jdljwq+P{(Fhxo?6%IMsRZnTc9Sd1lbT!ZX0#I*vtW-5L$<
z7_+7tHEIN>4<DlaAt+ic0tohG!`1!%m^LU~!u}<fT6zL-A9o>5Q{q(eHx)%J22M8h
zXB_Aw=2b94NT%(Yax{yoj;4DUgZ8!g`DESchkDS^*OPm;+@10|8XBWNOyxG|MCNd@
zmWX(zADH@-B?o%cD4tNC)lr4!^g<-w_O0OyjJYW^b>1rl+C}+CW_z-v#lWb9RR<EC
z<6Dpw;Ec4beJzA%{F@U>YxD3pJ*;W!gFOksX|vPNsGYM!#6xj)l!|tk|H2egdVdrd
zd{m0{wp65`Z3em{YpT++Di<~)Uar3$n7Ra!p#9Vau3%`2A@ZOQNuGttQCSr?k-%0b
z$Y+BP+UJ_ecwvf^A`{f2dT#GCLyPyCXzit}+F~g;l3bEC(%|SG*-tv%5YsIzYC?R}
zg*5fwSuWd}SQUTul&((lV8nt~#KgTq%h*T1AC~1#t&;k?RRVtvO~Y)w>`0JhAJB0+
zmHp{%gm<y1&Ia5~>A=ZQ=GU%NB&kJu)ZENyAB~3GkkNx*cv!p7!jgC$v#0&5;gsux
z1(kpP@C@k1XlhE;9V?)@Vts-VhFsynhjnz(MZDT(E><DzCWh>!f0h}J6Rgh5+`)rP
zdr6MLLZ7D(>tmad5n~-Ky`X|KVuEI}{qE!$9hE+TQAcYGUv~oT($4?(=4y|Ii(V3b
z7h;%$h$Uj}6FW%0o4#_Ax#%7=YnCoAXhF-yv!3TemYH|5x1}4%DGiW`kga{!f(zIw
zKtGrEp1tc&!AKT+!_F(27K-E-JO%eyL0oXD{HaBMWdSCpD)A$RuD{b&(}F1wPfJZt
ze;?w#KATGP;H_ITqeG)t%l)B4w}hv;g#W9jB>22I;mJ%=gWOZjYdrL2q_K$!tm+2X
zM+7_06j&WAsB9_ZZh{o$zqS=ds*Xv0LZUICF-gwOgW1+=&eVQ-{qC#mBh9lcGV0*f
zMsR=gG;*+`L}5XS|0zu@`9E8&ggznCwRP?rUN<o1f4h!c%5<l>*LNBbGpjRF>CGL&
z37bxVr|_*+c=HGp<T!_0gXxUn*ol#LpQ=WAx)0__4$KIGm>gW=H{D(@E0X?n?3Y8^
zSlU<UErs!=hA$3k-Kehv|2(jqVkT}>5Z`PT53pH1M%%}6xJ10VNp%(j0Cw&DKApGI
zH0)430|q2y?+slPW<aEP6V%_uz)>q-d(V|Y7}R4v&j9Km#WVc+dk(PyU#$g%`rDsY
zZtjV%j5Kso9lM+X!k1MUg`L{bN3ZGJ*V#Sn=(x$4s9R_&0Nx?Y9qAm}{Qa!Vw5&cN
z6A}Y9tEfc7S!DfGg9?P>?F+JM0FtT(O(M#_yi5$?-JG(k`Ry1d(UDDP#raAEOCSnS
zyaaM@%f=rKu%5(dD^wzX7(jPp^@R$r6QOi;z4*x6dvoz<HKkZ<yqsMsresI>JxM>;
zN8G6KDyZ=x1T<ZK>kv-77ma{1zc?x#C4V0u&h|4V(ELUMh1u#M5nqd|*y<F~jJ3c+
zt~<WYo7cQ&+)iV4>p-!ss9sg*tMS*Nc#p}Xqvgx+*4Ofxi1!;%eM}GmmIhxIV1)0n
zRQaQ&pv=rJb(Gkwigu@Bvd|Y$(CuH3rHaB!y*lxDa-&Ra#CA6QZ!}auD!hUR+1Sdf
zXinX4=ItkPMRxfH*kHrf0c9|^!J^T#I(brclYOgW@#c4)xk;f2I?pas&bEFlb;F1p
z2jacW^o%6o3SjFzbe;b|y`iYGE^Wcu9Fe{Ch^5B-0*8(wXw2?>*+tw+L<2k_T)ubo
zPX1ye&Cuocd^|YtRO+YCgtZT~CsNzazV`5!+#nVWG+LPIs#NHXxc-;$rj-~PLz2S6
zq^Gs3FuK<eH8Wb2cZ*-jraYNx^IsM`E!B%6Y}#I7_^yfgg`9_QUG*m;09uN>31l0B
z>{JYZx79e&3JTd6SOLF>^DYW^(?eLvKuR}BI$ygdx(qL+zJ$INS3mXZSN`qb<u+a9
zBb06<hm)+&^Em~Z2^uFlFH*c>D$r(Zs^Dq}(vf%lEG!k+v@u{YLgiQY-*Blao4E@e
zed^v{DGI=&!|6%?1m1(+>CxKPcCEa4uU_BXVd&gE&jAHne4e%OU`_jnY`aINkkh-M
zPL9&2K`57ty83(&u0LVS14&6bSU@<(x>}lh;5{)2q`cjF`N=x#7OO`Rbe7Tc3?O~q
zv7xG<qO!0~uh{6-@CRkTwXkTz(CBo<wZ41Av!Na%NuJX~Lt5Q<YFa49()CBD-`&Y`
zwEY%~sKDjBd0u;8I@&()f;4X<Uaa?gggVQD|0>X5Q>!J`ZfCD&TMhfjRHxX%Fz4&l
zYY)3u_>|6ie>Xh#vi}Lr`~1zs9wbKwB1nvFZMi$jXa&UmG+jgKxu|}X0?%pH<;G?U
z_vBj_RY+#<WNw=AzDik=qnT0AdWCK$Y3^(#8BP5g?LT!)N3%s<gC*sip*N6rXoAv^
zD;AaSn=#y;fXM3_)_np!l_?T8u1t4elsJF0uy}H|-dvX3mr4P)5@$C}Y8sXA4z8r6
z#>T`rXc5cdJQIeu(bs8bEAwIA`KN)>;9u>t-<3;M(CkQ~#M$NZVAct4{}KED8<#Dv
zuabObq~LUw1Eq)mIC${CO9z#_Oz=ukW*njEI1n7ayD*)>zuM5T*Yl3c$MZ<xnQ?cb
z;NaaEBi)|O*DQ>Hs9}1Hi+UZH_(m6uQGf4yX`QhXUn}M{^p6AvEU8MV`4=e!CVRcE
zgF=mH6m6~~J6Q2K(Z6DUMg;H3Cx{H&6|0GSUMi?D`ns9U_WRF|&=52$alEU_Vzp`d
zX?f8tnJE3L@0c4<#m`d^fkXZde5R+tu!p>NpWnbiTiI55$i$C#xV<4%XPA+t4vjhX
zF{lyN5AB{c^8Ey0Q;(}XQ@&sJ@nw#lj>+n86nNXTU+HLxC$u*bo^N(`oW6||(5ngG
zqvv*T;OU%k%^|8?K)gEVv5I>em%^8g%*(~gLAY&>r#hU@E1|^l6)>*1n!EmE0Mad>
zdO+U9%o~AvJ5)|=VHUP6xEIcD?cF|?RKTojuGkzR*G{Gf<*r%RodhEl1;IvjmO*_B
zTrw#hawa!ty`(*Qy`P-ez9TMn)V@vViA7%0)IQ&bvvmJ1z^P>7YG^wb4m&!WLa0ee
z#27NXQ|OWu;J=axc(F`_9V?*U-j{3&AJ%7@-cd4tI&TcB0on5o;(9a#<1SK{S}!|m
z=62WI?6U%1Z$Fg%$-fnaNLt11Ktzvd)uC=ROMF!+l>pnrjyt?vn%P4=4x3Yi>dX}(
zmN6^2b3ya>MuX7{2K?nXD~Z;5hV>KtHR=xnVqYn5>_6*tTAQ!`UJ`3GYS2M-6zq#q
ziP}Y20vdl+{9Ya>!;E5R$dA9hRrnl5NsY=SOueEdcI255aUfN$ggUqqNS^&1Nk)`7
z-o5S(m^__`@O~8fq-)}=bmP@WAN4_zgKTg4Y^?)a6)i6In7@fT65DUUQDF@b#Dx0@
zza(VH6}Xb>NhDkYA8ayy*Fp?z4^K5*T2~z(t$!;pwnk>??5;w%9z4&!gkU`8um`bH
z4$g^NtFH75kAPIKeUa5#EpV@a5XUkc?h4p=^jycpbutQ)L-fS$B$`&Fr#j8aR9&Ni
z_-^!pAF59UyixkgV@f020uxO5M?3pA^m?(*Ix~GX$F%h8ro01%xLtEbdE1+{AT{uJ
zFv@0Xww6DVwDK8V>Ko61*Lz&oOfuWUO)pKppRVz%JPd$Oq7!P09kfjTX2mY4xCSl$
zBEGdrN@}5sUrz2GIxz|T*6_s*(<t6e`ND@oS6!6DV3Q|3-j`cLpBP#7uI54meU<Gr
zBp1riKFi^D7%NYo?(oZYNuN{yw*?eiqU=Yk;j|CfREosa-_M3?ozm949m73DwM%{i
z4cgG{?=iyfzqrE#umkvBRU%cQ=C$THETCxH^xT;)utTIUgT1)-gdyPPC8C0O{wT?$
zYQc@3v$kId%bb@eOtbr33^-w?Y8E|Z?<yeH;b`}5j@YHWYxDaS#FLQxPLKLAFVKSj
zVljsm$0Ths{GE@u6&2ci%ykzgIDccdGY2!(X+!D6$N$CcjbDnwUdM#~B&>j$sR#)Z
z$t5rv2+;dlDNb$yGSulW5m@`qs6k9hmK?r4d;tq)tDfv6eUL!u6!#(B;+G2i<_C05
zxO$h2(z6V_&Kst`pFcE6@!*Iyji6}MH+SJ?F{Uh2n<%&62Pbc%%Rzc7xPoAprB8e>
z2CZ$_g`gg$I8HW%OX73y0QaM!HMxX#XL^YORbM-qQ(=bf8b-Iwjn{LH!y_aO<^Dtp
zd6|iWxp?UyWQtSj3|Ha(C*FRb^A;6tR?4#Ro^Gv~|0lYZua$%nimS*XKA0m1nobtJ
z<*;^R%$9V2xn}&}qKF9fEkAGy5Vbx*2?RNGYIqHakdb7R)-J~i5AqDKMOlijCtp>4
zID7l;fo~JLX>XO>gcU_!zOy*f_nwmRn%z7iQCEU(jCx*UmH{%T$>uYRHnDOj*_=x-
zt=Zf#=UQ>7tKC#z4e@uC8G+(pMT{#SvW;FTTeU(Nh`;!XINM?EWgQC~1X{e|UV{C}
zWLVwb1rfml2s)g;$9`;{X%KUIulXZ-C`Tq$n&ulaSaQeg#nPI?jn&~KqFm1xUb6I-
z@MnjbddLdfKs#TkU}m|2V<TnAv<<5|=0*}VHmlN!*{28D)8?rV3U!VztJd6%t;@fS
zi5Pej)B@~^Y2$<7`Rq<&IG6^=e)E8A4Xh@|oF&nnM88dHHT4GL{S+JuQy_bo9vJ`t
zQ2%%)yz^?AO_J8hGryVS!0@`pAy?mM(IFM9C2P$)Mrw8-!(!5pF5sq$G@29X7TO+c
zkG3Bg8PR9T`lqtq=pG4-eWW+S+$j2ni%G<-3G5?m@2dbm1LBWej*mYjGq6T901qSL
zJk|uPHqvuQcE3{Ct?rC7Fzb(#SIfZM!B?9l;7+aU*rdNNzDdW~C2<p8i~&ARAAe}k
z)j@v+)Fd2(N~!l|g6a9#;7M%>!QUi0(<HL37uzRO%m8nmPEQgGKLo_%%~@BovEYX-
z#90gNO4G!zmmNvY?naw}H~(<Gqu=<Cco(l3%~eV4yYHT<lb1!FqL&X%j=N2xL8#Zf
zn2_Iaf`{&x5{Vy*^k1YA)hiOhB%>eC5X++d$_nB<>sPt>)jD{Vt7?|1H}(NY3Dli#
z*8rld!WF4HUleA^r?{1_bzWmCjGp=+Fv=oB^Vl!UfKIb=V7AHi5aC@NqbV>x31(od
zOa7-}0#@Ii&!|E?9t5n0)K4h#eiab92JJm$drNp3nd&4yJOiGh{&%lM)bHB%83BCR
zaTkG|`k&i4tyER%5gFS`PgJ|bBrA@R?^GH3^|ErltV&-emGiEOEY&GNqRB?s*pino
zw1Om_hEn$bqGCkwFg}qglcH@m?<UVnj0F@&JW-)+dCJB%yLdPzi&J0JjC#c1-w@4y
zg?kO=5=d?$`e<LX8|j^H*(tV8A1$fsVgTS`>n`Uy2GZ<rQX{FLk4{WFXA*NIf;o7f
zIkOtkxR*qk<t>_z8PF<Ej^}Gosq5Dzr%O^O{a>^7Za9v>*GkIP1UEu2Go?69&RWb)
zh-NH14O-LPcsFkh*<r4Q?v&!d?r!)S;PEQknb5#Vtf6dGEXR?!q8B=wlat>Y#~kah
z0N{47C-xNsSyg6`O0I!DH%HqFP6L1HYZ)>O3z%1Go5<em2N}D~pI&Np>9Dyyq_T`2
z8u<dIu<+%WJ<6-6lMfYhp}4-na)s3d7}Zsp-0u1oSK0B%jFxa-0L99pvc$mDTmx@I
z$f)lUKMv`4dx4?@5`3X)`=V=oDkm6w>Lp;r=cYR72V9KEHgZmrSgV~|JPUWS$A>dh
z?L(;PR2wg^dLcj`!<6s6?+f?W2cPr>NnB8N>u5tyK4y}}?;<c)`d;rH=^k$Q>kp5e
zTiIJ7E_3lsNH!C0C1*lC!(!vsty$obEqi)CxCd{)Eg}3fe?}Qq_WaEC^n$U0j2Wv_
z7Jhp$4HJfl(#+z4+TIM_V)FxCSK9Z)N9e40;z#=*|4iS_nA*%{;l?U|^%rI&G#fe4
zf(P5S)<9K4c^5MXaX_xZ2T3vqCz^&!zYs%wCEZBL9mxB-j+t2s#%7l$;ng=eKipLN
zrn8Q{v29bHD8~#alzxfHX2(B4^oWX%!nc$V8uDmCi@Ud1Rfe-ZE|Mz2lEFYsY940i
z$5Z!!oX^rk`@9_OPF|Kp+qR6Rt5UbNiVPsTY-Dxie7Bx%#(|%kk0qydQ*D;fkTs<S
z$o^yRxp{IkrfD#$O0q6t2e!|Q%hLL@u_$C8lMHmWmt&}^yLr)<eixsyblq>GoBRgt
zI`dUia0_ngLKW6IU<)(9U~lP5otd;Te+t=Ve9d+|96%Ho7pT2t8d<W>a*aUM*hR5`
zTJV-V>XQd2I_#E*T*NAd<x|8UCY|ObcRNj2xCZ$~%*V0(ERFm`&;qE0@D7CA>N`Tl
z8yW~ugMD(}O-}Mc>={fclFO%X>sh=|q<VlCN#V__m)OsfHWf{1#JwA?ec`|K$XAbq
zUZq^W4L7Kc8F3YgoX~j#e3kLJ!HrXaar;SVmti`m&`*jmi1LgQw#w1ah;k|1*E4LW
z%QcGUC0AdhR%T-xdXXN-g3%Pfa#<-!DKxvFWQ`qi_6)F4q>1jDuL#J92$I`eA(Zc$
zs+X`dq7)mF+sA#Wn3?PPMeLoA@XF1{t6akNARMF%)<#!MeW28m5Ue+pLQ!1sUyNQU
z(PiV>7g8Q&LO-48Onz|({oxe6tSYyf>!b{FIiu=)GbhgEa5~bTQk7ZoiTp!)d8ueY
zl$Z<r#LiKQIrt1^;g@H;v@+yRv$u3@+{f0q%e<VTyel#goOr4TKUx1lNsAk#ELRE^
z(H|Yfxexit&^Vidr5jhhD$RO`BmnP02!EeE5kGuBB|lT^K!Q)mP_A=E-@OgmTcnBo
zZRvYtOhzWi(4bD|dN9L^-ETo3gkpUHBiwJa(o=U=?}3}#%jTu=?N($}`&u$H?J7(W
z<rUU-E`ieN^E}3CH5CIZabJO&Z(u^sLx0<$ojH+a4P3n^kt)caR-aKO{CCc;jO&{M
zeEzucQkG!e;5G}h?YP3I;w&MO*7eg@F7C1%6`$+x?MK~cco<47*970B_;K&6zi2S)
zJ6}Q=>-Ua`DoFFn_me3}kR^18Wp$h`JJOKNBqUc=avU=_$Y)|XfPmA`h^bZ+H~APB
z-X|5`wH+5J7K=<FI|O10BBFk1-55TOlU%7fh>MF3BSU(TZe<g*nO>?Fp?sG}(y5;T
z_Vh}PRhi+G**@@(!_y5;gPrigOatg-IB(f^OBuMDLTFk5njymJ^xxG!d);ds8DC9h
z5Pk=*9vMRez?YWb0WIi8H^64BEPC#x_{-$%C}9y878(_@AsFpm9el5jvO8_*e2sF`
zNN@?co;bYwA+0Hxz#B%btT_%Cu{I|(ypy{2LYbA=hY-(5z5_q1b`+&Lam*HMMKBnP
z%gDNXj&Dy`84HmJ(l}dL`x<0cu`F7);;5HVw_HCgeGW>hWwk0ER__3SeHt?ZOO!Ex
zx)GlIU?#x1Aj>|3zi-6}S<7DxwHYm~g{jTycL!PJQ=uv6I_#*R3KRD7!4b+|dYFOT
zu<e@@WiKDUN+-Th`;R0u7-(e6W$A~K^}rg7V9B3$Zq((YOf7o;)?slr8UWvPQ-Ab`
z0~6iYB9lIg$6`=C-fNKs(9rF<|84?2D}Q5*`s%W|VVaJ3>}96e&s_OTCUVK}4%&^0
zFPK&3&NH@SjoFA~9FY{cammk<)(I=jXnQ$0_J$eJ;u7e!#+|=h^Bp$6m$)&FnDnow
zqg$wZn7sq<_6J<IgqAvHMJ_j;I}%G&<b6$B`VFUSyfj<IBM6*F&=QH;x#a~3%()5J
ztJcp~D;7Ce(qVJ$u%x;%g;A!aSB>3Aw@v5jHAy<B50GHFeZO)>RsaHazetXDQZ)Tp
zn$`7S5qeG9Cr0X;ZO0&dU?z*wGM@UkJrrkl1NPafzsKSkJ_>8w`hy@Xcq-OkM}Go^
zulIIB3DNZ^1R(7RY$Ib11099!jA1d`3z58b_J|zWfXm-fE@BfXnS#j>K>t2mE=EF8
z19$kb$Vw34ibG>m>{<^zRl&*9%hJk79!-QQ+a9D|RgBU1j-PSbwfYeP@F`eb^^iZu
znqA1R1v25%l6IA;DmAUFV=rx)zY7eZ+l`24Ti<D*UtiZcDy5&kH7eOA>W_tLKN2#C
zUsjche^{4Lkv`oCD|nhLI*>h`ZPzrgZ;g!1Swhbs`h{tJE|6=pL$7cRpbc?<LPuTn
zJ_B$C0-ph2O<5-s>Kq)L4+?vM^kVR(uxuO##uuc={tPkagx_f2NYXzjkXD0XO1~PH
zZ+z!I1GnGhko$-?jn(6kKG8&E0dCxI!SmN2QNhKdmZwpL$dgz79we*zVhe^gDkK&!
zhkPj6s9P{R!qx;P`jCmyS<n)$Z&&J=%V1ad=f@e%J<s|Ym^MJ?4M(f>A!t3}>cXX-
zXu!Evsm0dqd!kJCyuVjyu>+|l%5!I<czOk6lrulA8HDGJMd_!3)uz81gxN5YKO;_E
zG*-E|ApW7;XAl3s=FA*gW?qvQW#=_yA~5U<mQJySeZ%eTw4A<B0z<{(Z`{|_2(F}>
zY**gGthysuh$Y*08%w?u3)jzCEkJ3)$ujM9hwmw>N;*}wX&Rk&p?Vp;VWvvYt4&V0
zKgA+0Vw;=+7exWs_Bo+NX=&HY=!RnVwl>@ys$8~+(XsCPmCMq##Z;~?(=_ZhP8pH)
z!YWJicQ`I=9{nXmbrN4KItWs%j73F&=kJ0(b*fIs@k4%FB{u}{FdQd*pJ?nMdu5K_
zp9FaF26nbW%hS~hZo_w0_vwy5S!BLQY%NBw<XedO(YwjgpdGoTBv`_Fl)x>05|iiP
zMPW2Z-|q==hl7#=5;p7G1^nC`r_8YBQ>iL1{`g-GUgi?)8Z-pcGjmoX_Zh!qtEc_x
zk0n(_HIIhh8#~a#RuAP4*b0c*yISNtDu0JT=C$)eiS8PieO*bZ`s3)Wr?FBP!o#wd
zj>a>90&p2f=}@_qwSVptB&%Js>zKlmn0u!)L1@H)$~1?{1{FLmGGu&C`FODhO&ikR
z_fYN>OVPzgSTD|SSQw+COx~K@`$oF=+RNw{`QV>()5X0~lnvCt`tuBU8|0MV6jpq?
z8rk@v%|0tI(#Cv*vP4ICVpL>8;$Yi_m4%ZDljL?24KKfmwvheiMr+Af0D<|Ia7R$8
z9nQ2j#u-!KmN9z%pOtF>(Jcj_>$g&C+>KDleK{Q^*;NnP_SF@P?Pt9+i4J-?lGgCj
zL{Zu75I5fSMIEaJbr>BBdp@0eU>IsXd++b`=xZ^roFCIMfNNUp1!Hi?lp9g|!UY45
ze09yLNo|O;6+|z2%rjs#(Z`<2eRTWOYeF)OJs|s=9YMC)BMonW&ydK(zQc5?mlZiE
z_yKsxH@^y@c41Z#2wI1s=-l1iSrdM(H~rVb)@;#+znlXruD+<MGzy5;Q7vB){EY?W
z8MAew`B3?;F0(NHr%E`c5TP6-FbnWKWiNh3^ySby3QJA}Em!cN|4wBYC<&5#jFlDf
ze(B5_H&cW7&85g-PcAxLIbQNbdwjV+5}LMvx}Lh%IPHLz|G@~Kl0mO~5#nn;D%?#4
zJTPt_O_jF^Qe?2(rsfS6ozDX&>Q5eZlB*Um)<CbXH<U7Cfq<8N08BvYd>TIx8Q@F7
zN9k36XItN1|8(*sW)R>V!@wxIi&-Bu_m3+5Z<dCr<5Ts>qWK3!mlDUfss;K6O8Cno
zH?M#<+IA_PSmXz$8E3dKiVsiC{9`0B4gvbhb;q}r#8R6ck>l$vd#hc!2hV^7t!tf`
zLxmrH>mJwUe*PYgt=V)<W&VDS`e!p+^TKPVYM~1&Y02$?E$*ez&A^J_KZqx(I}NOh
zp-R-rCe{(K+@bZu_QTTbRUKndrVaam%aLU-j67&(DRU|F7P5PO&P8mrk6TJD$-ipe
z&qZJDG8W$-PQVR>hx~N93z&Wetp7Bt*+~{@oodIC$nJN!pgY5CqC{2-apn?!KF~A@
z?Gfv;8WALPTW8V)l8f%tt^_<DAf;)C-{(s9Fb<T1|I1x6D&k4jDHk|$Q~p|%80uxs
zsW6m|^AhLHwYlj0l^xf^YrAW<%q3+>>g^w(<Vq(7kvp@Pu+a6)XFv^ol44(i%-}QN
z+i|`BGobqp@bnoJMlTuo-d3ECrYIl$b;y(KbxvqusDAu20DbN;Ci~be+BzrL&+r+r
zb!YJm2)BRgAN35O3f=blzej*4jrU<w%sT)Jl!n;7?p(12X~O9u&XgbcOJcQ!MoNfj
z!RxiNs{MjzK##yPz_Lh3?)2cxw&L|p9sEgsn(_&!<o<QriCZ+9<kC*9luYQqS~C{<
zlPGW8#jDb^?iZf{SF`>ct`^M+LK;<)z0C|{7RgZX`c2jT`u_|0tBtU)QbMXpAm>TF
zkoHtHaiKhPOpGbctMWiG?5c|&_)xZYr=4-GLbgQie}tg9nlywLJNy~Esq;^P-_WCN
z>(R7RAy2FJd1+DaZw@Vhqf&$hgpDob&w%q_o_|mFL#oF5O9sj(#h>Zk%V75z!1NdG
z)?(UC)5R9|(Ui2c={1`wF?EqrpLH&Xo1DrMyGnoV>KQ=jw4^gOAMIThjIPh?@0;wx
z{`c*Uoy|+~Sg&qsr#oe{|H)<=;TR;&D$y`z9eVVL^RMSCkFk>}IfU3uB~Qz9{&&xS
z;z_IvTKva`j()?mi`!h53+b&UEPzk<5Ve;9&HKigDu&vbom&n!lciN|NqsF=#gO$x
zwX{ch_`hK5k8$)aL#Kyc3kQZhw8@<V4(k6-Zyu8>E%ljBiR_bHw4at{dzq=snLD~4
zexu!bPG2&Ur>|+W+;h~UR_IHd<9t7->Iq;o*f_|YL=6kP<O>gRUA()~yF7meoT{BH
z>?_10Hf~3anI6;{AXw{MHJ?IJOzMYj3|OJji*&nBa)vM|t|s$;HIVohtCcwUU@VC=
zM_M!c^W5gX;%oa|)Mwj7>h`8D5Rn><?#j6+xfSySReyM0buC0!^}sd@Xgn5(H}(`k
zzHJW{)l5V&xgB~}?QlU}Hp&dnU4;$)4MpBTr2hNOlmMGUd%>06|1F<YMIrkf8?Kc&
z-Zp}L*%Dtq7i0a6TsaQ!bsRBe0&=M<zwqB2`#r%O*wi`!l2&ni&j1%EjIVc(Z2}?i
z>lcqH{BvtI>r(9h@WM*R`BA1_<iQ^8b}Ai>_J<!vxku)fhQVOJeQq2uNdYW!T{vrt
zTePq;jw^o=@kV;r`dbPm)tyh(-&W)`#$&2$frG2~tK)Ic?gPWlfBO%-ca{3c8ES5}
z$a$9U@bJ=$_((bnRt_Nu<oHXzTV)7%$T$^xc%uUUKjgi4Toc{CE<T8giW-zAH8ce&
zq7+dC0wN+J#0C)%qS8bJRH}d(MCl-k0t#ZV04idnMrolVqEsO?fzUe%LKsLg`HlPB
z-{*7B>wEUu`|NY>+2`Ir7JtmFnXI+G<$0b}2I=i#YHTMvE0#!C`p4~!3w4CkHfHz7
zB^mJ<e&hiOcpHK0ppsws-ABn|ZZ<equj#P;56_;APMa6N-MTdwACEX@VP29DYfo_E
zUj5Wz8z_F0`3U!R0t%9gEMGS}BzQ1fz$xaS$DC^ECT4q&MuDJF&J~7*;O@^Vat;w|
z1yFpi(@|fWCEz+;`=)T;_z2yaXL29ID$U&vo60&EuX%qe<ouEhFGT&464xAAj)pwP
zk1_Znnta`?H+Y8hjtYDh%l#=BSFt3_**SscH4qKJpGviEDTq?@oReE{x{vQa=(G}~
zH>0@_pDIzdqMbT~?`|9<$I6AGwnHu|6SIvw9?W@Koh{P1_HYlD_kG|=zJ=VOR57*=
z=vjQe?Kt&{f?Lzsh->ex0$r0hD%0`Zom)&TzYi7COIxN+|L}6X7tl1~sTpc>Gyt7O
z_&$aC&^(iyy#q;Xx7)C?WYak8X~Vm#>q>UKCs(2Kl4p=e*SFMntRifWuA1AaoX6kT
z5a9XA#?@D`FZ43+&yrzEZJGCxqI?MR`b7Hx=v1B+@ae|qiG<)+YmBS{Zh_+LeGE*L
zda2b-gZy{fsj@}JGEJL8uTvH8?fV8g5O#4=4K_m6HB@O020Glar1Sl|o+|g|LVFW=
zJA;J=)~83CSK@#2lsqd_sflL`Mlkm|9ZRK+S!0T~lHc7&eAKHCi6XU&ugcSe^BZ<8
z72CHT$Asyx7<6d&4Rv<P25kt6iQt#Kdok=|rPPg^hawh9lkKq7JWD3kzkmze<y+oU
zB8DmQ4fa^%0`dKrP2_As1u^gFr)$Z!$svvj$A-^6%6#*tMp!5bQ1!pUr@%}{jS;K7
z-Bex|DF5tH`Mgm!&sM|Il%IXLyn){IAp5dzuwTmBedad<^}1Z2-t~<y4z&p!5$D`1
z;)MM2EVJ5LO2{dv9WrUSvsXPPs~xu0`nAIinEcu5-qL=NOCE*-!)Lx9tvFCGYK(~k
zKy8XxsiT|k(2jy>iN>g_T02f$ll9Kcx>Whp*>FoZ?}SRFn!0CZD05-noAdnG4b)eG
zJE7Qvin}PUQ@H@77(WyA=5t#=#QW9NTOO<#$DKU4T-ASj_3SCc)em7DA3qq5r>$7s
zSGvd{zq=4N$pzGZ<Qt-6(YeI1VD;Al^)?KbLWwx_svhMj#cwJLpTiaVZhRWv(&8$-
z!eF=#?aE@{hNSa{XHStW-W-2^)1_DPSZ)aa_Uj8{lpKycQ=5}oAjM}z?~JDjx@S%M
zAwxhpwq$Y4Oi$wYii@M~SXj^XkYRFqeIki1sK}H#xrV*JLW++$R~XMxPe+YnOk33p
zRm{sy|1b)#H9r2e()8O?M+GNFuh#1Yt&nFSs7^}u2$Hxw3AL>~Wsg9VjoL_MK(c*j
z=su~9Yq)^qS+jqE>@%JN5twTuuID?k*c>i^;NLjHb8K}gNA69Xky@I*xqBnumCT{u
z@I&nK!k;;hG#zT@y)}i%*d({D$2M*KF11y&ei+{wo{PMW!HM^UWQsaU*SJP^jqQYc
zIt6x*vyvO1WxaPt!%`V6!Ih(E2xsbe1IO~Wt>gj?2qVCXpV`go+DrR5r>s&^QUo5%
zo4Cg7Tc@&Ghd>@UbM%!4TStr+y&%~c2oB!jg*QHDZI5I>pbw8UUFVeKfD5+(a1R<)
zV4+zP_{dM^XR7lJSATis!*4EqtUp8M?du>$R!J#iXKraYvG^NGV=tXZAJ)6Kb(pQq
zG4Dc*eGqii*YWQvmsSmme#iv`)9gQ;d9X~nr;LO?TM)}s?AS9xp+GlWo}K33NA-RF
zG>D(hH>kwBqFQwCM}}biu0^9z)OqSf&vNmfqvox8WQ`h%%f1gLHe{*Fg}B7tIf_FE
z$Fdd~o<>fj%vuwA*XE~O;Ip?ariuMM2D#kIiF&}Ug>Lu<askh2Qxb>L!nct6+D=t7
z@+{{$J<}x8`{8ov(&TJPuG5DeJF{!i){0k6$Iy?Zhtua!SKxOth@GzzYW?yvIw;lo
zlDQ+<?@Myl{K^6F_ik`7Wgzziw4JT1%A?9d^?m1j&#b<e(SR5_b1Lv1`Q7|3OFq75
z`q}c9PWOXfMU4A`=bDjLwQ-_eu?Du@`bgD&&L&O%`i;wknxyW%>;t{`P1zCJFDq9E
zQULhuiy-GBzsCaI_0q(|>#hclp%t|9GgB(7!x*{+rt4_}w)*Kf{4%8zvsnIy2<=jz
zIS|O!M&jwztQQwZ65?T}oZpyGcPRWo+`wgE)e+P5uB)W4s)6UwZ5~sKHpl53(wJ|Y
z$gCsx@Zp2+K%Xt%wg3S)+?JpY?Q)$lSu-0!t2BDbAi3Xcrm_x)V3JaM8;{V>(+?)_
z=W4vm^$r(1^DOQ9Jx;drRCU#<NoKNvXh&8_SwPE=UaSO4*-}IJOS-(mV)JqMy(eWb
zbs*Pw2JKo5`6(Q}Vb-}6QWI}2+8aOQZh+7|><oriB!X7dX6gO^d!Ev)T>91Fz+r!i
z@Rg<&u{9qC>cuAU9d{7N(!^Zaz0no&N<i#dv-}tS>jTnHAUq*qXE(Y!7RA~+jb{@P
z3j0VDC-8NeUwG@@3h8v$oc#+cqlMyUUn;dLM1|atbmg7!$1PnY(k;NQOwC7-@10oi
zv$u^NL1*z7Vs~+()9#R~Nl&haYL_|rOt!%xm`C64n<}_(+aiBKNQzgQ*j8AIOP}r+
z>X2*GGrwHqAExtYYl76P`x~89b?@N6S0RnnqFizY_Yov%`G|9Ry4!<vgZFsk`T;KB
zc*}ZtHZUt>yo?A3_60<oPh?Ofh$j`rX4^tA52G~0A4+^Mm|qgk89MM)S~%ADz{lIY
zH)RA)h0_W~V11R<EG`gng;2|zRZV2ScSm}BT8Ay@&QuB7s8tX7Y$<prb$>dr&YUN{
zj5%9<rweg@lZ-^=FBQ^Dq)19JW*@$z1{pT6i?Bx?@`&XE--8f3G8%^DudRq*aDj=Z
zXtwmfjO1VWAASF9h4-)gn}&b3!uwag+xgE{c>l^LSpL}x@9$?K7v|$Ag7T0y{b4Op
z*txye8q4p76Hh(&ZopM%%@6;Zmrf^K{V`pbJ83BW(uA-HtX}W|SLKs2&?zL$R3?y6
z8$tdon(hJVFR?JLg>T+o7}|}<%Z64YQtqAS0<@z<HtBt8C7y0;uUO}x(Gn~}+_=X>
z;{5lS#nx-Vh6x+u`Wm)!h!^a8{awYx>NJ#imqnu4A2}q-V5T@Ylg79jto#WI(usOH
zX<bb0ec93Z`O@esy!w~@4{r^qzn}AND|d*2`5!#jdYvDPE;-f+%#_O>RsJ**#sV66
zi;mv9%)9&|`c2kA_f(Nc&oiQOv-{1>-j&KXNJ4MLb_5B_L_=qo1DsD+k<^2N4#U*J
z$>3lA2Oxs^en9<{IM_|eH)wb|)_)6j?V)t{lFI`CR!=lr=#PD;&YD(X&{?%!Vb27h
zG~oyBXKGWVi8*Qy&BrA!f@>`0G}c*+>dgKq^o||$Nk<v~Q#iyQHf)m;DW2*pTIw-G
zrt%fcsw%ZZdx1QQkcnMk3~#vB!jub`ARw%w^nzka8B88n0}B&c@C94RgOr%n?a&>Q
z0(#tB)|Tw^eLZ0%(ab7^hqvB+_*7*fQ+bK9|JdiX0O1<-b+7;zNN62IvBb5!II7{4
z?0CpeeFotVN9xqslGA8*nr)yWThO1WLZ8dOIJ8BAR%+c7{=|37=&Nd62eI+lkD3SN
z)H3HoHb&KJP}fWVf+T_*mnb9iXOJeUaDk)esiRhew|{aG09`0_EEk9zpci1AP~j=;
zycM#w_~8kEn}gT)+?#dc=K=+jn;PbJNH48C-~#KKrs-ICjKZnGrGu5*%jLO%8+#vg
zoBnp}d_%hX{+@4nx#OQZWcPl=Gf$hJAQ~%{-9%`d=pj-ihLyqvmbV$AL$o;`37^pm
zSMYoYy`(S0_l@y2w?I#H9v?d;xpIKDtyG^2yb@^PYkhRe1Q7afF5n-xnEb6ip|Ug%
zZ^-8YidI8dmOvqzb6_%YWec8!p_>p_bV=L6uCUi!V6y&1I%;Zbv=SmJ9ASQ8q<$ds
zVmJJ%#u!C8dkOd3wb#5$Xm}%vApr|edWNXgqT6Q*8Rb#0-PWC>8MLm+SyTmk5cB%r
zml^%#WP~@4`$CFbz#9(_sW8qA`qzjNgo2&u*qX=PiNQJ~x7A0Lfu#bLaT?c~q-DO`
ziX*fmj&fsX^bjUguwq)_hI(|Gl%-W-_<f_bzH5;{t+0jr5MNo*R=-1G$_E5-fn&0y
zAp;5-)y)fAm=Df#BKxJeK--4Pyc1uPUW9D=Z!VZW&Qt%*2AsfjlbMN71WPqw?&lD?
z`j}65q4}(`hqP6POi-l3H@z0i8r2&$#`EM8QZ<fx-u2CoPV!BQvJK8Ki?{$0#Rm?)
zALjxO-Itc(jb$urwk0Q<%{w$N7>tcL9y)K_DVtj)ZdIDZc>L<N)1jJ#ujZcmMv{J{
zkx<Gj5Ry}8C!it+m>Rv{q+APMC53*Dv~uV>7sx$xoC~xjYp?jen#`Zp&3X3V%2|tB
z*M$q5?+NLB-FD-a#!b?9Jfw<ar%i!fZ!*A%#uPS{j$+3<Ac^5aVLTjv92i%>`o5sI
zH%@nTSLj$LF8uP-iwVaXtWWD3trh2-;FJ>N!Kx0<BhblfhnafXjUH5#)-+jBm1=vc
z?VXFuqPoI53i|lUuTS|v9$a8kKC=vZNP{jd<ft#XP}TPC4VStovUryZI4e9EW-6Ip
zVZ?7^AMpqp1aFs1oIiLoSdj!hW6FS`?dKxQl<xF46{eNv7)oRCy%96F5ldvy{oxuf
z6gat7n{7&E(pWNJ!<%3!r1KKh1FJ?`fLmfFLMM6tn+x9`3Gd&Y8~EUj>hyNnd@Z)e
z)PX)<L)z;0OtEc{ZqFI94lI1<e{JU%{ABC9w+Y!wzGhO!jxzhCrWaNz4&Y!6X2I7%
z0T~JYQ(U0^-V;M~8HHX4=DBjVqt<bO!2~3J<8ax*2GA*bBTYZ9^9jAass|gEqn;ty
zSNY1O)>X3Y?d;a+?XO+<>#zq%hDeAc#{YG9;V2<_q!w)G&*DU<;NaL#q;DXAsOTkH
zGmHNm!fY1PQQag+ja=<DGam_}2&z4`kxOOD)5ayfk{b)UkI<74q-dM1V8(ahXtkgX
znr=-DAE2kfpLL7MyhNYe989yWwvWHO!hSK<be%XCId>u!)75+t-%th!{}029&i_=r
zxJsy`6r#hqfKz;|E~$nnG(qhd&3sO4%n?>ASdQCi<62zsaqEc;++~pw=@t3@5KP{2
z6^0Is_NIHoQPe03U9Oo6+(Uc?^$9wNkc#P=0ce{m7pPa_9VGobW|u|GUU6QHI_v7;
zlm0rjO8iKObh>6AdK#bF&%*^COji?`BDqL5nlwcBMbvt&>1Jag$D!s39o7+P#a6Gy
zB$o-|)!Rd;nUfzb1cqwjtNfl{yqSUTn+&{bv99B3n_aUYy|qzL*w=t|dp(7+3DyD!
z)49MF3Jpi-LT}ePaB1P)lK#o*&c{29MLxs?RPrsKwsDG=TK{#c67R71|1>0`{=2SG
z5o`rrf6jJ*t`A|trFTA?>pjjeAns4~*N%DRzkBm^VXTG1jr41}B1fg`LNIrgRaOZI
z@m3}@VivX7h6r-sOXdP!QZTeH#JpzC7K{Lf?wG*^7BWLHkH!Cv%KH%P!Y}yr_;aEH
z72&Y!_%!K%ZE$=iZdQ~FtnGs&SQgMKI<jAns%LZYjZvoUq>9J`f9EZqLR&r^RnZTt
zo<GzyOp)5VE}#gZkZWBzkG1S=8_yLoOyeEg`6J&u+Guat`#j*hZaDApwV|d5WQNNC
z0vY%7CBip9LLN-C6#EcFb{B2Po=gth()+q%yIWgKqz+gx=_|wcUY;q;5yds33+87^
z=;O>>`p)EPE)b=on~|85_NF%5?#JbY>UBL>q0`mmVETE*qy|k-`=|G}9#!In5=gVv
zOk^A$o`w!_flE3Ol*LeSNC%dD!&2n}E$s|mF0ft~&jpm-msDt!+gkBqNEnrB(|Zk5
z#)ePOiypeZ>~0MBysTm5xT#v=c<ZanZNi4<-YO}k^F{-+N-v^;|L*dqa{P(HgKCLy
zns1Lr+dR1^eD;Q!VhBJ=*0W=I!VL}^OK)Ln(89r5<b6(N!fAuw#Wqa6Q(N16&i_nv
zA#lsWB={ntbt{c2mu4+5ZXws&ONm9E^pr0yI#0AtS$k5yq4t)^-~c*6VrWl-_Iv~^
z+g56xnbgfJ+r^aV;&nV^UN!eTWNPE*^sPnF-#WF^(ACBEou5bpc5W#iu@>4LqazJo
zUTe)7^%6c?Z8MxY7oyUDp&?%Bie6PN-^c~3Vl279@FLG_0WJ!xHiw%qi&nvcTp&y&
z4M}Q~47d%<f7c`*Geitc>kY{slG1y)xF!%_zEu%5VyH*xow=lq*?gtQw(Q9PQ4!H?
zeKlAXLsNa)w%uY&f%^4p(?X|q`}@mUSsgV~paYT#m)9IusiFMdfF&|*;2wT08~?5s
z@~^@R=&9vQQB&dOi&^g0IR7&@FSlWmH=oWg`flwQaxMK~g%;1$*<TQWdo(>DZNLZF
z;Xct3KZRwXGsikqyLNs{gvrhx-uwbPHp(SA`|Lb+K<1j!yLiYA?5>BSNueP9MLPxJ
z06`wY;|8iwEj_*>@KK=7y<jg|^VWgJO?~z5*;hJ~G)uSISex9tc`8~{9;mpGD6c0z
z_IC^)BH+W5IZwffx4$&QCN(51;#>HNS{-&GNm-qB0Ev7nL;(uf`f~wvwkW>9b!Np`
zCVY7ayyG!)dFZi1xlDU&thZc)L`eIc!eM7$eX(Qmp-Q~nmr2|I<khWz^44^e$BR;P
zSRBv1&IMj%4-(l*1@kb*l&wXX8Ah-YSBZg6xec%hA^JtpKh?JfyF)sIz0e{>6#7}M
zD>d`M)LW`3<DE^<3A%Y&!dnaFT+_;)iVMSc&Lc|n&)&gM|KlKgT&74FYz#=4R1MZ=
z@KqIOe2utb?3`nB{#bpBs`oy{2_@d|6E8_}AF(@vPeac11$TE44V4_Ge<i=2znW5)
z<#D0?ozwb#Q6q<GW<X+-hNhv^58)v^y^Rax$8&`7Yq<c;BnxD$&d(ai1fWjR9|pkH
zH7O>|;oA?ocwCWy6xyv1h$Y~3j*kiC7UzBX5hiozvlb8a)Suen{d6T4*ak}n8{eDq
z0s>x|Ftq$sV|-Q(o_i5KXoWo5F5!PIEHv$T?o&yh^sP<Nf9lVF@rbkl^I^U!Ecy!e
z1teP6FUgR8E~$2dnPQpac1yP^_HEma!Ne{Z*OTXB*HrimPZR*B9QHBfnbD9SJ^Z>W
zL$f}GFT%6S$<|@u2-(T;pa?Ct_ZIU~=}~n^i8O=LZtfNw%6x=A&{!FOAi+Q#c_TCy
zV$kuTltgQ;N8cfeI{HJ7!xpHTZvwl{74%NHKHGb!VH5fB9nPrm)Fa@OiO@e%c>Xxu
zmzl4;8;SIzW_kdhw<YNb<!ZBNe}E|SER;25e~?}BQEwmUwKin1UTwssTM|7le|$&K
zZ9{Yuc9zAu3AHn08J#(U__b4Hajz<l+?cuDA#<C}j_39!#NG7yY?P>Q!FI>vnIk>N
z=M|`9iNZ_785@=cX4a8WPNl`JK20%5_PTgIdy4u&u0hYw`kSQFk(`D31e=$JcC!AS
z)sAk!ibff3aG;J7h3C=paz*?$Z1wBv(KnZ;$CUT&U%qxHDRfM7HbrzUr~U2yifyY%
z5U=C=wOJy-m1$1*yv>lO4Mh6tI~sp4)NUnt6voTWT_{cxQ;a^6uz_YB*D1!ce(%|^
zl~jN9BP|||U+{V8+e<<Vo^C-A3wCH37NJ8C6+L(Jdm;vycApcU7vJ&Y@ly8j*=*Pc
zT-{7vP{fyE@(c>S--4A2<p<rCw~N}#jo0|y-wkhg^&#(51yke1_>?={He{2^G^LBo
zw89i}fm#c5+I<FwEeCe5ZfPPj+b?onQf8L-7s0qhX3SMjmgQ`3)Ba(%Ces|an@G2e
zmxez-lV~sX>z6NNfMN5b@U)#HA|%J_?%r~mHM_`eyLc4NUXXISu*2hk>L&n7rZv~1
zBJms879PXs@Mkg<`W)%Xmqu?#P1Dldd`@qccg8;WX)2eumv&ncx0KCNA+$%atl%%Y
z5%Gl^o)<Et(;Q#BNy`-7iR^^?d#@*HE2>B`ijTic%Xp&U=fnl1I#|C}TCaD`*;Nn=
z_`*l-rv@y3(^wUn$<q^mbc5UxT8A0b;(@UEU<4!8e=Ry0?BD{F94;`K1edQTm4k!H
zzqTr&H-iJ6Twt*gG(>kv37s-T*EO?+>|iWzD2o$@Nb1FV{pGt!g_OY;0}Fu^Va$w*
z7ou|fmKYWQ0U5|jXXM?Jzm(4<Y2<|&J#mENxW#X*pkM3fguQSF7uc~#j56S%mTG6Z
zbrQt#TKlCg4K1kL(J!n0{<Xr$RrjijZiqSW{eTJVcti~zQZSw6r#I7<qsrx{3A^de
zb!jwvggx7qgm+G#bdQp09}J2Tky#CteUPLfq^Z=TVK^3oQC50U9?5yk1zbqta0h-{
zCgeP*W^CTBt>n`fXO-D8lA_|hrKDCu>9TCv@<Zjpt93jh*A3B!sF`d#gigM#hii$O
zz{%(;3Kn6Zm;!`_!ib2i_-4)p5(}x&FuY-ubredqE&Bd07&rKMIKs5mhq?X7lx%FV
zXR3$mZV8_;3EN}mNC%aV8Xg3A8Pd_5T@V-1rfbWgQI;-yCzY@ds;?mkQrfgoxiK-f
zG{#oV$t;iW`=dtRb?&XZt}tb{$Kd4khauqp%fO5BPn<^>M{E?jkb{7;7Q&VTiy|`2
zXptVfigmwJ_o>DNw!Pg@-t2YFZ2hhuAJtFAGFis3<V)5Ggf9*Z;@O+OQ&#K@r4doL
z?leLyBkALuNNFkLrVHttGDi;y&jPph%Uqyf?7^!(jnX2A4J|pZoElEI-kdl-!W(KT
zwuZ8I0(e1jHxNTCDOre#;sP7=<Qc}tp`3LY%`sYAbk4_Her%CwB<qG1_)D9g&skB+
zC;S-NRwCA;iyNWTlEPqRNR1(1gXY)s5W4Q}AX(~ePTCn$t;jQ+w9DE0@@QPrk)1}$
z)iTmbyo(rkV=K!C8L`3TS`><{$ml0~X9pi*?CjG$84A0kvc!i*lMd`rOIv6?tRU+g
zxlOvx71-Ob$`A8LZ~=L86_K^h9lfgCL*b{TxVydlNcOvT?y;`!Q;oc*p{Pr!<D4R-
z&n;I_*;gp*d~FOk^AUyo;j>>!SL#<<_=a|ZW&`WMQGQzzCmKe=r9FoO?$_oh1`Bh6
zM`~9nOcjX21uV&nJnSy&Ocr~a>yQpxo(o8q;^_Tj_DS#_I`k<@b9vq;%D8SH7dWr@
z(W{CgK0P_mRgKhCj_)DTh;dHIpNsC`i}Fez9@yym#^uXsd|ve-bX5qZ@Mjw(L>ER#
z{c#wW;9Y8jH<Td?+>Qix#k~P1390x%#0sZC&jA6pKzQ#Uw(^HzR{#Z9VE4@xcbfvf
z>OOufS_yS%k0+pt506&Wh-*{Hs>IVx=2vuo1i>{Ph#Q+P_CPph5rZ>c!v%U=hg{?K
zjA^QkNBM5>uqlpF*=>>Y0&#ecp*V08K$n=F{$aUr%k=ceq`A4NqbWDX{Ss`Pyg#M=
zh;ngJNH9}K$+p!!`tbF1PhnET%igjd@XPDM8Sl2mmgYCn<V~a+H39u^gmP#a-q6eN
zt{m7f&kk}M)>p?dq!Y8uUjKmn_z#{sXM}#Dx_>#`c<hVNUc(EqhX4)D`#dYC^y$^{
zu)<W#wgC5&#chT523F77m|t8&hc=#>E4?AR`JKMeHxNgmTVQ(y&vIT9L<c4e44&*{
z41|6axT3R3cx#610k8c2t0&Ws9oO<+C*cqD-MnqOV1s`{p_|T&^g$rAEW+rX#RrI3
zU7Sf&b$z*Gjl-Mz<>Z-qzLp35A(*$T|FFXT;{r|$IQYW4&7M$86uuNQzvsc`2u|1g
zK|hWVwa1DE7R-n4F;E~h4Qvlax$xUh!8<x+3av&`pL@;&_0JQ}qOSn3)b!FkydnRl
zmlx|yKvMr{-X8&?Cyzx<+4yeJ{t^#udI;f0cHWX@DFpi_Gp}*dOLsEtTQl1WrZbB=
zo}Wm1Xi;jsuBpY~=POUASRW0!@n`_PO&QEbFSrG|a_*(L!U=fXLOZ?_WD7;mC~+7!
zO1GoY2MCn~Ryk_Jl#FRV%Ef2GW(8vf#kEy>ZAW7xzMZ%*GB?>tLDVU&mkSh8Iop32
za{*o?UBSoGQ6&^d?23ubED}N&r4T%@5ceR6;TBEkri1adn2-VbiTEDgDo|7pqZ6U+
z-mP7Bl;3SM+&aict8qt?;e`Yfpw#lCB1Zj$Bc^E<Ae15zAOem|m6{<~BZ7$XEGZ3&
zHD&M}!&Gs`YRL84#(1k%8|-tP2k${S6T;~~tByme6BnGNcXNRc&ted`YCXxfa0*Yx
z(@oV^*0Dh@kn3-OBuQU!wh5`11j#3}LtzXT=qkzN0u#D%06~sAfT1JNv|<n+j+vhZ
zSDh)O+u8F(2qDC5qG>gHd5OZ&7-->R^8K2aW#l6XSOiJH9nc$O80<ifJed^jKI;W3
zk=f5kwOH0BWaK8L%7V`rq6Z2o?4VkB2+{d;Oiw#(fgeV5A`K9g((YUvH2PO=0-!+Q
z>aV>;?#NFSA(<-o&{;0fma5E7BXz1n@_2R{g4LX;o-FuL_es7b?O$yhUuFv{!Y6P;
zII0oymVP4s^G*;C($5lC_Ti)O_6Uc=2HpZ?9`UfMkyjr?a58mho)a*ES=C@to)^P6
zF@q791<hc4E<ln(Y9Do=F6tPfztpouRA9>`%*@#~%A)f(f)#Fx^v6pl`Iz%8B!M=(
zWlR2=L$1cJdXh<F7<f~vxZ><LhEO_haG>D+L&TY&ZNxT87OEQ!Ti^x}6mt+q8tYpI
zYGCMRf7!t+5?pHh)dBrPfDnY6#j!=ub8MtJxz^KM;OaEPnsS9Qm<zmy1m5j64fCwz
zgMTRTB3EC{hf)^8a&T}hD2mvi6Q-n!!w<_hae*%)g?N@Q8;>}R-6{ZIb^AOo@$Nyc
z^=UC1%MJ3+`ErGNlz3T0XdPpVfhv0&UA^W$ZImH$J8R&)BjouijL<?nn;J;Gj;~$^
zTH)!(P>}=l$8bY7O(M$wJS1;VX<s9lBtmxfdf~Nf-gi6(9@FK)f5`y|pTJ5{%E+|u
zJZoE_I!C?TeSuoHpjWO%9lbwFJX_{s@apRbbqdGc76e<89e%AsAa35q*-ud|bwyAx
zyae&FL(Lq?MINN<c_;RrCw%7ue9xa4%LmL?-#pVYd@6*>9Jndu-QB!4`;$Uk>+K1v
z+iM9{?BnofaKV?z2hIf1$Kj_kq}eJfb&2$;FNW;PywG}53kdCem<RW9fvt~x0+vQG
z*cta>c5NV)eUS8*MW%T^aIkHh3*671B6ShrjTx*Xgl1wv{au4S0dw=!Hzoqbr$Q%v
zSSy*IFjw2(=Qwu7dx#VJPkd_Jya%hV#JgM<t(3mzA1J6lIfBm%4I-c)N@z+(=M!gT
zhqj1ReeH$pYHpN&qEW4CFis_x+Uzn9pq(F=+IfGJIjXm}xyFh^gnPie_y~$S=B}s#
z>f_$-fYjsaw`gUj5hs%-mt4E_AViHB6td>{`s)iH*S$Q2uUCxKlO4hX0a;dbT&&MZ
zL7A6Hal)6?rt49%De~cbxl$dsl`BFwuHDYVvO*#$okLEp>WRymDPbJv0-g`vSeoAT
z8V^>>82M^buzcy7+{YWXyll<wPgi2dt9wX;;s+JNO;SXh9_&EKjK+r%0aKYf_zogl
z(45(W?ZH%l^c;dr{~ZRp%J22Aq@ycKX$SX41!y*;Xjtvx^HWh|+)qba!hQIK%Xm>F
z0>6WcHl(3EN+G5<2DacI8s|i(#KSS#Z0nPJ)6EFAfi1IZh)mflnAPj;DvR|nKku-b
zpb;m*nO-*g)$KJzv~TyA@gSr28(kioa^0BLD}S!SrH)sZw{bHU*z2&F!3FNYl2;Pk
ziKt++YzTikWqo17&!go;?8hK~XTPWnazJ0**XUZaO69E@>ojZ2bs6ON!fn~me2p$C
zaz62ROpYzneX{Cd!rF%=MVj-5k~xF{uu}4p_e;1%lV?FaVzE%MCGW}+RJ|LiMjVdC
z3?edq^E~?yYcKmOL<Bd6={c)*COK0^3*X1M>#oG~dJ(-fz|x48lYBpk|CN#mBp^>R
z=0#aC?Cc6I;Er9<24g{{3`9imFIjj#>95=s;$a`APK&a)kzmUn1VU?O&v1d`SF;!V
zDCa1Hao~a<l?yNxuMk(yI2)qBcl>G@ap1RfoyfU`^zSq{QcKu*%LmQTpIl;xp5&WH
zu?5EAqh2wTrQvi0%o=;(@adIbdxMeu`}rHgA1*~Iiv{6ZegL2f`nN@1EBxEvSAMOK
zc2FxoNQp9Yi%w;FLf2_T!GL-3@rY9N^GRxtM^W<YZ@Lb)=c<K1gxh&3CHkn8eC;L<
z)oZio;dU;7XbakNf<DwdyvepKjuJ`gm{l8<X%tR-x38yHHPsBS`8iByR>8Ar;||ig
z7a{ttgSaXW@8RUyflch)^o2v`p_tR*oo2%3{6XjEK7PCkZWf4mP?kiorwo#<={*pI
zwlk;rZnPBII!?&P$|ffS9U?q7KsTfG=nRfm4Mg$M$g!nr?v6uP@e{><X~WtHW{Mgo
zrbi~*>*Y0!h1xEt-oN`}SEcfY>a1UL&DRj8@q-YnT*z_c0;YB+`Dj*uhj3^c9M*rM
zGN~^}BeNCId0@1`E<2O*;VJ{|wwzrT3`UbkuGikztloOjzpkEjmS+_q9&0V3IL-rx
zdp(ig)43NFrFB5t-Pf`5Q=7}em)G!56Th#wjs!0XL#cRsxRSDsLbHacn9Xc+)pDzx
zrhMsmKeMV0+F|Y@2s$`#rg5Uj3xlH!(eHm#2JAcrk$q2mo^y8|v*=Bo^7<PfW`>xD
zW~aGU4zQ%z2sy~wpt7pPc}p40EEnP=mG3#v-qpe8f9<|3!rY%+x6lKt1bi+&UFoNH
z^~T4M@f7$57jVL?=r-S>F!dpCWQ+uGokThgT+z$H!WH5eIQj~}s)x~c2GOfK1MA@}
z7r4N%_7r9<q7mOaY=+tyj#UGjt`elKq}bO-YwswSnBVpNV$uQe^R#XenRA<c*5ZEh
z;B5(2n1ujvBRJzy02lCZUj4(9cfXxBgwDX5)EKElrWN>ZL_!UTR^^<#T+9|PPrZ`t
z($haL(09z*WMR%RN%P~@j2nlx8KQluBPg~oiizm)unw9V;ShW8hk;?r79{FxnwoxK
zZsxe%-%L*rUbg<CiDsBdJFZ06yj+lgrIT4cV5=#XEigf0-@)gh>Bk3p{D=K#cfSZW
zDTSJcWQR5uNaXBN(+`VFOHN2O^Ksr$5Gufmbzjbpy&n5C1XQz{AZ{#If=UL-HTHZ%
z;BC*i%t9Kgp!oK^;7>xqdB#d>J)<u-n#zqh?}+|&v@A3mZtMXoC~-*U5(t)XDS9RZ
zMJkq^ljFIR-|_r{m#m4T!i}3z8e5<ETk)LaSwS*W7pA^Bnji%s#C9#6L9X@MRPHmd
z9ooLY5WMCRdS;tV`i%nvYrilI4)kSG;-fiPoLGW<W6rN##-N*5xajGEc$zzZ&hfr|
ztfZdW>^%stb+T}if9ijKl{!=l1d3MU!_eE{eeUf6jx;cWRBDlJ*Q38!loIT4^^J$b
zE05h`Xr-Im%$6=XOp4A(u`XH2)etuZALEx?!+b8vaJj%Y<UWIe<eJ%OxG2obVFV9{
zGjU6NhUiA}%nH)zaA;-tTVNC7ZdXhO(VOL8C7-(WLZZxJOy-7TsFL`(=Pp3p&%L|v
z2a_l9tyyeY=^c;<{nBuS1AlJ3Mav=@)pxF|r@rmLCGs^5tm@YrO<&D5w|_NLAX>e*
ztH&=WKzHCu9A$Oq1TUoeC#Zwx#r>u+(or*i*_$=&iuf8AP|RkWfvXVSwQA~xM<nC`
z{gl^=K0cbr6ec6ldMFUe48c&`L1;OKQwv)Sf`wV^6iOY2B@m3|0-24`%Z>l`Jph(<
zUy6Y@AZVlLfk>iDeu#9**l)FR2>%XGKT26Sgs2RbU?G;XJ1-qIb>&yPn&%;9Ec-F3
zhV=dpk_yTUDEE)U<w&Hy!7N;&Y%ecH!Os>~VIzd-MZg=7XqVTi9av?wfQ!zvps_D|
z0j%5#j<`Tbc5%=}!Lene3C};-4)T`N@y88CZ_`mfuwjUR!=n)F*B%^*+CLzqu9ZD6
z65wy%`7M8<wXf21HSC@LdexZMPZIfOw^YiwN@XJ)W!S$8vz^Tc<qTo(64V2nJA!rm
znQks*g=(!Ea^E($&hZpAZjKxj*s$f!H_!>p!?06GmCY=HQf*|IrUPLo%;1|Z*(~qi
zBQk)k{#v3pC;k%VemW{db$(9)>!bQi#$`{nS7y%>w~8smhFhQM3guZ(@c;)40v~kx
z5<^$36_dP5F|Yd)(N!)%xO!R&+lbUdf>bd-AQUp{IaIj2g>NY5@0*#L;ivb)A_Fs~
zEG#5)pp=zb5~Px?#7LkP`v~^izFu}4G$IDF-ANPK@CE{JfZ$NxhtIl22^;h`EbLL@
zUHMT^^65iy_-fP9@S*-ANxKDT2}fiTZ_gNs2|JXLnDLM&L4X~|Sgv-C|8mEOI-ipx
z6zlT&i$g~)+);9LATA)|&qPdP9k_77ox&7EG<<9GuW6XS3O_A;d4xa6k;!Ie6q1a*
z*c&*R<qFLV?9lq`p%@E?p|+le7i}ap*`jSdZ_di@%73yfaPtsjMr9?Ib00zLX@jkZ
zdS9kBa}F5cd(!}L6JDZJEF<^;LOJFmQiL8hW<vN{@unEpo$V@3%+*^XMGUQX(a~)}
zu_DTEH#Py1xIFlOLy*E6LI-8R2iyV95EvNv>6|;6a~B+;!`qRc`R2yC%*#6V4{!ec
z<7Td}SV)D;ev+AuK<_LX(b<KBH0qcsTlkCEPEKrLvQc8h`PQ`N7f+buKQACg)Fn;0
z|0T%es7R2(NRZjjf_jClNhG)FF{~eMnXips+pN1Q!&f@yt!)LiS*`3-NjNQJF)HIO
zdUZmHcY*?`?TUB1$=Vy>ea;7crJe2Olxx;!dfhoVPrWtzxxtjmN(gB(73Q}Y;;3Ue
z#9;JbQrgk1cTk=Rl>WJ|Gv!uV+X-koENN^TME$90h<*j;uKOBAM={^$uboMz^&B_7
z<ajd#6aEvQnz-u4+Uh1~&eA4y_AskQ?E*wPn?VmM+WjH=yz#?Hh&pESZ_NI@)`jty
z-!`J*ze@qajRDi}5uyOtrM%1qj+FUo|KS1vu1j2QW+P^Uu`g-ytknVdiP!Yt71l#|
zW8wRWXX2bff}}e^{=1q_j&Ao7QFo5%L?*`&9t6jfn{9eA=dwxTrovVv%jQO_d_h=j
zAbT4Zco9a!v!!f6##912jti`Nzw?+3l4!z4la6kPO!@XuQ&SQEQWYLntO>y+5PzQn
z!n=c&CX|sSf-=};J-`Ky%}x)c05Au^#^HYTWziMfZMc)TaD@vX!ezz?alq6)Dg$bN
z<t`$D!+xIu!i~%la=}V*BtT|KNL|Yg%wp!35X_smzveD6ls{%|l~ooJe6P4bLp1yN
z>I7yrsC{~6Z91wS4aqjMV+TaR>3XAIilC6Qh5EDM&nAli*cvmKi(l}6^Xoi+A{ThM
z$9>@~#R~lWVhDx|{yy7-|KDbN4*zAg2ehF4o|BQbBWM~tAixEtlfsaTLCOGo>5qAp
zI+R1`04p!T^A#XV*ptF+3c(1wuUbMXTtLaT1DwGzKse27dL@@Md1#Qte(sLw_FO!|
zL{@zfEFP<)yr4j`^Xy29FgT-z49rAKH0-OgiaZ`FjmW7O1`e+3!NQRr(^2sV3g-T0
zE14iCYbMy=L!{SB^0Ek7qak*Ed3#j;qoCQ_YE57dso^-Bg48Vlk*adgI+|CMb*tAW
zx*vsklZd`ikBe`-KMt46lF{+w>@SE^PyTl~`qFADVhg0g!yGDQ=ID3IBE^E#h?RI*
zKdetU$YX7PnsH3uNYKCp2ojx%K;Yhn?hn^fwt|yYo8Z1_$QD8kOJQgO^{9w)gO09@
zhzPwiFRzfV3gwD0aStr^03&J90g}{ZL7gbJju)+tad$N%<+7O@C%q@tGW4tM)t`D?
z;E(}6F@J0z?c?}?bkvYH6LIE;FQIBK;JA#W^u=*+d&-PF^4k&gWVp^9JMEyupw#w&
zHK;gg1IE~Wvs{K^w04@q_Yca!F{}pHc$tN*R7q)*AjN<6lp(su1QEpR{(*x2ZO7yz
zjHh~-ctjnk8#g2xQgCidQ}+H8?Jc@Otc4$w3H3K6&EURFwCdK;Ts*GT5M3eVBQ45s
zjSfb=w+l$E46KFkWOpa+UtV?on&f}VbDf>jhdkX;Gd{li*8)fr>dY?0TP*t_R;@0v
zHop74yNbTCRf739Y}N8TwVcu7`*Sx{chx6vON?>}Kb;${@GknJ5wtvn?YhG(p=b0Z
z*=AK?L@X3cH}`m^?s<cxA3r-;y{q~iaX<j>9zhO5q=;vpo-sqBCWREWq#b*h99T9&
z%~vo?+LrzGs};|s!?8*VgE$Gi<z+C}Yu0^8<xycfECAIhJ_uc3);f1pzF{e0QqDwr
zG(@^^HSO1IZKX`9iD;y%o-gZ6Sx!08QTZGC?$t57H+#}<o(l5j-;p2_STA_YNmBIG
z{R%0}%o5%B6oe$@wV6=<P_uxYnR|AyaZ90^*Ox@UVz&k$yk^^^-1;=E?-TcxInwMf
z^95ZrG8klOvyC9%K{b6Z?KsEk<UqgVO9>`d6OJ=x?`hw(J@8WMwu_bY3(8|J$hUd6
z8_DL)TtH<N0Y+6N-hRrT;Q?VQSh<(ti0;8L1CVjafqI8U5uQpzw|eQx2W1-ja<Ve}
z=SotTRZj7Z`NhwS9@Fm6DGPa29+W}%>jElC3@SUyK!yu^u$qUX0;k-0YyEJx$zg?Y
zx(#}bF*ycP8_vl3n<<=lt5L&~VAvpYl8<g;a_iUn@77P863oOCE-(rj|2nUTrcV=l
z^Wi8Wj9bLO=T7of2zLkTa)E?92nuaRAbRy=BGZelJI<Uz00jx>L=KX*l7!nJO?cx2
z)-^YSy)A|I#x!!GyX%|oKCB{hF0xlH+R63mp7e7xqXWRho)EqIKT`?F`(~db#^7+?
zm#f0xr7=(xoeNZeJ>}A!OB-B2l)_zY9_)$Eo*fMf@6|6QUYj^7#xvY5yuby1YmN{P
zCkR2U`cnLy`T~iUlY<%QfcGIB=*|$x*?%5KIh-LIXBR5OyR@b>h8aPBUp7n%LD;q+
z%?@8Q?I1%BFUgqf?033;b2&Ll(|9w%>D`0O70E44UtS(m*m{{4a{3e0x(8Oj2R)lt
zcY!PT76c3~;-6#a7O1XlW(tQ$xtvOo3bv<vF}Fsjhm#f;i{bC>UYg!o%=b~FJ@(%e
zRU{;5d-gSqIPosG{hN{n5q(}>VdaOQc9v4WFfFTEUz6oplTz7cQ0vT$R0|%+n@aN6
zfSF^*p4;ahnf-a7X|KjHz7-^!MVyC!5EoA%;6p(Md7&!AVCc{0)(8ktRVs4<XZ3hu
zzTYQ?_|IW10#h`p2#12UOYOa^!&R)NAlG7zSew44GnXF_pp)Kp*RHd6|LMBQJYpK5
zm&{$9ECPnm+BiIL_t|E+za=7KktOKQd6Q|w1zs8cOvdh+n-e3PoNoG&r6*mu@@H-d
zfLQeJXo|qmTOhtSd1#ybJKb#vvN06%NK-mYUwS5G5F3Kt5-d1Wg8wk>fTrJz$h@+@
z-08-OsGr}-YAu4(2}XH?P~7LQSz>GNxih@rO@~;#gjS*$7jTmxMx)p3sg^6W`IgCJ
zMQ_BJWAiSndkFMuIjirv;Idw6=)#vx>>5|O5X_os=1Z7=ld)oj%bEMZyM2tL>Q|+L
zbAImt;WnX%n1`9Y&N>`?2-?Dl7!>))5Dn8)+?6=wZr!Q%82$#LyN5sDRJT63w%`2N
z<`XnyphicChs_0Wi)nNme6sK@;=m-tY#iMI>S)C8G05_#S2KN~dfEWAOZquW&)opc
z!qkW@qPKOMzT^~r`>78<_t!7Jm7(Z<s{G)oJm;$M%|>eh)Tqdx@CA1J?@mLxj2TQE
z$j8-Dx+ztlfL3#yG~z*b{l@LS`%KOV&UWI;eXf~keD-$LqxmKAZZ<kNti{9hngxG}
zzVVrQhGNC3+VQ@D%c5txO=IWEKdhPiPS6oZCk<IrC{;W=wAn;9LZd=$VCqTs3C4MF
zD~x{sl6El%pSFF{H%*Rb&r?_LtNrJxxt}Axs3bbCmELD4MgEOvl<(%`!8-=na-7!&
z@{q=YNVqWd{SyD?1qtl;r$2h`2kw_mw2FjfOi!Bpg}CpdT;c*fcFaIddZCwO@CCX*
zbA6OA&HTrH71FH!{-3^mRKL@&2=*D@7dF4z<1f5vU+4`(%tho$Bg};o^`7R#c?_>R
zd(;Yuk>zNzdyv`OjiTbjXNaYoKKfcaDUGIx0kY;AA9{N4^R6hqPr-@@)On$@?v7Fm
zby|iGJv`yw5SQ?DTy70~?w}Z}aQ2x7CmwSJ&vPYj0#<-<Lm4TG-DBO8-cus?>a&u)
zFXtO6ve$jPrOwhqny?ph8H^*y6ntX9QMc&RRU73BXW>F#yDQs|puS1vJW4;|bg^~x
zNF*v%)$k|)T>``UHHsiRH%3B`2$sKp`UVu(Kbxo5IB~%);^e+BGoBI$RCoBEaTsN7
zKnOLBy%QPNl=fBXqC4v%p}y#u7AFQ<fxaEMcGu6Uyh-vivGyY^m19_sJq?Y`hw9O(
zYNgc83&#daW6cg;VL#<O1P7nti$tq2J?6B5_)@Py)XWdQ!&J3-ZGOsZnjE-m!_QBp
zAJv@_857a<Jt3H^EC1Q22mXo6Z>PXXsg$c|f$4HVPBK9eO0E_UYf8*^D;KAH%rDDN
zO#euJBEQq&pg{Q1Gc9)>;Ez$i43I_HDWbK_EMaXlN8~c^iUAi0ujjnOOniV4g~msv
zu>B|}e;s$Cpb0wc)0|hnTmThp#+Z*RJ(W>8Si<`JZt0fg(8Ah}=A45fR`+nuTi?jP
zzUs7I{u8O{E$1c@jjD(rbObzvYt&4+fTgZ80G{;uCpba$`-!5~|1&30|B+?j|BCY4
z|Ihk=r{n*J&K&=Dcl7s;|3}a2{*UkYfA}Qn|MZUkU-cap_C-!6IQY(%JhQ@Rt_Atj
zU~xP52asn_0Pf^1x7ifXphqJ1aoE$_*T-gA;|H39Px8$y39p#4M8L}9g_xf9A%qt5
zd$M`>!cR+yOk1<A24*|t?r*C^Cy%C{J1WuCG~4Hxr58*cR)^Fq$uz9!^fOWH-6FEe
z%PE}S8b?yGn8~|uA{@%aL;fC38rP={(d9z8aq^55>js|CU0uI^xsnlpg$204Oj@~h
zIu%g`a68MzySRVLGkiDL^P{BbAZO!0fm{4`ZtcI~(=4NS-tyhu!Jd!_4HKh#>q+}_
z#?dERpELJAvh;Xn6cPDZnD=p?@V|Vb<PEIFw#b7t>8Z68VPAe@5EWLCnuDE*QM%h#
zy1_<vyYRJe(<;xNuBK~&C;75Y;X{dZb{ZOv9Bqb$+_=D(RSa!K7sJ`sNMtJ^8YFR%
zhegHL>#&7VVXXI1G6y^dP8PROKCmQ6MP0r9VcpEg1p7}-I<FBoaiQ#?xTAWPnHG@X
zP!Jc`Vnz#6kAx4B@7KS!?e6KlX`O#`|BAo=Lfzo;y+W_tRd(&A9RorLh!Fi>)6JCs
zHQP)%0Ph7GY#C%uY#<p<Z2Yw<1c4%#d+tn0^Flg<Y3sT)Htug!fX@i{iOGo6+*=<2
zJZLM>)8qo{eA_KwJq$odm(E?^4Lfg8H73J6vUc7xzpW?AbMI#5MdJL{0-k9K-B_9^
zVNfo_1^UVeFtrYyXF7X^r46^*dUQkDTZ(RzOg34(g$VA)uKMn1-P&>g-NAc9J6$Uh
z_FpRr@rdmr5ujd%2IdZaqn-`J+FrlViC&a={Y_!?H>USBHL8Eo&fUAd^_SR5KjN9v
z!VPAzF^Wh!d~wj53xtV-3+3?;!7`o;9Jw*h1vVj4V)Pb3SZc+GzCpV1xs@ML;e4K<
z%knkHu%n!3n6#kfDh#BGof#hf;m~`SF_!!;V0}>5xi;paX;7y8zKZQwp6zuT_3{n3
z9W~duodR&KzWCr(YV3##-=l}iG81{}l7xC~w6pXr<NRScjhCi!bEn^bRIZk}^B{$-
z@uzOLBFaK;R9gEC^k9Y~!pr%4*;+)yhczyXTTGTRO3oS7yXp_@jX4nGDR7lFERo-|
z7qmx0fU?a%7J2M4TWydc4aHZknpR81-Do!M@Y3qi)}o$XTV`&SBCA`^+`V5l)nBR4
za>H0r`4;2}hx$4&x?C8tdLAtMDfDNpcuvt%GG7h9T<@!<wfTAcfX&5tpIDx?VR|im
zvs;9rC6+N*Y3tJ*f)`_-q7%Sy&1o-M>g(AQj&@;@&2qJ5@7<$c4nO|6FK#^3y$<}{
zt$&Zd>DP2BTV$D*_G9EaM4=^p%IL|hZp@kzS&bomymvOA4_+1GVMUk(kSdycL}`k%
zQZ)Ht^}8uEwq;NE$d!b=319f)vNm$gqi>_U<DG&Bg%vx+BD5Kzv$qhV?nQprX+Fl0
zX4PEXU3y~tc;R>WhxGd*V^KA^6~d{4)VY;g{@%|X@vO%G10QW7*~i11Ml%}dBE!S+
zY-QGMDN4*Ndp9SQ^ReVfR&L7jth9gE2VmRP?)<0Y{ySvQx!?Z|=lmOzg-Nh0ON2lz
zq7*5HYR`-HK(^RT?<3yE?d@#{R{#2{>fz1Q8UYU$REIh-R{r%rIUoNAHOQ|s$nZxb
zWjunFxWL_b=5G3})bbS{i640L`{RnEWl1!iRa0G_nRWJvBFlub;BBO?mv!_ymSX34
zTfxVBfh*(|Ga2^9Xd^t5f+_{|PB8~=m+R4k4942@PLl_v-=@Sp-FJKO$L0FzlwZ5P
zNepb40S}~DwSk4VVVo<ypj%*j>*-YWWceuS`z8Q(ef_IR#o%B%u^>E)bpZa74bto$
zx(|^=a>{SNY>F$gJEOO5Zcn>pc(~AoSc4go7!&jPdtRd+NpG&rOkULghRu`5BMDfA
zhu^8Q%WRSO8h_0xF0h_0Un0V^-2!J6pv!g+_tqxphmp}|@DT;TDSYbyd;2_74MGpa
zch5Bso7SQ>xs|JT>fwTd)kM#c?MmDaNr?4-Rk(IsTy0)e<Iu6QMVoHNO0w0E4%u)X
z6VQZaP`Ff+6s+F<vQ-N$KDn$>l)QdEzjwfGL9VGK)bjI)*^t3G+PVFEUjaNTz4ZJc
z*O>CH!A33cPDq3?<D0W)?of&U>BGl_*z_+v5<`g^39_^Yk^1hdZJZb7a&Bl5#758h
zwV>4JTZ#-6p<Da2go4PAExvv5i;5Quc>KuIU?BxQ<i4s6@eN7DdBYoehxyHu`g}Z4
zwYq`ZZ}{;)aXktC5WEn?V~B3D62eWHvbSSs;~|8da9av|hapjIYZ~qIIanC<mwHy{
zxc<3k@<uRA?n~}@`Sb^;ei-xI-w`{Q0<g(1C>dVRZt9F19aTM$??7gNH0qrK(uQeR
zu(*9p{e^8ttd2F6e671d=)>Xdf_HR3=j7jbRB^zCZ{<xoY7zx+G-157VKmQFG9+l0
z6rbfA0c&<kSh}6dug{z+THYebd+<xGmY^^^_0a(kX7}S}{n^_(ZPo+_grFa=)m=sc
z6ImDd=zZ>tqag+>h*RRZK*M72J}v;-ae;O<4tR2)P`%a)Qe^1`u!e3Nmo0AfvAc7j
zW*FWjDr46jUpIEH7F7T3v_eNbq=v2annB-n*a{gr?(ZdvTv@o{AD#8k`BnO+dzj*7
z!Met&O9tT~m=vaqpK48lrI}uW1%dJl!VLtuK$Shqcp5LHE<4~ls3umkecQ6O6yCQK
zzoJTZSg9pos7vl#U~MdfMG^}aV4fi}!bS`no)6ESp2oRcj1ch~pGkTRcFTz--pWWv
zRiXaYb#NupEZ&|IO>v?KU)H$18efIoU{~wQ6PMZU6XT&f>HnU8XYH%&$76NFt=CGs
zLv*NqFrZv4_&kGL9dpxR2+bc5W7Ya1#gMmAD(w4xm8aK}&hjzRQEw=NPtoGq#5<Hi
z@Q!?8alm5yjsas@nr-j(ZCL47LlS-$+kJG@B(k^N=iMAqS4RB9m$1rtp^d8dgMA=h
zJyZAkp>JEhuL_sny@Mx!|N1j$EqtShJ1&{94*ohCNpS=v;pTxYdTv9+i0gQF+vU4H
z`q)#&y6>~ap3TjD5p#Ly^#4)!o>5J9>$-3d6%{ZdA|NFy2+~BFbfO|4AfVEuM(G{t
zEhLE2I|wLMDS{wGq}NFA(uwpCdQT`Jkir+&9%G%e_WSPdjJ@{xbAIGc26=eqocFx1
z>zeZ}K7~<@zcU1jqR{}EPrxPbrayN%NvB4Uo8SN36TNCctZ`7dqKFJ9fFZFcDw~k&
zq`sJ;De^nrW@Of>r1?k^INI07%v{lL6I>~!z@>VddxCFIX<`}25MA%HxpK?n?R`*(
z77O_uytNGeD*KpE431uTLFH-d6n&(f4uc)+0^tZJ)ZD~YdDZyd+XcpeCnF_q8-nRI
z<&Wk=6?Y}%onlygBqTVk68$~_uje$1qMP345sDXB-zbP8rpSmV;|iL&zs-Ld#cMiy
z`CWPbWl?aWmM!}0Y1?4NKPg<Bkl(hHh-e5wb{zbt_v#a>o%2%doDp{dAjeS0l=swd
zOVJnA>^gBcPq&H7fe<{<D`Bavb>0P@qAqBY;$oyY`erB6Yjou9(G>;(+Src>YbsRi
z!Xw}u)Ya$xL4?E{^qQ~=8p~S>TVS4oYodE=R^m#a^a~(@z+7mF`C|pfdHP0W`x~~%
z8WR<zd40Yvk{#`VMkMKeJ@s`yl8lpkjeLF7s?B?Lc=KR9w!2^c6heOj6Xl`x_+&SX
z$oa@ab|0l7hN!^Q2)2|9!SBLJW@zsR9oA({dpgLjK?EfPVg(f^mr>4=bP_~_y+Vdv
zGnMJJo?(Iw_zR!%TC{;)-3RGC)1TcQm-q1DE&LubZ6$nfq0|F%3;Kjyt#pPYo#Mzh
zcCkK?-pMggASa{v;%B7qg@v{8Af?6}<c$XE9zXN2Mp(DS{49r$+pPo2u-aFZpase?
zLXrx4!5^S6efq23<UVSOSyn$@f+quDm}iji6cAQdC-Qq2$5ZThg6G?!PTu$=LOd1q
z8|RwgSY0?Br1wm93`r;;pB1CNxnfc?dK}+<k#6BWsPMgEI#iBOizQ-8letUKF&0x#
z)y(=YYs5&tK!@quOg>PEM&%9u_X}D5+l3FmIQpf`+?hBRs^&XHWQ`VhbwGmx8w1E4
z)Zt(E&D}&^YP#(!j3m9=cb3*We*$>95%G!_j<y?^*ZmXO4b{bGbCQIy&yl3J6`8tv
zo^+I8=GF^ICx9U5xQ-?#>Qf#Pa*4F~u95vrB7FW9mV(G%00;EOh*C{8@gqr4haj{Q
z39mi@IGN1wz;+0#4f1*RA1G_dR>)3@)(X|r^wtU5J1>XaNYoRoK4%r3jk(|VF3!0}
zZB$Q^hR8)-!Bl?ARa7g}3E;T`_}EYpCWG4aAzg(~G*GP|BGdc{V7PVz*AWE%?n>YT
zkv<Hxf{vHIQGF)n7^w(G*CIERs1COtgCMt|R&7bl%#<g#^KoSNarizi5RwJQn$8_$
zpHa#ZqzWP}0PK|EK9G2ay4u&3s16DRrn>gkLdPQlVikm^lA!nZNroqYQW!tgyF4AF
z+r$0MVGg3p;qOndVN_4ltc_gkfbqjoA{-|GovTu$0Mr4II?6|l)#c<+3eUG~mQr}x
z%W&HikK&1YbVGXCpQK1{p3-d@l9;A;px%EnxKMv;VdD&t&Pa4@iZsv?xA*)4G#o1Z
ziuRt&oZ#G#=wploBtnwruc2Ipe`1%R22{42N;G$z)XJN6$wUWeLKvseq$Vf8fVbO3
z%Ca91|5v8C`*iRBG&Uev=R@Vl#SQ!mWVfm{3dcx;PSK1<@T(t#QUV!3cUIcjCS4pP
zLJGo8$bEqet>@4D>X>?HoV=JlS5u$-B^k+TVMn7NGT&&}p~OF|!1GyUW!-p*T$OIi
zdboXO=|v8t{r3gRMiVzdRD<A#7QF~n8tkAlZ^ktPfBkAUJ|P(c7R&8s_ds<i(w`!k
zg0Mee+ea?l7ct)kNo!-J@&_XBNCQ)Uy*npz7T!=Tp?00?ar7}K+(eItM77YrVkXh#
zZvp`Z=??$Y+~&r?Ymhz22=L?~MZ0`~l^h4VN#zyq4#-s||Ge49@Zb@R)uV6+P*nAJ
zEN`$YCm|yDwL3e!g1?n^)j!Swumn2;?{*;soB%8hB2EDL-%+b{|9VdiWhE;7o_2tP
zVAt%&i_9GntgClBK3Sy%5cJ#*qz()I^{)XieZ#*?4aD3;{xvKN5J>;Wb3oeYwy5vS
zuZD}FPz{edZEL@lk=4hP>tKgDs(gut;K6@#Y_xqOX`+bo@a~^~1aVpCed>-P2oXOb
z=F{<1b4z+du%-?p_6>CySi?h!`)6Qolxaw%4wb>0O+Xc}ia(~-uT^EC+}BGt8JOxN
z9d7CgLYpgNw^})0JMOzTi4*3D0uxX#0y2kC-&QTa9g=51G}TyhCNE3po|>RPpoXV*
z-S-o)b>KWyiSQYRfcQyjnlw5b`#h7{>XpbSlM!CweKX)d%%-~ECv(@<UzZF-lhhpx
zE~{-j=lDUmc1>O)ev4l4m2Oo!H@q;^AX?B|Fxde(f7+2vW`W<1U20^IZdt#8#4I#F
z>UO3M$3^;KnR4k9`w5^a#=;SdeFCP}VyCp>ocn;k6gFPAo&dPqAVn<Z+uM^JlbXHV
zS8u<1zP<UHMU9urfcbETBxVHWFywQ<z{NQu$3Z^ruC|2!HzP}eY8#L<4#t7YNpQD(
z2eBicdp{&~RsAMcU$<g!A~lc>kg0k@oarI=S%S2OTfY5MEnXkFw&zD4Ga)?~TK4I1
zKly5_XlQQrO2IoQI|dnEw@Mw0?VWtMJgY}9XW3F_EpMWqB+X|xoEnB}F2oY6)fryN
zI*19}uyEmQ{dt|SwgVv3Aw=IoVI6O<{8Ra;^?P6r9-YAH_fux^7&TjmBr!)}LbK6%
zD5nE?&Bj;v{VJA>&a%2ZHs}-vvI#0xVzmy!!bz;9iuse%_EavPuRUy;BFp+Vl=JQW
zCm{9bR1P~q$SiG1H5VHH=4m&h?Ds4$u}9+f;`N0Mb1E@`H;X~p8I*~Z?b1G%U)uIo
z>$8(gQLID($_z?Cs-Sf)dZb(K3X{=B9N*z|ZOgRlQLGxrp;*`20H}1ZpQTSg;Uc%}
zm4B2cxE={0b&bN&AGuGZoW156fq0o(=F1Yc+R_BYp-9Y@7^RTY)lI<h&4WDU1cnG+
z2^Ks+W?%tQz5kSMcOW32q)y<$?59{aU@4Ua8W*&fC7qMOv!<6zVl%7^w^BFtiI07g
z7Q({rRK&3w6^`!f38HYdLhg}IPxVaPpuk|38MaMyqhKZq3xOZ=B}D1%0@pqIuH}ct
zLLDW-YUMnaG~xq=THrP(fQcqZ5cf?S?>!%NpWO93RzI9rl37T(WzAhZ$qJ#eYzm$L
zklE0GH>Kv^y=9sn2!Wx9lA<xe@Gj9#t$fyf%J9gepYX+mc3*2)Fi9MXAn}5++TiHP
z(*BiJb6IRhkxaMQ>NqdO&=&g%c!&H>;n@k`T-a6!Hr;UUyB0>%OtQ+Yqv%>2#R95}
zbOm0adf->YS0tmc!<|cn#FZzEsF>R#;h>=EcIXCL^s+j7j+5Zij=Ky}9{c8Xi>L5j
zQeG?f2|$EDmZZ)f-Qb1+vG%DanU1-7@$r{#)XrLFLn{IPY8`NTc+0I^sA#$8l*r+m
z5-)Y&!?{Vh*j)E_Cx9v0OTd>xtwQ_slnbKsu7n4a+av|7y;jU;DnUuf=#A#We^=+Q
zo&J#+xUq*10$U={KTZI<22E@yfZuUIO7Z|CR_Z?p1(ljqVmm2qzVQ80f0ElL;3kN2
zp6aIgB&grkI)aaVn-BwF!X4M+f#7T%7Wg(FQW=c?kiBaOW`J*`l%D_!qSi@!R4iRS
z0em9}?Bfh67&}_*W#lLLgb(EzEe=Ad{o`6ylpzD{aH>Q7u|vwC!yw5XI4~uWsv)x@
zj}7rJ$b|~_L_Vl;6CnX@CZRc2Nl)euy!u$m>LdCEf7YzG*CkDQS4Njl*5S<xwx^+E
zDuBRp;xpJBm<#F1$lcpAD=%k|Fuy_n*}u*p!d3WE|LdY>yqPO$epYs4A8yYU(lb}f
z@GP7FfW86dIGbwgc?A6$%DAeeu<yI^i;0JO(>g+)j~DJ6eK@9hF=o?)-_vS%`*frr
zWqf^7C53(7gR|^$nBeNVvXB7#X-=vr8V}o4Cki=$f6Q$bV;CjcagVaZar*hoC8fen
zpv}3}Zz=eIPDZ?Ew}p6<Q{oxn8vY|b#JVBn{0vdgw-_Hy{z!72p9}YK{pwr%^Pa1%
zTVZcsbzR`nw~k*%>4cTD=X1R~Ufis|yxD<FDFRem2l^E}L0y%QysV&mzc1``yBmj!
zAemd*TB&VJ<Mt=u8iaDL44X}1+Ib7RLud@VIF-%1zE)sVeo-qlKJTjTZ^gFVVw%x5
zi9y3H5!fGr$wuV?EzhuYZ4i2w<vAa8pi{rgJ90nxg+ba~Ix@7=U5D6;BS-)DGK!3$
zMpUCpBo~q%%x`4UKN^M#%-5FQuv5*qwDr2R$dPL23mftg7F;M4;fTf~x@%X`*8T3d
zSlQboPb?;M+xS=}_UZ5@b@P{~r~qKU;LQR^O9-29ImSDg>Y;YjQ(BuT*XF!F2mZJh
zy*`;F@Yv?fi&KLpm#y|-Yst?Hy+N)S|4CGjfvHS*%W=W=T{Z_v7VBd;x-AMlzYz0K
z<oeo(Y>GUWDz3_S+PD}r!&+ml9z1WxR(`50&-6c4k^KbhDI!Y};MBoE$OTOtzRayi
zpn{_HyxK5HEZ@iuujNr-sxDjgJ>+_LSFiWyj2y<c+o$m?N2%0dbVC)XkE^GQDc!~$
zhBioieL;9+>~P#364M-|RbzD8P$JK@BE5yy*)sUSN+n!NpTq~HvX?|8+Lg%e8Ale1
zMApjzga|?8V))`JMGXG?1b~5)Wv5a26Tsgxn;<c`t?Q8tC=`O1Sp^+K&cHpSND{DL
zbGxs>49HElLGXUl1<JDB|8l4ups6{0b`7f19>(Cyz5c>;<7~22eR$p!KH|qvy6gMJ
zoS>;UGV)=ZhHC@Ve-oZNZ`%T4@@+rQdM`ycF#h6~g<hKn19hl9wvI!6BzZALab~gB
zo^vV72q@gPtFEX8@IL|kM8267AZ%gAu**TGuMPqZeYDR%&h0Y4cStHeW+F&nMSoH!
zSOLtPFdroo(j9XZv)8MiV)Lw<zw~@}hn5GjoWHpdgg$KLl6X>C9U&z&Wyg>FsMgQ>
zEht{STV7q}7&W8^Fzka@fH&LG$k=0!lD4~R$NT(&O?mNeZ^$$ootx~-1DfBJK@|Kc
zV{VHvY>m5262y5OzHN90O!l!B;#>OFeZ{@>U6982W=<c(DCjpW{zK#FN*p>hdYjuO
z@^|LtWwmLI))YGq9|g6;yN_waB9Hm;^8_wyobtRA<;I9}4)=8|QKY}2?bTvPxcW_D
z`Af<k+4Yd%Sr!~4Rct_2z7XOxKcZ{D*TnkHN>ql9bPd!kf-I>nMTDgVdKc&5yEDHM
z1~q?|RJ2xw61S~DTubHjzvo#0Z=Q$$yMYRL2%ZyLP2z)Kbr6%OkIpa4O>(S`u#51e
zTOEee)!L~lZs2nML?se<RKuJx@Hg3P4N_FC$9-J&nK8O{(a-0exawT)Q@Xuovz-<s
zeKsdl2OAa~yrXm-Rnaf%de}7O!6`%XL2<yXJ-*DD+M~iPYbuk`$w2+YdxBJ+*hIC4
z-~eBfKdDnw^795My1rH8v4y^9xV1?y6o`HaiU9<&QY|JD07E5EIr+n^KN%t}j=Nuw
z`bcyceAg#|ig$m~0H@MOUq1nV?+~c^J{b`T#`92_ZN3L;AqLh7|3`(gl0WCBW!xaL
zP!^KYj+XeRKAi=;JDNoOy3}}pk|kQaH$b6Jr<9`$M%p372*lt3fsg-RHMYVD;6Frm
zpo0DhpoU73Pyd}(Mp32mAb7L>1aSKe0dWE_CFz_1az1|ou3(S`aCBS~GqyS!ZjZdQ
z1`{2sAiMtp)2=h;H|0CBObZFFUvmgMFZd(uLLaTA46l#Wk=EbFPz>r21o=0sv8pJ%
zDUP*W=K?`m1$!6)74Y~n-5QYlyY<zrHtE#wM*UYP4?iV)4>bCO3U=K~NTE9lMr`s>
zE_nT+062L{t=-(QZy91?HVEuUmDuGPWhCEfhDWaR0n*l+MoPc0kndX_p)fIjvSqlM
z4m(|mEY5KJHj>4Tb{uw|BvnhOUD(Io3b$>j8)|sqXMZhl&84F8<}T%2C)qP)Mi+<R
zLo`td1pqXaJs+<Se7y2Uo40@+kRf4c#1<=#c0SL|?`oZD^=l_)wvKF1mHupsrY094
zFpkQ<BmWf5ImfzX<~q;O-B1tYUX%7$7UI0#Pz`db@}Laun%_E1<=Qx|K%iIV3u2{2
zL*Yyc5;$hHfhnj&@r1)5z^!(3S^Xi%W~w6g-DO6&7X^fp9AI9RbB*vcQt8MpHhvIj
ze|wFWRqR{B_Y;60+cf}10sPmx4uK_qSH_2GM<L^I8^{Ez-JfIi_yo`@dVa=uy2a9s
z9AnQJ$@SV;)-u8>hRnroq;vgkKb#%TslaTBMJ=es!MN6<cdX~*m>rH4iyymhor#(L
zuKMEe)+Od0$c)H8EB#P-PXLZo1v@}hu!@8zs)A)6q~pR~ws)q;L1k;+M5?n!c}lBt
zvRF603s!7KApeqMMWt?NLsH647!ogKmwjx)2n+g~b7{DFb~)>2CQ*!#igzIxVni=N
zsZ2As$RUe<P*l|Qj%R?8ZB1=f3;V4UHM?Gk`Z5~}clB<>;+?<K<PTmEZ@_xx%nq6g
zzL5B^ft53PUlkj0cH>`ppSLw948409Y5)k9J#9Gj{@MLA@JpadS5hXZLzD>mvr!7<
z(<pNre?`N=v!a_@R3xOu_EI{zXior|XvDS+GSqcqilR+7pGuCEqobrYL#F%x8L$Zb
zb8E#Y&4Y)=o2=N6Ik$ZPH!lvPkz@%Tc*}(u`mG=~*xXstu2_TNzAaJ9_Y@=oe5OHd
zzE_3O2d`dGN!PH({O;I&j5Me$iI=ulu<8`P!^YIiKxINDz7NBn-fjtDqa9(n<x9oB
zxClAhc1Xx1FiP@Bvs)@dz`NuyxAq09Pj}xb`VjH*AKscFCh$g*^5|tWEqhh!YlUcM
zDbnY4%#|_MtJ5@>YTv8HDm`5R<-^q=m5BBz@H_ZfDQD}vSA~%GW#40z_WA{Sy;e^<
ztVofT2_7o-xQq1#c2{5ay7{?r3azUvP`!E#+!7~4&QxH#BT>KU8hrxr>4(CS_bdH&
zTHqJrPLrgub0Obp?T?)+o?8}txJ0$?&T{jRe=}L?-whNymZ$pO8}RPCgpbs%v;idZ
zIZ)jG?ppv!g<RY~UBh#RTT(ckR>3S&1K6E$g^&(0SCP>~s*8`$blgG`cv3^CX6R^t
zQ2nGJOhM%9oKRM<`eJoC?YhDI2>{^Ok3<)lQ#bEBNBlT0vxl$CYs!pYKiu-|vXL@F
z7%q(!tP631Hv<(!mN&px6&wXEH^=MlrP3}SCb`$`gO2^gY}aqoE+YuS5K`tM{2$jo
z_m+`@jt3?bdMZHi`+@$!BV%e2J!ybHX~)5RLck~x183ZO!p-Zzn!0pwpW#9vYz^LQ
zuOQ&YPLNpmFqTFi!~b;H`lXVduTsCl{cOX_-EoJEu&aY~cq)%L-FltU3SxLHOP;L&
zi`Y>91AFrPkY`l==rOr*UxytzDCemVbLJ1RvPDmlE)$jtO??AB<)?~cK)RZ;J0kg&
zO$nvk>{rKSZPYLOB)q*M*n_rWSy|X22<U8i%>yTkF@G{7FHD=N&x6ms&~mi(@nQ<r
z>@Dsztodm9nv18+?PeIwkC1S7008ES+Giq)3W<^~(_+eaXmW6}+zUP7a52b0Bm6P-
zHJ~DH^VtL*+lah+1NBM-BOzVycI#<gltiA|Do!<4F)aw39{IOt#V}>Vzf>K%O^XNr
z4M-us#}NcjR8Vf)IbO<zuVFfnasB{u5%sC^fjhBtc)`gNz}5^*5cM}_$bWx{8u*I(
z@?Qyt<Ttpm<~dg3&r{Brer~OMTkl`HdWNytC`L_9s}^VF@Wh5T>HN*_VVm$~Lki0Y
zprw<X;Fak<43d6|l_D2}znoO^I3-q9$4*&qme*)4*zWxF3Ak8?M1Tpm4%>AI#-OsD
zcj(&mU!w|Kw>m?%cir_~TpG{ix_{OEr_v|XE<2<af_*d)nLW{@h}&r{o+!IoTkrt!
zf`^mFtpJ(ux=_9%!ITGte}$K%!9xC>`b2~zG6KH1p+xnuhZs?^j1FYV`u`t!Sg=AA
zO`p~|;<XALvPdZM{=W-1E+>G$BpclnIy^)pNYtsE*J%a5ojpr%{^|>)vKZJE>~eC>
zfX8WkjzIp%mSwfi{a<WCS9onRxb0{UDUl?t6F}JXpR?i|FN`bcPZa7xGCpq8kLd0z
zf$ylp=_B5eWQ*+RS`vP%%Z^%ww6&0avD&`xk7;`FD^T?|?e?|59u!NFktiGu(SW+#
zLnI5T8Jz&ysN&e8_7el-FNgzYm@BU)WdK`6iJYE5vS=`}HtnC4?;p~hDv0-$BFGb6
zD1FsPMg=4OI4Hk$eXH^4k6yvnM3Fn}QOQE2+j^v$g(XFqfgLW(4GL%o`Yhkn4tD)V
zD5YcVg68Q}F1EYZu@6>G?~Mn6GvX#X@yR&XO)`eH_PaR5&ahqu|Do@~y^#doSKnDW
z9-~V=y4N5zbMz+w2YB!t%jQD*0~DsBUXUThIOyJps*VNZ(CNX#k~hoI3~qyRegVUH
zZ#xi<UW?srpP8vxvz`#XpAi(QeU3{OidwO0#O`&@UTU<HYP@{hgSl+z8=b*~y7-aI
z2!KDgZOh_fIx5iraUSI}$<w(~*W^p6B$|_02%6S6Mx~O+yspohdS7!$kKihs>9`5-
z>5X%sP!Y45<g|u|Y$@6&6(r+}6KnRT>OuLQuq%WIIO$Fw%v39kyP-DC^+VU%($_;<
z_uI6E1RQRs1I`UK;X`87XXVdX!8iNGbhb-)oM=Kg*)J4!%gX+`cpg#vr%!h7(`+N1
zXl|*p^Y#q9Yft+RKQ8thg#^6vh(3<ofZJvh_<z_N8c=Q%x);s53b_@<rEOKbDU_K{
z=zuh`-pD?Yi?4@EUMpDM(ZrLf{fY(?lio`J-Kn5E|907+|8qB%|8C0-N-TA=g+q3q
zDDlC6`%~diJ*^S=cReGvAQP5&Wr8#D=BnIISQCeX@p8U1hQ7wt#l$pg((m%)ryV&G
z&W=u};{6!dRvH1Y+b4i#Cz22z6l+e4OZ+l6t{{v*9UH@!?kALVFy)=Qdgc!yK5dGv
z#v5*qV04&!(ydWYGk2!4!;;M{5lfvOgOsKYaxvIqE(Bb4+WcA^#{6^XTFJaYqoaVN
ze3YY)8|?a?fv$(6CmTHXv)Sj@9vRDx%J={RBYI#0G4GO&P5NngEo3(7i<Xz1sY9ZQ
z$l?#PzCGE5`OtH}=$%bfYxDt&i}An}=D#8^1&OrRA@GBmfs?5i8A3LW&J<^mT~wOw
z`X$`cvHrGmL%L1E`>mR?n!v>_cb|nXfE}vWBFXCFjZOfc3ovvP22UhKZ;);TT-CWb
z<3`kh_39EtAL+X?+h3a8$O294KT5^N|2R664xkUWO1!Rqfh##Z1hKGSFzlsBr&m8D
zRj>X{ivIj!Rb6FmOitQ)j0J)-{HJ)`-5YNJ!9v8viYiU{$4(gDJf=JildtCh>>aY0
zCQ)+U3E(AYVhW$x;CjgysgeB%Cx6=jRl%=mG7%hoyB5e9Km8IwtIi&O`$B1MB!F^n
z6|u_tf{IBTlMQ{xbRFzB-<3_Vtc1ObWv#M`CDZVbo3kC}u-T+bht2rZ@BItek&`K3
z?JinZ4_Aa&tiA9T9x*kiIS>Qo17O#orwE`0$RrOYD+*ivb9_K#wm^<tw0OhLNjUkv
zj*l!G{S`rX_XjpDcZ}YHHkk1RSnnw84xSNr7}Oxk9;Jz03HmbpZLF;3fvr;+ABL*h
z3x(afyAg&2I-)p<jhqIRqi_+lKB*LN#3NlsZIocS(B2G=s1%Ohr_}X0EFWr*nx^f*
z1W7W36j7)Q4%7;~JmBM;@0+cYu2rAbJ}mz})N8VXFH!cX3>Q5Q(DFX0h2`(7f;@o#
zrH@Qg4Ee*KJh?MStDSIGBol?p(fszPmk{};^R>s7#r3jV?G1a)^5P|pG361oCZA5%
zvhgqR1_Su0vzt2E>qi7apN6ss_d4eH+-E;}H72}hNf1nQBy1ygSTTmwt#^@RfTatE
zarjp9CaK}>WV(Hs^%K6VA31-4HR9t7;qb>+7I|j@=zT<Q9KpR{lL}GFI&DA_+Zz1O
z$we3(9cPHgt;0F?t6uZhU_E`#)h^~Sir0325-){S5;`F$+n-<pUurXWqPN2bCW8e=
zkZh%9C`kc1W>f3ZRhOr9Y@wgz>RJmP9vM7JI0vP>|Cr}GA?|OidI9yHZ_1CSafo;O
z2yS0#GptfwmQ5yx>)wt=y{YY8^R~fm6ggE2EBX^oxV7^WG_itd3ZW7u{}Vv8s8=>H
zJ=gi{*ML_d>EzOJN434nTuSFJ@_dZkN`SpQ-_-@qlcXUr6FOTa5pPIlB?KWe9nt55
zQXGwUaB|Ky<;kDpJyyFM=a3e2k=fWUa0hUhxqO=I%?>UbAx4$%mXg>!#>`e}3!YdD
z(&1D8NJ<1%4mJzGZ9y>*X6OT)VVm4Q)PAE*TQ$VFp=#LG>1Mf6k6^uOlKoy6Lv;R}
zXH2RM4=up2fFx`9k69@GU$cNg{taVVKg6VxE(hQP3CM*;9gJucNq^zXxD>oRy*l^=
zprx0vg^rz80zL7l9ltxU_p*!^aF>pTy7qeH6!@w=;mrx)EtlvCAX$>;827(jun$b#
z95(?^b}pQj5HN7%aQqRZs$_(?m7s(9b`G(XdF7_y#Yg}<9?_4C1!FaJCQu7=?Od)H
zRK$VnReQPWaBcxtk$uNrHmAO_M+xjK{NHO{51(c@0W@4M<E5cWDpRG4kf}8YD->8{
zF7sHJq@Fje(f69=W_`qmq*VZ7aOYnuW|0LzSQW^GmAiue|ArA$FvUOZpPSCZhMGjb
z;|AKm%)WgN<JY8OBdvclevdX)v0xJ(Iq$iqp7n4k&ss2VUuEq+s4Jg^42HKRgRQfV
zufeXv(VdznfF&&uc1dT#mJ*sB4kCyRp8$?@?}PdnVR-6)U_>s8;^HWc4YJe)S(n=X
ztBImepdSUBD%b-2{aTy|s#S}+&gs7S!nqCCw)#tcM!#T>h8a$jh<GQhRBcU_zlrvU
z2bLB87suyRR(c7JP5_s?wq<h@QZanB7#+?BUwsP<k>iM)708jqS^1cUJ~hb}h9kUQ
z(F*Tw+uG1amnp;pm#6+NBmnZhi8}MaU|7G>SzKtyf-`?xlUy3H^*A}J*qN)Jk~Y{d
zuFE_0Ei%nm>|qz}8EanK)7*{+4*!}(+dkSLJ-=m3QNCuDd`N~)bxKo0zf=`|x_Ab5
zg>=Vo&#-wC0ILuE=m1<<LKzjTPAVnVOBQoDN>P>Xg-2rhPlYu8huxU|A5P)@>t|&@
zn}y(E*4Q}W8KXM6zM~!A?seK-NR$3+^TnWT&f~~b-ZZUk#|u*Y?AlDuYCcn_vcYF6
zEUFLw%Sbf+rl!gfr-D(@ycf<}x%Soxu`EnyUu3^LqdO!u!_k%o^{;vxaE6?Lba(W-
z`Uo7ED52Yj=nd4;zZRQblyl_jxQ}#98-1qoEdIabgfEOw01*{HdJ`2t3<p7y!2j{3
zx(lajsM@cw={AN8H<M?YoI~FR>$*9Dde$Ep=yqL?Jtrlo-lTURm3%EBxDaz>K9F05
zhbgb-MCM-qzcSH(=|cUlA4C^2LM{}E22C=zABTmA@{Sy^mENq6#t!wAw{z6haTW{A
zttI?MZREqAP)6KJQn$_&c4hA#*t(dke}4$hhpKV!b<$j@NPiwZmNw%88$&xr??JUM
z=RA*I?O7`>uveKVEkY@E5Cn)C1Rsoe^ZXo>g0W#laI&M1JWs9l`d|t_Z>;xXHC^O!
zF!KC?qFBCXQ-ycv@>L_Agp2HEey0s5P5|XQTbkg>Z%y1JokW>DaLtb~lS2mrK#jA(
ziNXJD&)c6J{<zn3>_tCbJZYZ{5b%UGW~2Q{@Oj$L+J0Z|XMCzmR-E>)=Em*L_+@{V
z)a6OI6=NOoHaDoJ$Nii_Fz~hg!SM|eY4Gnjegwu@(aZJXy1&UOm6^Q3c)83~!(-F}
zqD3?^ON^k;=^q!yCo$odFS_4N@y$Eu|K+ij6Z7E<;4?^t)92BztExiSs-de>hU1b;
z#02viP&muc0QXqQLtiIVZf$XGV?+X(5gl@YZJOIM6@xC&BHqK`iT0!egMcq_zkwlh
zY)}rIrKWTfXWcWebC61-$KKQT`y}>mG*4v&{cgUFMim*(o8@=Z&oerJm<bwdn>$;-
z?^@F&SH=IfR$xkie8~nN?Z`Zs%Gx2R=8LHqO=~TDdrwK10_!{JXZ1y)7UJT5EUVZ#
zR^3ji(Dr~z_<4W7BM=w^3}N{Z-Yed-qsxdo`n)mYM<x#xQr!$u7Z?9`hPH&5V%9R*
z2{w)ydOr8EzPyG_ro-lO_rWT;c**r0sKN$`?J>~;wf#`~I&Y+ZO5zSN>N;uh?olR<
zLMVgVAZiL(k(^@=WyU=c_q_CQE^>g0l6)kV=ZqW@8Gew__K9)|DYPJL!+$3IdD|;%
z+umJoSJk@gk=ZNOAA}d)ZM>9V^JtN>Ua$SkWpONJi&%wC`I@xDK)5eat{5Prd3&I>
z`{%^RAMOFYUMg+SHq*uXqf{Ufb3n>X0uo)-Bo%iNJSlkuBHw9w_F+l2V=K?Sq~ign
zZJ`2cgS7<_Nnt0H&)0a(ob_a0a31>z?ROT$_Vhfgl6#3hb&jVH@oj#V|MN$+iQbu_
zYDm#8Sajh8z$liX2>vz%8)4+nJ4Oh2!verR_m6MqG<_nq{f}Gk4gXjBdN=MoR6VRc
z`;x-5d3h%0NrF#TbYDzO#V;i<#n6t^OdCdeCFeB6lE$@rw~?#f^X|ulNH53dF$-EA
z>Uga}M0@VoYEDDkLRecFHhX?N7eh!CD4iEmv1iB&Nwhb;&32kOr1z!w6+^@Y$tC05
z3X4+8gH-DS-0vb^1@VUE(dT<ET?b#RRqiaFd6uYi{|roq1VO#T&2=J~9Iig6E3Zg)
z%Jp1ic8Q?hn_E#fla4q6IEcn%DPWt2wyqEFhwt3ftEs7oRn3UQ&^M{-GmgY-%O4_c
zV<BNKk~0bYwO>Bg@+Z2xs~;*l?s7|DBH7k2wa$z7WKLC9feT6Zutb*D=WRB!8JMD)
z8dZVW?usc_mo(_FD7`_K{aOQAy$>_WyqV!VQf-cPf&=stv<IA*9M?IDWkkOzwYqhk
z11PrAG$T02JeMo8Ol0dlm5P6(R<4N6&T^K|zzvm%w+3!KH$QAcvP>T$CT#Jc^<|^N
zO_zO_^>#s?##*G3@7wDs+psnM_;=_mI)23Jp}7i-mJm5?ViG4#XZIy!{DqZy;i?Z0
z@bf983DO1>sSABhuyhRkdWAANycDRk&ktyLar?JIbVrv?lOtaHG)C6q6ILe7PsNUi
z*i*w$B(W@<H{&iX4OPn4YYSQPBg8lJQRN3pkvWk<`<6$G|Fn`K<CM?#d25Gq`J`gT
z$~+y(AF>yU5`z2G6##%z`g!SCYeEdV7tYdq`QaVwkIyb8-cwzA(0$P1$ZvchCvUby
zde`6tAW_90=r?a0^Nc)g90haN%0E=eN>*XnwcQdSK6IEnyY0!v-+Hymr!Mx(u%@_~
zix5|XQxGSQz?t2jm)$y*Uo7B8UwhsPFWtK0ZN+|3Lbg-+&QH~YTLEShcIiHWl4`@;
zcW^9W?;0e&5|VTiEUHIJtZTeI-h_`<fi*~a*gNSS7>@L)uO?R2<q~gW#bK4xBt1ek
z&UHbg!C18#uLxE*n06LsDii3s-nG50EjDP`6!?t*)Cdp?zX8C|)W#u?SP0b|ZoFb6
z!L5*#^Xtb|@aI_ma|ZLK1x&guGIa;eUaVd$921aY=Z#%iV&)yptYKAcbne&dZ%vg7
zEPcM1Hy5oXHdZc`N4!c?Dq433DsTsI3$2mi8gT~Ivkj(?F1E-Mui*k8_UUk_PKz&E
z4x&1qcLvz)mGB~g65H;k^9JU}yNPQj0EU4<#6<bRF4Sb$cBtY0jY`~|_Yo^CC2<w)
zK~4SwTlK*-^6nC&w(D{v;IM-JH<B#QEH%2~?D>EKC5^j1>g+u3chTs0AYCPFg`m^s
ztt5&a|A+~cT%OXa3|+tD5%Q7tP4;KRjIVUKxpk=L26$E(E;V!l_((!wP5?BzU1i@p
z(E8sG5Z0t0CY?juO^%-jhg4YbY71}vNs|1s+Y#XgbBqcc;P9p0S@=CRk<STLM?ZSd
z&RpH}wKe;Q`y(p>#q^FJ0YKr$n{-dUpT_*q|FkZrzMkm15&%<ke$v!%_j`xNy?5!6
zfz!`jx0h9VZX*Ux08yYyL=;H?r>uundn>smemtV35|LjgepUJmQ~G-^wueTKJKW_W
z7y9;0l};s=M0jgWH5DLQIr%@V5I(+gUoE)Z-aV6-s3kJ@bpujKeV%iJJeJDlpX^;R
zchsGlnCj5!YkPdlf{vI_3G*YEv`S0Mv3_(-Njx_e>BBSml`vvX2*X*nixHwa_S$B3
zE}59z(DY^Hx^lVCW4+Hm?O^Bh&vC5!y>q6gO%FRy07Xdpg^SmZmqj<O=;vNZM4G{M
zj|;-Y1+WO<H;%Mqd(ABGF|&!=1>@a;hYDX7bnJPoyqY;L`7f7|L@@(QP=1^zw<xw1
zhCkbe-|F+Zl-=~so7a;k{{Fg*5(-nob)l-j>8|gdp64+tek0|fiT6jp>mK`v3!$%s
zI+;}_)z=mWzW0{B7u&z3%)}z-VesC3avy9?)e;&*FhPQNZ+n{jC;L?EvAU||sv2$X
zdz_aZELt&qrTcug@h0-xpQdRMhuMrU!53?nYbfnFkrtyFRgzN{B#~eDck1tp{&6rz
zyw>BF?0%=M4EKQyD~=M)f&&Z2nkdS7QWOSqMv0?;mOHD$ruGvFQN9;D>o8DQ@k}M~
z{1N(pRB8RM4L$xrAC`3{l`;J*Z#*3#7YW`fTDC82$!oGi#ftl^PzHBR!RUlh6p#qA
z(^a;_057Z8bOuVgscxMBM6U5ASXl&Qwq}?3t#rhlBP3zeI*&*qIRe5dcP0Atewh4J
z>)VQ^sR^Owb%$Rd);GhLM;d_hG2oVC1Fgn)LYKTd*4Tg_r#P+S_@_}F=rs$skNr>d
z%>;%UEH}!@a9X_S22)UXjZ&y#SUDo%Sq5=;?jr=N?x%i$Dn#_|Oqq15wJC{@D6vn7
zSIFt+&kWM>YU2`vV(04Lqt+_P)86-VXEp9WwzTElKT>tXBA<=t<B)Bc9_@RXbFPh9
zcEmUA7Cf}8A6VKkS8cF_GhuJXbE~^ukGW<~FS@najCp7j;XZSL+eKKX5d^N~R0acs
zyFVk99?`Bl4oNafcRwpM1<uMGUBS~edNgs2s7$wDo<cv=1yuTrz*wUY-5_hwM<Sm`
zw2O9zIRd`RIq=Id7H9n_Wn_!$8oq_mG@?jp8zxH0313As?G@+<Lt$&?PaJBr)Va;i
zx@6k*`zU$hG|mh6ZH&2P=Lbp=&pH}15s+;Z5a(2{E7x!C*vAjymx7zDQ0Z5z#kh;u
zV5&`F<lrsqR195&Xi$&ZD^9Cpt`(BwzBb+a6jv>^f$g#brJF6l;Ig8EM<pkKH>#cM
zl~<lY1`Dts{=-Vt#DwU799(#OjCqp>3!sc-v$`BO+id*2rtn!Z^PZGk)YtCX%%G&6
z0j<J%50rd3rm2W<etwN4g)LVZae1FN#hW}D?L5cB)H%X}(`j*icU;g80?lnq7W(ds
z$iGO@{CMF6&^h|O%gExn@8rEgsO{TWq5W~0;oIZ9Y<e{J_fIuRhY47?u@y~Z@!JQK
zL1uK0Njeh>s%>cT>2ms38G31Y?OaHIuQPOJDlk=WRY*K1)iUU;x?&KbjVb_V@16ic
z%5iZ|ahGm<bG~3axg~q{+{X-$?Y<eI1AhEl+#9S;i_WF>AsNjG5$^F*+F~M|+wbFE
zzqm#U#!7t(rOT|Vw`uZe%V?iWIR%9KQL?`t%+f9vWipuiNFlKEN4@(b9m9851sH@<
zod9S2wUb|_SvL(d@{oSb4VNiMe>q|bta?T4BnIKRD@XSrv6gP<DeLk)+vQIn3XSjY
znH;@=`XIz{)`b=ICLfv>kN78$-3WE)LV_tID(Tno1hH)jscd>h(0$D8gVml}TW9&;
z(MWsQ>GzN6dauiJ9~?&!uR0paRX5Aa-0`Cf)TRspiA=BbU;x9V&M2!Hhq%=aq}HDs
ze|2XH{kLCttFMLhMe4jZ0godMv6Ig!gNY{Y$bRO9=<9@s>Dg^Xs&k%5<xPj%IY?J<
z%s-;wip^%4EgeOcM#3>6n(|^l0RdxaxD!BJs_q2zChk^yy|Y(^!m+y$gO;ncs#gFX
zWzlEpg=ndz-MpxapQ`kMJqSQp>6Dx6I00}?c6=l<RDTh<Ippr$hLlbVG#gf&IV<ju
zTCdEno1AQQ%1gK`c*=iXRR|L|0Y{H5XY+zDL)AH2c1=zXZ<%?&k9}feFd+X?&l$}i
zwgGWP^<%#<Ghfr~uvC&Or9>4R{3e6ipP*<Iv^cYcs>@pWDyBY89v@UD&l#DbDg3@I
zsGsJv<4}F?o?>ekZx@-f>gQtU$onlw)&|~@4daf_n36{}E6-}OmdMh-mZlK3QitHJ
zG0b=swkir8<wJ9ziLCfVv)Jw;XE_q^l_azPr=R%n?Pc&?&AR}abw@N*xzEhW^R63g
zlVz@$x}Pi$2F~v4znSm(_&ybBZlFU<7{U3FE^fDs9nimVKG$;K%@yMRgh|cul*z-p
zg#d2KL3aKNzHGa)i&ih`vps$ZX=b$`MLI0}=7hb~zQ(l&*zb1EL&iEZuD+P$UovF@
zE1Qd!n2=+)1MV%kQvtZn5A>@s@wuK&LwU!>58u)-T<HkGrWRWXl8;mMHwE(*?|Q;N
z?se2F)EVSe$8)ONDi|_lt46fGJ&Gh_v5KU$g0~fB51)l)waiSdKea)gYA|O&!JZ#{
z5M=N#`-zwx2=m@?L~EUzeGsZ8H_dbc0I(1ZLnV^*Q?<ali%JR4-ZoqB5e-vk>@t(7
zj^tZ*PxF5>Me$$L75~x<<j+U-Wsy-0z>0E(W`6Ek(`~!#GYvA7+a@xlUS`@Dp~u%5
zc>Ly)Qk<A8SryQ`_jk-I=eJbNEFX+i+7GJTTFR5Y80pTEcfSqzQVXUGwa0Ct+D`zH
zX>IYDleS@x@c#a9Yt_~D6mkoX+Fs(0QR|@QY$g-m+<AEDfr<C&Ou1Qs`?6EQk1wkz
z&A(yUtyK!-bg?uKk=||=^4ll|zgW0)&PWvavP{a-f6sX|Fe&nNnDb@0d};V++?-+3
zLxK*5OXH?;r%TW!x0vCa695k+X7+4QeV*f34a;#Y(P*9i6;|5pOmO;J*9*aJiPi=`
zNmr4g6!r&o2kgj@7bgG>(g~n#Q>E;EstO00in|HN1;JOwxUaQioQu;*JfJ<>p)}{B
z$;oz??3P@ml}69IMiKxm<($d%(96;fNE>xk6(GUFZpAY&k??k-CQP4LLz2(*5=2Md
z@%`BRu5z3TxC`~ed_ttIh&e?lY0KOY<H_`Gi~RdHB{}P=%eQaZy3zQ`=Soj-3L#f<
zVcxI7%n)06Gk7aU&Nb4Nu*dj2YR)c}`N#^@HM#x4W&S-7V*xiFBuL{l+mWXf)I7f0
zS1Id_Ac9Ql?|H|0gCp3^($snBW>_Gf&p**uIQ!}XAuh};zz&w(@$nvy+`RvhHx0sJ
zbJzt{u8s0{w8Yb6vSZ>}5vSH+;+N<XzI=0+e6%(FMa2Ms-V1iyF$0A_RV*<B7uP5}
zBOeqSN%Z2$H-h+g?x=Y=z1>Ij>_meqmMd|tD%@OV97Le%bmEL~61z=}-G|3TN{@e<
ztvC9(r5)?yIdDPaN}LYdS3icOe|8WLPxXFWU2{r*q59V^MH$5SUCw99tZ53j&YN@A
zfh7+}V4kB~B`lKt{p+H>vcV<9wXEGb*kYmv-q}pub4^62nkod3M{wvoYli$6R!qT)
zF(U5VN;v0&H&BjmzEy{374Hn21m!IR<RnI98#n<wa`G0=)%IGshPI9(j3sXu_h|9f
zSLZ0CwnNzV5obs`*nt*N;BOV-<KhTWcD9?7oe~+)qKjtX77sd~`t=7gLn6)TaDfLa
zZO-zT@rL%i8r*3K(|YDz6V}M<;+;9Fif;Re$#5IZ@aMkaRtd@iT+Pc(uA$|XABgq^
zImwBeB?arSRE#a%aF<en>V@6cuwi53n5bVMO5M+~7K_>%DORk0>uJWNP9NyOBdq|s
zmGcV1O1RKw_8|xCd8vP&Wq)UD4OZedFCy~dD#+nOsUJ-hz>O+?5T^*vtf^MJKEkZn
zc9<IG>aB0Hxtoa)cdEoa)VcWTz~yYdOtGvixJe847=PPR^xcElAd9LS-+A>jxjQ{!
zju(yV>E%JPE!U5eCXqsj$jV_QANIJX&OBk+I@b-;2xZ>()jZ@RQcS?|XQ%LA5nZOy
zsCR@hG0U4LfI!^wwK>s7<M0ES0Ol<>CZs2{0Mo7U^Xs}gsTdE!8&pJ&pj|^By&!Mp
zJ+A^c;68(6U{8FLlmjZcjTULm=djB7k2u5T#&ZO){t$=h2#>}1w<O8uty#rAGD6Xo
zY#l-eP3QYwA9)KtZ<iMkIRVVaeZ?7umQ5?i>$WbbYvl3eEqIoG8;_Z=_t=MHblRi9
zVcfjf(&Vp?zKpaPicfaS%Rp|#3ov*zb7t(y8-7P&_&Wxo<>uOnOXHQrdLtGUYH`{>
z)EPo=+<5+L^Wjo#`)Y0@tQvX^_Zo+41zz<1@ZH{JpTIznFO&OpnSm%Hb!?;Frnkpn
z?JqgAz#(&NJb)t&teDGUx2ql`y>#<haQLwt^C%M~H5FT3-I`mK3XvGGqZ(_{ZctI`
zxPcFTz_IXA()~F<UclGRLMfLf3vw|`&=e{`aOuv!C*|zoT4o&o+pgKbCjRByUGzn8
zqiM~wzJk<wR57;QEUW3kdyI!dM=b4m+%I)eQE=kuEWrm?hr)o`kj%cKYLySZ5d1W5
zp#wYop0&A#(9$T|((&_f3C(Tn?%^LaR%27!UhF$2GD$UZ<~`At);S+hHt^ig?Er&(
zy3swKF>Dk{zrpNZMKNA&+5qWeY=N(SIIXPv-k!|n6+Qu^YidAb`C(C?k8TlPts@Fa
zR%TKW69vuJ3KbiEV=Rv&+p!|?o+j0tH(#mMenU)}6C5C*$`OvUmn502IMI0;d9c%l
z_Vec=?Y+xH4eslVqR>#YNLPtA&4#oio?{OhU=cRuY_w;i3`I<fV(WZbL;zEn`<>Ur
zcrq|3_SS%@hnZq&7H>=*SnxK#(wC;QRib5BnQ!eX6Hb1WTPa-=jY92Ezcw*ZB4h#b
z*Z~_?Ufbz#w9ql+m(&i-S=sCNmo>FEu+P?S`49_zWOWQu%qf|Rm6TT(`=O=Xac|&>
z<SK9vG1quaD(rDtgwndnqg?Jc0L0Hs_=5&%h~p3U#Ey-d;)~*S8DH79&-Di;&4Z_G
z+x_`N<_8b5FGP{GhnW}*?cImkh^kDPPqbC(ARkt^>S5hKCpwt##Ax_d_XbFAo&fIS
zl7jcNZ|1%&ey^gFxK^AuwpCi<JxUBvCzRO+;Cx;X^t~>(x>-6ij#bom?zDxor`m7V
z@JHj!TOr|fqU~JTpqNQuTa1m0^x?GzQRuVqN7dQR<=1&v=z)mS$A()K;@@z*UG6__
zzuM=KItE^}jS>$r5-sOTEl|dSFW2yp&5A>!4Uz>q)2kIcGaJ&&j}o7$u<VB||JRpH
z|0ixS_E&C!;36C>D5G^k>SpWDxA*+CtY+`9a;1Ei+SJEpZ_O8J*`v9*Tf`rl&E4C}
z>I#b+Z^$^jik%2F9-84NtOmN$EIsY3d3*ltS8Q$ZQGPK*GA>w&t-{;&MpEYLm89td
zsqHKVLexU`yVOHNC14^)zuZA}Z-H4V(^=lkp=6oo>b#@^Swy;mh}V*;+bE{-+4ij<
z!QKq<VBn|?@&ned1bS6qG?$;<2VA*F`VlMcUJx0a!Jiv7F?C=z{sq}S5Oo5$M3JC(
z7B#JUt2H8WYcFwpCiAe1=BZgM%};)isDCk<k$tQ5b$}}TLlJ&GF$2>GZ<Z4}f;+gy
zNpGJ3>a!`8>`nHDSC_)ub<%W{+dA}Hto>|9zw3?3Ia<{t&5YLMq*9X{vhr-|x8(XB
z2HP%uaN872Ni8^v<Mf@s&sTq|k{^o*LGaDQwRs5pNKQ7bFc&TUY8||=n|)<Ua>!J*
z(O8^r$sF}{B0(PX%=Auq0qdC%uX&*WzBEPQbk=Jg(Q$Ezck!+<oq~_0dQ4@nSGmP$
z9D~}pSu1K1@)Pcrts6$8GJT_-RE$(;z7M_IK%2pklrY=$)z-lv+Q)WVR@+MzA#73U
z%+2+!iD2Radj?T~wZZN<vtstMxSfvt4{CLPo!zioa_ekzT%KA;eznf%4JuFGOaXC`
zcm%xyAKU<|YquU>JC0>*>&dd#C^$@=-nXspWcL(<N=LP7xoYbyC!;V4#0ixvhWmaL
zk26qqq9>vKTf>bnzJfEgW2IL$gD!%-=+CppdB-;GA-W(_j{0c}n0@1b%RCi7!t4f4
zS7Efl*N(I$+j~NFbyNKUkT9xPI4*c=r03S~OjUO>&Eu$~X?f&`8;&My-BFO4H0udY
z3_T4}T{t$Z@CD<82>ICF$Jb7anfL~`FwWUJ*79nGH?P>cW?TY3cmt93wOGo087vVz
zePLsEt(q+#boT(U(pRj|{!*}eei<{c{$z)z#j-$9W?dtXW4U~l_~jd_`vXN92a1LX
z`4$oi+Dq6nZnj>zyS<we<NmPFA|O#`ywT*RvB|B1lz?vX8TYH-&x@78EMC(!2GY)p
zT$+4v`R-8||Awh-m7IQUu|e_*pP#~m56@cAJa1duA2JQ8I3>!<3q3sbDAN~|>0LG6
z>&)H0cqnx-;Z=$R)5se$x`~TI3qtbspzsB^jNzr)71lQyWe0o>@*U&uy*B-9%hJNI
z4Ac;-!8-}s-)VbWj+!&|*Dp<UNo~9=Gw*PCd<+c(U6Xo0kg&68O)J%J+H`hVA;7SH
zz3K9I@s!*5yN}c~_CTCdt&V5Dz0UbU&p;D<R%neULoiWqew2*l@3%u`2#lCyNtDW3
z@N%8+5Zdp>pT{{mWStpn;OFzmnHJ*H!A>`n!tV&}@f$3k<qmBcI{^d-LgWa&?bm#X
ziNDpvjyrD_o&W}mw+Zx2w{2cS`aLN-dkXMt?gR^8jrzp#Y~j?RL`ahDdOKAaHG-Ny
zL*nPEfKdYx6j9~Rsy@c6cR!3|#ND&V(N>JMK$_*t#0=yl9UG!W<GhS2bt3!^$j$QE
zPqTwPf_Pno_U4#yi3O>u?_g6TB>Fdb<0ogSRC(m@HCK&m{=J&yZp6n8BI9<ttw>Dk
zr1^xiFMs&_f;C$gPnH_pZ`60`EeI}3a|rn(f5daDzVgAfx$Su7SZQ&0O(x2m@zI7#
zO`2VHPxtO9r$KzJQ5S;*B-)Ck64R`zhdtm7$gZ<7l}}x;$^9@GqtEIUFat3g(VjKo
zv~J2Qc9?AcRsXHWwxRLkHh=tLN}{T8XGT`RcvBwMB@LSXvUR%yxMpsdXI~QFbA?HC
z_Imb9SwtQb{3V<R0Id52Y-tc4Vd^WLSv*jP741ir#js77Sk;NdY|u+czL5in!-DHH
zlbMX_KK-OURkBufR)*Fxb#bh?Ufek&z_3?+R&7BF=iudpSE$!}I6fRGw32;ovM1Hv
zJ$F%%6}Q}!+fY8kaYrt4k1;?c79$;M#ZWNW*oWlW<oDQ?ag~U<@U?u&aqZ%6LFCGv
zrQa9T`B}D8l~})5XY@R+)s5$f7wUjoedR`os{&{Y-~3z^nu~SZ%HN#-O)kIHCt%?q
z=!w$I(ke*-@&S3RKpNzE0wZRQphaOOz}vJk_kMPvGxn}TXLns7fyT8pvK`1Ua@daf
z4%)gxXLy{l%yRq+bW{n;op1D0W05nv1!@NqJoa?*R8O(E3(C|73>K#Ls233O4?!=7
zR9J}YB!_>$*!bVn<3%JOop#P?VszeltQ(-&CGBBjBboI^+ThDV8)?7BDtZ+iwQ7bD
z3r5b{xnf<>;^&ldYRWlp{(se-*H;tTy2XQtC>LadAc8>DD4?N9ks=Zm0Z~H)gh-7D
z2pD=VArT8mq-?shMCk}gXaZtL1VX5Sbm^VYdr2U`*=LM<-}ZSqPy0Un{)2C=HOKho
zT(iM8FC62n5{yzyZ@u<Y=7nPaKr_U&7uDOrh^gO8l^J9pc|-U@Zspaw=MUVz@_4SZ
zKynx!hB9Wl7qDg4S3XZzZns@;S$3A0zw*s)rn28n=_Wj%eTyQJ`s7r6^~Dk@Zz#Kv
zr5xd5s@RQc>H1IxA$v#a@|vB-K~90|%$$ioor2oKCmwPoTD`9SwMBC4-0C%b3;>)4
z2-iCaq{|0R*2L(A2W93rtF8++wi|Z&Lj)#e>x$ACiR~YBi^so7_V(-Nv1=d?zUMe+
zsy`NHh##u<-m(Aer5kbs8ux_$9UuEbG$(h^G38~Dk?$}!Xy~iQ?jG7S3_RvmBvde2
z6=l&VK<RC6@MLI&Sn(3%qT5JnHL;t-k{o*t0Q~0>;7p3^#TXb64a=wr!|e6$NRm!+
zgj%p-CNXc_zkW;Fh5DEa+)%nszb*YIMr>1Q$=>XecIN=_>zbi0KT&6>rE`_>i=|-V
z5M@;|#}}lqM969;u~BP-dfAQ6$|D-|+Z(3YqI-#?>+8PRsnDJz<*Gp8J6_~hFm+Pb
z>Tl!(FGX~X&`-1W;(EC31+92FO!g~YfsVfVE;2tP-oKoFCb?BKDo=(D9(8ZVr0l6h
zpkU#x>Mv^0$d+uYi?h?IY~it{{RONHX-<cE9K6xEv$K}nCkg5#BL&|`3_tH}I>*Wy
z4usqVZ)=hfQ;d3b$~BZqFIgQM#<ErZ{rz-2?H-n6nVfGN!WV$jPu6ln7)Qcus<#o0
zl3ldey10_z#m|vN%TS6rCd@)@V{96IovCILK`QD=clc4etGXo~1SMwHcOcTrPJi9-
z@vEc&duO^=e>Hg9dKl~8O5umJP%75iCRb!~Bh%H7!#7@pJa}^LY9q8`i6XTtgzQXO
z#L!mR8WU+Z9R;tgcm&7|)}%cw9{e<w<2fjVk`F=tRzd1`EQ*oD?f2oW2SFyu<Q4Q8
znnskq^wsZasn%f^jfOWZ#|Dl73b3w9*&^X5fUi{*4`;@)drNuYUnVnW4`3}NfrLDt
zjtjjigd!^iZX%bbSakY1L4869XYjLZM`1?w2(G8ehC_q&KdSYnwH<Mem5DFfp&*8}
z-2<)h)7u;2w5xrt=F3z26)af6940ZOp-At<UlQg*z~Yb8^wjj-KCi}|z>JJaK^}X?
zF9yL77WJC2-{{u3s>SuO>uI#hJ%U3{N7{CZ(It)5LCWf1Z&cu1X>$Ryj24}JNtf%3
zxCe?Zi&2oLa8k;@^{5JUZEdNYd8m*mNP^oTs>c9m5#6=431Z?zfdHhO7p%IUcawOz
zwW@jg-HQvsLGV?a<V<Pdho|^5E@qA3fgxU;85hPMZo>f?g*#t4=;@AU3$k#%e<`Eo
z@OAY_wW|mtEE{x?sime6idI@Qlc!dHOCe4TD&A;Yst1OWMh2OXonfX91WQ(So;nZ|
zMlK6vxb^UAC3VR#hO;gJFkcZs`hZ=-O#5Saf-1}R2mp!Q=YNedcnI$31OBmWSUpX3
zb_X`XQr7xkk+Q0APQ9g%p2f7mi53AtEjutpB3&!4W^opH{N=H3c<At-;zI75On5&I
zXiW1Sq$YYtqg36TZgtE@OMBJ#dgm_t_~Xw1awQ1gli>g*HA>YW9~JLoxvk)GpY@bd
zBntb>&!16_;9-A(SgcKaNHj2C=%`a>(@|Xs19{H28~L1{guSe9%IK+U_x23_j^x00
z#WnkFkxGAf{Iuwi(Aj)2K*-C|(tq5|`>0;r?^0EW$s^wLkz#vi9v54w3D2g^6zIE<
z&P`I_itiq&>Ki)t%xDzGn`wLX7o8ovN(6E|*YgTVctO!zKTe<B3C6WEfOi_VNMth1
zKG_d`<E`r%y=MHQ*UAW?0BUV@Zj?mt$Z+QY?s}qwv|RiT`mIGOsG+vGpvI<gOCfyV
z9WbyjF(=ao)2*drmGWfV>o#eS|97`evMy5~TWi5|b+)SdLZm?Q#t|S6KHX7w1PHfC
zZot2<hQD=*-&H%4Wpm%)7}&n`!GJj9c{)eW9(;8rCdYg($hsmnk6vOqNC(|BdIi|o
z)#~4Zhnu^^<CH8dTKoNX(RmFA7ptNpJ$#fb+&1GG$qA-i`$HJdoWBNVA#cOuzg}tn
zz3-B9mNaNG9tjj-OObN2uaf2s9m-SaY9L;NGm6v40H8N5Sa#`}%C5Hf`td#OqA1RA
zCx@u&Mp?(>k|Ewrq&@^zQ-t>OEHi*H;X7s3_Qv%v;wD~dLCd4leYB)0FaF*6Pz@~r
zMp64RGZS$>U~rMvFQ(~~Y@%qHW(rYEyv^HwBd_iL<#aD7`pP7l=WTzvr)OHX>*Z>d
zeL||A<F?4#r$yFQ!~kw%RmGj^{;@ppqKF6qPfM-d{O%kAo1hIBL{Cy;*BXkHEE{BW
z`6}b1ky9OEHkTg0x9eU_6U+oekI}f@iQq-*DeEHH;uf@-I8X=CX7vT9sj}!qMD2=p
z7D8KY!6$=ivN@h`34av_9m}^!ybuC*I7vtDRfc(eQCVAfY|T%*E_^;I=hWx%e()E|
z0yEVCLp?sv!QMI@&iI}+@HAULD?IB>qCrLqGCn^6CbTZ@bS2q|Q+Sg^le6LDe^f<I
zn5Ymqw{7?106D_8{xUdUQD$RJ0W=S>9|dzD_yedkfkldRSv=f8s@rT<K&~8Bc3a%t
z6cAY^uWz%>l++IkAm63Lemmf-{f1gpy{h2r&X|sF-0?rayHn%>QndUh%Z(;l!8Nm2
z@7M)jetPl7`hM~6_J9k2+>yXo$+@~N5i-llqn?Keof5lH_a*<wUmD;Txo|={g0OvX
z;$%7G^oUcCT+!W|c7CyS_MlbaDAD(#(n+<_(!+Z*7!MDkN!X8ZJ8|vGk-`4`JwJ%#
z`k9DL-Z5p*2IAB1F2!n8Vf&!BHr4-jCKfyo3+0i?t(JY?S$XZpn=KU%R`))F%^A1h
ztPN%wjzZ!D4hYBXkdUOi5eYt*FV>$vEkb?3!cQ1}DQ!4N*3h<hP3Z8|Is!z646KW7
zPFB_qC~V)-JTt}5Wdl~J@Rzp;mYZ_Hn)m6)NlAN%j@v)ub=-_MtaAEVpKq>LF*LJj
z1akRezr`I5;W_kKzsYf@&+Dy~Be){9>j=<>`w5u`?QOm)oVt#JY`@$F8K=uF&EhH!
z4H^TgmWfff&Ks!hI)?RdM;0GHAu8Fs<@Uir@RQ6Z&gj<^^R=^;?uCP&x$Rp#nlK+p
z`E0p>xVsm<BSdn8|GLd(A|)MpRJXoE6sFFZzDf4+uULx)h?{*3#}eFhosR)Xi;vP|
za|~b4=uexzR0By(N`l|_$^8Nep3orf&4htFwDf)QamM(MZ&KM=4JU2qj2OW<I;`Vb
z1gL(SW|ZzPMS(HDPjYp;v}d>&e5<-_8}#l7u(*!UW$x1|s)b8x1+8w}y|BE3oOKTm
zI(#QWWBPW8&L?Xw8G*@Wed`hF?dE=Qku5p5hc%{B*{yF&SBcLjmJzb<-yxr?EcuKx
zMC}~7uN)u5jzWEU_Fy}Y4^oc+6X!Q5Qq0Md**$Kydfl$p{%KE8Y9GCS{26)rg#HCd
zL-YX=Q?L2;urj+Le?iQr+N4cQu6!xiRHtdIxb)2ehw3l*&LJ#$VlCilXT5^|I@;wh
zU~=?ABSSRtk<GJ%<v7EIt1gM<m3Vl*k*@GOUP+j*P0{Md&aMne=v5*3m1*eGor1#i
zG%=N+!&uK81C@%=pm8W?xtCtBQmODWbXYFDtn^!su!!+B!<PM>O$d<cL<;q%o<f;R
zk+SL3wV0Rw@;iDEmcKM(<D(z_zOj;GO*I_8wrCP#Rvh*i6NEi`JLt9gVd6Yqj0{_c
z)#1*4XL_%Lp>JrKA>CZv+Z%U}U3%8io~c#z9c_}dh=XB1YH=07G7%9XSG1Qt;LgD}
zsPDh|o}9c~-08X4(p$7g{OJp|1`Y(8x}a_Uyc;k;_l}M&5b-s>(Mc)TdTDTzV6>a}
z_IVWJUaZauo2i=Ml|)CeOXC2*9GHPPIaV9UtCkc~^~dR(F?NXiPX0z#Ls?g+IjVxh
z*kf<zy9g;?RLdPF#I2VvN*!+IR)*JDIt64`(zz_3U&kI6{cz}+pXj>J?(%li<C?xu
zaDv=V^SD$ib$f?oM7Din1DizV#AXOZ754Oxqh*45Z{5rKuAO#~k*I4&+nxqMib+vy
z^dLTp409fj;nj1KcXPOJs?THZ-GghXG1wt}(w1S?%3Z`myAjGte{Niz@b2M9nJNst
zp;gPjD;#@(6Q}gC4T3#qEUhf*QR3HyANw1Ci0u!PE;w>iA8Z70N{1;+KqnnqMW%;X
zS9-S~pOgwFm4+*Foq153*j+oH#Qo-qqNJt0)tw-wa1QF+S~1oX%dnwHSuXyds{M?-
zSLEe)fipBTJ>5PI9hUEkGnbo+^V!ID;ELB6gc;#qrc%q+K3Y5tx}K$Lan%W<;3!H2
zE770OryPG88!jJyXm%mL#>x=mfByGPWd9)=KuSl;AGS*hG7}K+?yg%P8@Z~{yEh`L
zY6bIImY-PIcvkA3CU&avnIf}AK1_<oC`5FAMuV;_OOrJ_k@dFUt*~r`oWj!2XREGv
z)CZ4&Xg40&>J3SZlx#jn`GA0$)0jZrVE5PT=VI!F)ie*zV|V&vEcS7;U41)eE6HIR
zlkVg=8DGd_FL3Ku#Op)uo-4=?H(^VxG$tV>7PI>5?qMQR<Sg@w)<a*VYV266oY<B#
z+UY?0@RB?b_;6r0fuJxOJ?8C?0PhJhF;Amsg(4|amDfUa{hU2`wn>m~is;zfZ%aO-
z3?X)=QTNa*WXXqneNSA2KT@)!S%hFK?$~uHYu)j(2XLb<C1b<Iob5T3yz{n3k9YkO
zC`5{S_hD<(ctlQYaVA;6;ZU)nLLqGP%Hhd`7d5GjIyp=^!ltQ7GZXa*pI@6(yvF@b
z)<NW0-PPH4RC8@&*%5$K4m&Z~ae8y~BK?|og0t<^$Vl^U>HOfbgoc@I^7s)T&|)*$
zp>p&H(8Nr|aG~xn69X`1%Mx<aE+LsSZ;kZ0L#P2$1JGbnea8U4mLi-afuI>lReqt5
zJ`1dMvU3}<Q`d?9l-Q1(zdsdyS%CIgIDjV$fIfytc-B!wXUtWe5SFE?o52dYhyIR!
z&W)@jspQ_`jscTpiNVd_gFYQ2!OKsl9>34x`JxDrcqOzTL+XTu{omkRN<HWHJU|{~
z{yg?UwK{K6-s_WEe;_A2u!vHdi~{TCN&c{038m?%4d<l>*BQ?d^=EIR>t8bBhx><w
z;K^zBzaO=H`268r|6~nNXQU}0MzMJ@*o9C3{7SWfACffxi=9={#fFVX>AI>8X_W8h
zH$fD6-v(<YnXvl1Z3NbR;K9cUGwmm9CHO+j3!N-(eCMd_ll?@FId{ydcYW)!I9hln
znaW9)X?N%xbk!(J*IR1EKWn?q2D2Dg6hHk*T47?Z@lrO+p5j-==BE%EKZ>_xlxz)4
zkG!OI%oOxF2POC$adXGk^NemXiE7X_?XsK++a5DhaiHQed^0i!Dq;o_w4&eYabyuf
zjsPcShVST{C}t7BQ0L%WJT8)b1d!lWE3XmFrC_EX_kL9`nj8V4XyQC9Mgv;;B92eZ
zx1ru%5R2gc4M5HXviY3ROM4kT-EZi>8UT{`tHOmjOh~=v^^v^!zIEzu%L&Z>d@06)
zCB9fUy!c*O8UZv`nbV($V&MxPKBQXnBf#xS?BjtsA{rsBt3ij{^+A|gejw_0^}gOG
zNSW-%73URk(R09+YpW0(c!3&@IZi&cHls^Vwv(V|J^_yzYBfh|F3VfKfT>&YY%hSf
zZA8blNLR2vpr4T0MAF6_m0-|bHKp9<d|=%gm%Pz<?;wcU+Vt;?g3eUk|Nf=Lt02I1
zytD3>DF0#dri}a2EPXEbc0K5`=$wB3EQM=*bt#L;e7<6BH?bL|ZzvD@Z6AN8F7K0G
zd>Ch58*3hsxdji!d-QRu<t(jx_Gc$8GWLK*_34Nd`%>g7i07(E5u!C~(*mE2KGUlT
zIc;-*ThMULxodp?g)uq0CIDiDFlFjDoZUTtIijKjsO7i^uS6blujNG~906SBlQx?$
zGsGXIF-)-us>Npg8tg$?x|LIM*}yX7+FAMQ^GUKu))ZvTL@nq2)1usL`|j%gBt$em
zVw*Xt*s}S+eet@_>>+a1;*k53`RL`6!p}{%vG7zhIK7(<CO%b2Qg|M#|A+zE<3k<+
zY!{5>2i)rHeeWDzqFPR{rF^$f)&upEGA$NTSufEc@85Bm?0Q2{f1U3cwk~mKK<83<
z=zXAa5dS(UjSZcYGqLpVV&6R8U7qK3T|pKzItLL1FW9ZE-uvdd_c?Bh;dy#V2=8%@
zbF0Bu%<Wy4(;TQ<_EQBX+4BpY78;MpfYtF1X|&ncW|&2SLO{U4oK8Qgzh8)yHBFtj
zS|kVBgU4Zy0QhN?!31d_4Y97<^-^2y<I|^QZZ}FO^V0}Da2=yZ8@a@Pg2`QnKGvNK
zU87|1C4^Xaddt4umS@N}E<pWM;LBFG>NMP-P@Pl!!7N-UMjH>7d=cC*fJ3f4mwp*?
zsXS(+zjyfG&Ir5NWB+Ak$+5qyE%^t-`JeM5|2R1RgGczE2<P9M#r~0S{@wEV9}4IH
JtLDCee*v!CRkr{D

literal 0
Hc$@<O00001

diff --git a/airlink-forte-55610.html b/airlink-forte-55610.html
new file mode 100644
index 0000000..df94b47
--- /dev/null
+++ b/airlink-forte-55610.html
@@ -0,0 +1,2999 @@
+<!DOCTYPE html>
+<html lang="en">
+    <head>
+      <meta name="viewport" content="width=device-width, initial-scale=1.0">
+        <meta charset="utf-8">
+                        <title>CAPITAL PHARMA Brands</title>
+                <meta name="description" content="A-Z Drug Index for Prescription, Interactions & Side Effects, Medications and prescription drug information for consumers and medical health professionals.">
+                <meta name="keywords" content="Pharmacological Index, Search For Drug, A to Z Medicine in India, Indian Medicine Dictionary, The Best Pharmaceutical Company  ">
+                <meta name="author" content="">
+          
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/bootstrap.css" media="screen" />
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/icoMoon.css" media="all" />
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/superfish.css" media="screen" />
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/prettyPhoto.css" media="screen" />
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/flexslider.css" media="screen" />
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/style.css">
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/marquee.css">
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/bootstrap-responsive.css" media="all">
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/js/autocomplete/jquery.auto-complete.css">
+        <link href="http://www.drugtodayonline.com/assets-design/css/responsive.css" rel="stylesheet">
+        <script src="http://www.drugtodayonline.com/assets-design/js/modernizr.custom.js"></script>
+
+
+        <link href='http://fonts.googleapis.com/css?family=Rokkitt' rel='stylesheet' type='text/css'>
+        <link href='http://fonts.googleapis.com/css?family=Open+Sans' rel='stylesheet' type='text/css'>
+
+        <!-- Le HTML5 shim, for IE6-8 support of HTML5 elements -->
+
+        <!--[if lt IE 9]>
+            <script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
+            <script src="http://css3-mediaqueries-js.googlecode.com/svn/trunk/css3-mediaqueries.js"></script>
+            <link rel="stylesheet" href="css/ie.css" type="text/css" media="all" />
+			<script src="js/PIE_IE678.js"></script>
+        <![endif]-->
+        <link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/jquery.gritter.css" />
+        <script src="http://www.drugtodayonline.com/assets-design/js/jquery-1.8.3.min.js"></script>
+        <script src="http://www.drugtodayonline.com/assets-design/js/jquery-ui.min.js"></script>
+        <script src="http://www.drugtodayonline.com/assets-design/js/bootstrap.js"></script>
+        <script src="http://www.drugtodayonline.com/assets-design/js/bootbox.min.js"></script>
+        <script src="http://www.drugtodayonline.com/assets-design/js/jquery.gritter.min.js"></script>
+        <script src="http://www.drugtodayonline.com/assets-design/js/custom-function.js"></script>
+
+        <!-- Colors style -->
+    	<link rel="stylesheet" href="http://www.drugtodayonline.com/assets-design/css/colors/default.css" type="text/css" id="colors" />
+
+        <!-- Le fav and touch icons -->
+        <link rel="shortcut icon" href="http://www.drugtodayonline.com/assets-design/img/favicon.ico">
+        <link rel="apple-touch-icon" href="http://www.drugtodayonline.com/assets-design/img/apple-icon.png">
+        <link rel="apple-touch-icon" sizes="72x72" href="http://www.drugtodayonline.com/assets-design/img/apple-icon-72x72.png">
+        <link rel="apple-touch-icon" sizes="114x114" href="http://www.drugtodayonline.com/assets-design/img/apple-icon-114x114.png">
+		<script type="text/javascript" src="//platform-api.sharethis.com/js/sharethis.js#property=5c52f3cd89f1bd00113e1c18&product=custom-share-buttons"></script>
+
+  <!-- Global site tag (gtag.js) - Google Analytics -->
+<script async src="https://www.googletagmanager.com/gtag/js?id=UA-47276742-2"></script>
+<script>
+  window.dataLayer = window.dataLayer || [];
+  function gtag(){dataLayer.push(arguments);}
+  gtag('js', new Date());
+
+  gtag('config', 'UA-47276742-2');
+</script>
+
+</head>
+
+<body>
+<div id="fb-root"></div>
+<script>(function(d, s, id) {
+  var js, fjs = d.getElementsByTagName(s)[0];
+  if (d.getElementById(id)) return;
+  js = d.createElement(s); js.id = id;
+  js.src = 'https://connect.facebook.net/en_GB/sdk.js#xfbml=1&version=v3.2&appId=525526284189788&autoLogAppEvents=1';
+  fjs.parentNode.insertBefore(js, fjs);
+}(document, 'script', 'facebook-jssdk'));</script>
+<div class="wrapper kopa-shadow">
+    <div class="row-fluid">
+
+        <div class="span12 clearfix">
+            <header id="page-header">
+                <div id="header-top" class="clearfix">
+                    <div class="span5" id="cdatetime">
+
+                    </div>
+                    <div class="span2 solink">
+                      <ul class="social-links clearfix">
+                        <li><a href="https://www.facebook.com/drugtodaymedicaltimes" class="icon-facebook" target="_blank"></a></li>
+                        <li><a href="https://twitter.com/DTMedicalTimes" class="icon-twitter" target="_blank"></a></li>
+                        <!--<li><a href="#" class="icon-google"></a></li>
+                        <li><a href="#" class="icon-instagram"></a></li>-->
+                        <li><a href="http://www.drugtodayonline.com/cart.php" class="icon-cart" title="Drugtoday Cart"></a></li>
+                                                <li><a href="http://www.drugtodayonline.com/login.php" class="icon-user" title="Drugtoday Login"></a></li>
+                                            </ul><!--social-links-->
+                    </div>
+                    <div class="sdrug-text span2">Search Drug</div>
+                    <div class="span3 sform-box">
+                      <!--div class="sb-search">
+                        <form method="get" action="article-search.php" id="afrm" class="pure-form" style="border-top: 1px solid #eee;border-bottom:1px solid #eee;background:#fafafa;margin:30px 0;padding:20px 10px;text-align:center">
+                            <input id="aq" autofocus type="text" name="aq" placeholder="Search Articles ..." style="outline:0">
+                            <span class="sb-icon-search" onclick="afrm.submit();"></span>
+                        </f orm>
+                      </div-->
+
+
+                      <div class="sb-search">
+                        <form class="pure-form">
+                            <input id="csearch" autofocus type="text" name="q" placeholder="Search Generic,Company,Brand ..." style="outline:0">
+                            <span class="sb-icon-search" onclick="callMe();"></span>
+                        </form>
+                      </div>
+                      <div class="search-popup" id="search-result" style="display:none;">
+
+                      </div>
+
+                    </div>
+
+
+                </div><!--header-top-->
+
+                <div id="header-middle" class="clearfix">
+
+                	<div id="logo-image">
+                    	<a href="http://www.drugtodayonline.com/"><img src="http://www.drugtodayonline.com/assets-design/placeholders/logo.png" alt="Drug Today Online" /></a>
+                    </div><!--logo-image-->
+
+                    <div class="top-banner">
+                                                <a href="http://www.drugmedpharma.com/" target="_blank"><img src="http://www.drugtodayonline.com/siteimg/ads/th-1580716963.jpg" alt="Drugmed Pharma" title="Drugmed Pharma" /></a>
+                                          </div><!--top-banner-->
+
+                </div><!--header-middle-->
+
+               <div id="header-bottom">
+
+              		<nav id="main-nav">
+
+                        <ul id="main-menu" class="clearfix">
+                        	<li class="current-menu-item"><a href="http://www.drugtodayonline.com/">Home</a><span></span></li>
+                            <li>
+                            	<a href="#">Medical News</a><span></span>
+                                <ul>
+                                  	                                    <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=business">Business</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/business.html">Business</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=city">City</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/city.html">City</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=exclusive">Exclusive</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/exclusive.html">Exclusive</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=globe">Globe</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/globe.html">Globe</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=institutions">Institutions</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/institutions.html">Institutions</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=latest">Latest</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/latest.html">Latest</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=mix">Mix</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/mix.html">Mix</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=nation">Nation </a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/nation.html">Nation </a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=opinion">Opinion</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/opinion.html">Opinion</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=paramedical">Paramedical</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/paramedical.html">Paramedical</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=pharmacy">Pharmacy</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/pharmacy.html">Pharmacy</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=review">Review</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/review.html">Review</a>
+                                    </li>
+                                                                        <li>
+                                      <!--a href="http://www.drugtodayonline.com/articles.php?cid=trends">Trends</a-->
+                                      <a href="http://www.drugtodayonline.com/medical-news/trends.html">Trends</a>
+                                    </li>
+                                                                    </ul>
+                            </li>
+                                                            <li><a href="http://www.drugtodayonline.com/buy-subscriptions.php">Buy Subscription</a><span></span>
+                                  <!--ul>
+                                                                        <li>
+                                      <a href="http://www.drugtodayonline.com/buy-subscriptions.php?cid=3">Drug Today Book</a>
+                                    </li>
+                                                                        <li>
+                                      <a href="http://www.drugtodayonline.com/buy-subscriptions.php?cid=4">Medical News Paper</a>
+                                    </li>
+                                                                        <li>
+                                      <a href="http://www.drugtodayonline.com/buy-subscriptions.php?cid=9">Advertisement Slider</a>
+                                    </li>
+                                    
+                                  </ul-->
+                                </li>
+                                                            <li><a href="http://www.drugtodayonline.com/advertisement.php">For Advertisement</a><span></span>
+                                  <!--ul>
+                                                                        <li>
+                                      <a href="http://www.drugtodayonline.com/advertisement.php?cid=5">Drugtoday News Paper Advertisment</a>
+                                    </li>
+                                                                        <li>
+                                      <a href="http://www.drugtodayonline.com/advertisement.php?cid=6">Drugtoday Book Advertisment</a>
+                                    </li>
+                                                                        <li>
+                                      <a href="http://www.drugtodayonline.com/advertisement.php?cid=7">Drugtoday Online Advertisment</a>
+                                    </li>
+                                    
+                                  </ul-->
+                                </li>
+                                                        <li>
+                            	<a href="http://www.drugtodayonline.com/drug-directory.html">Drug Directory</a><span></span>
+                                <ul>
+                                                                        <li>
+                                        <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76">Pharmacological Index</a-->
+                                        <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index.html">Pharmacological Index</a>
+                                          <ul>                                              <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=105">Alimentary system</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/alimentary-system.html">Alimentary system</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=102">Antibiotics</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/antibiotics.html">Antibiotics</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=100">Cardiovascular System</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/cardiovascular-system.html">Cardiovascular System</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=103">Central Nervous system(CNS)</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/central-nervous-system-cns.html">Central Nervous system(CNS)</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=108">Eyes</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/eyes.html">Eyes</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=104">Genito-Urinary Tract</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/genito-urinary-tract.html">Genito-Urinary Tract</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=110">Hormones</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/hormones.html">Hormones</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=112">Metabolism</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/metabolism.html">Metabolism</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=101">Musculo-Skeletal Disorders</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/musculo-skeletal-disorders.html">Musculo-Skeletal Disorders</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=111">Nutrition</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/nutrition.html">Nutrition</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=109">Oropharyngeal</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/oropharyngeal.html">Oropharyngeal</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=107">Respiratory System And Anti-allergic</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/respiratory-system-and-anti-allergic.html">Respiratory System And Anti-allergic</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=106">Skin</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/skin.html">Skin</a>
+
+                                              </li>
+                                                                                      <li>
+                                                <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=113">Surgical and Vaccines</a-->
+                                                <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/surgical-and-vaccines.html">Surgical and Vaccines</a>
+
+                                              </li>
+                                        </ul>                                      </li>
+                                                                        <li>
+                                        <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=77">Hospital Equipments Manufacturer</a-->
+                                        <a href="http://www.drugtodayonline.com/drug-directory/hospital-equipments-manufacturer.html">Hospital Equipments Manufacturer</a>
+                                                                                </li>
+                                                                        <li>
+                                        <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=78">Lab's Equipments Manufacturer</a-->
+                                        <a href="http://www.drugtodayonline.com/drug-directory/labs-equipments-manufacturer.html">Lab's Equipments Manufacturer</a>
+                                                                                </li>
+                                                                        <li>
+                                        <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=87">Medical College & Institute</a-->
+                                        <a href="http://www.drugtodayonline.com/drug-directory/medical-college-a-institute.html">Medical College & Institute</a>
+                                                                                </li>
+                                                                        <li>
+                                        <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=89">Packing Material & Bulk Drug Supplier</a-->
+                                        <a href="http://www.drugtodayonline.com/drug-directory/packing-material-and-bulk-drug-supplier.html">Packing Material & Bulk Drug Supplier</a>
+                                                                                </li>
+                                                                        <li>
+                                        <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=94">Private Jobs</a-->
+                                        <a href="http://www.drugtodayonline.com/drug-directory/pharma-jobs.html">Private Jobs</a>
+                                                                                </li>
+                                                                  </ul>
+                            </li>
+
+
+                            <li><a href="http://www.drugtodayonline.com/drug-directory/pharma-jobs.html">Pharma Jobs</a><span></span></li>
+                            <li><a href="http://www.drugtodayonline.com/third-party-manufacturing.html">Third Party Manufacturing</a><span></span></li>
+                            <li><a href="http://www.drugtodayonline.com/e-newspaper.php">E Newspaper</a><span></span></li>
+                        </ul><!--main-menu-->
+
+                        <div id="mobile-menu">
+                            <span>Menu</span>
+                            <ul id="toggle-view-menu">
+                                <li class="clearfix"><h3><a href="http://www.drugtodayonline.com/">Home</a></h3></li>
+                                <li class="clearfix">
+                                	<h3><a href="#">Medical News</a></h3>
+                                  <span>+</span>
+                                  <div class="clear"></div>
+                                  <div class="menu-panel clearfix">
+                                    <ul>
+                                      	                                        <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=92">Business</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/business.html">Business</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=90">City</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/city.html">City</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=91">Exclusive</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/exclusive.html">Exclusive</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=81">Globe</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/globe.html">Globe</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=88">Institutions</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/institutions.html">Institutions</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=82">Latest</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/latest.html">Latest</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=93">Mix</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/mix.html">Mix</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=83">Nation </a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/nation.html">Nation </a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=101">Opinion</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/opinion.html">Opinion</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=86">Paramedical</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/paramedical.html">Paramedical</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=87">Pharmacy</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/pharmacy.html">Pharmacy</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=85">Review</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/review.html">Review</a>
+                                        </li>
+                                                                                <li>
+                                          <!--a href="http://www.drugtodayonline.com/articles.php?cid=102">Trends</a-->
+                                          <a href="http://www.drugtodayonline.com/medical-news/trends.html">Trends</a>
+                                        </li>
+                                                                            </ul>
+                                  </div>
+                                </li>
+                                                                    <li class="clearfix"><h3><a href="http://www.drugtodayonline.com/buy-subscriptions.php">Buy Subscription</a></h3>
+                                      <span>+</span>
+                                      <div class="clear"></div>
+                                      <div class="menu-panel clearfix">
+                                      <!--ul>
+                                                                                <li>
+                                          <a href="http://www.drugtodayonline.com/buy-subscriptions.php?cid=3">Drug Today Book</a>
+                                        </li>
+                                                                                <li>
+                                          <a href="http://www.drugtodayonline.com/buy-subscriptions.php?cid=4">Medical News Paper</a>
+                                        </li>
+                                                                                <li>
+                                          <a href="http://www.drugtodayonline.com/buy-subscriptions.php?cid=9">Advertisement Slider</a>
+                                        </li>
+                                        
+                                      </ul-->
+                                      </div>
+                                    </li>
+                                                                    <li class="clearfix"><h3><a href="http://www.drugtodayonline.com/advertisement.php">For Advertisement</a></h3>
+                                      <span>+</span>
+                                      <div class="clear"></div>
+                                      <div class="menu-panel clearfix">
+                                      <!--ul>
+                                                                                <li>
+                                          <a href="http://www.drugtodayonline.com/advertisement.php?cid=5">Drugtoday News Paper Advertisment</a>
+                                        </li>
+                                                                                <li>
+                                          <a href="http://www.drugtodayonline.com/advertisement.php?cid=6">Drugtoday Book Advertisment</a>
+                                        </li>
+                                                                                <li>
+                                          <a href="http://www.drugtodayonline.com/advertisement.php?cid=7">Drugtoday Online Advertisment</a>
+                                        </li>
+                                        
+                                      </ul-->
+                                      </div>
+                                    </li>
+                                                                <li>
+                                	<h3><a href="http://www.drugtodayonline.com/drug-directory.html">Drug Directory</a></h3>
+                                  <span>+</span>
+                                  <div class="clear"></div>
+                                  <div class="menu-panel clearfix">
+                                    <ul>
+                                                                                <li>
+                                            <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76">Pharmacological Index</a-->
+                                            <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index.html">Pharmacological Index</a>
+                                              <ul>                                                  <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=105">Alimentary system</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/alimentary-system.html">Alimentary system</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=102">Antibiotics</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/antibiotics.html">Antibiotics</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=100">Cardiovascular System</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/cardiovascular-system.html">Cardiovascular System</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=103">Central Nervous system(CNS)</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/central-nervous-system-cns.html">Central Nervous system(CNS)</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=108">Eyes</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/eyes.html">Eyes</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=104">Genito-Urinary Tract</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/genito-urinary-tract.html">Genito-Urinary Tract</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=110">Hormones</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/hormones.html">Hormones</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=112">Metabolism</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/metabolism.html">Metabolism</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=101">Musculo-Skeletal Disorders</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/musculo-skeletal-disorders.html">Musculo-Skeletal Disorders</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=111">Nutrition</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/nutrition.html">Nutrition</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=109">Oropharyngeal</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/oropharyngeal.html">Oropharyngeal</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=107">Respiratory System And Anti-allergic</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/respiratory-system-and-anti-allergic.html">Respiratory System And Anti-allergic</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=106">Skin</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/skin.html">Skin</a>
+
+                                                  </li>
+                                                                                              <li>
+                                                    <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=76&sid=113">Surgical and Vaccines</a-->
+                                                    <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-index/surgical-and-vaccines.html">Surgical and Vaccines</a>
+
+                                                  </li>
+                                            </ul>                                          </li>
+                                                                                <li>
+                                            <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=77">Hospital Equipments Manufacturer</a-->
+                                            <a href="http://www.drugtodayonline.com/drug-directory/hospital-equipments-manufacturer.html">Hospital Equipments Manufacturer</a>
+                                                                                        </li>
+                                                                                <li>
+                                            <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=78">Lab's Equipments Manufacturer</a-->
+                                            <a href="http://www.drugtodayonline.com/drug-directory/labs-equipments-manufacturer.html">Lab's Equipments Manufacturer</a>
+                                                                                        </li>
+                                                                                <li>
+                                            <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=87">Medical College & Institute</a-->
+                                            <a href="http://www.drugtodayonline.com/drug-directory/medical-college-a-institute.html">Medical College & Institute</a>
+                                                                                        </li>
+                                                                                <li>
+                                            <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=89">Packing Material & Bulk Drug Supplier</a-->
+                                            <a href="http://www.drugtodayonline.com/drug-directory/packing-material-and-bulk-drug-supplier.html">Packing Material & Bulk Drug Supplier</a>
+                                                                                        </li>
+                                                                                <li>
+                                            <!--a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=94">Private Jobs</a-->
+                                            <a href="http://www.drugtodayonline.com/drug-directory/pharma-jobs.html">Private Jobs</a>
+                                                                                        </li>
+                                                                          </ul>
+                                  </div>
+                                </li>
+                                <li class="clearfix"><h3><a href="http://www.drugtodayonline.com/pharmacological-index.php?cid=94">Pharma Jobs</a></h3></li>
+                                <li class="clearfix"><h3><a href="http://www.drugtodayonline.com/third-party-manufacturing.html">Third Party Manufacturing</a></h3></li>
+                                <li class="clearfix"><h3><a href="http://www.drugtodayonline.com/e-newspaper.php">E Newspaper</a></h3></li>
+                            </ul><!--toggle-view-menu-->
+                        </div><!--mobile-menu-->
+
+                    </nav><!--main-nav-->
+
+               </div><!--header-bottom-->
+
+            </header><!--page-header-->
+
+            
+            <style>
+              .sideAdsL{height:360px;width:170px;position: fixed;bottom:1px;left:1px;display: block;background: #cccccc;z-index: 10;}
+              .sideAdsL .saHead{width: 100%;height: 30px;text-align: right;position: relative;}
+              .sideAdsL .saBody{width: 100%;height: 270px;text-align: right;position: relative;}
+              .img-responsive{
+                display: block;
+                width: 100% \9;
+                max-width: 100%;
+                height: auto;
+              }
+              .sideAds{height:360px;width:170px;position: fixed;bottom:1px;right:1px;display: block;background: #cccccc;z-index: 10;}
+              .sideAds .saHead{width: 100%;height: 30px;text-align: right;position: relative;}
+              .sideAds .saBody{width: 100%;height: 270px;text-align: right;position: relative;}
+
+              @media screen and (max-width: 800px) {
+                .sideAdsL{
+                  visibility: hidden;
+                  clear: both;
+                  display: none;
+                }
+                .sideAds{
+                  visibility: hidden;
+                  clear: both;
+                  display: none;
+                }
+              }
+            </style>
+            <div class="sideAdsL" id="sideAdsL">
+              <div class="saHead">
+                  <a href="javascript:void(0);" id="dismisadL">X Close</a>
+              </div>
+              <div class="saBody">
+                <a href='http://www.drugtodayonline.com/productdetails.php?pid=42' target="_blank"><img src='http://www.drugtodayonline.com/siteimg/ads/th-1584355930.jpg' alt='CLEAN-ALL' /></a>
+              </div>
+              <script>
+                $("#dismisadL").click(function(){
+                  $("#sideAdsL").css({"display":"none"});
+                });
+              </script>
+            </div>
+                        <div class="sideAds" id="sideAds">
+            <div class="saHead">
+                <a href="javascript:void(0);" id="dismisad">X Close</a>
+            </div>
+            <div class="saBody">
+              <a href='http://www.drugtodayonline.com/pcd-franchisee.php' target="_blank"><img src='http://www.drugtodayonline.com/siteimg/ads/th-1547624192.jpg' alt='Pharmaceutical companies in India' /></a>
+            </div>
+            <script>
+              $("#dismisad").click(function(){
+                $("#sideAds").css({"display":"none"});
+              });
+            </script>
+            </div>
+          <script>
+  function showBrands()
+  {
+    $("#cmpbrands").css("display","inline-block");
+    $('html, body').animate({scrollTop: $("#cmpbrands").offset().top}, 800);
+  }
+  function showSubstitute()
+  {
+    $("#substitute").css("display","inline-block");
+    $('html, body').animate({scrollTop: $("#substitute").offset().top}, 800);
+  }
+  function showOthercomb()
+  {
+    $("#othercomb").css("display","inline-block");
+    $('html, body').animate({scrollTop: $("#othercomb").offset().top}, 800);
+  }
+</script>
+<div id="main-content">
+
+    <!--div class="row-fluid">
+        <div class="span12">
+            <div class="breadcrumb clearfix">
+                <span>You are here:</span>
+                <a href="index.html">Home</a>
+                <span>/</span>
+                <a href="pharmalogical-index.php">Pharma Companies</a>
+                <span>/</span>
+                <span class="current-page">Company Name </span>
+            </div>
+        </div>
+    </div--><!--row-fluid-->
+    <div class="clearfix"></div>
+
+    <div class="clearfix"></div>
+
+    <div id="main-col" style="position:relative;">
+      <div class="main-col-cls">
+  <a href="https://mediboonpharma.com/" target="_blank"><img src="http://www.drugtodayonline.com/siteimg/banner/th-1580816771.jpg" alt="Mediboon" title="Mediboon" class="img-responsive" /></a>
+</div>
+<div class="clear"></div>
+<div class="kopa-divider"></div>
+        <h3 class="heading-black" style="display:inline-block"> AIRLINK FORTE</h3>
+                <div class="clearfix"></div>
+        <p style="padding-right:10px;">Manufactured by :
+          <!--a href="company-info.php?cid=3381">CAPITAL PHARMA</a-->
+          <a href="http://www.drugtodayonline.com/drug-directory/pharmacological-companies/capital-pharma.html">CAPITAL PHARMA</a>
+		  </p>
+          <div class="tag-box1" style="display:inline-block">
+            <a href="javascript:void(0)" onclick="showSubstitute()" style="font-size:14px;">Other Substitutes</a>
+          </div>
+          <div class="tag-box1" style="display:inline-block;position:absolute;right:335px;"><a href="javascript:void(0)" onclick="showBrands()" style="font-size:14px;">Others Brands</a></div>
+          <div class="tag-box1" style="display:inline-block;position:absolute;right:10px;"><a href="javascript:void(0)" onclick="showOthercomb()" style="font-size:14px;">Others Combination Brands</a></div>
+
+        <hr>
+        <h4 class="heading-black">Generic Used</h4>
+        <div class="tag-box1">
+                        <!--a href="http://www.drugtodayonline.com/generic-info.php?gid=613">Acebrophylline</a-->
+              <a href="http://www.drugtodayonline.com/drug-directory/acebrophylline.html?salt_id=613">Acebrophylline</a>
+                        <!--a href="http://www.drugtodayonline.com/generic-info.php?gid=1064">Guaiphenesin</a-->
+              <a href="http://www.drugtodayonline.com/drug-directory/guaiphenesin.html?salt_id=1064">Guaiphenesin</a>
+                        <!--a href="http://www.drugtodayonline.com/generic-info.php?gid=1793">Terbutaline Sulphate</a-->
+              <a href="http://www.drugtodayonline.com/drug-directory/terbutaline-sulphate.html?salt_id=1793">Terbutaline Sulphate</a>
+                  </div>
+        <hr>
+        <div class="widget-area-3">
+          <div class="widget kopa-entry-list-widget">
+          	<h4 class="heading-black">Packaging details</h4>
+            <div class="pd-mainbox span12">
+            	<div class="pd-box pd-box1 span12">
+                  <div class="pd span2">Type</div>
+                  <div class="pd span4">Strength</div>
+                  <div class="pd span2">Packing</div>
+                  <div class="pd span2">MRP</div>
+                  <div class="pd span2">PTR</div>
+              	</div>
+                                  <div class="pd-box pd-box2 span12">
+                    <div class="pd span2">tab</div>
+                    <div class="pd span4">100+100+5mg</div>
+                    <div class="pd span2">10</div>
+                    <div class="pd span2">79.00</div>
+                    <div class="pd span2">NA</div>
+                  </div>
+                
+             </div>
+          </div>
+        </div>
+        <hr>
+
+        <h3 class="heading-black"></h3>
+        <div class="widget-area-110 no-leftborder" id="substitute" style="display:none">
+          <div class="widget kopa-entry-list-widget">
+          	<h4 class="heading-black">Other Brands with Same Generic</h4>
+            <div class="box">
+                                        <a href="http://www.drugtodayonline.com/drug-directory/airlink-forte/airlink-forte-55610.html">AIRLINK FORTE</a>
+                                                <a href="http://www.drugtodayonline.com/drug-directory/tusp-ab/tusp-ab-47247.html">TUSP-AB</a>
+                                  </div>
+          </div>
+        </div>
+
+        <div class="widget-area-110" id="cmpbrands" style="display:none">
+          <div class="widget kopa-entry-list-widget">
+          	<h4 class="heading-black">Company Other Brands</h4>
+            <div class="box">
+                                  <a href="http://www.drugtodayonline.com/drug-directory/a-clav/a-clav-55604.html">A-CLAV</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/a-top/a-top-55627.html">A-TOP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ac-bose/ac-bose-55602.html">AC-BOSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/acl/acl-55603.html">ACL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/action-cof/action-cof-55605.html">ACTION-COF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/active-cap/active-cap-55606.html">ACTIVE CAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/active-inj/active-inj-55607.html">ACTIVE INJ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/active-plus/active-plus-55608.html">ACTIVE-PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/adl/adl-55609.html">ADL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/airlink-plus/airlink-plus-55611.html">AIRLINK PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/airlink-plus-ax/airlink-plus-ax-55612.html">AIRLINK PLUS-AX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/airlink-fb/airlink-fb-55613.html">AIRLINK-FB</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/airlink-ff/airlink-ff-55614.html">AIRLINK-FF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/airlink-tfc/airlink-tfc-55615.html">AIRLINK-TFC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/airlink-xp/airlink-xp-55616.html">AIRLINK-XP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/all-q/all-q-55617.html">ALL-Q</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/allzyme/allzyme-55618.html">ALLZYME</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/alzol/alzol-55619.html">ALZOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/amicare/amicare-55620.html">AMICARE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/amoped-cv/amoped-cv-55950.html">AMOPED CV</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/amsol/amsol-55621.html">AMSOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/amtrex/amtrex-55622.html">AMTREX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ancaine/ancaine-55623.html">ANCAINE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/argicap/argicap-55624.html">ARGICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/arocet/arocet-55625.html">AROCET</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/arpicap/arpicap-55626.html">ARPICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ax-250-500/ax-250-500-55628.html">AX-250/500</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/azitop/azitop-55629.html">AZITOP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/baclocap/baclocap-55630.html">BACLOCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/baclomax-gm/baclomax-gm-55631.html">BACLOMAX-GM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/best-8-16/best-8-16-55632.html">BEST-8/16</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/bioflex-4/bioflex-4-55633.html">BIOFLEX-4</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/brocap/brocap-55634.html">BROCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/c-clav/c-clav-55694.html">C-CLAV</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capceph-ds/capceph-ds-55635.html">CAPCEPH-DS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capcoril-ls/capcoril-ls-55636.html">CAPCORIL-LS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capi-gm/capi-gm-55659.html">CAPI-GM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capi-gold/capi-gold-55660.html">CAPI-GOLD</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capi-qa/capi-qa-55664.html">CAPI-QA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capical-500/capical-500-55637.html">CAPICAL-500</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capicetam-250-500/capicetam-250-500-55638.html">CAPICETAM-250/500</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capiclin-600/capiclin-600-55639.html">CAPICLIN-600</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capigem/capigem-55656.html">CAPIGEM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capigest/capigest-55657.html">CAPIGEST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capiglit-m/capiglit-m-55658.html">CAPIGLIT M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capigrel-a/capigrel-a-55661.html">CAPIGREL-A</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capinol-la/capinol-la-55662.html">CAPINOL LA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capipenam/capipenam-55663.html">CAPIPENAM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capired/capired-55665.html">CAPIRED</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capiric/capiric-55666.html">CAPIRIC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capirose/capirose-55667.html">CAPIROSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capivas/capivas-55668.html">CAPIVAS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capivas-h/capivas-h-55669.html">CAPIVAS-H</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capivit/capivit-55670.html">CAPIVIT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capmoist/capmoist-55671.html">CAPMOIST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capress/capress-55672.html">CAPRESS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capride/capride-55674.html">CAPRIDE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capride-m/capride-m-55673.html">CAPRIDE-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capro-bm/capro-bm-55675.html">CAPRO-BM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/caproflex-trio/caproflex-trio-55676.html">CAPROFLEX-TRIO</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/caproneph/caproneph-55677.html">CAPRONEPH</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capsalic/capsalic-55678.html">CAPSALIC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capsense/capsense-55679.html">CAPSENSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capsia/capsia-55680.html">CAPSIA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capsin/capsin-55681.html">CAPSIN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capsivon-p/capsivon-p-55682.html">CAPSIVON P</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capsivon-nasal-drops/capsivon-nasal-drops-55683.html">CAPSIVON-NASAL DROPS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/captar/captar-55684.html">CAPTAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/captar-d/captar-d-55685.html">CAPTAR-D</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/captar-dsr/captar-dsr-55686.html">CAPTAR-DSR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/captar-lsr/captar-lsr-55687.html">CAPTAR-LSR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/captaz/captaz-55688.html">CAPTAZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capzole/capzole-55689.html">CAPZOLE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capzone/capzone-55690.html">CAPZONE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/capzone-s/capzone-s-55691.html">CAPZONE-S</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/carniday-syp/carniday-syp-55692.html">CARNIDAY SYP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/carniday-tab/carniday-tab-55693.html">CARNIDAY TAB</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cefix/cefix-55695.html">CEFIX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ceflor/ceflor-55696.html">CEFLOR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ceftil/ceftil-55697.html">CEFTIL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cepha/cepha-55698.html">CEPHA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetmine/cetmine-55699.html">CETMINE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetmine-d-syp/cetmine-d-syp-55700.html">CETMINE-D SYP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetmine-d-tab/cetmine-d-tab-55701.html">CETMINE-D TAB</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetop/cetop-55702.html">CETOP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetri/cetri-55703.html">CETRI</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetroxol-syp/cetroxol-syp-55704.html">CETROXOL SYP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cetroxol-tab/cetroxol-tab-55705.html">CETROXOL TAB</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cezinc/cezinc-55707.html">CEZINC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cezinc-plus/cezinc-plus-55706.html">CEZINC PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/chill/chill-55708.html">CHILL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/chill-plus/chill-plus-55709.html">CHILL-PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/chirocap/chirocap-55710.html">CHIROCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/chlorest/chlorest-55711.html">CHLOREST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/chlorest-ah/chlorest-ah-55712.html">CHLOREST-AH</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cifix/cifix-55713.html">CIFIX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ciss-built/ciss-built-55714.html">CISS BUILT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/clear/clear-55715.html">CLEAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/clinicap/clinicap-55716.html">CLINICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/clobe/clobe-55717.html">CLOBE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/clocap/clocap-55718.html">CLOCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/clomicap/clomicap-55719.html">CLOMICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/clonar/clonar-55720.html">CLONAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cofsol/cofsol-55721.html">COFSOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/crany-dm/crany-dm-55722.html">CRANY-DM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cucof/cucof-55723.html">CUCOF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/cyplin/cyplin-55724.html">CYPLIN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/d-clav-dry-syp/d-clav-dry-syp-55725.html">D-CLAV DRY SYP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/deltabest-d3/deltabest-d3-55726.html">DELTABEST D3</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dexyl/dexyl-55727.html">DEXYL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dgm-forte/dgm-forte-55728.html">DGM FORTE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dic-gel/dic-gel-55729.html">DIC-GEL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dic-plus/dic-plus-55731.html">DIC-PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dic-plus-inj/dic-plus-inj-55732.html">DIC-PLUS INJ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dicor-250-500/dicor-250-500-55730.html">DICOR-250/500</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/different/different-55733.html">DIFFERENT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dipiz/dipiz-55734.html">DIPIZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dipiz-m/dipiz-m-55735.html">DIPIZ-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/direct/direct-55736.html">DIRECT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dispas/dispas-55737.html">DISPAS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dispas-d/dispas-d-55738.html">DISPAS-D</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/doms/doms-55739.html">DOMS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/doxime/doxime-55740.html">DOXIME</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/doxime-cv/doxime-cv-55741.html">DOXIME-CV</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/doxma/doxma-55742.html">DOXMA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/drocef/drocef-55743.html">DROCEF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/drocef-cv/drocef-cv-55744.html">DROCEF-CV</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/drycof/drycof-55745.html">DRYCOF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ducof/ducof-55746.html">DUCOF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dx-drops/dx-drops-55747.html">DX-DROPS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/dzire/dzire-55748.html">DZIRE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/escam/escam-55749.html">ESCAM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/escam-plus/escam-plus-55750.html">ESCAM PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/esocap/esocap-55751.html">ESOCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/esocap-dsr/esocap-dsr-55752.html">ESOCAP-DSR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/espril/espril-55753.html">ESPRIL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/etocap/etocap-55754.html">ETOCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/etocap-p/etocap-p-55755.html">ETOCAP-P</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/excellent/excellent-55756.html">EXCELLENT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/f-5-10/f-5-10-55757.html">F-5/10</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fericap-xt/fericap-xt-55758.html">FERICAP XT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fericap-xt-tab/fericap-xt-tab-55759.html">FERICAP XT TAB</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fetose/fetose-55760.html">FETOSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fexofit/fexofit-55761.html">FEXOFIT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fine-drops/fine-drops-55762.html">FINE DROPS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fluidic/fluidic-55763.html">FLUIDIC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fluidic-b/fluidic-b-55764.html">FLUIDIC-B</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fluprint-p/fluprint-p-55765.html">FLUPRINT-P</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/flutreat/flutreat-55766.html">FLUTREAT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/flymin/flymin-55767.html">FLYMIN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/footmoist/footmoist-55768.html">FOOTMOIST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/freblock/freblock-55769.html">FREBLOCK</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/freblock-at/freblock-at-55770.html">FREBLOCK-AT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/freetool/freetool-55771.html">FREETOOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/frenvit/frenvit-55772.html">FRENVIT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/freshlac/freshlac-55773.html">FRESHLAC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/freshlac/freshlac-55775.html">FRESHLAC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/freshlac-sachet/freshlac-sachet-55774.html">FRESHLAC SACHET</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/fulzyme/fulzyme-55776.html">FULZYME</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/gabci/gabci-55777.html">GABCI</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/gemox/gemox-55778.html">GEMOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/glicap/glicap-55779.html">GLICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/glicap-m/glicap-m-55780.html">GLICAP M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/glipisit/glipisit-55781.html">GLIPISIT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/glit/glit-55782.html">GLIT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/glymin-sr/glymin-sr-55783.html">GLYMIN SR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/glymin-g/glymin-g-55784.html">GLYMIN-G</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/gocip/gocip-55785.html">GOCIP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/gocip-tz/gocip-tz-55786.html">GOCIP-TZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/gospar/gospar-55787.html">GOSPAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/grey-shine/grey-shine-55788.html">GREY SHINE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/grey-shine-plus/grey-shine-plus-55789.html">GREY SHINE PLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/gyde-100/gyde-100-55790.html">GYDE-100</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/hairry-shine/hairry-shine-55791.html">HAIRRY SHINE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/hical/hical-55792.html">HICAL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/hical-d/hical-d-55793.html">HICAL-D</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/hical-m/hical-m-55794.html">HICAL-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/hicetam/hicetam-55795.html">HICETAM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/hipride/hipride-55796.html">HIPRIDE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/i-fen/i-fen-55797.html">I-FEN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ilocap/ilocap-55798.html">ILOCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/incam/incam-55799.html">INCAM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ipod-m/ipod-m-55800.html">IPOD-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/iq-star/iq-star-55801.html">IQ STAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/joint-kit/joint-kit-55802.html">JOINT-KIT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/keyzol/keyzol-55803.html">KEYZOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/keyzole-z-shampoo/keyzole-z-shampoo-55805.html">KEYZOLE-Z SHAMPOO</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/keyzole-z-soap/keyzole-z-soap-55804.html">KEYZOLE-Z SOAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/klick/klick-55806.html">KLICK</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/kofam/kofam-55807.html">KOFAM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/l-cetri/l-cetri-55811.html">L-CETRI</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/l-cetri-cc/l-cetri-cc-55812.html">L-CETRI-CC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/l-cetri-m/l-cetri-m-55810.html">L-CETRI-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/l-cetri-m/l-cetri-m-55813.html">L-CETRI-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/l-dox/l-dox-55814.html">L-DOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/lactools/lactools-55808.html">LACTOOLS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/lamilet/lamilet-55809.html">LAMILET</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/lemilet/lemilet-55815.html">LEMILET</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/leoflox/leoflox-55816.html">LEOFLOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/linclox/linclox-55817.html">LINCLOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/linea/linea-55818.html">LINEA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/liod/liod-55819.html">LIOD</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/livin/livin-55820.html">LIVIN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/logan/logan-55821.html">LOGAN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/lopot/lopot-55822.html">LOPOT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/loracap/loracap-55823.html">LORACAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/lycobal/lycobal-55824.html">LYCOBAL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/lycyp/lycyp-55825.html">LYCYP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/m-pride/m-pride-55834.html">M-PRIDE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/maxtac/maxtac-55826.html">MAXTAC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mef/mef-55827.html">MEF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/metfin/metfin-55828.html">METFIN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/metro/metro-55829.html">METRO</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mirtacap/mirtacap-55830.html">MIRTACAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/momicap/momicap-55831.html">MOMICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/momicap-spray/momicap-spray-55832.html">MOMICAP-SPRAY</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/most/most-55833.html">MOST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mucold/mucold-55835.html">MUCOLD</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mucorant/mucorant-55836.html">MUCORANT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mukast/mukast-55837.html">MUKAST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mydox/mydox-55838.html">MYDOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mygaba/mygaba-55841.html">MYGABA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mygaba-forte/mygaba-forte-55839.html">MYGABA FORTE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mygaba-m/mygaba-m-55840.html">MYGABA M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mygaba-nt/mygaba-nt-55842.html">MYGABA-NT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/mygel-mint/mygel-mint-55843.html">MYGEL MINT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/n-lox/n-lox-55849.html">N-LOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/n-lox-m/n-lox-m-55850.html">N-LOX-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/n-lox-tz/n-lox-tz-55851.html">N-LOX-TZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nancy/nancy-55844.html">NANCY</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/neuro-bm/neuro-bm-55845.html">NEURO-BM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nircef/nircef-55846.html">NIRCEF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nissan/nissan-55847.html">NISSAN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nitracap/nitracap-55848.html">NITRACAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nuclav/nuclav-55852.html">NUCLAV</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nuclave/nuclave-55853.html">NUCLAVE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/numol/numol-55854.html">NUMOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nuse/nuse-55855.html">NUSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nuse-p/nuse-p-55856.html">NUSE-P</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nutrovas-as/nutrovas-as-55857.html">NUTROVAS-AS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/nutrovas-f/nutrovas-f-55858.html">NUTROVAS-F</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ons/ons-55859.html">ONS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/opl/opl-55860.html">OPL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/opl-dm/opl-dm-55861.html">OPL-DM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ova-great/ova-great-55862.html">OVA GREAT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/oxitrack/oxitrack-55863.html">OXITRACK</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ozole/ozole-55864.html">OZOLE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/pacitrix/pacitrix-55865.html">PACITRIX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/paramine/paramine-55866.html">PARAMINE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/pars/pars-55867.html">PARS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/pars-cold/pars-cold-55868.html">PARS COLD</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/pilisil-h/pilisil-h-55869.html">PILISIL-H</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/pilisil-h-cap/pilisil-h-cap-55870.html">PILISIL-H CAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/pinerest/pinerest-55871.html">PINEREST</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/polo/polo-55872.html">POLO</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/prime/prime-55873.html">PRIME</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/profit-z/profit-z-55874.html">PROFIT-Z</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/q-lox/q-lox-55875.html">Q-LOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/q-lox-m/q-lox-m-55876.html">Q-LOX-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/q-lox-oz/q-lox-oz-55877.html">Q-LOX-OZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/q-lox-tz/q-lox-tz-55878.html">Q-LOX-TZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/quicker/quicker-55879.html">QUICKER</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/quit-mz/quit-mz-55880.html">QUIT-MZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rabicare-lsr/rabicare-lsr-55881.html">RABICARE-LSR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rabtar/rabtar-55882.html">RABTAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rabtar-d/rabtar-d-55883.html">RABTAR-D</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rabtar-dsr/rabtar-dsr-55884.html">RABTAR-DSR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rabtar-lxr/rabtar-lxr-55885.html">RABTAR-LXR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/radin-d/radin-d-55886.html">RADIN-D</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/radix/radix-55887.html">RADIX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rain-cof/rain-cof-55888.html">RAIN-COF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/relief/relief-55889.html">RELIEF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/relief-p/relief-p-55890.html">RELIEF-P</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/roboflox/roboflox-55891.html">ROBOFLOX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rover/rover-55892.html">ROVER</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/rover-tx/rover-tx-55893.html">ROVER-TX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/roxi-french/roxi-french-55894.html">ROXI FRENCH</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/roxicap/roxicap-55895.html">ROXICAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/salcoryl/salcoryl-55896.html">SALCORYL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/salite/salite-55897.html">SALITE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/salus/salus-55898.html">SALUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/scroza/scroza-55899.html">SCROZA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sertocap/sertocap-55900.html">SERTOCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/shemin-z/shemin-z-55901.html">SHEMIN-Z</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/shezin/shezin-55902.html">SHEZIN</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/silsul/silsul-55903.html">SILSUL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sitrate/sitrate-55904.html">SITRATE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/smooth/smooth-55906.html">SMOOTH</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/smooth-lax/smooth-lax-55905.html">SMOOTH LAX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/snic/snic-55907.html">SNIC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/snooze/snooze-55908.html">SNOOZE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/spinact/spinact-55909.html">SPINACT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sporix/sporix-55910.html">SPORIX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sporix-az/sporix-az-55911.html">SPORIX-AZ</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sporix-of/sporix-of-55912.html">SPORIX-OF</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sporix-s/sporix-s-55913.html">SPORIX-S</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/stilo/stilo-55914.html">STILO</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sucaine/sucaine-55915.html">SUCAINE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/sucaine-o/sucaine-o-55916.html">SUCAINE-O</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tamsucap-d/tamsucap-d-55917.html">TAMSUCAP-D</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/teenlac/teenlac-55918.html">TEENLAC</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/teenlac-sachet/teenlac-sachet-55919.html">TEENLAC SACHET</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/teenlac-syp/teenlac-syp-55920.html">TEENLAC SYP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tefur/tefur-55921.html">TEFUR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/telus/telus-55922.html">TELUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/telus-am/telus-am-55923.html">TELUS-AM</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/telus-h/telus-h-55924.html">TELUS-H</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tendo-race/tendo-race-55925.html">TENDO RACE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tericap-oint/tericap-oint-55927.html">TERICAP OINT</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tericap-tab/tericap-tab-55926.html">TERICAP TAB</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/theos/theos-55928.html">THEOS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/thioflex/thioflex-55929.html">THIOFLEX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/thioflex-a/thioflex-a-55930.html">THIOFLEX-A</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tolrix/tolrix-55932.html">TOLRIX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/top-citi/top-citi-55931.html">TOP CITI</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/topimax/topimax-55933.html">TOPIMAX</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/torvas/torvas-55934.html">TORVAS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/traxol/traxol-55935.html">TRAXOL</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/trendset/trendset-55936.html">TRENDSET</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/trendset-m/trendset-m-55938.html">TRENDSET-M</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/trendset-m-forte/trendset-m-forte-55937.html">TRENDSET-M FORTE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/trigene/trigene-55939.html">TRIGENE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/triplus/triplus-55940.html">TRIPLUS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/tristar/tristar-55941.html">TRISTAR</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/urocap/urocap-55942.html">UROCAP</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/ventocyst-a/ventocyst-a-55943.html">VENTOCYST-A</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/vg-bose/vg-bose-55944.html">VG BOSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/vg-bose/vg-bose-55945.html">VG BOSE</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/vintrans/vintrans-55946.html">VINTRANS</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/zag/zag-55947.html">ZAG</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/zinova/zinova-55948.html">ZINOVA</a>
+                                    <a href="http://www.drugtodayonline.com/drug-directory/zybex/zybex-55949.html">ZYBEX</a>
+                            </div>
+          </div>
+        </div>
+
+        <div class="widget-area-110" id="othercomb" style="display:none">
+          <div class="widget kopa-entry-list-widget">
+          	<h4 class="heading-black">Other Combination Brands</h4>
+            <div class="box">
+                                <a href="http://www.drugtodayonline.com/drug-directory/24 by 7 t/24 by 7 t-16070.html">24 BY 7 T	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/4-get/4-get-33369.html">4-GET</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/a-browin/a-browin-40123.html">A-BROWIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-100/ab-100-34477.html">AB 100</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-sr/ab-sr-34220.html">AB SR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-trio/ab-trio-34219.html">AB TRIO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-flo-n/ab-flo-n-43736.html">AB-FLO-N</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-n/ab-n-34221.html">AB-N</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-sr/ab-sr-34478.html">AB-SR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ab-xanthin/ab-xanthin-53298.html">AB-XANTHIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abl/abl-52489.html">ABL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ablife/ablife-33719.html">ABLIFE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ablife-m/ablife-m-29230.html">ABLIFE-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abrehox/abrehox-46997.html">ABREHOX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abrobat/abrobat-23355.html">ABROBAT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abrodyl/abrodyl-33348.html">ABRODYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abrodyl-ls/abrodyl-ls-29123.html">ABRODYL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abrofyl-m/abrofyl-m-36209.html">ABROFYL M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abrophyll/abrophyll-33720.html">ABROPHYLL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/abroxy/abroxy-27534.html">ABROXY</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acbid/acbid-12492.html">ACBID	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acebrofact-m/acebrofact-m-51655.html">ACEBROFACT M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aceday/aceday-33721.html">ACEDAY</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acedru/acedru-33722.html">ACEDRU</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acerix/acerix-27442.html">ACERIX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aceway/aceway-22896.html">ACEWAY</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acibofil-dm/acibofil-dm-51060.html">ACIBOFIL-DM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acibofil-lm/acibofil-lm-51059.html">ACIBOFIL-LM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acibro/acibro-28373.html">ACIBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acibro-plus/acibro-plus-28374.html">ACIBRO PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/acphy-100/acphy-100-33718.html">ACPHY-100</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/action-cof/action-cof-55605.html">ACTION-COF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ad-cof/ad-cof-15024.html">AD-COF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/adicoff-juniur/adicoff-juniur-50154.html">ADICOFF-JUNIUR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aero-x/aero-x-43290.html">AERO-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aerodil-ls/aerodil-ls-51657.html">AERODIL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aexicof/aexicof-15025.html">AEXICOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aexo-100/aexo-100-25165.html">AEXO-100</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/afasma/afasma-19709.html">AFASMA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/afrodyl/afrodyl-25256.html">AFRODYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/afylin/afylin-54145.html">AFYLIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/afyzen/afyzen-53977.html">AFYZEN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/agbronc/agbronc-16078.html">AGBRONC	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/agcam-plus/agcam-plus-16079.html">AGCAM PLUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ags/ags-15027.html">AGS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/agt-plus/agt-plus-33359.html">AGT-PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aidol/aidol-40700.html">AIDOL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/airlin/airlin-58364.html">AIRLIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/airlin-ls/airlin-ls-58365.html">AIRLIN-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/airlink-plus/airlink-plus-55611.html">AIRLINK PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/airlink-xp/airlink-xp-55616.html">AIRLINK-XP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/airway-bgs/airway-bgs-16080.html">AIRWAY-BGS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/albro/albro-15028.html">ALBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/albro/albro-38431.html">ALBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/albro-lz/albro-lz-38432.html">ALBRO-LZ</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/albro-m/albro-m-38433.html">ALBRO-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alcof-am/alcof-am-34081.html">ALCOF-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alcof-br/alcof-br-34079.html">ALCOF-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alcof-d/alcof-d-34080.html">ALCOF-D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alernyl-b/alernyl-b-16085.html">ALERNYL-B	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alkatrum/alkatrum-51029.html">ALKATRUM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/allbro/allbro-50663.html">ALLBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/allcough/allcough-39594.html">ALLCOUGH</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alldex-ls/alldex-ls-50340.html">ALLDEX LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alldex-a/alldex-a-50344.html">ALLDEX-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alldex-br/alldex-br-50343.html">ALLDEX-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/allitophylline/allitophylline-43066.html">ALLITOPHYLLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/almoril/almoril-53030.html">ALMORIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/almoril-susp/almoril-susp-53031.html">ALMORIL SUSP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/almoril-ls/almoril-ls-53032.html">ALMORIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alodryl-m/alodryl-m-34110.html">ALODRYL M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alokoff-ls/alokoff-ls-50791.html">ALOKOFF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alokoff-t/alokoff-t-50790.html">ALOKOFF T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alrex-ls/alrex-ls-53731.html">ALREX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/altex/altex-41874.html">ALTEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/altidil-am/altidil-am-45844.html">ALTIDIL-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/altidil-m/altidil-m-45846.html">ALTIDIL-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alto-e/alto-e-44441.html">ALTO-E</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alvo/alvo-16088.html">ALVO	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/alvotrak/alvotrak-54353.html">ALVOTRAK</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amatic/amatic-16089.html">AMATIC	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amb/amb-16090.html">AMB		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambcoff-ar/ambcoff-ar-49251.html">AMBCOFF-AR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambcoff-ls/ambcoff-ls-49253.html">AMBCOFF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambo-x/ambo-x-33378.html">AMBO-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amboril-plus/amboril-plus-49249.html">AMBORIL PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amboril-plus/amboril-plus-49157.html">AMBORIL-PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambozex-ls/ambozex-ls-33380.html">AMBOZEX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambro-ls/ambro-ls-46590.html">AMBRO LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambro-tg/ambro-tg-26088.html">AMBRO-TG</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambrogem-s/ambrogem-s-39798.html">AMBROGEM-S</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambromix-+/ambromix-+-33901.html">AMBROMIX +</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambromox-ls/ambromox-ls-39846.html">AMBROMOX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambroson/ambroson-16094.html">AMBROSON		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambrotis-gs/ambrotis-gs-15040.html">AMBROTIS-GS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambrowin-expectorant/ambrowin-expectorant-16096.html">AMBROWIN EXPECTORANT	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambrowin-junior/ambrowin-junior-16097.html">AMBROWIN JUNIOR	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambrox-t/ambrox-t-16098.html">AMBROX-T	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambroxin-l/ambroxin-l-16100.html">AMBROXIN-L	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambroza/ambroza-40850.html">AMBROZA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ambroza-ls/ambroza-ls-53771.html">AMBROZA-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amconil-a/amconil-a-29382.html">AMCONIL-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amconil-ls/amconil-ls-29384.html">AMCONIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amo/amo-54613.html">AMO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amrovis/amrovis-16104.html">AMROVIS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amtal-br/amtal-br-40916.html">AMTAL-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amvoryl/amvoryl-51751.html">AMVORYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amvoryl-d/amvoryl-d-51752.html">AMVORYL D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/amvoryl-ls/amvoryl-ls-51750.html">AMVORYL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/anbrocit-ls/anbrocit-ls-55965.html">ANBROCIT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/andcof/andcof-27779.html">ANDCOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arcof/arcof-33381.html">ARCOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arcuf plus/arcuf plus-16109.html">ARCUF PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arik/arik-16110.html">ARIK		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arnakof-ls/arnakof-ls-34187.html">ARNAKOF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arolin/arolin-58050.html">AROLIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arolin-ls/arolin-ls-58049.html">AROLIN-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arolin-xn/arolin-xn-58048.html">AROLIN-XN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aroline/aroline-53384.html">AROLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arophyll-hd/arophyll-hd-44194.html">AROPHYLL-HD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arophyll-sr/arophyll-sr-44195.html">AROPHYLL-SR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arovent/arovent-39573.html">AROVENT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arovent-c/arovent-c-39579.html">AROVENT-C</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arovent-ls/arovent-ls-39580.html">AROVENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/aroxol-ax/aroxol-ax-39841.html">AROXOL-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arrocof-plus/arrocof-plus-33383.html">ARROCOF PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/arrow/arrow-50882.html">ARROW</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/askuf/askuf-16103.html">ASKUF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asma-zed-at/asma-zed-at-45653.html">ASMA ZED AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asma-zed-at/asma-zed-at-44671.html">ASMA ZED AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asma-zed-s-f/asma-zed-s-f-45651.html">ASMA ZED S.F.</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asmasef/asmasef-16113.html">ASMASEF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asmaterb/asmaterb-16114.html">ASMATERB</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asmoryl expt/asmoryl expt-16116.html">ASMORYL EXPT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asmotone-plus/asmotone-plus-16117.html">ASMOTONE PLUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asta-4/asta-4-16118.html">ASTA-4	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asta-q/asta-q-16119.html">ASTA-Q	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthabent-br/asthabent-br-16120.html">ASTHABENT-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthacan/asthacan-19618.html">ASTHACAN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthadox/asthadox-53195.html">ASTHADOX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthagrip-sr/asthagrip-sr-53196.html">ASTHAGRIP SR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthagrip-n/asthagrip-n-53185.html">ASTHAGRIP-N</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthakon-br/asthakon-br-40544.html">ASTHAKON BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthakon-ls/asthakon-ls-40545.html">ASTHAKON-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthalin-exp/asthalin-exp-16123.html">ASTHALIN EXP	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthalin-exp/asthalin-exp-15051.html">ASTHALIN EXP 		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthamol-bg/asthamol-bg-16129.html">ASTHAMOL-BG	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthanik/asthanik-24536.html">ASTHANIK</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/asthavent-br/asthavent-br-44673.html">ASTHAVENT-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/at-ment/at-ment-16131.html">AT-MENT	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/atg-dial/atg-dial-33392.html">ATG-DIAL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/atoril/atoril-16132.html">ATORIL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/atoril-ls/atoril-ls-39767.html">ATORIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/atp-sf/atp-sf-16133.html">ATP-SF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/atx/atx-56341.html">ATX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/auricof-ls/auricof-ls-26013.html">AURICOF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/auricof-x/auricof-x-26009.html">AURICOF-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/autex/autex-33394.html">AUTEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/autex-p/autex-p-33396.html">AUTEX-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/avokuf-am/avokuf-am-36860.html">AVOKUF-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/avokuf-ls/avokuf-ls-36863.html">AVOKUF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/avokuf-m/avokuf-m-36862.html">AVOKUF-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/axalin/axalin-16135.html">AXALIN	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ay-tuss/ay-tuss-35281.html">AY-TUSS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ay-tuss-l/ay-tuss-l-35282.html">AY-TUSS L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/azestho-bor/azestho-bor-16136.html">AZESTHO-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bacof-at/bacof-at-16138.html">BACOF-AT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/baldric-tx/baldric-tx-33397.html">BALDRIC-TX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/banocof/banocof-44198.html">BANOCOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/banohist/banohist-45873.html">BANOHIST</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/banohist-am/banohist-am-45872.html">BANOHIST-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bb-vent-ls/bb-vent-ls-46419.html">BB VENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bb-vent-ls/bb-vent-ls-46414.html">BB VENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bb-vent-ls-p/bb-vent-ls-p-46416.html">BB VENT-LS-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bacof-t/bacof-t-16142.html">BECOF-T	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/beep-ls/beep-ls-37701.html">BEEP-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/benakof-bs/benakof-bs-15640.html">BENAKOF-BS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/benstil/benstil-53108.html">BENSTIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bentamin-ap/bentamin-ap-33402.html">BENTAMIN-AP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/berycof-ls/berycof-ls-55008.html">BERYCOF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bestofyline-a/bestofyline-a-12495.html">BESTOFYLINE-A	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bilituss-ls/bilituss-ls-58422.html">BILITUSS-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/biokof/biokof-42007.html">BIOKOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/blazcuf-ax/blazcuf-ax-55641.html">BLAZCUF-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/blazcuf-ls/blazcuf-ls-55643.html">BLAZCUF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bliskof/bliskof-16147.html">BLISKOF		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/blukoff-ls/blukoff-ls-33403.html">BLUKOFF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/boldcof-br/boldcof-br-16148.html">BOLDCOF-BR	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/boldcof-dx/boldcof-dx-15646.html">BOLDCOF-DX	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/boonkuf-ls/boonkuf-ls-57144.html">BOONKUF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/boonkuf-am/boonkuf-am-57172.html">BOONKUF-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/boonkuf-m/boonkuf-m-57171.html">BOONKUF-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bricanyl/bricanyl-16153.html">BRICANYL </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bricanyl/bricanyl-16151.html">BRICANYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bricanyl-durules/bricanyl-durules-33404.html">BRICANYL DURULES</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bricanyl-inhaler/bricanyl-inhaler-16154.html">BRICANYL INHALER 		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ bricanyl-nebulising/ bricanyl-nebulising-16152.html">BRICANYL NEBULISING	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bricarex-a/bricarex-a-16156.html">BRICAREX A	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bricarex-expectorant/bricarex-expectorant-16155.html">BRICAREX EXPECTORANT </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bro-coughtek/bro-coughtek-45457.html">BRO COUGHTEK</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bro-zeet/bro-zeet-16182.html">BRO-ZEET		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brocap/brocap-55634.html">BROCAP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brocon-100/brocon-100-12496.html">BROCON-100	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brodexin-ax/brodexin-ax-42008.html">BRODEXIN AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brofex/brofex-25710.html">BROFEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brofy/brofy-12497.html">BROFY	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brofy-fm/brofy-fm-57644.html">BROFY-FM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brolima/brolima-16158.html">BROLIMA	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brolin/brolin-34044.html">BROLIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bromcuf/bromcuf-16159.html">BROMCUF		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bromo/bromo-16161.html">BROMO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncho solvin/broncho solvin-15651.html">BRONCHO SOLVIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncho-am/broncho-am-53109.html">BRONCHO-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronchodian/bronchodian-16163.html">BRONCHODIAN	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronchofit/bronchofit-16164.html">BRONCHOFIT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronchosolvin/bronchosolvin-15650.html">BRONCHOSOLVIN 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncof-g/broncof-g-16168.html">BRONCOF-G	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncogard/broncogard-38241.html">BRONCOGARD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronconex/bronconex-15649.html">BRONCONEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncoril/broncoril-16169.html">BRONCORIL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncowel-ls/broncowel-ls-50698.html">BRONCOWEL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broncox-exp/broncox-exp-43076.html">BRONCOX EXP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronem-ls/bronem-ls-36042.html">BRONEM-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronhyte-ls/bronhyte-ls-28303.html">BRONHYTE-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronkonil/bronkonil-16173.html">BRONKONIL              </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brontaline/brontaline-16175.html">BRONTALINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brontaline-g/brontaline-g-16176.html">BRONTALINE-G </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronter/bronter-38885.html">BRONTER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronter-ls/bronter-ls-38886.html">BRONTER-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronus/bronus-12498.html">BRONUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bronx/bronx-16177.html">BRONX		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brophy/brophy-38866.html">BROPHY</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broscaphane-a/broscaphane-a-41960.html">BROSCAPHANE-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brosef-br/brosef-br-16178.html">BROSEF-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brosid-t/brosid-t-41851.html">BROSID-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brosix-levo/brosix-levo-44398.html">BROSIX LEVO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broson/broson-16183.html">BROSON	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brotex/brotex-36093.html">BROTEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brotex-g/brotex-g-52109.html">BROTEX-G</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brotex-ls/brotex-ls-36094.html">BROTEX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brox-cz/brox-cz-54339.html">BROX-CZ</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brox-tr/brox-tr-33410.html">BROX-TR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broxcof-am/broxcof-am-53464.html">BROXCOF-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broxil/broxil-33411.html">BROXIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broxil-b/broxil-b-33412.html">BROXIL-B</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broxil/broxil-b/broxil/broxil-b-15655.html">BROXIL/BROXIL-B	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/broxovic/broxovic-33413.html">BROXOVIC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brozeet-ls-plus/brozeet-ls-plus-46509.html">BROZEET LS PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brucof-pd/brucof-pd-16184.html">BRUCOF-PD		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brucof-t/brucof-t-15657.html">BRUCOF-T		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brutex/brutex-16185.html">BRUTEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brutex-g/brutex-g-16186.html">BRUTEX G</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/brutus/brutus-15658.html">BRUTUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/butabrom/butabrom-16194.html">BUTABROM	   </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/butexine-br/butexine-br-51952.html">BUTEXINE-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/bx-corant/bx-corant-33800.html">BX-CORANT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cadiphylate/cadiphylate-16197.html">CADIPHYLATE 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/capcoril-ls/capcoril-ls-55636.html">CAPCORIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/castcare/castcare-50465.html">CASTCARE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/caugh-at/caugh-at-16198.html">CAUGH-AT		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cebofyl/cebofyl-12499.html">CEBOFYL   	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ceebro/ceebro-15663.html">CEEBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ceftadril/ceftadril-33422.html">CEFTADRIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cepticof-p/cepticof-p-33423.html">CEPTICOF-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cervpure/cervpure-53140.html">CERVPURE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cetacold-la/cetacold-la-41963.html">CETACOLD LA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cf-phyline-100/cf-phyline-100-57216.html">CF-PHYLINE-100</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cherifon/cherifon-16199.html">CHERIFON	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chestodil-am/chestodil-am-45880.html">CHESTODIL-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chestodil-m/chestodil-m-45883.html">CHESTODIL-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cheston/cheston-33425.html">CHESTON</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cheston-plus/cheston-plus-33426.html">CHESTON PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chestorex/chestorex-15668.html">CHESTOREX	 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chestorex-br/chestorex-br-16201.html">CHESTOREX-BR	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chupp/chupp-34924.html">CHUPP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chupp/chupp-34928.html">CHUPP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chupp-a/chupp-a-34925.html">CHUPP A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chupp-d/chupp-d-34926.html">CHUPP D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/chupp-ls/chupp-ls-34927.html">CHUPP LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cib-tag/cib-tag-38304.html">CIB TAG</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/clarry-ac/clarry-ac-46878.html">CLARRY-AC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/clarry-am/clarry-am-46879.html">CLARRY-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/clarry-ls/clarry-ls-46880.html">CLARRY-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/co-exit/co-exit-15672.html">CO-EXIT		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cobrex/cobrex-16204.html">COBREX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/codicil-sf/codicil-sf-34573.html">CODICIL SF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cof-q/cof-q-51710.html">COF Q</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofbenz-ex/cofbenz-ex-36338.html">COFBENZ-EX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofgon/cofgon-25222.html">COFGON</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofina/cofina-22466.html">COFINA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coflex-p/coflex-p-33987.html">COFLEX-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofmark-t/cofmark-t-42809.html">COFMARK-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofnil/cofnil-45881.html">COFNIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofodd-a/cofodd-a-38371.html">COFODD-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofopt-q/cofopt-q-16212.html">COFOPT Q	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coform-ax/coform-ax-16213.html">COFORM-AX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofosyp ex/cofosyp ex-16214.html">COFOSYP EX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofrav/cofrav-16215.html">COFRAV</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofren-ab/cofren-ab-53785.html">COFREN-AB</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofris/cofris-41842.html">COFRIS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofris-br/cofris-br-38996.html">COFRIS-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofris-t/cofris-t-38997.html">COFRIS-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofsal-a/cofsal-a-38372.html">COFSAL-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofsol/cofsol-15681.html">COFSOL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofsol/cofsol-16216.html">COFSOL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coftar-ax/coftar-ax-42732.html">COFTAR - AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coftime/coftime-41738.html">COFTIME</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofzin-a/cofzin-a-33434.html">COFZIN-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cofzine-p/cofzine-p-25953.html">COFZINE-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coldgold-super/coldgold-super-45413.html">COLDGOLD SUPER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coldis-ls/coldis-ls-42895.html">COLDIS-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coldiz-ax/coldiz-ax-33436.html">COLDIZ-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/conil-am/conil-am-16219.html">CONIL-AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/conil-tr/conil-tr-16220.html">CONIL-TR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/corech-br/corech-br-35722.html">CORECH-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/corech-ls/corech-ls-35723.html">CORECH-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/corem-x/corem-x-52162.html">COREM-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coriminic-x/coriminic-x-16221.html">CORIMINIC-X	    </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/corkof-xl/corkof-xl-53560.html">CORKOF-XL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cosome-a/cosome-a-16224.html">COSOME A		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cosryl/cosryl-16225.html">COSRYL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cosyp-e/cosyp-e-16226.html">COSYP E 	    </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cough-o-dryl-plus/cough-o-dryl-plus-46510.html">COUGH'O'DRYL PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coughberry-xt/coughberry-xt-52705.html">COUGHBERRY XT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coughtek-ag/coughtek-ag-45463.html">COUGHTEK AG</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/coughtek-ls/coughtek-ls-45465.html">COUGHTEK LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cp-fen/cp-fen-43546.html">CP-FEN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cs-am/cs-am-40983.html">CS-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/csp-at/csp-at-24906.html">CSP-AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuf-gtb/cuf-gtb-15711.html">CUF-GTB		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuf-out/cuf-out-15712.html">CUF-OUT		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufdex-ex/cufdex-ex-55383.html">CUFDEX-EX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufexil-br/cufexil-br-53605.html">CUFEXIL-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufexil-l/cufexil-l-53602.html">CUFEXIL-L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufexil-sf/cufexil-sf-53606.html">CUFEXIL-SF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuffrest-ls/cuffrest-ls-38376.html">CUFFREST-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufgone/cufgone-33441.html">CUFGONE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufrax-tr/cufrax-tr-54343.html">CUFRAX-TR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufriv-ls/cufriv-ls-33444.html">CUFRIV-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufruz-am/cufruz-am-51855.html">CUFRUZ-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufruz-ls/cufruz-ls-51854.html">CUFRUZ-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufslit/cufslit-54425.html">CUFSLIT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuftech-am/cuftech-am-57439.html">CUFTECH-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuftech-ls/cuftech-ls-57401.html">CUFTECH-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuftech-ls/cuftech-ls-57441.html">CUFTECH-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cuftreat-at/cuftreat-at-25197.html">CUFTREAT-AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/cufzer/cufzer-25805.html">CUFZER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dalvo-plus/dalvo-plus-53086.html">DALVO PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/daslin-nf/daslin-nf-32993.html">DASLIN-NF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/decostar/decostar-34010.html">DECOSTAR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/decostar-ls/decostar-ls-34009.html">DECOSTAR-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/deekof-tr/deekof-tr-33446.html">DEEKOF-TR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/deletus-bx/deletus-bx-35257.html">DELETUS BX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/deletus-ls/deletus-ls-34959.html">DELETUS LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/deletus-bx/deletus-bx-47208.html">DELETUS-BX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dexokav/dexokav-15724.html">DEXOKAV	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dexomine ap/dexomine ap-16233.html">DEXOMINE AP	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dextrum-plus/dextrum-plus-51027.html">DEXTRUM PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/diabetus/diabetus-16234.html">DIABETUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dicof-a/dicof-a-41585.html">DICOF-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/digicof-sf/digicof-sf-15727.html">DIGICOF-SF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/diocold/diocold-41587.html">DIOCOLD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dombroo/dombroo-12500.html">DOMBROO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/domvent-ax/domvent-ax-16235.html">DOMVENT-AX	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dorbroxyl/dorbroxyl-54654.html">DORBROXYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dorkof-q/dorkof-q-54657.html">DORKOF-Q</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory//-28455.html">DOXOMAG-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/drukof-t/drukof-t-53203.html">DRUKOF-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/drycof-exp/drycof-exp-56125.html">DRYCOF-EXP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/dynex/dynex-41492.html">DYNEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/e-toux/e-toux-16254.html">E-TOUX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ebm-xl/ebm-xl-33454.html">EBM-XL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ecof-am/ecof-am-16246.html">ECOF-AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ecof-ls/ecof-ls-35956.html">ECOF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/efelin-x-pd/efelin-x-pd-16248.html">EFELIN-X-PD	    </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/elzin/elzin-55068.html">ELZIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/elzin-ls/elzin-ls-55067.html">ELZIN-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/elzin-tr/elzin-tr-55070.html">ELZIN-TR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/embroxia/embroxia-37738.html">EMBROXIA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/embroxia-ls/embroxia-ls-37741.html">EMBROXIA LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/emcrolin/emcrolin-51474.html">EMCROLIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/enhist-p/enhist-p-33458.html">ENHIST-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/eskof/eskof-19836.html">ESKOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/esma-pd/esma-pd-16249.html">ESMA-PD	         </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/estharil-plus/estharil-plus-16251.html">ESTHARIL-PLUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/estibro/estibro-12501.html">ESTIBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/eucofryl/eucofryl-16255.html">EUCOFRYL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/eupnease/eupnease-52701.html">EUPNEASE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/eupnease-ls/eupnease-ls-52702.html">EUPNEASE LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ex-expectorant/ex-expectorant-15744.html">EX-EXPECTORANT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ex-pd/ex-pd-16260.html">EX-PD	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exaril-sb/exaril-sb-46393.html">EXARIL SB</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exdril-at/exdril-at-54898.html">EXDRIL AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exdril-ls/exdril-ls-54900.html">EXDRIL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exem-t/exem-t-54474.html">EXEM-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exemt-ls/exemt-ls-54476.html">EXEMT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exit/exit-41588.html">EXIT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exit-dx/exit-dx-41590.html">EXIT-DX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exol/exol-16258.html">EXOL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exor/exor-41800.html">EXOR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/exovent-ls/exovent-ls-57929.html">EXOVENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/expand/expand-16259.html">EXPAND	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/expolate/expolate-16261.html">EXPOLATE		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ezee cof/ezee cof-15748.html">EZEE COF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ezeecof-ax/ezeecof-ax-16262.html">EZEECOF-AX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ezeecof-br/ezeecof-br-16263.html">EZEECOF-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/eziklik/eziklik-56930.html">EZIKLIK</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ezikoz/ezikoz-57001.html">EZIKOZ</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ezikoz-l/ezikoz-l-56931.html">EZIKOZ-L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/f-108/f-108-53389.html">F-108</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/felavus-ls/felavus-ls-40727.html">FELAVUS-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/fexoll-ma/fexoll-ma-58381.html">FEXOLL-MA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/fexorin-abm/fexorin-abm-50382.html">FEXORIN-ABM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/forcof-t/forcof-t-45299.html">FORCOF-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/forphylline/forphylline-45295.html">FORPHYLLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/frekof/frekof-41262.html">FREKOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/fricof/fricof-16278.html">FRICOF	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/fumaze/fumaze-37742.html">FUMAZE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/g2-kof/g2-kof-55324.html">G2 KOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gat-m/gat-m-48598.html">GAT-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gbs/gbs-37802.html">GBS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gbt/gbt-33473.html">GBT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gdcit/gdcit-41798.html">GDCIT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gemicof/gemicof-16280.html">GEMICOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gemsyp-ax/gemsyp-ax-40653.html">GEMSYP-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/geocough-agl/geocough-agl-43196.html">GEOCOUGH-AGL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/geriresp/geriresp-16281.html">GERIRESP	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/giacof-a/giacof-a-45236.html">GIACOF-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/giacof-ls/giacof-ls-45238.html">GIACOF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gialiv-ac/gialiv-ac-45243.html">GIALIV-AC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gocuf-ld/gocuf-ld-56613.html">GOCUF LD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gokaf/gokaf-54615.html">GOKAF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/goricof-dx/goricof-dx-15767.html">GORICOF-DX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/grandkof-x/grandkof-x-29009.html">GRANDKOF-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/greetus-br/greetus-br-40571.html">GREETUS BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/grenitus/grenitus-15769.html">GRENITUS	  </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/grilinctus-bm/grilinctus-bm-16283.html">GRILINCTUS-BM 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/grimtus/grimtus-33475.html">GRIMTUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gtb/gtb-16284.html">GTB		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/gusyn-dm/gusyn-dm-15772.html">GUSYN-DM	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/heltus-b/heltus-b-16285.html">HELTUS-B	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/hexicof-p/hexicof-p-33483.html">HEXICOF-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/histamol/histamol-16286.html">HISTAMOL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/histoden/histoden-33484.html">HISTODEN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/histral-plus/histral-plus-33485.html">HISTRAL PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/hybro-lm/hybro-lm-41241.html">HYBRO-LM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/hycaf/hycaf-41274.html">HYCAF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/hycaf-lg/hycaf-lg-41276.html">HYCAF-LG</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/iffcold-d/iffcold-d-35448.html">IFFCOLD D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/instaryl-p/instaryl-p-42016.html">INSTARYL-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ivacof/ivacof-54175.html">IVACOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ivacof-ls/ivacof-ls-54177.html">IVACOF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/jbrolin/jbrolin-12502.html">JBROLIN	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/jollycof/jollycof-16294.html">JOLLYCOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/jollycof/jollycof-16295.html">JOLLYCOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/jotair-la/jotair-la-32952.html">JOTAIR-LA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kafban/kafban-54778.html">KAFBAN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kaffi-ls/kaffi-ls-49964.html">KAFFI-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kafno/kafno-15788.html">KAFNO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kambro-t-jr/kambro-t-jr-16296.html">KAMBRO-T/JR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kavcof/kavcof-16298.html">KAVCOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kazicof-tl/kazicof-tl-46715.html">KAZICOF-TL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kidivent/kidivent-46283.html">KIDIVENT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kidivent-ls/kidivent-ls-46292.html">KIDIVENT LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kidivent-ls/kidivent-ls-46147.html">KIDIVENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kidivent-ls/kidivent-ls-46288.html">KIDIVENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kidivent-ls-p/kidivent-ls-p-46285.html">KIDIVENT-LS-P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kill-cold/kill-cold-46533.html">KILL COLD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/klofex/klofex-16301.html">KLOFEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kloter-g/kloter-g-16303.html">KLOTER-G		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofam/kofam-55807.html">KOFAM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koff/koff-16306.html">KOFF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koffcure/koffcure-15797.html">KOFFCURE	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koffshri-ls/koffshri-ls-43432.html">KOFFSHRI-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koffu-br/koffu-br-49025.html">KOFFU-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofgon/kofgon-33501.html">KOFGON</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofhit/kofhit-41783.html">KOFHIT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koflatch-l/koflatch-l-49344.html">KOFLATCH-L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koflatch-x/koflatch-x-49345.html">KOFLATCH-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koflink/koflink-15799.html">KOFLINK	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koflink-tm/koflink-tm-16307.html">KOFLINK TM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koforil/koforil-49764.html">KOFORIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koforil-ls/koforil-ls-49763.html">KOFORIL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofron-t/kofron-t-16308.html">KOFRON-T	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofshri/kofshri-43430.html">KOFSHRI</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofsooth-t/kofsooth-t-16309.html">KOFSOOTH-T	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koftion/koftion-57902.html">KOFTION</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/koftion-junior/koftion-junior-57908.html">KOFTION-JUNIOR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/korsa-ls/korsa-ls-53081.html">KORSA LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/korsa-tga/korsa-tga-53080.html">KORSA TGA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kouf-x/kouf-x-29331.html">KOUF-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/krush/krush-16310.html">KRUSH	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufberry-at/kufberry-at-49028.html">KUFBERRY-AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory//-42707.html">KUFCY-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kuff-j/kuff-j-52672.html">KUFF J</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kuff-l/kuff-l-52673.html">KUFF L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufgel/kufgel-41931.html">KUFGEL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kofgen-x/kofgen-x-16311.html">KUFGEN-X		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufgold/kufgold-43684.html">KUFGOLD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufgold-a/kufgold-a-43685.html">KUFGOLD-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufnil-a/kufnil-a-33518.html">KUFNIL-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufnil-d/kufnil-d-39705.html">KUFNIL-D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufnil-ls/kufnil-ls-39707.html">KUFNIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufren/kufren-43363.html">KUFREN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufriven-ls/kufriven-ls-57498.html">KUFRIVEN-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufset-ls/kufset-ls-33645.html">KUFSET-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kufzil-ac/kufzil-ac-51507.html">KUFZIL-AC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kyoxol/kyoxol-45637.html">KYOXOL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kyoxol-br/kyoxol-br-45642.html">KYOXOL-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/kyoxol-l/kyoxol-l-45640.html">KYOXOL-L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/larybro/larybro-16312.html">LARYBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/latch-br/latch-br-37536.html">LATCH-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/lc-one-3d/lc-one-3d-35306.html">LC-ONE 3D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/leemon-plus/leemon-plus-33727.html">LEEMON PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/levirate/levirate-53388.html">LEVIRATE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/levome-plus/levome-plus-53040.html">LEVOME PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/levovent/levovent-47092.html">LEVOVENT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/levovent-kid/levovent-kid-16314.html">LEVOVENT-KID	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/levovent-ls/levovent-ls-47091.html">LEVOVENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/levsit-3d/levsit-3d-43481.html">LEVSIT-3D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/limcuf/limcuf-38652.html">LIMCUF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/limcuf/limcuf-29408.html">LIMCUF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/limcuf-tab/limcuf-tab-29410.html">LIMCUF-TAB</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/lintus-br/lintus-br-15814.html">LINTUS-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/lm-one-3d/lm-one-3d-57935.html">LM-ONE-3D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/lorasafe-am/lorasafe-am-46374.html">LORASAFE AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/lyrax-bt/lyrax-bt-16317.html">LYRAX-BT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/m-tag/m-tag-16325.html">M-TAG	    </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mantuss-ls/mantuss-ls-33521.html">MANTUSS LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/marex-ls/marex-ls-33522.html">MAREX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mecodryl-m/mecodryl-m-16320.html">MECODRYL-M	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/medorex-a/medorex-a-36962.html">MEDOREX-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/megabrith-sr/megabrith-sr-26130.html">MEGABRITH SR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/megaphylline/megaphylline-12503.html">MEGAPHYLLINE	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/merocof-a/merocof-a-53490.html">MEROCOF-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/merocof-l/merocof-l-53491.html">MEROCOF-L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mescoril-ls/mescoril-ls-53658.html">MESCORIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mituss-ax/mituss-ax-16322.html">MITUSS-AX 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/monty-ac/monty-ac-26868.html">MONTY AC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mordryl-expectorant/mordryl-expectorant-48189.html">MORDRYL EXPECTORANT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mt-4/mt-4-16324.html">MT-4		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mt-4/mt-4-56340.html">MT-4</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucambo-t/mucambo-t-15831.html">MUCAMBO-T	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucoace/mucoace-25303.html">MUCOACE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucobus/mucobus-24334.html">MUCOBUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucodac/mucodac-39269.html">MUCODAC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucoder/mucoder-16326.html">MUCODER	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucolay-a-sf/mucolay-a-sf-53318.html">MUCOLAY-A SF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucophyline/mucophyline-12504.html">MUCOPHYLINE	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucorant/mucorant-55836.html">MUCORANT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucosant/mucosant-33531.html">MUCOSANT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucosol/mucosol-33533.html">MUCOSOL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/mucout-am/mucout-am-47177.html">MUCOUT-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/muter-ls/muter-ls-36063.html">MUTER-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nanbro/nanbro-24680.html">NANBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nanbro/nanbro-56503.html">NANBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/new-zephrol-kidz/new-zephrol-kidz-16329.html">NEW ZEPHROL KIDZ	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nexdox-a/nexdox-a-12505.html">NEXDOX-A	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nexdyn-s/nexdyn-s-16331.html">NEXDYN-S		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nioxol/nioxol-33539.html">NIOXOL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nishkuf-am/nishkuf-am-40344.html">NISHKUF AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nixoril-ls/nixoril-ls-51805.html">NIXORIL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nocuff/nocuff-33293.html">NOCUFF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nosardi-plus/nosardi-plus-49355.html">NOSARDI PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nosardi-plus/nosardi-plus-49327.html">NOSARDI PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/noscophane-dm/noscophane-dm-41964.html">NOSCOPHANE DM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/notus-plus/notus-plus-33540.html">NOTUS PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nsphylline-100/nsphylline-100-12506.html">NSPHYLLINE-100	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nucoril/nucoril-15854.html">NUCORIL		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nutuss-br/nutuss-br-16335.html">NUTUSS BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nutuss-a/nutuss-a-16336.html">NUTUSS-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/nuvent-ls/nuvent-ls-33541.html">NUVENT-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ocebro/ocebro-53814.html">OCEBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oktakuf/oktakuf-33557.html">OKTAKUF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/onarex/onarex-33560.html">ONAREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/orcicof/orcicof-53825.html">ORCICOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/orcicof-ls/orcicof-ls-53826.html">ORCICOF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/orex-d/orex-d-41908.html">OREX-D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oril-ap/oril-ap-26232.html">ORIL-AP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oritus-ax/oritus-ax-33561.html">ORITUS AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/orizen-am/orizen-am-56238.html">ORIZEN AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/orizen-ls/orizen-ls-56240.html">ORIZEN-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oxidyne/oxidyne-15858.html">OXIDYNE	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oxidyne/oxidyne-41501.html">OXIDYNE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oxybro-plus/oxybro-plus-41203.html">OXYBRO PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oxydryl/oxydryl-19662.html">OXYDRYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/oylline/oylline-19710.html">OYLLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/papaz-ax/papaz-ax-35830.html">PAPAZ-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/papaz-px/papaz-px-35832.html">PAPAZ-PX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pardex-g/pardex-g-25951.html">PARDEX-G</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/parter-bg/parter-bg-25952.html">PARTER BG</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pathicold/pathicold-23188.html">PATHICOLD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pelbrox-ls/pelbrox-ls-33562.html">PELBROX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pericoff/pericoff-52906.html">PERICOFF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/phensedyl-cr/phensedyl-cr-35261.html">PHENSEDYL CR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/philmont/philmont-28015.html">PHILMONT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/phylair-ab/phylair-ab-23203.html">PHYLAIR-AB</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/phynex/phynex-48884.html">PHYNEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pifalgin-am/pifalgin-am-16343.html">PIFALGIN-AM  </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pinbro/pinbro-37440.html">PINBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pinkuf-am/pinkuf-am-37249.html">PINKUF-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pinkuf-ls/pinkuf-ls-37260.html">PINKUF-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pinkuf-m/pinkuf-m-37259.html">PINKUF-M</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pinkuf-s/pinkuf-s-37261.html">PINKUF-S</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pinnacle/pinnacle-43133.html">PINNACLE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pladril-plus/pladril-plus-33986.html">PLADRIL PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pre-dcof-at/pre-dcof-at-28316.html">PRE-DCOF-AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/prescuf-xp/prescuf-xp-16345.html">PRESCUF-XP	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/prexcuf-xp/prexcuf-xp-16346.html">PRESCUF-XP	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/presil am/presil am-16347.html">PRESIL AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/prodyl/prodyl-15881.html">PRODYL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/prodyl-x/prodyl-x-16348.html">PRODYL-X	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pulmorest-s/pulmorest-s-16351.html">PULMOREST S	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pulmorest-s/pulmorest-s-16352.html">PULMOREST S	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pulmovent/pulmovent-56643.html">PULMOVENT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/pulmowin br/pulmowin br-16353.html">PULMOWIN BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/q-nik/q-nik-42591.html">Q-NIK</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qril/qril-42592.html">QRIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qril-bm/qril-bm-42600.html">QRIL BM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qril-br/qril-br-42601.html">QRIL BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qril-ls/qril-ls-42602.html">QRIL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qucof-dx/qucof-dx-15891.html">QUCOF-DX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qussive/qussive-43164.html">QUSSIVE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/qussive-am/qussive-am-43165.html">QUSSIVE-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/r-cet-forte/r-cet-forte-54762.html">R-CET FORTE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/racer/racer-27389.html">RACER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/radicof-ls/radicof-ls-56424.html">RADICOF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rain-cof/rain-cof-55888.html">RAIN-COF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ralin/ralin-29861.html">RALIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ranbrox/ranbrox-45767.html">RANBROX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ranbrox-ls/ranbrox-ls-45781.html">RANBROX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ravcof-d/ravcof-d-15895.html">RAVCOF-D	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rayberry-xt/rayberry-xt-24962.html">RAYBERRY-XT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rayforte/rayforte-33724.html">RAYFORTE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rekof/rekof-39172.html">REKOF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/relaitus/relaitus-56375.html">RELAITUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/relaitus-ls/relaitus-ls-56376.html">RELAITUS-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/renovent-pd/renovent-pd-43406.html">RENOVENT-PD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rescue/rescue-19736.html">RESCUE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/resipax/resipax-15906.html">RESIPAX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/respiclean/respiclean-16357.html">RESPICLEAN	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/respidox-a/respidox-a-12507.html">RESPIDOX-A	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/respin/respin-16358.html">RESPIN	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/respiter/respiter-45745.html">RESPITER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/respiter/respiter-45746.html">RESPITER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/respiter-l/respiter-l-45748.html">RESPITER-L</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/resporex-br/resporex-br-16359.html">RESPOREX-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/resporex-cr/resporex-cr-45183.html">RESPOREX-CR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/resporex-pd/resporex-pd-15908.html">RESPOREX-PD		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/resporex plus/resporex plus-15909.html">RESPOREX-PLUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/restaril/restaril-33575.html">RESTARIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rex/rex-16361.html">REX		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rex-s/rex-s-41869.html">REX-S</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rexam/rexam-16362.html">REXAM		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rexoryl/rexoryl-16363.html">REXORYL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rhinopin-asr/rhinopin-asr-37470.html">RHINOPIN-ASR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rinofit-ls/rinofit-ls-25362.html">RINOFIT LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/robkof/robkof-16366.html">ROBKOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rofort/rofort-19711.html">ROFORT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/roxrol-gt/roxrol-gt-16367.html">ROXROL-GT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/roxter/roxter-58190.html">ROXTER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/roxter-ls/roxter-ls-58191.html">ROXTER-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/rytus/rytus-16368.html">RYTUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/s-cadol/s-cadol-16379.html">S.CADOL	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/saam/saam-16369.html">SAAM		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/safemark-am/safemark-am-15926.html">SAFEMARK-AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salbery-ls/salbery-ls-33581.html">SALBERY-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salborex/salborex-33582.html">SALBOREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salbrom-gm/salbrom-gm-15929.html">SALBROM-GM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salcoryl/salcoryl-55896.html">SALCORYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salex-a/salex-a-16341.html">SALEX-A	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salkon/salkon-40601.html">SALKON</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/salus/salus-55898.html">SALUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sansadryl-a/sansadryl-a-33584.html">SANSADRYL-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sarbo-am/sarbo-am-16376.html">SARBO-AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sardilop/sardilop-16377.html">SARDILOP	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sarpec-a/sarpec-a-33590.html">SARPEC-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sarter-am/sarter-am-16378.html">SARTER-AM	    </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbcoff-at/sbcoff-at-47228.html">SBCOFF-AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbcoff-ax/sbcoff-ax-45196.html">SBCOFF-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbrox-3d/sbrox-3d-25756.html">SBROX-3D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbter/sbter-50580.html">SBTER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbter/sbter-50582.html">SBTER</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbter-am/sbter-am-50583.html">SBTER-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sbter-ls/sbter-ls-50584.html">SBTER-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/scc/scc-16380.html">SCC		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/scodex/scodex-15935.html">SCODEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/scorkof-x/scorkof-x-16381.html">SCORKOF-X	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/secrest-xp/secrest-xp-55501.html">SECREST-XP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sedil-am/sedil-am-46060.html">SEDIL-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/seekof/seekof-15941.html">SEEKOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sefrox/sefrox-15942.html">SEFROX 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sefydex/sefydex-15943.html">SEFYDEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sekiwent-s/sekiwent-s-57719.html">SEKIWENT-S</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/selrex/selrex-40191.html">SELREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/serra-6/serra-6-15946.html">SERRA-6		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sharex/sharex-42654.html">SHAREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/shonkof/shonkof-15948.html">SHONKOF		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/silex/silex-22791.html">SILEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/silicof/silicof-16386.html">SILICOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/silkof-x/silkof-x-16387.html">SILKOF-X	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/simbro/simbro-16388.html">SIMBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sinobrit/sinobrit-53422.html">SINOBRIT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/siokof/siokof-15957.html">SIOKOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sisphylline/sisphylline-25943.html">SISPHYLLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/snokast-ag/snokast-ag-51479.html">SNOKAST-AG</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/solucuf-ap/solucuf-ap-40765.html">SOLUCUF-AP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/soothex/soothex-16389.html">SOOTHEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/spid/spid-40826.html">SPID</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sudohist-dmr/sudohist-dmr-15970.html">SUDOHIST-DMR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sudohist-dmr/sudohist-dmr-15971.html">SUDOHIST-DMR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sukof-at/sukof-at-25177.html">SUKOF-AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/sumdly-cs/sumdly-cs-50738.html">SUMDLY-CS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/supko/supko-15973.html">SUPKO		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/supko-x/supko-x-15976.html">SUPKO-X	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/supko-x/supko-x-34650.html">SUPKO-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/suprivent-a/suprivent-a-16391.html">SUPRIVENT A	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/synacar-a/synacar-a-41461.html">SYNACAR-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/t-kuf/t-kuf-16394.html">T-KUF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tag-expectorant/tag-expectorant-52110.html">TAG EXPECTORANT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tags/tags-16395.html">TAGS		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tatakof-a/tatakof-a-57781.html">TATAKOF-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tbrox-ax/tbrox-ax-16398.html">TBROX-AX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tcr/tcr-16399.html">TCR		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tecoril plus/tecoril plus-16421.html">TECORIL PLUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/teguphen/teguphen-15986.html">TEGUPHEN	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tehist/tehist-36363.html">TEHIST</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tencol-k/tencol-k-56568.html">TENCOL K</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tencol-la/tencol-la-56572.html">TENCOL-LA</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terbo-a/terbo-a-33598.html">TERBO-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terbodex/terbodex-16404.html">TERBODEX	           </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terborex/terborex-33312.html">TERBOREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terborex/terborex-42036.html">TERBOREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terboril/terboril-50936.html">TERBORIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terboril-ls/terboril-ls-50937.html">TERBORIL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terboril-ls-kid/terboril-ls-kid-50938.html">TERBORIL LS KID</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terboxol/terboxol-16405.html">TERBOXOL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terbutol-a/terbutol-a-16406.html">TERBUTOL-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tercort/tercort-16407.html">TERCORT	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terfen-ax/terfen-ax-47240.html">TERFEN-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tergil/tergil-16408.html">TERGIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tergil-t/tergil-t-16409.html">TERGIL-T </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terpect/terpect-16410.html">TERPECT	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terpect-am/terpect-am-15988.html">TERPECT AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terpect-expectorant/terpect-expectorant-15987.html">TERPECT-EXPECTORANT </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/terphylin/terphylin-16411.html">TERPHYLIN 	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tervent-g/tervent-g-33601.html">TERVENT-G</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/texo/texo-52835.html">TEXO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/theobric-sr/theobric-sr-16415.html">THEOBRIC-SR </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/theos/theos-55928.html">THEOS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tixol-d/tixol-d-52945.html">TIXOL-D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tixol-g/tixol-g-52944.html">TIXOL-G</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tixylix-ls/tixylix-ls-35205.html">TIXYLIX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/torcox-dm/torcox-dm-38906.html">TORCOX-DM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/torexo-br/torexo-br-43547.html">TOREXO-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/torexo-ls/torexo-ls-43548.html">TOREXO-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tossex-xp/tossex-xp-35263.html">TOSSEX XP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tossex-ax/tossex-ax-16423.html">TOSSEX-AX		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/toussera-ls/toussera-ls-47230.html">TOUSSERA-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tpcof-dcg/tpcof-dcg-16424.html">TPCOF-DCG	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tricodril/tricodril-29248.html">TRICODRIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tricodril-plus/tricodril-plus-29241.html">TRICODRIL PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tricodril-a/tricodril-a-29242.html">TRICODRIL-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tricodyl/tricodyl-51229.html">TRICODYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/trocof-dx/trocof-dx-15996.html">TROCOF-DX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/trukuf/trukuf-15997.html">TRUKUF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/truphylline/truphylline-23589.html">TRUPHYLLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/trurex-am/trurex-am-50450.html">TRUREX-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/trussex-dmr/trussex-dmr-16428.html">TRUSSEX-DMR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/trustyl/trustyl-15998.html">TRUSTYL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/trustyl-br/trustyl-br-35224.html">TRUSTYL-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/turbutex/turbutex-16432.html">TURBUTEX	  </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tursil/tursil-16433.html">TURSIL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusal-ls/tusal-ls-27798.html">TUSAL LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tuscudex/tuscudex-16001.html">TUSCUDEX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tuscuex/tuscuex-16434.html">TUSCUEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tuscure-plus/tuscure-plus-33613.html">TUSCURE PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tuskos plus/tuskos plus-16002.html">TUSKOS PLUS	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusp/tusp-55158.html">TUSP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusp-br/tusp-br-55159.html">TUSP-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tussirol/tussirol-16008.html">TUSSIROL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusswinch/tusswinch-24827.html">TUSSWINCH</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tussy/tussy-16011.html">TUSSY		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tussy-a/tussy-a-16438.html">TUSSY-A		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusty-am/tusty-am-46144.html">TUSTY-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusty-am/tusty-am-46367.html">TUSTY-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tusty-am/tusty-am-46368.html">TUSTY-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tysil-am/tysil-am-47063.html">TYSIL-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/tyskoff-am/tyskoff-am-47062.html">TYSKOFF-AM</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/unicof/unicof-16013.html">UNICOF	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/unobro/unobro-12508.html">UNOBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/varex-ax/varex-ax-16442.html">VAREX-AX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/vcufsup-t/vcufsup-t-54385.html">VCUFSUP-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ventakof/ventakof-16449.html">VENTAKOF		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ventakof/ventakof-16021.html">VENTAKOF 	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ventasma-a/ventasma-a-37519.html">VENTASMA-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ventclear-a/ventclear-a-33323.html">VENTCLEAR-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ventordyl/ventordyl-16453.html">VENTORDYL		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/ventorlin-expectorant/ventorlin-expectorant-16022.html">VENTORLIN EXPECTORANT 	 		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/vexil/vexil-16456.html">VEXIL	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viburil-as/viburil-as-16457.html">VIBURIL-AS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/vicol-x/vicol-x-40722.html">VICOL-X</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viocof-br/viocof-br-16023.html">VIOCOF-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viscodyne-exp/viscodyne-exp-16024.html">VISCODYNE EXP.	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viscodyne-ls/viscodyne-ls-41113.html">VISCODYNE LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viscodyne-ls-plus/viscodyne-ls-plus-41112.html">VISCODYNE LS PLUS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viscof-s/viscof-s-16458.html">VISCOF-S	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/viscof-st/viscof-st-33324.html">VISCOF-ST</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/wellbrox-t/wellbrox-t-33620.html">WELLBROX-T</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/wemo-3d/wemo-3d-27541.html">WEMO-3D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/wikof-at/wikof-at-55990.html">WIKOF AT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/wikof-ls/wikof-ls-55989.html">WIKOF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/wincoriza-ls/wincoriza-ls-54375.html">WINCORIZA-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/winnow-x/winnow-x-16459.html">WINNOW-X		</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/winodryl/winodryl-55193.html">WINODRYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/wintoryl-ls/wintoryl-ls-49035.html">WINTORYL-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/worpex/worpex-16460.html">WORPEX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/x-plus/x-plus-16462.html">X-PLUS	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xclud/xclud-33621.html">XCLUD</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory//-12509.html">XENBRO	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xenkof-ls/xenkof-ls-33772.html">XENKOF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xeroc-ax/xeroc-ax-16461.html">XEROC-AX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory//-16047.html">XING CUF	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xing cuf/xing cuf-16046.html">XING CUF	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xituss/xituss-51986.html">XITUSS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xo-phylline/xo-phylline-40035.html">XO-PHYLLINE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xomilax-sr/xomilax-sr-41099.html">XOMILAX-SR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xpect-b/xpect-b-16049.html">XPECT-B	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xpelite/xpelite-33331.html">XPELITE</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xpelite-ac/xpelite-ac-33725.html">XPELITE-AC</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xpelite-ls/xpelite-ls-33334.html">XPELITE-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xrate/xrate-16463.html">XRATE	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/xynex-am/xynex-am-16050.html">XYNEX-AM	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/y-cold/y-cold-16051.html">Y-COLD	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/y-gin-br/y-gin-br-16464.html">Y-GIN-BR	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/yumitus/yumitus-16439.html">YUMITUS	 </a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zebo/zebo-35689.html">ZEBO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zebo-mont/zebo-mont-35691.html">ZEBO MONT</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zebro-sf/zebro-sf-34524.html">ZEBRO SF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zed/zed-45648.html">ZED</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zedoryl/zedoryl-33622.html">ZEDORYL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zedril/zedril-33623.html">ZEDRIL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zeet-p/zeet-p-43726.html">ZEET P</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zenbro/zenbro-33847.html">ZENBRO</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zentocuf/zentocuf-54014.html">ZENTOCUF</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zentocuf-ls/zentocuf-ls-54013.html">ZENTOCUF LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zentocuf-dx/zentocuf-dx-54015.html">ZENTOCUF-DX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zephrol/zephrol-33624.html">ZEPHROL</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zerotuss-xp/zerotuss-xp-45016.html">ZEROTUSS XP</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zgtuss-ax/zgtuss-ax-33629.html">ZGTUSS-AX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zgtuss-br/zgtuss-br-33630.html">ZGTUSS-BR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zipcold-dmr/zipcold-dmr-45571.html">ZIPCOLD-DMR</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zipcold-dx/zipcold-dx-45600.html">ZIPCOLD-DX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zoblin/zoblin-51550.html">ZOBLIN</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zotarex/zotarex-16467.html">ZOTAREX	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zycof-a/zycof-a-16468.html">ZYCOF-A	</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zykuf-a/zykuf-a-41739.html">ZYKUF-A</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zykuf-d/zykuf-d-40090.html">ZYKUF-D</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zyrex/zyrex-33631.html">ZYREX</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zyrex-ls/zyrex-ls-33632.html">ZYREX-LS</a>
+
+                                <a href="http://www.drugtodayonline.com/drug-directory/zysma/zysma-40094.html">ZYSMA</a>
+
+                          </div>
+          </div>
+        </div>
+
+
+
+    </div><!--main-col-->
+
+    <div class="widget-area-3 sidebar">
+      <div class="widget top-link-widget" style="position:relative">
+  <h3 class="widget-title" style="margin-bottom:0px !important;"><span class="title-line"></span><span class="title-text">Search for Articles</span></h3>
+    <form class="pure-form" action="http://www.drugtodayonline.com/article-search.php" id="afrm" style="border-top: 1px solid #eee;border-bottom:1px solid #eee;position:relative;">
+      <input id="aq" autofocus type="text" name="aq" placeholder="Search Articles ..." style="outline:0;width:85%;border-radius:0px;margin:0px;height:30px;">
+      <span class="sb-icon-search" onclick="afrm.submit();"></span>
+  </form>
+</div>
+<div class="clear"></div>
+<div class="widget kopa-adv-widget">
+    <div class="kopa-banner-300">
+                      <a href="http://www.drugmedpharma.com/" target="_blank"><img src="http://www.drugtodayonline.com/siteimg/ads/th-1570279760.jpg" alt="THRIFTY" title="THRIFTY" /></a>
+          
+      </div><!--kopa-banner-300-->
+  </div><!--widget-->
+
+  <div class="widget kopa-most-review-widget">
+    <h3 class="widget-title"><span class="title-line"></span><span class="title-text">Trending News</span></h3>
+      <ul>
+                <li>
+            <article class="entry-item clearfix">
+                <h4 class="entry-title">
+                  <!--a href="article-details.php?aid=10858">RML trauma center to be a COVID-19 ward: Dr Vardhan</a-->
+                  <a href="http://www.drugtodayonline.com/medical-news/latest/10858-rml-trauma-center-to-be-a-covid-19-ward-dr-vardhan.html">RML trauma center to be a COVID-19 ward: Dr Vardhan</a>
+                </h4>
+                  <div class="entry-thumb">
+                    <!--a href="article-details.php?aid=10858"><img src="http://www.drugtodayonline.com/images/796929a987.jpg" alt="" /></a-->
+                    <a href="http://www.drugtodayonline.com/medical-news/latest/10858-rml-trauma-center-to-be-a-covid-19-ward-dr-vardhan.html"><img src="http://www.drugtodayonline.com/images/796929a987.jpg" class="img-responsive" alt=""></a>
+                  </div>
+                  <div class="entry-content">
+                    <span class="entry-date"><span class="kopa-minus"></span> April 3, 2020</span>
+                  </div>
+              </article>
+          </li>
+                <li>
+            <article class="entry-item clearfix">
+                <h4 class="entry-title">
+                  <!--a href="article-details.php?aid=10857">Beggars hit by lockdown, not getting food in Delhi</a-->
+                  <a href="http://www.drugtodayonline.com/medical-news/latest/10857-beggars-hit-by-lockdown-not-getting-food-in-delhi.html">Beggars hit by lockdown, not getting food in Delhi</a>
+                </h4>
+                  <div class="entry-thumb">
+                    <!--a href="article-details.php?aid=10857"><img src="http://www.drugtodayonline.com/images/79681cad8b.jpg" alt="" /></a-->
+                    <a href="http://www.drugtodayonline.com/medical-news/latest/10857-beggars-hit-by-lockdown-not-getting-food-in-delhi.html"><img src="http://www.drugtodayonline.com/images/79681cad8b.jpg" class="img-responsive" alt=""></a>
+                  </div>
+                  <div class="entry-content">
+                    <span class="entry-date"><span class="kopa-minus"></span> April 3, 2020</span>
+                  </div>
+              </article>
+          </li>
+                <li>
+            <article class="entry-item clearfix">
+                <h4 class="entry-title">
+                  <!--a href="article-details.php?aid=10856">Delhi: Kalyanpuri Govt. school turned into shelter home</a-->
+                  <a href="http://www.drugtodayonline.com/medical-news/latest/10856-delhi-kalyanpuri-govt-school-turned-into-shelter-home.html">Delhi: Kalyanpuri Govt. school turned into shelter home</a>
+                </h4>
+                  <div class="entry-thumb">
+                    <!--a href="article-details.php?aid=10856"><img src="http://www.drugtodayonline.com/images/7967534845.jpg" alt="" /></a-->
+                    <a href="http://www.drugtodayonline.com/medical-news/latest/10856-delhi-kalyanpuri-govt-school-turned-into-shelter-home.html"><img src="http://www.drugtodayonline.com/images/7967534845.jpg" class="img-responsive" alt=""></a>
+                  </div>
+                  <div class="entry-content">
+                    <span class="entry-date"><span class="kopa-minus"></span> April 3, 2020</span>
+                  </div>
+              </article>
+          </li>
+        
+      </ul>
+  </div><!--kopa-most-review-widget-->
+  <div class="widget kopa-adv-widget">
+      <div class="kopa-banner-300">
+                          <a href="http://www.drugmedpharma.com/" target="_blank"><img src="http://www.drugtodayonline.com/siteimg/ads/th-1570279760.jpg" alt="THRIFTY" title="THRIFTY" /></a>
+            
+        </div><!--kopa-banner-300-->
+    </div><!--widget-->
+    </div><!--widget-area-3-->
+
+    <div class="clear"></div>
+
+</div><!--main-content-->
+
+
+<div class="bottom-sidebar clearfix">
+	<div class="widget-area-50">
+			</div>
+<div style="position:absolute;overflow:auto;width:0"></div>	<div class="widget-area-50">
+			</div>
+	<div class="clearfix"></div>
+	<div class="clear"></div>
+		<div class="widget-area-14">
+			<div class="widget widget_text">
+					<div id="footer-logo">
+							<a href="#"><img src="http://www.drugtodayonline.com/assets-design/placeholders/logo.png" alt="" /></a>
+						</div><!--footer-logo-->
+						<!--div class="textwidget"></div-->
+				</div><!--widget-->
+		</div><!--widget-area-13-->
+
+		<div class="widget-area-13">
+					</div>
+
+		<div class="clear"></div>
+
+</div><!--bottom-sidebar-->
+
+<footer id="page-footer">
+	<nav id="footer-nav">
+        <ul id="footer-menu" class="clearfix">
+            <li><a href="http://www.drugtodayonline.com/privacy-policy.php">Privacy Policy</a></li>
+						<li><a href="http://www.drugtodayonline.com/term-and-conditions.php">Terms & Conditions</a></li>
+						<li><a href="http://www.drugtodayonline.com/disclaimer-policy.php">Disclaimer</a></li>
+						<li><a href="http://www.drugtodayonline.com/shipping-and-delivery.php">Shipping & Delivery</a></li>
+						<li><a href="http://www.drugtodayonline.com/cancellation-and-refund.php">Cancellation & Refund</a></li>
+						<li><a href="http://www.drugtodayonline.com/site-map.php">Site Map</a></li>
+						<li><a href="http://www.drugtodayonline.com/services.php">Services</a></li>
+						<li><a href="http://www.drugtodayonline.com/contact-us.php">Contact us</a></li>
+						<li><a href="http://www.drugtodayonline.com/about-us.php">About us</a></li>
+            			<li><a href="http://www.drugtodayonline.com/pcd-franchisee.php">Pharma PCD Franchise companies</a></li>
+						<li><a href="http://www.drugtodayonline.com/inquiry.php">Inquiry Form</a></li>
+        </ul><!--footer-menu-->
+	</nav><!--footer-nav-->
+</footer><!--page-footer-->
+
+<p id="back-top">
+		<a href="#top">Back to Top</a>
+</p>
+
+</div><!--span12-->
+
+</div><!--row-fluid-->
+
+</div><!--wrapper-->
+
+
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery-1.8.3.min.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/superfish.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/retina.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/bootstrap.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.carouFredSel-6.0.4-packed.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/classie.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/uisearch.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.flexslider-min.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.prettyPhoto.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/tweetable.jquery.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.timeago.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.backstretch.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.validate.min.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/jquery.form.js"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/custom.js" charset="utf-8"></script>
+<script src="http://www.drugtodayonline.com/assets-design/js/autocomplete/jquery.auto-complete.min.js" charset="utf-8"></script>
+
+<script>
+
+$(document).on("keyup","#csearch",function (){
+	var offset=$(".sb-search").offset().top;
+	var width1=$("#csearch").outerWidth()+19;
+
+	//Get Data Here
+	if($("#csearch").val().length>1){
+		var url="http://www.drugtodayonline.com/ajaxscript/get-quick-list.php?q="+$("#csearch").val();
+
+		$.get(url).done(function( data ) {
+			$(".search-popup").css({"width":width1,"top":(offset+40),"display":"block"});
+			$(".search-popup").html(data);
+			$(".search-popup").show();
+		});
+	}
+});
+$(document).ready(function() {
+  var block_arr = $('.ticker li p').map(function() { return $(this).get(0);}).toArray();
+  
+  var ticker_item = $(block_arr[0]);
+  $(".ticker").html(ticker_item);
+  var ticker_width = $(".ticker").width();
+  var text_x = ticker_width;
+    
+  console.log(block_arr.indexOf(ticker_item.get(0)));
+  console.log(block_arr.length);
+
+  scroll_ticker = function() {    
+    text_x--;
+    ticker_item.css("left", text_x);
+    if (text_x < -1 * ticker_item.width()) {
+      ticker_item = $(block_arr[(block_arr.indexOf(ticker_item.get(0)) + 1 == block_arr.length) ? 0 : block_arr.indexOf(ticker_item.get(0)) + 1]);
+      ticker_item.css("left", text_x);
+      $(".ticker").html(ticker_item);
+      text_x = ticker_width;
+    }
+  }
+  setInterval(scroll_ticker, 7);
+});
+
+$(document).on("click",function(){
+	$(".search-popup").hide();
+});
+
+var d = new Date(1585976079000);
+function digitalClock() {
+d.setTime(d.getTime() + 1000);
+var hrs = d.getHours();
+var mins = d.getMinutes();
+var secs = d.getSeconds();
+mins = (mins < 10 ? "0" : "") + mins;
+secs = (secs < 10 ? "0" : "") + secs;
+var apm = (hrs < 12) ? "AM" : "PM";
+hrs = (hrs > 12) ? hrs - 12 : hrs;
+hrs = (hrs == 0) ? 12 : hrs;
+var ctime = hrs + ":" + mins + ":" + secs + " " + apm;
+ctime="Saturday 4 April 2020 "+" "+ctime;
+document.getElementById("cdatetime").firstChild.nodeValue = ctime;
+//$("#cdatetime").html("Saturday 4 April 2020 10:24:39");
+}
+setInterval('digitalClock()',1000);
+
+</script>
+<script language="javascript">
+    document.onmousedown=disableclick;
+    status="All Content Of This Website is Copywrited.\n\nPlease do not copy the content.";
+    function disableclick(event)
+    {
+      if(event.button==2)
+       {
+         alert(status);
+         return false;    
+       }
+    }
+</script>
+
+<script data-ad-client="ca-pub-2954285447080709" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
+</body>
+
+</html>
diff --git a/atlassian-developer-terms.html b/atlassian-developer-terms.html
new file mode 100644
index 0000000..7ac8ebc
--- /dev/null
+++ b/atlassian-developer-terms.html
@@ -0,0 +1,227 @@
+<!DOCTYPE html>
+    <html lang="en">
+      <head><meta name="csrf" content="tOr81uP8-F4hF5Qv0UjODofurLq3x9wOyj38">
+        <meta charset="utf-8">
+        <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
+        
+        <link rel="shortcut icon" href="/favicon.ico" type="image/x-icon">
+        <link rel="search" href="/opensearch.xml" type="application/opensearchdescription+xml">
+        <script type="text/javascript">window.__DATA__ = {"jiraIssueCollectorId":"ee87e716","page":{"document":[{"type":"markdown","content":"# Atlassian Developer Terms\n\nWe're excited that you've chosen to develop on the Atlassian development platform (the \"**Atlassian Platform**\").  The Atlassian Platform allows you to build amazing add-ons for teams.  When you develop on the Atlassian Platform, you agree to be bound by the following terms, so please read them carefully. \n\nThese Atlassian Developer Terms (the \"**Terms**\") are a binding agreement between you and Atlassian Pty Ltd (ABN 53 102 443 916) (\"**we**\" or \"**Atlassian**\").  In these Terms, you are referred to as \"**you**\" or \"**Developer**\".  If you are entering into these Terms on behalf of a company, organization or another legal entity (an \"**Entity**\"), you are agreeing to these Terms for that Entity and representing to Atlassian that you have the authority to bind such Entity to these Terms, in which case the terms \"you\" or \"Developer\" shall refer to such Entity. If you do not have such authority, or if you do not agree with these Terms, you must not accept these Terms or use the Atlassian Developer Assets.  Atlassian may modify these Terms from time to time, subject to Section 17 (Changes to Terms) below.\n\n**By clicking on \"I agree\" (or a similar button) or by using or accessing any Atlassian Developer Assets, you agree to be bound by these Terms.**\n\n1.            **Atlassian Developer Assets**. Atlassian makes available certain APIs, software development kits (SDKs), and cloud-based development tools (collectively, \"**Atlassian Developer Assets**\") for use with its products and services (\"**Atlassian Products**\"). Atlassian also makes available the Atlassian Developer Guidelines at \u003chttps://developer.atlassian.com/index.html> (\"**Developer Guidelines**\"), which include directions and guidelines for use of the Atlassian Developer Assets and which may be modified by Atlassian from time to time. Except where noted, references to any Atlassian Developer Assets include the related Developer Guidelines.\n\n2.            **Registration**. You agree to follow the registration or credentialing requirements (if any) established by Atlassian for access to the Atlassian Developer Assets. All Atlassian Developer Assets access keys or developer credentials are Atlassian's confidential information and may not be shared with third parties.\n\n3.            **Your Use Rights**.** **Subject to these Terms, you may use the Atlassian Developer Assets to enable products and services (\"**Add-Ons**\") to access or interface with Atlassian Products, but only as permitted by the relevant Developer Guidelines. All of your use rights in these Terms (including your rights to use Atlassian Marks below) are limited, non-exclusive, non-sublicenseable and non-transferable. You may, however, permit your agents and contractors to exercise your use rights on your behalf, provided that you remain responsible for their compliance with these Terms.\n\n4.            **Conditions on Use**. In accessing and using the Atlassian Developer Assets, you agree to comply with Atlassian's Acceptable Use Policy at [https://www.atlassian.com/legal/acceptable-use-policy](https://www.atlassian.com/legal/acceptable-use-policy) (\"**AUP**\") (as may be modified from time to time). As conditions on your use rights, you also agree not to (and not to authorize any third party to): (a) use the Atlassian Developer Assets except with the related Atlassian Products and in accordance with the Developer Guidelines; (b) modify or create any derivative works of the Atlassian Developer Assets (except to the extent the Add-Ons are deemed derivative works under applicable law); (c) take any action that would subject the Atlassian Developer Assets to any third party terms, including without limitation any \"open source\" software license terms; (d) make any calls to the Atlassian Developer Assets that are not driven by a request from an end user (as described in Section 7.1) or the Add-On itself, other than as part of reasonable testing of your Add-Ons with the Atlassian Developer Assets; (e) copy, frame or display any elements of the Atlassian Products through the Add-Ons or use the Atlassian Developer Assets with Add-Ons that substantially replicate any features or functionality of Atlassian Products, except as expressly authorized by Atlassian in writing; (f) copy, distribute, sell, sublicense, rent or lease the Atlassian Developer Assets or any access key provided by Atlassian or use such items for hosting, service provider or like purposes; or (g) access the Atlassian Developer Assets for competitive analysis or disseminate performance information (including uptime, response time and/or benchmarks) relating to the Atlassian Developer Assets or Atlassian Products. From time to time, Atlassian may place limits on access to the Atlassian Developer Assets (e.g., limits on numbers of calls or requests). Further, Atlassian may monitor your usage of the Atlassian Developer Assets and limit the number of calls or requests you may make if Atlassian believes that your usage is in breach of this Agreement or may negatively affect the Atlassian Platform (or otherwise impose liability on Atlassian).\n\n5.            **Use of Atlassian Marks**. Subject to these Terms, you may use the appropriate Atlassian names, logos and trademarks as designated in the Atlassian Trademark Guidelines at [https://www.atlassian.com/legal/trademark](https://www.atlassian.com/legal/trademark)> (\"**Atlassian Marks**\") to promote your Add-Ons as compatible with the relevant Atlassian Products. Your use of Atlassian Marks must comply with the Atlassian Trademark Guidelines and (without limiting Atlassian's other termination rights) you must promptly cease any use of Atlassian Marks identified by Atlassian as problematic. You may not register any domain name containing Atlassian Marks, the word \"Atlassian\" or the name of any Atlassian Product (or anything confusingly similar) and if you have done so you agree to transfer ownership of the domain name to Atlassian at no charge. You also agree not to contest the validity of ownership of any Atlassian Marks. You receive no other rights to Atlassian Marks under these Terms. All goodwill arising from use of Atlassian Marks inures to Atlassian.\n\n6.            **Use of Your Marks; Your Ownership Rights**. Atlassian may (but is not obligated to) use your name, logos and other trademarks (including those related to the Add-Ons) to identify you as an Atlassian developer and to promote your Add-Ons and Atlassian Products. Atlassian receives no other rights to your trademarks under these Terms. All goodwill arising from use of your trademarks belongs to you. For clarity, nothing in these Terms assigns ownership of your Add-Ons or intellectual property rights to Atlassian.\n\n7.            **Your Responsibilities**.\n\n7.1.                Add-Ons and End Users. You are solely responsible, at your own expense, for (a) your Add-Ons and their distribution, operation and support and (b) your own relationships and agreements with end users regarding their use of Add-Ons. As a result of your use of Atlassian Developer Assets, an end user may direct you to retrieve certain of its data, content or information from Atlassian Products (\"**End User Data**\") for the end user's further use with Add-Ons. You agree to retrieve End User Data only to the extent enabled by the end user and will ensure that all End User Data is collected, processed, transmitted, maintained and used in accordance with (i) your agreement with the end user, a legally adequate privacy policy, and appropriate contextual notices to and consents from end users, (ii) all Laws (as defined below) and (iii) reasonable measures that protect the privacy and security of End User Data.\n\n7.2.                Atlassian Customer Agreement. Use of Atlassian Products requires each end user to have a valid license or subscription with Atlassian subject to the then-current Atlassian Customer Agreement, which is currently located at [https://www.atlassian.com/end-user-agreement/](https://www.atlassian.com/end-user-agreement/) and which includes the AUP (\"**Atlassian Customer Agreement**\"). You will not facilitate or encourage any end user to violate the Atlassian Customer Agreement or interfere with any end user's review or acceptance of the Atlassian Customer Agreement. For the avoidance of doubt, your use of the Atlassian Developer Assets is subject to this Agreement, not the Atlassian Customer Agreement.  If you use Atlassian Products as a customer, that use remains subject to the Atlassian Customer Agreement.\n\n7.3.                No Resale. These Terms do not grant you the right to distribute or resell Atlassian Products or to create any binding commitment on behalf of Atlassian. In addition, you may not directly or indirectly charge end users for use of, or access to, the functionality of the Atlassian Products or Atlassian Developer Assets (but this does not limit you from charging a standard overall fee for the Add-Ons).\n\n7.4.                Your Representations and Warranties. You represent and warrant that (a) you have full power and authority to enter into and perform these Terms and to exploit the Add-Ons without violating any other agreement; (b) the Add-Ons and their use will not violate any third party rights (including intellectual property rights and rights of privacy or publicity) or any laws, rules, regulations or orders, including those relating to data privacy, data transfer, international communications or the export of technical or personal data (\"**Laws**\"); (c) all information you provide to Atlassian is and will be true, accurate, and complete and (d) you will not interfere with Atlassian's business practices or the way in which it licenses or distributes the Atlassian Products or Atlassian Developer Assets. You may not suggest any affiliation with Atlassian, including any suggestion that Atlassian sponsors, endorses or guarantees the Add-Ons, except for the Atlassian Developer Assets integration relationship expressly contemplated in these Terms. You may not make any representations, warranties or commitments regarding Atlassian or Atlassian Products or on behalf of Atlassian.\n\n7.5.                Indemnification. You will indemnify, defend (at Atlassian's request) and hold harmless Atlassian and its affiliates and their respective directors, officers, employees, agents, contractors, end users and licensees from and against any claims, losses, costs, expenses (including reasonable attorneys' fees), damages or liabilities based on or arising from (a) the Add-Ons, (b) your relationships or interactions with any end users or third party distributors of the Add-Ons, or (c) your breach or alleged breach of these Terms. Atlassian may at its own expense participate in the defense and settlement of any claim with its own counsel, and you may not settle a claim without Atlassian's prior written consent (not to be unreasonably withheld).\n\n8.            **Ownership**. Atlassian and its third party licensors retain all ownership and other rights in the Atlassian Developer Assets, Atlassian Products and Atlassian Marks, including all intellectual property rights. Providing feedback, comments, or suggestions about the Atlassian Developer Assets or Atlassian Products (**\"Feedback**\") to Atlassian is wholly voluntary. By providing Feedback, Developer grants Atlassian a worldwide, royalty-free, non-exclusive, perpetual and irrevocable license to use, copy, modify, sublicense (through multiple tiers) and otherwise exploit the Feedback (including any ideas, concepts, methods, know-how or techniques embodied in Feedback) for any purpose, without any restriction or obligation to Developer based on intellectual property rights or otherwise.\n\n9.            **No Support or Maintenance**. Atlassian has no obligation to provide any maintenance or support for the Atlassian Developer Assets (or to end users of Add-Ons) or to fix any errors or defects. If Atlassian in its discretion provides any updates, modifications, enhancements, and other new releases to the Atlassian Developer Assets, such materials will be deemed included in the \"Atlassian Developer Assets\" under these Terms unless Atlassian specifies otherwise.\n\n10.            **Changes to Atlassian Developer Assets**. From time to time, Atlassian may change the Atlassian Developer Assets or related Atlassian Products. Future versions of the Atlassian Developer Assets may not be compatible with Add-Ons developed using previous versions. Atlassian typically makes these changes as part of its overall developer program and is unable to provide notice of the changes to developers individually. Atlassian will have no liability resulting from the actions described in this paragraph.\n\n11.            **Termination. **These Terms remain in effect until terminated. Developer may terminate these Terms at any time by ceasing all use of the Atlassian Developer Assets and any relevant developer credentials. Atlassian may terminate these Terms (a) for no reason or any reason upon thirty (30) days' notice to Developer or (b) if Developer breaches any provision of these Terms and does not cure such breach within fifteen (15) days after written notice of the breach (or immediately in Atlassian's discretion in case of willful or significant breaches). Atlassian may also suspend Developer's use of Atlassian Developer Assets or terminate these Terms immediately if Atlassian is required to do so by Law, if Atlassian ceases to offer the Atlassian Developer Assets, Atlassian Products or its developer program or if Atlassian determines that continuing under these Terms could result in legal or business liability or cause harm to its products, services, reputation or users. Upon any termination, Developer's rights to use Atlassian Developer Assets (including related access keys and credentials) and Atlassian Marks will immediately terminate and Developer will cease all such use, but all other provisions of these Terms will survive. Developer understands that after termination it will have no further access to any Atlassian developer website or portal or to any data or content that Developer submitted to Atlassian relating to the Atlassian Developer Assets. Atlassian will have no obligation or liability resulting from termination or suspension of these Terms as permitted above.\n\n12.            **Disclaimer of Warranties**. TO THE FULL EXENT PERMITTED BY LAW, ALL ATLASSIAN DEVELOPER ASSETS, ATLASSIAN PRODUCTS AND ATLASSIAN MARKS ARE PROVIDED \"AS IS\" AND \"WITH ALL FAULTS\" AND ATLASSIAN AND ITS THIRD PARTY LICENSORS DISCLAIM ALL REPRESENTATIONS, WARRANTIES AND GUARANTEES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY, TITLE, NON-INFRINGEMENT AND FITNESS FOR ANY PURPOSE. ATLASSIAN MAKES NO REPRESENTATION, WARRANTY OR GUARANTEE RELATED TO RELIABILITY, ACCURACY, OR COMPLETENESS OF THE ATLASSIAN DEVELOPER ASSETS OR ATLASSIAN PRODUCTS, THAT ATLASSIAN WILL CONTINUE TO OFFER ANY ATLASSIAN DEVELOPER ASSETS OR ITS DEVELOPER PROGRAM OR THAT USE OF ANY ATLASSIAN DEVELOPER ASSETS OR ATLASSIAN PRODUCTS WILL BE SECURE, TIMELY, UNINTERRUPTED, ERROR-FREE OR MEET DEVELOPER'S REQUIREMENTS OR EXPECTATIONS. You may have other statutory rights, in which case the disclaimers above will apply to the full extent permitted by law.\n\n13.            **Limitations of Liability**.** **TO THE FULL EXTENT PERMITTED BY LAW, IN NO EVENT WILL ATLASSIAN BE LIABLE (A) FOR ANY LOSS OF USE, LOST DATA, FAILURE OF SECURITY MECHANISMS, INTERRUPTION OF BUSINESS, OR ANY INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES OF ANY KIND (INCLUDING LOST PROFITS OR LOST DATA), REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY OR OTHERWISE, EVEN IF INFORMED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE OR (B) IN ANY EVENT, FOR ANY DAMAGES OR LIABILITIES EXCEEDING ONE HUNDRED U.S. DOLLARS ($100).** **NOTWITHSTANDING ANYTHING TO THE CONTRARY, ATLASSIAN HAS NO WARRANTY, INDEMNIFICATION OR OTHER OBLIGATION OR LIABILITY WITH RESPECT TO YOUR ADD-ONS OR THEIR COMBINATION, INTERACTION, OR USE WITH ANY ATLASSIAN PRODUCTS OR ATLASSIAN DEVELOPER ASSETS. Developer acknowledges and agrees that this Section 13 reflects a reasonable allocation of risk and that Atlassian would not enter into these Terms without these liability limitations. This Section 13 will survive notwithstanding any limited remedy's failure of essential purpose.\n\n14.            **Atlassian Confidential Information**.\n\n14.1.             Definition. All information disclosed by Atlassian that is marked as confidential or proprietary or that you should reasonably understand to be confidential or proprietary is \"**Confidential Information**.\" Confidential Information includes non-public aspects of the Atlassian Products and Atlassian Developer Assets. Confidential Information shall not include any information that: (i) is or becomes generally known to the public; (ii) was known to you before its disclosure hereunder; or (iii) is received from a third party, in each case without breach of an obligation owed to Atlassian or anyone else.\n\n14.2.             Your Obligations. During and after the term of this Agreement, you shall (a) maintain Confidential Information in confidence (using at least the same measures as for your own confidential information, and no less than reasonable care) and not divulge it to any third party and (b) only use Confidential Information to fulfill your obligations under this Agreement. If you are compelled by law to disclose Confidential Information, you must provide Atlassian with prior notice of such compelled disclosure (to the extent legally permitted) and reasonable assistance, at Atlassian's cost, if Atlassian wishes to contest the disclosure.\n\n14.3.             Injunctive Relief. In the event of actual or threatened breach of this Section 14, Atlassian shall have the right, in addition to any other remedies available to it, to seek injunctive relief to protect its Confidential Information, it being specifically acknowledged by the parties that other available remedies may be inadequate.\n\n15.            **Information You Provide Is Not Confidential**.\n\n15.1.             You understand and agree that Atlassian develops its own products and services and works with many other vendors and developers, and either Atlassian or these third parties could in the future develop (or already have developed) products similar to yours.\n\n15.2.             You should not provide to Atlassian any information that you consider confidential and you agree that Atlassian is not subject to any confidentiality obligations or use restrictions related to information that you may provide to Atlassian in relation to this Agreement. You expressly agree that neither this Agreement nor your development on the Atlassian Platform limits Atlassian's right to develop or have developed for it products, concepts, systems or techniques that are similar to or compete with any Add-Ons or any other products, concepts, systems or techniques contemplated by or embodied in information you disclose to Atlassian. For clarity, however, this paragraph, in itself, does not grant Atlassian any license under your intellectual property rights.\n\n16.            **Export Restrictions**. The Atlassian Developer Assets are subject to export restrictions by the United States government and import restrictions by certain foreign governments, and you agree to comply with all applicable export and import laws and regulations in your use of the Atlassian Developer Assets. You shall not (and shall not allow any third-party to) remove or export from the United States or allow the export or re-export of any part of the Atlassian Developer Assets or any direct product thereof: (a) into (or to a national or resident of) any embargoed or terrorist-supporting country; (b) to anyone on the U.S. Commerce Department's Table of Denial Orders or U.S. Treasury Department's list of Specially Designated Nationals; (c) to any country to which such export or re-export is restricted or prohibited, or as to which the United States government or any agency thereof requires an export license or other governmental approval at the time of export or re-export without first obtaining such license or approval; or (d) otherwise in violation of any export or import restrictions, laws or regulations of any United States or foreign agency or authority. You represent and warrant that you are not located in, under the control of, or a national or resident of any such prohibited country or on any such prohibited party list. The Atlassian Developer Assets are restricted from being used for the design or development of nuclear, chemical, or biological weapons or missile technology without the prior permission of the United States government.\n\n17.            **Changes to Terms**. Atlassian may modify these Terms from time to time, including any referenced policies and other documents. Atlassian will use reasonable efforts to notify you of modifications as provided in Section 19 (General). You may be required to click through the modified Terms to show your acceptance and in any event your continued use of any Atlassian Developer Assets after the modification constitutes your acceptance to the modifications. If you do not agree to the modified Terms, your sole remedy is to terminate your use of the Atlassian Developer Assets as described in Section 11 (Termination).\n\n18.            **Open Source Software. **The Atlassian Developer Assets may contain or be provided with components subject to the terms and conditions of \"open source\" software licenses (\"**Open Source Software**\"). To the extent applicable, Atlassian will identify Open Source Software included in the Atlassian Developer Assets.  To the extent required by the license that accompanies the Open Source Software, the terms of such license will apply in lieu of the terms of this Agreement with respect to such Open Source Software, including, without limitation, any provisions governing access to source code, modification or reverse engineering.\n\n19.**            General. **These Terms are the parties' entire agreement and supersede any prior or contemporaneous agreements relating to its subject matter. Except as set forth in Section 17 (Changes to Terms), all amendments or modifications must be in writing and signed by both parties. The words \"including\" and similar terms are to be construed without limitation. Failure to enforce any provision is not a waiver and all waivers must be in writing. If any provision is found to be unenforceable it (and related provisions) will be interpreted to best accomplish its intended purpose. Developer may not assign, transfer or delegate any right or obligations under these Terms and any non-permitted assignment is void. Atlassian may assign these Terms and its rights and obligations to any of its affiliates or in connection with a merger, reorganization, acquisition or other transfer of all or substantially all of its assets or voting securities to which these Terms relate. Notices must be in writing and will be deemed given when delivered. Atlassian may provide notice to the email or physical address provided by Developer or through Atlassian's developer website. Your notices to Atlassian must be given by post to Atlassian Pty Ltd, c/o Atlassian, Inc., 1098 Harrison Street, San Francisco, CA, USA 94103, Attn: Legal. The parties are independent contractors and these Terms do not create any agency, partnership, or joint venture. These Terms will be governed by and construed in accordance with the laws of the State of California, excluding conflicts of law rules and principles. Each party submits to the personal and exclusive jurisdiction of the federal or state courts for San Francisco County, California. Atlassian will not be liable to Developer for any delay or failure to perform any obligation under these Terms if the delay or failure is due to unforeseen events that are beyond its reasonable control. The Atlassian Developer Assets and Atlassian Products are commercial computer software. If the user or licensee of such technology is an agency, department, or other entity of the United States Government, the use, duplication, reproduction, release, modification, disclosure, or transfer of such technology, or any related documentation of any kind, including technical data and manuals, is restricted by these Terms in accordance with Federal Acquisition Regulation 12.212 for civilian purposes and Defense Federal Acquisition Regulation Supplement 227.7202 for military purposes. The Atlassian Developer Assets and Atlassian Products were developed fully at private expense. All other use is prohibited.\n\n \n\n**Last updated 04 Dec 2015**\n\nBy downloading and/or using this SDK you agree to the [Atlassian Developer Terms](/platform/marketplace/atlassian-developer-terms)\n\n"}],"metadata":{"source":"https://bitbucket.org/atlassian-developers/marketplace/src/master/content/platform/marketplace/atlassian-developer-terms.md?at=master&fileviewer=file-view-default&mode=edit&spa=0","aliases":["market/atlassian-developer-terms-37879876.html","/market/atlassian-developer-terms-37879876.md"],"confluence_id":37879876,"dac_edit_link":"https://developer.atlassian.com/pages/editpage.action?cjm=wozere&pageId=37879876","dac_view_link":"https://developer.atlassian.com/pages/viewpage.action?cjm=wozere&pageId=37879876","title":"Atlassian Developer Terms","platform":"platform","product":"marketplace","category":"devguide","subcategory":"other","date":"2020-06-05"},"deprecatedNavigation":{"title":"Atlassian Marketplace","name":"marketplace","url":"/platform/marketplace/","categories":[{"title":"Guides","name":"devguide","url":"/platform/marketplace/","indexLinkTitle":"About Atlassian Marketplace","subcategories":[{"title":"Build","name":"build","items":[{"title":"Getting started","url":"/platform/marketplace/getting-started"},{"title":"Registering apps","url":"/platform/marketplace/registering-apps"},{"title":"Installing cloud apps","url":"/platform/marketplace/installing-cloud-apps"},{"title":"Cloud app operations guide","url":"/platform/marketplace/cloud-app-operations-guide"},{"title":"Adding watching and rating controls to server apps","url":"/platform/marketplace/adding-watching-and-rating-controls-to-server-apps"},{"title":"Alternate deployment model for server apps","url":"/platform/marketplace/alternate-deployment-model-for-server-apps"},{"title":"Developing apps for Atlassian Data Center products","url":"/platform/marketplace/developing-apps-for-atlassian-data-center-products"},{"title":"Guidelines for Data Center app development","url":"/platform/marketplace/guidelines-for-data-center-app-development"},{"title":"Submitting your Data Center app","url":"/platform/marketplace/dc-apps-submitting-your-app"},{"title":"Tracking your Data Center app submission","url":"/platform/marketplace/dc-apps-tracking-your-submission"},{"groupItems":[{"title":"Performance and scale testing your Data Center app","url":"/platform/marketplace/dc-apps-performance-and-scale-testing"},{"title":"Testing your app with a large data set","url":"/platform/marketplace/testing-your-app-with-a-large-data-set"},{"title":"Data Center App Performance Toolkit User Guide For Jira","url":"/platform/marketplace/dc-apps-performance-toolkit-user-guide-jira"},{"title":"Data Center App Performance Toolkit User Guide For Confluence","url":"/platform/marketplace/dc-apps-performance-toolkit-user-guide-confluence"},{"title":"Data Center App Performance Toolkit User Guide For Bitbucket","url":"/platform/marketplace/dc-apps-performance-toolkit-user-guide-bitbucket"}],"title":"Performance and scale testing","url":"/platform/marketplace/dc-apps-performance-and-scale-testing","isGroup":true}]},{"title":"Licensing","name":"licensing","items":[{"title":"Cloud app licensing","url":"/platform/marketplace/cloud-app-licensing"},{"title":"Server app licensing","url":"/platform/marketplace/server-app-licensing"},{"title":"Server app license validation rules","url":"/platform/marketplace/server-app-license-validation-rules"},{"title":"Adding licensing support to server apps","url":"/platform/marketplace/adding-licensing-support-to-server-apps"},{"title":"Omitting web resources for unlicensed server apps","url":"/platform/marketplace/ommitting-web-resources-for-unlicensed-server-apps"},{"title":"Timebomb licenses for testing server apps","url":"/platform/marketplace/timebomb-licenses-for-testing-server-apps"},{"title":"Understanding generated license API support","url":"/platform/marketplace/understanding-the-generated-license-api-support"}]},{"title":"Pricing and payments","name":"pricing","items":[{"title":"Pricing, payment, and billing","url":"/platform/marketplace/pricing-payment-and-billing"},{"title":"Why can't I change the payment model","url":"/platform/marketplace/why-cant-i-change-the-payment-model"},{"title":"Sales tax","url":"/platform/marketplace/sales-tax"}]},{"title":"List","name":"listing","items":[{"title":"App approval guidelines","url":"/platform/marketplace/app-approval-guidelines"},{"title":"Creating a Marketplace listing","url":"/platform/marketplace/creating-a-marketplace-listing"},{"title":"Listing and managing apps","url":"/platform/marketplace/listing-and-managing-apps"},{"title":"Creating a server app package ","url":"/platform/marketplace/creating-a-server-app-package"},{"title":"Declaring marketing assets for server apps","url":"/platform/marketplace/declaring-marketing-assets-for-server-apps"},{"title":"Listing an app version from Java","url":"/platform/marketplace/listing-an-app-version-from-java"},{"title":"Listing an app version using REST","url":"/platform/marketplace/listing-an-app-version-using-rest"},{"title":"Managing permissions on your vendor account","url":"/platform/marketplace/managing-permissions-on-your-vendor-account"},{"title":"Upgrading and versioning cloud apps","url":"/platform/marketplace/upgrading-and-versioning-cloud-apps"},{"title":"Archiving apps","url":"/platform/marketplace/archiving-apps"}]},{"title":"Sell","name":"sell","items":[{"title":"Selling on Marketplace","url":"/platform/marketplace/selling-on-marketplace/"},{"title":"Building your presence on Marketplace","url":"/platform/marketplace/building-your-presence-on-marketplace/"},{"title":"Atlassian brand guidelines for Marketplace vendors","url":"/platform/marketplace/atlassian-brand-guidelines-for-marketplace-vendors/"},{"groupItems":[{"title":"AdWords での商標に関するポリシー","url":"/platform/marketplace/adwords-trademark-policy-ja"}],"title":"AdWords trademark policy","url":"/platform/marketplace/adwords-trademark-policy/","isGroup":true},{"title":"Marketplace search results and rankings","url":"/platform/marketplace/marketplace-search-results-and-rankings/"},{"title":"SEO best practices","url":"/platform/marketplace/seo-best-practices/"},{"title":"Marketing funnel insights","url":"/platform/marketplace/marketing-funnel-insights"},{"title":"Attracting new customers","url":"/platform/marketplace/attracting-new-customers/"},{"title":"Converting from try to buy","url":"/platform/marketplace/converting-from-try-to-buy/"},{"title":"Creating a press release","url":"/platform/marketplace/creating-a-press-release/"},{"title":"Contributing to the Atlassian blog","url":"/platform/marketplace/contributing-to-the-atlassian-blog/"},{"title":"Sales promotions","url":"/platform/marketplace/sales-promotions/"},{"title":"Sales and evaluations reports","url":"/platform/marketplace/sales-and-evaluations-reports/"},{"title":"Accessing sales reports with the REST API","url":"/platform/marketplace/accessing-sales-reports-with-the-rest-api/"}]},{"title":"Programs","name":"programs","items":[{"title":"Programs and features","url":"/platform/marketplace/programs-and-features"},{"title":"Top Vendor program","url":"/platform/marketplace/top-vendor-program"},{"title":"Cloud security program","url":"/platform/marketplace/cloud-security-program"},{"title":"Marketplace security bug bounty program","url":"/platform/marketplace/marketplace-bounty-program"},{"title":"Early access program","url":"/platform/marketplace/early-access-program"},{"title":"Sales promotions","url":"/platform/marketplace/sales-promotions"},{"title":"Reports for paid via Atlassian listings","url":"/platform/marketplace/sales-and-evaluations-reports"},{"title":"Sales and renewals email campaigns","url":"/platform/marketplace/sales-and-renewals-email-campaigns"},{"title":"Manage permissions on your vendor account","url":"/platform/marketplace/managing-permissions-on-your-vendor-account"},{"title":"App archiving","url":"/platform/marketplace/archiving-apps"}]},{"title":"Data privacy and security","name":"guidelines","items":[{"title":"Data privacy guidelines","url":"/platform/marketplace/data-privacy-guidelines/"},{"groupItems":[{"title":"Security requirements for cloud apps","url":"/platform/marketplace/security-requirements/"},{"title":"FAQ: Security requirements for cloud apps","url":"/platform/marketplace/security-requirements-faq/"},{"title":"Enforcement Procedure: Security requirements","url":"/platform/marketplace/security-requirements-enforcement"},{"title":"Additional information: Security requirements","url":"/platform/marketplace/security-requirements-more-info"}],"title":"App security requirements","url":"/platform/marketplace/security-requirements/","isGroup":true},{"groupItems":[{"title":"Security guidelines for marketplace apps","url":"/platform/marketplace/app-security-guidelines/"},{"title":"Security guidelines for marketplace vendors","url":"/platform/marketplace/vendor-security-guidelines/"},{"title":"Security considerations for server apps","url":"/platform/marketplace/security-considerations-server/"},{"title":"Security considerations for cloud apps","url":"/platform/marketplace/security-considerations-cloud/"}],"title":"Security guidelines","url":"/platform/marketplace/security-guidelines/","isGroup":true},{"groupItems":[{"title":"Incident management guidelines","url":"/platform/marketplace/app-security-incident-management-guidelines/"},{"title":"Preparing for a security incident","url":"/platform/marketplace/preparing-for-a-security-incident/"},{"title":"Incident notification comms template","url":"/platform/marketplace/app-security-incident-communication-template/"},{"title":"Vulnerability notification comms template","url":"/platform/marketplace/app-vulnerability-notification-template/"}],"title":"App security incident management","url":"/platform/marketplace/app-security-incident-management-guidelines/","isGroup":true}]},{"title":"Knowledge Base","name":"kbs","items":[{"title":"Creating access token leads to a 404 Page Not Found","url":"/platform/marketplace/knowledge-base/creating-access-token-leads-to-a-404-page-not-found/"},{"title":"Access tokens overview","url":"/platform/marketplace/knowledge-base/access-tokens-overview/"},{"title":"App is appearing multiple times on the Marketplace","url":"/platform/marketplace/knowledge-base/app-is-appearing-multiple-times-on-the-Marketplace/"},{"title":"Artifact upload restrictions","url":"/platform/marketplace/knowledge-base/artifact-upload-restrictions/"},{"title":"Changing the app version build number","url":"/platform/marketplace/knowledge-base/changing-the-app-version-build-number/"},{"title":"I can't change my app's payment model","url":"/platform/marketplace/knowledge-base/i-cant-change-my-apps-payment-model/"},{"title":"My copyright has been infringed and I want to issue a takedown notice","url":"/platform/marketplace/knowledge-base/my-copyright-has-been-infringed-and-i-want-to-issue-a-takedown-notice/"},{"title":"I can't edit my listing during the review process","url":"/platform/marketplace/knowledge-base/i-cant-edit-my-listing-during-the-review-process/"},{"title":"Why is my app hidden on the Marketplace","url":"/platform/marketplace/knowledge-base/why-is-my-app-hidden-on-the-marketplace/"},{"title":"How do I import a workflow into a Jira cloud instance","url":"/platform/marketplace/knowledge-base/how-do-i-import-a-workflow-into-a-jira-cloud-instance/"},{"title":"Removing inappropriate reviews from app Listings","url":"/platform/marketplace/knowledge-base/removing-inappropriate-reviews-from-app-listings/"},{"title":"Licensing FAQ","url":"/platform/marketplace/knowledge-base/licensing-faq/"},{"title":"Editing your Marketplace listing","url":"/platform/marketplace/knowledge-base/editing-your-marketplace-listing/"},{"title":"How do I remove a private app version","url":"/platform/marketplace/knowledge-base/how-do-i-remove-a-private-app-version/"},{"title":"Promotion codes in Marketplace reporting","url":"/platform/marketplace/knowledge-base/promotion-codes-in-marketplace-reporting/"},{"title":"About app archiving","url":"/platform/marketplace/knowledge-base/retiring-your-app/"},{"title":"How can my app be added to the staff-picked section on the Marketplace","url":"/platform/marketplace/knowledge-base/having-your-app-featured-in-staff-picked/"},{"title":"Can I list a third party integration on the Atlassian Marketplace","url":"/platform/marketplace/knowledge-base/listing-a-third-party-integration-on-the-atlassian-marketplace/"},{"title":"Transfering apps between vendors","url":"/platform/marketplace/knowledge-base/transfering-apps-between-vendors/"}]},{"title":"Other considerations","name":"other","items":[{"title":"Atlassian Developer Terms","url":"/platform/marketplace/atlassian-developer-terms/"},{"title":"Atlassian REST API policy","url":"/platform/marketplace/atlassian-rest-api-policy/"},{"title":"Marketplace Vendor Agreement","url":"https://www.atlassian.com/licensing/marketplace/publisheragreement"},{"title":"Developer Community Contributor Agreement","url":"/platform/marketplace/contributor-license-agreement"},{"title":"Atlassian design guidelines","url":"https://atlassian.design/"},{"title":"AtlasKit","url":"https://atlaskit.atlassian.com/"},{"title":"Atlassian UI library","url":"https://docs.atlassian.com/aui/"},{"title":"Collaborating with Atlassian Support","url":"/platform/marketplace/collaborating-with-atlassian-support/"},{"title":"Glossary","url":"/platform/marketplace/glossary/"}]}]},{"title":"Reference","name":"reference","url":"/platform/marketplace/rest","subcategories":[{"title":"Marketplace REST API","name":"rest","expandAlways":true,"items":[{"title":"Marketplace REST API","url":"/platform/marketplace/rest"}]},{"title":"REST API tutorials","name":"apitutorials","expandAlways":true,"items":[{"title":"Marketplace API Java client","url":"/platform/marketplace/marketplace-api-java-client"},{"title":"Getting app details from Java","url":"/platform/marketplace/getting-app-details-from-java"},{"title":"Getting app details using JSON","url":"/platform/marketplace/getting-app-details-using-json"},{"title":"Searching for apps from Java","url":"/platform/marketplace/searching-for-apps-from-java"},{"title":"Searching for apps using JSON","url":"/platform/marketplace/searching-for-apps-using-json"},{"title":"Examples of API usage through JSON requests","url":"/platform/marketplace/examples-of-api-usage-through-json-requests"}]},{"title":"In-product license API","name":"licenseapi","expandAlways":true,"items":[{"title":"License API for cloud apps","url":"/platform/marketplace/license-api-for-cloud-apps"},{"title":"License API for server apps","url":"/platform/marketplace/license-api-for-server-apps"}]},{"title":"License import API","name":"importapi","expandAlways":true,"items":[{"title":"License import API for server apps","url":"/platform/marketplace/license-import-api-for-server-apps"}]}]},{"name":"help","title":"Resources","url":"/platform/marketplace/get-help/"}]},"navigation":[{"label":"About Atlassian Marketplace","href":"/platform/marketplace/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Build","href":"/platform/marketplace/getting-started/","expandState":"collapsed","childNavigationNodes":[{"label":"Getting started","href":"/platform/marketplace/getting-started/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Registering apps","href":"/platform/marketplace/registering-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Installing cloud apps","href":"/platform/marketplace/installing-cloud-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Cloud app operations guide","href":"/platform/marketplace/cloud-app-operations-guide/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Adding watching and rating controls to server apps","href":"/platform/marketplace/adding-watching-and-rating-controls-to-server-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Alternate deployment model for server apps","href":"/platform/marketplace/alternate-deployment-model-for-server-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Developing apps for Atlassian Data Center products","href":"/platform/marketplace/developing-apps-for-atlassian-data-center-products/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Guidelines for Data Center app development","href":"/platform/marketplace/guidelines-for-data-center-app-development/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Submitting your Data Center app","href":"/platform/marketplace/dc-apps-submitting-your-app/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Tracking your Data Center app submission","href":"/platform/marketplace/dc-apps-tracking-your-submission/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Performance and scale testing","href":"/platform/marketplace/dc-apps-performance-and-scale-testing/","expandState":"collapsed","childNavigationNodes":[{"label":"Performance and scale testing your Data Center app","href":"/platform/marketplace/dc-apps-performance-and-scale-testing/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Testing your app with a large data set","href":"/platform/marketplace/testing-your-app-with-a-large-data-set/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Data Center App Performance Toolkit User Guide For Jira","href":"/platform/marketplace/dc-apps-performance-toolkit-user-guide-jira/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Data Center App Performance Toolkit User Guide For Confluence","href":"/platform/marketplace/dc-apps-performance-toolkit-user-guide-confluence/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Data Center App Performance Toolkit User Guide For Bitbucket","href":"/platform/marketplace/dc-apps-performance-toolkit-user-guide-bitbucket/","expandState":"collapsed","childNavigationNodes":[]}]}]},{"label":"Licensing","href":"/platform/marketplace/cloud-app-licensing/","expandState":"collapsed","childNavigationNodes":[{"label":"Cloud app licensing","href":"/platform/marketplace/cloud-app-licensing/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Server app licensing","href":"/platform/marketplace/server-app-licensing/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Server app license validation rules","href":"/platform/marketplace/server-app-license-validation-rules/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Adding licensing support to server apps","href":"/platform/marketplace/adding-licensing-support-to-server-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Omitting web resources for unlicensed server apps","href":"/platform/marketplace/ommitting-web-resources-for-unlicensed-server-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Timebomb licenses for testing server apps","href":"/platform/marketplace/timebomb-licenses-for-testing-server-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Understanding generated license API support","href":"/platform/marketplace/understanding-the-generated-license-api-support/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Pricing and payments","href":"/platform/marketplace/pricing-payment-and-billing/","expandState":"collapsed","childNavigationNodes":[{"label":"Pricing, payment, and billing","href":"/platform/marketplace/pricing-payment-and-billing/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Why can't I change the payment model","href":"/platform/marketplace/why-cant-i-change-the-payment-model/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Sales tax","href":"/platform/marketplace/sales-tax/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"List","href":"/platform/marketplace/app-approval-guidelines/","expandState":"collapsed","childNavigationNodes":[{"label":"App approval guidelines","href":"/platform/marketplace/app-approval-guidelines/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Creating a Marketplace listing","href":"/platform/marketplace/creating-a-marketplace-listing/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Listing and managing apps","href":"/platform/marketplace/listing-and-managing-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Creating a server app package ","href":"/platform/marketplace/creating-a-server-app-package/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Declaring marketing assets for server apps","href":"/platform/marketplace/declaring-marketing-assets-for-server-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Listing an app version from Java","href":"/platform/marketplace/listing-an-app-version-from-java/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Listing an app version using REST","href":"/platform/marketplace/listing-an-app-version-using-rest/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Managing permissions on your vendor account","href":"/platform/marketplace/managing-permissions-on-your-vendor-account/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Upgrading and versioning cloud apps","href":"/platform/marketplace/upgrading-and-versioning-cloud-apps/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Archiving apps","href":"/platform/marketplace/archiving-apps/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Sell","href":"/platform/marketplace/selling-on-marketplace/","expandState":"collapsed","childNavigationNodes":[{"label":"Selling on Marketplace","href":"/platform/marketplace/selling-on-marketplace/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Building your presence on Marketplace","href":"/platform/marketplace/building-your-presence-on-marketplace/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Atlassian brand guidelines for Marketplace vendors","href":"/platform/marketplace/atlassian-brand-guidelines-for-marketplace-vendors/","expandState":"collapsed","childNavigationNodes":[]},{"label":"AdWords trademark policy","href":"/platform/marketplace/adwords-trademark-policy/","expandState":"collapsed","childNavigationNodes":[{"label":"AdWords での商標に関するポリシー","href":"/platform/marketplace/adwords-trademark-policy-ja/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Marketplace search results and rankings","href":"/platform/marketplace/marketplace-search-results-and-rankings/","expandState":"collapsed","childNavigationNodes":[]},{"label":"SEO best practices","href":"/platform/marketplace/seo-best-practices/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Marketing funnel insights","href":"/platform/marketplace/marketing-funnel-insights/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Attracting new customers","href":"/platform/marketplace/attracting-new-customers/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Converting from try to buy","href":"/platform/marketplace/converting-from-try-to-buy/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Creating a press release","href":"/platform/marketplace/creating-a-press-release/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Contributing to the Atlassian blog","href":"/platform/marketplace/contributing-to-the-atlassian-blog/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Sales promotions","href":"/platform/marketplace/sales-promotions/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Sales and evaluations reports","href":"/platform/marketplace/sales-and-evaluations-reports/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Accessing sales reports with the REST API","href":"/platform/marketplace/accessing-sales-reports-with-the-rest-api/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Programs","href":"/platform/marketplace/programs-and-features/","expandState":"collapsed","childNavigationNodes":[{"label":"Programs and features","href":"/platform/marketplace/programs-and-features/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Top Vendor program","href":"/platform/marketplace/top-vendor-program/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Cloud security program","href":"/platform/marketplace/cloud-security-program/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Marketplace security bug bounty program","href":"/platform/marketplace/marketplace-bounty-program/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Early access program","href":"/platform/marketplace/early-access-program/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Sales promotions","href":"/platform/marketplace/sales-promotions/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Reports for paid via Atlassian listings","href":"/platform/marketplace/sales-and-evaluations-reports/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Sales and renewals email campaigns","href":"/platform/marketplace/sales-and-renewals-email-campaigns/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Manage permissions on your vendor account","href":"/platform/marketplace/managing-permissions-on-your-vendor-account/","expandState":"collapsed","childNavigationNodes":[]},{"label":"App archiving","href":"/platform/marketplace/archiving-apps/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Data privacy and security","href":"/platform/marketplace/data-privacy-guidelines/","expandState":"collapsed","childNavigationNodes":[{"label":"Data privacy guidelines","href":"/platform/marketplace/data-privacy-guidelines/","expandState":"collapsed","childNavigationNodes":[]},{"label":"App security requirements","href":"/platform/marketplace/security-requirements/","expandState":"collapsed","childNavigationNodes":[{"label":"Security requirements for cloud apps","href":"/platform/marketplace/security-requirements/","expandState":"collapsed","childNavigationNodes":[]},{"label":"FAQ: Security requirements for cloud apps","href":"/platform/marketplace/security-requirements-faq/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Enforcement Procedure: Security requirements","href":"/platform/marketplace/security-requirements-enforcement/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Additional information: Security requirements","href":"/platform/marketplace/security-requirements-more-info/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Security guidelines","href":"/platform/marketplace/security-guidelines/","expandState":"collapsed","childNavigationNodes":[{"label":"Security guidelines for marketplace apps","href":"/platform/marketplace/app-security-guidelines/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Security guidelines for marketplace vendors","href":"/platform/marketplace/vendor-security-guidelines/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Security considerations for server apps","href":"/platform/marketplace/security-considerations-server/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Security considerations for cloud apps","href":"/platform/marketplace/security-considerations-cloud/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"App security incident management","href":"/platform/marketplace/app-security-incident-management-guidelines/","expandState":"collapsed","childNavigationNodes":[{"label":"Incident management guidelines","href":"/platform/marketplace/app-security-incident-management-guidelines/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Preparing for a security incident","href":"/platform/marketplace/preparing-for-a-security-incident/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Incident notification comms template","href":"/platform/marketplace/app-security-incident-communication-template/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Vulnerability notification comms template","href":"/platform/marketplace/app-vulnerability-notification-template/","expandState":"collapsed","childNavigationNodes":[]}]}]},{"label":"Knowledge Base","href":"/platform/marketplace/knowledge-base/creating-access-token-leads-to-a-404-page-not-found/","expandState":"collapsed","childNavigationNodes":[{"label":"Creating access token leads to a 404 Page Not Found","href":"/platform/marketplace/knowledge-base/creating-access-token-leads-to-a-404-page-not-found/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Access tokens overview","href":"/platform/marketplace/knowledge-base/access-tokens-overview/","expandState":"collapsed","childNavigationNodes":[]},{"label":"App is appearing multiple times on the Marketplace","href":"/platform/marketplace/knowledge-base/app-is-appearing-multiple-times-on-the-Marketplace/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Artifact upload restrictions","href":"/platform/marketplace/knowledge-base/artifact-upload-restrictions/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Changing the app version build number","href":"/platform/marketplace/knowledge-base/changing-the-app-version-build-number/","expandState":"collapsed","childNavigationNodes":[]},{"label":"I can't change my app's payment model","href":"/platform/marketplace/knowledge-base/i-cant-change-my-apps-payment-model/","expandState":"collapsed","childNavigationNodes":[]},{"label":"My copyright has been infringed and I want to issue a takedown notice","href":"/platform/marketplace/knowledge-base/my-copyright-has-been-infringed-and-i-want-to-issue-a-takedown-notice/","expandState":"collapsed","childNavigationNodes":[]},{"label":"I can't edit my listing during the review process","href":"/platform/marketplace/knowledge-base/i-cant-edit-my-listing-during-the-review-process/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Why is my app hidden on the Marketplace","href":"/platform/marketplace/knowledge-base/why-is-my-app-hidden-on-the-marketplace/","expandState":"collapsed","childNavigationNodes":[]},{"label":"How do I import a workflow into a Jira cloud instance","href":"/platform/marketplace/knowledge-base/how-do-i-import-a-workflow-into-a-jira-cloud-instance/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Removing inappropriate reviews from app Listings","href":"/platform/marketplace/knowledge-base/removing-inappropriate-reviews-from-app-listings/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Licensing FAQ","href":"/platform/marketplace/knowledge-base/licensing-faq/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Editing your Marketplace listing","href":"/platform/marketplace/knowledge-base/editing-your-marketplace-listing/","expandState":"collapsed","childNavigationNodes":[]},{"label":"How do I remove a private app version","href":"/platform/marketplace/knowledge-base/how-do-i-remove-a-private-app-version/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Promotion codes in Marketplace reporting","href":"/platform/marketplace/knowledge-base/promotion-codes-in-marketplace-reporting/","expandState":"collapsed","childNavigationNodes":[]},{"label":"About app archiving","href":"/platform/marketplace/knowledge-base/retiring-your-app/","expandState":"collapsed","childNavigationNodes":[]},{"label":"How can my app be added to the staff-picked section on the Marketplace","href":"/platform/marketplace/knowledge-base/having-your-app-featured-in-staff-picked/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Can I list a third party integration on the Atlassian Marketplace","href":"/platform/marketplace/knowledge-base/listing-a-third-party-integration-on-the-atlassian-marketplace/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Transfering apps between vendors","href":"/platform/marketplace/knowledge-base/transfering-apps-between-vendors/","expandState":"collapsed","childNavigationNodes":[]}]},{"label":"Other considerations","href":"/platform/marketplace/atlassian-developer-terms/","expandState":"expanded","childNavigationNodes":[{"label":"Atlassian Developer Terms","href":"/platform/marketplace/atlassian-developer-terms/","expandState":"expanded","childNavigationNodes":[]},{"label":"Atlassian REST API policy","href":"/platform/marketplace/atlassian-rest-api-policy/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Marketplace Vendor Agreement","href":"https://www.atlassian.com/licensing/marketplace/publisheragreement/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Developer Community Contributor Agreement","href":"/platform/marketplace/contributor-license-agreement/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Atlassian design guidelines","href":"https://atlassian.design/","expandState":"collapsed","childNavigationNodes":[]},{"label":"AtlasKit","href":"https://atlaskit.atlassian.com/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Atlassian UI library","href":"https://docs.atlassian.com/aui/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Collaborating with Atlassian Support","href":"/platform/marketplace/collaborating-with-atlassian-support/","expandState":"collapsed","childNavigationNodes":[]},{"label":"Glossary","href":"/platform/marketplace/glossary/","expandState":"collapsed","childNavigationNodes":[]}]}],"navigationLocation":{"pathname":"/platform/marketplace/atlassian-developer-terms/"},"theme":"grouped-sidebar"},"forgeBetaFeatures":{"shouldShowBanner":true,"shouldShowLozenge":true,"shouldShowForgeExamples":false}};</script>
+        <title>Atlassian Developer Terms</title>
+        <style data-styled-components="bZGgwh cZJnvt iLtbJJ hSsjZP ibwhYF eMLfYp cBmaau gDbkJB NOhXB crFfcM eUeRWO jcVgLC korNWI gvARzl cbfRuT liBBhk dCjvvZ cdPAyM dNZQPs kZeISe jrUTxp kNmAFp xJFVv cWzNpR gPMNop kAVIyY haEKDc kTyqtG ecYrWe hwJUsK ehWPwe bxYetS bowRKG dDwgdQ kSMesQ bkfxoS gPNCks itpCRG hMFZeH eAGaQN cgvHEO guXpGX eAStwQ eqRbYe fTJEma bFOiok iVHYcz jyVZKI eZLTjc gquOGD eYtBtU hmJBNx jtHslp diXMlj elcyBS ccKvAG hsosOW bXEwLc dHqrCN iupNTM bjNbqg fmTriT lcCoJI bZyNdS izWJaw dtaSm bWqBcu jlpzOk bDiWCG befayn eMbiOW dBCoRU dPFaNp cvkujJ jLNhLN cvsNuQ gZiCdV hZDoUZ cQIBQR eKNiXZ bqhCtA hRgvkS fsZLpn dwpqw drayYj hfAxZG hbuXXI bDqdly hDhiuP gIPXRY gWPgmQ cdtUPR dTdch ewqcYX fRrBax kTqZVQ hDeCr kRQryd bVMXRJ">
+/* sc-component-id: sc-bwzfXH */
+.kZeISe{height:16px;width:16px;color:currentColor;display:inline-block;fill:#FFFFFF;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;line-height:1;} .kZeISe > svg{height:16px;width:16px;max-height:100%;max-width:100%;overflow:hidden;pointer-events:none;vertical-align:bottom;} .kZeISe stop{stop-color:currentColor;}.jrUTxp{height:24px;width:24px;color:#0747A6;display:inline-block;fill:#DEEBFF;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;line-height:1;} .jrUTxp > svg{height:24px;width:24px;max-height:100%;max-width:100%;overflow:hidden;pointer-events:none;vertical-align:bottom;} .jrUTxp stop{stop-color:currentColor;}.kNmAFp{height:24px;width:24px;color:currentColor;display:inline-block;fill:inherit;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;line-height:1;} .kNmAFp > svg{height:24px;width:24px;max-height:100%;max-width:100%;overflow:hidden;pointer-events:none;vertical-align:bottom;} .kNmAFp stop{stop-color:currentColor;}.xJFVv{color:#B3BAC5;display:inline-block;fill:#FFFFFF;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;line-height:1;} .xJFVv > svg{max-height:100%;max-width:100%;overflow:hidden;pointer-events:none;vertical-align:bottom;} .xJFVv stop{stop-color:currentColor;}
+/* sc-component-id: sc-htpNat */
+.kSMesQ{position:absolute;background-size:contain;margin-top:-2px;width:24px;height:24px;top:16px;left:16px;} .kSMesQ + p{margin-top:0;}
+/* sc-component-id: sc-ifAKCX */
+.ecYrWe{position:relative;} .ecYrWe:not(:hover) .copy{position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden;}
+/* sc-component-id: sc-bZQynM */
+.hwJUsK{position:relative;top:0px;left:0px;width:100%;z-index:0;}
+/* sc-component-id: sc-gzVnrw */
+.ehWPwe{border-radius:3px;background-color:#f4f5f7;color:#172b4d;font-size:12px;line-height:20px;overflow:auto;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;} .ehWPwe pre{margin:0;padding:8px;} .ehWPwe pre:first-child{float:left;text-align:right;background-color:#ebecf0;color:#8993a4;font-size:14px;} .ehWPwe code{display:inline-block;position:relative;left:16px;padding-right:16px;}
+/* sc-component-id: sc-dnqmqq */
+.kTyqtG{margin:16px 0;padding:0;max-height:500px;overflow:auto;}
+/* sc-component-id: sc-iwsKbI */
+.dDwgdQ{overflow-wrap:break-word;word-wrap:break-word;}
+/* sc-component-id: sc-gZMcBi */
+.eYtBtU{min-height:100vh;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;}
+/* sc-component-id: sc-gqjmRU */
+.cdtUPR{-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;}
+/* sc-component-id: sc-keyframes-bZGgwh */
+@-webkit-keyframes bZGgwh{from{opacity:0;}to{opacity:0;}} @keyframes bZGgwh{from{opacity:0;}to{opacity:0;}}
+/* sc-component-id: sc-keyframes-cZJnvt */
+@-webkit-keyframes cZJnvt{from{-webkit-transform:rotate(50deg);-ms-transform:rotate(50deg);transform:rotate(50deg);}to{-webkit-transform:rotate(230deg);-ms-transform:rotate(230deg);transform:rotate(230deg);}} @keyframes cZJnvt{from{-webkit-transform:rotate(50deg);-ms-transform:rotate(50deg);transform:rotate(50deg);}to{-webkit-transform:rotate(230deg);-ms-transform:rotate(230deg);transform:rotate(230deg);}}
+/* sc-component-id: sc-keyframes-iLtbJJ */
+@-webkit-keyframes iLtbJJ{from{-webkit-transform:rotate(230deg);-ms-transform:rotate(230deg);transform:rotate(230deg);}to{-webkit-transform:rotate(510deg);-ms-transform:rotate(510deg);transform:rotate(510deg);}} @keyframes iLtbJJ{from{-webkit-transform:rotate(230deg);-ms-transform:rotate(230deg);transform:rotate(230deg);}to{-webkit-transform:rotate(510deg);-ms-transform:rotate(510deg);transform:rotate(510deg);}}
+/* sc-component-id: sc-keyframes-hSsjZP */
+@-webkit-keyframes hSsjZP{from{opacity:1;}to{opacity:0;}} @keyframes hSsjZP{from{opacity:1;}to{opacity:0;}}
+/* sc-component-id: sc-keyframes-ibwhYF */
+@-webkit-keyframes ibwhYF{to{-webkit-transform:rotate(360deg);-ms-transform:rotate(360deg);transform:rotate(360deg);}} @keyframes ibwhYF{to{-webkit-transform:rotate(360deg);-ms-transform:rotate(360deg);transform:rotate(360deg);}}
+/* sc-component-id: sc-keyframes-eMLfYp */
+@-webkit-keyframes eMLfYp{from{opacity:0;}to{opacity:1;}} @keyframes eMLfYp{from{opacity:0;}to{opacity:1;}}
+/* sc-component-id: sc-keyframes-cBmaau */
+@-webkit-keyframes cBmaau{from{stroke-dashoffset:56.548667764616276px;}to{stroke-dashoffset:45.23893421169302px;}} @keyframes cBmaau{from{stroke-dashoffset:56.548667764616276px;}to{stroke-dashoffset:45.23893421169302px;}}
+/* sc-component-id: sc-keyframes-gDbkJB */
+@-webkit-keyframes gDbkJB{from{stroke-dashoffset:84.82300164692441px;}to{stroke-dashoffset:67.85840131753953px;}} @keyframes gDbkJB{from{stroke-dashoffset:84.82300164692441px;}to{stroke-dashoffset:67.85840131753953px;}}
+/* sc-component-id: sc-keyframes-NOhXB */
+@-webkit-keyframes NOhXB{from{stroke-dashoffset:141.3716694115407px;}to{stroke-dashoffset:113.09733552923257px;}} @keyframes NOhXB{from{stroke-dashoffset:141.3716694115407px;}to{stroke-dashoffset:113.09733552923257px;}}
+/* sc-component-id: sc-keyframes-crFfcM */
+@-webkit-keyframes crFfcM{from{stroke-dashoffset:282.7433388230814px;}to{stroke-dashoffset:226.19467105846513px;}} @keyframes crFfcM{from{stroke-dashoffset:282.7433388230814px;}to{stroke-dashoffset:226.19467105846513px;}}
+/* sc-component-id: sc-keyframes-eUeRWO */
+@-webkit-keyframes eUeRWO{from{stroke-dashoffset:43.982297150257104px;}to{stroke-dashoffset:35.18583772020568px;}} @keyframes eUeRWO{from{stroke-dashoffset:43.982297150257104px;}to{stroke-dashoffset:35.18583772020568px;}}
+/* sc-component-id: sc-keyframes-jcVgLC */
+@-webkit-keyframes jcVgLC{from{stroke-dashoffset:69.11503837897544px;}to{stroke-dashoffset:55.29203070318036px;}} @keyframes jcVgLC{from{stroke-dashoffset:69.11503837897544px;}to{stroke-dashoffset:55.29203070318036px;}}
+/* sc-component-id: sc-keyframes-korNWI */
+@-webkit-keyframes korNWI{from{stroke-dashoffset:135.0884841043611px;}to{stroke-dashoffset:108.07078728348888px;}} @keyframes korNWI{from{stroke-dashoffset:135.0884841043611px;}to{stroke-dashoffset:108.07078728348888px;}}
+/* sc-component-id: sc-keyframes-gvARzl */
+@-webkit-keyframes gvARzl{from{stroke-dashoffset:270.1769682087222px;}to{stroke-dashoffset:216.14157456697777px;}} @keyframes gvARzl{from{stroke-dashoffset:270.1769682087222px;}to{stroke-dashoffset:216.14157456697777px;}}
+/* sc-component-id: Button__StyledButton-sc-1o41kgk-0 */
+.ccKvAG{-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;background:none;border-radius:3px;border-width:0;box-sizing:border-box;color:#505F79 !important;cursor:default;display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:inherit;font-style:normal;height:2.2857142857142856em;line-height:2.2857142857142856em;margin:0;max-width:100%;outline:none !important;padding:0 8px;text-align:center;-webkit-text-decoration:none;text-decoration:none;-webkit-transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);-webkit-transition-duration:0.1s,0.15s;transition-duration:0.1s,0.15s;vertical-align:middle;white-space:nowrap;width:auto;} .ccKvAG::-moz-focus-inner{border:0;margin:0;padding:0;}
+/* sc-component-id: Button__StyledLink-sc-1o41kgk-1 */
+a.bXEwLc{-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;background:#253858;border-radius:3px;border-width:0;box-sizing:border-box;color:#F4F5F7 !important;cursor:default;display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:inherit;font-style:normal;height:2.2857142857142856em;line-height:2.2857142857142856em;margin:0;max-width:100%;outline:none !important;padding:0 8px;text-align:center;-webkit-text-decoration:none;text-decoration:none;-webkit-transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);-webkit-transition-duration:0.1s,0.15s;transition-duration:0.1s,0.15s;vertical-align:middle;white-space:nowrap;width:auto;} a.bXEwLc::-moz-focus-inner{border:0;margin:0;padding:0;}a.dHqrCN{-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;background:none;border-radius:3px;border-width:0;box-sizing:border-box;color:#505F79 !important;cursor:default;display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:inherit;font-style:normal;height:2.2857142857142856em;line-height:2.2857142857142856em;margin:0;max-width:100%;outline:none !important;padding:0 8px;text-align:center;-webkit-text-decoration:none;text-decoration:none;-webkit-transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);-webkit-transition-duration:0.1s,0.15s;transition-duration:0.1s,0.15s;vertical-align:middle;white-space:nowrap;width:auto;} a.dHqrCN::-moz-focus-inner{border:0;margin:0;padding:0;}a.iupNTM{-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;background:#FFFFFF;border-radius:3px;border-width:0;box-sizing:border-box;color:#253858 !important;cursor:default;display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:inherit;font-style:normal;height:2.2857142857142856em;line-height:2.2857142857142856em;margin:0;max-width:100%;outline:none !important;padding:0 8px;text-align:center;-webkit-text-decoration:none;text-decoration:none;-webkit-transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);-webkit-transition-duration:0.1s,0.15s;transition-duration:0.1s,0.15s;vertical-align:middle;white-space:nowrap;width:auto;} a.iupNTM::-moz-focus-inner{border:0;margin:0;padding:0;}a.bjNbqg{-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;background:#FFFFFF;border-radius:3px;border-width:0;box-sizing:border-box;color:#0052CC !important;cursor:default;display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:inherit;font-style:normal;height:2.2857142857142856em;line-height:2.2857142857142856em;margin:0;max-width:100%;outline:none !important;padding:0 8px;text-align:center;-webkit-text-decoration:none;text-decoration:none;-webkit-transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);transition:background 0.1s ease-out,box-shadow 0.15s cubic-bezier(0.47,0.03,0.49,1.38);-webkit-transition-duration:0.1s,0.15s;transition-duration:0.1s,0.15s;vertical-align:middle;white-space:nowrap;width:auto;} a.bjNbqg::-moz-focus-inner{border:0;margin:0;padding:0;}
+/* sc-component-id: sc-cSHVUG */
+.hsosOW{display:inline-block;line-height:1;} .hsosOW svg{vertical-align:bottom;}
+/* sc-component-id: AvatarImage__ShapeGroup-sc-1hf6c4m-0 */
+.lcCoJI circle,.lcCoJI rect{fill:#C1C7D0;} .lcCoJI g{fill:#FFFFFF;}
+/* sc-component-id: styledCache__StyledSpan-zohhd2-3 */
+.fmTriT{height:24px;width:24px;-webkit-align-items:stretch;-webkit-box-align:stretch;-ms-flex-align:stretch;align-items:stretch;background-color:#FFFFFF;border:0;border-radius:50%;padding:2px;box-sizing:content-box;cursor:inherit;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;outline:none;overflow:hidden;pointer-events:auto;position:static;-webkit-transform:translateZ(0);-ms-transform:translateZ(0);transform:translateZ(0);-webkit-transition:background-color 0s ease-out;transition:background-color 0s ease-out;} a .fmTriT,button .fmTriT{cursor:pointer;} .fmTriT::after{background-color:transparent;border-radius:50%;bottom:2px;content:' ';left:2px;opacity:0;pointer-events:none;position:absolute;right:2px;top:2px;-webkit-transition:opacity 200ms;transition:opacity 200ms;} .fmTriT::-moz-focus-inner{border:0;margin:0;padding:0;}
+/* sc-component-id: sc-kkGfuU */
+.jtHslp,.jtHslp *,.jtHslp span{box-sizing:border-box;}
+/* sc-component-id: sc-iAyFgw */
+.hmJBNx > div.large-screen{display:initial;} .hmJBNx > div.small-screen{display:none;} @media (max-width:1024px){.hmJBNx > div.large-screen{display:none;}.hmJBNx > div.small-screen{display:initial;}}
+/* sc-component-id: sc-hSdWYo */
+.diXMlj{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;width:100%;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;height:88px;background-color:#0052CC;} @media (max-width:1024px){.diXMlj{height:88px;}}
+/* sc-component-id: sc-eHgmQL */
+.elcyBS{-webkit-flex-basis:1200px;-ms-flex-preferred-size:1200px;flex-basis:1200px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;padding:0 24px;} .elcyBS,.elcyBS h1{color:#FFFFFF;} @media (max-width:1024px){.elcyBS{padding:0 16px;}} .elcyBS > *{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;} .elcyBS > a.title-link,.elcyBS > a.title-link:visited .elcyBS > a.title-link:hover,.elcyBS > a.title-link:active{color:currentColor;-webkit-text-decoration:none;text-decoration:none;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;} .elcyBS > a.title-link > h1{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI","Roboto","Oxygen","Ubuntu","Fira Sans","Droid Sans","Helvetica Neue",sans-serif;font-size:24px;line-height:24px;font-weight:400;margin:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:baseline;-webkit-box-align:baseline;-ms-flex-align:baseline;align-items:baseline;} .elcyBS > a.title-link > h1 svg{height:24px;position:relative;top:5px;margin-right:-8px;fill:currentColor;} .elcyBS > a.title-link > h1 svg + .title{display:none;} .elcyBS > a.title-link > h1 .title{margin:0 8px;} .elcyBS > a.title-link > h1 .subtitle{font-weight:300;} @media (max-width:1024px){.elcyBS > a.title-link > h1{font-size:20px;line-height:20px;}.elcyBS > a.title-link > h1 svg{height:20px;top:4px;}} .elcyBS .lozenge{margin-right:16px;} .elcyBS > ul{margin:0;padding:0;list-style-type:none;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .elcyBS > ul li + li{margin-top:0;} .elcyBS > ul.actions{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-left:auto;color:#FFFFFF;} .elcyBS > ul.actions:first-child{margin-left:0;} .elcyBS > ul.actions li{position:relative;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex:initial;-ms-flex:initial;flex:initial;} .elcyBS > ul.actions li .actions__loading,.elcyBS > ul.actions li .actions__button{color:currentColor !important;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:32px;line-height:32px;cursor:pointer;} .elcyBS > ul.actions li .actions__loading,.elcyBS > ul.actions li .actions__button--glyph{position:relative;top:2px;width:32px;padding:5px 0 0;} .elcyBS > ul.actions li .actions__button--glyph{border-radius:50%;} .elcyBS > ul.actions li .actions__button--glyph.actions__button--selected,.elcyBS > ul.actions li .actions__button--glyph:hover{background-color:rgba(9,30,66,0.42);} .elcyBS > ul.actions li .actions__button--glyph:active{background-color:#2684FF;} .elcyBS > ul.actions li .actions__button--title{margin-right:4px;} .elcyBS > ul.actions li .actions__loading{-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;cursor:wait;} .elcyBS > ul.actions li div:first-child{display:inherit;} .elcyBS ul.links{font-size:16px;color:#FFFFFF;} .elcyBS ul.links li{-webkit-flex:initial;-ms-flex:initial;flex:initial;} .elcyBS ul.links .links__item__button{color:currentColor !important;-webkit-text-decoration:none;text-decoration:none;vertical-align:baseline;margin:0 8px;} .elcyBS ul.links .links__item__button.links__item__button--selected,.elcyBS ul.links .links__item__button:hover{background-color:rgba(9,30,66,0.42);}
+/* sc-component-id: sc-jbKcbu */
+.kTqZVQ{color:#5E6C84;display:inline-block;fill:#5E6C84;height:24px;position:relative;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;} .kTqZVQ > svg{fill:inherit;height:100%;left:0;position:absolute;top:0;width:100%;} .kTqZVQ > canvas{display:block;height:100%;visibility:hidden;}
+/* sc-component-id: sc-kafWEX */
+.dTdch{margin-top:2rem;padding:1rem 8px;background:#F4F5F7;color:white;min-height:100px;} .dTdch,.dTdch *{box-sizing:border-box;} @media (min-width:680px){.dTdch{padding:2rem 8px;}}
+/* sc-component-id: sc-iELTvK */
+.ewqcYX{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;max-width:75rem;margin-left:auto;margin-right:auto;padding-left:0.9375rem;padding-right:0.9375rem;} @media (min-width:680px){.ewqcYX{-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;}}
+/* sc-component-id: sc-cmTdod */
+.hDeCr{-webkit-flex:1;-ms-flex:1;flex:1;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;} @media (min-width:680px){.hDeCr{-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;}}
+/* sc-component-id: sc-jwKygS */
+.bVMXRJ{color:#0a0a0a;display:inline-block;line-height:1;padding:.7rem 2rem .7rem 0;} @media (min-width:680px){.bVMXRJ{padding:.7rem 1rem;}}
+/* sc-component-id: sc-btzYZH */
+.kRQryd{color:#0057D8;display:inline-block;line-height:1;padding:.7rem 2rem .7rem 0;} @media (min-width:680px){.kRQryd{padding:.7rem 1rem;}} .kRQryd.hide-optanon-link{display:none;}
+/* sc-component-id: sc-esOvli */
+.befayn a{line-height:18px;height:auto;padding:0;text-align:left;}
+/* sc-component-id: sc-cmthru */
+.dPFaNp{white-space:normal;}
+/* sc-component-id: sc-VJcYb */
+.eMbiOW{padding:4px 0 2px;} .eMbiOW > a{font-weight:inherit;} .eMbiOW > a:before{content:" ";display:inline-block;line-height:18px;min-width:0.5rem;}.dBCoRU{padding:4px 0 2px;} .dBCoRU > a{font-weight:700;} .dBCoRU > a:before{content:"•";display:inline-block;line-height:18px;min-width:0.5rem;}
+/* sc-component-id: sc-ipXKqB */
+.bqhCtA{list-style:none;margin-left:32px;margin-top:8px;padding:0;}
+/* sc-component-id: sc-hmXxxW */
+.jLNhLN{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;cursor:pointer;}
+/* sc-component-id: sc-cqCuEk */
+.cvkujJ{border-top:1px solid #EBECF0;margin:0;padding:12px 0;position:relative;} .cvkujJ:last-child{border-bottom:1px solid #EBECF0;}
+/* sc-component-id: sc-dliRfk */
+.cvsNuQ{color:#253858;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;font-weight:700;line-height:22px;text-transform:uppercase;}
+/* sc-component-id: sc-kLIISr */
+.gZiCdV{-webkit-box-flex:0;-webkit-flex-grow:0;-ms-flex-positive:0;flex-grow:0;height:24px;text-align:center;-webkit-transform:none;-ms-transform:none;transform:none;visibility:visible;width:24px;}.hZDoUZ{-webkit-box-flex:0;-webkit-flex-grow:0;-ms-flex-positive:0;flex-grow:0;height:24px;text-align:center;-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);visibility:visible;width:24px;}
+/* sc-component-id: sc-qrIAp */
+.cQIBQR{height:0;list-style:none;margin:0;overflow:hidden;padding:0;} .cQIBQR.cQIBQR{margin-top:0;}.eKNiXZ{height:auto;list-style:none;margin:0;overflow:hidden;padding:0;} .eKNiXZ.eKNiXZ{margin-top:0;}
+/* sc-component-id: sc-iqzUVk */
+.bDiWCG{list-style:none;margin:0;padding:0;}
+/* sc-component-id: sc-ipZHIp */
+.jlpzOk{padding:12px 0;}
+/* sc-component-id: sc-keyframes-cbfRuT */
+@-webkit-keyframes cbfRuT{from{opacity:0;-webkit-transform:translate(-200px,0);-ms-transform:translate(-200px,0);transform:translate(-200px,0);}to{opacity:1;-webkit-transform:translate(0,0);-ms-transform:translate(0,0);transform:translate(0,0);}} @keyframes cbfRuT{from{opacity:0;-webkit-transform:translate(-200px,0);-ms-transform:translate(-200px,0);transform:translate(-200px,0);}to{opacity:1;-webkit-transform:translate(0,0);-ms-transform:translate(0,0);transform:translate(0,0);}}
+/* sc-component-id: sc-keyframes-liBBhk */
+@-webkit-keyframes liBBhk{from{opacity:1;-webkit-transform:translate(0,0);-ms-transform:translate(0,0);transform:translate(0,0);}to{opacity:0;-webkit-transform:translate(-200px,0);-ms-transform:translate(-200px,0);transform:translate(-200px,0);}} @keyframes liBBhk{from{opacity:1;-webkit-transform:translate(0,0);-ms-transform:translate(0,0);transform:translate(0,0);}to{opacity:0;-webkit-transform:translate(-200px,0);-ms-transform:translate(-200px,0);transform:translate(-200px,0);}}
+/* sc-component-id: sc-hjRWVT */
+.gIPXRY{height:24px;width:24px;color:#6B778C;display:inline-block;fill:#FFFFFF;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;line-height:1;} .gIPXRY > svg{height:24px;width:24px;max-height:100%;max-width:100%;overflow:hidden;pointer-events:none;vertical-align:bottom;} .gIPXRY stop{stop-color:currentColor;}
+/* sc-component-id: sc-fyjhYU */
+.bDqdly{text-align:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;margin-left:15px;}
+/* sc-component-id: sc-ugnQR */
+.hDhiuP{font-size:14px;color:#6B778C;margin:0 5px 0 0;}
+/* sc-component-id: sc-eIHaNI */
+.drayYj{display:none;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;margin:0 15px;} @media (min-width:600px){.drayYj{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-top:20px;}}
+/* sc-component-id: sc-eTpRJs */
+.hfAxZG{display:none;} @media (min-width:900px){.hfAxZG{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;color:#6B778C;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;}}
+/* sc-component-id: sc-dxZgTM */
+.hbuXXI{display:none;padding-right:4px;} @media (min-width:1200px){.hbuXXI{display:initial;}}
+/* sc-component-id: sc-iomxrj */
+.hRgvkS{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:3;-webkit-flex-grow:3;-ms-flex-positive:3;flex-grow:3;} @media (min-width:900px){.hRgvkS{overflow:visible;max-width:75%;}}
+/* sc-component-id: sc-dvCyap */
+.fsZLpn{display:block;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;margin-top:0px;} @media (min-width:900px){.fsZLpn{margin-right:152px;}}.dwpqw{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;margin-top:40px;} @media (min-width:900px){.dwpqw{margin-right:152px;}}
+/* sc-component-id: sc-exkUMo */
+.dtaSm{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column-reverse;-ms-flex-direction:column-reverse;flex-direction:column-reverse;margin:0 auto;max-width:1200px;} @media (min-width:900px){.dtaSm{-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;}}
+/* sc-component-id: sc-kcDeIU */
+.bWqBcu{box-sizing:border-box;-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;padding:20px;padding-top:8px;display:none;} @media (min-width:900px){.bWqBcu{display:block;min-width:25%;max-width:25%;}}
+/* sc-component-id: sc-BngTV */
+.gWPgmQ{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:3;-webkit-flex-grow:3;-ms-flex-positive:3;flex-grow:3;margin:15px;margin-top:8px;}
+/* sc-component-id: sc-cqpYsc */
+@media (min-width:900px){.dCjvvZ{position:relative;margin-right:152px;}}
+/* sc-component-id: sc-jdfcpN */
+.izWJaw{-webkit-flex:1 0 auto;-ms-flex:1 0 auto;flex:1 0 auto;} .izWJaw h1 + h2{margin-top:12px;} .izWJaw h1 + h3{margin-top:16px;}
+/* sc-component-id: sc-jRuhRL */
+.bZyNdS img{max-width:100%;} .bZyNdS tr{border-bottom:1px solid #C1C7D0;} .bZyNdS thead{border-bottom:none;} .bZyNdS th{background-color:#F4F5F7;padding:8px;} .bZyNdS td{padding:8px;} .bZyNdS .aui-lozenge{background:#C1C7D0;border:1px solid #C1C7D0;border-radius:3px;color:#253858;box-sizing:border-box;display:inline-block;font-size:11px;font-weight:700;line-height:1;max-width:200px;padding:2px 4px 3px 4px;text-transform:uppercase;vertical-align:baseline;} .bZyNdS .aui-lozenge-success{background-color:#00875A;border-color:#00875A;color:#FFFFFF;} .bZyNdS .aui-lozenge-error{background-color:#DE350B;border-color:#DE350B;color:#FFFFFF;} .bZyNdS .aui-lozenge-current{background-color:#FFC400;border-color:#FFC400;color:#42526E;} .bZyNdS .aui-lozenge-complete{background-color:#5E6C84;border-color:#5E6C84;color:#FFFFFF;} .bZyNdS .aui-message{position:relative;margin:16px 0;border-radius:3px;padding:16px;padding-left:56px;} .bZyNdS .aui-message p strong,.bZyNdS .aui-message p.title{font-size:1.1428571428571428em;font-style:inherit;line-height:1.25;color:#172B4D;font-weight:600;-webkit-letter-spacing:-0.006em;-moz-letter-spacing:-0.006em;-ms-letter-spacing:-0.006em;letter-spacing:-0.006em;margin-top:24px;font-size:16px;margin-top:0;} .bZyNdS .aui-message p.title{margin-bottom:8px;} .bZyNdS .aui-message p.title + p{margin-top:0;} .bZyNdS .aui-message.tip{background-color:#E3FCEF;} .bZyNdS .aui-message.note,.bZyNdS .aui-message.info{background-color:#DEEBFF;} .bZyNdS .aui-message.warning{background-color:#FFFAE6;} .bZyNdS blockquote{padding:8px 16px 0 16px;border-left:1px solid #C1C7D0;margin:0 0 16px;color:#97A0AF;} .bZyNdS blockquote:after,.bZyNdS blockquote:before{content:'';}
+/* sc-component-id: sc-kNBZmU */
+.gquOGD{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;}
+/* sc-component-id: sc-hHjfor */
+.cdPAyM span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-kwXFOU */
+.dNZQPs span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-erheUI */
+.cWzNpR span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-jlBbkx */
+.gPMNop span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-eYcuFG */
+.kAVIyY span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-gyFTku */
+.haEKDc span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-cbcvrX */
+.bxYetS span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-ckixc */
+.bowRKG span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-gvDkQG */
+.bkfxoS span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-kvjbNB */
+.gPNCks span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-kREsUy */
+.itpCRG span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-OzIbW */
+.hMFZeH span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-lmuQER */
+.eAGaQN span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-koJQpy */
+.cgvHEO span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-exEFER */
+.guXpGX span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-bogHal */
+.eAStwQ span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-iDVEbA */
+.eqRbYe span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-WyXTO */
+.fTJEma span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-iaLokm */
+.bFOiok span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-eCgsJI */
+.iVHYcz span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-eQTbwJ */
+.jyVZKI span{font-size:0.86em !important;font-weight:500;}
+/* sc-component-id: sc-dlheSc */
+.eZLTjc span{font-size:0.86em !important;font-weight:500;}</style><style data-styled-components="cOjmWH">
+/* sc-component-id: sc-fihQgH */
+.cOjmWH span{font-size:0.86em !important;font-weight:500;}</style>
+        
+        <link href="/_static/documentation.918dd1f7.css" rel="stylesheet">
+        
+      </head>
+      <body>
+        <div id="root"><div class="sc-kNBZmU gquOGD" data-reactroot=""><div class="sc-gZMcBi eYtBtU"><div><div class="sc-iAyFgw hmJBNx sc-kkGfuU jtHslp"><div class="large-screen"><div class="sc-hSdWYo diXMlj sc-kkGfuU jtHslp"><div class="sc-eHgmQL elcyBS sc-kkGfuU jtHslp"><ul class="actions"><li><button class="actions__button actions__button--glyph Button__StyledButton-sc-1o41kgk-0 ccKvAG" spacing="default" type="button"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cSHVUG hsosOW"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24"><title>Documentation</title><path fill="currentColor" d="M6 8c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              m6 0c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              m6 0c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              M6 14c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              m6 0c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              m6 0c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              M6 20c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              m6 0c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z
+              m6 0c1.85 0 2-.15 2-2s-.15-2-2-2c-1.85 0-2 .15-2 2s.15 2 2 2z"></path></svg></span></span></span></button></li></ul><a class="title-link" href="/platform/marketplace/"><h1><span class="title">Atlassian Marketplace<!-- --> <span class="subtitle">Developer</span></span></h1></a><ul class="links links--primary"><li class="links__item"><a class="links__item__button links__item__button--selected Button__StyledLink-sc-1o41kgk-1 bXEwLc" spacing="default" href="/platform/marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1">Guides</span></span></a></li><li class="links__item"><a class="links__item__button Button__StyledLink-sc-1o41kgk-1 dHqrCN" spacing="default" href="/platform/marketplace/rest"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1">Reference</span></span></a></li><li class="links__item"><a class="links__item__button Button__StyledLink-sc-1o41kgk-1 dHqrCN" spacing="default" href="/platform/marketplace/get-help/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1">Resources</span></span></a></li></ul><ul class="actions"><li><a class="actions__button actions__button--glyph Button__StyledLink-sc-1o41kgk-1 dHqrCN" spacing="default" href="/search/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-bwzfXH kNmAFp" aria-label="Search"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M16.436 15.085l3.94 4.01a1 1 0 0 1-1.425 1.402l-3.938-4.006a7.5 7.5 0 1 1 1.423-1.406zM10.5 16a5.5 5.5 0 1 0 0-11 5.5 5.5 0 0 0 0 11z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></span></a></li><li><a class="actions__button actions__button--glyph Button__StyledLink-sc-1o41kgk-1 dHqrCN" spacing="default" href="/account/login?returnTo=%2Fplatform%2Fmarketplace%2F"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><div style="display:inline-block;position:relative;outline:0;height:28px;width:28px"><span class="styledCache__StyledSpan-zohhd2-3 fmTriT"><svg style="background-color:transparent;border-radius:50%;height:100%;width:100%" viewBox="0 0 128 128" version="1.1" xmlns="http://www.w3.org/2000/svg" role="img" aria-label="Log in"><g class="AvatarImage__ShapeGroup-sc-1hf6c4m-0 lcCoJI" mode="light"><circle cx="64" cy="64" r="64"></circle><g><path d="M103,102.1388 C93.094,111.92 79.3504,118 64.1638,118 C48.8056,118 34.9294,111.768 25,101.7892 L25,95.2 C25,86.8096 31.981,80 40.6,80 L87.4,80 C96.019,80 103,86.8096 103,95.2 L103,102.1388 Z"></path><path d="M63.9961647,24 C51.2938136,24 41,34.2938136 41,46.9961647 C41,59.7061864 51.2938136,70 63.9961647,70 C76.6985159,70 87,59.7061864 87,46.9961647 C87,34.2938136 76.6985159,24 63.9961647,24"></path></g></g></svg></span></div></span></span></a></li></ul></div></div></div><div class="small-screen"><div class="sc-hSdWYo diXMlj sc-kkGfuU jtHslp"><div class="sc-eHgmQL elcyBS sc-kkGfuU jtHslp"><ul class="actions"><li><button class="actions__button actions__button--glyph Button__StyledButton-sc-1o41kgk-0 ccKvAG" spacing="default" type="button"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-bwzfXH kNmAFp" aria-label="Expand"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M5 15h14v2H5zm0-8h14v2H5zm0 4h14v2H5z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></span></button></li></ul><a class="title-link" href="/platform/marketplace/"><h1><span class="title">Atlassian Marketplace<!-- --> <span class="subtitle">Developer</span></span></h1></a><ul class="actions"><li><a class="actions__button actions__button--glyph Button__StyledLink-sc-1o41kgk-1 dHqrCN" spacing="default" href="/search/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-bwzfXH kNmAFp" aria-label="Search"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M16.436 15.085l3.94 4.01a1 1 0 0 1-1.425 1.402l-3.938-4.006a7.5 7.5 0 1 1 1.423-1.406zM10.5 16a5.5 5.5 0 1 0 0-11 5.5 5.5 0 0 0 0 11z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></span></a></li><li><a class="actions__button actions__button--glyph Button__StyledLink-sc-1o41kgk-1 dHqrCN" spacing="default" href="/account/login?returnTo=%2Fplatform%2Fmarketplace%2F"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><div style="display:inline-block;position:relative;outline:0;height:28px;width:28px"><span class="styledCache__StyledSpan-zohhd2-3 fmTriT"><svg style="background-color:transparent;border-radius:50%;height:100%;width:100%" viewBox="0 0 128 128" version="1.1" xmlns="http://www.w3.org/2000/svg" role="img" aria-label="Log in"><g class="AvatarImage__ShapeGroup-sc-1hf6c4m-0 lcCoJI" mode="light"><circle cx="64" cy="64" r="64"></circle><g><path d="M103,102.1388 C93.094,111.92 79.3504,118 64.1638,118 C48.8056,118 34.9294,111.768 25,101.7892 L25,95.2 C25,86.8096 31.981,80 40.6,80 L87.4,80 C96.019,80 103,86.8096 103,95.2 L103,102.1388 Z"></path><path d="M63.9961647,24 C51.2938136,24 41,34.2938136 41,46.9961647 C41,59.7061864 51.2938136,70 63.9961647,70 C76.6985159,70 87,59.7061864 87,46.9961647 C87,34.2938136 76.6985159,24 63.9961647,24"></path></g></g></svg></span></div></span></span></a></li></ul></div></div></div></div></div><div class="sc-jRuhRL bZyNdS sc-jdfcpN izWJaw"><div class="sc-exkUMo dtaSm"><nav class="sc-kcDeIU bWqBcu"><ul class="sc-ipZHIp jlpzOk sc-iqzUVk bDiWCG"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">About Atlassian Marketplace</span></span></span></a></div></li></ul><ul class="sc-iqzUVk bDiWCG"><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Build</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/getting-started/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Getting started</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/registering-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Registering apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/installing-cloud-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Installing cloud apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/cloud-app-operations-guide/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Cloud app operations guide</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/adding-watching-and-rating-controls-to-server-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Adding watching and rating controls to server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/alternate-deployment-model-for-server-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Alternate deployment model for server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/developing-apps-for-atlassian-data-center-products/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Developing apps for Atlassian Data Center products</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/guidelines-for-data-center-app-development/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Guidelines for Data Center app development</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-submitting-your-app/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Submitting your Data Center app</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-tracking-your-submission/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Tracking your Data Center app submission</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-performance-and-scale-testing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Performance and scale testing</span></span></span></a><ul class="sc-ipXKqB bqhCtA"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-performance-and-scale-testing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Performance and scale testing your Data Center app</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/testing-your-app-with-a-large-data-set/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Testing your app with a large data set</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-performance-toolkit-user-guide-jira/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Data Center App Performance Toolkit User Guide For Jira</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-performance-toolkit-user-guide-confluence/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Data Center App Performance Toolkit User Guide For Confluence</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/dc-apps-performance-toolkit-user-guide-bitbucket/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Data Center App Performance Toolkit User Guide For Bitbucket</span></span></span></a></div></li></ul></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Licensing</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/cloud-app-licensing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Cloud app licensing</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/server-app-licensing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Server app licensing</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/server-app-license-validation-rules/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Server app license validation rules</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/adding-licensing-support-to-server-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Adding licensing support to server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/ommitting-web-resources-for-unlicensed-server-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Omitting web resources for unlicensed server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/timebomb-licenses-for-testing-server-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Timebomb licenses for testing server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/understanding-the-generated-license-api-support/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Understanding generated license API support</span></span></span></a></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Pricing and payments</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/pricing-payment-and-billing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Pricing, payment, and billing</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/why-cant-i-change-the-payment-model/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Why can&#x27;t I change the payment model</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/sales-tax/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Sales tax</span></span></span></a></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">List</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/app-approval-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">App approval guidelines</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/creating-a-marketplace-listing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Creating a Marketplace listing</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/listing-and-managing-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Listing and managing apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/creating-a-server-app-package/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Creating a server app package </span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/declaring-marketing-assets-for-server-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Declaring marketing assets for server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/listing-an-app-version-from-java/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Listing an app version from Java</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/listing-an-app-version-using-rest/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Listing an app version using REST</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/managing-permissions-on-your-vendor-account/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Managing permissions on your vendor account</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/upgrading-and-versioning-cloud-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Upgrading and versioning cloud apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/archiving-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Archiving apps</span></span></span></a></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Sell</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/selling-on-marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Selling on Marketplace</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/building-your-presence-on-marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Building your presence on Marketplace</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/atlassian-brand-guidelines-for-marketplace-vendors/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Atlassian brand guidelines for Marketplace vendors</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/adwords-trademark-policy/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">AdWords trademark policy</span></span></span></a><ul class="sc-ipXKqB bqhCtA"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/adwords-trademark-policy-ja/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">AdWords での商標に関するポリシー</span></span></span></a></div></li></ul></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/marketplace-search-results-and-rankings/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Marketplace search results and rankings</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/seo-best-practices/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">SEO best practices</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/marketing-funnel-insights/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Marketing funnel insights</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/attracting-new-customers/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Attracting new customers</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/converting-from-try-to-buy/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Converting from try to buy</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/creating-a-press-release/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Creating a press release</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/contributing-to-the-atlassian-blog/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Contributing to the Atlassian blog</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/sales-promotions/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Sales promotions</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/sales-and-evaluations-reports/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Sales and evaluations reports</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/accessing-sales-reports-with-the-rest-api/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Accessing sales reports with the REST API</span></span></span></a></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Programs</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/programs-and-features/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Programs and features</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/top-vendor-program/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Top Vendor program</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/cloud-security-program/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Cloud security program</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/marketplace-bounty-program/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Marketplace security bug bounty program</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/early-access-program/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Early access program</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/sales-promotions/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Sales promotions</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/sales-and-evaluations-reports/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Reports for paid via Atlassian listings</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/sales-and-renewals-email-campaigns/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Sales and renewals email campaigns</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/managing-permissions-on-your-vendor-account/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Manage permissions on your vendor account</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/archiving-apps/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">App archiving</span></span></span></a></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Data privacy and security</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/data-privacy-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Data privacy guidelines</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-requirements/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">App security requirements</span></span></span></a><ul class="sc-ipXKqB bqhCtA"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-requirements/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Security requirements for cloud apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-requirements-faq/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">FAQ: Security requirements for cloud apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-requirements-enforcement/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Enforcement Procedure: Security requirements</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-requirements-more-info/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Additional information: Security requirements</span></span></span></a></div></li></ul></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Security guidelines</span></span></span></a><ul class="sc-ipXKqB bqhCtA"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/app-security-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Security guidelines for marketplace apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/vendor-security-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Security guidelines for marketplace vendors</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-considerations-server/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Security considerations for server apps</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/security-considerations-cloud/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Security considerations for cloud apps</span></span></span></a></div></li></ul></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/app-security-incident-management-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">App security incident management</span></span></span></a><ul class="sc-ipXKqB bqhCtA"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/app-security-incident-management-guidelines/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Incident management guidelines</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/preparing-for-a-security-incident/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Preparing for a security incident</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/app-security-incident-communication-template/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Incident notification comms template</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/app-vulnerability-notification-template/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Vulnerability notification comms template</span></span></span></a></div></li></ul></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Knowledge Base</div><div class="sc-kLIISr gZiCdV"><span class="sc-bwzfXH xJFVv" aria-label="show"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp cQIBQR"><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/creating-access-token-leads-to-a-404-page-not-found/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Creating access token leads to a 404 Page Not Found</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/access-tokens-overview/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Access tokens overview</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/app-is-appearing-multiple-times-on-the-Marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">App is appearing multiple times on the Marketplace</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/artifact-upload-restrictions/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Artifact upload restrictions</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/changing-the-app-version-build-number/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Changing the app version build number</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/i-cant-change-my-apps-payment-model/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">I can&#x27;t change my app&#x27;s payment model</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/my-copyright-has-been-infringed-and-i-want-to-issue-a-takedown-notice/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">My copyright has been infringed and I want to issue a takedown notice</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/i-cant-edit-my-listing-during-the-review-process/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">I can&#x27;t edit my listing during the review process</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/why-is-my-app-hidden-on-the-marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Why is my app hidden on the Marketplace</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/how-do-i-import-a-workflow-into-a-jira-cloud-instance/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">How do I import a workflow into a Jira cloud instance</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/removing-inappropriate-reviews-from-app-listings/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Removing inappropriate reviews from app Listings</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/licensing-faq/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Licensing FAQ</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/editing-your-marketplace-listing/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Editing your Marketplace listing</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/how-do-i-remove-a-private-app-version/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">How do I remove a private app version</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/promotion-codes-in-marketplace-reporting/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Promotion codes in Marketplace reporting</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/retiring-your-app/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">About app archiving</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/having-your-app-featured-in-staff-picked/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">How can my app be added to the staff-picked section on the Marketplace</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/listing-a-third-party-integration-on-the-atlassian-marketplace/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Can I list a third party integration on the Atlassian Marketplace</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/knowledge-base/transfering-apps-between-vendors/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Transfering apps between vendors</span></span></span></a></div></li></ul></li><li class="sc-cqCuEk cvkujJ"><div class="sc-hmXxxW jLNhLN"><div class="sc-dliRfk cvsNuQ">Other considerations</div><div class="sc-kLIISr hZDoUZ"><span class="sc-bwzfXH xJFVv" aria-label="hide"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M10.294 9.698a.988.988 0 0 1 0-1.407 1.01 1.01 0 0 1 1.419 0l2.965 2.94a1.09 1.09 0 0 1 0 1.548l-2.955 2.93a1.01 1.01 0 0 1-1.42 0 .988.988 0 0 1 0-1.407l2.318-2.297-2.327-2.307z" fill="currentColor" fill-rule="evenodd"/></svg></span></div></div><ul class="sc-qrIAp eKNiXZ"><li class="sc-esOvli befayn"><div class="sc-VJcYb dBCoRU"><a class="Button__StyledLink-sc-1o41kgk-1 bjNbqg" spacing="default" href="/platform/marketplace/atlassian-developer-terms/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Atlassian Developer Terms</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/atlassian-rest-api-policy/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Atlassian REST API policy</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="https://www.atlassian.com/licensing/marketplace/publisheragreement/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Marketplace Vendor Agreement</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/contributor-license-agreement/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Developer Community Contributor Agreement</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="https://atlassian.design/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Atlassian design guidelines</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="https://atlaskit.atlassian.com/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">AtlasKit</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="https://docs.atlassian.com/aui/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Atlassian UI library</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/collaborating-with-atlassian-support/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Collaborating with Atlassian Support</span></span></span></a></div></li><li class="sc-esOvli befayn"><div class="sc-VJcYb eMbiOW"><a class="Button__StyledLink-sc-1o41kgk-1 iupNTM" spacing="default" href="/platform/marketplace/glossary/"><span style="align-self:center;display:inline-flex;flex-wrap:nowrap;max-width:100%;position:relative"><span style="align-items:center;align-self:center;flex:1 1 auto;margin:0 4px;max-width:100%;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;transition:opacity 0.3s;opacity:1"><span class="sc-cmthru dPFaNp">Glossary</span></span></span></a></div></li></ul></li></ul></nav><div class="sc-iomxrj hRgvkS"><div class="sc-dvCyap fsZLpn"><div class="sc-eIHaNI drayYj"><span class="sc-eTpRJs hfAxZG"><span class="sc-dxZgTM hbuXXI">Last updated</span>Jun 5, 2020</span><div class="sc-fyjhYU bDqdly"><p class="sc-ugnQR hDhiuP">Rate this page:</p><style data-emotion-css="fwv93l">.css-fwv93l{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:0;}.css-fwv93l [data-rating-icon-checked]{display:inline-block;}.css-fwv93l [data-rating-icon]{display:none;}.css-fwv93l label:hover ~ label [data-rating-icon-checked][data-rating-icon-checked],.css-fwv93l input:checked ~ label [data-rating-icon-checked]{display:none;}.css-fwv93l label:hover ~ label [data-rating-icon][data-rating-icon],.css-fwv93l input:checked ~ label [data-rating-icon]{display:inline-block;}.css-fwv93l:hover [data-rating-icon-checked][data-rating-icon-checked]{display:inline-block;}.css-fwv93l:hover [data-rating-icon][data-rating-icon]{display:none;}</style><div class="css-fwv93l"><style data-emotion-css="i9qcsw">.css-i9qcsw{border:0 !important;-webkit-clip:rect(1px,1px,1px,1px) !important;clip:rect(1px,1px,1px,1px) !important;height:1px !important;overflow:hidden !important;padding:0 !important;position:absolute !important;width:1px !important;white-space:nowrap !important;}</style><label for="rating-top--empty" class="css-i9qcsw"></label><input type="radio" id="rating-top--empty" name="rating-top" checked="" class="css-i9qcsw"/><label for="rating-top--0" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Unusable</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-top--0" value="1" name="rating-top" class="css-i9qcsw"/><label for="rating-top--1" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Poor</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-top--1" value="2" name="rating-top" class="css-i9qcsw"/><label for="rating-top--2" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Okay</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-top--2" value="3" name="rating-top" class="css-i9qcsw"/><label for="rating-top--3" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Good</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-top--3" value="4" name="rating-top" class="css-i9qcsw"/><label for="rating-top--4" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Excellent</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-top--4" value="5" name="rating-top" class="css-i9qcsw"/></div></div></div></div><div class="sc-BngTV gWPgmQ"><div class="sc-cqpYsc dCjvvZ"><h1 class="sc-fihQgH cOjmWH" id="atlassian-developer-terms">Atlassian Developer Terms</h1><p>We&#x27;re excited that you&#x27;ve chosen to develop on the Atlassian development platform (the &quot;<strong>Atlassian Platform</strong>&quot;).  The Atlassian Platform allows you to build amazing add-ons for teams.  When you develop on the Atlassian Platform, you agree to be bound by the following terms, so please read them carefully. </p><p>These Atlassian Developer Terms (the &quot;<strong>Terms</strong>&quot;) are a binding agreement between you and Atlassian Pty Ltd (ABN 53 102 443 916) (&quot;<strong>we</strong>&quot; or &quot;<strong>Atlassian</strong>&quot;).  In these Terms, you are referred to as &quot;<strong>you</strong>&quot; or &quot;<strong>Developer</strong>&quot;.  If you are entering into these Terms on behalf of a company, organization or another legal entity (an &quot;<strong>Entity</strong>&quot;), you are agreeing to these Terms for that Entity and representing to Atlassian that you have the authority to bind such Entity to these Terms, in which case the terms &quot;you&quot; or &quot;Developer&quot; shall refer to such Entity. If you do not have such authority, or if you do not agree with these Terms, you must not accept these Terms or use the Atlassian Developer Assets.  Atlassian may modify these Terms from time to time, subject to Section 17 (Changes to Terms) below.</p><p><strong>By clicking on &quot;I agree&quot; (or a similar button) or by using or accessing any Atlassian Developer Assets, you agree to be bound by these Terms.</strong></p><p>1.            <strong>Atlassian Developer Assets</strong>. Atlassian makes available certain APIs, software development kits (SDKs), and cloud-based development tools (collectively, &quot;<strong>Atlassian Developer Assets</strong>&quot;) for use with its products and services (&quot;<strong>Atlassian Products</strong>&quot;). Atlassian also makes available the Atlassian Developer Guidelines at <a href="https://developer.atlassian.com/index.html" target="_self">https://developer.atlassian.com/index.html</a> (&quot;<strong>Developer Guidelines</strong>&quot;), which include directions and guidelines for use of the Atlassian Developer Assets and which may be modified by Atlassian from time to time. Except where noted, references to any Atlassian Developer Assets include the related Developer Guidelines.</p><p>2.            <strong>Registration</strong>. You agree to follow the registration or credentialing requirements (if any) established by Atlassian for access to the Atlassian Developer Assets. All Atlassian Developer Assets access keys or developer credentials are Atlassian&#x27;s confidential information and may not be shared with third parties.</p><p>3.            <strong>Your Use Rights</strong>.** <strong>Subject to these Terms, you may use the Atlassian Developer Assets to enable products and services (&quot;</strong>Add-Ons**&quot;) to access or interface with Atlassian Products, but only as permitted by the relevant Developer Guidelines. All of your use rights in these Terms (including your rights to use Atlassian Marks below) are limited, non-exclusive, non-sublicenseable and non-transferable. You may, however, permit your agents and contractors to exercise your use rights on your behalf, provided that you remain responsible for their compliance with these Terms.</p><p>4.            <strong>Conditions on Use</strong>. In accessing and using the Atlassian Developer Assets, you agree to comply with Atlassian&#x27;s Acceptable Use Policy at <a href="https://www.atlassian.com/legal/acceptable-use-policy" target="_blank">https://www.atlassian.com/legal/acceptable-use-policy<span class="sc-bwzfXH kZeISe" aria-label="Follow"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><g fill="currentColor" fill-rule="evenodd"><path d="M11.031 7A1.03 1.03 0 0 0 10 8.036a1.05 1.05 0 0 0 1.044 1.045l3.121.014.014 3.121a1.05 1.05 0 0 0 1.045 1.044 1.03 1.03 0 0 0 1.036-1.035l-.019-4.161a1.053 1.053 0 0 0-1.045-1.045L11.035 7h-.004z"/><path d="M13.364 8.292l-7.072 7.071a1.002 1.002 0 0 0 0 1.415c.39.39 1.024.39 1.415 0l7.071-7.071A1.002 1.002 0 0 0 14.071 8a1 1 0 0 0-.707.292z"/></g></svg></span></a> (&quot;<strong>AUP</strong>&quot;) (as may be modified from time to time). As conditions on your use rights, you also agree not to (and not to authorize any third party to): (a) use the Atlassian Developer Assets except with the related Atlassian Products and in accordance with the Developer Guidelines; (b) modify or create any derivative works of the Atlassian Developer Assets (except to the extent the Add-Ons are deemed derivative works under applicable law); (c) take any action that would subject the Atlassian Developer Assets to any third party terms, including without limitation any &quot;open source&quot; software license terms; (d) make any calls to the Atlassian Developer Assets that are not driven by a request from an end user (as described in Section 7.1) or the Add-On itself, other than as part of reasonable testing of your Add-Ons with the Atlassian Developer Assets; (e) copy, frame or display any elements of the Atlassian Products through the Add-Ons or use the Atlassian Developer Assets with Add-Ons that substantially replicate any features or functionality of Atlassian Products, except as expressly authorized by Atlassian in writing; (f) copy, distribute, sell, sublicense, rent or lease the Atlassian Developer Assets or any access key provided by Atlassian or use such items for hosting, service provider or like purposes; or (g) access the Atlassian Developer Assets for competitive analysis or disseminate performance information (including uptime, response time and/or benchmarks) relating to the Atlassian Developer Assets or Atlassian Products. From time to time, Atlassian may place limits on access to the Atlassian Developer Assets (e.g., limits on numbers of calls or requests). Further, Atlassian may monitor your usage of the Atlassian Developer Assets and limit the number of calls or requests you may make if Atlassian believes that your usage is in breach of this Agreement or may negatively affect the Atlassian Platform (or otherwise impose liability on Atlassian).</p><p>5.            <strong>Use of Atlassian Marks</strong>. Subject to these Terms, you may use the appropriate Atlassian names, logos and trademarks as designated in the Atlassian Trademark Guidelines at <a href="https://www.atlassian.com/legal/trademark" target="_blank">https://www.atlassian.com/legal/trademark<span class="sc-bwzfXH kZeISe" aria-label="Follow"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><g fill="currentColor" fill-rule="evenodd"><path d="M11.031 7A1.03 1.03 0 0 0 10 8.036a1.05 1.05 0 0 0 1.044 1.045l3.121.014.014 3.121a1.05 1.05 0 0 0 1.045 1.044 1.03 1.03 0 0 0 1.036-1.035l-.019-4.161a1.053 1.053 0 0 0-1.045-1.045L11.035 7h-.004z"/><path d="M13.364 8.292l-7.072 7.071a1.002 1.002 0 0 0 0 1.415c.39.39 1.024.39 1.415 0l7.071-7.071A1.002 1.002 0 0 0 14.071 8a1 1 0 0 0-.707.292z"/></g></svg></span></a>&gt; (&quot;<strong>Atlassian Marks</strong>&quot;) to promote your Add-Ons as compatible with the relevant Atlassian Products. Your use of Atlassian Marks must comply with the Atlassian Trademark Guidelines and (without limiting Atlassian&#x27;s other termination rights) you must promptly cease any use of Atlassian Marks identified by Atlassian as problematic. You may not register any domain name containing Atlassian Marks, the word &quot;Atlassian&quot; or the name of any Atlassian Product (or anything confusingly similar) and if you have done so you agree to transfer ownership of the domain name to Atlassian at no charge. You also agree not to contest the validity of ownership of any Atlassian Marks. You receive no other rights to Atlassian Marks under these Terms. All goodwill arising from use of Atlassian Marks inures to Atlassian.</p><p>6.            <strong>Use of Your Marks; Your Ownership Rights</strong>. Atlassian may (but is not obligated to) use your name, logos and other trademarks (including those related to the Add-Ons) to identify you as an Atlassian developer and to promote your Add-Ons and Atlassian Products. Atlassian receives no other rights to your trademarks under these Terms. All goodwill arising from use of your trademarks belongs to you. For clarity, nothing in these Terms assigns ownership of your Add-Ons or intellectual property rights to Atlassian.</p><p>7.            <strong>Your Responsibilities</strong>.</p><p>7.1.                Add-Ons and End Users. You are solely responsible, at your own expense, for (a) your Add-Ons and their distribution, operation and support and (b) your own relationships and agreements with end users regarding their use of Add-Ons. As a result of your use of Atlassian Developer Assets, an end user may direct you to retrieve certain of its data, content or information from Atlassian Products (&quot;<strong>End User Data</strong>&quot;) for the end user&#x27;s further use with Add-Ons. You agree to retrieve End User Data only to the extent enabled by the end user and will ensure that all End User Data is collected, processed, transmitted, maintained and used in accordance with (i) your agreement with the end user, a legally adequate privacy policy, and appropriate contextual notices to and consents from end users, (ii) all Laws (as defined below) and (iii) reasonable measures that protect the privacy and security of End User Data.</p><p>7.2.                Atlassian Customer Agreement. Use of Atlassian Products requires each end user to have a valid license or subscription with Atlassian subject to the then-current Atlassian Customer Agreement, which is currently located at <a href="https://www.atlassian.com/end-user-agreement/" target="_blank">https://www.atlassian.com/end-user-agreement/<span class="sc-bwzfXH kZeISe" aria-label="Follow"><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><g fill="currentColor" fill-rule="evenodd"><path d="M11.031 7A1.03 1.03 0 0 0 10 8.036a1.05 1.05 0 0 0 1.044 1.045l3.121.014.014 3.121a1.05 1.05 0 0 0 1.045 1.044 1.03 1.03 0 0 0 1.036-1.035l-.019-4.161a1.053 1.053 0 0 0-1.045-1.045L11.035 7h-.004z"/><path d="M13.364 8.292l-7.072 7.071a1.002 1.002 0 0 0 0 1.415c.39.39 1.024.39 1.415 0l7.071-7.071A1.002 1.002 0 0 0 14.071 8a1 1 0 0 0-.707.292z"/></g></svg></span></a> and which includes the AUP (&quot;<strong>Atlassian Customer Agreement</strong>&quot;). You will not facilitate or encourage any end user to violate the Atlassian Customer Agreement or interfere with any end user&#x27;s review or acceptance of the Atlassian Customer Agreement. For the avoidance of doubt, your use of the Atlassian Developer Assets is subject to this Agreement, not the Atlassian Customer Agreement.  If you use Atlassian Products as a customer, that use remains subject to the Atlassian Customer Agreement.</p><p>7.3.                No Resale. These Terms do not grant you the right to distribute or resell Atlassian Products or to create any binding commitment on behalf of Atlassian. In addition, you may not directly or indirectly charge end users for use of, or access to, the functionality of the Atlassian Products or Atlassian Developer Assets (but this does not limit you from charging a standard overall fee for the Add-Ons).</p><p>7.4.                Your Representations and Warranties. You represent and warrant that (a) you have full power and authority to enter into and perform these Terms and to exploit the Add-Ons without violating any other agreement; (b) the Add-Ons and their use will not violate any third party rights (including intellectual property rights and rights of privacy or publicity) or any laws, rules, regulations or orders, including those relating to data privacy, data transfer, international communications or the export of technical or personal data (&quot;<strong>Laws</strong>&quot;); (c) all information you provide to Atlassian is and will be true, accurate, and complete and (d) you will not interfere with Atlassian&#x27;s business practices or the way in which it licenses or distributes the Atlassian Products or Atlassian Developer Assets. You may not suggest any affiliation with Atlassian, including any suggestion that Atlassian sponsors, endorses or guarantees the Add-Ons, except for the Atlassian Developer Assets integration relationship expressly contemplated in these Terms. You may not make any representations, warranties or commitments regarding Atlassian or Atlassian Products or on behalf of Atlassian.</p><p>7.5.                Indemnification. You will indemnify, defend (at Atlassian&#x27;s request) and hold harmless Atlassian and its affiliates and their respective directors, officers, employees, agents, contractors, end users and licensees from and against any claims, losses, costs, expenses (including reasonable attorneys&#x27; fees), damages or liabilities based on or arising from (a) the Add-Ons, (b) your relationships or interactions with any end users or third party distributors of the Add-Ons, or (c) your breach or alleged breach of these Terms. Atlassian may at its own expense participate in the defense and settlement of any claim with its own counsel, and you may not settle a claim without Atlassian&#x27;s prior written consent (not to be unreasonably withheld).</p><p>8.            <strong>Ownership</strong>. Atlassian and its third party licensors retain all ownership and other rights in the Atlassian Developer Assets, Atlassian Products and Atlassian Marks, including all intellectual property rights. Providing feedback, comments, or suggestions about the Atlassian Developer Assets or Atlassian Products (<strong>&quot;Feedback</strong>&quot;) to Atlassian is wholly voluntary. By providing Feedback, Developer grants Atlassian a worldwide, royalty-free, non-exclusive, perpetual and irrevocable license to use, copy, modify, sublicense (through multiple tiers) and otherwise exploit the Feedback (including any ideas, concepts, methods, know-how or techniques embodied in Feedback) for any purpose, without any restriction or obligation to Developer based on intellectual property rights or otherwise.</p><p>9.            <strong>No Support or Maintenance</strong>. Atlassian has no obligation to provide any maintenance or support for the Atlassian Developer Assets (or to end users of Add-Ons) or to fix any errors or defects. If Atlassian in its discretion provides any updates, modifications, enhancements, and other new releases to the Atlassian Developer Assets, such materials will be deemed included in the &quot;Atlassian Developer Assets&quot; under these Terms unless Atlassian specifies otherwise.</p><p>10.            <strong>Changes to Atlassian Developer Assets</strong>. From time to time, Atlassian may change the Atlassian Developer Assets or related Atlassian Products. Future versions of the Atlassian Developer Assets may not be compatible with Add-Ons developed using previous versions. Atlassian typically makes these changes as part of its overall developer program and is unable to provide notice of the changes to developers individually. Atlassian will have no liability resulting from the actions described in this paragraph.</p><p>11.            <strong>Termination. </strong>These Terms remain in effect until terminated. Developer may terminate these Terms at any time by ceasing all use of the Atlassian Developer Assets and any relevant developer credentials. Atlassian may terminate these Terms (a) for no reason or any reason upon thirty (30) days&#x27; notice to Developer or (b) if Developer breaches any provision of these Terms and does not cure such breach within fifteen (15) days after written notice of the breach (or immediately in Atlassian&#x27;s discretion in case of willful or significant breaches). Atlassian may also suspend Developer&#x27;s use of Atlassian Developer Assets or terminate these Terms immediately if Atlassian is required to do so by Law, if Atlassian ceases to offer the Atlassian Developer Assets, Atlassian Products or its developer program or if Atlassian determines that continuing under these Terms could result in legal or business liability or cause harm to its products, services, reputation or users. Upon any termination, Developer&#x27;s rights to use Atlassian Developer Assets (including related access keys and credentials) and Atlassian Marks will immediately terminate and Developer will cease all such use, but all other provisions of these Terms will survive. Developer understands that after termination it will have no further access to any Atlassian developer website or portal or to any data or content that Developer submitted to Atlassian relating to the Atlassian Developer Assets. Atlassian will have no obligation or liability resulting from termination or suspension of these Terms as permitted above.</p><p>12.            <strong>Disclaimer of Warranties</strong>. TO THE FULL EXENT PERMITTED BY LAW, ALL ATLASSIAN DEVELOPER ASSETS, ATLASSIAN PRODUCTS AND ATLASSIAN MARKS ARE PROVIDED &quot;AS IS&quot; AND &quot;WITH ALL FAULTS&quot; AND ATLASSIAN AND ITS THIRD PARTY LICENSORS DISCLAIM ALL REPRESENTATIONS, WARRANTIES AND GUARANTEES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY, TITLE, NON-INFRINGEMENT AND FITNESS FOR ANY PURPOSE. ATLASSIAN MAKES NO REPRESENTATION, WARRANTY OR GUARANTEE RELATED TO RELIABILITY, ACCURACY, OR COMPLETENESS OF THE ATLASSIAN DEVELOPER ASSETS OR ATLASSIAN PRODUCTS, THAT ATLASSIAN WILL CONTINUE TO OFFER ANY ATLASSIAN DEVELOPER ASSETS OR ITS DEVELOPER PROGRAM OR THAT USE OF ANY ATLASSIAN DEVELOPER ASSETS OR ATLASSIAN PRODUCTS WILL BE SECURE, TIMELY, UNINTERRUPTED, ERROR-FREE OR MEET DEVELOPER&#x27;S REQUIREMENTS OR EXPECTATIONS. You may have other statutory rights, in which case the disclaimers above will apply to the full extent permitted by law.</p><p>13.            <strong>Limitations of Liability</strong>.** <strong>TO THE FULL EXTENT PERMITTED BY LAW, IN NO EVENT WILL ATLASSIAN BE LIABLE (A) FOR ANY LOSS OF USE, LOST DATA, FAILURE OF SECURITY MECHANISMS, INTERRUPTION OF BUSINESS, OR ANY INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES OF ANY KIND (INCLUDING LOST PROFITS OR LOST DATA), REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY OR OTHERWISE, EVEN IF INFORMED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE OR (B) IN ANY EVENT, FOR ANY DAMAGES OR LIABILITIES EXCEEDING ONE HUNDRED U.S. DOLLARS ($100).</strong> **NOTWITHSTANDING ANYTHING TO THE CONTRARY, ATLASSIAN HAS NO WARRANTY, INDEMNIFICATION OR OTHER OBLIGATION OR LIABILITY WITH RESPECT TO YOUR ADD-ONS OR THEIR COMBINATION, INTERACTION, OR USE WITH ANY ATLASSIAN PRODUCTS OR ATLASSIAN DEVELOPER ASSETS. Developer acknowledges and agrees that this Section 13 reflects a reasonable allocation of risk and that Atlassian would not enter into these Terms without these liability limitations. This Section 13 will survive notwithstanding any limited remedy&#x27;s failure of essential purpose.</p><p>14.            <strong>Atlassian Confidential Information</strong>.</p><p>14.1.             Definition. All information disclosed by Atlassian that is marked as confidential or proprietary or that you should reasonably understand to be confidential or proprietary is &quot;<strong>Confidential Information</strong>.&quot; Confidential Information includes non-public aspects of the Atlassian Products and Atlassian Developer Assets. Confidential Information shall not include any information that: (i) is or becomes generally known to the public; (ii) was known to you before its disclosure hereunder; or (iii) is received from a third party, in each case without breach of an obligation owed to Atlassian or anyone else.</p><p>14.2.             Your Obligations. During and after the term of this Agreement, you shall (a) maintain Confidential Information in confidence (using at least the same measures as for your own confidential information, and no less than reasonable care) and not divulge it to any third party and (b) only use Confidential Information to fulfill your obligations under this Agreement. If you are compelled by law to disclose Confidential Information, you must provide Atlassian with prior notice of such compelled disclosure (to the extent legally permitted) and reasonable assistance, at Atlassian&#x27;s cost, if Atlassian wishes to contest the disclosure.</p><p>14.3.             Injunctive Relief. In the event of actual or threatened breach of this Section 14, Atlassian shall have the right, in addition to any other remedies available to it, to seek injunctive relief to protect its Confidential Information, it being specifically acknowledged by the parties that other available remedies may be inadequate.</p><p>15.            <strong>Information You Provide Is Not Confidential</strong>.</p><p>15.1.             You understand and agree that Atlassian develops its own products and services and works with many other vendors and developers, and either Atlassian or these third parties could in the future develop (or already have developed) products similar to yours.</p><p>15.2.             You should not provide to Atlassian any information that you consider confidential and you agree that Atlassian is not subject to any confidentiality obligations or use restrictions related to information that you may provide to Atlassian in relation to this Agreement. You expressly agree that neither this Agreement nor your development on the Atlassian Platform limits Atlassian&#x27;s right to develop or have developed for it products, concepts, systems or techniques that are similar to or compete with any Add-Ons or any other products, concepts, systems or techniques contemplated by or embodied in information you disclose to Atlassian. For clarity, however, this paragraph, in itself, does not grant Atlassian any license under your intellectual property rights.</p><p>16.            <strong>Export Restrictions</strong>. The Atlassian Developer Assets are subject to export restrictions by the United States government and import restrictions by certain foreign governments, and you agree to comply with all applicable export and import laws and regulations in your use of the Atlassian Developer Assets. You shall not (and shall not allow any third-party to) remove or export from the United States or allow the export or re-export of any part of the Atlassian Developer Assets or any direct product thereof: (a) into (or to a national or resident of) any embargoed or terrorist-supporting country; (b) to anyone on the U.S. Commerce Department&#x27;s Table of Denial Orders or U.S. Treasury Department&#x27;s list of Specially Designated Nationals; (c) to any country to which such export or re-export is restricted or prohibited, or as to which the United States government or any agency thereof requires an export license or other governmental approval at the time of export or re-export without first obtaining such license or approval; or (d) otherwise in violation of any export or import restrictions, laws or regulations of any United States or foreign agency or authority. You represent and warrant that you are not located in, under the control of, or a national or resident of any such prohibited country or on any such prohibited party list. The Atlassian Developer Assets are restricted from being used for the design or development of nuclear, chemical, or biological weapons or missile technology without the prior permission of the United States government.</p><p>17.            <strong>Changes to Terms</strong>. Atlassian may modify these Terms from time to time, including any referenced policies and other documents. Atlassian will use reasonable efforts to notify you of modifications as provided in Section 19 (General). You may be required to click through the modified Terms to show your acceptance and in any event your continued use of any Atlassian Developer Assets after the modification constitutes your acceptance to the modifications. If you do not agree to the modified Terms, your sole remedy is to terminate your use of the Atlassian Developer Assets as described in Section 11 (Termination).</p><p>18.            <strong>Open Source Software. </strong>The Atlassian Developer Assets may contain or be provided with components subject to the terms and conditions of &quot;open source&quot; software licenses (&quot;<strong>Open Source Software</strong>&quot;). To the extent applicable, Atlassian will identify Open Source Software included in the Atlassian Developer Assets.  To the extent required by the license that accompanies the Open Source Software, the terms of such license will apply in lieu of the terms of this Agreement with respect to such Open Source Software, including, without limitation, any provisions governing access to source code, modification or reverse engineering.</p><p>19.<strong>            General. </strong>These Terms are the parties&#x27; entire agreement and supersede any prior or contemporaneous agreements relating to its subject matter. Except as set forth in Section 17 (Changes to Terms), all amendments or modifications must be in writing and signed by both parties. The words &quot;including&quot; and similar terms are to be construed without limitation. Failure to enforce any provision is not a waiver and all waivers must be in writing. If any provision is found to be unenforceable it (and related provisions) will be interpreted to best accomplish its intended purpose. Developer may not assign, transfer or delegate any right or obligations under these Terms and any non-permitted assignment is void. Atlassian may assign these Terms and its rights and obligations to any of its affiliates or in connection with a merger, reorganization, acquisition or other transfer of all or substantially all of its assets or voting securities to which these Terms relate. Notices must be in writing and will be deemed given when delivered. Atlassian may provide notice to the email or physical address provided by Developer or through Atlassian&#x27;s developer website. Your notices to Atlassian must be given by post to Atlassian Pty Ltd, c/o Atlassian, Inc., 1098 Harrison Street, San Francisco, CA, USA 94103, Attn: Legal. The parties are independent contractors and these Terms do not create any agency, partnership, or joint venture. These Terms will be governed by and construed in accordance with the laws of the State of California, excluding conflicts of law rules and principles. Each party submits to the personal and exclusive jurisdiction of the federal or state courts for San Francisco County, California. Atlassian will not be liable to Developer for any delay or failure to perform any obligation under these Terms if the delay or failure is due to unforeseen events that are beyond its reasonable control. The Atlassian Developer Assets and Atlassian Products are commercial computer software. If the user or licensee of such technology is an agency, department, or other entity of the United States Government, the use, duplication, reproduction, release, modification, disclosure, or transfer of such technology, or any related documentation of any kind, including technical data and manuals, is restricted by these Terms in accordance with Federal Acquisition Regulation 12.212 for civilian purposes and Defense Federal Acquisition Regulation Supplement 227.7202 for military purposes. The Atlassian Developer Assets and Atlassian Products were developed fully at private expense. All other use is prohibited.</p><p><strong>Last updated 04 Dec 2015</strong></p><p>By downloading and/or using this SDK you agree to the <a href="/platform/marketplace/atlassian-developer-terms" target="_self">Atlassian Developer Terms</a></p></div></div><div class="sc-dvCyap dwpqw"><div class="sc-fyjhYU bDqdly"><p class="sc-ugnQR hDhiuP">Rate this page:</p><style data-emotion-css="fwv93l">.css-fwv93l{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;font-size:0;}.css-fwv93l [data-rating-icon-checked]{display:inline-block;}.css-fwv93l [data-rating-icon]{display:none;}.css-fwv93l label:hover ~ label [data-rating-icon-checked][data-rating-icon-checked],.css-fwv93l input:checked ~ label [data-rating-icon-checked]{display:none;}.css-fwv93l label:hover ~ label [data-rating-icon][data-rating-icon],.css-fwv93l input:checked ~ label [data-rating-icon]{display:inline-block;}.css-fwv93l:hover [data-rating-icon-checked][data-rating-icon-checked]{display:inline-block;}.css-fwv93l:hover [data-rating-icon][data-rating-icon]{display:none;}</style><div class="css-fwv93l"><style data-emotion-css="i9qcsw">.css-i9qcsw{border:0 !important;-webkit-clip:rect(1px,1px,1px,1px) !important;clip:rect(1px,1px,1px,1px) !important;height:1px !important;overflow:hidden !important;padding:0 !important;position:absolute !important;width:1px !important;white-space:nowrap !important;}</style><label for="rating-bottom--empty" class="css-i9qcsw"></label><input type="radio" id="rating-bottom--empty" name="rating-bottom" checked="" class="css-i9qcsw"/><label for="rating-bottom--0" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Unusable</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-bottom--0" value="1" name="rating-bottom" class="css-i9qcsw"/><label for="rating-bottom--1" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Poor</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-bottom--1" value="2" name="rating-bottom" class="css-i9qcsw"/><label for="rating-bottom--2" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Okay</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-bottom--2" value="3" name="rating-bottom" class="css-i9qcsw"/><label for="rating-bottom--3" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Good</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-bottom--3" value="4" name="rating-bottom" class="css-i9qcsw"/><label for="rating-bottom--4" style="transition:transform 100ms cubic-bezier(0.15,1,0.3,1)"><div><div><span class="css-i9qcsw">Excellent</span><span aria-hidden="true" data-rating-icon="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12 16.373l3.98 2.193-.76-4.655 3.276-3.347-4.524-.69L12 5.687l-1.972 4.189-4.524.689L8.78 13.91l-.762 4.655L12 16.373zm0 2.283l-3.016 1.662a2 2 0 0 1-2.939-2.075l.599-3.656-2.57-2.624a2 2 0 0 1 1.129-3.377l3.47-.528 1.518-3.224a2 2 0 0 1 3.618 0l1.519 3.224 3.47.528a2 2 0 0 1 1.127 3.377l-2.569 2.624.599 3.656a2 2 0 0 1-2.94 2.075L12 18.656z" fill="currentColor"/></svg></span></span><span aria-hidden="true" data-rating-icon-checked="true"><span class="sc-hjRWVT gIPXRY" aria-label=""><svg width="24" height="24" viewBox="0 0 24 24" focusable="false" role="presentation"><path d="M12.072 17.284l-3.905 2.053a1 1 0 0 1-1.451-1.054l.745-4.349-3.159-3.08a1 1 0 0 1 .554-1.705l4.366-.635 1.953-3.956a1 1 0 0 1 1.794 0l1.952 3.956 4.366.635a1 1 0 0 1 .555 1.705l-3.16 3.08.746 4.349a1 1 0 0 1-1.45 1.054l-3.906-2.053z" fill="currentColor" fill-rule="evenodd"/></svg></span></span></div></div></label><input type="radio" id="rating-bottom--4" value="5" name="rating-bottom" class="css-i9qcsw"/></div></div></div></div></div></div><div class="sc-gqjmRU cdtUPR"><footer class="sc-kafWEX dTdch"><div class="sc-iELTvK ewqcYX sc-feJyhm fRrBax"><span class="sc-jbKcbu kTqZVQ"><canvas height="32" width="190" aria-hidden="true"></canvas>
+  <svg viewBox="0 0 190 32" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
+    <defs>
+      <linearGradient x1="99.684716%" y1="15.8138128%" x2="39.8444399%" y2="97.4388388%" id="42c70975-a660-4447-b937-3c181c3e3dc6">
+        <stop stop-color="#5E6C84"  offset="0%"></stop>
+        <stop stop-color="#5E6C84" offset="100%"></stop>
+      </linearGradient>
+    </defs>
+    <g stroke="none" stroke-width="1" fill-rule="nonzero">
+      <path d="M6.90502605,15.6123193 C6.76436383,15.4302139 6.53773035,15.3340846 6.30742588,15.35884 C6.0771214,15.3835955 5.876643,15.525635 5.7787929,15.7333781 L0.0719979599,27.0218487 C-0.0337056449,27.2310259 -0.0224063827,27.4794358 0.101860917,27.6783741 C0.226128216,27.8773125 0.445645594,27.9984148 0.68202605,27.9984369 L8.62844459,27.9984369 C8.88847261,28.0044096 9.12761649,27.8581627 9.23847268,27.6253781 C10.9526159,24.1210252 9.91378448,18.7926722 6.90502605,15.6123193 Z" fill="url(#42c70975-a660-4447-b937-3c181c3e3dc6)"></path>
+      <path d="M11.0859556,5.33713587 C8.19309829,9.74089822 7.85921851,15.3267488 10.2073011,20.0371359 L14.0383488,27.6176065 C14.1538739,27.8462194 14.3900332,27.9906411 14.6483769,27.9906653 L22.5933685,27.9906653 C22.829749,27.9906431 23.0492663,27.8695408 23.1735336,27.6706025 C23.2978009,27.4716641 23.3091002,27.2232543 23.2033966,27.014077 C23.2033966,27.014077 12.5147056,5.8619594 12.2460792,5.33290058 C12.1377032,5.11315026 11.9118188,4.97410225 11.6646746,4.97500451 C11.4175304,4.97590676 11.1926893,5.11660025 11.0859556,5.33713587 L11.0859556,5.33713587 Z" fill="currentColor"></path>
+      <path d="M104.2774,14.3919316 C104.2774,17.1872257 105.588069,19.4065198 110.714802,20.3862846 C113.773504,21.0215787 114.414212,21.5100493 114.414212,22.5187551 C114.414212,23.4985198 113.772077,24.1327551 111.617715,24.1327551 C109.013896,24.0864379 106.462135,23.403307 104.189999,22.1442846 L104.189999,26.6972257 C105.733976,27.4465198 107.772754,28.2822846 111.559566,28.2822846 C116.919251,28.2822846 119.045788,25.9175787 119.045788,22.4033434 M119.045788,22.4033434 C119.045788,19.0892257 117.268858,17.5327551 112.25878,16.4668728 C109.491535,15.8615787 108.821574,15.2566375 108.821574,14.3919316 C108.821574,13.297814 109.811889,12.835814 111.646968,12.835814 C113.860906,12.835814 116.045591,13.4986375 118.113622,14.4208728 L118.113622,10.0691081 C116.130615,9.17615406 113.970906,8.73311319 111.792518,8.7724022 C106.840589,8.7724022 104.2774,10.9048728 104.2774,14.3919316" fill="inherit"></path>
+      <polygon fill="inherit" points="173.129997 9.07000017 173.129997 28.0038825 177.20791 28.0038825 177.20791 13.5657649 178.926691 17.3983531 184.694132 28.0038825 189.820865 28.0038825 189.820865 9.07000017 185.742952 9.07000017 185.742952 21.2891766 184.198975 17.7442355 179.567399 9.07000017"></polygon>
+      <rect fill="inherit" x="142.740005" y="9.07000017" width="4.45677247" height="18.9338824"></rect>
+      <path d="M137.600792,22.4033434 C137.600792,19.0892257 135.823862,17.5327551 130.813784,16.4668728 C128.046539,15.8615787 127.376579,15.2566375 127.376579,14.3919316 C127.376579,13.297814 128.366893,12.835814 130.201972,12.835814 C132.41591,12.835814 134.600595,13.4986375 136.668626,14.4208728 L136.668626,10.0691081 C134.685619,9.17615406 132.52591,8.73311319 130.347522,8.7724022 C125.395593,8.7724022 122.832404,10.9048728 122.832404,14.3919316 C122.832404,17.1872257 124.143073,19.4065198 129.269806,20.3862846 C132.328508,21.0215787 132.969216,21.5100493 132.969216,22.5187551 C132.969216,23.4985198 132.327081,24.1327551 130.172719,24.1327551 C127.568901,24.0864379 125.017139,23.403307 122.745003,22.1442846 L122.745003,26.6972257 C124.28898,27.4465198 126.327758,28.2822846 130.11457,28.2822846 C135.474256,28.2822846 137.600792,25.9175787 137.600792,22.4033434" fill="inherit"></path>
+      <polygon fill="inherit" points="69.6599979 9.07000017 69.6599979 28.0038825 78.8204081 28.0038825 80.2627142 23.9115296 74.1456665 23.9115296 74.1456665 9.07000017"></polygon>
+      <polygon fill="inherit" points="51.5549984 9.07000017 51.5549984 13.1620002 56.5069282 13.1620002 56.5069282 28.0038825 60.9925967 28.0038825 60.9925967 13.1620002 66.2941332 13.1620002 66.2941332 9.07000017"></polygon>
+      <path d="M45.0573091,9.07000017 L39.1785647,9.07000017 L32.5050001,28.0038825 L37.6014102,28.0038825 L38.5474889,24.815059 C40.877531,25.4919503 43.3551322,25.4919503 45.6851743,24.815059 L46.6312529,28.0038825 L51.7287333,28.0038825 L45.0573091,9.07000017 Z M42.1177585,21.4007061 C41.287584,21.4006584 40.4616854,21.2831148 39.6651602,21.0516472 L42.1177585,12.7889413 L44.5703569,21.0544708 C43.7736914,21.2849831 42.9477956,21.4015755 42.1177585,21.4007061 L42.1177585,21.4007061 Z" fill="inherit"></path>
+      <path d="M94.6019534,9.07000017 L88.7235658,9.07000017 L82.0500011,28.0038825 L87.1474815,28.0038825 L88.0935601,24.815059 C90.4236023,25.4919503 92.9012034,25.4919503 95.2312455,24.815059 L96.1773242,28.0038825 L101.274805,28.0038825 L94.6019534,9.07000017 Z M91.6627596,21.4007061 C90.8325851,21.4006584 90.0066865,21.2831148 89.2101613,21.0516472 L91.6627596,12.7889413 L94.1153579,21.0544708 C93.3186924,21.2849831 92.4927966,21.4015755 91.6627596,21.4007061 L91.6627596,21.4007061 Z" fill="inherit"></path>
+      <path d="M163.256954,9.07000017 L157.378566,9.07000017 L150.705002,28.0038825 L155.802482,28.0038825 L156.748561,24.815059 C159.078603,25.4919503 161.556204,25.4919503 163.886246,24.815059 L164.832325,28.0038825 L169.930162,28.0038825 L163.256954,9.07000017 Z M160.315977,21.4007061 C159.485802,21.4006584 158.659903,21.2831148 157.863378,21.0516472 L160.315977,12.7889413 L162.768575,21.0544708 C161.971909,21.2849831 161.146014,21.4015755 160.315977,21.4007061 L160.315977,21.4007061 Z" fill="inherit"></path>
+    </g>
+  </svg></span><nav class="sc-cmTdod hDeCr"><a class="sc-btzYZH kRQryd" target="_blank" href="https://status.developer.atlassian.com">System status</a><a class="sc-btzYZH kRQryd" target="_blank" href="https://www.atlassian.com/legal/privacy-policy">Privacy</a><a class="sc-btzYZH kRQryd" target="_blank" href="https://developer.atlassian.com/market/atlassian-developer-terms">Developer Terms</a><a class="sc-btzYZH kRQryd" target="_blank" href="https://www.atlassian.com/legal/privacy-policy">Trademark</a><a class="optanon-toggle-display hide-optanon-link sc-btzYZH kRQryd">Cookie preferences</a><span class="sc-jwKygS bVMXRJ">© <!-- -->2020<!-- --> Atlassian</span></nav></div></footer></div></div></div></div>
+        <script type="text/javascript" src="/_static/documentation.918dd1f7.bundle.js"></script>
+        </body>
+      </html>
\ No newline at end of file
diff --git a/dview.dlink.com.html b/dview.dlink.com.html
new file mode 100644
index 0000000..3d9643f
--- /dev/null
+++ b/dview.dlink.com.html
@@ -0,0 +1,174 @@
+﻿<!DOCTYPE html>
+<html lang="zh-tw">
+<head>
+<meta charset="utf-8">
+<meta http-equiv="X-UA-Compatible" content="IE=edge">
+<meta name="description" content="A web-based network management software that provides an easy and efficient tool to manage wired and wireless devices in multiple locations." />
+<meta name="keywords" content="network management,network monitoring, d-link nms, dview, d-view, d-view 7, convergent networks, nms, network topology, virtual nms" />
+<title>D-View 7 | D-Link Network Management Software</title>
+<link rel="stylesheet" href="css/vendor/bootstrap.css">
+<link rel="stylesheet" href="css/index.css">
+<!--<script type="text/javascript" src="http://use.typekit.net/vsi0qij.js"></script>
+<script type="text/javascript">try{Typekit.load();}catch(e){}</script>-->
+<!--[if lt IE 9]>
+<script src="js/html5shiv.js" ></script>
+<script src="https://code.jquery.com/jquery-1.11.1.min.js" >
+<![endif]-->
+<!--[if gte IE 9]><!-->
+<script src="https://code.jquery.com/jquery-2.1.1.min.js" ></script>
+<!--<![endif]-->
+<script src="js/jquery.nicescroll.min.js" ></script>
+<script src="js/bootstrap.js" ></script>
+<script src="js/jquery.transit.min.js" ></script>
+<script src="js/mobile/iscroll-probe.js"></script>
+<script src="js/jquery.scrollmagic.min.js"></script>
+<!--CDN link for the latest TweenMax-->
+<script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/latest/TweenMax.min.js"/></script>
+<!--CDN links for the latest TweenLite, CSSPlugin, and EasePack-->
+<script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/latest/plugins/CSSPlugin.min.js"></script>
+<script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/latest/easing/EasePack.min.js"></script>
+<script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/latest/TweenLite.min.js"></script>
+<script src="js/ScrollToPlugin.min.js"></script>
+
+<script src="js/effect.js" ></script>
+<link rel="shortcut icon" href="images/favicon.ico"/>
+<style>
+.new{
+  color: #ffffff;
+  background: #ed7626;
+  border-radius: 4px;
+  text-align: center;
+  position: relative;
+  width: 32px;
+  font-size: 12px;
+  right: 10px;
+  height: 14px;
+  line-height: 1.2;
+}
+</style>
+</head>
+<body>
+<nav class="navbar navbar-default navbar-fixed-top" role="navigation">
+  <div class="container">
+    <h1 title="D-View 7"><a href="/">D-View 7</a></h1>
+    <a href="download.php" class="free"><span>FREE TRIAL</span><img src="images/icon/arrow.png" alt=""></a>
+    <p class="toplink"><a href="http://dview.dlink.com/DV-600/" target="_blank">D-View 6</a><a href="contact.php">Contact Us</a></p>
+
+
+    <ul class="nav navbar-nav" >
+      <div class="new">new</div>
+      <li><a href="https://dvonlinedemo.dlink.com.tw/DView7/" target="_blank">Online Demo</a></li>
+      <li class="dropdown"> <a href="architecture.php" class="dropdown-toggle" data-toggle="dropdown">Product Tour</a>
+        <ul class="dropdown-menu" role="menu">
+          <li> <a href="architecture.php">Architecture</a> <a href="features.php">Feature Highlights</a> <a href="license.php">License Packages</a> <a href="specs.php">Technical Specs</a> <a href="models.php">Supported Models</a> </li>
+        </ul>
+      </li>
+      <li class="dropdown"> <a href="download.php" class="dropdown-toggle" data-toggle="">Download</a>
+        <ul class="dropdown-menu" role="menu">
+          <li> <a href="download.php#download_2">D-View 7</a> <a href="download.php#download_3">Probe</a> <a href="download.php#Patch">Patch</a></li>
+        </ul>
+      </li>
+      <li class="dropdown"> <a href="resources.php" class="dropdown-toggle" data-toggle="">Resources</a>
+        <ul class="dropdown-menu" role="menu">
+          <li> <a href="javascript:;" class="hidden">Get Started Resources</a> <a href="resources.php">Documentation</a> </li>
+        </ul>
+      </li>
+      <li class="dropdown"> <a href="https://wfp.zendesk.com/" class="dropdown-toggle" data-toggle="" target="_blank" >Support</a>
+        <ul class="dropdown-menu" role="menu">
+          <li> <a href="https://wfp.zendesk.com/" target="_blank">Support</a></li>
+          <!-- <li> <a href="" target="blank">Demo</a></li> -->
+        </ul>
+      </li>
+<!--      <li class="dropdown"> <a href="https://dviewsupport.zendesk.com/" class="dropdown-toggle" data-toggle="">Support</a>
+        <ul class="dropdown-menu" role="menu">
+          <li> <a href="https://dviewsupport.zendesk.com/hc/en-us/categories/200142680-Product-News-Updates">Product News &amp; Updates</a> <a href="https://dviewsupport.zendesk.com/hc/en-us/categories/200144964-FAQ">FAQs</a> <a href="https://dviewsupport.zendesk.com/hc/en-us/categories/200144974-Knowledge-Base">Knowledge Base</a> </li>
+        </ul>
+      </li>
+-->
+    </ul>
+  </div>
+</nav>
+<a href="javascript:;" class="btn btn-link btn-xs goup" role="button"><img src="images/icon/gotop.png" alt=""></a>
+
+<div class="jumbotron mainbanner">
+  <div class="container">
+    <div class="title" id="title-1">Finally, a NMS that Fits Your Organization</div>
+    <img class="img" id="img-1" src="timthumb.php?src=upload/banner/141203908246.png&h=358&w=414&zc=1" alt="D-View 7">
+    <div class="note" id="main-note">
+      <p>D-View 7 allows hierarchical administration to manage convergent networks in multiple locations.</p>
+      <a class="btn btn-primary btn-lg" role="button" href="http://dview.dlink.com/features.php">Learn more</a> 
+    </div>
+  </div>
+</div>
+<div class="jumbotron enjoy">
+    <div class="container">
+        <h2 class="title" id="title-2">Enjoy the flexibility to</h2>
+        <div class="row">
+          <div class="col-md-4 col-sm-4 col-xs-4" id="box-1"><a href="features.php#Real-time" class="link"><p class="img"><img src="images/icon/3-1.png" alt="wireless devices"></p><p class="intro">Manage both wired and wireless devices</p></a></div>
+          <div class="col-md-4 col-sm-4 col-xs-4" id="box-2"><a href="architecture.php" class="link"><p class="img"><img src="images/icon/3-2.png" alt="NMS"></p><p class="intro">Manage multiple sites with one NMS</p></a></div>
+          <div class="col-md-4 col-sm-4 col-xs-4" id="box-3"><a href="features.php#NMS" class="link"><p class="img"><img src="images/icon/3-3.png" alt="team"></p><p class="intro">Create a hierarchical administration team</p></a></div>
+        </div>
+    </div>
+</div>
+<div class="jumbotron quicklink" id="quicklink">
+    <div class="container">
+        <div class="row">
+            <div class="col-xs-6 col-sm-6 col-xs-6" id="box-4">
+                <a href="download.php">
+                    <img src="images/icon/2-1.png" class="img">
+                    <h2 class="title">Try it for Free</h2>
+                    <p class="note">Download D-View 7 and start your trial now !</p>
+                </a>
+            </div>
+            <div class="col-xs-6 col-sm-6 col-xs-6" id="box-5">
+                <a href="resources.php">
+                    <img src="images/icon/2-2.png" class="img">
+                    <h2 class="title">Get a Quick Start</h2>
+                    <p class="note">Check out the resources to get a jump start on D-View 7.</p>
+                </a>
+            </div>
+        </div>
+    </div>
+</div>
+<div class="jumbotron footer" >
+  <div class="container">
+    <div class="row">
+      <div class="box">
+        <h3><a href="architecture.php">Product Tour</a></h3>
+        <a href="architecture.php">Architecture</a> <a href="features.php">Feature Highlights</a> <a href="license.php">License Packages</a> <a href="specs.php">Technical Specs</a> <a href="models.php">Supported Models</a> </div>
+      <div class="box">
+        <h3><a href="download.php">Download</a></h3>
+        <a href="download.php#download_2">D-View 7</a> <a href="download.php#download_3">Probe</a> <a href="download.php#Patch">Patch</a></div>
+      <div class="box">
+        <h3><a href="resources.php">Resources</a></h3>
+       <a href="resources.php">Documentation</a> </div>
+      <div class="box">
+        <h3><a href="https://wfp.zendesk.com/hc/en-us">Support</a></h3>
+        <a href="https://wfp.zendesk.com/hc/en-us">Support</a></div>
+<!--
+        <h3><a href="https://dviewsupport.zendesk.com/hc/en-us">Support</a></h3>
+        <a href="https://dviewsupport.zendesk.com/hc/en-us/categories/200142680-Product-News-Updates">Product News &amp; Updates</a> <a href="https://dviewsupport.zendesk.com/hc/en-us/categories/200144964-FAQ">FAQs</a> <a href="https://dviewsupport.zendesk.com/hc/en-us/categories/200144974-Knowledge-Base">Knowledge Base</a> </div>
+-->
+      <div class="box">
+        <h3><a href="about.php">About D-Link</a></h3>
+        <a href="contact.php">Contact Us</a>
+        <a href="http://dview.dlink.com.tw/" target="_blank">D-View 6</a>
+      </div>
+    </div>
+    <footer>&copy; Copyright 2014 D-Link Corporation. All rights reserved.<a href="privacy.php">Privacy Policy</a><a href="terms.php">Terms of Use</a></footer>
+  </div>
+</div>
+    <script>
+	(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
+	(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
+	m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
+	})(window,document,'script','//www.google-analytics.com/analytics.js','ga');
+	
+	ga('create', 'UA-55359567-1', 'auto');
+	ga('require', 'displayfeatures');
+	ga('send', 'pageview');
+	
+	</script>
+	
+</body>
+</html>
diff --git a/package-summary.html b/package-summary.html
new file mode 100644
index 0000000..206f13a
--- /dev/null
+++ b/package-summary.html
@@ -0,0 +1,182 @@
+<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
+<!-- NewPage -->
+<html lang="en">
+<head>
+<!-- Generated by javadoc (1.8.0_212) on Fri Jun 05 22:03:47 UTC 2020 -->
+<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
+<title>com.atlassian.application.host.plugin (Atlassian JIRA - Server 8.5.5 API)</title>
+<meta name="date" content="2020-06-05">
+<link rel="stylesheet" type="text/css" href="../../../../../stylesheet.css" title="Style">
+<script type="text/javascript" src="../../../../../script.js"></script>
+
+<script type="text/javascript" src="https://atl-global.atlassian.com/js/atl-global.min.js"></script>
+<script class="optanon-category-2" type="text/plain">ace.analytics.Initializer.initWithPageAnalytics('BpJ1LB9DeVf9cx42UDsc5VCqZvJQ60dC');</script>
+
+
+<style>
+  body .optanon-alert-box-wrapper
+  {
+    width: auto;
+    margin-right: 12px;
+  }
+</style>
+<script type="text/javascript" src="https://cdn.cookielaw.org/consent/141bbadf-8293-4d74-9552-81ec52e16c66.js"></script>
+<script type="text/javascript">
+    window.addEventListener("load", function () {
+      const toggle = document.createElement('a');
+      toggle.className = 'optanon-toggle-display';
+      toggle.innerText = 'View cookie preferences';
+      toggle.style.cursor = 'pointer';
+      if (document.getElementsByClassName("gc-documentation").length) {
+        toggle.style.marginBottom = '20px';
+        toggle.style.marginLeft =  '30px';
+        toggle.style.display = 'inline-block';
+        const docContent = document.getElementById('doc-content');
+        docContent.appendChild(toggle);
+      } else if (document.querySelectorAll("nav.wy-nav-side .wy-menu").length) {
+        const sideNavMenu = document.querySelectorAll('nav.wy-nav-side .wy-menu')[0].firstElementChild;
+        sideNavMenu.appendChild(toggle);
+      } else {
+        toggle.style.marginBottom = '20px';
+        toggle.style.display = 'inline-block';
+        document.body.appendChild(toggle);
+      }
+    });
+  </script>
+
+</head>
+<body>
+<script type="text/javascript"><!--
+    try {
+        if (location.href.indexOf('is-external=true') == -1) {
+            parent.document.title="com.atlassian.application.host.plugin (Atlassian JIRA - Server 8.5.5 API)";
+        }
+    }
+    catch(err) {
+    }
+//-->
+</script>
+<noscript>
+<div>JavaScript is disabled on your browser.</div>
+</noscript>
+<!-- ========= START OF TOP NAVBAR ======= -->
+<div class="topNav"><a name="navbar.top">
+<!--   -->
+</a>
+<div class="skipNav"><a href="#skip.navbar.top" title="Skip navigation links">Skip navigation links</a></div>
+<a name="navbar.top.firstrow">
+<!--   -->
+</a>
+<ul class="navList" title="Navigation">
+<li><a href="../../../../../overview-summary.html">Overview</a></li>
+<li class="navBarCell1Rev">Package</li>
+<li>Class</li>
+<li><a href="package-use.html">Use</a></li>
+<li><a href="package-tree.html">Tree</a></li>
+<li><a href="../../../../../deprecated-list.html">Deprecated</a></li>
+<li><a href="../../../../../index-all.html">Index</a></li>
+<li><a href="../../../../../help-doc.html">Help</a></li>
+</ul>
+</div>
+<div class="subNav">
+<ul class="navList">
+<li><a href="../../../../../com/atlassian/activeobjects/jira/package-summary.html">Prev&nbsp;Package</a></li>
+<li><a href="../../../../../com/atlassian/configurable/package-summary.html">Next&nbsp;Package</a></li>
+</ul>
+<ul class="navList">
+<li><a href="../../../../../index.html?com/atlassian/application/host/plugin/package-summary.html" target="_top">Frames</a></li>
+<li><a href="package-summary.html" target="_top">No&nbsp;Frames</a></li>
+</ul>
+<ul class="navList" id="allclasses_navbar_top">
+<li><a href="../../../../../allclasses-noframe.html">All&nbsp;Classes</a></li>
+</ul>
+<div>
+<script type="text/javascript"><!--
+  allClassesLink = document.getElementById("allclasses_navbar_top");
+  if(window==top) {
+    allClassesLink.style.display = "block";
+  }
+  else {
+    allClassesLink.style.display = "none";
+  }
+  //-->
+</script>
+</div>
+<a name="skip.navbar.top">
+<!--   -->
+</a></div>
+<!-- ========= END OF TOP NAVBAR ========= -->
+<div class="header">
+<p><a href="http://download.oracle.com/javase/7/docs/api/javax/annotation/ParametersAreNonnullByDefault.html?is-external=true" title="class or interface in javax.annotation">@ParametersAreNonnullByDefault</a>
+</p>
+<h1 title="Package" class="title">Package&nbsp;com.atlassian.application.host.plugin</h1>
+</div>
+<div class="contentContainer">
+<ul class="blockList">
+<li class="blockList">
+<table class="typeSummary" border="0" cellpadding="3" cellspacing="0" summary="Class Summary table, listing classes, and an explanation">
+<caption><span>Class Summary</span><span class="tabEnd">&nbsp;</span></caption>
+<tr>
+<th class="colFirst" scope="col">Class</th>
+<th class="colLast" scope="col">Description</th>
+</tr>
+<tbody>
+<tr class="altColor">
+<td class="colFirst"><a href="../../../../../com/atlassian/application/host/plugin/MockPluginApplicationMetaDataManager.html" title="class in com.atlassian.application.host.plugin">MockPluginApplicationMetaDataManager</a></td>
+<td class="colLast">&nbsp;</td>
+</tr>
+</tbody>
+</table>
+</li>
+</ul>
+</div>
+<!-- ======= START OF BOTTOM NAVBAR ====== -->
+<div class="bottomNav"><a name="navbar.bottom">
+<!--   -->
+</a>
+<div class="skipNav"><a href="#skip.navbar.bottom" title="Skip navigation links">Skip navigation links</a></div>
+<a name="navbar.bottom.firstrow">
+<!--   -->
+</a>
+<ul class="navList" title="Navigation">
+<li><a href="../../../../../overview-summary.html">Overview</a></li>
+<li class="navBarCell1Rev">Package</li>
+<li>Class</li>
+<li><a href="package-use.html">Use</a></li>
+<li><a href="package-tree.html">Tree</a></li>
+<li><a href="../../../../../deprecated-list.html">Deprecated</a></li>
+<li><a href="../../../../../index-all.html">Index</a></li>
+<li><a href="../../../../../help-doc.html">Help</a></li>
+</ul>
+</div>
+<div class="subNav">
+<ul class="navList">
+<li><a href="../../../../../com/atlassian/activeobjects/jira/package-summary.html">Prev&nbsp;Package</a></li>
+<li><a href="../../../../../com/atlassian/configurable/package-summary.html">Next&nbsp;Package</a></li>
+</ul>
+<ul class="navList">
+<li><a href="../../../../../index.html?com/atlassian/application/host/plugin/package-summary.html" target="_top">Frames</a></li>
+<li><a href="package-summary.html" target="_top">No&nbsp;Frames</a></li>
+</ul>
+<ul class="navList" id="allclasses_navbar_bottom">
+<li><a href="../../../../../allclasses-noframe.html">All&nbsp;Classes</a></li>
+</ul>
+<div>
+<script type="text/javascript"><!--
+  allClassesLink = document.getElementById("allclasses_navbar_bottom");
+  if(window==top) {
+    allClassesLink.style.display = "block";
+  }
+  else {
+    allClassesLink.style.display = "none";
+  }
+  //-->
+</script>
+</div>
+<a name="skip.navbar.bottom">
+<!--   -->
+</a></div>
+<!-- ======== END OF BOTTOM NAVBAR ======= -->
+<p class="legalCopy"><small>Copyright &#169; 2002-2020 <a href="https://www.atlassian.com/">Atlassian</a>. All Rights Reserved.</small></p>
+</body>
+</html>
diff --git a/playgrounds.html b/playgrounds.html
new file mode 100644
index 0000000..d026a35
--- /dev/null
+++ b/playgrounds.html
@@ -0,0 +1,916 @@
+<!DOCTYPE html>
+<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US" lang="en-US" prefix="og: http://ogp.me/ns#" class="no-js">
+<head>
+	<meta http-equiv="X-UA-Compatible" content="IE=edge" />
+
+	
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+<meta charset="utf-8" />
+<link rel="canonical" href="https://www.apple.com/swift/playgrounds/" />
+
+
+	
+	<!--no hreflang found-->
+
+
+
+	
+<meta name="viewport" content="width=device-width, initial-scale=1" />
+
+	
+	
+	<link rel="stylesheet" type="text/css" href="/ac/globalnav/6/en_US/styles/ac-globalnav.built.css" />
+	<link rel="stylesheet" type="text/css" href="/ac/localnav/5/styles/ac-localnav.built.css" />
+	<link rel="stylesheet" type="text/css" href="/ac/globalfooter/6/en_US/styles/ac-globalfooter.built.css" />
+	
+
+
+	<title>Swift Playgrounds - Apple</title>
+	<meta name="Description" content="Swift Playgrounds is a new app for iPad that teaches you to write Swift code in a fun, interactive way. Learn the code developers use to build apps." />
+	<meta property="og:url" content="https://www.apple.com/swift/playgrounds/" />
+	<meta property="og:title" content="Swift Playgrounds" />
+	<meta property="og:description" content="Swift Playgrounds is an app for iPad that teaches you to write Swift code in a fun, interactive way. Program robots and drones directly from the app." />
+	<meta property="og:image" content="https://www.apple.com/swift/playgrounds/images/og.png?202002271425" />
+	<meta property="og:type" content="website" />
+	<meta property="og:site_name" content="Apple" />
+	<meta property="og:locale" content="en_US" />
+
+	<meta property="analytics-track" content="swift - playgrounds" />
+	<meta property="analytics-s-channel" content="swift" />
+
+	<meta property="analytics-s-bucket-0" content="appleglobal,applestoreww" />
+	<meta property="analytics-s-bucket-1" content="apple{COUNTRY_CODE}global,applestoreww" />
+	<meta property="analytics-s-bucket-2" content="apple{COUNTRY_CODE}global,applestoreww" />
+
+
+
+	<link rel="stylesheet" href="/wss/fonts?families=SF+Pro,v1|SF+Pro+Icons,v1" type="text/css" media="all" />
+	<link rel="stylesheet" href="/v/swift/playgrounds/e/built/styles/main.built.css" />
+	<script src="/v/swift/playgrounds/e/built/scripts/head.built.js" type="text/javascript" charset="utf-8"></script>
+</head>
+<body class="page-overview ac-nav-overlap">
+	
+<meta name="ac-gn-store-key" content="SFX9YPYY9PPXCU9KH" />
+<aside id="ac-gn-segmentbar" class="ac-gn-segmentbar" lang="en-US" dir="ltr" data-strings="{ 'exit': 'Exit', 'view': '{%STOREFRONT%} Store Home', 'segments': { 'smb': 'Business Store Home', 'eduInd': 'Education Store Home', 'other': 'Store Home' } }">
+</aside>
+<input type="checkbox" id="ac-gn-menustate" class="ac-gn-menustate" />
+<nav id="ac-globalnav" class="no-js" role="navigation" aria-label="Global" data-hires="false" data-analytics-region="global nav" lang="en-US" dir="ltr" data-www-domain="www.apple.com" data-store-locale="us" data-store-root-path="/us" data-store-api="/[storefront]/shop/bag/status" data-search-locale="en_US" data-search-locale="en_US" data-search-suggestions-api="/search-services/suggestions/" data-search-defaultlinks-api="/search-services/suggestions/defaultlinks/">
+	<div class="ac-gn-content">
+		<ul class="ac-gn-header">
+			<li class="ac-gn-item ac-gn-menuicon">
+				<label class="ac-gn-menuicon-label" for="ac-gn-menustate" aria-hidden="true">
+					<span class="ac-gn-menuicon-bread ac-gn-menuicon-bread-top">
+						<span class="ac-gn-menuicon-bread-crust ac-gn-menuicon-bread-crust-top"></span>
+					</span>
+					<span class="ac-gn-menuicon-bread ac-gn-menuicon-bread-bottom">
+						<span class="ac-gn-menuicon-bread-crust ac-gn-menuicon-bread-crust-bottom"></span>
+					</span>
+				</label>
+				<a href="#ac-gn-menustate" role="button" class="ac-gn-menuanchor ac-gn-menuanchor-open" id="ac-gn-menuanchor-open">
+					<span class="ac-gn-menuanchor-label">Global Nav Open Menu</span>
+				</a>
+				<a href="#" role="button" class="ac-gn-menuanchor ac-gn-menuanchor-close" id="ac-gn-menuanchor-close">
+					<span class="ac-gn-menuanchor-label">Global Nav Close Menu</span>
+				</a>
+			</li>
+			<li class="ac-gn-item ac-gn-apple">
+				<a class="ac-gn-link ac-gn-link-apple" href="/" data-analytics-title="apple home" id="ac-gn-firstfocus-small">
+					<span class="ac-gn-link-text">Apple</span>
+				</a>
+			</li>
+			<li class="ac-gn-item ac-gn-bag ac-gn-bag-small" id="ac-gn-bag-small">
+				<div class="ac-gn-bag-wrapper">
+					<a class="ac-gn-link ac-gn-link-bag" href="/us/shop/goto/bag" data-analytics-title="bag" data-analytics-click="bag" aria-label="Shopping Bag" data-string-badge="Shopping Bag with item count :">
+						<span class="ac-gn-link-text">Shopping Bag</span>
+					</a>
+					<span class="ac-gn-bag-badge">
+						<span class="ac-gn-bag-badge-separator"></span>
+					<span class="ac-gn-bag-badge-number"></span>
+					<span class="ac-gn-bag-badge-unit">+</span>
+					</span>
+				</div>
+				<span class="ac-gn-bagview-caret ac-gn-bagview-caret-large"></span>
+			</li>
+		</ul>
+		<div class="ac-gn-search-placeholder-container" role="search">
+			<div class="ac-gn-search ac-gn-search-small">
+				<a id="ac-gn-link-search-small" class="ac-gn-link" href="/us/search" data-analytics-title="search" data-analytics-click="search" data-analytics-intrapage-link aria-label="Search apple.com">
+					<div class="ac-gn-search-placeholder-bar">
+						<div class="ac-gn-search-placeholder-input">
+							<div class="ac-gn-search-placeholder-input-text" aria-hidden="true">
+								<div class="ac-gn-link-search ac-gn-search-placeholder-input-icon"></div>
+								<span class="ac-gn-search-placeholder">Search apple.com</span>
+							</div>
+						</div>
+						<div class="ac-gn-searchview-close ac-gn-searchview-close-small ac-gn-search-placeholder-searchview-close">
+							<span class="ac-gn-searchview-close-cancel" aria-hidden="true">Cancel</span>
+						</div>
+					</div>
+				</a>
+			</div>
+		</div>
+		<ul class="ac-gn-list">
+			<li class="ac-gn-item ac-gn-apple">
+				<a class="ac-gn-link ac-gn-link-apple" href="/" data-analytics-title="apple home" id="ac-gn-firstfocus">
+						<span class="ac-gn-link-text">Apple</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-mac">
+				<a class="ac-gn-link ac-gn-link-mac" href="/mac/" data-analytics-title="mac">
+						<span class="ac-gn-link-text">Mac</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-ipad">
+				<a class="ac-gn-link ac-gn-link-ipad" href="/ipad/" data-analytics-title="ipad">
+						<span class="ac-gn-link-text">iPad</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-iphone">
+				<a class="ac-gn-link ac-gn-link-iphone" href="/iphone/" data-analytics-title="iphone">
+						<span class="ac-gn-link-text">iPhone</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-watch">
+				<a class="ac-gn-link ac-gn-link-watch" href="/watch/" data-analytics-title="watch">
+						<span class="ac-gn-link-text">Watch</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-tv">
+				<a class="ac-gn-link ac-gn-link-tv" href="/tv/" data-analytics-title="tv">
+						<span class="ac-gn-link-text">TV</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-music">
+				<a class="ac-gn-link ac-gn-link-music" href="/music/" data-analytics-title="music">
+						<span class="ac-gn-link-text">Music</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-support">
+				<a class="ac-gn-link ac-gn-link-support" href="https://support.apple.com" data-analytics-title="support">
+						<span class="ac-gn-link-text">Support</span>
+					</a>
+			</li>
+			<li class="ac-gn-item ac-gn-item-menu ac-gn-search" role="search">
+				<a id="ac-gn-link-search" class="ac-gn-link ac-gn-link-search" href="/us/search" data-analytics-title="search" data-analytics-click="search" data-analytics-intrapage-link aria-label="Search apple.com"></a>
+			</li>
+			<li class="ac-gn-item ac-gn-bag" id="ac-gn-bag">
+				<div class="ac-gn-bag-wrapper">
+					<a class="ac-gn-link ac-gn-link-bag" href="/us/shop/goto/bag" data-analytics-title="bag" data-analytics-click="bag" aria-label="Shopping Bag" data-string-badge="Shopping Bag with item count : {%BAGITEMCOUNT%}">
+							<span class="ac-gn-link-text">Shopping Bag</span>
+						</a>
+					<span class="ac-gn-bag-badge" aria-hidden="true">
+								<span class="ac-gn-bag-badge-separator"></span>
+					<span class="ac-gn-bag-badge-number"></span>
+					<span class="ac-gn-bag-badge-unit">+</span>
+					</span>
+				</div>
+				<span class="ac-gn-bagview-caret ac-gn-bagview-caret-large"></span>
+			</li>
+		</ul>
+		<aside id="ac-gn-searchview" class="ac-gn-searchview" role="search" data-analytics-region="search">
+			<div class="ac-gn-searchview-content">
+				<div class="ac-gn-searchview-bar">
+					<div class="ac-gn-searchview-bar-wrapper">
+						<form id="ac-gn-searchform" class="ac-gn-searchform" action="/us/search" method="get">
+							<div class="ac-gn-searchform-wrapper">
+								<input id="ac-gn-searchform-input" class="ac-gn-searchform-input" type="text" aria-label="Search apple.com" placeholder="Search apple.com" autocorrect="off" autocapitalize="off" autocomplete="off" spellcheck="false" role="combobox" aria-autocomplete="list" aria-expanded="true" aria-owns="quicklinks suggestions" />
+								<input id="ac-gn-searchform-src" type="hidden" name="src" value="globalnav" />
+								<button id="ac-gn-searchform-submit" class="ac-gn-searchform-submit" type="submit" disabled aria-label="Submit Search"></button>
+								<button id="ac-gn-searchform-reset" class="ac-gn-searchform-reset" type="reset" disabled aria-label="Clear Search">
+										<span class="ac-gn-searchform-reset-background"></span>
+									</button>
+							</div>
+						</form>
+						<button id="ac-gn-searchview-close-small" class="ac-gn-searchview-close ac-gn-searchview-close-small" aria-label="Cancel Search">
+								<span class="ac-gn-searchview-close-cancel" aria-hidden="true">
+									Cancel
+								</span>
+							</button>
+					</div>
+				</div>
+				<aside id="ac-gn-searchresults" class="ac-gn-searchresults" data-string-quicklinks="Quick Links" data-string-suggestions="Suggested Searches" data-string-noresults=""></aside>
+			</div>
+			<button id="ac-gn-searchview-close" class="ac-gn-searchview-close" aria-label="Cancel Search">
+					<span class="ac-gn-searchview-close-wrapper">
+						<span class="ac-gn-searchview-close-left"></span>
+						<span class="ac-gn-searchview-close-right"></span>
+					</span>
+				</button>
+		</aside>
+		<aside class="ac-gn-bagview" data-analytics-region="bag">
+			<div class="ac-gn-bagview-scrim">
+				<span class="ac-gn-bagview-caret ac-gn-bagview-caret-small"></span>
+			</div>
+			<div class="ac-gn-bagview-content" id="ac-gn-bagview-content">
+			</div>
+		</aside>
+	</div>
+</nav>
+<div class="ac-gn-blur"></div>
+<div id="ac-gn-curtain" class="ac-gn-curtain"></div>
+<div id="ac-gn-placeholder" class="ac-nav-placeholder"></div>
+
+<script type="text/javascript" src="/ac/globalnav/6/en_US/scripts/ac-globalnav.built.js"></script>
+
+	
+
+
+
+<script src="/metrics/ac-analytics/2.10.0/scripts/ac-analytics.js" type="text/javascript" charset="utf-8"></script>
+<script src="/metrics/ac-analytics/2.10.0/scripts/auto-init.js" type="text/javascript" charset="utf-8"></script>
+
+
+	<main class="main" role="main">
+
+		<section class="section section-hero hero section-nopad-bottom" data-analytics-section-engagement="name:hero">
+			<div class="section-content">
+				<div class="hero-wrapper" data-layer-group="headline">
+					<figure class="image-icon-swift"></figure>
+					<h1 class="hero-headline">Swift Playgrounds</h1>
+					<h2 class="hero-subheadline">Learn serious code. In a seriously fun way.</h2>
+					<ul class="hero-ctas typography-intro links-stacked">
+						<li><a href="https://apps.apple.com/app/id1496833156" data-analytics-click="prop3:download swift playgrounds - hero" data-analytics-title="download swift playgrounds" data-analytics-region="learn more" data-analytics-exit-link>Download Swift Playgrounds for Mac<span class="icon icon-after icon-downloadcircle"></span></a></li>
+						<li><a href="https://apps.apple.com/app/id908519492" data-analytics-click="prop3:download swift playgrounds - hero" data-analytics-title="download swift playgrounds" data-analytics-region="learn more" data-analytics-exit-link>Download Swift Playgrounds for iPad<span class="icon icon-after icon-downloadcircle"></span></a></li>
+					</ul>
+				</div>
+			</div>
+
+			<div class="intro">
+				<figure class="intro-wrapper" id="intro-wrapper">
+					<div class="intro-layers">
+						<div class="intro-layer intro-layer-13" data-layer-group="ipad"></div>
+						<div class="intro-layer intro-layer-12" data-layer-group="middle"></div>
+						<div class="intro-layer intro-layer-11" data-layer-group="bottom"></div>
+						<div class="intro-layer intro-layer-10" data-layer-group="top"></div>
+						<div class="intro-layer intro-layer-9" data-layer-group="middle"></div>
+						<div class="intro-layer intro-layer-8" data-layer-group="bottom"></div>
+						<div class="intro-layer intro-layer-7" data-layer-group="middle"></div>
+						<div class="intro-layer intro-layer-6" data-layer-group="water"></div>
+						<div class="intro-layer intro-layer-5" data-layer-group="bottom"></div>
+						<div class="intro-layer intro-layer-4 intro-character" data-layer-group="bottom"></div>
+						<div class="intro-layer intro-layer-3" data-layer-group="ipad"></div>
+						<div class="intro-layer intro-layer-2" data-layer-group="shadow"></div>
+						<div class="intro-layer intro-layer-1" data-layer-group="rock"></div>
+					</div>
+				</figure>
+			</div>
+
+			<div class="hero-content section-content">
+				<p class="hero-copy">Swift Playgrounds is a revolutionary app for iPad and Mac that makes learning Swift interactive and fun. It requires no coding knowledge, so it’s perfect for students just starting out. Solve puzzles to master the basics using Swift — a powerful programming language created by Apple and used by the pros to build today’s most popular apps. Then take on a series of challenges and step up to more advanced playgrounds designed by Apple and other leading developers.</p>
+				<ul class="typography-intro links-stacked">
+					<li><a href="/105/media/us/swift/2016/09fce853-39bd_43d3_a8f8_cab73842d554/films/playground-demo/swift-playground-demo-cc-us-20160620_r848-9dwc.mov" id="video-demo" data-analytics-id="film-swift-demo" data-analytics-title="view swift playgrounds demo">Watch the demo<span class="icon icon-after icon-playcircle"></span></a></li>
+					<li><a href="/swift/" data-analytics-region="learn more" data-analytics-title="learn more about swift" >Learn more about Swift<span class="more"></span></a></li>
+				</ul>
+			</div>
+
+			<div class="hero-banner">
+				<div class="section-content">
+					<figure class="hero-banner-image image-commands-drone"></figure>
+					<div class="column large-6 medium-8 large-centered">
+						<p><strong>Robots and drones await your commands.</strong><br />Now you can make robots do incredible things with code you write yourself. Learn to program connected devices like the Sphero SPRK+, LEGO® MINDSTORMS® EV3, and drones by Parrot, and watch them come alive right before your&nbsp;eyes.</p>
+						<p><a href="#subsection-robots" id="anchorlink-robots" data-analytics-click="prop3:jumplink - find out more about connected devices" data-analytics-title="find out more about connected devices">Find out more about connected devices<span class="icon icon-after icon-chevrondowncircle"></span></a></p>
+					</div>
+					<figure class="hero-banner-image image-commands-robot"></figure>
+				</div>
+			</div>
+		</section>
+
+		<section class="section section-code section-nopad-bottom">
+			<div class="section-content interface-display" data-analytics-section-engagement="name:real codes">
+				<div class="row">
+					<div class="column large-6 large-offset-1 medium-8 medium-offset-0 small-12">
+						<h2 class="section-headline" role="text">Real Swift code.<br />Real simple. Real playful.</h2>
+						<p class="section-copy">Learning to code with Swift Playgrounds is incredibly engaging. The app comes with a complete set of Apple-designed lessons. Play your way through the basics in “Fundamentals of Swift” using real code to guide a character through a 3D world. Then move on to more advanced concepts.</p>
+					</div>
+					<div class="column large-10 large-offset-1 medium-12 medium-offset-0">
+						<figure class="image-real-swift image-padding">
+						</figure>
+						<p class="ipad-hardware-caption"><span class="ipad-hardware-caption-headline">What you see is what you code:</span> Create code on the left side of your screen and instantly see the results on the right — with just a tap.</p>
+					</div>
+				</div>
+			</div>
+
+			<section class="subsection subsection-concepts" data-analytics-section-engagement="name:concepts">
+				<div class="tilegrid">
+					<div class="tilegrid-column tilegrid-column-right tilegrid-column-main">
+						<div class="tilegrid-copy">
+							<h3 class="subsection-headline">Conquer levels, puzzles, and coding concepts.</h3>
+							<p class="subsection-copy">Starting with the “Fundamentals of Swift” lesson, you’ll tackle goals using the same code professional developers use every day. As you move along, more advanced concepts come into play. You’ll continually build on what you’ve learned and create even more complex code.</p>
+						</div>
+					</div>
+					<div class="tilegrid-column tilegrid-column-world">
+						<figure class="image-commands"></figure>
+					</div>
+				</div>
+			</section>
+
+			<section class="subsection subsection-icons">
+				<div class="subsection-icons-caption">
+					<h4>Fundamentals of Swift.</h4>
+					<p>You’ll start out by learning the important concepts you need to understand code.</p>
+				</div>
+				<ul class="icons-list">
+					<li class="icons-item icons-item-commands">
+						<figure class="icons-item-image image-icon-commands"></figure>
+						<p class="icons-item-caption">Commands</p>
+					</li>
+					<li class="icons-item icons-item-functions">
+						<figure class="icons-item-image image-icon-functions"></figure>
+						<p class="icons-item-caption">Functions</p>
+					</li>
+					<li class="icons-item icons-item-loops">
+						<figure class="icons-item-image image-icon-loops"></figure>
+						<p class="icons-item-caption">Loops</p>
+					</li>
+					<li class="icons-item icons-item-parameters">
+						<figure class="icons-item-image image-icon-parameters"></figure>
+						<p class="icons-item-caption">Parameters</p>
+					</li>
+					<li class="icons-item icons-item-conditionals">
+						<figure class="icons-item-image image-icon-conditionals"></figure>
+						<p class="icons-item-caption">Conditional Code</p>
+					</li>
+					<li class="icons-item icons-item-variables">
+						<figure class="icons-item-image image-icon-variables"></figure>
+						<p class="icons-item-caption">Variables</p>
+					</li>
+					<li class="icons-item icons-item-operators">
+						<figure class="icons-item-image image-icon-operators"></figure>
+						<p class="icons-item-caption">Operators</p>
+					</li>
+					<li class="icons-item icons-item-types">
+						<figure class="icons-item-image image-icon-types"></figure>
+						<p class="icons-item-caption">Types</p>
+					</li>
+					<li class="icons-item icons-item-initialization">
+						<figure class="icons-item-image image-icon-initialize"></figure>
+						<p class="icons-item-caption">Initialization</p>
+					</li>
+					<li class="icons-item icons-item-bugfixing">
+						<figure class="icons-item-image image-icon-bug-fixing"></figure>
+						<p class="icons-item-caption">Bug Fixing</p>
+					</li>
+				</ul>
+			</section>
+
+			<section class="subsection subsection-library" data-analytics-section-engagement="name:library">
+				<div class="subsection-content row">
+					<div class="column large-4 large-offset-1 medium-offset-0 medium-9 small-12">
+						<div>
+							<h3 class="subsection-headline" role="text">Master the basics,<br/>then step up to more challenges.</h3>
+							<p class="subsection-copy">In addition to the built-in library of lessons, Swift Playgrounds includes a collection of extra challenges — with new ones added over time. Go deeper on a topic you’ve already studied or try your hand at something new. You’re not just building fun creations, you’re building your skills, too.</p>
+						</div>
+					
+						<figure class="image-master-the-basics image-position image-padding"></figure>
+					
+						<div class="violator-copyblock">
+							<h3 class="subsection-headline">A big world of playgrounds from a big community of developers.</h3>
+							<p class="subsection-copy">Discover dozens of channels with fun new challenges created by leading developers and publishers. Subscribe to your favorites and you’ll receive their latest creations right in the app. Now there are no bounds to your playgrounds.</p>
+						</div>
+					</div>
+				</div>
+
+			</section>
+
+		<section class="section section-ui section-nopad-bottom">
+
+			<div class="section-content interface-display" data-analytics-section-engagement="name:ui interface">
+				<div class="row">
+					<div class="column large-9 large-offset-1 medium-offset-0 small-12">
+						<h2 class="section-headline" role="text">A new way to create code. <br class="section-headline-break" />On the best device for learning.</h2>
+						<p class="section-copy">Easily drag braces around code, wrap existing code in a loop, or choose from dozens of drag-and-drop snippets included in Swift Playgrounds — right from your iPad or Mac. Take full advantage of powerful Multi-Touch, multitasking, and split view capabilities on iPad. Also, enjoy the view from your Mac. The larger screen makes room for a new sidebar with a complete table of contents and quick access to other Swift files. Just tap, drag, or type text and numbers. Then interact with what you’ve created.</p>
+						<figure class="image-new-way image-padding"></figure>
+					</div>
+				</div>
+			</div>
+
+			<section class="subsection subsection-ui-keyboard">
+				<figure class="image-quicktype-coding image-position small-hide"></figure>
+				<div class="keyboard-copyblock">
+					<h3 class="subsection-headline">QuickType and coding keyboard.</h3>
+					<p class="subsection-copy">Write an entire line of code with just a tap. With QuickType for code, the Shortcut Bar automatically and intelligently suggests commands as you go. When typing is the best option, iPad has an innovative keyboard designed for coding. Simply touch a key to access multiple characters, then drag to choose the one you want. Experience similar code suggestions on Mac, which comes with even more help to complete your code.</p>
+					<figure class="image-quicktype-coding small-show"></figure>
+				</div>
+			</section>
+
+			<section class="subsection subsection-ui-features" data-analytics-section-engagement="name:ui features">
+				<div class="tilegrid">
+					<div class="tilegrid-column tilegrid-column-right tilegrid-column-snippets-library">
+						<figure class="image-snippets-library tilegrid-image"></figure>
+						<div class="tilegrid-caption tilegrid-caption-aligned">
+							<h4>Snippets Library.</h4>
+							<p>Quickly drag commonly used pieces of code from the Snippets Library to minimize typing.</p>
+						</div>
+					</div>
+					<div class="tilegrid-column tilegrid-column-boundaries-code">
+						<figure class="image-boundaries-code tilegrid-image"></figure>
+						<div class="tilegrid-caption tilegrid-caption-aligned">
+							<h4>Touch to edit.</h4>
+							<p>Conveniently drag the boundaries of a statement around existing code.</p>
+						</div>
+					</div>
+				</div>
+			</section>
+
+			
+
+			<section class="subsection subsection-ui-code">
+				<div class="subsection-content">
+					<div class="code-copyblock">
+						<h3 class="subsection-headline">Help is just a tap away.</h3>
+						<p class="subsection-copy">If you come across a command that’s hard to understand, simply tap it and hold. A menu of options will appear. Choose the most relevant one and get the answer you need.</p>
+					</div>
+					<figure class="image-code us-image-code-center-small"></figure>
+				</div>
+			</section>
+
+			<section class="subsection subsection-ui-templates" data-analytics-section-engagement="name:ui templates">
+				<div class="subsection-content jump-start">
+					<div class="subsection-image image-left">
+						<figure class="image-jump-start"></figure>
+					</div>
+					<div class="subsection-copy-block">
+						<h2 class="subsection-headline">Jump-start your creativity with Starting Points.</h2>
+						<p class="subsection-copy">Use what you’ve learned to create something brand new. With Starting Points, you can get a head start on more advanced coding, add multiple files to your playground at once, and use iPad features such as Multi-Touch interactions, accelerometer, and gyroscope. Personalize your project by adding graphics, audio, and more. Then easily share with friends, family, or the world. Students can also share code with classmates when teachers use Starting Points to create lessons.</p>
+					</div>
+					<div class="subsection-image image-bottom">
+						<figure class="image-jump-start"></figure>
+					</div>
+				</div>
+				<div class="subsection-content explore">
+					<div class="subsection-copy-block large-5 medium-offset-0 small-12">
+						<h2 class="subsection-headline">Explore your creations in full screen.</h2>
+						<p class="subsection-copy">Immerse yourself by using the vivid Retina displays of iPad or Mac. Simply tap the center divider, then drag to view your code or live project on the full screen. You can also customize built-in games like Battleship and Brick Breaker, then immerse yourself by letting them take up the whole screen.</p>
+					</div>
+					<div class="subsection-image">
+						<figure class="image-explore-creation"></figure>
+					</div>
+				</div>
+			</section>
+			<section id="subsection-robots" class="subsection subsection-robots" data-analytics-section-engagement="name:robots">
+				<div class="subsection-content row">
+					<div class="column large-centered large-9 medium-12">
+						<h2 class="subsection-headline">See your code crawl, roll, or fly through the sky.</h2>
+						<div class="subsection-copy">
+							<p>Watch your code spring to life by programming real robots, musical instruments, and drones. The Accessories channel is filled with engaging playgrounds that let you configure and control popular educational toys like LEGO® MINDSTORMS® EV3. And that’s just the beginning. </p>
+						</div>
+					</div>
+				</div>
+				<div class="tilegrid">
+					<div class="tilegrid-column tilegrid-column-1 tilegrid-column-sphero">
+						<div class="tilegrid-image-container">
+							<figure class="tilegrid-image image-sphero"></figure>
+						</div>
+						<div class="tilegrid-copy">
+							<p class="subsection-copy">Sphero playgrounds let you guide this spherical robot through tricky courses, accelerate over jumps, and change colors.</p>
+						</div>
+					</div>
+					<div class="tilegrid-column tilegrid-column-1 tilegrid-column-dot-dash">
+						<div class="tilegrid-image-container">
+							<figure class="tilegrid-image image-dot-dash"></figure>
+						</div>
+						<div class="tilegrid-copy">
+							<p class="subsection-copy">Dash playgrounds challenge you to make it sing, dance and respond to sensor inputs to react to their environment.</p>
+						</div>
+					</div>
+				</div>
+				<div class="tilegrid">
+					<div class="tilegrid-column tilegrid-column-2 tilegrid-column-jimu">
+						<div class="tilegrid-image-container">
+							<figure class="tilegrid-image image-jimu"></figure>
+						</div>
+						<div class="tilegrid-copy">
+							<p class="subsection-copy">MeeBot playgrounds guide you through coding Jimu Robot Meebot’s six robotic servo motors to make him move in lifelike ways. Or even dance.</p>
+						</div>
+					</div>
+					<div class="tilegrid-column tilegrid-column-2 tilegrid-column-tello">
+						<div class="tilegrid-image-container">
+							<figure class="tilegrid-image image-tello"></figure>
+						</div>
+						<div class="tilegrid-copy">
+							<p class="subsection-copy">Tello EDU playgrounds let you command multiple Tello drones to fly in a swarm, perform flips and other acrobatic movements, and push the limits of your creativity.</p>
+						</div>
+					</div>
+				</div>
+				<div class="subsection-content row row-link">
+					<div class="large-4 medium-6 small-12 large-centered">
+						<p>Explore robots, drones, and many other connected devices that support Swift Playgrounds.</p>
+						<p><a href="/us/shop/goto/accessories/all_accessories/toys_games" data-analytics-title="shop devices" data-analytics-region="buy">Shop devices<span class="more"></span></a></p>
+					</div>
+				</div>
+			</section>
+		</section>
+
+		</section>
+
+		<section class="section section-share" data-analytics-section-engagement="name:share">
+			<div class="section-content">
+				<div class="row">
+					<div class="column large-9 large-offset-1 medium-offset-0 small-12">
+						<h2 class="section-headline" role="text">Share your creation with<br class="section-headline-break" /> a friend. Or the world.</h2>
+						<p class="section-copy">Send your code to a friend’s iPad using Mail, Messages, or AirDrop. Your friends can view it in Swift Playgrounds and even build on it by adding their own twists. You can also post a video of your running program to the web for the world to see.</p>
+						<figure class="image-share-creation image-padding">
+						</figure>
+					</div>
+				</div>
+			</div>
+
+			<section class="subsection subsection-share-xcode">
+				<div class="subsection-content row">
+					<div class="column large-5 large-offset-1 medium-offset-0 small-12">
+						<h3 class="subsection-headline" role="text">Take things to Xcode.<br />Then take them further.</h3>
+						<p class="subsection-copy">Because you’re working with real code, you can import and export directly between Swift Playgrounds and Xcode. So you can try out your ideas with the tool pros use to develop iOS and Mac apps.</p>
+					</div>
+					<div class="column large-5 large-offset-1 small-offset-0 small-12 ">
+						<h3 class="subsection-headline" role="text">Code is universal. So we teach it in many languages.</h3>			
+						<p class="subsection-copy">Swift Playgrounds is now available in 15 languages — Castilian and Latin American Spanish, Brazilian Portuguese, Traditional and Simplified Chinese, English, German, French, Italian, Korean, Japanese, Thai, Turkish, Dutch, and Swedish. Because we believe that everybody, everywhere should be able to learn to code.</p>
+					</div>
+				</div>
+			</section>
+		</section>
+
+		<section class="section section-router section-nopad" data-analytics-section-engagement="name:router" data-analytics-region="router">
+			<div class="teaser section-content">
+				<figure class="image-icon-swift"></figure>
+				<h3 class="teaser-headline">Swift Playgrounds</h3>
+				<ul class="typography-intro links-stacked">
+					<li>
+						<a href="https://apps.apple.com/app/id1496833156" data-analytics-click="prop3:download swift playgrounds - router" data-analytics-title="download swift playgrounds" data-analytics-region="learn more" data-analytics-exit-link>Download Swift Playgrounds for Mac<span class="icon icon-after icon-downloadcircle"></span></a>
+					</li>
+					<li>
+						<a href="https://apps.apple.com/app/id908519492" data-analytics-click="prop3:download swift playgrounds - router" data-analytics-title="download swift playgrounds" data-analytics-region="learn more" data-analytics-exit-link>Download Swift Playgrounds for iPad<span class="icon icon-after icon-downloadcircle"></span></a>
+					</li>
+				</p>
+			</div>
+
+			<footer id="footer" class="footer">
+				<div class="footer-content">
+					<section class="footer-buystrip with-3-columns">
+						<section class="footer-buystrip-column">
+							<div class="footer-buystrip-content">
+								<a href="/everyone-can-code/" class="block" data-analytics-title="learn more about everyone can code" data-analytics-region="learn more">
+									<h5 class="footer-buystrip-title">Everyone Can Code</h5>
+									<p class="footer-buystrip-copy">A program that gives everyone the power to learn, write, and teach code.</p>
+									<span class="block-link footer-buystrip-cta more">Learn more</span>
+								</a>
+							</div>
+						</section>
+						<section class="footer-buystrip-column">
+							<div class="footer-buystrip-content">
+								<a href="https://search.itunes.apple.com/WebObjects/MZContentLink.woa/wa/link?path=appdevswift&v0=www-us-swift-itunes-book-app-development-with-swift" class="block" data-analytics-title="learn more about app development with swift" data-analytics-region="learn more" data-analytics-exit-link>
+									<h5 class="footer-buystrip-title">App Development with Swift</h5>
+									<p class="footer-buystrip-copy">A comprehensive guide that will help you build an app of your own from the ground up.</p>
+									<span class="block-link footer-buystrip-cta icon icon-after icon-external">View in Apple Books</span>
+								</a>
+							</div>
+						</section>
+						<section class="footer-buystrip-column">
+							<div class="footer-buystrip-content">
+								<a href="/education/teaching-code/" class="block" data-analytics-title="learn more about teaching code" data-analytics-region="learn more">
+									<h5 class="footer-buystrip-title">Teaching code in schools</h5>
+									<p class="footer-buystrip-copy">Find out how Apple is making it easy to teach coding in your classroom.</p>
+									<span class="block-link footer-buystrip-cta more">Learn more</span>
+								</a>
+							</div>
+						</section>
+					</section>
+				</div>
+			</footer>
+		</section>
+
+	</main>
+
+	<footer id="ac-globalfooter" class="no-js" lang="en-US" data-analytics-region="global footer" role="contentinfo" aria-labelledby="ac-gf-label">
+		<div class="ac-gf-content">
+			<h2 class="ac-gf-label" id="ac-gf-label">Apple Footer</h2>
+
+			<section class="ac-gf-sosumi">
+				<ul>
+					<li>Features are subject to change. Some features may not be available in all regions or all languages.</li>
+				</ul>
+			</section>
+			<nav class="ac-gf-breadcrumbs" aria-label="Breadcrumbs" role="navigation">
+				<a href="/" class="home ac-gf-breadcrumbs-home">
+					<span class="ac-gf-breadcrumbs-home-icon" aria-hidden="true"></span>
+					<span class="ac-gf-breadcrumbs-home-label">Apple</span>
+					<span class="ac-gf-breadcrumbs-home-chevron"></span>
+					<span class="ac-gf-breadcrumbs-home-mask"></span>
+				</a>
+				<div class="ac-gf-breadcrumbs-path">
+					<ol class="ac-gf-breadcrumbs-list" vocab="http://schema.org/" typeof="BreadcrumbList">
+						<li class="ac-gf-breadcrumbs-item" property="itemListElement" typeof="ListItem"><a class="ac-gf-breadcrumbs-link" href="/swift/" property="item" typeof="WebPage" ><span property="name">Swift</span></a><meta property="position" content="1" /></li>
+						<li class="ac-gf-breadcrumbs-item" property="itemListElement" typeof="ListItem"><span property="name">Swift Playgrounds</span><meta property="position" content="2" /></li>
+					</ol>
+				</div>
+			</nav>
+			<nav class="ac-gf-directory with-5-columns" aria-label="Apple Directory" role="navigation">
+	<!--googleoff: all-->
+	<div class="ac-gf-directory-column"><input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-products" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-products">
+		<h3 class="ac-gf-directory-column-section-title">Shop and Learn</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-products" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/mac/" data-analytics-title="mac">Mac</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/ipad/" data-analytics-title="ipad">iPad</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/iphone/" data-analytics-title="iphone">iPhone</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/watch/" data-analytics-title="watch">Watch</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/tv/" data-analytics-title="tv">TV</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/music/" data-analytics-title="music">Music</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/airpods/" data-analytics-title="airpods">AirPods</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/homepod/" data-analytics-title="homepod">HomePod</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/ipod-touch/" data-analytics-title="ipod touch">iPod touch</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/buy_accessories" data-analytics-title="accessories">Accessories</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/giftcards" data-analytics-title="gift cards">Gift Cards</a></li>
+			</ul>
+		</div>
+	</div>
+	<div class="ac-gf-directory-column">
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-services" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-services">
+		<h3 class="ac-gf-directory-column-section-title">Services</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-services" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-music/" data-analytics-title="apple music">Apple Music</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-news/" data-analytics-title="apple news plus">Apple News+</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-tv-plus/" data-analytics-title="apple tv plus">Apple TV+</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-arcade/" data-analytics-title="apple arcade">Apple Arcade</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-books/" data-analytics-title="apple books">Apple Books</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-card/" data-analytics-title="apple card">Apple Card</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/icloud/" data-analytics-title="icloud">iCloud</a></li>
+			</ul>
+		</div>
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-accounts" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-accounts">
+		<h3 class="ac-gf-directory-column-section-title">Account</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-accounts" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="https://appleid.apple.com/us/" data-analytics-title="manage your apple id" data-analytics-exit-link>Manage Your Apple ID</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/account" data-analytics-title="apple store account">Apple Store Account</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="https://www.icloud.com" data-analytics-title="icloud.com" data-analytics-exit-link>iCloud.com</a></li>
+			</ul>
+		</div>
+	</div>
+	<div class="ac-gf-directory-column"><input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-storeservices" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-storeservices">
+		<h3 class="ac-gf-directory-column-section-title">Apple Store</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-storeservices" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/retail/" data-analytics-title="find a store">Find a Store</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/shop" data-analytics-title="shop online">Shop Online</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/retail/geniusbar/" data-analytics-title="genius bar">Genius Bar</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/today/" data-analytics-title="today at apple">Today at Apple</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/today/camp/" data-analytics-title="apple camp">Apple Camp</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/retail/fieldtrip/" data-analytics-title="field trip">Field Trip</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="https://itunes.apple.com/app/apple-store/id375380948?pt&#x3D;2003&amp;ct&#x3D;footer&amp;mt&#x3D;8" data-analytics-title="apple store app" data-analytics-exit-link>Apple Store App</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/special_deals" data-analytics-title="refurbished and clearance">Refurbished and Clearance</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/payment_plan" data-analytics-title="financing">Financing</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/trade_in" data-analytics-title="apple trade in">Apple Trade In</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/order/list" data-analytics-title="order status">Order Status</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/help" data-analytics-title="shopping help">Shopping Help</a></li>
+			</ul>
+		</div>
+	</div>
+	<div class="ac-gf-directory-column">
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-business" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-business">
+		<h3 class="ac-gf-directory-column-section-title">For Business</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-business" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/business/" data-analytics-title="apple and business">Apple and Business</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/retail/business/" data-analytics-title="shop for business">Shop for Business</a></li>
+			</ul>
+		</div>
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-education" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-education">
+		<h3 class="ac-gf-directory-column-section-title">For Education</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-education" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/education/" data-analytics-title="apple and education">Apple and Education</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/education/k12/how-to-buy/" data-analytics-title="shop for k12">Shop for K-12</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/educationrouting" data-analytics-title="shop for college">Shop for College</a></li>
+			</ul>
+		</div>
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-healthcare" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-healthcare">
+		<h3 class="ac-gf-directory-column-section-title">For Healthcare</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-healthcare" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/healthcare/" data-analytics-title="apple in healthcare">Apple in Healthcare</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/healthcare/apple-watch/" data-analytics-title="health on apple watch">Health on Apple Watch</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/healthcare/health-records/" data-analytics-title="health records on iphone">Health Records on iPhone</a></li>
+			</ul>
+		</div>
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-government" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-government">
+		<h3 class="ac-gf-directory-column-section-title">For Government</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-government" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/r/store/government/" data-analytics-title="shop for government">Shop for Government</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/us/shop/goto/eppstore/veteransandmilitary" data-analytics-title="shop for veterans and military">Shop for Veterans and Military</a></li>
+			</ul>
+		</div>
+	</div>
+	<div class="ac-gf-directory-column">
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-responsibility" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-responsibility">
+		<h3 class="ac-gf-directory-column-section-title">Apple Values</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-responsibility" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/accessibility/" data-analytics-title="accessibility">Accessibility</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/education/connectED/" data-analytics-title="education">Education</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/environment/" data-analytics-title="environment">Environment</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/diversity/" data-analytics-title="inclusion and diversity">Inclusion and Diversity</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/privacy/" data-analytics-title="privacy">Privacy</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/supplier-responsibility/" data-analytics-title="supplier responsibility">Supplier Responsibility</a></li>
+			</ul>
+		</div>
+		<input class="ac-gf-directory-column-section-state" type="checkbox" id="ac-gf-directory-column-section-state-about" />
+		<div class="ac-gf-directory-column-section">
+			<label class="ac-gf-directory-column-section-label" for="ac-gf-directory-column-section-state-about">
+		<h3 class="ac-gf-directory-column-section-title">About Apple</h3>
+	</label>
+			<a href="#ac-gf-directory-column-section-state-about" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-open">
+		<span class="ac-gf-directory-column-section-anchor-label">Open Menu</span>
+	</a>
+			<a href="#" class="ac-gf-directory-column-section-anchor ac-gf-directory-column-section-anchor-close">
+		<span class="ac-gf-directory-column-section-anchor-label">Close Menu</span>
+	</a>
+			<ul class="ac-gf-directory-column-section-list">
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/newsroom/" data-analytics-title="newsroom">Newsroom</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/leadership/" data-analytics-title="apple leadership">Apple Leadership</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/jobs/us/" data-analytics-title="job opportunities">Job Opportunities</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="https://investor.apple.com/" data-analytics-title="investors" data-analytics-exit-link>Investors</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/apple-events/" data-analytics-title="events">Events</a></li>
+				<li class="ac-gf-directory-column-section-item"><a class="ac-gf-directory-column-section-link" href="/contact/" data-analytics-title="contact apple">Contact Apple</a></li>
+			</ul>
+		</div>
+	</div>
+	<!--googleon: all-->
+</nav>
+
+<section class="ac-gf-footer">
+	<div class="ac-gf-footer-shop" x-ms-format-detection="none">
+		More ways to shop: <a href="/retail/" data-analytics-title="find an apple store">Find an Apple Store</a> or <a href="https://locate.apple.com/" data-analytics-title="other retailers or resellers" data-analytics-exit-link>other retailer</a> near you. <span class="nowrap">Or call 1-800-MY-APPLE.</span>
+	</div>
+	<div class="ac-gf-footer-locale">
+		<a class="ac-gf-footer-locale-link" href="/choose-country-region/" title="Choose your country or region" aria-label="United States. Choose your country or region" data-analytics-title="choose your country"><span class="ac-gf-footer-locale-flag" data-hires="false"></span>United States</a>
+	</div>
+	<div class="ac-gf-footer-legal">
+		<div class="ac-gf-footer-legal-copyright">Copyright ©
+			
+			2020
+			Apple Inc. All rights reserved.</div>
+		<div class="ac-gf-footer-legal-links">
+			<a class="ac-gf-footer-legal-link" href="/legal/privacy/" data-analytics-title="privacy policy">Privacy Policy</a>
+			<a class="ac-gf-footer-legal-link" href="/legal/internet-services/terms/site.html" data-analytics-title="terms of use">Terms of Use</a>
+			<a class="ac-gf-footer-legal-link" href="/us/shop/goto/help/sales_refunds" data-analytics-title="sales and refunds">Sales and Refunds</a>
+			<a class="ac-gf-footer-legal-link" href="/legal/" data-analytics-title="legal">Legal</a>
+			<a class="ac-gf-footer-legal-link" href="/sitemap/" data-analytics-title="site map">Site Map</a>
+		</div>
+	</div>
+</section>
+
+<script type="text/javascript" src="/ac/globalfooter/6/en_US/scripts/ac-globalfooter.built.js"></script>
+<script type="application/ld+json">
+	{
+		"@context": "http://schema.org",
+		"@id": "https://www.apple.com/#organization",
+		"@type": "Organization",
+		"name": "Apple",
+		"url": "https://www.apple.com/",
+		"logo": "https://www.apple.com/ac/structured-data/images/knowledge_graph_logo.png?202002271425",
+		"subOrganization": {
+			"@type": "Organization",
+			"name": "Apple Support",
+			"url": "https://support.apple.com",
+	    "@id": "https://support.apple.com/#organization"
+		},
+		"contactPoint": [
+			{
+				"@type": "ContactPoint",
+				"telephone": "+1-800-692-7753",
+				"contactType": "sales",
+				"areaServed": "US"
+			},
+			{
+				"@type": "ContactPoint",
+				"telephone": "+1-800-275-2273",
+				"contactType": "technical support",
+				"areaServed": "US",
+				"availableLanguage": ["EN", "ES"]
+			},
+			{
+				"@type": "ContactPoint",
+				"telephone": "+1-800-275-2273",
+				"contactType": "customer support",
+				"areaServed": "US",
+				"availableLanguage": ["EN", "ES"]
+			}
+		],
+		"sameAs": [
+			"http://www.wikidata.org/entity/Q312",
+			"https://www.youtube.com/user/Apple",
+			"https://www.linkedin.com/company/apple",
+			"https://www.facebook.com/Apple",
+			"https://www.twitter.com/Apple"
+		]
+	}
+</script>
+
+<script type="text/javascript" src="/ac/localeswitcher/3/en_US/scripts/localeswitcher.built.js"></script>
+
+		</div>
+	</footer>
+
+	<script src="/v/swift/playgrounds/e/built/scripts/main.built.js" type="text/javascript" charset="utf-8"></script>
+</body>
+</html>
--
Working Copy 4.2.7

